Clustering O 0 1.1295254864762683e-07
of O 0 2.6578813816513502e-08
missense O 0 8.498382157995366e-07
mutations O 0 2.7041121342108454e-08
in O 0 6.988820078213109e-10
the O 0 5.05530088901196e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 1 0.916037917137146
in O 0 6.472132696444532e-08
a O 0 1.7253606321432358e-09
sporadic B-Disease 0 4.4472778881754493e-07
T I-Disease 0 4.126971361984033e-06
- I-Disease 0 1.3739650057686958e-06
cell I-Disease 0 0.005621382500976324
leukaemia I-Disease 1 0.9998248219490051
. O 0 1.7119280215638355e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.9027444550512307e-11
is O 0 9.243792797181127e-13
a O 0 5.131864551366494e-12
recessive B-Disease 0 6.341637970308511e-08
multi I-Disease 0 1.6362231463062926e-06
- I-Disease 0 3.3989056191785494e-07
system I-Disease 0 3.6817344728490298e-09
disorder I-Disease 0 8.871057275428029e-07
caused O 0 6.037980115891628e-10
by O 0 2.5360612047886644e-12
mutations O 0 1.4251774760332125e-10
in O 0 1.0882117255917034e-11
the O 0 9.398616607203536e-11
ATM O 0 9.789610899701984e-09
gene O 0 9.433697156779886e-10
at O 0 1.3021178801864153e-08
11q22 O 0 5.8703729877152e-08
- O 0 6.460179058365156e-09
q23 O 0 2.981532531975972e-08
( O 0 1.945216904220004e-10
ref O 0 1.6803571867285427e-08
. O 0 1.3316746594327356e-09
3 O 0 1.7938251772875446e-08
) O 0 1.691769724310177e-09
. O 0 3.126503145267634e-08

The O 0 4.914038242986862e-08
risk O 0 2.468804893851484e-07
of O 0 1.1559167489849642e-07
cancer B-Disease 0 3.944885520468233e-06
, O 0 2.8481568214999697e-09
especially O 0 1.8272007196173945e-07
lymphoid B-Disease 1 0.9796484112739563
neoplasias I-Disease 1 1.0
, O 0 2.066782966991809e-09
is O 0 3.2839392316574845e-10
substantially O 0 3.6059898178564254e-08
elevated O 0 1.8982782989951374e-07
in O 0 1.0739282352290047e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.043044986521636e-07
and O 0 3.786097269031785e-10
has O 0 1.9577221788136256e-11
long O 0 6.4405945854328905e-12
been O 0 2.5380450779238783e-12
associated O 0 8.901402531735769e-11
with O 0 1.8631762799259377e-10
chromosomal O 1 1.0
instability O 1 1.0
. O 0 4.389437435747823e-07

By O 0 3.908771972760405e-09
analysing O 0 7.132107384677511e-07
tumour B-Disease 1 1.0
DNA O 0 1.8153025749256813e-08
from O 0 5.970402505717232e-10
patients O 0 2.285833848592045e-11
with O 0 4.518069945946834e-12
sporadic B-Disease 0 1.7162493293199077e-07
T I-Disease 0 9.131676961260382e-07
- I-Disease 0 2.796103331093036e-07
cell I-Disease 0 0.0005047160666435957
prolymphocytic I-Disease 0 0.0030213987920433283
leukaemia I-Disease 1 0.9997534155845642
( O 0 6.54548304446223e-10
T B-Disease 0 9.199351325150928e-08
- I-Disease 0 3.411712867773531e-08
PLL I-Disease 0 1.383950092304076e-07
) O 0 1.0086142858412028e-11
, O 0 1.0349892600944322e-12
a O 0 4.701240698817832e-12
rare O 0 3.525874869847456e-10
clonal B-Disease 0 1.1582284997757597e-07
malignancy I-Disease 0 1.1748568340408383e-07
with O 0 2.7909407424031585e-11
similarities O 0 4.044967472083272e-09
to O 0 7.558763615023167e-10
a O 0 1.2814315830667056e-08
mature B-Disease 0 6.376520786943729e-07
T I-Disease 0 2.7155920179211535e-06
- I-Disease 0 3.2727749044170196e-07
cell I-Disease 0 7.465422413588385e-07
leukaemia I-Disease 0 8.132229595503304e-06
seen O 0 4.837894529430287e-10
in O 0 1.3580371549526404e-10
A B-Disease 1 1.0
- I-Disease 1 0.9845178723335266
T I-Disease 1 1.0
, O 0 1.60969751417106e-10
we O 0 1.1602439495272954e-11
demonstrate O 0 2.5432123421098574e-11
a O 0 1.7106720553994315e-11
high O 0 1.1799304588944182e-10
frequency O 0 2.376330243691882e-10
of O 0 1.0644874981480257e-09
ATM O 0 1.2395162229950074e-06
mutations O 0 1.7694881648822047e-07
in O 0 1.5812925369118602e-07
T B-Disease 0 0.00020950539328623563
- I-Disease 0 0.00016262891585938632
PLL I-Disease 0 0.0002920200058724731
. O 0 5.726400900130102e-07

In O 0 3.867568487692097e-09
marked O 0 1.2194898424411349e-08
contrast O 0 6.792711948477859e-10
to O 0 1.435730839771665e-10
the O 0 1.3562673206735099e-09
ATM O 0 2.479408465205779e-07
mutation O 0 1.901969914896995e-09
pattern O 0 1.0146011142353473e-08
in O 0 1.4014807092621595e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 6.222201087702217e-10
the O 0 6.681902947613949e-11
most O 0 2.920570252654131e-12
frequent O 0 6.532754805860241e-12
nucleotide O 0 2.838554565010032e-11
changes O 0 2.0341717893446187e-11
in O 0 3.867003939284075e-11
this O 0 8.872353962630086e-10
leukaemia B-Disease 0 8.9316199591849e-05
were O 0 1.839063479280867e-08
missense O 0 1.1649043472061749e-06
mutations O 0 5.149141202309693e-07
. O 0 2.97967744700145e-07

These O 0 1.4466229991683122e-08
clustered O 0 2.876097582316106e-08
in O 0 6.515162714881839e-11
the O 0 4.537574482821327e-10
region O 0 6.098083149552735e-10
corresponding O 0 1.7839149601961424e-10
to O 0 5.163858785017794e-10
the O 0 1.895802803630886e-08
kinase O 0 9.812212056203862e-07
domain O 0 5.814521841784881e-08
, O 0 4.3794354254167445e-10
which O 0 9.735934974886007e-11
is O 0 9.931709621380236e-11
highly O 0 7.837190896253787e-10
conserved O 0 1.7458384737878418e-09
in O 0 1.9809738571741065e-10
ATM O 0 6.603598734500338e-08
- O 0 5.1261004330172e-09
related O 0 1.5682044551823537e-09
proteins O 0 4.6770944756024946e-11
in O 0 2.1094750946026863e-11
mouse O 0 3.708401363766711e-10
, O 0 3.717216118248601e-11
yeast O 0 8.433294618193088e-10
and O 0 1.7687769304775003e-10
Drosophila O 0 2.1234769498335027e-09
. O 0 9.547707513490877e-09

The O 0 4.220810012611764e-07
resulting O 0 3.273780464496667e-07
amino O 0 4.839592406824522e-07
- O 0 3.470877274480699e-08
acid O 0 8.333028489460048e-09
substitutions O 0 7.735903584382697e-10
are O 0 1.6859182452866328e-11
predicted O 0 8.486947811192636e-10
to O 0 2.383488684198909e-10
interfere O 0 4.392990415880149e-09
with O 0 7.274267854739946e-10
ATP O 0 1.5491274325540871e-06
binding O 0 4.2071697237133776e-08
or O 0 4.6267372155739395e-09
substrate O 0 3.512581159270667e-08
recognition O 0 5.2824212559698935e-08
. O 0 1.147929182820917e-07

Two O 0 1.1003858269020839e-08
of O 0 5.788683665741701e-08
seventeen O 0 1.1408602773599341e-07
mutated O 0 2.6898533178609796e-07
T B-Disease 0 4.888181592832552e-07
- I-Disease 0 1.5532087616065837e-07
PLL I-Disease 0 4.0696642145121587e-07
samples O 0 1.1820574519205707e-09
had O 0 2.898320194955062e-10
a O 0 3.1304007996890704e-11
previously O 0 1.3343894045281246e-10
reported O 0 3.1274318690321934e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999966621398926
T I-Disease 1 1.0
allele O 0 5.076001912129868e-07
. O 0 7.780674593504955e-08

In O 0 1.4193086705915903e-08
contrast O 0 4.0666218836804546e-08
, O 0 7.323969208883341e-10
no O 0 8.42597880357232e-10
mutations O 0 7.97244936734387e-09
were O 0 4.554969457171154e-10
detected O 0 2.686585176547851e-09
in O 0 1.3437730095322564e-10
the O 0 4.206188730648819e-09
p53 O 0 1.1455304260721277e-08
gene O 0 1.0311725695544283e-08
, O 0 3.0706706066752076e-09
suggesting O 0 5.9428542087403e-09
that O 0 9.051517868563508e-11
this O 0 1.254801706984665e-09
tumour B-Disease 1 1.0
suppressor O 0 5.6466098612872884e-05
is O 0 1.046025155382324e-09
not O 0 3.759744182652014e-10
frequently O 0 1.5555555732404969e-09
altered O 0 5.958051829679789e-09
in O 0 4.707939038617326e-10
this O 0 8.279512186959437e-09
leukaemia B-Disease 0 0.00023994753428269178
. O 0 2.0296218394832977e-07

Occasional O 0 2.679596718735411e-06
missense O 0 2.4202513486670796e-06
mutations O 0 7.326909923222047e-08
in O 0 2.5451558638422966e-09
ATM O 0 1.6929297999013215e-06
were O 0 3.3265699084239486e-09
also O 0 6.790066425788055e-11
found O 0 3.7949227094102866e-11
in O 0 9.62702417783845e-11
tumour B-Disease 1 1.0
DNA O 0 1.0204700195970418e-08
from O 0 9.92932847054817e-10
patients O 0 4.16731128771719e-11
with O 0 2.5721405907952466e-11
B B-Disease 0 9.778547394034831e-08
- I-Disease 0 1.4720128227452278e-08
cell I-Disease 0 4.275496394257061e-06
non I-Disease 1 0.9999741315841675
- I-Disease 1 0.9998975992202759
Hodgkins I-Disease 1 0.9999880790710449
lymphomas I-Disease 0 1.2730557727991254e-06
( O 0 3.647379065441214e-10
B B-Disease 0 2.13592432629639e-08
- I-Disease 0 1.281245221029792e-09
NHL I-Disease 0 6.37503617326729e-05
) O 0 3.2508329361746746e-11
and O 0 4.1973851477861146e-11
a O 0 5.468976937983427e-10
B B-Disease 0 1.778535185792407e-08
- I-Disease 0 2.0070116679704597e-09
NHL I-Disease 0 0.05861234292387962
cell O 0 1.4503712918667588e-05
line O 0 4.001444267487386e-06
. O 0 3.192226571968604e-08

The O 0 3.4328733189425975e-09
evidence O 0 4.550976928641148e-09
of O 0 2.739514448624192e-10
a O 0 1.582731862237452e-11
significant O 0 4.628676608664506e-10
proportion O 0 1.946539152086757e-09
of O 0 4.465948444387635e-10
loss O 0 1.5893432125935192e-09
- O 0 2.5296251759954202e-09
of O 0 4.565285109947581e-07
- O 0 4.915582607623037e-09
function O 0 6.260721108208855e-11
mutations O 0 3.510981783083622e-11
and O 0 7.521016144942938e-13
a O 0 6.523823907304827e-13
complete O 0 1.0138373647550214e-11
absence O 0 2.41449904514468e-09
of O 0 5.668526981139621e-09
the O 0 1.2005462179942583e-09
normal O 0 8.107559623660165e-10
copy O 0 6.046843026297211e-10
of O 0 2.71197064805051e-10
ATM O 0 4.930268193703569e-09
in O 0 1.753408702953596e-11
the O 0 6.563369986389844e-11
majority O 0 8.695479232490033e-12
of O 0 3.2214417244880167e-10
mutated O 0 1.121827835959266e-06
tumours B-Disease 1 1.0
establishes O 0 8.97153373813353e-09
somatic O 0 3.4228328615881765e-08
inactivation O 0 3.122450564774226e-08
of O 0 3.3192160131534365e-10
this O 0 1.3376222872396593e-11
gene O 0 3.869408959911169e-11
in O 0 1.6798909485693514e-10
the O 0 1.0507041903196068e-09
pathogenesis O 0 2.958047844003886e-06
of O 0 3.560934658253245e-08
sporadic B-Disease 0 3.6667818221758353e-06
T I-Disease 0 2.5936147721949965e-05
- I-Disease 0 6.200258940225467e-05
PLL I-Disease 0 0.0032896273769438267
and O 0 1.2034997887155896e-08
suggests O 0 1.018005058028848e-08
that O 0 6.89286475119566e-11
ATM O 0 5.818371207055861e-08
acts O 0 3.929613079378669e-09
as O 0 4.9973745142040116e-09
a O 0 6.085794979071579e-08
tumour B-Disease 1 1.0
suppressor O 0 0.0013970190193504095
. O 0 7.02785200701328e-07

As O 0 3.319523500522337e-08
constitutional O 0 2.1475297984352437e-08
DNA O 0 7.45406936175641e-08
was O 0 6.021021015101269e-09
not O 0 1.2533556657812195e-11
available O 0 4.763998084911236e-10
, O 0 2.1770181143909717e-11
a O 0 6.269280650172959e-10
putative O 0 5.730477369070286e-06
hereditary O 1 0.9998846054077148
predisposition O 1 1.0
to O 0 1.4647872376372106e-05
T B-Disease 1 0.9999521970748901
- I-Disease 0 0.0027692806906998158
PLL I-Disease 0 3.456638296484016e-05
will O 0 5.658024604393574e-10
require O 0 7.534552426413654e-10
further O 0 2.921488384544091e-09
investigation O 0 1.009177297284225e-09
. O 0 1.263490645442289e-09
. O 0 2.084504302501955e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 2.282168497913517e-05
kinase O 0 7.052552746245055e-07
is O 0 2.8129538628962614e-11
involved O 0 1.283635524262916e-12
in O 0 2.124833783315877e-13
the O 0 9.011234683789504e-13
modulation O 0 1.1844417807660435e-11
of O 0 1.723461130753723e-11
the O 0 1.1308755321071118e-10
Ca2 O 0 6.138463515270587e-09
+ O 0 3.320055341760053e-08
homeostasis O 0 5.389978952052843e-08
in O 0 9.413211543574107e-09
skeletal O 0 5.951051662123064e-06
muscle O 0 1.992655370486318e-06
cells O 0 1.6586395759077277e-06
. O 0 2.2796196930130463e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.897281799756456e-05
DM B-Disease 1 1.0
) O 0 2.640744511950288e-09
, O 0 2.1359943327969866e-11
the O 0 2.0872782668934775e-11
most O 0 3.4226576434148726e-11
prevalent O 0 4.3332173049748235e-07
muscular B-Disease 0 2.2208494556252845e-05
disorder I-Disease 0 0.10398926585912704
in O 0 2.0938666078773593e-10
adults O 0 1.8020708536514718e-10
, O 0 1.3030295158839023e-12
is O 0 1.0276559334401747e-12
caused O 0 4.175410364681831e-11
by O 0 9.421680796650733e-11
( O 0 1.0700142993869122e-09
CTG O 0 3.181880856573116e-07
) O 0 2.940672358398011e-11
n O 0 1.2921805292442912e-10
- O 0 9.647041498972442e-11
repeat O 0 1.7603720564585146e-11
expansion O 0 8.926361733108124e-11
in O 0 1.407178518673946e-12
a O 0 1.4396890797574446e-12
gene O 0 1.2639709157796775e-12
encoding O 0 7.172669402866205e-11
a O 0 2.4256880948314574e-09
protein O 0 3.789554270383633e-08
kinase O 0 5.784726226920611e-07
( O 0 7.183194128401738e-08
DM B-Disease 1 1.0
protein O 0 2.443544815378118e-07
kinase O 0 7.236205590288591e-08
; O 0 1.5575654099819758e-09
DMPK O 0 1.6154311879290617e-06
) O 0 1.7025537230042076e-11
and O 0 3.935187245507343e-12
involves O 0 5.5260756907926645e-12
changes O 0 1.2506714414106668e-11
in O 0 2.2520965647920832e-10
cytoarchitecture O 0 9.90814555734687e-07
and O 0 2.152274092281914e-08
ion O 0 6.863029284431832e-06
homeostasis O 0 2.7264700293017086e-06
. O 0 6.270518042583717e-07

To O 0 4.87807072513391e-10
obtain O 0 4.358313265839797e-09
clues O 0 1.0848089004866779e-07
to O 0 1.4806052217597454e-10
the O 0 3.424697192500048e-10
normal O 0 1.7505199512157787e-09
biological O 0 7.647896538287569e-09
role O 0 5.783600820485901e-10
of O 0 3.34383614131184e-08
DMPK O 1 0.9994947910308838
in O 0 1.4901173628345532e-08
cellular O 0 5.1563450398361965e-08
ion O 0 1.8778681578623946e-06
homeostasis O 0 8.309590526778265e-08
, O 0 7.259381984425772e-10
we O 0 3.555745697880752e-10
have O 0 8.711902033109453e-11
compared O 0 8.77633410389933e-10
the O 0 2.6760449411966647e-09
resting O 0 2.3040859886691578e-08
[ O 0 1.2479705047141465e-09
Ca2 O 0 1.218494194432651e-09
+ O 0 3.979287122035657e-09
] O 0 3.8615537434338876e-09
i O 0 1.6265184754615802e-09
, O 0 5.1900431868867614e-11
the O 0 1.3557571731936946e-10
amplitude O 0 3.2055913479211995e-10
and O 0 8.416690955304063e-11
shape O 0 6.266509977592705e-09
of O 0 4.2688288459658e-08
depolarization O 0 2.2047261794000406e-08
- O 0 4.7825029270143204e-08
induced O 0 4.612395088088306e-08
Ca2 O 0 5.893559418268524e-09
+ O 0 5.5675775101349245e-09
transients O 0 4.231948125266172e-09
, O 0 1.2382906332264465e-11
and O 0 9.51852745928461e-12
the O 0 4.4410065902500406e-11
content O 0 3.134136561389056e-10
of O 0 1.2750384081883226e-09
ATP O 0 7.081641939521433e-08
- O 0 2.435359647279256e-08
driven O 0 7.417661862518798e-08
ion O 0 8.768624937260938e-09
pumps O 0 1.6748177289471755e-09
in O 0 9.89532969453144e-11
cultured O 0 1.0077582324186096e-08
skeletal O 0 5.210314668602223e-08
muscle O 0 1.4140179693811206e-08
cells O 0 2.4337623472092673e-08
of O 0 5.041028483532273e-09
wild O 0 2.0606976125492338e-09
- O 0 5.466025410072461e-10
type O 0 1.0155493113117586e-09
and O 0 6.580533340461159e-10
DMPK O 0 9.379170364809397e-07
[ O 0 2.5163293670971143e-09
- O 0 8.444163590581866e-09
/ O 0 9.315743731974635e-09
- O 0 3.897361366966834e-08
] O 0 3.4601805865008828e-09
knockout O 0 1.096824036039834e-07
mice O 0 7.837272875121926e-08
. O 0 3.388315050756319e-08

In O 0 1.6459848950489686e-07
vitro O 0 1.2494905377025134e-06
- O 0 9.528624218546611e-07
differentiated O 0 1.670956635280163e-06
DMPK O 0 8.084381261141971e-05
[ O 0 5.078242892864182e-08
- O 0 3.701409312384385e-08
/ O 0 1.933308446666615e-08
- O 0 1.5678223164172778e-08
] O 0 1.522038828305483e-09
myotubes O 0 9.413265722457709e-09
exhibit O 0 2.584160108121125e-10
a O 0 1.2360590329052457e-10
higher O 0 2.3196284892890162e-09
resting O 0 7.51999884585075e-09
[ O 0 7.570565840886445e-10
Ca2 O 0 1.2213001721050887e-09
+ O 0 4.692056077004736e-09
] O 0 7.3374377684842784e-09
i O 0 3.0946063489523112e-09
than O 0 4.652912499736317e-10
do O 0 1.8305296167753227e-10
wild O 0 9.172518855571354e-10
- O 0 4.877735992891985e-10
type O 0 4.992293800576419e-10
myotubes O 0 1.1778652719840466e-08
because O 0 7.675127894346545e-11
of O 0 2.2256127496511624e-10
an O 0 9.353105095977199e-11
altered O 0 8.793709649346226e-10
open O 0 4.989618718198585e-10
probability O 0 1.670689142585502e-09
of O 0 3.913755097784133e-09
voltage O 0 3.2704286923035397e-07
- O 0 5.315116169413159e-08
dependent O 0 8.884877189530016e-08
l O 0 2.141152144474745e-09
- O 0 8.050130562153868e-10
type O 0 1.5759277216531586e-10
Ca2 O 0 1.4771808776181672e-10
+ O 0 4.0821759861309204e-10
and O 0 2.6059135405098743e-10
Na O 0 3.5570210665802904e-10
+ O 0 1.812174299509195e-09
channels O 0 6.205705727069244e-09
. O 0 6.835501498159147e-09

The O 0 3.1650597520638257e-07
mutant O 0 7.665993848604558e-07
myotubes O 0 3.841621946776286e-06
exhibit O 0 2.260982334689743e-08
smaller O 0 1.4084776678302546e-09
and O 0 7.085915187943215e-11
slower O 0 5.873405317657898e-09
Ca2 O 0 3.5440608225911774e-09
+ O 0 2.5577404638710277e-09
responses O 0 3.2564323459993716e-10
upon O 0 1.8324544659442665e-10
triggering O 0 5.661078827934318e-10
by O 0 4.6451599511332375e-11
acetylcholine O 0 6.984028999568181e-08
or O 0 1.3056369319031091e-08
high O 0 4.75459849269555e-08
external O 0 2.3333143417403335e-08
K O 0 1.4351878974139254e-07
+ O 0 3.795536329675997e-08
. O 0 3.103456691633255e-08

In O 0 3.55555940245722e-08
addition O 0 4.2127265231783895e-08
, O 0 2.019506784023406e-09
we O 0 4.2500250541088747e-10
observed O 0 5.390765056567659e-10
that O 0 3.3031394459925867e-12
these O 0 2.6052215940097767e-11
Ca2 O 0 2.4231553652498405e-08
+ O 0 1.6219750875734462e-07
transients O 0 2.4936935005825944e-07
partially O 0 1.4174474038952667e-08
result O 0 2.0864991678859468e-10
from O 0 7.273612268043905e-11
an O 0 3.465884176878653e-11
influx O 0 1.7621240022691609e-09
of O 0 1.3924003061660528e-09
extracellular O 0 4.01659860926884e-09
Ca2 O 0 1.8266034240710383e-09
+ O 0 2.0693706748176055e-09
through O 0 7.724182404800217e-10
the O 0 2.4144390931013504e-09
l O 0 3.078415578006144e-10
- O 0 1.068528945880054e-10
type O 0 4.9645738908754566e-11
Ca2 O 0 2.478592053822837e-10
+ O 0 3.370883350228837e-09
channel O 0 2.009644362033214e-08
. O 0 7.753885533645644e-09

Neither O 0 2.1118619031312846e-07
the O 0 1.9651400506859318e-08
content O 0 8.626853009729984e-09
nor O 0 2.0025845870463854e-08
the O 0 1.6736234620395862e-09
activity O 0 8.276353824498983e-09
of O 0 1.4559007333048157e-09
Na O 0 1.0801932681658855e-09
+ O 0 4.154482535767556e-09
/ O 0 8.88895801409717e-09
K O 0 1.9885243673911646e-08
+ O 0 2.838124402160247e-09
ATPase O 0 3.85529830282394e-09
and O 0 2.8440458321732365e-10
sarcoplasmic O 0 1.493574686151078e-08
reticulum O 0 1.7520907391599394e-08
Ca2 O 0 3.1455107407651894e-09
+ O 0 7.719326511335112e-09
- O 0 4.717631618689211e-09
ATPase O 0 3.0761866387507553e-09
are O 0 7.793491546559395e-12
affected O 0 1.225509138613745e-10
by O 0 1.0191930632785784e-10
DMPK O 0 8.74279357958585e-05
absence O 0 9.958238251783769e-07
. O 0 1.8420726632939477e-07

In O 0 1.252500112514099e-07
conclusion O 0 7.187058486124442e-07
, O 0 1.5952655862960796e-09
our O 0 2.3983701691321357e-09
data O 0 1.9597266032178595e-09
suggest O 0 3.0554863084120143e-09
that O 0 4.4105688545847954e-10
DMPK O 0 2.3460886950488202e-05
is O 0 4.798906758085586e-11
involved O 0 4.545314211817919e-12
in O 0 4.9078835613614036e-12
modulating O 0 1.5061727420828674e-09
the O 0 5.3195906013492333e-11
initial O 0 2.171739732492739e-10
events O 0 5.090182789158071e-11
of O 0 6.348590542160082e-10
excitation O 0 5.829345468555402e-07
- O 0 7.693665082797452e-08
contraction O 0 5.222111632008364e-09
coupling O 0 8.673015194915479e-09
in O 0 8.006351137623824e-10
skeletal O 0 2.306241100313855e-07
muscle O 0 1.3851462199454545e-07
. O 0 2.0633338593256667e-08
. O 0 3.6341472053891266e-08

Constitutional O 0 9.954601409845054e-06
RB1 O 0 0.005224420689046383
- O 0 3.9539747831440764e-07
gene O 0 1.1622478979234074e-08
mutations O 0 8.871174017599515e-09
in O 0 4.611834178436247e-11
patients O 0 1.3921731822907901e-11
with O 0 1.7240749843397407e-12
isolated O 0 3.4454963326879806e-08
unilateral B-Disease 0 3.6975891362089897e-06
retinoblastoma I-Disease 1 1.0
. O 0 2.0456453057704493e-05

In O 0 4.533897979275281e-10
most O 0 1.0337986716679737e-10
patients O 0 3.430958642192117e-11
with O 0 1.8801561869896677e-12
isolated O 0 3.3975420254961364e-09
unilateral B-Disease 0 1.411458612210481e-07
retinoblastoma I-Disease 1 0.9999997615814209
, O 0 3.704818896110851e-09
tumor B-Disease 0 1.2148616406193469e-05
development O 0 2.4508956641966506e-08
is O 0 1.049905822003705e-11
initiated O 0 1.9189193636859336e-11
by O 0 1.3660528871278776e-12
somatic O 0 8.477941015883061e-09
inactivation O 0 1.537803129281201e-08
of O 0 2.2158157253482358e-10
both O 0 1.2021357520541898e-10
alleles O 0 2.2830997092881944e-09
of O 0 7.3611556850039506e-09
the O 0 6.060242441208175e-08
RB1 O 0 2.9428671041387133e-05
gene O 0 2.574668371835287e-07
. O 0 1.686173732196039e-06

However O 0 1.3657695774327294e-07
, O 0 5.869392749602298e-10
some O 0 4.5745066068469953e-10
of O 0 1.9593826561248306e-09
these O 0 2.0017959512230732e-10
patients O 0 1.1543816597070489e-10
can O 0 1.2429196560859168e-10
transmit O 0 5.296929828091379e-08
retinoblastoma B-Disease 0 0.014264330267906189
predisposition O 0 0.0003883288591168821
to O 0 8.986193122950681e-09
their O 0 2.199618620579713e-08
offspring O 0 2.594203351691249e-06
. O 0 9.413682278136548e-08

To O 0 4.616474147400851e-10
determine O 0 1.3022686262686989e-09
the O 0 3.002301740551161e-10
frequency O 0 2.1222541501941805e-09
and O 0 2.8525359158093622e-11
nature O 0 1.2263188242656042e-09
of O 0 2.1033783603741085e-09
constitutional O 0 1.693979783112809e-07
RB1 O 0 0.000679842836689204
- O 0 6.261123530748591e-08
gene O 0 3.00966496169508e-09
mutations O 0 4.596952596358506e-09
in O 0 1.7302494506599153e-11
patients O 0 9.6984547129364e-12
with O 0 2.361651672833087e-12
isolated O 0 1.0147849671682252e-08
unilateral B-Disease 0 4.579015566719136e-08
retinoblastoma I-Disease 1 0.9852305054664612
, O 0 1.3282170918671454e-09
we O 0 5.749679621303017e-10
analyzed O 0 9.057566918713178e-10
DNA O 0 1.1737806282496877e-09
from O 0 1.1031886515411315e-09
peripheral O 0 4.9587612238610745e-08
blood O 0 2.482302363659983e-09
and O 0 2.4794810649098054e-10
from O 0 3.077343047053205e-09
tumor B-Disease 0 2.2760838191970834e-07
tissue O 0 2.7594030171940176e-08
. O 0 5.1616293461620444e-08

The O 0 3.340468568424626e-09
analysis O 0 7.393561762825129e-09
of O 0 3.2710772757127415e-08
tumors B-Disease 1 1.0
from O 0 1.1928229071145324e-08
54 O 0 8.976018150974596e-09
( O 0 2.723767739132299e-11
71 O 0 3.816368554510063e-09
% O 0 9.401646822171372e-11
) O 0 5.938831241017462e-13
of O 0 8.378570059974777e-11
76 O 0 9.048035098935259e-10
informative O 0 9.058326866373534e-10
patients O 0 2.6786056012140236e-11
showed O 0 1.0296503927254008e-10
loss O 0 2.9503255394303096e-10
of O 0 2.4908393125855355e-09
constitutional O 0 1.7971714783016068e-07
heterozygosity O 1 1.0
( O 1 0.6605103015899658
LOH O 1 1.0
) O 0 1.6316274553673793e-08
at O 0 1.015852433283726e-07
intragenic O 0 7.595108399982564e-07
loci O 0 1.1111254849538454e-07
. O 0 1.4509551249375363e-07

Three O 0 7.18091968110457e-08
of O 0 1.644854989990563e-07
13 O 0 2.0132203815137473e-07
uninformative O 0 3.2882864616112784e-05
patients O 0 3.354862343485365e-08
had O 0 1.06256301535268e-08
constitutional O 0 3.2468386734763044e-07
deletions O 0 1.6549183783354238e-05
. O 0 1.5802507959961076e-06

For O 0 2.5476243337152482e-08
39 O 0 1.0939570529444609e-06
randomly O 0 1.0967654873184074e-07
selected O 0 1.4768083929084241e-06
tumors B-Disease 1 1.0
, O 0 1.580179969096207e-07
SSCP O 1 0.9992297887802124
, O 0 4.665731978548138e-08
hetero O 0 3.578228415790363e-07
- O 0 2.5869443476267406e-08
duplex O 0 8.550743224589041e-09
analysis O 0 1.8974903592816617e-10
, O 0 2.150620176735729e-12
sequencing O 0 7.812050485667132e-12
, O 0 1.11064664409799e-11
and O 0 6.682884107211962e-11
Southern O 0 7.770585952471265e-09
blot O 0 1.1017471024388215e-07
analysis O 0 2.2949313560616247e-09
were O 0 3.7871081270957063e-10
used O 0 2.568857071505448e-10
to O 0 1.2331724530412203e-09
identify O 0 1.6755477361130033e-07
mutations O 0 2.912212721639662e-06
. O 0 1.3165921473046183e-06

Mutations O 0 3.644177581918484e-07
were O 0 5.465559560491329e-09
detected O 0 2.076939065176475e-09
in O 0 6.920938128152088e-11
21 O 0 1.537802218898321e-09
( O 0 3.9741637064549806e-11
91 O 0 7.098259313664812e-09
% O 0 2.378166552574612e-10
) O 0 5.697991557751525e-12
of O 0 1.8442823934705643e-09
23 O 0 3.50902701029554e-06
tumors B-Disease 1 1.0
with O 1 0.9915903210639954
LOH O 1 1.0
. O 0 0.0001384943607263267

In O 0 7.716028704862765e-09
6 O 0 5.113867018735618e-08
( O 0 1.8933907219853552e-10
38 O 0 3.534706394248133e-08
% O 0 3.158109329604031e-10
) O 0 7.096081968555046e-12
of O 0 1.7067433022432965e-09
16 O 0 3.3412547395528236e-07
tumors B-Disease 1 1.0
without O 0 0.1337743103504181
LOH O 1 1.0
, O 0 2.433742540830508e-09
one O 0 5.53502688127594e-10
mutation O 0 1.7467435831086675e-10
was O 0 2.0829364621999247e-10
detected O 0 7.093298171056972e-11
, O 0 2.8263114505017173e-12
and O 0 4.932066473978258e-12
in O 0 9.276088230869561e-11
9 O 0 4.161286426551669e-09
( O 0 8.253629724119804e-11
56 O 0 1.564166574041792e-08
% O 0 4.991674851240191e-10
) O 0 9.007287103679484e-12
of O 0 2.952302846637167e-09
the O 0 3.17823861450961e-07
tumors B-Disease 1 1.0
without O 0 0.001083860290236771
LOH O 1 1.0
, O 0 7.510583799330561e-08
both O 0 5.4156384265979796e-08
mutations O 0 1.779523444156439e-07
were O 0 1.885241296406548e-08
found O 0 1.1429267310347768e-08
. O 0 6.739792723919891e-08

Thus O 0 1.8989766203958425e-08
, O 0 1.179743663870525e-10
a O 0 7.656266592936944e-11
total O 0 4.1212142032343024e-10
of O 0 1.718614361934101e-09
45 O 0 5.353960386145218e-09
mutations O 0 4.716588009046063e-09
were O 0 2.0912174214515744e-09
identified O 0 7.668097268265228e-09
in O 0 9.300439529624782e-09
tumors B-Disease 1 1.0
of O 0 1.6125281945278402e-06
36 O 0 3.1329059879681154e-07
patients O 0 1.1977404845708861e-08
. O 0 1.0219820012480341e-07

Thirty O 0 5.885451628273586e-07
- O 0 5.701196847951451e-09
nine O 0 2.3053036812825667e-08
of O 0 5.484607434880218e-09
the O 0 1.423358098051608e-09
mutations O 0 5.214961795729778e-10
- O 0 4.0861486416687853e-10
including O 0 5.5147494210094905e-11
34 O 0 3.494718470165026e-08
small O 0 3.0644626836107136e-09
mutations O 0 6.800052965161285e-09
, O 0 3.0550650897964715e-10
2 O 0 4.392244790096811e-09
large O 0 6.322746326503648e-09
structural O 0 2.3840668461616588e-07
alterations O 0 9.611090945327305e-07
, O 0 2.7598121565830525e-09
and O 0 3.549594618235119e-09
hypermethylation O 0 1.2053030332026538e-05
in O 0 1.6871149455255363e-07
3 O 0 2.018912709900178e-06
tumors O 1 1.0
- O 0 9.306419634924623e-09
were O 0 1.028535451252921e-10
not O 0 3.2776279520335683e-12
detected O 0 2.626866779653625e-11
in O 0 5.998713353307095e-13
the O 0 1.1439522072664854e-11
corresponding O 0 6.85921541787593e-10
peripheral O 0 1.1463275484402402e-07
blood O 0 2.6431848709762562e-08
DNA O 0 5.389911166275851e-07
. O 0 3.934490280244063e-07

In O 0 1.4264598391378058e-08
6 O 0 1.2216298728162656e-07
( O 0 6.945830022253574e-10
17 O 0 2.382968311565037e-08
% O 0 2.1664896265871647e-10
) O 0 4.656216818360592e-13
of O 0 6.112193390306331e-11
the O 0 2.1942696271093354e-10
36 O 0 2.3020159112263627e-09
patients O 0 1.7596243906403686e-10
, O 0 2.6184830345665766e-11
a O 0 2.005365318247243e-10
mutation O 0 1.9531070094558345e-09
was O 0 2.278470967453927e-09
detected O 0 4.5288589545222635e-10
in O 0 2.1885422293865808e-11
constitutional O 0 5.512606482405147e-10
DNA O 0 8.623858072098756e-09
, O 0 3.7285652343399533e-10
and O 0 1.447819503175296e-10
1 O 0 7.69140218181974e-09
of O 0 8.302568410556432e-09
these O 0 2.316445035788206e-09
mutations O 0 7.296755200059124e-09
is O 0 2.466528647993016e-10
known O 0 3.659238745346016e-10
to O 0 6.085394965715807e-10
be O 0 1.5476980808060148e-09
associated O 0 3.093386524710695e-08
with O 0 1.580606645568139e-09
reduced O 0 2.2602154103879002e-07
expressivity O 0 1.5048121895233635e-05
. O 0 2.7638969868348795e-07

The O 0 5.209437325959243e-09
presence O 0 5.281823867164803e-09
of O 0 9.233433573285765e-09
a O 0 3.685519667229187e-10
constitutional O 0 1.8444934468675456e-09
mutation O 0 2.0560961822013724e-09
was O 0 7.190315565175354e-10
not O 0 4.774627308107293e-12
associated O 0 2.92939894563915e-10
with O 0 4.373496356735451e-12
an O 0 6.322474488396068e-11
early O 0 3.019266836545853e-09
age O 0 9.619617991063478e-09
at O 0 3.734915932085414e-09
treatment O 0 2.351996108984622e-08
. O 0 2.7743908503907733e-08

In O 0 3.2018778739484333e-09
1 O 0 2.357327133495346e-08
patient O 0 2.617716488018118e-09
, O 0 1.0632735664151127e-10
somatic O 0 2.2072218541779876e-07
mosaicism O 0 1.1614262803050224e-05
was O 0 7.5805681731822e-09
demonstrated O 0 9.453722527030806e-11
by O 0 2.89692467063396e-12
molecular O 0 1.553443762514206e-10
analysis O 0 2.856112568672131e-11
of O 0 1.8470767970679702e-10
DNA O 0 3.41057126984623e-10
and O 0 2.9868685302858466e-10
RNA O 0 8.384668959138253e-09
from O 0 6.837483024213498e-09
peripheral O 0 1.1041818197554676e-06
blood O 0 2.1807539951623767e-07
. O 0 9.3470184481248e-08

In O 0 2.7749609277094578e-09
2 O 0 1.568013807684565e-08
patients O 0 6.620337611451532e-11
without O 0 6.317339013017786e-11
a O 0 1.6562078097859256e-10
detectable O 0 1.275640357789598e-07
mutation O 0 8.742367940683948e-10
in O 0 8.763265113564955e-11
peripheral O 0 7.803160428920819e-08
blood O 0 4.8812562880584665e-09
, O 0 1.996922349700725e-10
mosaicism O 0 2.347176888406466e-07
was O 0 2.040165592021026e-09
suggested O 0 2.5280275095518334e-10
because O 0 9.308115389572436e-11
1 O 0 1.0192362509542363e-09
of O 0 3.019224870115522e-10
the O 0 5.778088008057125e-10
patients O 0 1.748697853187764e-09
showed O 0 6.09727450751052e-08
multifocal O 1 0.9998915195465088
tumors B-Disease 1 1.0
and O 0 3.4994525055509484e-09
the O 0 3.1965079472229263e-09
other O 0 4.1148048857131414e-10
later O 0 1.9366956927058254e-09
developed O 0 6.3024701013603135e-09
bilateral B-Disease 0 4.1633936120888393e-07
retinoblastoma I-Disease 0 8.152958616847172e-05
. O 0 3.275404196756426e-07

In O 0 1.0937485583895068e-08
conclusion O 0 9.169203707415363e-08
, O 0 8.771430248799561e-10
our O 0 7.4610750910864e-10
results O 0 4.940469700009942e-10
emphasize O 0 8.162767684005701e-10
that O 0 6.100473425030284e-12
the O 0 4.084549365401813e-11
manifestation O 0 5.101228772730337e-09
and O 0 8.33073263151185e-11
transmissibility O 0 2.8811882657464594e-07
of O 0 1.2683705197247264e-09
retinoblastoma B-Disease 0 4.350687561327504e-07
depend O 0 2.091014028593463e-09
on O 0 5.577162065506513e-10
the O 0 1.004567679041557e-10
nature O 0 8.574975729480627e-10
of O 0 4.308480239245682e-10
the O 0 6.608343317004994e-10
first O 0 3.7601746716298123e-10
mutation O 0 1.7392036422148038e-10
, O 0 2.2633693530504928e-11
its O 0 6.759699050506995e-11
time O 0 6.469522140228889e-10
in O 0 5.567511451864959e-10
development O 0 3.46644455362366e-08
, O 0 8.589474964626476e-11
and O 0 1.367960189568862e-10
the O 0 8.157771680394887e-10
number O 0 2.2072328409450392e-09
and O 0 2.1106845160545618e-09
types O 0 7.32013560877931e-08
of O 0 2.249429371659062e-07
cells O 0 1.0242023229523056e-08
that O 0 4.833540789839219e-10
are O 0 3.184973673686642e-10
affected O 0 1.924974490918885e-08
. O 0 7.721004280369925e-09
. O 0 1.219800935814419e-07

Hereditary B-Disease 1 0.9999943971633911
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999873638153076
the I-Disease 0 8.708672680768359e-07
fifth I-Disease 0 1.4829673489202833e-07
component I-Disease 0 1.5799358266122e-07
of I-Disease 0 1.6006397984824616e-08
complement I-Disease 0 2.4414417154616785e-09
in O 0 3.694502037632219e-09
man O 0 2.9425223146972712e-06
. O 0 1.5403282986881095e-06

I O 0 0.004207337275147438
. O 0 8.35822538647335e-06

Clinical O 0 2.1069142803753493e-06
, O 0 3.5463081360376236e-08
immunochemical O 0 3.208671842003241e-05
, O 0 1.1967288493508477e-08
and O 0 6.951876851957195e-09
family O 0 5.022057791848056e-08
studies O 0 1.7987176192946208e-08
. O 0 1.3019192834917703e-08

The O 0 9.991107940976462e-10
first O 0 1.6155907167636485e-10
recognized O 0 5.024726190683282e-10
human O 0 5.750667164683421e-10
kindred O 0 3.318526069051586e-05
with O 0 4.509290857379611e-11
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 0 0.004476554226130247
the I-Disease 0 9.619307128616583e-09
fifth I-Disease 0 3.3730589876768136e-08
component I-Disease 0 2.613742253743112e-06
of I-Disease 1 0.9664953947067261
complement I-Disease 0 0.320618599653244
( O 0 3.70766701962566e-06
C5 O 1 1.0
) O 0 7.390938971951755e-09
is O 0 2.938264298535387e-09
described O 0 2.1643687730943384e-08
. O 0 1.4487166311027977e-07

The O 0 1.1722557502480413e-07
proband O 0 3.4770971524267225e-06
, O 0 5.799153934837875e-10
a O 0 3.828053152243882e-10
20 O 0 2.119341591111379e-09
- O 0 7.342484259487136e-11
year O 0 1.860268050712932e-10
- O 0 1.9254572936056036e-10
old O 0 1.5683899734497686e-09
black O 0 1.1706560200386296e-11
female O 0 1.104383338251802e-11
with O 0 3.281132657240171e-11
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9999983310699463
age O 1 0.999929666519165
11 O 0 1.2744087030114315e-07
, O 0 5.752970877459518e-10
lacked O 0 6.390461493310795e-08
serum O 0 2.776079632837991e-08
hemolytic O 0 3.204782501597947e-07
complement O 0 3.7993462598251426e-08
activity O 0 1.482422931076144e-07
, O 0 2.2359605833521812e-10
even O 0 9.492792107934633e-10
during O 0 4.230051420250902e-09
remission O 0 9.109151477559863e-08
. O 0 8.296346720726433e-09

C5 O 0 0.0028048185631632805
was O 0 7.191377449089487e-07
undetectable O 0 9.510633702802807e-08
in O 0 2.60858418199561e-10
her O 0 1.0791714050162327e-10
serum O 0 6.555178622136282e-10
by O 0 3.335371909218843e-11
both O 0 2.0335377826086187e-09
immunodiffusion O 0 6.018467956891982e-06
and O 0 1.2207558519605755e-08
hemolytic O 0 3.155531157972291e-05
assays O 0 6.181974754326802e-07
. O 0 3.5632726280709903e-07

Other O 0 4.479512594190993e-10
complement O 0 1.2538016180840827e-09
components O 0 6.6710463819674715e-09
were O 0 1.3345191618441277e-10
normal O 0 6.020305920451108e-10
during O 0 6.422553461282732e-11
remission O 0 7.799988210877018e-09
of O 0 4.3758283108097373e-10
lupus O 0 2.7966629900788575e-08
, O 0 2.939105181454238e-09
but O 0 4.879397508261718e-08
C1 O 0 1.3925802704761736e-05
, O 0 4.910280893000163e-08
C4 O 0 3.3832169719971716e-05
, O 0 5.930096236284044e-08
C2 O 0 7.489646804970107e-07
, O 0 9.675964030009254e-09
and O 0 1.3753739835919987e-07
C3 O 0 0.32050424814224243
levels O 0 2.835277427948313e-06
fell O 0 8.697984412719961e-06
during O 0 4.067366887738899e-08
exacerbations O 0 9.959202725440264e-05
. O 0 3.237417445234314e-07

A O 0 3.976762309321202e-05
younger O 0 2.003557892749086e-05
half O 0 2.842007461367757e-06
- O 0 9.919853027895442e-08
sister O 0 5.1128917988307876e-08
, O 0 3.168661999453093e-10
who O 0 2.5565882744160717e-10
had O 0 3.364804823657863e-10
no O 0 3.416698035607624e-10
underlying O 0 5.8750774911686676e-08
disease O 0 5.552820221055299e-05
, O 0 8.037733811860903e-10
was O 0 4.481140933876304e-07
also O 0 2.693628653460678e-10
found O 0 3.5522479402416707e-10
to O 0 4.604025161114578e-09
lack O 1 0.5384420156478882
immunochemically O 1 0.7475811839103699
detectable O 1 0.9920526742935181
C5 O 0 0.007429227698594332
. O 0 3.9174511812234414e-07

By O 0 2.3936550519465527e-08
hemolytic O 0 0.00016046853852458298
assay O 0 2.162204282285529e-06
, O 0 7.135670720970211e-09
she O 0 6.613853353876209e-10
exhibited O 0 3.575756801765806e-09
1 O 0 3.827994587979333e-10
- O 0 8.259062878046564e-11
2 O 0 1.4721686369956188e-10
% O 0 9.747375649682422e-12
of O 0 7.847668695437626e-12
the O 0 3.638184892240659e-11
normal O 0 1.3254206621127196e-09
serum O 0 1.5893159011071134e-09
C5 O 0 7.173350269340517e-08
level O 0 2.043998303946637e-09
and O 0 8.16843259698885e-11
normal O 0 2.436970847341513e-09
concentrations O 0 2.2741988292551696e-09
of O 0 3.4046174213209213e-10
other O 0 2.0107120135559597e-10
complement O 0 9.813802215319356e-09
components O 0 1.395947464288838e-07
. O 0 5.2603819966634546e-08

C5 O 0 0.00033399759558960795
levels O 0 3.61634917567244e-08
of O 0 1.5266384822965051e-09
other O 0 4.5049495384086313e-11
family O 0 1.1124175192112062e-10
members O 0 1.7961530700272288e-12
were O 0 2.0204285293423663e-12
either O 0 4.460495341140902e-12
normal O 0 9.1094166931871e-11
or O 0 4.024222361592722e-12
approximately O 0 7.547579922162484e-11
half O 0 1.5810468489974028e-09
- O 0 1.6832403249011918e-09
normal O 0 1.5574148193309156e-08
, O 0 1.512152729421512e-11
consistent O 0 8.972043108457228e-10
with O 0 2.9804252815734955e-11
autosomal O 0 8.38907183720039e-08
codominant O 0 3.3262546139667393e-07
inheritance O 0 1.912987457330928e-08
of O 0 1.1929450760561622e-09
the O 0 1.0272538375488693e-09
gene O 0 1.4048247010123305e-07
determining O 0 5.2645696996478364e-05
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 2.615694711494143e-06

Normal O 0 1.8048394849756733e-05
hemolytic O 0 0.0036734528839588165
titers O 0 2.93418561341241e-05
were O 0 2.082436889594419e-09
restored O 0 2.406283394762454e-09
to O 0 4.51238803267362e-11
both O 0 5.615524711899411e-10
homozygous O 0 1.1395894034649245e-05
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 7.482831733796047e-06
C5D B-Disease 1 1.0
) O 0 1.3094294537552287e-09
sera O 0 1.1337231597963182e-08
by O 0 2.2123505284687983e-12
addition O 0 8.264230966226194e-11
of O 0 1.1729883730993151e-09
highly O 0 5.117279044952738e-09
purified O 0 3.3004319277551986e-08
human O 0 3.574872380340821e-07
C5 O 1 0.9999030828475952
. O 0 3.942625994568516e-07

In O 0 3.9850920785511335e-08
specific O 0 7.477942176592478e-07
C5 O 0 0.00014377114712260664
titrations O 0 5.243451141723199e-06
, O 0 3.917160817934473e-09
however O 0 5.118225843148139e-09
, O 0 1.5672588227211293e-10
it O 0 9.99163668469194e-11
was O 0 3.5266838338543494e-09
noted O 0 1.7151294273709539e-10
that O 0 4.37294514835096e-12
when O 0 3.558023667360466e-11
limited O 0 6.884587344657689e-11
amounts O 0 6.936310970040438e-10
of O 0 2.3060952258902034e-08
C5 O 0 6.573566224687966e-06
were O 0 2.9850477645254614e-09
assayed O 0 1.4111726898136112e-08
in O 0 3.303349260797006e-11
the O 0 1.745984190559824e-10
presence O 0 8.707354837156345e-10
of O 0 2.3967832163407365e-09
low O 0 1.9343339374700008e-08
dilutions O 0 1.95543435665968e-07
of O 0 1.1413974654317371e-08
either O 0 3.2849769127096806e-07
C5D B-Disease 1 1.0
serum O 0 4.5315118768485263e-07
, O 0 1.708195918048716e-09
curving O 0 6.40065991319716e-08
rather O 0 5.334621078212365e-10
than O 0 3.4594530018416947e-10
linear O 0 6.2521592347764e-09
dose O 0 3.127945014114175e-09
- O 0 9.008120915865447e-10
response O 0 8.041045052031848e-10
plots O 0 1.1688149115229862e-08
were O 0 3.777327783893725e-09
consistently O 0 1.176270636449317e-09
obtained O 0 3.2688551865334148e-09
, O 0 6.063679419687773e-11
suggesting O 0 1.1557989010313463e-09
some O 0 2.979914925926863e-10
inhibitory O 0 9.9483668236644e-07
effect O 0 5.297637244439102e-07
. O 0 2.040346203102672e-07

Further O 0 2.7403334001974144e-07
studies O 0 2.72496727404814e-08
suggested O 0 1.9791659422452312e-09
that O 0 1.0363473967878178e-10
low O 0 2.667688470125995e-08
dilutions O 0 1.0847587645912427e-06
of O 0 6.158659715538306e-08
C5D B-Disease 1 1.0
serum O 0 1.3660843123375344e-08
contain O 0 1.111509703721758e-10
a O 0 2.9769497977838455e-10
factor O 0 2.175891244959871e-09
( O 0 7.995832468354891e-11
or O 0 4.4173881219577993e-10
factors O 0 7.693749637383007e-09
) O 0 3.340968821041734e-11
interfering O 0 1.0036392827927898e-09
at O 0 7.556716363765759e-10
some O 0 3.015718577636939e-11
step O 0 2.002124299682606e-10
in O 0 6.729083262824176e-11
the O 0 1.761606527317383e-09
hemolytic O 0 5.827339009556454e-06
assay O 0 1.8434097910358105e-06
of O 0 6.075246346881613e-06
C5 O 0 0.3021067976951599
, O 0 1.1785566966793226e-09
rather O 0 4.4435338741877217e-10
than O 0 1.4640871848214942e-10
a O 0 2.6811488584854715e-09
true O 0 1.5553997911865736e-07
C5 O 0 6.279125955188647e-06
inhibitor O 0 1.531860931436313e-07
or O 0 2.1470423661185123e-08
inactivator O 0 8.422663086093962e-06
. O 0 4.851468702327111e-07

Of O 0 2.6956975318626064e-08
clinical O 0 7.615178532205391e-08
interest O 0 8.402801654483483e-07
are O 0 4.742339299035336e-10
( O 0 9.122057276211848e-11
a O 0 3.569730622210443e-10
) O 0 2.0045753251762832e-12
the O 0 4.980182065350558e-12
documentation O 0 7.249202127468379e-09
of O 0 1.2638817992183249e-08
membranous O 1 0.9999887943267822
glomerulonephritis B-Disease 1 1.0
, O 0 2.668663796612236e-07
vasculitis B-Disease 1 1.0
, O 0 1.0557046792314395e-08
and O 0 1.671219074239616e-08
arthritis B-Disease 1 1.0
in O 0 6.720852208097483e-10
an O 0 2.7005220282205755e-10
individual O 0 1.5282319854037496e-09
lacking O 0 8.076398080447689e-05
C5 O 1 0.9963395595550537
( O 0 2.1396487359659488e-10
and O 0 3.56897983389004e-11
its O 0 9.5177879466668e-11
biologic O 0 2.482559402494644e-08
functions O 0 6.226733018088737e-11
) O 0 1.4331410407367184e-12
, O 0 6.5360451426133e-12
and O 0 2.7032209803934393e-11
( O 0 3.240865908971102e-11
b O 0 5.346019182894679e-10
) O 0 3.709996285877759e-12
a O 0 5.7208085491033955e-11
remarkable O 0 8.877805157680996e-10
propensity O 0 1.8746634466992873e-08
to O 0 2.733918647024325e-10
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 4.34185604136772e-11
the O 0 3.0645430637576965e-10
proband O 0 8.325629607952578e-08
, O 0 5.423496374223902e-11
even O 0 5.6799415171227e-10
during O 0 8.105874305108784e-10
periods O 0 2.0744774786862763e-08
of O 0 6.2041434212289914e-09
low O 0 1.9347766055943794e-08
- O 0 4.6269818532174156e-10
dose O 0 9.016457580557358e-10
or O 0 1.3321209413330592e-10
alternate O 0 2.6901283423086397e-09
- O 0 2.3043003061218315e-09
day O 0 4.3723744069801285e-10
corticosteroid O 0 4.501769623743712e-08
therapy O 0 1.4367513401225551e-08
. O 0 9.385101584769018e-09

Other O 0 1.520011849720504e-08
observations O 0 2.190345504970992e-08
indicate O 0 1.5340495540527854e-09
that O 0 1.4572244452781824e-11
the O 0 8.244460669715181e-10
C5D B-Disease 1 1.0
state O 0 1.633993496064079e-09
is O 0 4.889563406940134e-11
compatible O 0 8.670661966192483e-10
with O 0 5.2061046446061354e-11
normal O 0 3.430202788479164e-09
coagulation O 0 6.250439055222046e-10
function O 0 1.3707575352572832e-10
and O 0 3.880177429360643e-11
the O 0 1.4786070978711763e-10
capacity O 0 1.8783193056481906e-10
to O 0 2.386591202441224e-10
mount O 0 2.9887269192840904e-07
a O 0 3.4671057136392847e-08
neutrophilic O 0 0.014350411482155323
leukocytosis O 0 6.340097024803981e-05
during O 0 1.492274037673269e-07
pyogenic B-Disease 0 4.811250255443156e-05
infection I-Disease 0 1.7205199753789202e-07
. O 0 9.673376544228063e-10
. O 0 1.6756684928509458e-08

Susceptibility O 0 9.584235840520705e-07
to O 0 2.188002845571191e-08
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 5.14414431052046e-08
twins O 0 1.1657206755444349e-07
: O 0 1.2292823009518727e-11
the O 0 6.849197597968981e-11
role O 0 8.077965379937879e-11
of O 0 3.1698184077555425e-09
genes O 0 1.4880405796446894e-09
, O 0 8.169231957566581e-10
HLA O 0 2.131270321115153e-06
, O 0 4.151139876285015e-09
and O 0 9.489555807817851e-09
the O 0 2.4632856820971938e-06
environment O 0 2.8668416689470178e-06
. O 0 2.558015808062919e-07

OBJECTIVE O 0 1.0358364761486882e-06
To O 0 5.3036949831941627e-11
determine O 0 2.2454485493206278e-10
the O 0 5.110709425104609e-11
relative O 0 7.965153869804453e-09
effects O 0 3.508093815440816e-09
of O 0 1.3717461888607119e-10
genetic O 0 1.1046835668437893e-09
and O 0 2.0591554503179843e-11
environmental O 0 1.1994927273661915e-10
factors O 0 6.668648272478706e-11
in O 0 3.393754461483711e-12
susceptibility O 0 1.4127455649770582e-08
to O 0 5.489861454321954e-09
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 1.8099754584000038e-07
AS B-Disease 1 1.0
) O 0 1.7106216443352196e-09
. O 0 1.2411393690570094e-08

METHODS O 0 1.8968947188113816e-05
Twins O 0 3.6481557685874577e-07
with O 0 2.9353666719522664e-10
AS B-Disease 1 1.0
were O 0 2.4829249767321926e-11
identified O 0 4.08541213012259e-12
from O 0 2.819306637105723e-12
the O 0 1.9392662822803608e-11
Royal O 0 5.202652197944246e-10
National O 0 8.256263450689971e-10
Hospital O 0 7.10546785853694e-08
for O 0 2.217321881659018e-09
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 0.9988458156585693
database O 0 6.941716856090352e-05
. O 0 1.7823134612626745e-06

Clinical O 0 3.083695787609031e-08
and O 0 7.818572456130823e-10
radiographic O 0 1.1597564935073024e-06
examinations O 0 1.8790988320915858e-08
were O 0 4.716441681651418e-10
performed O 0 1.699932035414964e-11
to O 0 3.019424987815711e-11
establish O 0 3.4021330197475663e-09
diagnoses O 0 3.809029749390902e-06
, O 0 2.015573125069281e-10
and O 0 1.317060904781897e-10
disease O 0 1.7313124089923804e-07
severity O 0 1.0311832738807425e-06
was O 0 1.4691931005117453e-09
assessed O 0 5.707199712823297e-10
using O 0 1.1030214068508126e-11
a O 0 7.7541292831107e-11
combination O 0 1.834256302402082e-09
of O 0 1.1498427987532978e-08
validated O 0 6.502373395278482e-08
scoring O 0 1.6770825084222452e-07
systems O 0 4.863035769631097e-07
. O 0 5.318858598002407e-07

HLA O 0 3.5457280318951234e-05
typing O 0 1.4926838787232555e-07
for O 0 6.9146510739415135e-09
HLA O 0 6.726911010446202e-07
- O 0 4.053280520111002e-07
B27 O 0 9.257204283130704e-07
, O 0 4.574053080741436e-10
HLA O 0 8.040344390281007e-09
- O 0 2.832446277523104e-09
B60 O 0 1.8257127365473025e-08
, O 0 1.0552178922318411e-11
and O 0 8.89915745261316e-12
HLA O 0 3.512713453446281e-09
- O 0 1.7565545462616683e-08
DR1 O 0 8.59106148709543e-06
was O 0 1.6896057886128801e-09
performed O 0 1.1962288798406107e-12
by O 0 1.3334719613233847e-12
polymerase O 0 3.2749883360772003e-10
chain O 0 2.947593280566707e-09
reaction O 0 1.0564594754569612e-09
with O 0 4.594914726485655e-11
sequence O 0 1.2025026807638284e-10
- O 0 6.342790181967928e-11
specific O 0 9.410257989506121e-11
primers O 0 1.4713776863573003e-09
, O 0 6.969647775578736e-11
and O 0 1.7588759615438931e-10
zygosity O 0 1.305261321249418e-07
was O 0 2.8744946423131523e-09
assessed O 0 3.483244137569841e-09
using O 0 1.3808506560408773e-09
microsatellite O 0 6.018985345690453e-07
markers O 0 1.7466057897763676e-06
. O 0 1.2908008102385793e-06

Genetic O 0 1.8889558361934178e-08
and O 0 5.367802313749337e-10
environmental O 0 1.3290913924990377e-09
variance O 0 5.800747104878212e-10
components O 0 2.611876492863985e-09
were O 0 5.837125227614592e-11
assessed O 0 2.269704868496092e-09
with O 0 2.140149862883689e-11
the O 0 1.1851570835830216e-09
program O 0 1.6424668569658962e-10
Mx O 0 4.934564978853473e-10
, O 0 2.0815760139875072e-12
using O 0 4.386500928113546e-13
data O 0 4.846647388978553e-11
from O 0 4.0938384626709734e-11
this O 0 1.70308645658368e-11
and O 0 1.4724233984853008e-11
previous O 0 2.89713752987808e-10
studies O 0 4.274364473477732e-10
of O 0 9.59421764257229e-10
twins O 0 2.3702034113171067e-08
with O 0 2.7807787184030985e-09
AS B-Disease 1 1.0
. O 0 4.139938312164304e-07

RESULTS O 0 1.9394919092974305e-07
Six O 0 3.832087536181916e-09
of O 0 7.1705974491464985e-09
8 O 0 8.819669972126576e-08
monozygotic O 0 4.6564107947233424e-07
( O 0 1.7154221154669358e-08
MZ O 0 0.0006769128376618028
) O 0 5.731223051697043e-09
twin O 0 1.0298580832568405e-07
pairs O 0 1.1745225236836632e-08
were O 0 1.3297354328756228e-09
disease O 0 1.3299165857461048e-07
concordant O 0 1.1375728092843929e-07
, O 0 5.707054620551766e-11
compared O 0 9.795409622315177e-11
with O 0 1.318047233855868e-12
4 O 0 1.1227135887637019e-09
of O 0 1.0610718970127664e-09
15 O 0 2.5692210581240715e-09
B27 O 0 1.5300381406291308e-08
- O 0 1.376123215379721e-09
positive O 0 2.688854972010546e-10
dizygotic O 0 3.9084905978370443e-08
( O 0 4.77194672665604e-10
DZ O 0 1.3062451387213514e-07
) O 0 1.3656843711462585e-10
twin O 0 3.911486690100219e-09
pairs O 0 8.895228997829463e-10
( O 0 2.085822764508194e-10
27 O 0 8.03466022603061e-08
% O 0 3.641567603018814e-10
) O 0 1.1988647921623574e-12
and O 0 8.728497091770038e-12
4 O 0 7.051672579194701e-10
of O 0 2.8304805166357028e-09
32 O 0 2.8367387017169676e-07
DZ O 0 4.1565253923181444e-05
twin O 0 3.586667389754439e-07
pairs O 0 4.128519393020724e-08
overall O 0 8.892071150512493e-07
( O 0 1.1528200616339745e-09
12 O 0 2.459653103414894e-08
. O 0 1.230963553311426e-09
5 O 0 3.2179446662894406e-08
% O 0 3.771237544469841e-09
) O 0 3.6893460508835574e-10
. O 0 1.681893202487572e-08

Nonsignificant O 0 1.0344840575271519e-06
increases O 0 2.415447841741525e-09
in O 0 1.1499814121795904e-11
similarity O 0 2.651402708497841e-10
with O 0 4.050046702088611e-13
regard O 0 4.7615973663983624e-11
to O 0 3.62976185566688e-12
age O 0 3.1747421358474526e-10
at O 0 3.1214218709774144e-11
disease O 0 4.2772513308975135e-10
onset O 0 6.209941449952794e-10
and O 0 6.762387416529847e-13
all O 0 1.342321869976515e-12
of O 0 2.556626091387848e-11
the O 0 2.370452965860803e-11
disease O 0 4.965125532940817e-10
severity O 0 1.192942855610113e-09
scores O 0 9.057700423031889e-11
assessed O 0 2.9175122318036983e-09
were O 0 3.65598107343601e-10
noted O 0 8.695869024855085e-10
in O 0 1.0981560105705057e-10
disease O 0 1.8100127618936313e-08
- O 0 1.0314287379742382e-07
concordant O 0 2.3801168936188333e-05
MZ O 0 0.0002743534278124571
twins O 0 3.564271011669007e-08
compared O 0 1.8063663898004734e-09
with O 0 1.0555243484811072e-10
concordant O 0 2.125166247424204e-05
DZ O 0 0.0004402607155498117
twins O 0 1.135614456870826e-05
. O 0 8.90053001967317e-07

HLA O 0 6.0952793319302145e-06
- O 0 8.296000828522665e-07
B27 O 0 4.933374384563649e-07
and O 0 1.4733540776301624e-10
B60 O 0 1.0061142141637447e-08
were O 0 7.572984773995817e-12
associated O 0 8.650368615858994e-12
with O 0 2.5277683050016486e-13
the O 0 1.5002648429129906e-11
disease O 0 1.4198737741111245e-09
in O 0 3.485028238214838e-11
probands O 0 0.00013696594396606088
, O 0 1.8944986204805225e-11
and O 0 7.805913901370864e-12
the O 0 3.3221991824206043e-10
rate O 0 3.156189976039059e-09
of O 0 1.0673637668157099e-10
disease O 0 5.5992277481209385e-09
concordance O 0 1.250229142435444e-09
was O 0 4.677004963871134e-11
significantly O 0 1.4649474688877007e-10
increased O 0 6.032029320479637e-10
among O 0 5.324783280968859e-09
DZ O 0 3.8629591472272296e-06
twin O 0 7.633909149262763e-08
pairs O 0 4.158120958663858e-09
in O 0 3.6582337159529743e-10
which O 0 5.477244768847811e-10
the O 0 5.258684154796356e-09
co O 0 1.2484616007668592e-08
- O 0 2.8141547758764318e-08
twin O 0 6.192158963358452e-08
was O 0 2.395069476079925e-09
positive O 0 5.35138218460407e-11
for O 0 6.887739684158234e-11
both O 0 5.9834928123336795e-09
B27 O 0 2.3106956632545916e-06
and O 0 1.9953333207922697e-07
DR1 O 0 0.007227872498333454
. O 0 9.90393118627253e-07

Additive O 0 1.1892771567545424e-07
genetic O 0 7.336853258266274e-08
effects O 0 1.1272334887735269e-07
were O 0 6.253825790558665e-10
estimated O 0 5.078245463030484e-11
to O 0 5.140387247803968e-12
contribute O 0 1.1825777856966369e-10
97 O 0 1.8787502664707745e-09
% O 0 1.1895039640774652e-11
of O 0 6.379598238570594e-12
the O 0 3.006219578827185e-11
population O 0 3.8326536389021726e-11
variance O 0 5.6711764173655865e-09
. O 0 5.2555282792354774e-08

CONCLUSION O 0 1.2723834288408398e-06
Susceptibility O 0 8.42558520730563e-08
to O 0 1.2091000201053248e-08
AS B-Disease 1 1.0
is O 0 1.169748742313459e-09
largely O 0 9.189943250831334e-10
genetically O 0 2.265884285757025e-10
determined O 0 1.3555070399462466e-09
, O 0 8.109798249611444e-11
and O 0 4.9028055920663505e-11
the O 0 3.4939617865603623e-10
environmental O 0 2.223517814314846e-09
trigger O 0 3.5499196915367293e-09
for O 0 1.744838856732045e-10
the O 0 7.803767410052842e-09
disease O 0 1.3840714530033438e-07
is O 0 5.489785293022464e-10
probably O 0 1.69723595178084e-08
ubiquitous O 0 1.3673717376150307e-06
. O 0 1.764489923061774e-07

HLA O 0 2.2621898096986115e-05
- O 0 6.645028634011396e-07
B27 O 0 2.003322379096062e-07
accounts O 0 2.000458999840138e-11
for O 0 2.995255952986664e-13
a O 0 2.762409658657594e-12
minority O 0 1.8005537382251302e-12
of O 0 8.881318423747953e-12
the O 0 1.0613689094274292e-10
overall O 0 7.610495011967089e-10
genetic O 0 4.207440618131386e-09
susceptibility O 0 1.4219945398963318e-07
to O 0 2.3359866929695272e-07
AS B-Disease 1 1.0
. O 0 1.510646484348399e-06

Cell O 0 1.3470817066263407e-06
cycle O 0 7.640406352038553e-08
- O 0 8.889144531565307e-09
dependent O 0 1.2675755556301738e-08
colocalization O 0 6.472861002748687e-08
of O 0 4.5807606596781625e-09
BARD1 O 0 9.663546734373085e-06
and O 0 4.149864896163535e-09
BRCA1 O 0 6.294850196653101e-10
proteins O 0 4.815025114734972e-11
in O 0 3.1746921064224054e-11
discrete O 0 4.0275764945363335e-09
nuclear O 0 1.4874686371513235e-07
domains O 0 7.552197871518729e-07
. O 0 1.543098306910906e-07

Germ O 0 3.612311775214039e-05
- O 0 1.2607549706444843e-06
line O 0 1.356148260356349e-07
mutations O 0 3.0535580730628453e-09
of O 0 4.3265563354211167e-10
the O 0 5.788058921041284e-10
BRCA1 O 0 1.270576421852354e-09
gene O 0 3.3849159031262843e-09
predispose O 0 1.2219261407153681e-05
women O 0 2.229216589100247e-09
to O 0 4.587193402905143e-10
early O 0 1.0233546845483943e-06
- O 0 1.0866867796721635e-06
onset O 1 0.9999997615814209
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 9.22634191269367e-12
compromising O 0 1.6509227318550757e-09
the O 0 1.954007511351108e-10
genes O 0 1.5936992836529384e-09
presumptive O 0 3.463074094156582e-08
function O 0 4.726455338222024e-10
as O 0 4.4651476960311243e-10
a O 0 2.776437968421419e-09
tumor B-Disease 0 9.562196510159993e-07
suppressor O 0 3.341931733302772e-05
. O 0 6.452835918935307e-07

Although O 0 4.52730697375614e-09
the O 0 4.658295971182724e-09
biochemical O 0 1.1245871291976073e-06
properties O 0 2.143606707250001e-06
of O 0 5.155332587492012e-07
BRCA1 O 0 4.968559963458574e-08
polypeptides O 0 1.9025875985789753e-08
are O 0 5.581139023158599e-11
not O 0 1.5545137399541886e-10
understood O 0 1.9280121943410222e-09
, O 0 3.248700961022699e-11
their O 0 2.2489491172117404e-11
expression O 0 1.0301340891416544e-09
pattern O 0 3.5805747256034692e-09
and O 0 9.38262245675503e-11
subcellular O 0 1.6466474050957913e-07
localization O 0 3.377488155820174e-08
suggest O 0 3.0270512763053148e-09
a O 0 7.44824979470593e-10
role O 0 1.9085111269134813e-09
in O 0 3.458702435565897e-09
cell O 0 6.257422455746564e-07
- O 0 1.962020945711629e-07
cycle O 0 2.515121444446322e-08
regulation O 0 2.2774987229468024e-08
. O 0 4.1030531860997144e-08

When O 0 4.002056073204585e-07
resting O 0 7.801821993780322e-06
cells O 0 6.084680848061907e-08
are O 0 1.1375472092067795e-10
induced O 0 6.887299619506848e-09
to O 0 1.5729367808248185e-10
proliferate O 0 7.417008340837583e-09
, O 0 1.9051630065214376e-11
the O 0 2.358125084089835e-10
steady O 0 7.483012431919178e-09
- O 0 4.2077012013530535e-11
state O 0 3.307472351554708e-11
levels O 0 2.641599716746157e-10
of O 0 2.534796816888729e-10
BRCA1 O 0 2.791352149422721e-10
increase O 0 1.8022461301114845e-10
in O 0 2.1055367172007067e-10
late O 0 1.3117903563397704e-07
G1 O 0 3.6492618704642155e-08
and O 0 4.902188724398293e-11
reach O 0 4.077584936368339e-10
a O 0 7.995069883914852e-11
maximum O 0 4.004588660677655e-09
during O 0 1.1338464389609726e-08
S O 0 2.523275952626136e-07
phase O 0 7.177154515147777e-08
. O 0 1.8527563838688366e-07

Moreover O 0 2.126420923787009e-07
, O 0 7.247512034957992e-10
in O 0 2.479822791556785e-09
S O 0 2.1282346551743103e-07
phase O 0 2.9003473400734947e-08
cells O 0 3.351434330056691e-08
, O 0 4.430908973063197e-09
BRCA1 O 0 1.808070315689747e-08
polypeptides O 0 1.0310664322332741e-08
are O 0 5.652749379692068e-10
hyperphosphorylated O 0 1.1446245196111704e-07
and O 0 7.708023108676798e-10
accumulate O 0 1.8107922938881416e-09
into O 0 2.6474811232191087e-10
discrete O 0 1.8940861323812896e-08
subnuclear O 0 8.441089676125557e-07
foci O 0 1.0171751227971981e-06
termed O 0 1.519893544355e-07
" O 0 3.637170564729786e-08
BRCA1 O 0 3.1853389259595133e-07
nuclear O 0 2.8653357730945572e-06
dots O 0 1.0658680366759654e-05
. O 0 1.0683240816433681e-06

" O 0 2.575631015133695e-07
BRCA1 O 0 1.088064891519025e-06
associates O 0 9.151589210887323e-07
in O 0 6.452150369540277e-09
vivo O 0 5.534903202430996e-09
with O 0 1.361169163494047e-11
a O 0 6.67440380741624e-10
structurally O 0 1.7202648194825088e-08
related O 0 2.386575204127439e-08
protein O 0 1.2844280718127266e-05
termed O 0 1.8486912267690059e-06
BARD1 O 0 0.2668153643608093
. O 0 3.4478108545954456e-07

Here O 0 5.750881371113792e-08
we O 0 1.4897444389205816e-09
show O 0 5.300178629319419e-10
that O 0 1.4517565968819035e-11
the O 0 1.6871157249020996e-10
steady O 0 8.021626030085827e-09
- O 0 1.1818292178222833e-10
state O 0 2.2517186726300764e-10
levels O 0 3.320496988479249e-09
of O 0 3.1701146152585125e-09
BARD1 O 0 3.3298685593763366e-05
, O 0 2.8125998058348145e-11
unlike O 0 2.8670231119742873e-11
those O 0 6.652222522829376e-11
of O 0 1.932813464833316e-09
BRCA1 O 0 1.973515573183704e-09
, O 0 5.275958836481465e-11
remain O 0 4.5632478351542716e-10
relatively O 0 5.620743315226662e-10
constant O 0 2.1556008089618217e-09
during O 0 1.2263796644873537e-09
cell O 0 2.6269418640367803e-07
cycle O 0 3.371071244373525e-08
progression O 0 2.8719321676362597e-07
. O 0 4.2177916270702553e-08

However O 0 2.5317558538517915e-07
, O 0 6.9384582523923655e-09
immunostaining O 0 1.6395628108512028e-06
revealed O 0 1.1550038259144912e-08
that O 0 1.204968624879399e-10
BARD1 O 0 6.949353701202199e-05
resides O 0 3.740021981002428e-08
within O 0 7.830571746580972e-10
BRCA1 O 0 3.987493002455267e-09
nuclear O 0 5.160248228719411e-09
dots O 0 2.1378387948800537e-09
during O 0 4.5074699528413475e-10
S O 0 1.8115937638896185e-09
phase O 0 6.306687394541655e-10
of O 0 8.251413996518409e-10
the O 0 1.3302376977719632e-09
cell O 0 1.598354693044257e-08
cycle O 0 1.164030982714337e-09
, O 0 7.868112411602013e-12
but O 0 1.467956312062313e-11
not O 0 7.270186536123546e-11
during O 0 7.595239992497227e-10
the O 0 7.428787807128856e-09
G1 O 0 4.987973625247832e-07
phase O 0 1.2265749660400616e-07
. O 0 2.3472865962048672e-07

Nevertheless O 0 9.049456821230706e-06
, O 0 1.7022293263835309e-07
BARD1 O 0 0.00031276934896595776
polypeptides O 0 3.507480812459107e-07
are O 0 2.689752309770199e-10
found O 0 1.0717620541056405e-10
exclusively O 0 7.720113437414966e-11
in O 0 6.333587300455523e-12
the O 0 8.725688227517736e-11
nuclear O 0 9.518537069652666e-10
fractions O 0 1.8704158222249134e-09
of O 0 3.880099797015646e-09
both O 0 5.046021378518617e-09
G1 O 0 1.5362148531039566e-07
- O 0 1.1895284757201807e-08
and O 0 1.0025626551168898e-08
S O 0 3.3160335988213774e-07
- O 0 2.812341115543404e-08
phase O 0 4.698784650258858e-08
cells O 0 4.125670116650326e-08
. O 0 4.1645758841468705e-08

Therefore O 0 1.19894551176003e-07
, O 0 7.154077885651589e-10
progression O 0 1.1892200113550189e-08
to O 0 8.695936193348075e-10
S O 0 6.808945585135007e-08
phase O 0 5.031346006489912e-09
is O 0 3.930283876130147e-11
accompanied O 0 1.4264175951517188e-10
by O 0 1.698133474115071e-11
the O 0 4.3339151711840884e-10
aggregation O 0 4.779090012618781e-09
of O 0 8.389000050179618e-10
nuclear O 0 4.1226336122690554e-08
BARD1 O 0 5.3300940635381266e-05
polypeptides O 0 6.273825192693039e-07
into O 0 6.807296415445308e-08
BRCA1 O 0 4.413485328313982e-07
nuclear O 0 8.509387612321007e-07
dots O 0 8.477635446979548e-07
. O 0 3.12706418981179e-07

This O 0 1.175118580221124e-08
cell O 0 2.8105455385230016e-07
cycle O 0 1.663725868183974e-08
- O 0 1.9756019042915796e-09
dependent O 0 4.403527320562262e-09
colocalization O 0 6.087675785693136e-08
of O 0 2.0856247839873276e-09
BARD1 O 0 3.5142489650752395e-05
and O 0 1.1827046009216247e-09
BRCA1 O 0 8.623496583481938e-09
indicates O 0 1.2065514143344558e-09
a O 0 3.13102183069347e-11
role O 0 6.645563960239187e-11
for O 0 2.478280081152917e-10
BARD1 O 0 0.0005304652731865644
in O 0 2.568144452652632e-08
BRCA1 O 0 2.1248104076221352e-06
- O 0 7.622154498676537e-06
mediated O 0 1.2113839147787075e-05
tumor B-Disease 0 2.5783836008486105e-06
suppression O 0 1.6083110665476852e-07
. O 0 2.4749287064196324e-08

Ethnic O 0 1.5858072188734695e-08
differences O 0 1.2893629275367857e-08
in O 0 5.406209924174732e-10
the O 0 7.927112299910277e-09
HFE O 0 7.792213000357151e-05
codon O 0 6.077055445530277e-07
282 O 0 4.3116213532812253e-07
( O 0 7.62394165576552e-08
Cys O 0 2.618402140797116e-05
/ O 0 2.5955694127333118e-06
Tyr O 0 4.840843530473649e-07
) O 0 2.2768190111044362e-10
polymorphism O 0 2.695233369820471e-09
. O 0 3.711129181738215e-08

Recent O 0 1.8482344543713225e-08
studies O 0 2.796122444692628e-09
have O 0 3.4586840769873506e-12
shown O 0 3.2199534705235067e-11
that O 0 2.9477945084899204e-10
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 0.4422589838504791
HH B-Disease 1 0.9999996423721313
) O 0 1.7793816420308417e-10
is O 0 1.7431946511270446e-11
likely O 0 4.5088606459575686e-11
to O 0 2.1331851215999897e-11
be O 0 7.64174973300058e-11
caused O 0 6.422690712604151e-10
by O 0 9.722778138154808e-11
homozygosity O 0 2.984742195621948e-07
for O 0 9.391108723999508e-11
a O 0 1.6505197208971367e-09
Cys282Tyr O 0 6.981618838608483e-08
mutation O 0 3.7321654100530566e-10
in O 0 1.0056373789257833e-10
the O 0 6.296509980074916e-09
HFE O 0 7.2126190389099065e-06
gene O 0 1.3063721837625053e-07
located O 0 1.5061524436532636e-06
4 O 0 8.34036939068028e-07
. O 0 1.6682388093158806e-07

5 O 0 6.512130312330555e-06
Mb O 0 2.0615418634406524e-06
telomeric O 0 3.5910934457206167e-06
to O 0 5.0296023346163565e-08
HLA O 0 5.231722298049135e-06
- O 0 7.797170269441267e-07
A O 0 1.7476088487455854e-06
. O 0 2.4372647899895128e-08

Population O 0 1.7955632536370558e-09
studies O 0 4.5856185515447123e-10
of O 0 1.0429386521071393e-10
this O 0 6.6525613143242346e-12
polymorphism O 0 1.785405989718214e-10
are O 0 1.4202272170804608e-11
facilitated O 0 6.26442731022081e-10
by O 0 8.62680673424654e-12
the O 0 1.475795319283435e-10
fact O 0 7.662519230233755e-11
that O 0 2.4661836808825832e-11
the O 0 1.135765814730405e-09
Cys282Tyr O 0 5.168377583686379e-07
mutation O 0 1.7376535765833978e-08
creates O 0 1.714692743348678e-08
a O 0 1.955232420414177e-08
Rsal O 0 2.905759856730583e-06
restriction O 0 6.256647111513303e-07
site O 0 3.5251637200417463e-06
. O 0 4.831867954635527e-07

We O 0 7.619853192863957e-09
have O 0 2.7598212604118544e-10
studied O 0 1.9880417312378995e-09
the O 0 2.820917666124245e-10
codon O 0 4.944424603081643e-08
282 O 0 7.4800468041758e-08
( O 0 1.7048700229338465e-08
Cys O 0 9.113154192164075e-06
/ O 0 2.8557093401104794e-07
Tyr O 0 5.768711730524956e-08
) O 0 4.859956621167116e-12
polymorphism O 0 6.692625620363657e-12
in O 0 2.741079715637418e-12
different O 0 3.9424314507430225e-11
ethnic O 0 5.531924363033625e-10
groups O 0 5.044690776223604e-10
. O 0 9.669156142422253e-09

In O 0 7.428911374951497e-10
agreement O 0 4.206092807379491e-09
with O 0 2.952879954443155e-11
previous O 0 3.8216936282253755e-09
observations O 0 1.0760524027375595e-08
the O 0 1.0346808965167043e-09
Tyr O 0 1.4884136589898844e-07
allele O 0 4.159294686445492e-09
appeared O 0 2.733450799041748e-09
to O 0 1.2557946349467386e-10
be O 0 6.773483163247107e-11
rare O 0 7.48860529142803e-10
or O 0 2.749030170168254e-10
absent O 0 8.14207545829504e-09
in O 0 2.5098761957664806e-10
Asiatic O 0 3.0881338375365885e-08
( O 0 1.9842554682680813e-11
Indian O 0 5.304757327850851e-11
, O 0 3.8116145656408307e-11
Chinese O 0 1.5186112367615578e-09
) O 0 8.424994035749478e-11
populations O 0 3.795295633324258e-09
. O 0 3.470771403613071e-08

The O 0 9.342737250506161e-09
highest O 0 7.0615016056763125e-09
allele O 0 2.6189448387725633e-09
frequency O 0 6.617449921364482e-10
( O 0 4.274688242267288e-11
7 O 0 7.614561203794779e-10
. O 0 6.00498123448645e-11
5 O 0 1.5945841314035647e-09
% O 0 2.03832090095446e-10
) O 0 2.9018133382296973e-12
was O 0 3.0725846866808126e-10
found O 0 4.358899352574497e-11
in O 0 3.801502723721484e-10
Swedes O 0 1.1955543754993414e-07
. O 0 4.156641182362364e-07

Saamis O 0 1.3014076102990657e-05
( O 0 4.692575217291051e-09
2 O 0 3.252153035759875e-08
% O 0 8.75919281551063e-10
) O 0 5.688132256875811e-12
and O 0 7.72361827272583e-11
Mordvinians O 0 1.0811873174532138e-08
( O 0 2.1716517473180375e-11
1 O 0 1.083428680104248e-09
. O 0 1.2602698051811245e-10
8 O 0 2.1138510941653976e-09
% O 0 8.612474622360367e-11
) O 0 8.23712354835332e-13
had O 0 1.4857956878722156e-11
significantly O 0 6.033636784641416e-11
lower O 0 1.4576671814037212e-10
frequencies O 0 2.676482646624123e-10
of O 0 8.246411331569448e-10
the O 0 8.003317120142128e-09
Tyr O 0 1.2171009302619495e-06
allele O 0 1.3375037610785512e-07
. O 0 2.340549372092937e-07

Comparisons O 0 4.094367866969151e-08
with O 0 2.352065486821431e-10
allele O 0 9.077010254543438e-09
frequencies O 0 2.5414061965989276e-09
based O 0 1.6677179082158489e-10
on O 0 1.2077988609249246e-10
prevalence O 0 6.662857821027046e-09
estimates O 0 7.047921135594493e-10
of O 0 1.6070599295758825e-09
HH B-Disease 1 0.9999984502792358
showed O 0 1.5698803963459795e-06
some O 0 1.2392848525166755e-08
disagreements O 0 3.2628275903334725e-07
with O 0 2.7631819055073947e-10
the O 0 3.5919023311237197e-09
RFLP O 0 6.660521734147551e-08
data O 0 9.9952304211115e-09
, O 0 3.567974526941242e-10
particularly O 0 1.8959138703422695e-09
in O 0 3.0317199861684685e-09
Finns O 0 3.1685510748502566e-07
. O 0 3.3414778499718523e-07

The O 0 5.571840233642433e-07
newly O 0 3.930023012799211e-06
described O 0 1.4071524390146806e-07
HFE O 0 0.01704546995460987
marker O 0 4.839744747187069e-07
provides O 0 5.584530615720951e-09
a O 0 2.4335325421454e-10
new O 0 3.02282615605165e-10
approach O 0 1.150164130603315e-10
to O 0 2.2291888820968886e-11
the O 0 1.325187459766397e-10
screening O 0 1.5327501767803398e-10
of O 0 3.10199932407329e-09
HH B-Disease 0 7.92745195212774e-05
as O 0 3.717844032635753e-09
well O 0 1.9534336648252548e-10
as O 0 2.7840875438389645e-11
studies O 0 2.1029749122658536e-11
of O 0 1.8807348040050798e-11
the O 0 8.467476025897369e-11
relationship O 0 5.304597872068939e-10
between O 0 2.8377022953662845e-09
the O 0 2.694350698106973e-08
HFE O 0 6.96424103807658e-05
Tyr O 0 5.201785029385064e-07
allele O 0 6.30754515285048e-09
and O 0 5.325989094195904e-10
different O 0 6.145304265459117e-09
disorders O 0 8.873485057847574e-05
including O 0 2.125699154476024e-07
cancer B-Disease 1 0.9999997615814209

Autosomal B-Disease 1 0.9999659061431885
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9986262321472168
associated O 0 8.470565360241267e-10
with O 0 1.2221209287621715e-12
a O 0 5.3457308024640326e-11
missense O 0 3.1766211883166307e-09
mutation O 0 2.53533832816899e-10
encoding O 0 7.110938504695241e-10
Gly23 O 0 6.078521153085603e-08
- O 0 7.823126146888626e-09
- O 0 1.362605139831885e-08
> O 0 3.882424604029211e-09
Val O 0 5.411058823234782e-10
in O 0 2.69401917440959e-10
neurophysin O 0 1.3972061196909635e-07
II O 0 2.2519393496622797e-06
. O 0 1.4914516555109003e-07

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 3.740386205208779e-07
ADNDI B-Disease 1 1.0
) O 0 9.995143601670975e-11
is O 0 7.607918635355038e-12
an O 0 2.5461972807949707e-11
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 1.5989698454177415e-09
by O 0 3.320098970055474e-12
progressive O 0 3.7998863717803033e-06
degeneration O 1 1.0
of O 0 6.172907740520372e-10
the O 0 5.341289632809776e-10
magnocellular O 0 4.0333130613134927e-08
neurons O 0 8.647016436214017e-09
of O 0 3.4888741895500175e-10
the O 0 5.676411007904392e-10
hypothalamus O 0 4.035912493094429e-09
leading O 0 6.021901866049006e-10
to O 0 1.0775464548418157e-10
decreased O 0 3.825806782487007e-09
ability O 0 3.98388544375905e-11
to O 0 1.5126380703556208e-10
produce O 0 4.716786072833656e-09
the O 0 8.288201236439363e-09
hormone O 0 5.772871958242831e-08
arginine O 0 3.918448499007354e-07
vasopressin O 0 1.3253247743705288e-06
( O 0 1.0421328511256434e-07
AVP O 0 8.498102943121921e-06
) O 0 1.3311749924582728e-08
. O 0 8.728264333512925e-08

Affected O 0 1.1782061193343907e-07
individuals O 0 6.4292482448991e-10
are O 0 4.113892559942656e-11
not O 0 4.436688516573639e-11
symptomatic O 0 1.1195811566722114e-06
at O 0 1.5254916219120673e-09
birth O 0 3.5622780281130417e-09
, O 0 3.38608759087311e-11
but O 0 2.8865240059294806e-11
usually O 0 2.8908891946954896e-10
develop O 0 2.1015747364572235e-08
diabetes B-Disease 1 0.9857624769210815
insipidus I-Disease 0 0.0011324638035148382
at O 0 1.1968795732286708e-08
1 O 0 7.906881194230664e-08
- O 0 7.178427807730259e-08
6 O 0 4.527719283942133e-07
yr O 0 8.420394124186714e-07
of O 0 4.174660261924146e-08
age O 0 3.0563336395061924e-07
. O 0 2.1101547531543474e-07

The O 0 8.032262077684038e-10
genetic O 0 1.0588526500043827e-08
locus O 0 1.7592670431554325e-08
of O 0 1.4256131830592267e-09
the O 0 6.931814566790706e-10
disease O 0 3.312705132429983e-08
is O 0 3.732635311948229e-10
the O 0 1.757050327455545e-08
AVP O 0 1.9525345123838633e-05
- O 0 8.338317343259405e-07
neurophysin O 0 1.239507764694281e-05
II O 0 0.4342086613178253
( O 0 2.4046375557418287e-08
NPII O 0 0.004270642530173063
) O 0 2.532825060796995e-10
gene O 0 2.5498885225516688e-09
, O 0 2.234648466270528e-09
and O 0 9.289674030021899e-10
mutations O 0 7.2869088540983284e-09
that O 0 1.3559821321340593e-10
cause O 0 7.33425125076792e-08
ADNDI B-Disease 1 0.9606406092643738
have O 0 7.899306209147028e-10
been O 0 5.100700972704431e-10
found O 0 6.096242261000029e-11
in O 0 3.175909188413151e-11
both O 0 4.5339735438298945e-11
the O 0 2.583026847968739e-10
signal O 0 7.801713053368076e-09
peptide O 0 2.443379942818069e-09
of O 0 1.3722265101989706e-08
the O 0 7.947220836967972e-08
prepro O 0 1.81658524525119e-05
- O 0 1.7145401216112077e-05
AVP O 0 4.448622348718345e-05
- O 0 3.5799598663288634e-06
NPII O 0 0.00010004998330259696
precursor O 0 1.405253442499088e-07
and O 0 1.15394427346871e-09
within O 0 4.0329730666144314e-09
NPII O 0 0.001216428936459124
itself O 0 8.257085681862009e-09
. O 0 3.5932743003286305e-08

An O 0 1.7365991977769113e-09
affected O 0 9.463979822044166e-09
girl O 0 8.547612395659598e-09
who O 0 7.150081082762938e-10
presented O 0 1.95464600061257e-09
at O 0 1.114550340908238e-09
9 O 0 4.700779210331518e-10
months O 0 6.318351397638367e-11
of O 0 3.3858374437478744e-10
age O 0 6.898396076593372e-09
and O 0 3.1320149251889973e-10
her O 0 2.441836455258084e-10
similarly O 0 3.07448400072019e-10
affected O 0 1.079433431527832e-09
younger O 0 2.9491976860640534e-08
brother O 0 4.775120032718405e-08
and O 0 1.026564877548708e-08
father O 0 9.24626633036496e-08
were O 0 1.225173296148796e-09
all O 0 3.796566186431427e-11
found O 0 2.496887245573287e-11
to O 0 1.5168121966779857e-11
have O 0 7.824471973116864e-12
a O 0 7.456547185258344e-11
novel O 0 7.645588606663978e-10
missense O 0 1.7981550470835828e-08
mutation O 0 1.730152132672913e-09
( O 0 9.287760560638958e-10
G1758 O 0 9.369455256091896e-08
- O 0 1.3516298302818086e-08
- O 0 2.258577325164879e-08
> O 0 1.9000192530427285e-09
T O 0 5.514173562204405e-10
) O 0 8.331740787743958e-13
encoding O 0 2.6132389654986987e-11
the O 0 8.028203102306009e-10
amino O 0 9.973629699899789e-10
acid O 0 9.042924742352909e-11
substitution O 0 4.773476058872461e-10
Gly23 O 0 3.268619863661115e-08
- O 0 8.55945714306472e-09
- O 0 2.1457037036043403e-08
> O 0 1.034825469758971e-08
Val O 0 4.760186023133883e-09
within O 0 1.030533525181454e-08
NPII O 0 0.00010017160093411803
. O 0 9.395780153909072e-08

The O 0 1.2235069846155966e-07
mutation O 0 3.054474007058161e-08
was O 0 9.447423288122536e-09
confirmed O 0 2.0859340643664126e-10
by O 0 2.927956488374406e-11
restriction O 0 1.2258470682979805e-08
endonuclease O 0 4.0190457184507977e-07
analysis O 0 7.160910087122829e-08
. O 0 1.1110174114037363e-07

A O 0 8.229751074395608e-06
T1 O 0 9.694783329905476e-06
- O 0 1.6954079029574132e-08
weighted O 0 4.718837320893954e-09
magnetic O 0 2.3396404258413384e-10
resonance O 0 1.1879311423435013e-10
imaging O 0 7.285796854716864e-09
of O 0 1.458786091923514e-09
the O 0 1.610620437020316e-08
fathers O 0 1.942177050295868e-06
pituitary O 0 1.980069100682158e-05
gland O 0 1.0631264331095736e-06
demonstrates O 0 4.501331574147116e-08
an O 0 4.764455052708172e-09
attenuated O 0 4.6177348849596456e-05
posterior O 0 0.00019954868184868246
pituitary O 1 0.7795708775520325
bright O 1 0.7943822145462036
spot O 0 0.00014215492410585284
. O 0 1.7659727973295958e-06

This O 0 9.741368600657552e-09
mutation O 0 2.0804925782158534e-08
may O 0 4.395739772178331e-09
be O 0 1.9514674598486437e-10
valuable O 0 1.014705652835346e-08
for O 0 5.7473744513591996e-11
developing O 0 1.7939680851952744e-09
models O 0 1.0554731311174237e-08
of O 0 4.420627419676748e-09
dominantly B-Disease 0 9.430893442186061e-06
inherited I-Disease 0 0.2984232008457184
neurodegeneration I-Disease 1 1.0
, O 0 3.336455556279816e-10
as O 0 2.8177545366436796e-11
the O 0 9.068448249271999e-12
early O 0 6.389173218268596e-11
age O 0 1.5461187885534855e-10
of O 0 6.553774883899521e-11
onset O 0 6.29219059078423e-08
of O 0 8.787354732753272e-10
symptoms O 0 1.8105899357578892e-07
suggests O 0 1.5210636084006524e-09
that O 0 2.2652437217662857e-11
this O 0 1.4391798863755412e-10
mutation O 0 1.1094050123006127e-09
may O 0 4.3595166365761884e-10
be O 0 8.565070319654922e-10
particularly O 0 5.606879849295865e-09
deleterious O 0 7.263307679750142e-07
to O 0 1.1836712054957843e-08
the O 0 3.7194135416029894e-07
magnocellular O 0 2.3380214770440944e-05
neuron O 0 1.0912199286394753e-05
. O 0 3.3548499089874895e-08
. O 0 2.3859615794208366e-07

Frequent O 0 1.2661190851304127e-07
inactivation O 0 1.617910356799257e-06
of O 0 1.2814273020467226e-07
PTEN O 1 0.9999982118606567
/ O 1 0.7751210927963257
MMAC1 O 1 1.0
in O 0 6.153822340593251e-08
primary O 1 0.9999942779541016
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.968512357095278e-08

Sporadic B-Disease 1 0.9999998807907104
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 1.4223918709532768e-09
the O 0 1.125684961911233e-10
most O 0 1.3233580030413972e-11
common O 0 4.578720735892716e-11
male B-Disease 0 6.703565480492557e-11
cancer I-Disease 0 2.445775248993698e-10
in O 0 5.267590617169526e-12
the O 0 1.6657374091177957e-10
Western O 0 2.9622302388787602e-09
world O 0 9.407315898490864e-11
, O 0 6.5164397315686795e-12
yet O 0 1.3802356826908557e-11
many O 0 4.690295461046157e-12
of O 0 3.807923074083952e-11
the O 0 3.176048660180619e-11
major O 0 1.193524862275197e-10
genetic O 0 2.526147901971143e-10
events O 0 7.788710648659602e-11
involved O 0 7.110311645019962e-11
in O 0 5.342784895057129e-11
the O 0 5.221421628398559e-10
progression O 0 6.449248957096643e-08
of O 0 1.4023283645414608e-09
this O 0 8.160012665570093e-10
often O 0 2.628264006432346e-08
fatal O 0 1.1274006510575418e-06
cancer B-Disease 0 3.6568467294273432e-06
remain O 0 2.3485757338903568e-08
to O 0 3.0267857109578244e-09
be O 0 3.082578459157048e-08
elucidated O 0 3.826697138720192e-05
. O 0 4.256507111222163e-07

Numerous O 0 1.2951679195793986e-07
cytogenetic O 0 1.1989952326985076e-05
and O 0 9.885812168874963e-09
allelotype O 0 3.45756120623264e-06
studies O 0 1.3549020794201283e-09
have O 0 2.5935495071016668e-12
reported O 0 3.216375082937262e-11
frequent O 0 2.2169051316911492e-11
loss O 0 2.0655800681002034e-10
of O 0 1.602908805686809e-09
heterozygosity O 0 0.02909402921795845
on O 0 1.9813128915302514e-07
chromosomal O 0 4.880420874542324e-06
arm O 0 7.369333729911887e-07
10q O 0 5.415301984612597e-07
in O 0 2.83975976067552e-09
sporadic B-Disease 1 0.99998939037323
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.449172254477162e-07

Deletion O 0 1.8319465766580834e-07
mapping O 0 1.469809660648025e-07
studies O 0 5.467832853156551e-09
have O 0 4.4779898539237806e-11
unambiguously O 0 2.5614312892940916e-09
identified O 0 6.547743458540367e-10
a O 0 2.291846296076372e-10
region O 0 4.886659077385502e-09
of O 0 2.075473792828575e-09
chromosome O 0 1.1620485018681848e-08
10q23 O 0 6.238296634819562e-08
to O 0 2.1083336465554936e-10
be O 0 5.859546875486288e-11
the O 0 1.9441931398134216e-10
minimal O 0 6.39432684579333e-08
area O 0 1.2664450821375794e-07
of O 0 2.046222746798776e-08
loss O 0 6.200650091159332e-07
. O 0 8.077713005150144e-07

A O 0 4.9888380999618676e-06
new O 0 1.789632477766645e-07
tumor B-Disease 0 8.283573151857127e-07
suppressor O 0 2.4346852569578914e-06
gene O 0 6.79428637795354e-08
, O 0 2.700529755372827e-08
PTEN O 0 0.00021950082737021148
/ O 0 1.833257215366757e-06
MMAC1 O 0 0.05699572339653969
, O 0 4.0860706485013054e-10
was O 0 2.9939712931081885e-09
isolated O 0 1.8493090392368572e-09
recently O 0 1.0583386250706539e-10
at O 0 2.0579303885992495e-11
this O 0 2.46003304532616e-12
region O 0 1.2980967689646405e-10
of O 0 5.359914734270887e-10
chromosome O 0 3.349700961052804e-09
10q23 O 0 6.351370274160217e-08
and O 0 3.300781314941048e-10
found O 0 1.1129077520655173e-10
to O 0 1.315725167705395e-10
be O 0 1.3434091339359355e-10
inactivated O 0 5.561504035078713e-10
by O 0 2.9506152295771804e-12
mutation O 0 6.192530932480622e-10
in O 0 2.74991140969405e-10
three O 0 4.8398376861769066e-08
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 1.8228126918984344e-06
lines O 0 5.81787205078399e-08
. O 0 2.7154205994861513e-08

We O 0 2.2325839665882086e-07
screened O 0 7.460724873453728e-07
80 O 0 6.766273941138934e-07
prostate B-Disease 0 6.015547114657238e-06
tumors I-Disease 1 1.0
by O 0 1.822982598209677e-10
microsatellite O 0 1.1642625530328132e-08
analysis O 0 3.612346810566436e-10
and O 0 5.646992248808935e-11
found O 0 8.712151139400603e-11
chromosome O 0 3.4213818445039124e-09
10q23 O 0 1.9910597615080405e-08
to O 0 1.5366000694072568e-09
be O 0 2.182158675978485e-09
deleted O 0 9.005822754204473e-09
in O 0 5.619639198428672e-10
23 O 0 9.034209824676509e-09
cases O 0 2.688753664159549e-09
. O 0 5.269660974249746e-08

We O 0 1.4500705525222202e-08
then O 0 4.504318251719042e-09
proceeded O 0 2.8728122103416354e-09
with O 0 2.086328749735869e-13
sequence O 0 3.8247720962614196e-12
analysis O 0 2.190504895527301e-11
of O 0 7.982057376176854e-11
the O 0 5.880149700487891e-10
entire O 0 7.604771212754713e-08
PTEN O 0 2.9006743716308847e-05
/ O 0 1.7573646005075716e-07
MMAC1 O 0 3.0224457532312954e-06
coding O 0 6.173924038677114e-09
region O 0 4.347810556026843e-09
and O 0 3.1168172209827816e-11
tested O 0 1.815680765460126e-11
for O 0 6.388584539857023e-12
homozygous O 0 2.3321641839935126e-10
deletion O 0 2.12237449837005e-10
with O 0 3.2537236793750424e-11
new O 0 6.0027769421822086e-09
intragenic O 0 1.1280953913228586e-06
markers O 0 4.8697462062818886e-08
in O 0 2.5891086496976357e-10
these O 0 2.0001471312536268e-10
23 O 0 3.2483447043318847e-09
cases O 0 1.2142201133436004e-10
with O 0 2.6420317322806142e-11
10q23 O 0 2.8159007570138783e-07
loss O 0 2.3418884609327506e-08
of O 0 1.533310864942905e-07
heterozygosity O 0 0.00010572424798738211
. O 0 2.1348707832657965e-06

The O 0 8.698419068364771e-11
identification O 0 3.0982905130372274e-10
of O 0 7.67434116255572e-10
the O 0 4.6273351816950026e-10
second O 0 1.7431831533798459e-09
mutational O 0 1.589798017676003e-07
event O 0 2.612788208011807e-09
in O 0 7.962810411044074e-10
10 O 0 3.835992856693338e-09
( O 0 5.498409505477753e-10
43 O 0 4.3943757077613554e-07
% O 0 5.363591881746288e-08
) O 0 3.4950835559044435e-09
tumors B-Disease 1 1.0
establishes O 0 4.808300673175836e-07
PTEN O 0 0.002752151805907488
/ O 0 3.87533782486571e-06
MMAC1 O 0 0.00037614040775224566
as O 0 4.699326483503796e-10
a O 0 1.0558506152724689e-10
main O 0 6.15903050782407e-10
inactivation O 0 1.8778976151878624e-09
target O 0 4.6482467874753297e-10
of O 0 9.160525116236329e-10
10q O 0 1.8742635177204647e-07
loss O 0 1.7951668596083437e-08
in O 0 4.98573982099515e-09
sporadic B-Disease 1 0.9999977350234985
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.544179781935554e-09
. O 0 8.363473469330529e-09

Risk O 0 4.531525021889138e-08
reversals O 0 1.8001493629071774e-07
in O 0 1.1076727729486535e-10
predictive O 0 5.271236780401978e-09
testing O 0 7.63453883445564e-11
for O 0 6.87536527710364e-10
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.1587400194912334e-07

The O 0 9.579113058322264e-10
first O 0 4.480261994732615e-11
predictive O 0 3.73969744060787e-10
testing O 0 4.089146556085499e-12
for O 0 1.6819941273116257e-10
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 3.589304686801853e-10
HD B-Disease 0 2.0240156217710137e-08
) O 0 4.2065357273857185e-12
was O 0 4.546391388360327e-11
based O 0 1.5091445454418206e-11
on O 0 2.3418491104654215e-11
analysis O 0 1.964583357105809e-10
of O 0 5.812286762996166e-10
linked O 0 4.232715067331583e-09
polymorphic O 0 2.6963491439602194e-09
DNA O 0 3.4123297520949336e-09
markers O 0 3.307343288128095e-09
to O 0 4.609433321145495e-11
estimate O 0 1.3019680888959329e-09
the O 0 2.6601441535656356e-11
likelihood O 0 2.587061231906773e-09
of O 0 3.1773241815358233e-09
inheriting O 0 3.781947555125953e-07
the O 0 2.1694980034681066e-08
mutation O 0 4.4204249149970565e-09
for O 0 4.33416547096499e-09
HD B-Disease 0 1.8767599613056518e-05
. O 0 1.301790916841128e-06

Limits O 0 6.006934505364825e-09
to O 0 1.0540115308321774e-10
accuracy O 0 5.394799718061449e-09
included O 0 9.678796653034283e-11
recombination O 0 1.581993147592442e-10
between O 0 8.092728154274198e-10
the O 0 4.219364302393558e-10
DNA O 0 1.2848720976066375e-09
markers O 0 1.3933920683939505e-08
and O 0 1.9914307980428703e-09
the O 0 1.3656049624444222e-08
mutation O 0 1.3084414440811543e-08
, O 0 1.0666642014101058e-09
pedigree O 0 1.8601213014335372e-07
structure O 0 8.103764059796958e-08
, O 0 1.7792468609556522e-09
and O 0 1.1244386532993644e-09
whether O 0 7.296055426486703e-10
DNA O 0 2.480257776937833e-09
samples O 0 7.933218526545716e-10
were O 0 7.038822996685568e-11
available O 0 4.129665220897749e-10
from O 0 2.7592648166319123e-09
family O 0 9.094721420410679e-09
members O 0 3.1902467334532503e-09
. O 0 5.222522503345317e-08

With O 0 1.487114875686757e-10
direct O 0 2.1560777607732007e-09
tests O 0 1.616086257871796e-11
for O 0 1.211365591169411e-10
the O 0 5.491285204328733e-09
HD B-Disease 0 2.433925487821398e-07
mutation O 0 2.08228589926307e-09
, O 0 9.791954053151031e-11
we O 0 4.514299004054756e-11
have O 0 1.438715292734205e-11
assessed O 0 2.809305232887027e-09
the O 0 1.9365616055200263e-10
accuracy O 0 3.6394052216337514e-08
of O 0 7.516757882797265e-09
results O 0 2.801829657173016e-09
obtained O 0 8.908272342011969e-09
by O 0 3.659071379225054e-10
linkage O 0 8.755275615612845e-08
approaches O 0 1.0267724448453919e-08
when O 0 2.501684415179284e-10
requested O 0 5.206206021846072e-10
to O 0 6.36213082216841e-10
do O 0 5.060505348097877e-10
so O 0 1.2950575334347292e-10
by O 0 3.764191389143967e-11
the O 0 1.540008814915339e-10
test O 0 3.2697872187625876e-11
individuals O 0 7.216668373999369e-10
. O 0 9.46918277122677e-08

For O 0 7.9883566428407e-09
six O 0 2.0871449013526444e-09
such O 0 3.9222781272885143e-11
individuals O 0 9.8442004548005e-11
, O 0 8.547566300587395e-12
there O 0 1.1578644943874283e-12
was O 0 1.55745694119247e-11
significant O 0 4.674882356225929e-11
disparity O 0 8.61777493810223e-09
between O 0 4.129714348266589e-09
the O 0 1.760411549867058e-08
tests O 0 2.6537312347585384e-09
. O 0 6.159423548979248e-08

Three O 0 1.0404566097577117e-07
went O 0 4.851612445122555e-08
from O 0 1.1011705991492704e-09
a O 0 1.1036684899323745e-09
decreased O 0 3.1060089611401054e-08
risk O 0 1.5236821526709576e-10
to O 0 2.95081944989839e-11
an O 0 8.61043736311018e-11
increased O 0 7.115226186016343e-10
risk O 0 4.4298839596557116e-10
, O 0 2.004270534261554e-11
while O 0 4.8365266652750094e-11
in O 0 3.708194515339436e-11
another O 0 2.192972609060817e-10
three O 0 8.835635695314537e-11
the O 0 1.0864417143707783e-09
risk O 0 8.953344732276491e-09
was O 0 1.3188344638592753e-08
decreased O 0 1.1161596091824322e-07
. O 0 7.279757596734271e-08

Knowledge O 0 1.3573580304182542e-07
of O 0 4.6781185147892757e-08
the O 0 1.935159588128954e-09
potential O 0 8.235003789991424e-09
reasons O 0 1.4447748553081396e-09
for O 0 1.5880205136986625e-11
these O 0 3.130150305619139e-11
changes O 0 1.0355392238148298e-10
in O 0 3.480537733024924e-11
results O 0 2.062395254576188e-10
and O 0 6.156290754955052e-11
impact O 0 6.691321718932386e-09
of O 0 2.897679041158341e-10
these O 0 6.684885284213848e-11
risk O 0 8.330323653105154e-10
reversals O 0 1.167006047353425e-08
on O 0 1.2518064362865289e-09
both O 0 1.5914021489482622e-10
patients O 0 1.5988378676556891e-10
and O 0 2.1661672455763892e-10
the O 0 7.86466891611326e-10
counseling O 0 1.8878877627859225e-10
team O 0 1.538030258707579e-10
can O 0 4.0407066581593654e-11
assist O 0 4.7346868647935025e-09
in O 0 4.910369888477817e-10
the O 0 4.237917128335766e-09
development O 0 2.3432599860484515e-08
of O 0 7.36830207959116e-10
strategies O 0 5.408726244660045e-10
for O 0 6.175118749673913e-11
the O 0 8.837055531785154e-10
prevention O 0 7.655660994032587e-09
and O 0 2.0697288327653496e-10
, O 0 5.404310332579598e-11
where O 0 1.3728926329115154e-10
necessary O 0 1.2048221309512996e-09
, O 0 6.726696977210622e-11
management O 0 1.760561002539518e-10
of O 0 4.680237863929904e-10
a O 0 6.963326026898642e-10
risk O 0 3.27131255417612e-09
reversal O 0 3.979211182780773e-09
in O 0 2.6201865330199858e-11
any O 0 2.559476519614634e-10
predictive O 0 1.2339331334487724e-08
testing O 0 5.344489850678258e-10
program O 0 3.4137745963391808e-09
. O 0 9.354002017403218e-10
. O 0 3.207417265116419e-08

A O 0 1.6744871800256078e-07
novel O 0 9.827402003281804e-09
common O 0 1.1284757572838089e-09
missense O 0 1.3414496891073213e-07
mutation O 0 2.752536643058079e-09
G301C O 0 2.8727530576588833e-08
in O 0 3.36399630374018e-10
the O 0 5.454249496494867e-09
N O 0 5.447308026873543e-08
- O 0 1.1362994101205004e-08
acetylgalactosamine O 0 2.3651733727092505e-07
- O 0 1.2394740345200717e-08
6 O 0 2.376386909475059e-08
- O 0 2.1758164159280113e-09
sulfate O 0 1.346205591445937e-09
sulfatase O 0 3.4877181143144753e-09
gene O 0 2.0920142007607723e-10
in O 0 1.159767171188264e-09
mucopolysaccharidosis B-Disease 0 5.759438408858841e-06
IVA I-Disease 1 0.9972921013832092
. O 0 3.5773114177573007e-06

Mucopolysaccharidosis B-Disease 0 0.0005288386018946767
IVA I-Disease 1 1.0
( O 0 4.343958789831959e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 1.5893887317375288e-09
is O 0 4.216031690429389e-11
an O 0 7.641404176084166e-10
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 7.536923476436641e-07
by O 0 8.586522118325668e-12
a O 0 8.340227952707835e-10
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 2.928019215975297e-10
N O 0 4.950754028953952e-09
- O 0 9.255927690965393e-10
acetylgalactosamine O 0 2.562351220092296e-08
- O 0 1.549638639630757e-09
6 O 0 7.103175381217852e-09
- O 0 3.5568463729873656e-09
sulfate O 0 3.109931867584237e-09
sulfatase O 0 4.2576964176532783e-08
( O 0 3.3596634363419753e-09
GALNS O 0 1.1375990652595647e-05
) O 0 5.232650313047316e-09
. O 0 6.570230226543572e-08

In O 0 3.728583308770794e-08
previous O 0 3.402998629553622e-07
studies O 0 3.2144356509888894e-08
, O 0 1.4906020862071045e-10
we O 0 1.3795757591861246e-10
have O 0 6.500292665245766e-11
found O 0 1.193331405913156e-10
two O 0 2.4970969736415327e-11
common O 0 6.654544970619014e-11
mutations O 0 2.301180634933786e-10
in O 0 9.44453126816569e-11
Caucasians O 0 1.988060827073923e-09
and O 0 3.864823183707955e-10
Japanese O 0 6.101532079583194e-08
, O 0 1.4388128466436e-09
respectively O 0 1.3254567221565594e-08
. O 0 1.3787438035706145e-07

To O 0 6.492567816707151e-09
characterize O 0 1.4224745825686114e-07
the O 0 1.2611054422961843e-08
mutational O 0 2.6399561647849623e-06
spectrum O 0 4.260393282606856e-08
in O 0 8.497374331950525e-11
various O 0 1.5936954533835035e-10
ethnic O 0 1.8509949128997505e-10
groups O 0 1.49525131859507e-11
, O 0 5.327833226681511e-12
mutations O 0 4.22108493991491e-11
in O 0 3.295369532807513e-11
the O 0 1.218061873586862e-09
GALNS O 0 3.1486882789977244e-07
gene O 0 1.18668561088775e-10
in O 0 4.612883131027701e-10
Colombian O 0 1.4395359926311357e-07
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 2.00824565865787e-08
were O 0 9.632870057174614e-10
investigated O 0 1.9371724224725995e-09
, O 0 5.1063639427972873e-11
and O 0 2.6795558827341637e-11
genetic O 0 1.005657113140046e-09
backgrounds O 0 1.0110234427429532e-08
were O 0 1.1905039176696164e-09
extensively O 0 3.2729835508504834e-10
analyzed O 0 2.741155635810344e-10
to O 0 2.921763872509864e-11
identify O 0 1.8683727898149982e-09
racial O 0 9.382770116417305e-10
origin O 0 9.143836243730163e-10
, O 0 1.450093344013137e-11
based O 0 7.463007295482882e-11
on O 0 1.2629695900212567e-10
mitochondrial O 0 3.2756314327642144e-10
DNA O 0 5.809740688533793e-09
( O 0 6.115674633377921e-09
mtDNA O 0 1.7312885347564588e-08
) O 0 2.31129471117697e-09
lineages O 0 9.818299417929666e-08
. O 0 9.275393608731974e-08

Three O 0 1.3431747269976313e-08
novel O 0 1.9065764078618486e-08
missense O 0 4.87310103380878e-07
mutations O 0 1.0967153230012627e-07
never O 0 3.847205576335e-08
identified O 0 1.8463918394218126e-08
previously O 0 1.3600338633068532e-09
in O 0 1.53555553689122e-11
other O 0 2.970708748439854e-11
populations O 0 1.1537366895186807e-10
and O 0 9.098976780363977e-12
found O 0 4.964817619523831e-12
in O 0 7.80187980192748e-12
16 O 0 1.8170258353489288e-10
out O 0 3.457406236306859e-11
of O 0 1.1127782723052704e-10
19 O 0 1.8138582857929464e-09
Colombian O 0 7.848716876424078e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 1.282111838918354e-07
alleles O 0 1.86282878011923e-09
account O 0 5.971074745758642e-10
for O 0 3.8814451652768867e-10
84 O 0 4.0248758637062565e-07
. O 0 1.2872526156115782e-07

2 O 0 9.630416286654508e-08
% O 0 1.119407788685578e-09
of O 0 4.4379266928018524e-10
the O 0 1.5690684862512683e-10
alleles O 0 2.970375889699284e-10
in O 0 1.2348101707804204e-10
this O 0 1.7530316087643882e-10
study O 0 6.83663237133203e-10
. O 0 8.484929203689262e-09

The O 0 1.3341188775939372e-07
G301C O 0 1.0750122783065308e-06
and O 0 3.6750413823227746e-09
S162F O 0 7.443683358587805e-08
mutations O 0 1.1598777494015167e-09
account O 0 1.535430393939663e-10
for O 0 1.834920271281959e-10
68 O 0 1.3876321247607848e-07
. O 0 8.787380068042694e-08

4 O 0 1.3736924984186771e-06
% O 0 1.9285353758391466e-08
and O 0 5.869258412616318e-10
10 O 0 1.1860079141001734e-08
. O 0 2.368739160374389e-08

5 O 0 4.525509211816825e-07
% O 0 5.997981666894248e-09
of O 0 2.7731725804613916e-09
mutations O 0 3.436633866371608e-09
, O 0 3.2721844678285095e-10
respectively O 0 9.989431504209279e-10
, O 0 5.084205625949245e-11
whereas O 0 1.1393154197847366e-09
the O 0 1.0644981784935226e-08
remaining O 0 6.120967009337619e-05
F69V O 1 0.9845431447029114
is O 0 6.85777268305543e-11
limited O 0 3.7992026191702166e-11
to O 0 5.216999054979965e-11
a O 0 8.6661317011405e-10
single O 0 1.483511868904941e-09
allele O 0 1.24941735180073e-07
. O 0 1.6757778098508425e-07

The O 0 4.840760681190659e-08
skewed O 0 5.781300842500059e-07
prevalence O 0 5.606252173606663e-08
of O 0 1.1715529657507773e-09
G301C O 0 8.5076807820883e-09
in O 0 3.083491448285791e-11
only O 0 4.132373609966322e-11
Colombian O 0 3.813325211154961e-10
patients O 0 1.772551896928043e-11
and O 0 5.696709597102778e-12
haplotype O 0 3.408704707386079e-10
analysis O 0 9.30140166277571e-12
by O 0 5.817580033158631e-13
restriction O 0 4.7619241883012364e-11
fragment O 0 1.974421737216403e-10
length O 0 1.2830175810663036e-10
polymorphisms O 0 4.3925214576745475e-09
in O 0 2.295194034829251e-09
the O 0 5.3671119104592435e-08
GALNS O 0 2.27406471822178e-05
gene O 0 1.4845486617787174e-08
suggest O 0 1.5247884732616512e-08
that O 0 3.138700965799046e-10
G301C O 0 2.7044885442251143e-08
originated O 0 3.011749516446116e-09
from O 0 1.2811028626824594e-10
a O 0 8.516715804818276e-11
common O 0 4.435523337509295e-10
ancestor O 0 2.2409267330658622e-07
. O 0 7.541719782011569e-08

Investigation O 0 1.0820414786394394e-08
of O 0 4.8047730238920394e-09
the O 0 5.204280340009859e-10
genetic O 0 1.0494263236182633e-09
background O 0 2.461978676482346e-10
by O 0 4.476757506366447e-12
means O 0 6.633461002714114e-10
of O 0 1.5177483714268192e-09
mtDNA O 0 1.5558641042190402e-09
lineages O 0 4.141230469656421e-09
indicate O 0 5.855474771720992e-09
that O 0 1.076580907755087e-10
all O 0 1.6842799377414508e-10
our O 0 1.373867797305195e-09
patients O 0 6.172116290281693e-11
are O 0 3.6543949290257505e-12
probably O 0 1.4476041199085188e-10
of O 0 4.388985008763058e-10
native O 0 6.784739436938025e-09
American O 0 2.1412436979062477e-07
descent O 0 1.4290231774793938e-05

Low O 0 3.76342157437648e-08
frequency O 0 6.421787990262828e-09
of O 0 2.5345079368577217e-09
BRCA1 O 0 1.0802437344636928e-07
germline O 0 9.060563854745851e-08
mutations O 0 1.4633229072913423e-09
in O 0 3.687957925158081e-11
45 O 0 8.144668939280564e-09
German O 0 0.0001661035348661244
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.777511079609667e-09
. O 0 2.4905162376853696e-09

In O 0 1.4109251544880408e-08
this O 0 8.779799665070698e-10
study O 0 1.1558181495230357e-10
we O 0 1.4484844747253423e-11
investigated O 0 2.2605489702343107e-10
45 O 0 3.6318932306045326e-09
German O 0 4.899008217762457e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.546503286016133e-11
for O 0 2.8060075964175812e-12
germline O 0 1.0400984518099676e-09
mutations O 0 5.259302993110282e-10
in O 0 9.536014339284193e-11
the O 0 1.3447787328146887e-09
BRCA1 O 0 8.001058482420831e-09
gene O 0 2.6829352961499353e-08
. O 0 5.430299552244833e-07

We O 0 5.372076561371841e-09
identified O 0 1.781713265813778e-08
four O 0 1.5191269353564962e-09
germline O 0 7.845810614526272e-07
mutations O 0 5.137221847917317e-08
in O 0 2.276993926741966e-09
three O 0 3.4773959267653254e-09
breast B-Disease 0 4.558015831435114e-08
cancer I-Disease 0 4.7739817432557174e-08
families O 0 1.444652869553309e-10
and O 0 3.7657425788761856e-11
in O 0 1.5036583089766964e-09
one O 1 0.9999998807907104
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 2.2969632862412936e-09
. O 0 3.2214385239232035e-12
among O 0 1.0349457835873155e-12
these O 0 1.935976335840084e-12
were O 0 3.5179114395850197e-12
one O 0 2.3096352955165322e-11
frameshift O 0 6.1734528600254635e-09
mutation O 0 1.1461084165054203e-10
, O 0 5.378971226766005e-11
one O 0 7.153109216062603e-10
nonsense O 0 4.1912795012422066e-08
mutation O 0 1.6940566283096814e-08
, O 0 1.8279626701200868e-09
one O 0 3.2714624342844445e-09
novel O 0 2.3555744022019098e-08
splice O 0 1.0005302328863763e-06
site O 0 1.0680618345304538e-07
mutation O 0 5.475973008373103e-09
, O 0 5.339089725886481e-10
and O 0 4.823391686059608e-10
one O 0 2.1564982688460077e-08
missense O 0 4.426009581948165e-06
mutation O 0 7.752290684948093e-07
. O 0 3.52119513991056e-07

The O 0 1.399430544779534e-07
missense O 0 1.1067245395679493e-06
mutation O 0 5.230407751355415e-08
was O 0 2.942303645170341e-08
also O 0 3.011506599648328e-10
found O 0 1.7933307616679883e-10
in O 0 4.364625050268245e-10
2 O 0 1.2202674781747191e-07
. O 0 1.7501143645404227e-07

8 O 0 5.050357003710815e-07
% O 0 4.238256856581302e-09
of O 0 2.690903277979828e-09
the O 0 2.4760415939795166e-09
general O 0 8.76805561489391e-09
population O 0 2.522229980428392e-09
, O 0 9.2643656635083e-11
suggesting O 0 2.598861570390909e-09
that O 0 8.251929001223957e-11
it O 0 9.97126547996885e-11
is O 0 5.579691569890244e-11
not O 0 6.655411222133978e-10
disease O 0 7.964413129002423e-08
associated O 0 5.306395109982986e-07
. O 0 6.044658107384748e-07

The O 0 1.2064709231651705e-09
average O 0 2.2432151691731406e-09
age O 0 5.27979715503335e-10
of O 0 1.557531881246632e-10
disease O 0 3.4577016805315e-08
onset O 0 6.743456992808206e-08
in O 0 1.5415509146965434e-11
those O 0 3.792013925085769e-11
families O 0 1.0909929210045632e-10
harbouring O 0 8.290889752515795e-09
causative O 0 1.2205463306713682e-08
mutations O 0 7.1046524219298135e-09
was O 0 3.71431418955126e-09
between O 0 1.532204252363556e-09
32 O 0 2.5386975721630733e-07
. O 0 3.4230617984576384e-07

3 O 0 3.0981216241343645e-06
and O 0 4.302030376379662e-08
37 O 0 2.727588480411214e-06
. O 0 2.2981966196766734e-07

4 O 0 5.008020593777474e-07
years O 0 8.391148220709965e-09
, O 0 8.691553726736245e-11
whereas O 0 1.883058015073047e-10
the O 0 2.0828330726807565e-10
family O 0 1.5548404785903358e-09
harbouring O 0 2.8152125963742947e-08
the O 0 1.0221136159671573e-09
missense O 0 1.7601967883251746e-08
mutation O 0 2.8663793560923523e-10
had O 0 4.464821914962336e-11
an O 0 3.1846001530277945e-12
average O 0 9.604758655079593e-11
age O 0 2.703438861662022e-10
of O 0 2.0484787199848142e-09
onset O 0 0.00023821918875910342
of O 0 4.402958495575149e-07
51 O 0 2.2268541215453297e-06
. O 0 8.187566322703788e-07

2 O 0 9.094262168218847e-06
years O 0 4.512360192165943e-07
. O 0 4.3079054989902943e-07

These O 0 7.319377992587306e-09
findings O 0 2.589481518100456e-08
show O 0 2.4385562458206778e-09
that O 0 4.818132004480447e-10
BRCA1 O 0 7.322677220145124e-08
is O 0 7.483907382699329e-10
implicated O 0 8.430094400324606e-10
in O 0 1.9053229480259226e-11
a O 0 1.5978463344112903e-11
small O 0 2.8951641431462782e-11
fraction O 0 5.233987909747384e-09
of O 0 7.737593676893084e-08
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.6427042018318794e-11
suggesting O 0 3.355309953489982e-12
the O 0 4.4892648626282394e-13
involvement O 0 2.0569403385434226e-12
of O 0 1.2376642679473582e-12
another O 0 2.976321879927246e-12
susceptibility O 0 1.0193995647611587e-09
gene O 0 1.294098250781417e-08
( O 0 2.441341280245979e-07
s O 0 8.430297384620644e-06
) O 0 3.573658773348143e-07

Paternal O 0 6.466844206443056e-05
transmission O 0 2.06567274290137e-05
of O 0 1.6438200134416547e-07
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 2.124581442330964e-06

We O 0 2.9360027298253044e-08
report O 0 1.4653730451286151e-09
a O 0 3.112088711731964e-11
rare O 0 2.283377237288775e-10
case O 0 4.381657814356288e-10
of O 0 2.1381976189616125e-09
paternally O 0 0.08061069995164871
transmitted O 0 2.8205440685269423e-05
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.3026676387871703e-07
DM B-Disease 1 1.0
) O 0 2.5695641170386807e-09
. O 0 9.048212845641501e-09

The O 0 9.583672522239794e-08
proband O 0 4.740409167425241e-06
is O 0 4.843101475415779e-10
a O 0 1.0823547613725282e-09
23 O 0 3.80155711354746e-08
year O 0 3.801845505080337e-09
old O 0 3.046694018848939e-06
, O 0 1.6795850044104554e-08
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 0.0002824150724336505
who O 0 4.591686142418894e-09
suffers O 0 1.0518105000301148e-06
severe O 0 7.728249329375103e-06
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 0 5.546045485971263e-06

He O 0 2.350967864828135e-09
presented O 0 8.485749880549065e-10
with O 0 3.1115426207817265e-11
respiratory O 0 0.01313073467463255
and O 0 2.996667802790398e-09
feeding O 0 2.7627276722341776e-05
difficulties O 0 0.0008981973514892161
at O 0 0.00022233980416785926
birth O 1 0.8373355269432068
. O 0 2.627302592372871e-06

His O 0 5.292809532875253e-07
two O 0 2.2816040257112036e-07
sibs O 0 0.028247687965631485
suffer O 0 1.0902128906309372e-06
from O 0 5.691290994036535e-08
childhood O 1 0.9892464280128479
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 1.766351715559722e-06

Their O 0 3.0051676702669283e-09
late O 0 1.006335082820442e-06
father O 0 2.890765316010402e-08
had O 0 1.6410983683101676e-10
the O 0 3.796535134881207e-12
adult O 0 3.5708846903709235e-12
type O 0 2.8043772165586844e-11
of O 0 9.780535270564883e-10
DM B-Disease 1 1.0
, O 0 1.592098120006824e-09
with O 0 1.2137338356588145e-10
onset O 1 0.9999994039535522
around O 0 1.5082540771871322e-09
30 O 0 2.679877120215224e-08
years O 0 4.5920276470212684e-09
. O 0 1.909844726810661e-08

Only O 0 1.933178506163813e-09
six O 0 1.7272168417736822e-10
other O 0 1.9006942287430606e-12
cases O 0 5.616311669204288e-12
of O 0 5.839374817018239e-11
paternal O 0 4.9866332119563594e-05
transmission O 1 0.9383742809295654
of O 0 0.000288403156446293
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 1.1400100447644945e-05
been O 0 7.049511197010361e-09
reported O 0 3.4984448671337987e-09
recently O 0 1.4814591775547115e-09
. O 0 1.0986220821962434e-08

We O 0 3.2277909234323943e-09
review O 0 7.303406768244258e-10
the O 0 7.394654333303663e-11
sex O 0 7.025218948242262e-12
related O 0 5.402166561307986e-11
effects O 0 1.1849733694280218e-10
on O 0 3.215626723229725e-11
transmission O 0 2.9184155536654544e-08
of O 0 3.875529230867869e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 6.364646651491057e-06

Decreased O 0 2.1992248377955548e-07
fertility O 0 3.662976810758778e-09
of O 0 6.141490788147408e-11
males O 0 3.783617082836477e-12
with O 0 5.148477334022093e-14
adult O 0 1.5251206547661766e-11
onset O 0 8.79879813453499e-09
DM B-Disease 1 1.0
and O 0 2.6546180618286508e-12
contraction O 0 1.8916941624258499e-10
of O 0 5.6020108690768566e-11
the O 0 3.699166320481062e-11
repeat O 0 3.7321992718553076e-11
upon O 0 1.0928986882152714e-10
male O 0 5.053519061548606e-11
transmission O 0 1.68994346294582e-10
contribute O 0 6.702589872009668e-12
to O 0 8.316581798228917e-12
the O 0 1.7961171439040413e-10
almost O 0 1.2348806699424841e-10
absent O 0 1.87448367938714e-09
occurrence O 0 5.522825530235309e-10
of O 0 4.023211278014749e-11
paternal O 0 5.268194058771769e-07
transmission O 0 8.03056707354699e-07
of O 0 2.2191598247900401e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 2.0112594938836992e-05

Also O 0 2.2717709935449193e-09
the O 0 1.9276591434191914e-09
fathers O 0 5.9032149835047676e-08
of O 0 1.2802687798796342e-08
the O 0 7.031449644756549e-09
reported O 0 1.0024593599666787e-08
congenitally O 0 2.81901679954899e-06
affected O 0 1.5401454334096343e-08
children O 0 4.448148960278786e-09
showed O 0 1.841639907240733e-08
, O 0 6.587386885970048e-11
on O 0 3.0592592903389004e-09
average O 0 1.863497800513869e-08
, O 0 1.509335295635239e-10
shorter O 0 5.3071232741785934e-08
CTG O 0 1.2334893426668714e-06
repeat O 0 1.3791298769660898e-08
lengths O 0 3.2138757433131104e-07
and O 0 1.26804156064253e-09
hence O 0 6.244508465869103e-09
less O 0 1.8976433757700306e-09
severe O 0 1.49991237208269e-08
clinical O 0 1.9962986819166417e-09
symptoms O 0 4.173055789813418e-10
than O 0 4.184369430809687e-12
the O 0 2.1440394598615242e-11
mothers O 0 6.752431253032043e-11
of O 0 6.919209649680624e-11
children O 0 7.751397856914366e-10
with O 0 4.5174042284656934e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 6.130958354333416e-06

We O 0 2.1454691356836975e-09
conclude O 0 1.7236239102658146e-09
that O 0 3.765948924233653e-12
paternal O 0 8.513805482834869e-08
transmission O 0 3.059435726981974e-08
of O 0 7.486967490422103e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 2.2158210821743296e-09
rare O 0 1.4298033590431913e-10
and O 0 6.3871954600336345e-12
preferentially O 0 1.1327342536171514e-10
occurs O 0 1.5431336763960246e-11
with O 0 3.16268577082654e-13
onset O 0 5.7024831079388605e-08
of O 0 1.5185049662136407e-08
DM B-Disease 1 1.0
past O 0 9.132689626767387e-08
30 O 0 5.515249146270662e-09
years O 0 2.742750748740974e-10
in O 0 5.796894908538519e-11
the O 0 1.2802729987271277e-09
father O 0 1.2489666190163007e-08
. O 0 3.5300149470174347e-09
. O 0 3.0372081738505585e-08

The O 0 3.02984290101449e-07
RB1 O 0 4.915013414574787e-05
gene O 0 6.752296943801639e-09
mutation O 0 1.971329544048217e-09
in O 0 5.81882875216877e-11
a O 0 5.489460552787762e-10
child O 0 1.9498100911619076e-08
with O 0 6.036557920197083e-08
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 5.13654958922416e-06

The O 0 6.135527996775636e-07
RB1 O 0 2.5898483727360144e-05
gene O 0 1.3815125043947774e-08
mutation O 0 9.625546582014977e-09
was O 0 2.0464792083174643e-09
investigated O 0 1.7530182860880927e-10
in O 0 4.098180128586648e-12
a O 0 2.1289912888189377e-10
child O 0 1.5189712598839833e-08
with O 0 3.362614364732508e-08
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 0 4.199748218525201e-06
using O 0 2.2317755282719176e-11
DNA O 0 3.8925956902247094e-10
obtained O 0 5.699226091060439e-10
from O 0 1.4974868567385613e-10
both O 0 6.934375990086394e-11
the O 0 6.391150941809087e-10
pineal B-Disease 0 1.2809621239284752e-06
and I-Disease 0 1.3798790998720278e-09
retinal I-Disease 0 0.3962365984916687
tumours I-Disease 1 1.0
of O 0 1.1568662472427604e-07
the O 0 2.0158594793429074e-08
patient O 0 2.325374914846634e-08
. O 0 7.887841491083236e-08

A O 0 4.497971985983895e-07
nonsense O 0 5.771738287307926e-08
mutation O 0 1.9054120503625427e-09
in O 0 1.720791426018664e-10
exon O 0 1.65886824277095e-08
17 O 0 1.0186619192609214e-07
( O 0 1.8914423360882893e-09
codon O 0 5.425656723900829e-08
556 O 0 3.7085396087377376e-08
) O 0 5.625062915459722e-11
of O 0 2.3335979815186647e-09
the O 0 3.818066929284214e-08
RB1 O 0 8.834973414195701e-06
gene O 0 1.262128090928627e-08
was O 0 1.347459175349286e-07
found O 0 3.7800988034186744e-11
to O 0 2.3461455000983733e-11
be O 0 8.802145817776719e-11
present O 0 1.1876100103336285e-09
homozygously O 0 2.684691935428418e-07
in O 0 3.5885583393735487e-10
both O 0 8.799044826091063e-10
the O 0 1.0169376452040524e-08
retinal B-Disease 0 5.234986929281149e-06
and I-Disease 0 6.103928029688177e-09
the I-Disease 0 4.1335354694638227e-07
pineal I-Disease 1 0.9999899864196777
tumours I-Disease 1 1.0
. O 0 1.0018832199421013e-06

The O 0 3.84789311524969e-09
same O 0 6.69590161095357e-10
mutation O 0 9.545116919085217e-10
was O 0 9.215781471283435e-10
present O 0 2.0704041259200778e-10
heterozygously O 0 4.0025671665944174e-08
in O 0 1.1168565378083528e-10
the O 0 1.7891181591789262e-10
DNA O 0 2.761516848526213e-10
from O 0 2.7734040064508747e-10
the O 0 2.8232430282493226e-10
constitutional O 0 5.253408263961035e-10
cells O 0 1.006992933483275e-09
of O 0 5.331640684502759e-10
the O 0 8.513342253380074e-10
patient O 0 3.2994986742806987e-09
, O 0 5.161473679016204e-11
proving O 0 2.8151572184498264e-09
it O 0 2.0885446150309406e-11
to O 0 9.737309569768371e-11
be O 0 9.965680503043473e-10
of O 0 3.114617186383839e-08
germline O 0 3.981319878221257e-06
origin O 0 4.4754435180038854e-07
. O 0 3.9720632116768684e-07

The O 0 3.4866687315115996e-08
initial O 0 2.4970244538735642e-08
mutation O 0 2.7379591927001456e-09
was O 0 1.3160846856763442e-09
shown O 0 4.283078405831198e-11
to O 0 7.433514220833715e-11
have O 0 7.154934283937209e-11
occurred O 0 1.0280755802227759e-08
in O 0 9.816451124189385e-11
the O 0 7.160401604977551e-09
paternally O 0 4.057823389302939e-06
derived O 0 5.235248750068422e-07
RB1 O 0 0.00020902373944409192
allele O 0 4.969318752046092e-07
. O 0 3.229554010886204e-07

The O 0 2.0163826164321108e-08
mutation O 0 2.4232094109066793e-09
is O 0 2.8894156164915863e-11
in O 0 4.051145703620751e-12
an O 0 1.3477021582053439e-11
area O 0 3.3946661037731474e-09
of O 0 4.00534272415598e-10
the O 0 2.1128112592805337e-09
gene O 0 1.0793036464562533e-09
that O 0 3.3728579929004354e-09
encodes O 0 8.318799871176452e-09
the O 0 1.1302901725684933e-08
protein O 0 5.7957953991660816e-09
- O 0 6.584526257569223e-10
binding O 0 2.776512353364069e-09
region O 0 1.0938006944627432e-08
known O 0 6.300832078309782e-10
as O 0 5.775906419813737e-10
the O 0 9.734343331402329e-10
pocket O 0 8.06399725661322e-07
region O 0 2.733097836937759e-08
and O 0 1.0216346879587945e-08
has O 0 2.5336668318942657e-09
been O 0 4.766015915258492e-10
detected O 0 1.1525166376813445e-09
in O 0 1.1107462172255111e-11
other O 0 2.6326149593636217e-11
cases O 0 3.240465396014969e-10
of O 0 1.0963467467206556e-08
retinoblastoma B-Disease 0 1.3488272088579834e-05
. O 0 1.7093505277898657e-08
. O 0 8.211637236854585e-08

Low O 0 9.980990398616996e-07
levels O 0 9.912794141087033e-09
of O 0 1.594152365669288e-09
beta O 0 6.909747440886349e-09
hexosaminidase O 0 3.147528815361511e-08
A O 0 1.8617419828004245e-09
in O 0 1.6047855752598927e-11
healthy O 0 3.0889318880511496e-10
individuals O 0 3.422943352371366e-12
with O 0 5.210393314719619e-12
apparent O 0 7.068754115380216e-08
deficiency O 0 4.2005369323305786e-05
of O 0 9.714320015064004e-08
this O 0 3.0899824920993524e-09
enzyme O 0 1.667957121753716e-06
. O 0 2.741593334576464e-07

Appreciable O 0 7.336562703130767e-06
beta O 0 2.2487130024728685e-07
hexosaminidase O 0 2.6023310510936426e-06
A O 0 9.531432283438335e-07
( O 0 8.456509270615697e-09
hex O 0 5.089598289487185e-07
A O 0 2.0255129129509442e-07
) O 0 1.7575715882678367e-10
activity O 0 6.842075794821767e-09
has O 0 1.4477083594421902e-11
been O 0 1.1459941502700577e-11
detected O 0 2.21730800387121e-10
in O 0 2.679821815843031e-11
cultured O 0 4.458173918919783e-08
skin O 0 1.4626880329160485e-07
fibroblasts O 0 1.1645528985582132e-07
and O 0 2.1324304544378947e-09
melanoma B-Disease 0 1.271001792702009e-07
tissue O 0 2.515061214847236e-10
from O 0 1.6270262914730438e-10
healthy O 0 2.2924365183918383e-10
individuals O 0 1.9246952122353722e-12
previously O 0 8.406001589245093e-12
reported O 0 2.5552412616369757e-11
as O 0 9.212081618359402e-12
having O 0 2.297198820055968e-10
deficiency B-Disease 0 2.344776930840453e-06
of I-Disease 0 8.251850886153989e-06
hex I-Disease 0 1.063887702912325e-05
A I-Disease 0 4.4004565324939904e-07
activity O 0 1.4340784559863096e-07
indistinguishable O 0 2.6023897703453258e-08
from O 0 5.3089886653534535e-11
that O 0 1.1499677078641302e-12
of O 0 9.72683478900338e-12
patients O 0 2.942265528438348e-11
with O 0 2.4937913956080138e-09
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 3.209304168194649e-06
TSD B-Disease 1 0.9999723434448242
) O 0 1.3710151236523416e-08
. O 0 1.1196031834970199e-07

Identification O 0 2.2522008702452467e-09
and O 0 1.3688458144756055e-09
quantitation O 0 9.409925041836686e-06
of O 0 4.690896275860723e-06
hex O 0 1.2056605555699207e-05
A O 0 1.661348278503283e-06
, O 0 6.481848946471302e-10
amounting O 0 2.2816240008438626e-09
to O 0 9.363284592112109e-10
3 O 0 1.582891826501509e-07
. O 0 1.321259617270698e-07

5 O 0 8.806977348285727e-06
% O 0 1.8863819661874004e-07
- O 0 8.145978114271202e-08
6 O 0 4.1269103689955955e-07
. O 0 1.0964830465809428e-07

9 O 0 3.9543144225717697e-07
% O 0 4.572450418294238e-09
of O 0 5.556227034020367e-09
total O 0 3.1644784570517004e-09
beta O 0 2.087480410750686e-08
hexosaminidase O 0 3.177605094606406e-07
activity O 0 2.261668754499624e-07
, O 0 3.4781105773262766e-10
has O 0 1.2850699671052013e-10
been O 0 1.0880379236466453e-10
obtained O 0 4.5882453392209754e-09
by O 0 1.5664826102934626e-09
cellulose O 0 3.469944545031467e-07
acetate O 0 2.435471913031506e-07
gel O 0 2.324874515124975e-07
electrophoresis O 0 1.4676563075965987e-08
, O 0 4.480899207237599e-09
DEAE O 0 2.724770183704095e-06
- O 0 2.169245583161228e-08
cellulose O 0 6.848541289627974e-08
ion O 0 1.3242896557130734e-07
- O 0 3.1158769786543417e-08
exchange O 0 4.8276859843099373e-08
chromatography O 0 3.060782738373291e-09
, O 0 2.1608687061913656e-10
radial O 0 4.980277523713994e-08
immunodiffusion O 0 4.554652548449667e-07
, O 0 2.559087386444503e-09
and O 0 7.058781115176771e-09
radioimmunoassay O 0 0.00025739314150996506
. O 0 2.710861963350908e-06

Previous O 0 5.14026896780706e-06
family O 0 1.9246959936936037e-07
studies O 0 5.968994187810495e-09
suggested O 0 1.9266363504577555e-10
that O 0 1.1239545535599027e-12
these O 0 1.7549032973324108e-12
individuals O 0 4.105722272579326e-12
may O 0 4.03977407081868e-11
be O 0 1.1342015868165412e-11
compound O 0 5.431926020094124e-10
heterozygotes O 0 2.3736950183206318e-09
for O 0 4.152662155115783e-12
the O 0 4.9661649792476226e-11
common O 0 2.930157505520725e-11
mutant O 0 3.130714576471405e-09
TSD B-Disease 0 5.3977458946974366e-08
gene O 0 1.7629164794641383e-10
and O 0 1.849745495663413e-10
a O 0 4.944108455973151e-10
rare O 0 3.6984220130875656e-09
( O 0 6.402033347896463e-10
allelic O 0 9.78580239063831e-09
) O 0 1.564511020735182e-10
mutant O 0 3.734189846227309e-09
gene O 0 2.467886162094146e-08
. O 0 2.1712992293032585e-07

Thus O 0 3.6517821655479565e-08
, O 0 2.3311591546004706e-10
the O 0 3.4062089260267214e-10
postulated O 0 6.853114342675326e-08
rate O 0 8.640911874913115e-10
mutant O 0 2.2579806080447185e-10
gene O 0 4.528202535158954e-10
appears O 0 7.061444207145939e-10
to O 0 4.035236554622568e-12
code O 0 1.3819709265838753e-12
for O 0 1.4694466130005246e-11
the O 0 2.869442738973049e-10
expression O 0 1.9170407483670715e-09
of O 0 2.0974251224714635e-09
low O 0 4.847336310120909e-09
amounts O 0 1.891464096459572e-09
of O 0 1.0402239958295922e-08
hex O 0 1.477779164815729e-06
A O 0 1.6959694448814844e-06
. O 0 5.318599392012402e-07

Heterozygotes O 0 2.943567380953027e-07
for O 0 1.9973802611872316e-09
the O 0 5.6215716526253345e-09
rare O 0 5.049747286989259e-09
mutant O 0 4.482012627704535e-08
may O 0 1.4842024276262578e-09
be O 0 1.73303787986967e-10
indistinguishable O 0 1.9655487903946778e-08
from O 0 2.1286339357828865e-10
heterozygotes O 0 8.346374258394462e-09
for O 0 5.6695696748487734e-11
the O 0 1.3924507102913708e-09
common O 0 9.354041985432104e-09
TSD B-Disease 0 1.3599767044070177e-05
mutant O 0 1.0343893563913298e-06
. O 0 5.712486199627165e-07

However O 0 1.697339335748893e-08
, O 0 2.0665140432196694e-10
direct O 0 1.4708669837659727e-09
visualization O 0 1.3543964172413325e-08
and O 0 1.1662083798658074e-10
quantitation O 0 8.34837101137964e-06
of O 0 3.8233470149862114e-06
hex O 0 9.76765022642212e-07
A O 0 4.672152797979834e-08
by O 0 1.297559698576478e-10
the O 0 3.4942285176420285e-10
methods O 0 1.5972810851749841e-09
described O 0 6.6156202738199e-10
may O 0 4.773667017232697e-10
prevent O 0 2.002908283671445e-09
false O 0 2.6502121386329236e-08
- O 0 1.6109021894195052e-09
positive O 0 1.0010597212284367e-10
prenatal O 0 1.7212453684578577e-09
diagnosis O 0 1.0243033088386255e-09
of O 0 5.209504494452233e-10
TSD B-Disease 0 1.223051299348299e-06
in O 0 1.0472828160246195e-09
fetuses O 0 1.0966437535842033e-08
having O 0 2.7985808115360555e-10
the O 0 2.844952051717087e-10
incomplete O 0 4.6590447055905315e-08
hex B-Disease 0 1.766530743907424e-07
A I-Disease 0 8.302318121877761e-08
deficiency I-Disease 0 1.7965305687539512e-06
of O 0 8.391318147005222e-07
the O 0 1.3989149394433298e-08
type O 0 1.603025978624828e-08
described O 0 1.302139507330935e-09
in O 0 2.637456364418256e-10
the O 0 1.1061390026156914e-08
four O 0 8.250599314862939e-09
healthy O 0 2.6208257963844517e-07
individuals O 0 6.282752451625129e-08

The O 0 5.977495476372496e-08
tumor B-Disease 0 2.2391011498257285e-06
suppressor O 0 6.1236892179294955e-06
gene O 0 4.209280746181321e-07
Smad4 O 0 1.9150089428876527e-05
/ O 0 4.0136640677701507e-07
Dpc4 O 0 2.3521222658473562e-07
is O 0 1.0748076907651782e-11
required O 0 6.011510299969158e-12
for O 0 1.885303024806717e-11
gastrulation O 0 2.157288037096805e-08
and O 0 2.8988828698617297e-11
later O 0 2.697556900077558e-10
for O 0 9.645624576837264e-11
anterior O 0 4.543676368484739e-08
development O 0 5.880512077283129e-09
of O 0 1.3887057059847052e-09
the O 0 1.5592002133857363e-09
mouse O 0 1.271212113351794e-08
embryo O 0 1.7734615198605752e-07
. O 0 1.1176082637120999e-07

Mutations O 0 8.034231058218211e-08
in O 0 3.732950393242618e-09
the O 0 5.266998215347485e-08
SMAD4 O 1 0.9999972581863403
/ O 0 1.4406843547476456e-05
DPC4 O 0 8.180964505299926e-05
tumor B-Disease 0 1.456621561146676e-07
suppressor O 0 6.24566567353213e-08
gene O 0 6.675854868909425e-10
, O 0 2.951055719235818e-11
a O 0 2.8372772881146702e-11
key O 0 2.646058705479959e-09
signal O 0 2.0851961934909014e-08
transducer O 0 1.6049197526513126e-08
in O 0 4.118921648199603e-09
most O 0 8.021552844184043e-08
TGFbeta O 0 3.2472119073645445e-06
- O 0 5.1745129070468465e-08
related O 0 8.557763209182667e-08
pathways O 0 1.009187755585117e-07
, O 0 2.702808463150852e-11
are O 0 2.936050924953748e-13
involved O 0 4.633192158924604e-13
in O 0 2.1144125946642722e-12
50 O 0 1.1384877485198786e-09
% O 0 5.1975175274776575e-09
of O 0 2.152602540661519e-08
pancreatic B-Disease 0 0.00022569482098333538
cancers I-Disease 1 0.9917519688606262
. O 0 1.3671161696038325e-06

Homozygous O 0 7.79487479007912e-08
Smad4 O 0 2.382583261351101e-06
mutant O 0 6.584519240959708e-08
mice O 0 3.5074933180112566e-08
die O 0 8.91330387275957e-09
before O 0 1.226622914352049e-09
day O 0 1.886585554444764e-09
7 O 0 2.936758747296153e-08
. O 0 2.3333498688771215e-08

5 O 0 2.7174885417480255e-06
of O 0 4.505519370923139e-07
embryogenesis O 0 5.633533419313608e-06
. O 0 4.072832382462366e-07

Mutant O 0 1.0437063480139841e-07
embryos O 0 5.7227275362947694e-08
have O 0 1.1066111360591435e-09
reduced O 0 3.0766562630901717e-09
size O 0 1.5749248571950147e-09
, O 0 9.955682805928845e-11
fail O 0 1.6097565502803945e-09
to O 0 1.3745388161012784e-09
gastrulate O 0 1.0802792758113355e-06
or O 0 6.836932131548679e-10
express O 0 1.3214618288515112e-10
a O 0 1.002278607331597e-10
mesodermal O 0 8.452723676555252e-08
marker O 0 5.9545556041484815e-08
, O 0 4.70795680218572e-10
and O 0 1.1576323233342123e-09
show O 0 7.816014857553455e-08
abnormal O 0 1.3632246691486216e-06
visceral O 0 4.750500011141412e-05
endoderm O 0 0.00016948556003626436
development O 0 1.2606865311681759e-06
. O 0 1.1828930013280115e-07

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 2.7404403226682916e-06
the O 0 6.544403419184164e-08
Smad4 O 0 9.103296179091558e-07
- O 0 6.06212680054341e-08
deficient O 0 1.1825451728952885e-08
embryos O 0 2.12209227967719e-09
results O 0 7.95203403125555e-10
from O 0 4.1854752996783873e-10
reduced O 0 6.578638744869636e-10
cell O 0 1.8722041694729796e-09
proliferation O 0 2.025486223189432e-09
rather O 0 2.856542953566521e-11
than O 0 1.7482425229697895e-11
increased O 0 1.041585373506848e-09
apoptosis O 0 3.775140555717371e-08
. O 0 2.0768133879300876e-08

Aggregation O 0 8.668515683041278e-09
of O 0 5.444084738570609e-09
mutant O 0 9.460283223461374e-08
Smad4 O 0 5.228839654591866e-06
ES O 0 1.3234050584287615e-06
cells O 0 5.040718398241495e-10
with O 0 7.491155265548777e-12
wild O 0 6.064515001291682e-10
- O 0 1.606495214634407e-10
type O 0 1.5387932594812526e-10
tetraploid O 0 4.559154831440537e-08
morulae O 0 2.1071925004889636e-07
rescues O 0 7.707441795901104e-08
the O 0 5.436572525496786e-09
gastrulation B-Disease 0 3.544486389728263e-06
defect I-Disease 0 4.2789715735125355e-06
. O 0 5.575395789492177e-07

These O 0 2.687565547887516e-08
results O 0 5.1734765804667404e-08
indicate O 0 4.495360172995788e-08
that O 0 4.754530102957233e-10
Smad4 O 0 2.91106118766038e-07
is O 0 5.657212198695305e-11
initially O 0 2.6575984468646396e-11
required O 0 8.997666435701934e-13
for O 0 5.266394959013709e-12
the O 0 1.5824579147061257e-10
differentiation O 0 2.385204256327711e-09
of O 0 1.5516706808327285e-09
the O 0 1.171099439645218e-09
visceral O 0 8.957106700790973e-08
endoderm O 0 3.5492320193952764e-07
and O 0 2.994830772262702e-11
that O 0 3.646707935622828e-12
the O 0 9.74489031135839e-11
gastrulation B-Disease 0 8.616426683261125e-09
defect I-Disease 0 1.5871409742018727e-09
in O 0 1.9852026966749037e-10
the O 0 7.012940006489998e-09
epiblast O 0 1.3207019264882547e-06
is O 0 2.5371680312247236e-09
secondary O 0 2.9286422176255655e-08
and O 0 1.2217288292148965e-09
non O 0 2.087628416802545e-07
- O 0 2.0658823984831542e-07
cell O 0 5.359937495086342e-05
autonomous O 0 8.99615952221211e-06
. O 0 3.1716285775473807e-07

Rescued O 0 2.474738209912175e-07
embryos O 0 4.2643037545531115e-08
show O 0 2.388583730805749e-08
severe O 0 1.7938307337317383e-06
anterior O 0 0.0010978742502629757
truncations O 0 0.00019985332619398832
, O 0 1.993072373807081e-09
indicating O 0 1.132219118460398e-08
a O 0 2.6606478131796507e-10
second O 0 1.7282194564316455e-09
important O 0 1.8054605588346817e-09
role O 0 5.905619326895817e-10
for O 0 1.1806311484008347e-09
Smad4 O 0 3.322350266898866e-06
in O 0 2.190111381139559e-08
anterior O 0 6.126311745902058e-06
patterning O 0 5.7270026445621625e-06
during O 0 7.894976050693003e-08
embryogenesis O 0 8.676168476995372e-07
. O 0 8.672986240298997e-08

Prevalence O 0 9.343753504253982e-07
of O 0 1.9815731278072235e-08
p16 O 0 2.440240223222645e-07
and O 0 6.444290878704351e-09
CDK4 O 0 0.07073351740837097
germline O 0 1.3044731531408615e-05
mutations O 0 1.4272129078563012e-07
in O 0 6.268135788189966e-09
48 O 0 3.1891474350231874e-07
melanoma B-Disease 0 5.368952315620845e-06
- O 0 1.9834637043913972e-08
prone O 0 3.0822963736909514e-08
families O 0 5.456702312223172e-10
in O 0 6.120479123516986e-10
France O 0 1.065678567613304e-08
. O 0 8.206563961721258e-08

The O 0 5.797456310574489e-07
French O 0 8.596986845077481e-06
Familial B-Disease 0 4.911274663754739e-05
Melanoma I-Disease 0 0.00015064179024193436
Study O 0 5.8628395471771455e-09
Group O 0 7.240451571632889e-10
. O 0 6.1749605428929044e-09

Germline O 0 1.1498983440105803e-05
mutations O 0 2.424288538804831e-07
in O 0 4.373727602313693e-09
the O 0 5.267176028667109e-09
p16 O 0 4.8038959477025855e-08
and O 0 1.0411127515652652e-09
CDK4 O 0 3.9723390727886e-06
genes O 0 1.0873745237560684e-09
have O 0 4.1137981909855625e-11
been O 0 3.2552509299232923e-11
reported O 0 4.017843349690686e-11
in O 0 1.882104498293624e-12
a O 0 5.2440649045415455e-11
subset O 0 1.2295234164128033e-08
of O 0 4.371694828364525e-08
melanoma B-Disease 0 1.4310769984149374e-05
pedigrees O 0 6.879070042487001e-07
, O 0 1.9863060085612005e-09
but O 0 1.6803018976219164e-09
their O 0 1.0442196440862972e-08
prevalence O 0 5.984077802168031e-07
is O 0 1.5691910271176113e-10
not O 0 5.315313189591109e-10
well O 0 6.3701239838565016e-09
known O 0 4.6481272164555776e-08
. O 0 3.018062670889776e-07

We O 0 4.201329950603849e-09
searched O 0 3.5654457164469022e-09
for O 0 1.3381683781898968e-11
such O 0 1.3399620302223525e-10
germline O 0 2.2245417596877815e-07
mutations O 0 4.913061069089508e-09
in O 0 8.371401349904772e-10
48 O 0 1.1518606157778777e-07
French O 0 5.013559416511271e-07
melanoma B-Disease 0 1.2751901522278786e-05
- O 0 2.9559384273625255e-08
prone O 0 1.8789984679301597e-08
families O 0 1.4347835419759036e-10
selected O 0 2.3471760646209816e-10
according O 0 2.0394748390106798e-11
to O 0 1.648510668250669e-11
two O 0 1.243016193447355e-11
major O 0 3.607623366708168e-10
criteria O 0 3.7654282469823386e-10
families O 0 1.8835141779582898e-10
with O 0 1.3505480588038576e-11
at O 0 6.083027415115794e-10
least O 0 5.951752979349578e-11
three O 0 5.24626626863256e-11
affected O 0 4.5142842242107406e-10
members O 0 7.813023145120113e-11
( O 0 3.802762618687616e-11
n O 0 1.970001661799614e-10
= O 0 8.600987699836082e-10
20 O 0 5.509705469641801e-10
) O 0 8.28047428801798e-13
or O 0 1.9662910622636476e-12
families O 0 3.0253839797961257e-12
with O 0 1.9791582110163797e-13
two O 0 1.387607476838193e-12
affected O 0 3.8063982521485684e-11
members O 0 2.827918238121341e-12
, O 0 3.320289139116528e-12
one O 0 2.202781013149746e-11
of O 0 2.0071637407692577e-10
them O 0 4.0112427268645945e-11
affected O 0 8.638258996995773e-10
before O 0 9.804400347146469e-11
the O 0 3.2537503247276334e-10
age O 0 1.9377524029806636e-09
of O 0 1.2461437437494283e-09
50 O 0 1.9622026226073785e-09
( O 0 6.021266818478921e-11
n O 0 3.9125891415636715e-10
= O 0 4.023599231572916e-09
28 O 0 3.982113838674195e-08
) O 0 1.3855591673994638e-10
, O 0 5.520979853845809e-11
and O 0 2.57084561972043e-11
one O 0 5.245845771661983e-11
additional O 0 2.4052818070607884e-10
minor O 0 9.693032154700632e-09
criterion O 0 2.5087882022489794e-05
. O 0 1.1736132137230015e-06

Sixteen O 0 2.4145961106114555e-06
different O 0 8.060123946052045e-08
p16 O 0 2.240722551505314e-06
germline O 0 3.6201352031639544e-06
mutations O 0 6.79205740539146e-08
were O 0 1.1101500829724387e-09
found O 0 3.6285106863598315e-11
in O 0 6.592411512518215e-12
21 O 0 4.087317984069472e-10
families O 0 5.822092807861168e-11
, O 0 1.27374170239003e-11
while O 0 6.146376463345149e-11
one O 0 1.0518611537335687e-09
germline O 0 4.845369971917535e-07
mutation O 0 2.368721041534627e-08
, O 0 7.382876532346927e-10
Arg24His O 0 1.6310431760757638e-07
, O 0 5.332495001120208e-10
was O 0 5.013470971704237e-09
detected O 0 1.8041146354619286e-09
in O 0 1.926393905504753e-10
the O 0 1.7475983327130962e-08
CDK4 O 0 2.6248626454616897e-05
gene O 0 2.3375780244805355e-07
. O 0 1.1691736290231347e-06

The O 0 1.9904966563899507e-09
frequency O 0 3.0778182225077444e-09
of O 0 4.3185341414009315e-10
p16 O 0 7.783680366912904e-10
gene O 0 8.096089076925495e-11
mutation O 0 4.239044879006393e-11
in O 0 1.7290946452419576e-11
our O 0 8.061773471013112e-11
sample O 0 2.481551943100957e-11
( O 0 8.245745752866185e-11
44 O 0 2.301029233819918e-08
% O 0 3.9029740550589054e-10
) O 0 1.3321907596161586e-12
is O 0 1.621584485612948e-12
among O 0 7.822756331599123e-12
the O 0 1.1289143925230505e-10
highest O 0 1.4687279170644274e-09
rates O 0 1.0797607252754915e-09
yet O 0 1.8080512087514933e-10
reported O 0 1.1989854664662403e-09
and O 0 6.333143731662716e-11
the O 0 1.288558260092998e-09
CDK4 O 0 4.264558356226189e-06
mutation O 0 5.539315117708554e-10
is O 0 3.729772740657111e-11
the O 0 1.455328080268714e-10
second O 0 1.3601738624302584e-09
mutation O 0 2.7603386243413297e-09
detected O 0 3.4843470331225035e-09
in O 0 9.499162567649932e-11
this O 0 5.360201171811241e-10
gene O 0 2.8519417938355218e-08
worldwide O 0 1.0478192535856579e-07
. O 0 4.707692653482809e-07

In O 0 7.484268316204634e-09
summary O 0 7.142405706872523e-07
, O 0 1.1757950169055675e-09
our O 0 1.3374018559275669e-09
results O 0 6.794941276311306e-10
show O 0 1.8405529877973947e-10
frequent O 0 1.588809084296372e-10
involvement O 0 1.9019000263575947e-10
of O 0 5.290734517160445e-10
the O 0 9.366856179582328e-10
p16 O 0 7.34445260164307e-09
gene O 0 8.724011513194796e-10
in O 0 1.6824827087091876e-09
familial B-Disease 0 2.711808519961778e-07
melanoma I-Disease 0 2.3562084550121654e-07
and O 0 8.170439151633513e-12
confirm O 0 2.8166061150081134e-10
the O 0 4.677703224764684e-10
role O 0 7.936427626198395e-10
of O 0 5.841455674726603e-08
the O 0 1.3940810106305435e-07
CDK4 O 0 0.0055371434427797794
gene O 0 7.3888668516985945e-09
as O 0 2.6834676702947036e-08
a O 0 4.5592159381158126e-08
melanoma B-Disease 0 1.7812328678701306e-06
- O 0 1.3454368286147655e-07
predisposing O 0 5.003590786145651e-07
gene O 0 5.4339423627425276e-08
. O 0 4.9331678297903636e-08
. O 0 1.1565276736291707e-07

Progression O 0 3.3281648370575567e-07
of O 0 3.358467282055244e-08
somatic O 0 1.7829657736001536e-05
CTG O 0 7.1866525104269385e-06
repeat O 0 3.221382050000443e-09
length O 0 5.679205439257373e-10
heterogeneity O 0 1.0679126916102177e-08
in O 0 6.04806274506764e-11
the O 0 4.0092254516288506e-10
blood O 0 6.79320433238928e-10
cells O 0 1.7580451538989905e-09
of O 0 1.5775676320828325e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.4908309253769403e-08
. O 0 6.1648397498004215e-09

The O 0 3.007092908013931e-10
genetic O 0 1.1375543840230762e-09
basis O 0 1.0055439814138367e-09
of O 0 3.614993582257142e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 5.536352176704895e-08
DM B-Disease 1 1.0
) O 0 9.995977136301182e-12
is O 0 8.22302729380775e-13
the O 0 1.8159291344937989e-12
expansion O 0 1.1442742309242249e-09
of O 0 8.246756610930106e-10
an O 0 4.221137217541582e-09
unstable O 0 4.971989255864173e-05
CTG O 0 4.800649912795052e-05
repeat O 0 5.204004782655147e-09
in O 0 5.512059697565519e-10
the O 0 3.670215020790124e-09
34 O 0 2.1008613515505203e-08
UTR O 0 7.198347702797037e-06
of O 0 1.628331958158924e-08
the O 0 9.844720949558905e-08
DM B-Disease 1 1.0
protein O 0 3.159721586598607e-07
kinase O 0 4.16061425312364e-08
gene O 0 1.881953037852213e-09
on O 0 2.0179676596399077e-08
chromosome O 0 4.319329249824477e-08
19 O 0 5.756433552051021e-07
. O 0 1.4059800435006764e-07

One O 0 4.553859955791495e-09
of O 0 4.741274484132418e-09
the O 0 3.5940952436419593e-09
principal O 0 1.9805906248393512e-08
features O 0 2.739410087659877e-10
of O 0 5.197597019446221e-09
the O 0 2.541735284466995e-07
DM B-Disease 1 1.0
mutation O 0 2.1999793986537952e-08
is O 0 1.3348392703671497e-11
an O 0 3.766360140433633e-11
extraordinarily O 0 1.052597675688105e-09
high O 0 1.0871926470201743e-08
level O 0 1.9174446208580775e-07
of O 0 3.4456084563316836e-07
somatic O 1 0.9999948740005493
mosaicism O 0 0.000285274931229651
, O 0 1.8437117110803314e-10
due O 0 2.6202628955473983e-10
to O 0 2.553243901026736e-11
an O 0 3.2263160892886944e-11
extremely O 0 3.566122050435716e-11
high O 0 7.755238812245935e-11
degree O 0 8.896280934145295e-10
of O 0 2.71306754839884e-10
somatic O 0 2.0082156027001474e-07
instability O 0 7.043154059971357e-09
both O 0 4.2422820811793827e-10
within O 0 9.934953970613947e-10
and O 0 1.6809037495235657e-10
between O 0 4.214884274933439e-10
different O 0 1.747197608814588e-09
tissues O 0 4.861838931446982e-08
. O 0 2.763574613595665e-08

This O 0 1.8985710781294074e-08
instability O 0 1.6993486440242123e-07
appears O 0 6.159879273326396e-09
to O 0 1.3791416619834962e-10
be O 0 9.531504058246654e-11
biased O 0 1.1380822506623645e-08
towards O 0 5.828350579939467e-10
further O 0 8.572779985893675e-11
expansion O 0 6.194208479470831e-10
and O 0 3.5419760874289e-11
continuous O 0 1.724090870069972e-09
throughout O 0 1.052243847610157e-10
the O 0 6.640474281560671e-10
life O 0 1.0169216579924978e-09
of O 0 1.610423017162077e-09
an O 0 4.895089888989901e-10
individual O 0 1.934811755255339e-10
, O 0 1.7317029754604363e-10
features O 0 1.217276945908452e-09
that O 0 1.4050209606875086e-10
could O 0 2.0515665555276286e-10
be O 0 6.808377472911076e-11
associated O 0 4.6348078153179983e-10
with O 0 3.269251189208511e-11
the O 0 1.044466069188843e-09
progressive O 0 1.0648255965861608e-07
nature O 0 2.230960527427328e-09
of O 0 6.173920819030343e-10
the O 0 2.4335105042183613e-09
disease O 0 3.446324114975141e-08
. O 0 2.5096344558050987e-08

Although O 0 1.0919760651262322e-09
increasing O 0 6.694930720918535e-10
measured O 0 2.5317431484594977e-10
allele O 0 2.345923177937692e-10
size O 0 1.4969385453422746e-10
between O 0 3.3679189992419367e-10
patients O 0 3.681135674060698e-10
clearly O 0 5.15358644648245e-10
correlates O 0 5.571346162192015e-10
with O 0 6.980958237694235e-14
an O 0 5.532991599610515e-13
increased O 0 1.603855416532074e-11
severity O 0 3.502377499131626e-09
of O 0 8.734400980259238e-10
symptoms O 0 1.1864966786845343e-08
and O 0 1.0109794945645234e-11
an O 0 1.2819968177313346e-11
earlier O 0 6.154846771133649e-11
age O 0 1.1418607170909922e-09
of O 0 1.155228024352084e-09
onset O 0 2.292596157360549e-08
, O 0 1.2902194937436384e-11
this O 0 1.3357586738094174e-11
correlation O 0 7.243973754178512e-10
is O 0 1.0894120675009056e-11
not O 0 1.7540340707666857e-11
precise O 0 4.3003730354485015e-08
and O 0 8.891938296784474e-10
measured O 0 1.4662208336346794e-08
allele O 0 5.683564285874354e-09
length O 0 2.299317181098104e-09
cannot O 0 2.1396009408647387e-09
be O 0 7.74969699524064e-10
used O 0 9.825747993019718e-10
as O 0 1.350092954099935e-10
an O 0 3.278449040022835e-11
accurate O 0 1.3814836385961371e-08
predictor O 0 6.231874749573763e-07
of O 0 2.2981389236065297e-08
age O 0 1.7713093711790862e-06
of O 0 3.265360192017397e-06
onset O 0 0.0004943861858919263
. O 0 4.2701074676188e-07

In O 0 4.90439855393987e-10
order O 0 1.4860090935542303e-10
to O 0 1.8566689852228535e-11
further O 0 3.3078020877930214e-10
characterize O 0 4.580917867258449e-09
the O 0 6.130340124421707e-10
dynamics O 0 4.899728267560022e-08
of O 0 7.240899435601023e-08
DM B-Disease 1 1.0
CTG O 0 3.986832598457113e-05
repeat O 0 2.80677880937219e-08
somatic O 0 4.6363155092876696e-07
instability O 0 2.8494515191823666e-08
, O 0 1.2459626386185363e-10
we O 0 4.960153815458668e-11
have O 0 9.384371751908205e-12
studied O 0 2.415732336391585e-10
repeat O 0 3.4631481710123424e-11
length O 0 2.5562262376266354e-11
changes O 0 4.589116239794855e-11
over O 0 5.245365253259138e-11
time O 0 8.88288193001685e-11
in O 0 4.088704028126777e-11
111 O 0 2.430431678135392e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 0.9999973773956299
patients O 0 2.1128132229875085e-11
with O 0 7.631266088882829e-14
varying O 0 2.6650601864242063e-11
clinical O 0 7.694622716769572e-11
severity O 0 1.4113961555040078e-08
and O 0 8.376272453425315e-10
CTG O 0 9.392910556016432e-07
repeat O 0 1.948511574312306e-09
size O 0 2.49079668002139e-09
over O 0 2.373517216103238e-10
time O 0 4.1841263787034677e-10
intervals O 0 2.161644863107881e-09
of O 0 9.029847425345849e-10
1 O 0 9.347157714501009e-09
- O 0 8.312803778665057e-09
7 O 0 2.888670636025381e-08
years O 0 1.1254412513039824e-08
. O 0 7.866191964467362e-08

We O 0 1.1835764368584023e-08
have O 0 8.303178283819435e-11
found O 0 1.1013374240365081e-11
a O 0 3.330551546359972e-12
direct O 0 1.763562212930836e-10
progression O 0 1.8441065341434637e-09
of O 0 4.2011835676980525e-10
the O 0 4.495655792080555e-10
size O 0 3.5018097310768326e-09
heterogeneity O 0 6.998430990279303e-08
over O 0 6.665726859367282e-10
time O 0 3.774042189874649e-10
related O 0 6.625242021662814e-10
to O 0 4.1720532584221814e-10
initial O 0 1.9204964729624407e-08
CTG O 0 1.8932432510609942e-07
repeat O 0 5.726783491866172e-10
size O 0 1.6886779752312009e-09
and O 0 2.2635086860400833e-10
the O 0 2.0450277027350694e-09
time O 0 1.5018123411536521e-09
interval O 0 2.7189746010236604e-09
and O 0 5.182290707672621e-10
always O 0 2.931110687498517e-09
biased O 0 1.279370991369433e-07
towards O 0 1.7964136844739187e-08
further O 0 1.081290434967741e-08
expansion O 0 4.822467758458515e-07
. O 0 4.7648984491388546e-07

Attempts O 0 1.1584391224062074e-08
to O 0 2.821708977585047e-10
mathematically O 0 4.932038777383241e-08
model O 0 4.0189455319250555e-08
the O 0 2.0145451529174352e-08
dynamics O 0 8.025041609016625e-08
have O 0 1.7099723859104188e-09
proved O 0 6.072438196724761e-08
only O 0 6.9336953956167235e-09
partially O 0 4.820398658011982e-08
successful O 0 1.5946753917361889e-09
suggesting O 0 1.143059202846075e-09
that O 0 1.2524475380415456e-11
individual O 0 3.986272076317299e-11
specific O 0 3.292782713160136e-10
genetic O 0 1.6438850281019768e-08
and O 0 1.9903525494413543e-09
/ O 0 1.0031518726805189e-08
or O 0 2.795028375413011e-10
environmental O 0 2.585601066584786e-09
factors O 0 1.4374521573046195e-09
also O 0 4.684102411500746e-11
play O 0 1.0616908741045705e-10
a O 0 5.315070050748716e-10
role O 0 8.272025842082087e-10
in O 0 1.3962485612140085e-09
somatic O 0 3.234416681152652e-06
mosaicism O 0 1.4559090232069138e-05
. O 0 3.509273227564336e-08
. O 0 1.490681000859695e-07

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 5.376753264840772e-08
Palestinian O 0 0.00019427241932135075
Arabs O 0 1.5392283785331529e-06
. O 0 1.3438236123874958e-07

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.8533295392990112
AGU B-Disease 1 1.0
) O 0 3.187118902125974e-10
is O 0 4.2396732825855654e-12
a O 0 7.283257330570336e-12
rare O 0 1.3681149546584948e-09
disorder B-Disease 1 0.9999991655349731
of I-Disease 0 0.009660252369940281
glycoprotein I-Disease 0 0.0078710513189435
metabolism I-Disease 1 0.9997246861457825
caused O 0 3.508241031013881e-09
by O 0 8.707279688935365e-12
the O 0 3.131096493191876e-09
deficiency B-Disease 1 0.9999953508377075
of I-Disease 0 9.406409731127496e-07
the I-Disease 0 4.1710389808713444e-08
lysosomal I-Disease 0 2.902038716001698e-07
enzyme I-Disease 0 7.349066066808518e-08
aspartylglucosaminidase I-Disease 0 2.8509606408988475e-07
( O 0 1.7820217523834003e-09
AGA O 0 3.7228239762043813e-06
) O 0 2.937076581943643e-09
. O 0 2.795068354544128e-08

AGU B-Disease 1 1.0
is O 0 4.210734161347318e-08
inherited O 0 1.2200748642499093e-06
as O 0 3.246412250135222e-09
an O 0 1.4070330456306124e-09
autosomal O 0 1.126917777583003e-05
recessive O 0 1.517322743893601e-06
trait O 0 2.1509286796117522e-07
and O 0 2.0059226849000744e-11
occurs O 0 1.43570268520965e-11
with O 0 2.775451513037895e-14
a O 0 6.810425921127683e-12
high O 0 2.3410953731151096e-10
frequency O 0 5.460158991610342e-10
in O 0 1.3324005787573867e-10
Finland O 0 3.0673572570805163e-09
because O 0 3.2661378046583422e-09
of O 0 2.6651761686480313e-08
a O 0 1.874184363259701e-08
founder O 0 5.242662837190437e-07
effect O 0 2.8437403898351477e-07
. O 0 1.597087617710713e-07

While O 0 8.187490152522514e-08
very O 0 2.5856798924195346e-09
few O 0 3.5370109063848076e-09
patients O 0 1.7081071279623217e-10
with O 0 1.9870664835774932e-10
AGU B-Disease 1 1.0
have O 0 1.4584744523205018e-09
been O 0 1.0689774065930635e-10
reported O 0 9.023180119749341e-11
from O 0 3.339395079904328e-11
non O 0 5.829429161607891e-10
- O 0 3.20912602047585e-11
Finnish O 0 1.877767802360708e-10
origin O 0 2.2332541371739012e-10
, O 0 3.0287404528817063e-11
we O 0 2.9357699604659615e-10
diagnosed O 0 1.1139881905819493e-07
the O 0 3.983387841799413e-09
disorder O 0 5.945022962805524e-08
in O 0 1.4550893823184197e-10
8 O 0 1.0444003439857852e-09
patients O 0 1.4784203375417526e-11
originating O 0 1.9233026282705623e-10
from O 0 9.132676559442388e-11
3 O 0 4.495673000537437e-10
unrelated O 0 4.184988189326333e-10
families O 0 3.043396784585539e-11
, O 0 2.3551022243495368e-12
all O 0 6.052306225634574e-12
Palestinian O 0 8.493267422693407e-09
Arabs O 0 5.135297187486287e-10
from O 0 1.1444591108134006e-10
the O 0 2.5025145844459473e-10
region O 0 1.7894671300311416e-09
of O 0 9.024530456258617e-09
Jerusalem O 0 5.2919690460839774e-06
. O 0 5.361796979741484e-07

The O 0 2.118840436438063e-09
clinical O 0 8.99466456871778e-09
diagnosis O 0 9.344179488834925e-06
of O 0 0.0011499045649543405
AGU B-Disease 1 1.0
is O 0 4.833541424886789e-07
often O 0 1.0478743428521398e-09
difficult O 0 4.1026734787230623e-10
, O 0 2.2137741292893587e-11
in O 0 5.109137939107722e-12
particular O 0 7.236153343193052e-11
early O 0 3.451971763990258e-10
in O 0 8.1730577167205e-12
the O 0 1.6950374437385562e-10
course O 0 4.2549158640881046e-10
of O 0 4.490582072858018e-10
the O 0 1.767192947532692e-09
disease O 0 6.79701850359038e-09
, O 0 1.7326338280776454e-11
and O 0 1.7375713715073182e-11
most O 0 7.857258593757521e-11
of O 0 5.642882272560712e-10
the O 0 6.657810969201705e-10
patients O 0 1.9751938973300298e-10
are O 0 6.351991155284509e-11
diagnosed O 0 5.315749507239786e-10
after O 0 1.0428850144572621e-10
the O 0 8.735467349474391e-10
age O 0 9.646057286261112e-09
of O 0 9.905971154466897e-09
5 O 0 2.7572829353061934e-08
years O 0 2.033779367138777e-08
. O 0 2.4079702143353643e-07

However O 0 3.6159872252028435e-07
, O 0 3.669346826384867e-09
since O 0 1.2242528102390793e-09
these O 0 1.0143142992191656e-09
patients O 0 5.804420832866697e-10
excrete O 0 8.734788004005622e-09
early O 0 8.943919493908936e-10
large O 0 5.842249600762628e-11
amounts O 0 1.9349739865948123e-10
of O 0 9.243578125150975e-10
aspartylglucosamine O 0 8.16839786921264e-08
in O 0 9.324306882163569e-10
urine O 0 6.952947662064446e-10
, O 0 1.8831323653212273e-11
biochemical O 0 8.488567071474051e-10
screening O 0 1.537414362484668e-10
is O 0 1.1210824629737104e-10
easy O 0 7.661328460528694e-09
by O 0 7.306532268103183e-09
urine O 0 1.4459057950944043e-08
chromatography O 0 4.9960330983367385e-08
. O 0 1.3632524442641625e-08
. O 0 1.036941981169548e-07

Detection O 0 4.98885022182094e-09
of O 0 8.334916645758028e-10
heterozygous O 0 1.2734385768098377e-10
carriers O 0 2.951100822046193e-11
of O 0 2.1416413087393948e-10
the O 0 2.7109649636258837e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.003944061230868101
ATM O 0 1.4071234545554034e-05
) O 0 4.008489373763524e-11
gene O 0 2.2259853682538022e-11
by O 0 1.062454031003357e-11
G2 O 0 1.5926335805716008e-08
phase O 0 1.8287847625142462e-10
chromosomal O 0 7.125551704234567e-09
radiosensitivity O 0 4.1885942891894956e-07
of O 0 8.284522579060649e-08
peripheral O 0 6.275578925851732e-05
blood O 0 6.958021458558505e-06
lymphocytes O 0 4.7602608788110956e-07
. O 0 5.300851313450039e-08

In O 0 8.940345708197128e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 4.003859049861447e-11
patients O 0 6.562356213990483e-11
, O 0 7.612676222908121e-13
mutations O 0 3.061104971932571e-12
in O 0 6.134962329817917e-13
a O 0 2.410818506631829e-12
single O 0 1.881451374904919e-12
gene O 0 1.8800317205802664e-11
, O 0 2.6280394527233852e-11
ATM O 0 2.9907807341800208e-09
, O 0 3.398703193879804e-12
result O 0 6.470947475772926e-12
in O 0 5.283125933258637e-12
an O 0 2.002760268737802e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 6.573884769878191e-10
embraces O 0 2.4140891508039886e-09
a O 0 3.311411214679261e-11
variety O 0 1.623963186148103e-10
of O 0 5.934774893745498e-10
clinical O 0 1.512875491549437e-09
features O 0 9.038962911489534e-10
and O 0 1.485175871174249e-10
manifests O 0 5.418125503808824e-09
extreme O 0 2.3294546735996846e-08
radiosensitivity O 0 4.6007181708773714e-07
and O 0 6.987487255472047e-10
a O 0 9.072372186835764e-09
strong O 0 3.047302357117587e-07
pre O 0 1.0149785794055788e-06
- O 0 1.5772953076975682e-07
disposition O 0 2.007686362048844e-06
to O 0 3.630212219718487e-08
malignancy B-Disease 0 1.7400705473846756e-05
. O 0 9.975178727472667e-08

Heterozygotes O 0 1.744977851103613e-07
for O 0 2.2991373249681146e-09
the O 0 1.3332458692616456e-08
ATM O 0 2.2694989354477002e-07
gene O 0 7.254319367433482e-09
have O 0 3.8032937910159603e-10
no O 0 1.1847406389264847e-10
clinical O 0 3.3519939601767135e-10
expression O 0 8.414672292289538e-10
of O 0 1.425224581907969e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 3.505695076455595e-07
may O 0 8.929605499474746e-09
be O 0 4.264057551495171e-09
cancer B-Disease 0 1.6360900190193206e-08
prone O 0 4.6557888100373646e-10
with O 0 4.974106196375949e-12
a O 0 2.919459396455437e-10
moderate O 0 2.3153949868515156e-08
increase O 0 4.2573752856434055e-10
in O 0 2.7491142695623694e-10
in O 0 5.846870099190937e-09
vitro O 0 4.334564778218919e-07
radiosensitivity O 0 5.882123787159799e-06
. O 0 2.1527220894768107e-07

We O 0 9.684125501507879e-09
performed O 0 3.525478242671909e-10
a O 0 1.2725069886698748e-09
blind O 0 2.3923407255210805e-08
chromosomal O 0 9.538646850160148e-08
analysis O 0 2.475797522549783e-08
on O 0 8.716598109970164e-09
G2 O 0 1.4211647680895112e-07
- O 0 1.9134389628305826e-09
phase O 0 2.4705129053614883e-09
lymphocytes O 0 1.341534799914612e-10
from O 0 3.855117614026682e-11
7 O 0 5.214425002897372e-10
unrelated O 0 6.33433643315584e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 4.732700453757843e-09
, O 0 2.0910877196467226e-11
13 O 0 2.9104132992507914e-10
obligate O 0 2.2298009128007834e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 9.074224749383575e-07
( O 0 6.593621482142709e-11
parents O 0 6.560266219146627e-11
of O 0 5.6657536301463196e-11
the O 0 2.7009840544711672e-11
patients O 0 1.1630617259214548e-12
) O 0 2.2915588697436373e-13
, O 0 2.9340930726706738e-12
and O 0 3.648977647818796e-11
14 O 0 1.181181374931839e-08
normal O 0 1.5162220279307803e-07
controls O 0 9.080542540118586e-09
following O 0 7.781023048103464e-10
X O 0 1.819705097716451e-08
- O 0 1.4877822307468591e-09
irradiation O 0 2.4946333887498895e-09
with O 0 1.066612336647621e-11
1 O 0 1.240002989177924e-09
Gy O 0 1.2224428580509539e-08
in O 0 8.785402093314243e-12
order O 0 4.658984656402687e-11
to O 0 8.938116913270733e-11
evaluate O 0 1.138776628550886e-09
this O 0 2.573835033992111e-10
cytogenetic O 0 5.591156764239713e-07
method O 0 2.6374891604064032e-08
as O 0 8.383082006346854e-10
a O 0 1.4836583350774646e-10
tool O 0 2.891188177756021e-09
for O 0 1.5753769816440055e-11
detection O 0 1.0053412324850797e-08
of O 0 1.3309795043880968e-08
ATM O 0 2.9281503884703852e-05
carriers O 0 1.9669106166020356e-07
. O 0 4.402706395012501e-07

Both O 0 1.5592715953971492e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 7.599143714287493e-07
and O 0 3.4729796816179714e-10
heterozygotes O 0 1.490589340846782e-08
showed O 0 4.0348482888141746e-10
significantly O 0 3.5576588897079375e-10
increased O 0 1.8793371026060157e-10
levels O 0 2.8890370651346586e-10
of O 0 6.823748233131255e-10
radiation O 0 9.820320201470167e-07
- O 0 9.640851672543249e-09
induced O 0 3.7277086306630736e-08
chromatid O 0 2.5534134806548536e-08
damage O 0 5.349326759329642e-09
relative O 0 9.431179170960036e-10
to O 0 2.2424128526266074e-11
that O 0 1.874438972093717e-11
of O 0 9.70486691009853e-10
normal O 0 1.6610529840477284e-08
controls O 0 5.4623313872070867e-08
. O 0 9.265457379115105e-08

These O 0 3.2721862996965e-09
results O 0 6.871868407642978e-09
show O 0 3.2437756924963423e-09
that O 0 1.3774828500068281e-10
the O 0 7.208665220304056e-09
G2 O 0 1.3839542134519434e-06
- O 0 6.542094155292943e-08
phase O 0 8.104181858925585e-08
chromosomal O 0 3.4216552080579277e-07
radiosensitivity O 0 8.433083280579012e-07
assay O 0 2.3462565224008358e-08
can O 0 3.7976108369086603e-10
be O 0 7.258214862471135e-11
used O 0 9.111879653578292e-12
for O 0 2.7322061713769275e-12
the O 0 1.9696400760382815e-11
detection O 0 3.8021572557056516e-09
of O 0 6.579836764331048e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 0.00026154963416047394
. O 0 7.62920592478622e-07

In O 0 1.772002655719973e-09
combination O 0 8.927971251182498e-09
with O 0 1.1483337891693424e-10
molecular O 0 1.4856052388267926e-08
genetic O 0 2.123239006834865e-08
analyses O 0 4.474545178823064e-09
, O 0 1.724338900832567e-11
this O 0 4.5191727963966866e-12
test O 0 3.8454955365863075e-12
may O 0 4.6209473747449437e-11
be O 0 1.5641999848159394e-11
of O 0 3.074083695930874e-11
value O 0 1.0285942930732261e-10
in O 0 4.62459497779788e-12
studies O 0 1.853478481805837e-10
of O 0 2.659049647135703e-10
familial B-Disease 0 1.0439926256822218e-08
and I-Disease 0 1.6183056006369156e-09
sporadic I-Disease 0 1.0199571534030838e-06
cancers I-Disease 0 6.947995530026674e-07
aimed O 0 1.1589805559708566e-08
at O 0 6.568507404658419e-10
determination O 0 6.113968220589072e-10
of O 0 7.153873049503545e-10
the O 0 1.251829612192168e-10
potential O 0 2.9957363256727376e-09
involvement O 0 8.008600893560924e-09
of O 0 4.571877099124322e-08
ATM O 0 4.452390567166731e-05
mutations O 0 6.177643285809609e-07
in O 0 7.3541808198740455e-09
tumor B-Disease 0 2.179121111112181e-06
risk O 0 1.307408670214727e-08
or O 0 1.3062015913334335e-09
development O 0 2.174697399937031e-08
. O 0 1.3472948312553967e-09
. O 0 2.3703844220790415e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 2.0008513956781826e-08
identification O 0 1.8585275540772273e-09
and O 0 1.4486033032834467e-11
detection O 0 1.7327578261117083e-09
of O 0 8.567459630626217e-09
founder O 0 3.654458566870744e-07
- O 0 2.345343830256752e-08
effect O 0 1.6512768752363627e-07
mutations O 0 1.4782139068358902e-08
in O 0 1.425256301867961e-10
the O 0 4.3508111002843464e-10
ATM O 0 3.8856988737734355e-09
gene O 0 1.41513897822243e-10
in O 0 2.1873330924293555e-10
ethnic O 0 4.2821654555602606e-10
populations O 0 3.809670801047105e-09
. O 0 2.5583860363553868e-08

To O 0 4.1091580138541417e-10
facilitate O 0 2.560141876273292e-09
the O 0 1.0448147902408778e-09
evaluation O 0 9.321448501964369e-09
of O 0 9.051855265340691e-09
ATM O 0 3.0373752451851033e-05
heterozygotes O 0 2.879023213608889e-06
for O 0 3.483456856301359e-09
susceptibility O 0 5.343404723134881e-07
to O 0 2.379769492577566e-09
other O 0 9.243406928760578e-09
diseases O 0 0.005965336691588163
, O 0 3.0518967908399475e-10
such O 0 6.183796252834384e-10
as O 0 7.94684069660434e-08
breast B-Disease 0 1.4800512815327238e-07
cancer I-Disease 0 8.175333476856395e-08
, O 0 9.430184411129972e-11
we O 0 1.8952261982008167e-10
have O 0 2.6298145952563523e-11
attempted O 0 2.96283886314086e-10
to O 0 1.0631802382921052e-10
define O 0 1.3235209594952835e-09
the O 0 1.6306217487382924e-09
most O 0 5.654496870732828e-10
common O 0 3.471588572168116e-10
mutations O 0 8.279728569426936e-10
and O 0 1.7177507680155024e-11
their O 0 3.1000150363391654e-11
frequencies O 0 2.1821668916288672e-09
in O 0 2.409934918290446e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999979734420776
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.615531762868329e-10
homozygotes O 0 2.454365599646735e-09
from O 0 5.274409381472722e-11
10 O 0 5.270065286944181e-11
ethnic O 0 7.120354306167087e-11
populations O 0 6.199042390520049e-10
. O 0 1.7640182647937763e-08

Both O 0 8.459755918011069e-08
genomic O 0 2.2294267409961321e-07
mutations O 0 1.2123658166274254e-07
and O 0 8.574452814436029e-10
their O 0 3.04848757348708e-10
effects O 0 1.1326295457081414e-08
on O 0 2.2502815166802748e-09
cDNA O 0 9.836383263461812e-09
were O 0 4.695897004580729e-09
characterized O 0 1.8995564232682227e-08
. O 0 5.614384690488805e-08

Protein O 0 2.0236922182448325e-07
- O 0 1.1422097934143949e-08
truncation O 0 4.88290474720543e-09
testing O 0 2.1609748712680954e-11
of O 0 2.3253859948724198e-10
the O 0 2.606276583438927e-10
entire O 0 6.214894709977159e-10
ATM O 0 1.3977974333556631e-08
cDNA O 0 3.0828710695374184e-09
detected O 0 1.1457003123993559e-09
92 O 0 1.0523588667155082e-09
( O 0 2.2382424039180115e-11
66 O 0 2.7692719228866736e-09
% O 0 2.2227535090291184e-10
) O 0 7.9185919973912e-12
truncating O 0 1.281685202414451e-09
mutations O 0 3.000973358702197e-10
in O 0 4.206288789498913e-11
140 O 0 5.539483871608297e-10
mutant O 0 3.2909008851333965e-09
alleles O 0 1.0123588189969723e-08
screened O 0 1.7505851701571373e-07
. O 0 6.979488631486674e-08

The O 0 6.021781473464216e-08
haplotyping O 0 1.9019085812033154e-05
of O 0 2.3630533974028367e-08
patients O 0 5.694325566629743e-10
with O 0 3.2115140408128795e-11
identical O 0 6.63938859446489e-09
mutations O 0 6.86077896716597e-08
indicates O 0 5.184806894931171e-08
that O 0 2.4324776567996587e-11
almost O 0 4.242460271974835e-10
all O 0 7.465341539392156e-11
of O 0 1.8954211811195165e-10
these O 0 2.477597987882163e-11
represent O 0 8.547702129435564e-11
common O 0 5.434454553032708e-10
ancestry O 0 3.483263899539679e-09
and O 0 3.223525335549482e-10
that O 0 1.8539027257791219e-10
very O 0 1.1785319387058735e-09
few O 0 1.9512647497776925e-08
spontaneously O 0 7.137266067047676e-08
recurring O 0 9.49738208078088e-08
ATM O 0 6.3175743889587466e-06
mutations O 0 6.143385462564765e-07
exist O 0 1.4040504936474463e-07
. O 0 3.178381007273856e-07

Assays O 0 2.6676374886847043e-08
requiring O 0 9.054099692207274e-09
minimal O 0 2.8121166906203143e-07
amounts O 0 3.648871782502283e-08
of O 0 1.4386873914418175e-08
genomic O 0 1.2947327654444507e-08
DNA O 0 2.524069486753433e-08
were O 0 9.532454825489367e-10
designed O 0 6.428340637576468e-10
to O 0 5.305020311929809e-11
allow O 0 1.1113719666777655e-10
rapid O 0 1.2735363874583072e-09
screening O 0 1.5074155465533146e-11
for O 0 3.424172750898791e-11
common O 0 2.1072170675040525e-09
ethnic O 0 1.6251672008138485e-08
mutations O 0 8.324579994223313e-07
. O 0 2.0251826526873629e-07

These O 0 4.377174178671339e-09
rapid O 0 9.153145441587185e-08
assays O 0 1.7589885104030145e-08
detected O 0 3.4610254662226225e-09
mutations O 0 7.475486202279669e-11
in O 0 9.139049760020779e-12
76 O 0 1.0744767298120905e-09
% O 0 2.7325723281346193e-11
of O 0 2.6384562937242784e-11
Costa O 0 2.7129692936611605e-10
Rican O 0 1.877152877582944e-09
patients O 0 2.479991767501133e-10
( O 0 6.480461306468399e-11
3 O 0 2.0510435572163033e-09
) O 0 5.156875360762259e-12
, O 0 2.5389458330887793e-12
50 O 0 4.36514747959027e-11
% O 0 2.8519046499364542e-11
of O 0 1.7606381630397294e-10
Norwegian O 0 1.5607124481675783e-08
patients O 0 2.63878474626722e-10
( O 0 9.849158988384232e-11
1 O 0 8.344591684306124e-09
) O 0 3.050079633304392e-11
, O 0 1.5837737371571237e-11
25 O 0 6.669669816439239e-10
% O 0 8.575593707371709e-11
of O 0 2.1548308970498198e-10
Polish O 0 7.619737729669396e-09
patients O 0 7.004273827604379e-10
( O 0 7.881544028531806e-11
4 O 0 1.1326856785842665e-08
) O 0 3.340847737343111e-11
, O 0 1.3669762370660532e-11
and O 0 2.3880153063315923e-11
14 O 0 1.7406083241411352e-09
% O 0 1.6340549746640676e-10
of O 0 2.396206011390234e-10
Italian O 0 7.894034870226108e-10
patients O 0 1.420384920791662e-10
( O 0 3.5841787870971586e-11
1 O 0 1.9141772611419583e-08
) O 0 2.9921087829620774e-10
, O 0 5.156615134893627e-10
as O 0 1.0742452483114562e-09
well O 0 2.8358612680357e-10
as O 0 9.722055105410021e-11
in O 0 1.2345739881791662e-11
patients O 0 4.592057983865416e-11
of O 0 1.2169750762680565e-09
Amish O 0 3.524237968122179e-08
/ O 0 6.185217671372811e-08
Mennonite O 0 3.325322381897422e-07
and O 0 1.5921134410845639e-09
Irish O 0 1.412701733372046e-09
English O 0 4.6334753811549945e-09
backgrounds O 0 2.642605920755159e-07
. O 0 1.383203169780245e-07

Additional O 0 5.313190243327881e-08
mutations O 0 2.653156059295725e-07
were O 0 6.849622646853959e-09
observed O 0 1.4637360212788053e-09
in O 0 9.97822866000142e-11
Japanese O 0 4.109614870628775e-09
, O 0 7.187377776274317e-11
Utah O 0 2.7061797247540653e-09
Mormon O 0 4.83678919138697e-09
, O 0 1.588350631576141e-11
and O 0 2.0798111496911353e-11
African O 0 4.6395640801444316e-11
American O 0 2.083695438415134e-10
patients O 0 4.0825187674897734e-10
. O 0 8.406975560149021e-09

These O 0 8.665938189267308e-09
assays O 0 1.942892957629283e-09
should O 0 3.6998012292732696e-11
facilitate O 0 1.2679562955142387e-10
screening O 0 3.8645486116761774e-11
for O 0 3.4127706216580123e-10
A B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
heterozygotes O 0 3.66983883282046e-08
in O 0 1.3090042938479485e-10
the O 0 1.491432394251646e-10
populations O 0 1.582023262391985e-10
studied O 0 1.0282574791631305e-09
. O 0 3.63790247925877e-10
. O 0 1.6359152255063236e-08

The O 0 4.202164291200461e-06
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999994039535522
Lindau I-Disease 1 0.9768822193145752
tumor I-Disease 0 1.73069020092953e-05
suppressor O 0 3.0991034805083473e-07
gene O 0 2.2800479559936804e-10
is O 0 2.8149919461400996e-12
required O 0 5.30560187797513e-13
for O 0 1.3532574583488555e-12
cell O 0 5.509758205235471e-10
cycle O 0 3.450431607099347e-10
exit O 0 4.3660239312792726e-10
upon O 0 3.0631402969660826e-10
serum O 0 1.8545410540582452e-08
withdrawal O 0 2.6182071621860814e-08
. O 0 7.73155974798101e-08

The O 0 1.6864417418105404e-08
inactivation O 0 1.188324176837341e-06
of O 0 4.4715783076298976e-08
the O 0 2.3556468420338206e-07
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( I-Disease 0 0.0001484290260123089
VHL I-Disease 1 1.0
) I-Disease 0 3.4938452131427766e-08
tumor I-Disease 0 1.6385437220378662e-06
suppressor O 0 8.669799740346207e-07
gene O 0 5.345960563118979e-09
predisposes O 0 1.1842892888580536e-07
affected O 0 1.7444662381294052e-10
individuals O 0 4.422456595810226e-13
to O 0 1.3214153079046942e-12
the O 0 9.591169872202876e-12
human O 0 7.805639468116965e-10
VHL B-Disease 1 1.0
cancer I-Disease 1 0.999971866607666
syndrome I-Disease 0 0.0012301637325435877
and O 0 4.759561234718435e-12
is O 0 7.019428983380538e-13
associated O 0 3.581021937315576e-11
with O 0 1.4012201121627044e-11
sporadic B-Disease 0 0.03379169851541519
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 6.901122560520889e-06
RCC B-Disease 1 1.0
) O 0 1.609778799149808e-08
and O 0 6.729837309649156e-08
brain B-Disease 1 0.9999904632568359
hemangioblastomas I-Disease 0 0.00038742777542211115
. O 0 1.6958226467522763e-07

VHL O 1 0.9836999773979187
- O 0 8.942511340137571e-05
negative O 0 2.435238002362894e-06
786 O 0 1.164552259069751e-06
- O 0 1.326172878179932e-07
0 O 0 1.0758495960772052e-07
RCC B-Disease 0 3.2811738037707983e-06
cells O 0 9.670041656306694e-09
are O 0 3.356022404421566e-11
tumorigenic O 0 2.1908803660153353e-08
in O 0 6.004800545689193e-10
nude O 0 9.128283551262939e-08
mice O 0 1.0983219889126872e-09
which O 0 2.2036466401642585e-11
is O 0 4.134460569044096e-12
suppressed O 0 7.645205302164726e-11
by O 0 2.116559098125359e-12
the O 0 1.8380656718886001e-10
reintroduction O 0 9.06955506252416e-08
of O 0 2.884953964610304e-08
VHL B-Disease 0 0.0003814595111180097
. O 0 1.3197097814554581e-06

Remarkably O 0 8.741008969082031e-06
, O 0 5.855728679726724e-10
this O 0 1.1316107773051698e-11
occurs O 0 1.6111003156571435e-11
without O 0 8.562971512415807e-12
affecting O 0 4.0573208681671247e-10
the O 0 8.494101255696052e-11
growth O 0 3.598401021598363e-10
rate O 0 2.0591721383578232e-10
and O 0 2.5706986886420147e-11
cell O 0 3.6327731933738505e-09
cycle O 0 1.2034991891951563e-09
profile O 0 1.3648726593373794e-09
of O 0 2.1084634038714967e-09
these O 0 6.664328533467767e-10
cells O 0 1.973876839755917e-09
in O 0 4.021172839152598e-10
culture O 0 1.8588050210155416e-08
. O 0 1.3921328090304996e-08

The O 0 4.8057427193271e-07
786 O 0 1.0021784646596643e-06
- O 0 2.2423776613322843e-08
0 O 0 9.959776114953911e-09
cell O 0 1.5495508876028907e-08
line O 0 3.626744771167978e-08
, O 0 3.521054628419229e-11
like O 0 9.340228243615023e-12
many O 0 2.7858737539077083e-10
cancer B-Disease 0 4.0819290170190925e-09
cells O 0 1.1799107246801555e-09
, O 0 6.7246659629649486e-12
fails O 0 4.62182861427074e-11
to O 0 2.5506544792941455e-11
exit O 0 1.4574427220637176e-09
the O 0 1.452111764166375e-10
cell O 0 1.0848761888837544e-09
cycle O 0 2.109930702376417e-10
upon O 0 1.514323944018514e-10
serum O 0 6.103182403904839e-09
withdrawal O 0 1.3091405293153002e-08
. O 0 1.0839671205076229e-07

Here O 0 5.907393756388046e-07
, O 0 2.25365770489816e-09
it O 0 3.0209976881190315e-11
is O 0 1.2702982112380856e-12
shown O 0 1.0257094652799115e-12
that O 0 3.899232824643162e-13
reintroduction O 0 7.01826552429452e-09
of O 0 7.038127858294274e-10
the O 0 4.2260515087377826e-09
wild O 0 5.750113629687803e-08
- O 0 4.22821457846112e-08
type O 0 1.3745925286912097e-07
VHL B-Disease 0 1.8764179912977852e-05
gene O 0 3.329580167132917e-08
restores O 0 5.522746278074919e-07
the O 0 1.0286890228528023e-09
ability O 0 8.190481071146394e-10
of O 0 1.328403271827483e-07
VHL O 1 0.9999421834945679
- O 0 0.0007136153872124851
negative O 0 4.302532943256665e-06
RCC B-Disease 0 1.7479673260822892e-05
cancer I-Disease 0 1.0463149457962118e-08
cells O 0 7.704183124790376e-11
to O 0 3.3035492744137862e-12
exit O 0 1.5299257694056934e-10
the O 0 2.7453976592095586e-11
cell O 0 2.825106815151912e-10
cycle O 0 1.3285381128547158e-10
and O 0 1.8278458607801085e-11
enter O 0 6.5027552231811114e-09
G0 O 0 2.893082182708895e-06
/ O 0 1.2061026666287944e-07
quiescence O 0 3.810188786701474e-07
in O 0 5.14647746641117e-09
low O 0 1.0404247774431497e-07
serum O 0 2.521172959291107e-08
. O 0 1.570812635520724e-08

Both O 0 1.2579039321281016e-06
VHL O 1 0.9995213747024536
- O 0 4.340471787145361e-05
positive O 0 1.3673465559804754e-07
and O 0 8.988610744609105e-09
VHL O 0 0.001233937917277217
- O 0 1.1101051313744392e-06
negative O 0 1.315160034209839e-07
RCC B-Disease 0 2.4057305836322485e-06
cells O 0 8.783170635240367e-09
exit O 0 2.713306912482949e-09
the O 0 7.772134325012559e-11
cell O 0 2.8131483253979184e-10
cycle O 0 2.020861082641101e-11
by O 0 6.798071220531776e-12
contact O 0 1.073711075605388e-08
inhibition O 0 2.427902643376001e-07
. O 0 1.9131990214305006e-08

The O 0 3.5002135518880095e-06
cyclin O 0 2.370123183936812e-06
- O 0 4.991561581846327e-07
dependent O 0 1.655733257166503e-07
kinase O 0 2.73727238209176e-07
inhibitor O 0 2.588948255777268e-08
, O 0 2.1528384630542519e-10
p27 O 0 7.95476928772132e-09
, O 0 7.182426962210053e-12
accumulates O 0 2.8080449077094727e-10
upon O 0 6.172080901922783e-11
serum O 0 4.215615911906667e-10
withdrawal O 0 3.390936698099978e-10
, O 0 8.328217455944031e-12
only O 0 1.305194147205313e-11
in O 0 1.0378481928030592e-11
the O 0 1.6059255314448961e-10
presence O 0 3.925103797541851e-09
of O 0 1.8580044525151607e-07
VHL B-Disease 0 0.2072613686323166
, O 0 9.902944020367954e-10
as O 0 2.480862182352439e-10
a O 0 3.5698378281212584e-11
result O 0 9.688511798389143e-11
of O 0 2.593359138547413e-10
the O 0 2.890977457425947e-10
stabilization O 0 3.5855791225003486e-08
of O 0 1.959346285218544e-08
the O 0 4.752794424689455e-08
protein O 0 1.2507113069659681e-06
. O 0 2.008238482176239e-07

We O 0 3.036042528492544e-09
propose O 0 5.858633023159143e-10
that O 0 2.5633004399616688e-11
the O 0 2.557441480810496e-10
loss O 0 2.8557396447581596e-09
of O 0 6.212622416512659e-09
wild O 0 2.8831939502538262e-08
- O 0 1.2840055241269965e-08
type O 0 4.072210657568576e-08
VHL B-Disease 0 6.3239031078410335e-06
gene O 0 1.6655475887361604e-09
results O 0 1.5010391818393032e-09
in O 0 1.1141390761360004e-11
a O 0 1.3401837799242866e-11
specific O 0 3.3720390368863207e-10
cellular O 0 8.368643555911603e-09
defect O 0 2.7382112577356565e-08
in O 0 1.323803622277353e-09
serum O 0 7.78028486081439e-09
- O 0 8.47711589813116e-09
dependent O 0 1.2220353085012903e-07
growth O 0 5.010813097783284e-09
control O 0 1.0177172438119442e-09
, O 0 6.17992601537054e-11
which O 0 2.8820952568953118e-11
may O 0 6.29283347652887e-10
initiate O 0 9.946012902162238e-09
tumor B-Disease 0 1.320306523666659e-06
formation O 0 1.7516538264317205e-07
. O 0 2.817050415160338e-07

This O 0 2.9655995437138927e-09
is O 0 5.093293009572619e-10
corrected O 0 1.7605853441793329e-09
by O 0 8.045394211952939e-12
the O 0 1.2815110084218873e-10
reintroduction O 0 1.5340626191573392e-07
of O 0 5.909137623660854e-09
wild O 0 1.728676011225616e-07
- O 0 2.4031251655287633e-07
type O 0 2.010769549087854e-06
VHL B-Disease 1 0.9895389676094055
, O 0 2.4891690486583684e-08
implicating O 0 2.0858999050688e-05
VHL B-Disease 1 1.0
as O 0 2.4146938670810414e-08
the O 0 3.339755139109002e-09
first O 0 5.520498502775695e-10
tumor B-Disease 0 9.994010063962833e-09
suppressor O 0 5.1373593379366866e-08
involved O 0 4.7616612042222783e-11
in O 0 2.1656539408998476e-11
the O 0 2.2076360184364319e-10
regulation O 0 2.9651412436493274e-09
of O 0 9.088357622033527e-09
cell O 0 7.220212694392103e-08
cycle O 0 4.050881408090845e-09
exit O 0 3.4425053918596404e-09
, O 0 2.5299363298758593e-11
which O 0 1.1008460636119377e-11
is O 0 2.1865894511696737e-11
consistent O 0 1.1610066241729555e-09
with O 0 6.3932535480926145e-12
its O 0 3.9025571663131586e-10
gatekeeper O 0 4.539325360042312e-09
function O 0 2.1739818278909695e-10
in O 0 3.355326294585126e-10
the O 0 8.114448668550267e-09
kidney O 0 1.8045496119611926e-07
. O 0 1.873148036679595e-08
. O 0 8.37097786643426e-08

Piebaldism B-Disease 1 1.0
with O 0 0.000937978329602629
deafness B-Disease 1 1.0
: O 0 9.88371962051815e-09
molecular O 0 3.5752110161269e-09
evidence O 0 3.417975347197455e-10
for O 0 1.1479346986864591e-11
an O 0 1.1945201772167735e-10
expanded O 0 3.065060383278251e-08
syndrome O 1 0.5225740075111389
. O 0 8.477870210299443e-07

In O 0 1.7778076233376794e-10
a O 0 1.1981345082734407e-10
South O 0 1.891008738486022e-10
African O 0 5.80315621945271e-11
girl O 0 6.819987352635337e-10
of O 0 2.0416360269059908e-10
Xhosa O 0 2.959547718006661e-09
stock O 0 2.3939447646448286e-10
with O 0 2.3998023620380726e-13
severe O 0 1.8638524057479344e-09
piebaldism B-Disease 0 3.672510615615465e-07
and O 0 1.760618983936979e-09
profound O 1 0.9999997615814209
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 1.162773433094344e-08
identified O 0 1.6403191305247589e-10
a O 0 5.513673718982037e-12
novel O 0 2.031977017202813e-11
missense O 0 2.082214400900284e-09
substitution O 0 4.051670110527539e-09
at O 0 2.2412220967993335e-09
a O 0 8.061193379482745e-10
highly O 0 5.35312372207386e-09
conserved O 0 1.78369212733287e-08
residue O 0 8.35392768294696e-08
in O 0 6.519815798355921e-10
the O 0 1.1723359172322034e-08
intracellular O 0 8.738491885651456e-08
kinase O 0 3.010800924130308e-07
domain O 0 6.43250430698572e-08
of O 0 9.257648514449102e-08
the O 0 1.1878625372219176e-07
KIT O 0 1.7599351849639788e-05
proto O 0 3.0046019219298614e-06
- O 0 5.123576443111233e-07
oncogene O 0 1.811007791729935e-06
, O 0 4.931001384989031e-09
R796G O 0 8.317612127939356e-07
. O 0 8.497192993672797e-08

Though O 0 4.939739639553409e-08
auditory B-Disease 0 8.161063306033611e-05
anomalies I-Disease 0 5.570560915657552e-06
have O 0 2.9990621097653047e-10
been O 0 2.007738003628745e-10
observed O 0 3.749854038392897e-10
in O 0 3.3319385445151894e-11
mice O 0 2.110594893300899e-10
with O 0 3.645409321628712e-11
dominant O 0 4.491272136419866e-07
white O 0 1.377011393799421e-08
spotting O 0 1.879521960290731e-06
( O 0 9.830358749240986e-10
W O 0 9.0144676505588e-06
) O 0 2.3189901388054324e-10
due O 0 7.294834958315732e-09
to O 0 2.9387128286373354e-09
KIT O 1 0.9998898506164551
mutations O 0 0.002215744461864233
, O 0 6.067639333195984e-07
deafness B-Disease 1 1.0
is O 0 2.258197184801247e-09
not O 0 3.8407034497200954e-11
typical O 0 2.216717254199807e-09
in O 0 9.723315208542971e-11
human O 0 3.036581208704092e-09
piebaldism B-Disease 0 5.880104708921863e-06
. O 0 1.4206959519924567e-07

Thus O 0 5.078240494782449e-09
, O 0 1.1126206726774779e-11
the O 0 7.66058657480917e-12
occurrence O 0 5.808909797622164e-09
of O 0 7.936567847366405e-09
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 1.6960999715820435e-08
this O 0 2.3030062232254345e-11
patient O 0 7.256276829403774e-11
extends O 0 1.082229705157145e-11
considerably O 0 7.439921942409278e-12
the O 0 3.3096921470826546e-12
phenotypic O 0 2.8932389817271087e-10
range O 0 5.879435605038452e-09
of O 0 1.0447449572126288e-09
piebaldism B-Disease 0 1.271932887902949e-07
due O 0 8.494510650436382e-10
to O 0 3.1862193439202713e-10
KIT O 0 3.7301763455843684e-08
gene O 0 1.5930542995867825e-10
mutation O 0 2.1794870075364514e-10
in O 0 4.747810217892168e-12
humans O 0 4.979025525209124e-11
and O 0 7.200903501952682e-12
tightens O 0 1.3120494690710416e-09
the O 0 3.934198800070732e-11
clinical O 0 2.5108670698159585e-10
similarity O 0 4.9661510459486635e-09
between O 0 4.285411581150811e-09
piebaldism B-Disease 0 4.5978762841514254e-07
and O 0 1.3628947970190097e-10
the O 0 6.330704016566102e-11
various O 0 2.8835359447421105e-11
forms O 0 9.44172517947095e-10
of O 0 4.675404507992198e-09
Waardenburg B-Disease 0 0.0004177766677457839
syndrome I-Disease 0 1.4096203813096508e-05
. O 0 2.814761579372771e-08
. O 0 1.7986735656450037e-07

Cycloheximide O 0 6.706300155201461e-06
facilitates O 0 1.436893803941075e-08
the O 0 1.5501877559387367e-10
identification O 0 2.1326747035033122e-09
of O 0 1.7228622084530798e-08
aberrant O 0 2.0182685034342285e-07
transcripts O 0 1.8384742617172378e-08
resulting O 0 3.742460563671557e-09
from O 0 9.512657328514251e-10
a O 0 9.549888657645056e-10
novel O 0 4.571770517713958e-09
splice O 0 7.344539909581727e-08
- O 0 2.3544142191411765e-09
site O 0 2.625156536595341e-09
mutation O 0 1.5046673629282026e-10
in O 0 5.1213065038746564e-11
COL17A1 O 0 1.6794985640444793e-05
in O 0 7.289625847395342e-11
a O 0 3.678931881356817e-10
patient O 0 2.225049255955014e-09
with O 0 2.343374105873153e-10
generalized O 1 0.9999898672103882
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9902204275131226
. O 0 7.552947067779314e-07

Patients O 0 2.024204137640595e-09
with O 0 2.8822672026862506e-10
generalized O 1 0.9995286464691162
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 0 0.0002936123637482524
often O 0 5.655359514022962e-10
show O 0 3.205114784687879e-10
decreased O 0 4.7605941411177355e-09
expression O 0 7.009365865506823e-10
of O 0 1.2476421007434624e-09
type O 0 2.1289771723331796e-08
XVII O 0 4.643573447538074e-06
collagen O 0 1.0607166700538073e-07
, O 0 6.346075664964701e-09
a O 0 4.349197624264889e-08
transmembrane O 0 3.9683374097876367e-07
hemidesmosomal O 0 5.716977398151357e-07
protein O 0 2.5747263876496618e-08
encoded O 0 1.8274118884775703e-09
by O 0 5.148598436477414e-09
COL17A1 O 0 0.0004052816075272858
. O 0 2.780698764581757e-07

This O 0 1.1044777536994843e-08
report O 0 4.43308989517277e-09
documents O 0 1.4223764388532345e-08
a O 0 6.593024792778124e-09
novel O 0 4.1971912168037306e-08
splice O 0 8.55944165323308e-07
- O 0 1.4536151837774014e-08
site O 0 4.750960957977668e-09
mutation O 0 1.0267674210862054e-10
in O 0 5.144126791201131e-11
COL17A1 O 0 3.1000345188658684e-05
in O 0 2.5181655372019662e-11
a O 0 7.360306114589932e-11
patient O 0 3.1774499698045133e-10
with O 0 4.839589839988889e-11
generalized O 1 0.9999974966049194
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 0 0.0011021023383364081
, O 0 4.018949062434274e-10
and O 0 1.2901825441336001e-11
applies O 0 1.0844541931120943e-09
a O 0 8.280293811724349e-11
new O 0 1.0342561529430583e-10
methodology O 0 1.0207377304505272e-10
to O 0 1.7163130291986128e-11
define O 0 1.8609254137658127e-09
and O 0 1.1716311254517109e-09
characterize O 0 1.9368080472759175e-07
the O 0 1.4304840867396251e-08
resulting O 0 1.5626694604975455e-08
mRNA O 0 7.445515137760594e-08
splice O 0 9.113111332226254e-07
variants O 0 3.355835929141904e-07
. O 0 4.3461548671075434e-07

Mutational O 0 1.1919439202756621e-05
analysis O 0 5.820691129088118e-08
of O 0 1.2325681097991037e-07
COL17A1 O 1 0.9741076827049255
identified O 0 8.576014920436137e-08
a O 0 2.1411249662151022e-08
maternally O 0 7.844194556128059e-07
inherited O 0 3.018928964593215e-07
G O 0 1.4771393352930318e-07
- O 0 9.753676089019336e-09
to O 0 2.7632041099678872e-09
- O 0 3.8756045483978596e-08
T O 0 3.851287289080574e-08
transversion O 0 2.9741830331886376e-08
at O 0 4.612812909421393e-10
the O 0 7.882656333224602e-11
- O 0 8.384000958761018e-12
1 O 0 8.322807720784198e-11
position O 0 7.989692796250836e-10
of O 0 3.8452940831490423e-10
exon O 0 9.55852619277664e-10
32 O 0 4.3590056009179534e-08
. O 0 9.661638245006543e-08

This O 0 3.530250758387865e-09
acceptor O 0 1.1088174822759811e-08
splice O 0 5.767907396148075e-07
- O 0 2.1099770819432706e-08
site O 0 7.70715935516364e-09
mutation O 0 9.667210781882929e-11
led O 0 7.699379328540701e-11
to O 0 2.3153385458885012e-11
the O 0 8.390952377368421e-10
formation O 0 5.310310413619845e-09
of O 0 5.892157872722237e-08
aberrant O 0 2.7819319825539424e-07
transcripts O 0 4.788499907704136e-08
present O 0 8.730811629220625e-08
at O 0 2.843680988462438e-07
extremely O 0 1.9501081283124222e-07
low O 0 1.643366772441368e-06
levels O 0 6.903663773982771e-08
. O 0 3.86380989425561e-08

Based O 0 7.853374484056985e-08
on O 0 1.9248238558589037e-08
our O 0 2.165276180576825e-09
recent O 0 1.3608686399990688e-10
finding O 0 4.572744405351159e-10
that O 0 4.7678503506398684e-11
cycloheximide O 0 2.4780280227787443e-07
stabilized O 0 3.412911553368758e-07
mutant O 0 3.230102052498296e-08
COL17A1 O 0 4.733949026558548e-06
transcripts O 0 2.1229502600306205e-09
in O 0 8.50736425750398e-11
keratinocytes O 0 2.305655399936768e-08
homozygous O 0 9.476144174902501e-11
for O 0 2.3154355169308083e-11
a O 0 5.015142190423205e-10
frameshift O 0 7.488097963914697e-08
mutation O 0 8.104606985526175e-10
, O 0 3.336218107330424e-11
the O 0 2.877746374529977e-10
effects O 0 6.858698498035665e-08
of O 0 4.357235638963175e-07
the O 0 1.9120304273201327e-07
splice O 0 5.667891400662484e-07
- O 0 2.6927889251737724e-08
site O 0 8.86890649809402e-09
mutation O 0 3.210595331260002e-11
on O 0 7.65121577206429e-11
splicing O 0 7.778322430596063e-10
of O 0 9.270243239711817e-09
COL17A1 O 0 7.230518349388149e-06
transcripts O 0 4.448711266036298e-08
were O 0 1.883881495245987e-09
determined O 0 5.13302456095488e-10
using O 0 1.2012556227514182e-10
reverse O 0 1.8362690257234249e-09
transcriptase O 0 3.047470331640767e-10
polymerase O 0 1.3842411938913557e-10
chain O 0 4.513517892767993e-10
reaction O 0 6.124473150848075e-10
of O 0 3.0589151212012666e-09
total O 0 9.470728645766258e-10
RNA O 0 2.111320673847672e-09
from O 0 2.2141057876012837e-09
keratinocytes O 0 5.3727042370610434e-08
incubated O 0 2.3888478750677677e-08
for O 0 3.762111733252027e-10
2 O 0 3.152154803842677e-08
. O 0 5.785173229355678e-08

5 O 0 5.007476602258976e-07
h O 0 1.1608744188151832e-08
in O 0 3.014397342848696e-10
the O 0 7.331544815691871e-10
presence O 0 1.9997057343346114e-09
or O 0 2.249925357133975e-09
absence O 0 2.2440769953391282e-07
of O 0 1.933205240334246e-08
10 O 0 1.2748445854526835e-08
microg O 0 1.3741131397182471e-06
cycloheximide O 0 2.3600343865837203e-06
per O 0 1.1809722622047047e-07
ml O 0 2.208826401783881e-07
. O 0 6.6467649162405e-08

Using O 0 4.635320738355375e-10
this O 0 3.6906125377988985e-10
approach O 0 7.356060649499341e-09
, O 0 2.6927862717407436e-10
an O 0 1.8419411551562348e-09
abnormally O 0 1.9040689025473512e-08
spliced O 0 3.617066113292822e-08
transcript O 0 4.746298642999136e-08
was O 0 7.490980280522308e-09
identified O 0 7.046401795385293e-10
that O 0 9.36434523673979e-12
contains O 0 1.1724838981652663e-11
an O 0 1.5209810841354532e-11
extra O 0 1.4697920658335306e-10
264 O 0 7.466313678428094e-10
bases O 0 1.9738541912062146e-09
upstream O 0 2.3283085681669036e-08
from O 0 4.825526644935962e-10
exon O 0 7.061282114584344e-10
32 O 0 4.982489087979047e-09
, O 0 1.4065862190271172e-11
resulting O 0 4.8926418472206024e-11
in O 0 1.543943271842263e-11
a O 0 7.560436166009765e-10
premature O 0 3.8642639310637605e-07
termination O 0 2.6655072815628955e-07
codon O 0 1.1749726809284766e-06
27 O 0 3.12291467707837e-06
bp O 0 9.757901580087491e-07
downstream O 0 2.9523155262722867e-06
from O 0 4.11666185584636e-08
the O 0 8.615739943707013e-08
cryptic O 0 1.4618850627812208e-06
splice O 0 1.048489480126591e-06
site O 0 4.964671234120033e-07
. O 0 8.664454043127989e-08

Three O 0 5.373872369318633e-08
other O 0 4.803471842507179e-09
splice O 0 1.1509337838333522e-07
variants O 0 4.751975701822175e-09
, O 0 6.521193307573725e-11
including O 0 2.963994501226086e-12
one O 0 1.175825235788519e-11
derived O 0 1.5197754166251798e-10
from O 0 1.934856025398446e-10
the O 0 9.018590318987663e-10
skipping O 0 2.472681392973186e-09
of O 0 5.826252813534438e-09
exon O 0 2.9785811594962297e-09
32 O 0 1.4313197027604474e-07
, O 0 6.9906103128403174e-09
were O 0 1.961410411865927e-08
also O 0 7.68695862518598e-09
identified O 0 9.39570838909276e-08
. O 0 2.98692611977458e-07

These O 0 3.5345830706745573e-09
results O 0 3.775728618649055e-09
indicate O 0 7.766526088914816e-09
the O 0 6.296279053685794e-10
usefulness O 0 3.0148200380608614e-08
of O 0 4.603654124579748e-10
cycloheximide O 0 1.2286864858879198e-08
treatment O 0 8.481926966341646e-11
in O 0 2.81564723793315e-12
evaluating O 0 1.6411171033237082e-10
the O 0 5.127896995915648e-10
abnormal O 0 8.032955634007521e-09
processing O 0 3.6919118429068476e-08
of O 0 1.568654681705084e-07
mRNA O 0 9.750982599143754e-08
due O 0 4.007096876534888e-08
to O 0 8.832460096641626e-09
splice O 0 4.909447852696758e-07
- O 0 1.561984142028905e-08
site O 0 7.059548945420602e-09
mutations O 0 3.487410360492049e-10
, O 0 3.8604598684433e-11
because O 0 3.076009169600269e-10
( O 0 1.2424272721744956e-09
i O 0 4.6601645209420894e-08
) O 0 5.623863597037371e-10
aberrant O 0 3.053150177123598e-09
splicing O 0 3.6924152624351336e-10
often O 0 2.5035685330410118e-11
generates O 0 1.9346603485903557e-10
a O 0 4.351904600574663e-11
premature O 0 8.668681772405762e-09
termination O 0 2.3041957675218327e-08
codon O 0 4.434699008015741e-08
, O 0 1.5605182701605713e-09
( O 0 2.507024587927731e-10
ii O 0 3.968874295878777e-08
) O 0 3.6527675328912323e-10
transcripts O 0 4.392604946445999e-09
with O 0 1.1125553950330769e-10
premature O 0 4.108323636842215e-08
termination O 0 1.3833028944532089e-08
codons O 0 3.9963556908162445e-09
can O 0 6.696885268553388e-10
occur O 0 2.4564556611039734e-08
at O 0 2.520716257947697e-08
low O 0 2.7364632160242763e-07
or O 0 5.243460332593486e-09
undetectable O 0 9.625036057059333e-08
levels O 0 3.64347135795029e-10
due O 0 2.0839099890146429e-10
to O 0 1.7464137080924758e-10
nonsense O 0 3.9313672317575765e-09
- O 0 1.915629876947378e-09
mediated O 0 1.247997349906882e-08
mRNA O 0 7.636086762907723e-10
decay O 0 2.7436311000883506e-09
, O 0 6.8766567960787395e-12
and O 0 1.4962924996253513e-11
( O 0 1.645087017998481e-11
iii O 0 3.9374303817396594e-09
) O 0 2.433964141346223e-10
the O 0 1.7566046395245394e-08
levels O 0 1.5587163559871442e-08
of O 0 4.442298973117431e-09
these O 0 3.848390495164722e-10
transcripts O 0 1.6851869899525695e-09
can O 0 1.3296408418739247e-10
be O 0 1.4922690860785792e-10
increased O 0 6.098478388949502e-10
by O 0 2.6549751286353285e-10
cycloheximide O 0 2.7783260065916693e-06
. O 0 1.1826967494243945e-07

A O 0 3.029262245490827e-07
deletion O 0 4.533055175670597e-08
mutation O 0 1.1963135371217959e-08
in O 0 1.5739218817145684e-09
COL17A1 O 0 2.105750718328636e-05
in O 0 1.3310949564804275e-10
five O 0 7.754232672629868e-11
Austrian O 0 4.3857237841393726e-09
families O 0 1.3946375998497018e-10
with O 0 6.304627653275219e-11
generalized O 1 0.9689605236053467
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 0 0.16687257587909698
represents O 0 2.7973121596858164e-09
propagation O 0 1.9680959084666938e-08
of O 0 1.402788551985168e-09
an O 0 4.623153249116996e-10
ancestral O 0 3.1180354653770337e-07
allele O 0 1.4204778153725783e-07
. O 0 1.025846856350654e-07

Patients O 0 1.078324207703929e-09
with O 0 4.3066213789577645e-11
generalized O 1 0.999951958656311
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999992847442627
, O 0 1.4690362259983658e-09
a O 0 3.26134924621968e-10
usually O 0 1.552187822717599e-10
nonlethal O 0 6.902333637981428e-08
form O 0 2.536369780870018e-09
of O 0 8.563836928487945e-08
junctional B-Disease 1 0.9999957084655762
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9998053908348083
, O 0 1.8342605656584965e-08
have O 0 7.1955835734272e-10
generalized O 0 2.905339613334945e-07
blistering B-Disease 0 4.351015263637237e-07
, O 0 2.7511193323448424e-09
nail B-Disease 0 4.7649096813984215e-05
dystrophy I-Disease 1 0.9999884366989136
, O 0 5.480536628965638e-07
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 4.6893924832147604e-07
and O 0 0.00010526863479753956
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 0.04418579488992691

Skin B-Disease 0 0.0004803480696864426
fragility I-Disease 0 6.675989425275475e-06
in O 0 1.896064832918043e-10
most O 0 7.3029264927027e-12
cases O 0 9.080113397286205e-12
is O 0 6.595375829678007e-13
due O 0 1.9187545649557158e-11
to O 0 2.194791744181135e-11
mutations O 0 1.2605252397435152e-09
in O 0 8.967453168917672e-11
the O 0 9.394763439418696e-11
gene O 0 1.821932882339894e-10
encoding O 0 8.724881261912287e-09
type O 0 5.367551239032764e-07
XVII O 0 3.770639523281716e-05
collagen O 0 1.147380203292414e-06
( O 0 1.4270074188971194e-07
COL17A1 O 0 0.035520270466804504
) O 0 1.2312741048958742e-08
. O 0 8.343656787701548e-08

Recently O 0 3.3803601695581165e-07
, O 0 1.0118622606469785e-09
we O 0 8.700360570879084e-11
reported O 0 2.2003131261438824e-10
five O 0 1.0602616007382437e-11
Austrian O 0 2.036557589235599e-09
families O 0 6.210554986951777e-11
with O 0 9.775005457846042e-12
generalized O 1 0.9994834661483765
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999954700469971
who O 0 3.719645702560115e-09
share O 0 1.9279304541708342e-10
the O 0 1.7653357942126746e-10
same O 0 7.850940453302258e-10
COL17A1 O 0 5.685741143679479e-06
mutation O 0 3.582502827725875e-08
. O 0 2.7787759648845167e-08

Affected O 0 2.6083382564934254e-08
individuals O 0 3.6675681935882665e-10
in O 0 2.643273100400023e-10
three O 0 1.031201027346107e-10
families O 0 5.4367121915532834e-11
are O 0 2.7539923466712857e-12
homozygous O 0 2.901615579753436e-11
for O 0 1.447466035919831e-10
4003delTC O 0 1.084148593122336e-08
, O 0 1.0468349104231223e-10
whereas O 0 5.565196636858616e-10
those O 0 5.476868403242463e-10
in O 0 9.123123922982757e-10
two O 0 1.354752199311804e-09
others O 0 2.3085144906787036e-09
are O 0 1.769769053527881e-10
compound O 0 8.49547490133773e-08
heterozygotes O 0 2.5861409085337073e-06
. O 0 3.4587247910167207e-07

To O 0 2.268885773704099e-10
determine O 0 2.847166946651214e-10
if O 0 1.1916437281378478e-10
the O 0 7.894708498046299e-11
occurrence O 0 2.3396593551439082e-09
of O 0 2.1378988857012615e-10
4003delTC O 0 2.498500073500054e-09
in O 0 6.52615418303415e-12
these O 0 7.146255809331592e-12
unrelated O 0 1.5375023476593697e-10
families O 0 4.4963711573475784e-12
signifies O 0 1.1368250091292609e-10
propagation O 0 8.030316411833383e-10
of O 0 1.6168362482193999e-10
an O 0 4.750460580460469e-10
ancestral O 0 2.3711852747965168e-07
allele O 0 3.9893510717092795e-08
or O 0 3.5501772632784423e-09
a O 0 5.461974428300209e-09
mutational O 0 3.1364834285341203e-06
hot O 0 6.215860253178107e-07
spot O 0 1.7201294610913465e-07
, O 0 5.600507280156819e-10
haplotypes O 0 2.1812443407043247e-08
were O 0 9.395879629892079e-10
determined O 0 6.206365421590476e-10
for O 0 5.178733553101722e-10
polymorphisms O 0 7.798979595463607e-08
both O 0 7.701432025442045e-08
within O 0 2.399509071437933e-07
and O 0 1.4882604659760545e-07
flanking O 0 0.00010362629109295085
COL17A1 O 1 0.9998785257339478
. O 0 1.4439347069128416e-06

Five O 0 5.553315531869885e-07
intragenic O 0 3.4946033338201232e-06
polymorphisms O 0 5.132902813897999e-08
were O 0 3.855092245430569e-09
chosen O 0 2.3264075110773774e-09
based O 0 2.1428150365210286e-09
on O 0 2.5254984770128885e-09
their O 0 3.3133227272941213e-09
informativeness O 0 8.5929950728314e-06
. O 0 2.1769389491055335e-07

One O 0 4.5520902602902424e-08
of O 0 7.103042065637055e-08
these O 0 1.734553278787132e-09
, O 0 1.9481873059223886e-10
not O 0 1.771657126559134e-10
previously O 0 2.1054011867249756e-09
reported O 0 1.7549964814733698e-09
, O 0 4.761942923314777e-11
was O 0 4.350083404602856e-09
2988 O 0 4.319791173656995e-07
A O 0 4.1024242136700195e-07
or O 0 2.2041543701334376e-08
C O 0 3.24185907629726e-06
that O 0 1.265337418177026e-10
introduces O 0 1.2438831076266865e-09
a O 0 4.847944268249194e-10
new O 0 6.728829715640927e-10
restriction O 0 7.987365435724314e-09
site O 0 8.766952497296643e-09
for O 0 5.425961902005838e-10
Eco0109 O 0 2.3802895157132298e-06
I O 0 8.4773155322182e-06
. O 0 6.327651931314904e-07

All O 0 7.116909284121675e-10
the O 0 8.0880213637613e-10
4003delTC O 0 1.9914622839678486e-08
alleles O 0 1.282071449004718e-09
showed O 0 8.608012080912886e-10
the O 0 4.958706362190313e-11
same O 0 5.3772476055202745e-11
haplotype O 0 2.7831239535203167e-09
for O 0 1.746783551137554e-10
these O 0 8.463637568567606e-10
five O 0 2.1367136948668985e-09
polymorphic O 0 1.086585612597446e-07
markers O 0 2.1011694570916006e-06
. O 0 1.018478769765352e-06

Fourteen O 0 7.124473313524504e-07
microsatellite O 0 7.795321010917178e-08
polymorphisms O 0 2.155976019935224e-08
were O 0 9.87798620677438e-10
selected O 0 8.350017344227467e-10
based O 0 3.712682938861178e-10
on O 0 5.409572789716321e-10
their O 0 3.2495203750038115e-10
high O 0 7.743040697505421e-08
heterozygosity O 0 1.7738857422955334e-06
and O 0 2.296494550080297e-09
their O 0 2.449730862608135e-09
location O 0 1.135475940827746e-06
within O 0 1.4192111486011072e-08
10q23 O 0 7.512896900152555e-07
- O 0 1.231178288207957e-07
q25 O 0 2.50041148319724e-06
near O 0 1.2921037750857067e-06
COL17A1 O 0 0.00032208868651650846
. O 0 2.977129440751014e-07

Three O 0 4.772750195058961e-09
families O 0 6.186191559010012e-10
shared O 0 1.2157084228192616e-09
microsatellite O 0 2.3910907032131945e-08
polymorphisms O 0 2.1400021310569173e-08
covering O 0 2.817060185122955e-08
at O 0 1.9390029137866804e-08
most O 0 5.043365280954504e-09
19 O 0 3.5186094038408555e-08
cM O 0 5.602703012641541e-08
, O 0 2.2562327006703242e-10
whereas O 0 2.3379285174485176e-09
the O 0 4.934953334867487e-09
others O 0 4.802132025361061e-10
shared O 0 2.8266972096346876e-10
smaller O 0 2.433583612404533e-10
regions O 0 2.9103189302936983e-10
consistent O 0 2.109493024704534e-09
with O 0 2.2647946018583553e-11
cross O 0 7.109393074244963e-10
- O 0 4.627811744928323e-10
over O 0 2.4512672447407624e-10
events O 0 6.932035501172606e-11
during O 0 2.576083096839099e-11
passage O 0 3.8942293834054453e-10
of O 0 1.3315265556812506e-10
this O 0 3.328343503583575e-11
mutation O 0 1.919304437603131e-10
through O 0 9.08808792110527e-11
several O 0 1.0697530639092179e-09
generations O 0 8.45575556240874e-08
. O 0 1.9748085833271034e-07

These O 0 4.279049115041289e-09
results O 0 5.736844777004535e-09
indicate O 0 5.4207092148317315e-09
that O 0 4.105810830212775e-11
4003delTC O 0 1.0137925166020523e-08
occurs O 0 1.2626373557811377e-10
on O 0 8.347306179601333e-11
a O 0 5.753385268203459e-11
single O 0 1.6175888406522176e-10
ancestral O 0 1.0091704183423644e-07
allele O 0 3.478578136650867e-08
. O 0 8.703174181334816e-09
. O 0 5.698764127259892e-08

The O 0 9.373572424919985e-07
haptoglobin O 0 2.5789104256546125e-05
- O 0 9.326591765557168e-08
gene O 0 6.4339129579593646e-09
deletion O 0 7.609134655695016e-09
responsible O 0 2.4293365097349806e-09
for O 0 1.1546200662237993e-09
anhaptoglobinemia B-Disease 0 1.3891262824472506e-05
. O 0 1.6377641998133186e-07

We O 0 1.7973629695688942e-08
have O 0 1.6765876187374573e-10
found O 0 3.5442399015650494e-11
an O 0 6.5830878075157084e-12
allelic O 0 6.248556116972281e-10
deletion O 0 1.9870209644334835e-10
of O 0 2.7491944276647473e-09
the O 0 3.0999725453284555e-08
haptoglobin O 0 4.468361566978274e-06
( O 0 6.890637394008081e-09
Hp O 0 3.4508101265373625e-08
) O 0 2.336838188232715e-11
gene O 0 2.1953495965565395e-10
from O 0 1.2317345365886467e-08
an O 0 2.0984242121713237e-10
individual O 0 1.8074855501204468e-10
with O 0 4.0949185708960556e-10
anhaptoglobinemia B-Disease 0 3.327655122120632e-06
. O 0 2.6209360726170416e-07

The O 0 4.950794618707732e-08
Hp O 0 5.492919452620981e-09
gene O 0 2.475185889583287e-10
cluster O 0 1.093364176973921e-09
consists O 0 3.490975911124572e-11
of O 0 2.2182377462653946e-11
coding O 0 5.221182375336753e-10
regions O 0 4.939755715582805e-09
of O 0 3.0359345259967085e-07
the O 0 8.983489152569746e-08
alpha O 0 2.1613479894710963e-09
chain O 0 4.951223875337973e-10
and O 0 1.2772423743645511e-11
beta O 0 1.6999197882672235e-10
chain O 0 1.080926528840287e-10
of O 0 2.0874066364306998e-10
the O 0 8.915204130488519e-10
haptoglobin O 0 9.901985009719283e-09
gene O 0 1.5776720208027228e-10
( O 0 5.061033536701842e-11
Hp O 0 1.0322262489204093e-10
) O 0 1.0296880806771186e-13
and O 0 8.494481702238377e-13
of O 0 7.232786591870877e-11
the O 0 1.9105168835853448e-10
alpha O 0 2.5576465945142957e-10
chain O 0 2.3429849727030216e-10
and O 0 3.5835501233094647e-11
beta O 0 9.273722900715597e-10
chain O 0 1.1480715267353503e-09
of O 0 2.5400734848801676e-09
the O 0 1.9837738562955565e-08
haptoglobin O 0 1.9255698191500414e-07
- O 0 3.863071196263945e-09
related O 0 1.223076528944489e-09
gene O 0 2.8872868540474883e-09
( O 0 1.4148319182893943e-09
Hpr O 0 5.795930846375086e-08
) O 0 3.486916658190786e-11
, O 0 1.129689310847004e-11
in O 0 2.600540095765158e-11
tandem O 0 1.2942579230568185e-09
from O 0 2.2231614327239413e-09
the O 0 1.7812919139714722e-08
5 O 0 6.086177961606154e-08
side O 0 9.241450129593431e-07
. O 0 1.04458001715102e-06

Southern O 0 8.39127835661202e-07
blot O 0 9.663183391239727e-07
and O 0 1.4980588991519994e-09
PCR O 0 1.2256998083159942e-08
analyses O 0 1.2731478093996884e-09
have O 0 1.6942220196214386e-11
indicated O 0 1.5821501053725484e-10
that O 0 3.3917092225055345e-12
the O 0 2.0214045715061246e-11
individual O 0 9.643006879112015e-12
with O 0 1.1923115272871598e-11
anhaptoglobinemia B-Disease 0 8.744994062226397e-08
was O 0 2.0102479403316664e-10
homozygous O 0 2.3960814235501893e-11
for O 0 2.3329192744281357e-11
the O 0 1.8071685814469163e-10
gene O 0 1.664844789805997e-10
deletion O 0 8.436142340251251e-10
and O 0 9.453145211058e-11
that O 0 1.8622372741083915e-11
the O 0 1.7404978847057606e-10
gene O 0 1.4621448496399125e-10
deletion O 0 1.915973379951197e-09
was O 0 6.180050693416206e-09
included O 0 3.8868308571693433e-10
at O 0 8.195888412387831e-10
least O 0 2.4307630908104727e-10
from O 0 4.207615089679706e-10
the O 0 2.6254556861893263e-10
promoter O 0 2.3631434586945943e-08
region O 0 7.91620369255952e-09
of O 0 1.4990428454098037e-08
Hp O 0 1.4110301371772493e-08
to O 0 3.687194993773346e-09
Hpr O 0 2.3504631485593563e-07
alpha O 0 1.3435661472271931e-09
but O 0 7.908015908775212e-11
not O 0 6.828848597706383e-11
to O 0 3.046815022500482e-09
Hpr O 0 8.068643637670903e-07
beta O 0 1.4970206052566937e-07
( O 0 1.1677474986981906e-08
Hpdel O 0 1.8407782818030682e-06
) O 0 9.650455545795467e-09
. O 0 1.1389448673071456e-07

In O 0 5.4159348117366335e-09
addition O 0 1.7523672513064525e-09
, O 0 1.3291109879354224e-10
we O 0 2.624372767712213e-11
found O 0 1.7537464536143688e-11
seven O 0 1.5678021381138052e-11
individuals O 0 2.0743467707418084e-12
with O 0 2.8393272975824058e-12
hypohaptoglobinemia B-Disease 0 5.104304090508549e-09
in O 0 5.69870929958971e-12
three O 0 8.156363605349437e-12
families O 0 2.072378553485965e-11
, O 0 1.2327378701160185e-12
and O 0 3.181722246781149e-12
the O 0 1.4916087809346834e-10
genotypes O 0 1.2983086605800054e-08
of O 0 1.6048307571736586e-08
six O 0 8.081579849772424e-09
of O 0 6.638732230612732e-08
the O 0 1.1989587100913468e-08
seven O 0 1.3561405332040977e-09
individuals O 0 4.1345357693067797e-10
were O 0 8.50344772374001e-09
found O 0 1.3891189309944707e-09
to O 0 2.175592372921642e-09
be O 0 5.0432621634399766e-08
Hp2 O 0 2.494307409506291e-05
/ O 0 5.896890343137784e-06
Hpdel O 0 3.2711315725464374e-05
. O 0 1.4010452105139848e-06

The O 0 6.873418101349671e-08
phenotypes O 0 2.056670638239666e-07
and O 0 5.170491812478417e-10
genotypes O 0 4.9662101986314156e-08
in O 0 1.7295639920256178e-10
one O 0 1.816582301250591e-10
of O 0 8.788842570384148e-11
these O 0 6.8247434613366575e-12
three O 0 8.617383716325033e-12
families O 0 1.5744376635762336e-10
showed O 0 1.4770914491535336e-09
the O 0 8.212788227268675e-10
father O 0 2.4174482415872944e-09
to O 0 1.0623314450342036e-09
be O 0 7.97854937673037e-09
hypohaptoglobinemic B-Disease 0 8.475807931063173e-07
( O 0 1.8149727276650651e-09
Hp2 O 0 1.8268016788169916e-07
) O 0 1.1483732020867166e-10
and O 0 6.682836506399781e-10
Hp2 O 0 4.7390349777742813e-07
/ O 0 2.4070695658906516e-08
Hpdel O 0 6.661665565843577e-07
, O 0 5.812308967456659e-10
the O 0 1.0820414786394394e-08
mother O 0 2.008079924564754e-09
to O 0 8.699353459817871e-10
be O 0 1.5602772407419252e-09
Hp2 O 0 2.2743913064005028e-07
- O 0 3.112946567185304e-09
1 O 0 1.2418403194658367e-08
and O 0 1.7837150645405586e-09
Hp1 O 0 2.884946752601536e-07
/ O 0 5.675623970802235e-09
Hp2 O 0 5.4316416253641364e-08
, O 0 1.378065456886235e-11
one O 0 2.7111521361256052e-11
of O 0 2.3662349857289655e-10
the O 0 5.524690704916679e-10
two O 0 1.2221104683796113e-10
children O 0 6.048642697820128e-10
to O 0 6.506969962849496e-10
be O 0 2.564042844710457e-08
hypohaptoglobinemic B-Disease 0 9.392485662829131e-05
( O 0 1.6027691174258507e-08
Hp2 O 0 1.7408636949767242e-06
) O 0 7.654664124778776e-10
and O 0 4.020499932977373e-09
Hp2 O 0 1.1587682138269884e-06
/ O 0 3.591472363950743e-08
Hpdel O 0 1.1278242482148926e-06
, O 0 3.0793670391382477e-10
and O 0 1.3555762068406807e-10
the O 0 8.362384673610279e-10
other O 0 2.796873288524182e-10
child O 0 3.662772030121886e-10
to O 0 2.815660482546889e-10
be O 0 2.748093308468924e-09
Hp1 O 0 9.397372764397005e-07
and O 0 1.072789856948475e-08
Hp1 O 0 6.049356670700945e-06
/ O 0 4.1862020339067385e-07
Hpdel O 0 2.666933596628951e-06
, O 0 7.044158034652526e-10
showing O 0 1.2823259121219621e-09
an O 0 5.857222346028479e-11
anomalous O 0 2.594381669496215e-07
inheritance O 0 7.032793547523397e-08
of O 0 2.0655926391555113e-07
Hp O 0 1.7894242887450673e-07
phenotypes O 0 1.257338766436078e-07
in O 0 1.0440995845684142e-09
the O 0 8.002859708255983e-09
child O 0 4.3206287436703406e-09
with O 0 2.414001665229648e-09
Hp1 O 0 2.3209333448903635e-05
. O 0 4.2513752873674093e-07

The O 0 7.9055820378926e-07
Hp2 O 0 3.772714626393281e-05
/ O 0 4.966002506989753e-07
Hpdel O 0 3.258169840592018e-07
individuals O 0 3.130462278289059e-10
had O 0 9.403248180106516e-10
an O 0 6.536011315505519e-11
extremely O 0 2.9674596113693497e-10
low O 0 4.134080633377835e-09
level O 0 3.221015276722028e-08
of O 0 4.1230785541301884e-07
Hp O 0 2.5505519829494006e-07
( O 0 5.455682572375053e-10
mean O 0 7.5699055912537e-09
+ O 0 1.7735275470442957e-09
/ O 0 5.214256248997629e-10
- O 0 6.232106497527923e-10
SD O 0 2.403985011056875e-09
= O 0 1.0701509678412435e-09
0 O 0 4.813833220929098e-10
. O 0 6.050104861543559e-11
049 O 0 6.307412370176735e-09
+ O 0 7.286334313683085e-10
/ O 0 6.589739864892863e-10
- O 0 5.388873236533698e-10
0 O 0 4.61932797568565e-10
. O 0 6.478088898642653e-11
043 O 0 1.0584810361535801e-08
mg O 0 9.906934828052272e-09
/ O 0 2.1034694819288546e-10
ml O 0 2.2298023150124635e-10
; O 0 4.589239058216954e-11
n O 0 7.86903112115489e-11
= O 0 3.0107313864213836e-10
6 O 0 8.132557405282625e-10
) O 0 8.553547952393215e-13
, O 0 2.915136936097046e-13
compared O 0 1.328640648022572e-12
with O 0 1.2788670133729446e-13
the O 0 7.233242477200363e-11
level O 0 2.4039059631775217e-10
( O 0 3.284148777579765e-12
1 O 0 2.885402472507792e-10
. O 0 5.84820247784279e-11
64 O 0 4.811942511118161e-10
+ O 0 1.6337620145634446e-10
/ O 0 1.4805148773611165e-10
- O 0 2.2797956578113343e-10
1 O 0 2.1321325260892365e-10
. O 0 6.187156342818412e-11
07 O 0 3.29446636637698e-10
mg O 0 2.471271631776517e-09
/ O 0 1.928077419943719e-10
ml O 0 4.6030724371037834e-11
) O 0 6.767264700002773e-13
obtained O 0 4.110598320061776e-11
from O 0 5.0918141231148795e-11
52 O 0 1.1781836617430486e-09
healthy O 0 1.1874876637563148e-09
volunteers O 0 8.364809955807573e-10
having O 0 1.6169286742862e-10
phenotype O 0 6.118885664818663e-08
Hp2 O 0 2.3610581934008223e-07
, O 0 1.3696520306805127e-10
whereas O 0 5.294287785950758e-10
the O 0 7.4789557880095e-10
serum O 0 3.3436686752708056e-09
Hp O 0 8.692453423719826e-10
level O 0 1.9931711836562727e-09
of O 0 3.924472691263503e-10
an O 0 6.18150669540185e-11
individual O 0 3.9803611795452554e-11
with O 0 4.915176599062931e-10
Hp1 O 0 3.4518088796176016e-06
/ O 0 2.714950255722215e-07
Hpdel O 0 1.4565481478712172e-06
was O 0 8.743660373511375e-08
0 O 0 8.528823514097894e-08
. O 0 1.1373818153970205e-07

50 O 0 2.0932782263116678e-07
mg O 0 4.470921624033508e-07
/ O 0 3.6674716596962753e-09
ml O 0 8.026519449089164e-10
, O 0 2.2118316293090468e-12
which O 0 1.5713150995199515e-13
was O 0 5.695524780968686e-12
approximately O 0 3.570053974666365e-12
half O 0 6.1787324388828946e-12
the O 0 1.6660893151221323e-11
level O 0 1.8526170597610303e-09
of O 0 8.653331384778085e-10
Hp O 0 7.640544308351593e-10
in O 0 4.787661239680219e-11
control O 0 1.8639201293524366e-09
sera O 0 7.463074069846698e-08
from O 0 6.559252446747266e-11
the O 0 1.3190351033642855e-09
Hp1 O 0 9.893342678424233e-08
phenotype O 0 8.872189205533232e-09
( O 0 9.252604932230568e-11
1 O 0 4.646848683620419e-09
. O 0 6.639511718198321e-10
26 O 0 1.1706176472614516e-08
+ O 0 1.957361828175408e-09
/ O 0 1.1608426442322184e-09
- O 0 9.354894636715017e-10
0 O 0 4.407154641228317e-10
. O 0 5.213895287736747e-11
33 O 0 5.423168025764369e-10
mg O 0 1.8805035306712625e-09
/ O 0 9.49445244646796e-11
ml O 0 1.3617930394449473e-10
; O 0 6.527925422439296e-11
n O 0 1.255715531556234e-10
= O 0 1.3127203768448226e-09
9 O 0 7.832158921416976e-09
) O 0 4.521710436633519e-11
, O 0 1.0006321465860779e-10
showing O 0 2.194588955006793e-09
a O 0 9.448751780993803e-10
gene O 0 3.414549532010369e-09
- O 0 6.477060310317029e-08
dosage O 0 2.841105697370949e-07
effect O 0 8.24181185521411e-08
. O 0 3.2619432488445455e-08

The O 0 1.8132885415411693e-08
other O 0 2.319522129923257e-09
allele O 0 4.232652628388678e-08
( O 0 1.902935142794604e-09
Hp2 O 0 1.3692648792584805e-07
) O 0 2.792927000783152e-11
of O 0 3.203354526082336e-10
individuals O 0 7.337626339865011e-11
with O 0 6.032501165265103e-10
Hp2 O 0 8.064811481744982e-06
/ O 0 1.2830830087295908e-07
Hpdel O 0 2.7289804620522773e-06
was O 0 4.908902173639262e-09
found O 0 2.690094674795418e-11
to O 0 3.587749194955414e-11
have O 0 2.761346880320037e-11
, O 0 1.3870472478916263e-11
in O 0 6.292229931537108e-11
all O 0 1.4710578311039058e-09
exons O 0 1.0668682826064924e-08
, O 0 1.7585179978851784e-09
no O 0 2.4371706874859456e-09
mutation O 0 3.6024938587786437e-10
, O 0 3.9266347118260825e-11
by O 0 4.2713305115071876e-11
DNA O 0 7.497985343718483e-09
sequencing O 0 7.953862279919122e-08
. O 0 2.397933087650017e-07

On O 0 4.5674295456876735e-09
the O 0 1.6564669080842975e-10
basis O 0 6.695429211056592e-10
of O 0 5.869255775836635e-11
the O 0 1.6215243037187577e-10
present O 0 2.105018659381841e-10
study O 0 2.378528103641475e-11
, O 0 3.712821283058387e-12
the O 0 3.912490123547663e-11
mechanism O 0 1.623295164954186e-09
of O 0 1.6218559828473644e-09
anhaptoglobinemia B-Disease 0 1.5039837819585955e-07
and O 0 2.53565751728857e-10
the O 0 9.512148846368973e-10
mechanism O 0 8.046971977648809e-09
of O 0 1.0599553457169009e-09
anomalous O 0 9.986065379052889e-07
inheritance O 0 1.305771775150788e-07
of O 0 8.49401686764395e-08
Hp O 0 8.971382925437865e-08
phenotypes O 0 3.2367137237088173e-07
were O 0 1.651282666159659e-08
well O 0 1.6314904982550615e-08
explained O 0 1.4401759074189613e-07
. O 0 1.7014599507092498e-07

However O 0 1.283341219959766e-07
, O 0 9.121852717619561e-10
the O 0 1.3824844602439157e-09
mechanism O 0 2.2933834387117713e-08
of O 0 2.0651803822602233e-08
hypohaptoglobinemia B-Disease 0 0.00024480491993017495
remains O 0 5.656353096128441e-06
unknown O 0 8.39827407617122e-05

ATM O 0 6.445327016990632e-05
mutations O 0 5.461361638481321e-07
and O 0 4.243417617288969e-09
phenotypes O 0 4.178492076789553e-07
in O 0 1.5690011068159038e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 5.96931499785569e-08
in O 0 1.857122441939474e-11
the O 0 3.6011044840522644e-11
British O 0 1.229847473860346e-11
Isles O 0 1.4982981522138061e-10
: O 0 1.9370549001612725e-12
expression O 0 2.264431697707181e-11
of O 0 7.225286341450143e-11
mutant O 0 4.261990205201016e-10
ATM O 0 1.1178401315703468e-08
and O 0 5.892136778484769e-11
the O 0 1.016622550031876e-10
risk O 0 1.0435341479819726e-09
of O 0 3.785117108634495e-09
leukemia B-Disease 1 0.999977707862854
, O 0 4.3825775719597004e-07
lymphoma B-Disease 1 1.0
, O 0 1.8934915715362877e-05
and O 1 0.966029942035675
breast B-Disease 1 0.9999992847442627
cancer I-Disease 1 0.9999970197677612
. O 0 7.131400252546882e-07

We O 0 2.836306078890516e-09
report O 0 2.994523795596393e-10
the O 0 1.2303831564697276e-10
spectrum O 0 5.00981922613164e-09
of O 0 1.8374005650301228e-09
59 O 0 1.6019560789004572e-08
ATM O 0 8.377205631404649e-07
mutations O 0 3.1895911689616696e-08
observed O 0 3.972432160992412e-09
in O 0 1.5931431729399037e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.053239266635142e-11
patients O 0 3.40412702366788e-12
in O 0 5.958061734950837e-13
the O 0 2.4036342360922447e-11
British O 0 4.1187547816790016e-10
Isles O 0 3.116655378221367e-08
. O 0 7.874928797946268e-08

Of O 0 3.5116752314934274e-06
51 O 0 4.331082891440019e-06
ATM O 0 7.051368356769672e-06
mutations O 0 1.0690828133874675e-07
identified O 0 2.620603956060563e-09
in O 0 1.3624574558834812e-11
families O 0 1.4819322852188677e-11
native O 0 1.7655739717459262e-11
to O 0 7.835314862203457e-12
the O 0 4.222311111856669e-10
British O 0 7.341367513902242e-10
Isles O 0 1.0110157155907018e-08
, O 0 6.633334992400819e-10
11 O 0 1.6824579063268175e-08
were O 0 2.2426002388442612e-08
founder O 0 2.5360671429552895e-07
mutations O 0 1.1289586154816789e-08
, O 0 1.9353875446714852e-10
and O 0 1.0595303107097109e-10
2 O 0 2.9406639345808117e-09
of O 0 2.409484611831658e-09
these O 0 2.9004826318512755e-10
11 O 0 9.715386273256854e-10
conferred O 0 4.992170010709174e-10
a O 0 5.708894815215082e-11
milder O 0 1.3753787442283283e-08
clinical O 0 3.1461749872008227e-10
phenotype O 0 3.957041083690882e-10
with O 0 2.457341188172313e-12
respect O 0 2.4129095943514756e-10
to O 0 1.5201616632154469e-09
both O 0 4.819037968673001e-08
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 3.55494940151857e-08
cellular O 0 1.7107471705912758e-07
features O 0 2.3775210422627424e-07
. O 0 4.0542312262914493e-07

We O 0 5.6425005112714643e-08
report O 0 1.3763785666753847e-08
, O 0 7.736446205885983e-11
in O 0 7.673020552267928e-11
two O 0 2.258748521555276e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999960660934448
T I-Disease 1 1.0
families O 0 2.0803891942478003e-08
, O 0 4.873771872193622e-11
an O 0 1.4564333072897284e-10
ATM O 0 3.17945385575058e-08
mutation O 0 1.6000315516961905e-09
( O 0 1.723261394692699e-10
7271T O 0 9.808600154315172e-09
- O 0 2.276351329655313e-09
- O 0 8.560501640886287e-09
> O 0 1.7216261749553041e-09
G O 0 1.705377528082863e-08
) O 0 2.8862265008533505e-11
that O 0 6.10335957121344e-12
may O 0 2.364979566349401e-11
be O 0 5.010633401247855e-12
associated O 0 5.901450161882593e-11
with O 0 3.2776201457779264e-13
an O 0 3.0468104168096533e-12
increased O 0 3.505702325656834e-11
risk O 0 5.798003743784363e-10
of O 0 7.628986331553733e-09
breast B-Disease 0 5.2362547648954205e-06
cancer I-Disease 0 0.0001482908264733851
in O 0 3.618290944640279e-10
both O 0 9.377886245331979e-10
homozygotes O 0 1.3488460126609425e-08
and O 0 7.184088046674475e-11
heterozygotes O 0 4.746676829370244e-09
( O 0 5.681737719198665e-11
relative O 0 3.639356549456352e-08
risk O 0 2.526756137655184e-09
12 O 0 3.290147709833491e-09
. O 0 2.541651888954277e-10
7 O 0 8.408419738259454e-09
; O 0 5.740193653736014e-09
P O 0 8.320412803186628e-07
= O 0 3.648273505518773e-08
. O 0 8.037307708264052e-09
0025 O 0 1.7991951040130516e-07
) O 0 8.891391095611212e-11
, O 0 1.646210771866219e-11
although O 0 3.120600305939192e-11
there O 0 1.8349401859074632e-11
is O 0 2.1083558076478992e-12
a O 0 6.617897636146397e-12
less O 0 3.298729622791541e-10
severe O 0 1.135540856012085e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 2.1224644264350445e-09
in O 0 4.0508270566022575e-13
terms O 0 3.915212772043208e-12
of O 0 7.101155601041409e-13
the O 0 3.3492995703265915e-12
degree O 0 9.608904782965055e-10
of O 0 3.994953257091538e-09
cerebellar B-Disease 1 0.9999988079071045
degeneration I-Disease 1 0.9999996423721313
. O 0 1.3024640566072776e-06

This O 0 3.844093487970213e-09
mutation O 0 6.729423684959102e-09
( O 0 7.607302565659779e-10
7271T O 0 1.6849337924895735e-08
- O 0 6.139396768745087e-10
- O 0 6.036103838980011e-10
> O 0 9.289739810736108e-11
G O 0 6.980320765848091e-10
) O 0 1.7061288362998916e-12
also O 0 1.3002730944906837e-13
allows O 0 8.60165955932253e-14
expression O 0 5.147264992705347e-12
of O 0 3.410120449909293e-11
full O 0 5.7192705432695945e-11
- O 0 9.674330087028338e-11
length O 0 5.206700695592481e-11
ATM O 0 2.4232569728610542e-08
protein O 0 1.4501978284897632e-08
at O 0 1.7481976977151703e-09
a O 0 2.1959360718692977e-10
level O 0 9.941379941480477e-10
comparable O 0 6.737049251803739e-10
with O 0 1.6110472331187786e-12
that O 0 1.8180085258404088e-12
in O 0 3.3419121636679705e-11
unaffected O 0 1.2334225196752868e-08
individuals O 0 4.881421378222228e-10
. O 0 3.982675877978181e-08

In O 0 1.0123356375402182e-08
addition O 0 3.807977932979156e-09
, O 0 2.4874766135773996e-10
we O 0 2.0277193812923144e-10
have O 0 5.643374309527438e-11
studied O 0 3.036007667489571e-09
18 O 0 1.1381500542029244e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.048464153858731e-08
, O 0 1.3143424716643981e-11
in O 0 1.1195817710418776e-11
15 O 0 3.3088873307995925e-10
families O 0 7.778471200481363e-10
, O 0 6.69380384454854e-11
who O 0 3.1538593958657657e-10
developed O 0 2.71453011180256e-08
leukemia B-Disease 1 1.0
, O 0 9.93611593003152e-07
lymphoma B-Disease 1 1.0
, O 0 8.840908094498445e-08
preleukemic O 1 0.9999669790267944
T O 1 0.9993113279342651
- O 0 0.002194402040913701
cell O 0 0.23620198667049408
proliferation O 0 0.00022110604913905263
, O 0 5.982896400524851e-10
or O 0 7.82163400714353e-09
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 2.367472051734154e-10
mostly O 0 1.7110939054543195e-10
in O 0 1.0879217665626939e-10
childhood O 0 1.5089387943589827e-06
. O 0 2.4472760173921415e-07

A O 0 1.9154356323269894e-06
wide O 0 1.469085191274644e-07
variety O 0 2.5816257576138923e-08
of O 0 4.9740119578700615e-08
ATM O 0 1.520744604022184e-06
mutation O 0 8.753384683757304e-09
types O 0 5.966614757824118e-09
, O 0 2.1090656998623558e-10
including O 0 4.6009152043779977e-10
missense O 0 8.353806606464786e-07
mutations O 0 1.756568650534973e-07
and O 0 8.54674819805723e-09
in O 0 4.587650703768986e-09
- O 0 1.2558413864383056e-08
frame O 0 4.7638670253036253e-07
deletions O 0 3.112396385063221e-08
, O 0 1.076840283609215e-09
were O 0 1.5409173936831166e-09
seen O 0 2.0718231574790025e-09
in O 0 8.655026695336687e-11
these O 0 1.2168079877028504e-09
patients O 0 5.8123341695193176e-09
. O 0 1.2952791905718186e-07

We O 0 1.4263564551697527e-08
also O 0 5.49544187933293e-10
show O 0 6.920027745271895e-11
that O 0 1.1652377196816333e-12
25 O 0 3.223900313376049e-10
% O 0 3.698206671454152e-11
of O 0 1.5016111964971657e-10
all O 0 5.870784747230573e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.5329540303810063e-07
carried O 0 5.257169366501557e-09
in O 0 4.3829034845899173e-10
- O 0 5.024997307145895e-09
frame O 0 2.9373364895945997e-07
deletions O 0 1.5513569451286457e-07
or O 0 2.149992894828756e-08
missense O 0 7.893665809888262e-08
mutations O 0 1.5144980824999266e-09
, O 0 1.9095868983298736e-11
many O 0 2.4783071428391423e-11
of O 0 6.20736018142054e-10
which O 0 5.991000751048858e-11
were O 0 8.7477511345746e-11
also O 0 2.176063322589794e-11
associated O 0 1.0026075802915813e-10
with O 0 1.1174782453549081e-11
expression O 0 4.351261573276588e-09
of O 0 9.281955648532403e-09
mutant O 0 2.6517742668374922e-08
ATM O 0 3.568894499039743e-06
protein O 0 3.5527846193872392e-06
. O 0 1.333966253014296e-07

The O 0 7.059094286887557e-08
DMPK O 0 0.00020012372988276184
gene O 0 1.8925947031789292e-08
of O 0 5.263603952698759e-08
severely O 0 3.7254701510391897e-06
affected O 0 6.745959240106458e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.6974171401784588e-08
is O 0 1.7068913990558876e-11
hypermethylated O 0 3.3443321445503216e-09
proximal O 0 3.699016914993081e-08
to O 0 7.345597463626063e-10
the O 0 2.258215481276693e-08
largely O 0 2.300607881977612e-08
expanded O 0 2.9682324154123307e-08
CTG O 0 8.985475687950384e-06
repeat O 0 3.494179452445678e-07
. O 0 6.315613063634373e-07

Using O 0 4.984782364658713e-08
methylation O 0 1.2713850310319685e-06
- O 0 6.518398549815174e-07
sensitive O 0 3.9548800145894347e-07
restriction O 0 2.0002865142032533e-08
enzymes O 0 6.052578438442424e-10
, O 0 3.006190782417484e-11
we O 0 1.1605183827811949e-11
characterized O 0 2.9949220187175385e-11
the O 0 1.363466110848588e-11
methylation O 0 3.076396637435863e-10
pattern O 0 1.8422537939599692e-09
on O 0 2.0705738512649674e-10
the O 0 5.792230931001008e-11
5 O 0 2.3272318794287372e-10
side O 0 3.7812691866534465e-10
of O 0 1.072453792438921e-09
the O 0 1.5041409895388824e-08
CTG O 0 9.815020121095586e-07
repeat O 0 8.192856393307579e-10
in O 0 3.0026453545772824e-10
the O 0 5.722637475003012e-09
DMPK O 0 5.4023471420805436e-06
gene O 0 1.374095837114453e-09
of O 0 2.0479250295579732e-08
normal O 0 4.795379648925291e-09
individuals O 0 2.497077891683297e-11
and O 0 1.4958017463539974e-11
of O 0 3.042549545639872e-11
patients O 0 1.597325223479107e-11
affected O 0 6.908791594373298e-11
with O 0 1.91617707812064e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 1.3577108881612787e-10
showing O 0 4.3787004577744426e-10
expansions O 0 5.726152885188185e-09
of O 0 1.103222935228132e-08
the O 0 2.2308254798986127e-08
repetitive O 0 1.5371395534202748e-07
sequence O 0 7.435225768404052e-08
. O 0 3.136717623419827e-07

The O 0 2.3503503143729176e-08
gene O 0 1.0731255883911217e-08
segment O 0 2.448821057043915e-08
analyzed O 0 5.595179319861643e-10
corresponds O 0 2.6258062391093517e-10
to O 0 3.538646806133805e-11
the O 0 1.1069236638405755e-09
genomic O 0 8.021812902825332e-08
SacI O 0 3.7971913116052747e-06
- O 0 1.8138628377073474e-08
HindIII O 0 4.072730774851152e-08
fragment O 0 1.6003489644589308e-09
carrying O 0 1.0207518164051521e-09
exons O 0 8.918235039345745e-09
11 O 0 4.102521344861998e-08
- O 0 2.2901838647726436e-08
15 O 0 7.041182215061781e-08
. O 0 5.436160321892203e-08

There O 0 9.153438895737054e-09
is O 0 5.355551557784111e-10
constitutive O 0 1.2127172510645323e-07
methylation O 0 1.3501204421118018e-07
in O 0 2.719499647696466e-08
intron O 0 1.826735342547181e-06
12 O 0 2.863246493234328e-07
at O 0 5.431120886356666e-09
restriction O 0 4.8797486051910255e-09
sites O 0 3.469432519054294e-09
of O 0 3.8156335868677616e-09
SacII O 0 1.4470927567344916e-07
and O 0 3.2532805338547632e-09
HhaI O 0 4.5249609570419125e-07
, O 0 8.68711602652894e-10
localized O 0 3.071181708946824e-08
1 O 0 7.082733066710034e-09
, O 0 1.877760585911048e-10
159 O 0 1.2413139405254014e-09
- O 0 7.100164345352766e-10
1 O 0 4.109912854488584e-09
, O 0 1.1333717298001034e-10
232 O 0 1.3005880816763238e-09
bp O 0 5.027720018091486e-09
upstream O 0 4.359246830176744e-08
of O 0 1.2474476562829295e-08
the O 0 1.8309266636151733e-07
CTG O 0 1.0574704901955556e-05
repeat O 0 7.104126353851825e-08
, O 0 5.551481052634699e-09
whereas O 0 3.908458889867461e-09
most O 0 1.304008456770589e-09
, O 0 1.7515903658060772e-11
if O 0 2.7740268415676894e-11
not O 0 5.299630179145254e-11
all O 0 2.8278562824723963e-10
, O 0 1.8616203023569255e-10
of O 0 1.6790782098041745e-09
the O 0 1.6941721359131634e-09
other O 0 3.2110256120709835e-10
sites O 0 2.5950935622631732e-08
of O 0 4.3256939363800484e-08
SacII O 0 6.263715590648644e-07
, O 0 2.5429820471600806e-09
HhaI O 0 4.824032089345565e-07
, O 0 7.66534447027567e-10
and O 0 1.2205316757274431e-09
HpaII O 0 1.6327005880611978e-07
in O 0 1.4328692399256937e-10
this O 0 4.4759257411541853e-10
region O 0 8.383821636925859e-09
are O 0 6.314089251446831e-10
unmethylated O 0 2.5259171820835036e-07
, O 0 5.164232930177093e-10
in O 0 2.437206825245397e-10
normal O 0 2.5342274945217014e-09
individuals O 0 2.678278605838802e-11
and O 0 5.266658636982058e-11
most O 0 8.73681196833509e-11
of O 0 6.497283822071154e-10
the O 0 1.4332498521341108e-09
patients O 0 1.1607586003492543e-09
. O 0 2.9956122915564265e-08

In O 0 4.1490874624905416e-10
a O 0 9.831778446933725e-11
number O 0 4.025285660347322e-10
of O 0 1.2604921550973813e-08
young O 0 3.716527174901785e-08
and O 0 7.313280203646855e-09
severely O 0 2.0680795387306716e-06
affected O 0 1.6652053957955104e-08
patients O 0 2.1860078192048604e-09
, O 0 5.402702590862063e-11
however O 0 1.2297807217009904e-09
, O 0 1.8329778667114383e-11
complete O 0 1.8493045983447587e-10
methylation O 0 1.756507650441108e-08
of O 0 1.4928625446941624e-08
these O 0 2.0036752812480074e-10
restriction O 0 2.7878523933821953e-09
sites O 0 2.7134259283911888e-09
was O 0 6.866964774587814e-10
found O 0 8.938730311491838e-11
in O 0 5.582704090678625e-11
the O 0 7.458314521535669e-10
mutated O 0 4.009015697192808e-08
allele O 0 1.074012558888171e-07
. O 0 1.8425470216243411e-07

In O 0 2.8771716120701285e-09
most O 0 1.0286046459029308e-09
of O 0 3.573586426774966e-10
these O 0 1.4348047923384843e-11
patients O 0 1.2933140669524334e-11
, O 0 4.3788944367219307e-13
the O 0 3.4131903033085553e-12
onset O 0 3.3039210478591485e-08
of O 0 1.1684571366021856e-10
the O 0 7.249198463732398e-10
disease O 0 1.0482534662514809e-06
was O 0 1.0988027554503788e-07
congenital O 1 0.9999219179153442
. O 0 5.132109777150617e-07

Preliminary O 0 1.8454609573836933e-07
in O 0 4.101754669250113e-08
vivo O 0 1.1271855555605725e-06
footprinting O 0 5.898414656257955e-06
data O 0 2.164550494399009e-08
gave O 0 8.164095177676245e-09
evidence O 0 1.306810304413375e-08
for O 0 6.814045439007543e-10
protein O 0 5.244410239413355e-09
- O 0 2.3067527055165016e-10
DNA O 0 2.2148902156793326e-10
contact O 0 3.305249407503652e-09
in O 0 1.7447790434665933e-10
normal O 0 6.878559588585631e-08
genes O 0 7.079140829091557e-09
at O 0 3.6129828018260923e-09
an O 0 4.375143858315056e-10
Sp1 O 0 9.132477885032131e-09
consensus O 0 1.4822787441914897e-09
binding O 0 1.1108660658010194e-09
site O 0 1.9859887956386046e-08
upstream O 0 8.6039172231267e-08
of O 0 1.6663300073105347e-08
the O 0 2.3460872000669042e-07
CTG O 0 1.0489351552678272e-05
repeat O 0 3.234742917967992e-09
and O 0 4.267568590177184e-11
for O 0 1.6705591987867252e-12
a O 0 2.093816439674434e-12
significant O 0 9.633705291833827e-12
reduction O 0 2.0518171883754377e-10
of O 0 1.2616215017136057e-10
this O 0 4.020235186419363e-11
interaction O 0 5.971931837933653e-09
in O 0 4.882976800679728e-10
cells O 0 1.4996769381880881e-09
with O 0 7.552216491069075e-11
a O 0 4.843380807528774e-09
hypermethylated O 0 1.622369495635212e-06
DMPK O 0 6.2913359215599485e-06
gene O 0 1.1975646252437855e-08
. O 0 2.7101222599412722e-08
. O 0 9.902574760189964e-08

The O 0 6.158484779916762e-07
hemochromatosis B-Disease 1 1.0
gene O 0 6.018164526722103e-07
product O 0 1.0933505478760708e-07
complexes O 0 3.4684863869927085e-09
with O 0 9.125237024343313e-12
the O 0 5.780006473443677e-10
transferrin O 0 1.0483349655032725e-07
receptor O 0 1.6305298800034507e-07
and O 0 1.6043312234259588e-09
lowers O 0 9.539588674556398e-09
its O 0 3.225128844541736e-11
affinity O 0 5.309241588036251e-11
for O 0 1.3604735393801803e-11
ligand O 0 1.7946190311590726e-08
binding O 0 6.88177408392221e-08
. O 0 1.6039288652791583e-07

We O 0 1.7802728180527083e-08
recently O 0 1.6766108501542476e-09
reported O 0 5.762701427158845e-10
the O 0 1.364678595822122e-11
positional O 0 3.815546101293421e-09
cloning O 0 7.502344301357766e-10
of O 0 5.195205377006573e-10
a O 0 1.5094619998379244e-10
candidate O 0 1.5546774978503208e-09
gene O 0 2.8251299077908243e-09
for O 0 7.103272992026177e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9995372295379639
HFE O 1 0.9999990463256836
. O 0 1.1800086241464669e-07

The O 0 3.3403427579514755e-08
gene O 0 2.1220356583029343e-09
product O 0 5.514186884880701e-09
, O 0 1.6771238911528208e-11
a O 0 2.7318114784180558e-11
member O 0 1.7387825901327147e-10
of O 0 1.6908543898352946e-08
the O 0 2.5821358917710313e-07
major O 0 6.537130161632376e-07
histocompatibility O 0 2.615497578517534e-07
complex O 0 9.89100954029709e-07
class O 0 9.01649688245243e-09
I O 0 2.2721707182427053e-08
- O 0 9.500399356099365e-10
like O 0 1.0234240538364858e-10
family O 0 6.079988734697395e-10
, O 0 4.402462335656443e-12
was O 0 2.43776335923096e-11
found O 0 3.0019433119865546e-12
to O 0 1.567027757554129e-11
have O 0 7.67817337488097e-11
a O 0 9.427401082007236e-10
mutation O 0 1.751936262728293e-09
, O 0 3.3698530077508337e-10
Cys O 0 1.7206094327093524e-08
- O 0 1.81454780090462e-08
282 O 0 3.1354847607190095e-08
- O 0 1.2884802558232877e-08
- O 0 1.9688018326746715e-08
> O 0 4.9884416597478776e-09
Tyr O 0 2.2234086571870648e-08
( O 0 5.927983798281744e-11
C282Y O 0 4.0927812250401985e-09
) O 0 2.5433175530886754e-12
, O 0 6.225610305055085e-13
in O 0 1.948880293256572e-12
85 O 0 9.229238484564917e-10
% O 0 1.1460647708627647e-10
of O 0 1.5783463425123045e-10
patient O 0 2.3156849771055477e-09
chromosomes O 0 1.1776859309975407e-07
. O 0 4.872752583651163e-07

This O 0 1.0423406582305006e-09
mutation O 0 1.589241094279714e-08
eliminates O 0 2.8888084813161186e-08
the O 0 1.0984938514368991e-09
ability O 0 2.2040607117190802e-09
of O 0 3.634002041508211e-07
HFE O 0 0.0014376594917848706
to O 0 1.7351300840573458e-08
associate O 0 3.450768133461679e-07
with O 0 8.173907661834789e-10
beta2 O 0 1.919250462378841e-05
- O 0 3.5165504641554435e-07
microglobulin O 0 1.5449639931830461e-06
( O 0 1.301685093046956e-09
beta2m O 0 1.0651683624018915e-06
) O 0 2.142621913225895e-10
and O 0 6.97083391010267e-10
prevents O 0 1.226029411327545e-08
cell O 0 2.243586862960001e-07
- O 0 8.449322308479168e-08
surface O 0 2.4435034902126063e-06
expression O 0 2.5720177632138075e-07
. O 0 4.6323027191874644e-08

A O 0 6.335487796604866e-06
second O 0 1.218736969121892e-07
mutation O 0 1.3199316306611308e-08
that O 0 3.549769089783439e-10
has O 0 1.284952283464591e-10
no O 0 2.864012915715364e-10
effect O 0 1.4330674424911649e-08
on O 0 1.4185183694337411e-08
beta2m O 0 3.1228789794113254e-06
association O 0 2.3438367691142048e-08
, O 0 5.911279465919961e-09
H63D O 0 0.00016621935355942696
, O 0 2.9176944194020393e-10
was O 0 1.1740605154741957e-09
found O 0 2.9044728427907174e-11
in O 0 2.0683900772699992e-11
eight O 0 1.2918650871274195e-10
out O 0 1.5167289646456084e-10
of O 0 2.341689342433284e-10
nine O 0 3.02901315141213e-10
patients O 0 3.0449299331936075e-11
heterozygous O 0 6.228609988889744e-11
for O 0 3.7806849317867375e-10
the O 0 9.3507956933081e-09
C282Y O 0 6.122855324974807e-07
mutant O 0 3.624425346515636e-07
. O 0 2.8998891821174766e-07

In O 0 3.929883085618258e-09
this O 0 6.38021302457048e-10
report O 0 1.0765321967198815e-09
, O 0 1.5728938984604923e-11
we O 0 1.382831262691786e-11
demonstrate O 0 1.210150868402593e-10
in O 0 2.2604369764867016e-10
cultured O 0 3.9667551021693725e-08
293 O 0 6.119875273213893e-09
cells O 0 3.07103364960426e-09
overexpressing O 0 1.3996307757224713e-07
wild O 0 8.92017482101437e-09
- O 0 2.6320150503522655e-09
type O 0 1.2566315765738523e-09
or O 0 4.346150106471214e-10
mutant O 0 6.5321423825537295e-09
HFE O 0 1.0802313710200906e-07
proteins O 0 6.844470129552249e-11
that O 0 8.35010446204043e-12
both O 0 2.3293667342216828e-11
the O 0 8.225188308230713e-10
wild O 0 3.079297927754965e-09
- O 0 3.7771834549005234e-09
type O 0 2.2562392842928602e-08
and O 0 6.712236455541642e-08
H63D O 1 0.9903691411018372
HFE O 0 1.2520272321125958e-05
proteins O 0 2.9622357899938834e-09
form O 0 1.672130101049163e-09
stable O 0 2.4824931443845344e-08
complexes O 0 3.8961758819233694e-10
with O 0 7.55840962735066e-12
the O 0 1.395417892346984e-09
transferrin O 0 7.697114767779567e-08
receptor O 0 1.4964481920287653e-07
( O 0 4.527738628468114e-09
TfR O 0 3.399456716124405e-07
) O 0 1.7140836527929082e-09
. O 0 3.183877339552055e-08

The O 0 2.0244366183419515e-08
C282Y O 0 5.13343195507332e-07
mutation O 0 5.107771539059058e-09
nearly O 0 8.276538898677188e-10
completely O 0 1.9263608763697704e-10
prevents O 0 6.573843552848402e-11
the O 0 1.1777960551295763e-11
association O 0 4.764486374875254e-11
of O 0 5.973888050903042e-10
the O 0 2.3408019966808524e-09
mutant O 0 7.925967082655916e-08
HFE O 0 4.29700548920664e-06
protein O 0 6.079588388274715e-08
with O 0 2.685031641469493e-10
the O 0 3.125084191424321e-08
TfR O 0 5.038454219175037e-06
. O 0 1.2914911451389344e-07

Studies O 0 3.067564193770522e-07
on O 0 1.6489094534222204e-08
cell O 0 1.4042401907943258e-08
- O 0 2.2896715634601605e-09
associated O 0 2.4634925210875736e-09
transferrin O 0 3.021203909270298e-08
at O 0 1.4423573446720184e-09
37 O 0 9.275721857271435e-10
degrees O 0 3.6604692610353595e-09
C O 0 9.79819891888667e-10
suggest O 0 2.710381745429924e-11
that O 0 2.7531887360210394e-12
the O 0 8.354461566995042e-10
overexpressed O 0 1.504213287262246e-07
wild O 0 2.7016065828888713e-08
- O 0 2.3905069923557676e-08
type O 0 2.3411871552525554e-08
HFE O 0 1.3608359950012527e-06
protein O 0 1.4950055415852148e-08
decreases O 0 5.814826398164996e-10
the O 0 8.509209829810072e-12
affinity O 0 4.981640655543629e-10
of O 0 7.660316825308655e-10
the O 0 2.2279624811716303e-09
TfR O 0 1.0685019447009836e-07
for O 0 1.0215952528369598e-09
transferrin O 0 6.288654731179122e-06
. O 0 5.20879439136479e-07

The O 0 3.676038977573626e-05
overexpressed O 0 0.0018184668151661754
H63D O 0 0.43934834003448486
protein O 0 1.048941498993372e-06
does O 0 1.3454509728560993e-09
not O 0 8.710655807764311e-11
have O 0 9.61296407059331e-12
this O 0 6.79014006479961e-12
effect O 0 8.241552440502176e-10
, O 0 7.39377569586308e-12
providing O 0 2.3745358457283317e-10
the O 0 9.165693898305349e-11
first O 0 2.5484661256292007e-11
direct O 0 1.8469674401000447e-10
evidence O 0 2.1030684138612088e-10
for O 0 9.562527852891023e-12
a O 0 2.663557430171437e-10
functional O 0 5.21014591470248e-08
consequence O 0 5.8499853849980354e-08
of O 0 5.650510281896004e-09
the O 0 4.301965006447972e-08
H63D O 0 9.32375478441827e-05
mutation O 0 1.6650695044972963e-07
. O 0 9.889531327189616e-08

Addition O 0 1.639175195577991e-07
of O 0 7.027832111816679e-07
soluble O 0 1.5405503290821798e-05
wild O 0 3.441792273406463e-07
- O 0 1.9522964578300162e-07
type O 0 9.800793350223103e-07
HFE O 0 0.2243644893169403
/ O 0 4.298415660741739e-06
beta2m O 0 1.1373377901691128e-06
heterodimers O 0 5.358437960012452e-08
to O 0 2.877312832438861e-10
cultured O 0 1.5973116163081613e-09
cells O 0 1.72582045876446e-10
also O 0 1.7104820164426382e-12
decreased O 0 2.213292743524775e-11
the O 0 6.910866193546306e-13
apparent O 0 2.4811935839252897e-10
affinity O 0 3.48034018271548e-10
of O 0 5.427120974843547e-10
the O 0 2.030731582891576e-09
TfR O 0 2.493873552111836e-08
for O 0 3.2075592182323476e-11
its O 0 1.0038073150475668e-10
ligand O 0 2.207031890577582e-08
under O 0 3.0833415820552545e-09
steady O 0 4.003803866226008e-08
- O 0 1.1223490192779906e-10
state O 0 7.928722262073862e-11
conditions O 0 4.553477594981814e-09
, O 0 3.889550834190736e-11
both O 0 2.8426290835104062e-11
in O 0 7.435329435478977e-11
293 O 0 1.743890587491137e-10
cells O 0 1.6773105127043664e-10
and O 0 1.884318950873265e-10
in O 0 1.882279665466058e-09
HeLa O 0 2.2703778768118354e-07
cells O 0 1.2551882377920265e-07
. O 0 1.393231769952763e-07

Furthermore O 0 5.490868488777778e-07
, O 0 3.3241596142374874e-09
at O 0 4.5700003781234955e-09
4 O 0 7.089653308867128e-09
degrees O 0 9.157528069181353e-08
C O 0 4.902093309055999e-08
, O 0 6.134465851959092e-11
the O 0 8.518215022235154e-10
added O 0 1.3981253488282164e-08
soluble O 0 3.5696118061423476e-08
complex O 0 7.226671705495846e-09
of O 0 8.592207478841374e-08
HFE O 0 0.0032022171653807163
/ O 0 3.5063408176938538e-06
beta2m O 0 4.670567079756438e-07
inhibited O 0 4.1422971719384805e-09
binding O 0 4.744936110689935e-10
of O 0 1.2943369709361718e-09
transferrin O 0 3.377088830802677e-08
to O 0 3.6808849301905866e-09
HeLa O 0 2.2449587788742065e-07
cell O 0 5.977916828214802e-08
TfR O 0 3.0505910331157793e-07
in O 0 7.432298665399628e-10
a O 0 2.3628223821958727e-09
concentration O 0 8.737008982961925e-08
- O 0 3.021203909270298e-08
dependent O 0 4.488154914383813e-08
manner O 0 2.7191523699343634e-08
. O 0 2.612939020707472e-08

Scatchard O 0 0.0009655759786255658
plots O 0 1.2461181313483394e-06
of O 0 1.2265042315107166e-08
these O 0 2.2068696869936844e-10
data O 0 3.119329905487689e-09
indicate O 0 4.01144584216695e-09
that O 0 7.553412062488718e-11
the O 0 5.232570376989543e-09
added O 0 1.901122281822154e-08
heterodimer O 0 2.6597323454780053e-08
substantially O 0 2.5744992804277445e-09
reduced O 0 2.365747597821155e-10
the O 0 7.2854840216241e-11
affinity O 0 5.671349168068218e-09
of O 0 2.4251605168501555e-09
TfR O 0 4.247630513987133e-08
for O 0 1.1223730833620493e-09
transferrin O 0 4.33116565545788e-06
. O 0 4.951644427819701e-07

These O 0 7.163434734280827e-09
results O 0 6.749786063409147e-09
establish O 0 1.1743724215307338e-08
a O 0 8.367075921000833e-10
molecular O 0 1.1073971073471967e-08
link O 0 2.5036056783278582e-08
between O 0 1.0071299350045138e-08
HFE O 0 0.00017693366680759937
and O 0 1.254693904328974e-09
a O 0 3.138774351540974e-09
key O 0 2.965091994155955e-08
protein O 0 8.738671120056551e-09
involved O 0 7.420028480531471e-11
in O 0 1.50280884958498e-10
iron O 0 4.8432173826995495e-08
transport O 0 2.5207739895449777e-08
, O 0 7.670284546401618e-11
the O 0 1.1436092961503164e-08
TfR O 0 3.41796663860805e-07
, O 0 1.0605473443892066e-10
and O 0 6.105190658578508e-11
raise O 0 9.226157615671582e-10
the O 0 7.93082877148521e-10
possibility O 0 3.35889449587512e-09
that O 0 9.141146867230887e-11
alterations O 0 3.0629316860597555e-09
in O 0 1.273185463307458e-11
this O 0 9.982449762635515e-12
regulatory O 0 2.820508826495427e-10
mechanism O 0 5.139806802390012e-09
may O 0 5.983215589644431e-10
play O 0 6.390151185975412e-10
a O 0 8.57706961010507e-10
role O 0 2.0051281468536075e-10
in O 0 1.9661194547437866e-11
the O 0 1.5532333752510397e-10
pathogenesis O 0 3.8128421238070587e-06
of O 0 4.36185843000203e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 7.616048378622509e-07
. O 0 4.236206052610214e-08

Genomic O 0 1.7317516665116273e-07
organization O 0 2.4409775534195433e-08
of O 0 1.4286872129787298e-08
the O 0 3.991710428863371e-08
UBE3A O 0 2.0922609110129997e-05
/ O 0 2.405190855370165e-07
E6 O 0 2.5541767172398977e-06
- O 0 3.2958269002847373e-08
AP O 0 2.820399231495685e-06
gene O 0 6.612188574450784e-10
and O 0 3.227949019191101e-10
related O 0 1.4500810552320331e-09
pseudogenes O 0 2.846801123723708e-07
. O 0 4.0130931466819675e-08

The O 0 3.5735703818318143e-07
UBE3A O 0 9.884654900815804e-06
gene O 0 2.213296212971727e-08
encodes O 0 7.246661226645301e-08
the O 0 7.224993225918297e-08
E6 O 0 2.851017143257195e-06
- O 0 1.4581198115592997e-07
AP O 0 3.7123370475455886e-06
ubiquitin O 0 1.149768191766043e-08
- O 0 3.513611401828598e-09
protein O 0 4.570163691930418e-10
ligase O 0 1.3930079312274302e-10
and O 0 3.3791070636057796e-11
has O 0 9.399436957935325e-12
recently O 0 9.679567043729964e-12
been O 0 1.5575006562240645e-12
shown O 0 3.3360686717449906e-13
to O 0 4.2633171298822603e-13
be O 0 1.1552835511158266e-12
mutated O 0 2.233336182655421e-09
in O 0 3.2017358209124325e-10
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 4.2445185144401876e-09
who O 0 4.6169584821953435e-10
lack O 0 1.050348075182228e-08
15q11 O 0 1.4305773277101252e-07
- O 0 3.5859759606182706e-08
q13 O 0 3.1294212021748535e-07
deletions O 0 4.305116618752436e-08
or O 0 1.0889228407862106e-09
chromosome O 0 1.9654962102322315e-08
15 O 0 1.7539372265673592e-07
paternal O 0 0.0011259634047746658
uniparental B-Disease 0 0.010896935127675533
disomy I-Disease 0 0.0005289072869345546
. O 0 2.795881982819992e-06

Previous O 0 9.477256526224664e-07
UBE3A O 0 4.271404577593785e-06
cDNA O 0 1.2779607594382014e-08
analysis O 0 1.8090307030149688e-10
has O 0 5.970897387630458e-12
shown O 0 1.183203817041456e-12
a O 0 5.581242499413941e-12
coding O 0 1.4261843928053963e-09
region O 0 5.1028248293505385e-09
of O 0 5.465653263314607e-09
approximately O 0 8.18217849030134e-09
2 O 0 8.144921537223127e-08
. O 0 1.4536158232658636e-07

6 O 0 2.757635911621037e-06
kb O 0 2.595116484371829e-06
and O 0 4.533787567595482e-09
a O 0 5.818834303283893e-09
3 O 0 8.106547255692931e-08
- O 0 4.115547014293952e-08
untranslated O 0 2.832020618370734e-05
region O 0 5.2353485102685227e-08
( O 0 9.658018829128423e-10
UTR O 0 2.149158262909623e-06
) O 0 3.586368979568988e-10
of O 0 1.2487237022185127e-08
< O 0 2.0082916663000105e-08
50 O 0 4.184593294098704e-08
bp O 0 9.249103705144535e-09
, O 0 3.411187304847019e-11
whereas O 0 2.643121554957162e-10
Northern O 0 6.338826130658504e-10
analysis O 0 2.981176971950106e-10
has O 0 1.4003496973113982e-10
indicated O 0 4.080012161455926e-10
mRNA O 0 7.346830921406422e-10
sizes O 0 1.718664499605893e-08
of O 0 2.6649422224522823e-08
5 O 0 1.7014406239468371e-07
- O 0 1.272877057090227e-07
8 O 0 2.2212897476947546e-07
kb O 0 4.354574230092112e-06
. O 0 6.09593769240746e-07

We O 0 1.1119227139033683e-07
have O 0 2.3720971853435913e-09
analyzed O 0 6.243233929836833e-09
additional O 0 7.287599412819645e-10
cDNA O 0 1.9183401533950928e-08
clones O 0 4.4464886883588406e-08
and O 0 2.6767174587938314e-10
provide O 0 4.204004921959381e-10
evidence O 0 1.9970909370670142e-09
for O 0 7.226030190876642e-11
an O 0 2.516687969134068e-10
additional O 0 1.247040248841813e-09
0 O 0 9.962553804143681e-08
. O 0 1.0032420760808236e-07

5 O 0 5.713608857149666e-07
kb O 0 3.616912408688222e-06
of O 0 1.0102630767505616e-06
5 O 0 2.6250032192365325e-07
- O 0 3.901213929680125e-08
UTR O 0 2.589398263808107e-06
and O 0 1.0755778490079138e-09
> O 0 2.7963733550961933e-09
2 O 0 3.989097940859665e-09
kb O 0 1.0962259011648712e-07
of O 0 1.0477153011834162e-07
3 O 0 4.997224891667429e-07
- O 0 7.360862923633249e-07
UTR O 0 0.00011222756438655779
. O 0 4.66144911115407e-07

We O 0 6.37634789413255e-09
have O 0 9.430526498599434e-11
established O 0 5.797981539323871e-10
the O 0 4.452864466042428e-11
genomic O 0 6.964707699452788e-10
organization O 0 2.4495661055112805e-10
of O 0 5.53849077711277e-10
UBE3A O 0 2.083216486425954e-06
and O 0 4.0442324489298187e-10
the O 0 1.3621912486883048e-09
sequence O 0 7.581374417142683e-10
of O 0 9.74925029595397e-09
intron O 0 2.3203115517844708e-07
- O 0 1.5540682340997591e-07
exon O 0 5.2930008820339935e-08
borders O 0 3.83367648737476e-07
. O 0 5.565679543906299e-07

We O 0 4.104931861093064e-08
have O 0 1.5043811751880298e-09
also O 0 9.134215050998762e-10
mapped O 0 1.7897241022524213e-08
two O 0 1.488562828555473e-09
highly O 0 5.5017688183056634e-09
homologous O 0 4.142052478783853e-09
processed O 0 2.5111475565608998e-08
pseudogenes O 0 4.712166514764249e-07
, O 0 3.318420205289385e-09
UBE3AP1 O 0 1.7441907402826473e-05
and O 0 4.229696592972232e-09
UBE3AP2 O 0 0.00010183617996517569
, O 0 2.6267579777972117e-10
to O 0 2.2642383801230181e-10
chromosomes O 0 4.5395656678159924e-10
2 O 0 1.6517952561301286e-09
and O 0 2.292952633320411e-10
21 O 0 5.328095298295921e-09
, O 0 2.9480642926849043e-10
respectively O 0 1.4853466234754364e-09
, O 0 2.225315626214197e-10
and O 0 2.9824850922288704e-10
determined O 0 7.1945174262566525e-09
their O 0 4.653465168757975e-09
genomic O 0 3.163406177009165e-07
organization O 0 1.1517902720470374e-07
. O 0 7.945689617372409e-08

These O 0 3.75685225151301e-08
results O 0 8.508249216276909e-09
will O 0 3.2664836113749374e-11
form O 0 2.335376857176552e-11
the O 0 2.5568503911332918e-11
basis O 0 6.869581292701099e-11
for O 0 6.637804997496055e-13
studies O 0 3.100961154522963e-11
of O 0 5.030256419735757e-11
mutation O 0 2.3589977193871903e-10
and O 0 2.231785173334444e-10
imprinting O 0 2.33627497436828e-06
of O 0 1.2956946875419817e-06
UBE3A O 0 0.0032226911280304193
. O 0 4.055173576489324e-06

Mutation O 0 2.2985247483120474e-08
spectrum O 0 3.080932842181028e-08
and O 0 5.031948191458469e-10
genotype O 0 4.053812929782907e-08
- O 0 2.011657507239306e-08
phenotype O 0 2.6101398375999452e-08
analyses O 0 6.090899451471898e-10
in O 0 4.7137863057322704e-11
Cowden B-Disease 0 2.3483260065404465e-06
disease I-Disease 0 6.645548467076878e-08
and O 0 3.1813993661700124e-09
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.5719830992466655e-10
two O 0 1.8760852593668886e-10
hamartoma B-Disease 1 0.7759708166122437
syndromes I-Disease 0 2.65572944044834e-05
with O 0 2.3088459144560147e-08
germline O 1 1.0
PTEN O 1 1.0
mutation O 0 6.099262009229278e-06
. O 0 1.58904470026755e-07

The O 0 1.1109524393759784e-06
tumour B-Disease 1 1.0
suppressor O 0 0.005461918655782938
gene O 0 1.6144260371220298e-05
PTEN O 1 0.999790370464325
, O 0 2.676126653611277e-09
which O 0 3.126498365757513e-11
maps O 0 7.273536439811323e-09
to O 0 2.375080576655364e-09
10q23 O 0 1.2133426025684457e-05
. O 0 3.5679616416928184e-07

3 O 0 3.1716891157884675e-07
and O 0 4.4608233773502093e-10
encodes O 0 6.467745783389489e-10
a O 0 5.871475527996495e-10
403 O 0 6.921192508002605e-10
amino O 0 4.2888109730299107e-10
acid O 0 2.734575899054903e-10
dual O 0 3.7255674101288605e-09
specificity O 0 6.213205239191666e-08
phosphatase O 0 1.3039705663686618e-05
( O 0 3.070906871016632e-07
protein O 0 1.0402247426100075e-05
tyrosine O 0 7.98110818323039e-07
phosphatase O 0 3.1811373446544167e-07
; O 0 6.02015903794495e-09
PTPase O 0 7.712986871410976e-08
) O 0 1.8796193768100267e-11
, O 0 9.821315635760719e-12
was O 0 2.725245029644441e-10
shown O 0 4.9146121200438486e-11
recently O 0 4.522141341944952e-11
to O 0 5.42366186684351e-11
play O 0 9.168251158264695e-10
a O 0 3.2333611343915436e-09
broad O 0 2.146927791102371e-08
role O 0 1.1750126427401142e-09
in O 0 1.0441354447721096e-09
human O 0 5.420650595056031e-08
malignancy B-Disease 0 0.00010076885519083589
. O 0 9.816277213303692e-08

Somatic O 0 0.0002531908976379782
PTEN O 0 0.0015395419904962182
deletions O 0 1.5714531400590204e-06
and O 0 8.771033677135165e-09
mutations O 0 1.2147725492184236e-08
were O 0 1.9540299933673566e-10
observed O 0 1.4613586729605998e-10
in O 0 1.780861222377972e-11
sporadic B-Disease 0 3.7948203157611715e-07
breast I-Disease 0 5.0764306251949165e-06
, I-Disease 0 1.0610987644099623e-08
brain I-Disease 1 1.0
, I-Disease 0 2.4649941678944742e-06
prostate I-Disease 1 1.0
and I-Disease 0 5.658414011122659e-06
kidney I-Disease 0 0.004711485933512449
cancer I-Disease 0 6.596429216187971e-07
cell O 0 6.275099906360992e-08
lines O 0 4.981051682229065e-10
and O 0 7.330028077567885e-12
in O 0 1.3886486578684742e-11
several O 0 2.0517036680711698e-10
primary O 0 1.3875367699256458e-07
tumours B-Disease 1 1.0
such O 0 2.530159692870626e-10
as O 0 2.7157936344224254e-08
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 9.134568017543643e-07
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 0 1.895670357043855e-05
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 2.3706343199592084e-06

In O 0 8.446724208965861e-09
addition O 0 4.558639243867901e-09
, O 0 1.1266692023781388e-09
PTEN O 0 0.03342881053686142
was O 0 6.76215661243873e-09
identified O 0 4.627793981359929e-10
as O 0 1.716797537465453e-11
the O 0 8.426774035508178e-12
susceptibility O 0 1.1859546678039123e-10
gene O 0 1.878881078498651e-11
for O 0 2.051456053642209e-11
two O 0 7.974437776780974e-10
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 0.9999983310699463
disease I-Disease 1 0.9896315932273865
( O 0 1.5225150029607448e-09
CD B-Disease 0 6.919178758835187e-07
; O 0 3.4136721893673894e-08
MIM O 0 8.07963078841567e-06
158350 O 0 1.868310022246078e-07
) O 0 1.3046497215896125e-10
and O 0 4.688618937542799e-10
Bannayan B-Disease 0 1.4057204680284485e-05
- I-Disease 0 2.5949804694391787e-05
Zonana I-Disease 0 0.0017677347641438246
( I-Disease 0 8.170610499291797e-08
BZS I-Disease 0 4.998412259737961e-05
) I-Disease 0 4.3747100386681836e-10
or I-Disease 0 6.310381106544583e-10
Ruvalcaba I-Disease 0 4.947009415445791e-07
- I-Disease 0 3.79055187238464e-08
Riley I-Disease 0 1.5988081258910825e-06
- I-Disease 0 0.002697933465242386
Smith I-Disease 0 1.7579070572537603e-06
syndrome I-Disease 1 1.0
( O 0 6.025084644534218e-07
MIM O 0 0.007232883479446173
153480 O 0 2.8585152449522866e-06
) O 0 2.603441018322883e-09
. O 0 4.502164685504795e-08

Constitutive O 0 1.490200531861774e-07
DNA O 0 6.165288368720212e-08
from O 0 1.0002286110477598e-08
37 O 0 6.403111374453374e-09
CD B-Disease 0 2.373658603005424e-09
families O 0 1.0917922815822934e-10
and O 0 5.015550821885206e-11
seven O 0 6.299534227593995e-10
BZS B-Disease 0 3.853054749924922e-06
families O 0 1.1960892276619006e-09
was O 0 1.1968789292993165e-09
screened O 0 5.550091497497078e-10
for O 0 7.957814962544774e-10
germline O 0 8.677360165165737e-05
PTEN O 0 0.0015042158775031567
mutations O 0 1.105672799894819e-05
. O 0 1.4388294857781148e-06

PTEN O 0 0.0018346459837630391
mutations O 0 8.613142199465074e-07
were O 0 7.2653141280909495e-09
identified O 0 4.007375542514069e-10
in O 0 1.184066820286711e-11
30 O 0 4.5791331837463645e-10
of O 0 5.588267626421839e-10
37 O 0 4.7229433697282275e-09
( O 0 1.039302741090431e-10
81 O 0 3.0106942716656704e-08
% O 0 2.3276003346950347e-10
) O 0 4.783904934517469e-13
CD B-Disease 0 2.0946654133435771e-10
families O 0 6.163305282802511e-11
, O 0 3.0818787192382624e-12
including O 0 3.611750872337116e-12
missense O 0 2.723335690291151e-08
and O 0 1.7749557379431735e-09
nonsense O 0 2.921585462445364e-07
point O 0 8.609372343926225e-07
mutations O 0 1.6311732409235447e-08
, O 0 2.106164131987498e-09
deletions O 0 3.4652611446972514e-08
, O 0 1.731836007934362e-09
insertions O 0 8.379061000596266e-08
, O 0 4.1721012755679965e-10
a O 0 2.420950551140777e-09
deletion O 0 5.686950643735145e-08
/ O 0 5.171351062926988e-07
insertion O 0 1.5983705736744014e-07
and O 0 7.092442189104986e-08
splice O 0 1.6463191059301607e-05
site O 0 1.8756203417069628e-06
mutations O 0 6.752859462721972e-07
. O 0 6.426888035093725e-07

These O 0 1.771219615420705e-08
mutations O 0 6.98352309314032e-08
were O 0 8.839787235537244e-10
scattered O 0 1.2985852393399e-09
over O 0 3.1738202344033795e-11
the O 0 1.3056727921068045e-10
entire O 0 5.204677244741163e-10
length O 0 1.1520853021584898e-10
of O 0 2.924325892550428e-09
PTEN O 0 2.771183972072322e-06
, O 0 7.991441536292498e-11
with O 0 2.08852770147705e-12
the O 0 6.604471830540248e-11
exception O 0 1.1358215062928778e-10
of O 0 6.824980858244345e-11
the O 0 1.8378763788629016e-10
first O 0 9.75181158047178e-10
, O 0 2.251108882633801e-10
fourth O 0 2.1310652797978946e-08
and O 0 5.132811953245664e-09
last O 0 1.8193829021129204e-07
exons O 0 1.820908551053435e-06
. O 0 3.1363815651275218e-06

A O 0 4.99099405715242e-06
hot O 0 2.8600447876669932e-06
spot O 0 2.2192993753833434e-07
for O 0 3.676100090999057e-09
PTEN O 0 1.7254380509257317e-05
mutation O 0 4.173758227921098e-09
in O 0 3.821611360699251e-10
CD B-Disease 0 1.8996903605739135e-08
was O 0 6.7664913672160765e-09
identified O 0 1.4326950736887056e-09
in O 0 1.417462119901458e-10
exon O 0 1.8284578295890697e-09
5 O 0 4.295649169705484e-09
that O 0 1.6117303672236183e-11
contains O 0 9.565652436815952e-11
the O 0 3.617381949538867e-09
PTPase O 0 4.7444393658224726e-07
core O 0 1.0286389340308233e-07
motif O 0 1.9995312072751403e-08
, O 0 3.1429105845637295e-11
with O 0 3.0613502184639874e-12
13 O 0 1.502500013295105e-09
of O 0 1.473124400241943e-09
30 O 0 3.2967559793206647e-09
( O 0 1.732585186431379e-10
43 O 0 7.75025199573065e-08
% O 0 1.7275668673377709e-09
) O 0 1.537140900675915e-11
CD B-Disease 0 3.0026467978672144e-09
mutations O 0 3.643306545342284e-09
identified O 0 4.222804328435359e-09
in O 0 8.767478409943408e-11
this O 0 4.1981235154864294e-10
exon O 0 1.8441390636780852e-08
. O 0 1.8656143652151513e-07

Seven O 0 9.760119468182893e-08
of O 0 4.684583032599221e-08
30 O 0 2.873662907632024e-08
( O 0 1.331435101059597e-10
23 O 0 1.1643913389036697e-08
% O 0 1.951675904221517e-10
) O 0 1.183616898069173e-12
were O 0 1.749089588443109e-11
within O 0 1.232330210099164e-10
the O 0 1.12699161114449e-09
core O 0 8.008172791562629e-09
motif O 0 1.920990255754873e-09
, O 0 4.532224422149067e-12
the O 0 5.0759212805173703e-11
majority O 0 8.518514886535211e-12
( O 0 6.286948392442149e-12
five O 0 1.5922888008113034e-10
of O 0 3.3276104094426273e-09
seven O 0 8.502631931861515e-10
) O 0 2.0346608078924966e-11
of O 0 3.4705840423754353e-09
which O 0 1.0939564809575586e-09
were O 0 4.9523432466003214e-08
missense O 0 1.1092425893366453e-06
mutations O 0 2.9612044727400644e-07
, O 0 1.7319681244742924e-09
possibly O 0 7.98252219880169e-09
pointing O 0 2.9711213045402474e-08
to O 0 3.512282964468483e-10
the O 0 1.6752010889575786e-09
functional O 0 9.410697998646356e-09
significance O 0 1.1035006686199722e-08
of O 0 1.3292231759720607e-09
this O 0 1.0106836478840364e-09
region O 0 6.102766292315209e-08
. O 0 1.150339059563521e-07

Germline O 0 0.0017765817465260625
PTEN O 0 0.0006070356466807425
mutations O 0 4.781609277415555e-07
were O 0 1.435841112673586e-09
identified O 0 1.9918401650276252e-10
in O 0 1.6904035463061184e-11
four O 0 3.324219371991788e-11
of O 0 3.33970906485348e-10
seven O 0 7.182858752230459e-10
( O 0 2.416027100604623e-10
57 O 0 8.15317449109898e-08
% O 0 5.606901165577938e-09
) O 0 3.756224775663952e-10
BZS B-Disease 0 2.50925022555748e-05
families O 0 9.865732231162383e-09
studied O 0 1.1861486370889907e-07
. O 0 5.703124728029252e-08

Interestingly O 0 1.1936316468563746e-06
, O 0 2.2329613713623075e-09
none O 0 2.3064911758297058e-08
of O 0 4.467160419352467e-09
these O 0 6.33145591510953e-10
mutations O 0 2.70043205574666e-08
was O 0 6.296485999257584e-09
observed O 0 7.050489081450451e-10
in O 0 1.432180762872548e-10
the O 0 1.265247018267246e-08
PTPase O 0 9.286151907872409e-06
core O 0 2.297636228831834e-06
motif O 0 1.2192070926175802e-06
. O 0 1.2530496462659357e-07

It O 0 4.5965058426133965e-09
is O 0 2.2312998670948048e-10
also O 0 1.177499504151358e-11
worthy O 0 2.056182557552688e-09
of O 0 2.604517435056408e-10
note O 0 3.7036018696312567e-10
that O 0 1.0532553995634686e-11
a O 0 1.373259284065398e-10
single O 0 7.926624356890954e-10
nonsense O 0 4.206528103622986e-08
point O 0 6.542094155292943e-08
mutation O 0 1.6823575865743123e-09
, O 0 1.549921718746461e-10
R233X O 0 3.2067198674212705e-08
, O 0 1.593406656619223e-10
was O 0 1.1057460502783556e-09
observed O 0 3.8104389088466917e-10
in O 0 9.43689570931383e-11
the O 0 5.557180493553915e-09
germline O 0 6.891454518154205e-08
DNA O 0 9.691460967076182e-09
from O 0 6.665247465065249e-09
two O 0 4.012584153834098e-10
unrelated O 0 1.111361891403817e-09
CD B-Disease 0 3.993612551767001e-09
families O 0 4.070467019001711e-10
and O 0 2.4190704994708767e-10
one O 0 1.1220076423512637e-08
BZS B-Disease 0 0.00018073023238684982
family O 0 1.5328795655022986e-07
. O 0 2.9846569304936565e-07

Genotype O 0 6.045983269586941e-08
- O 0 7.266731216759581e-08
phenotype O 0 1.662780491074045e-08
studies O 0 1.535967131260918e-09
were O 0 3.6019836419098894e-11
not O 0 6.879910703638803e-12
performed O 0 1.6855388612624367e-11
on O 0 1.5978104950242766e-10
this O 0 3.687950986264177e-11
small O 0 8.972436682519458e-10
group O 0 1.406994659669536e-10
of O 0 9.053599647756982e-09
BZS B-Disease 0 0.0004890440031886101
families O 0 9.826261759826593e-08
. O 0 3.425864179007476e-07

However O 0 2.1964744689739746e-08
, O 0 8.181862409806229e-10
genotype O 0 7.104909549582317e-09
- O 0 9.975155812469438e-09
phenotype O 0 4.367716854858372e-09
analysis O 0 2.733897830342613e-10
inthe O 0 1.131860649650207e-08
group O 0 7.046210143135667e-11
of O 0 2.9861507711004265e-10
CD B-Disease 0 4.8761968685084867e-08
families O 0 6.258459084307333e-09
revealed O 0 2.277914967763195e-09
two O 0 2.0653780768986607e-11
possible O 0 2.5117055657553067e-10
associations O 0 5.13486586584122e-10
worthy O 0 5.134645775228819e-08
of O 0 8.331121570392952e-09
follow O 0 1.0402015915289553e-09
- O 0 1.4543576343228892e-09
up O 0 9.146470247856087e-10
in O 0 2.0007347167894096e-10
independent O 0 1.839315144636089e-09
analyses O 0 1.1832897328645231e-08
. O 0 3.146592320035779e-08

The O 0 2.0565130043337376e-08
first O 0 5.641744404982774e-09
was O 0 4.127556518795927e-09
an O 0 6.859473405951277e-11
association O 0 3.00562491561962e-10
noted O 0 1.4136531945041497e-09
in O 0 2.589844450007206e-10
the O 0 1.4662852265701076e-08
group O 0 6.319616357997049e-11
of O 0 6.639132021923899e-10
CD B-Disease 0 1.3273386230139295e-06
families O 0 1.2763072732013825e-07
with O 0 7.285480307928083e-08
breast B-Disease 1 0.978813648223877
disease I-Disease 1 0.9924936294555664
. O 0 1.2169518015525682e-07

A O 0 8.064737500035335e-08
correlation O 0 1.7836988774888596e-08
was O 0 1.1236154229266049e-09
observed O 0 7.966573928319676e-11
between O 0 2.597144548033281e-11
the O 0 1.2562857698572572e-10
presence O 0 2.301067558718728e-09
/ O 0 2.7150374393158927e-08
absence O 0 2.3976213014975656e-08
of O 0 2.4056272529549005e-09
a O 0 2.25734431147373e-09
PTEN O 0 3.1010215479909675e-06
mutation O 0 5.432723715337318e-10
and O 0 9.21768824463376e-12
the O 0 2.7249941886298146e-11
type O 0 4.489402183338598e-09
of O 0 4.976752343566204e-09
breast O 0 2.491715918040427e-07
involvement O 0 4.260824226776094e-08
( O 0 1.0330663435809129e-08
unaffected O 0 0.00021294946782290936
versus O 0 6.0751484852517024e-05
benign O 1 0.9996354579925537
versus O 0 7.3193368734791875e-06
malignant O 0 2.7515438887348864e-06
) O 0 2.018836875450347e-09
. O 0 2.2635282093119713e-08

Specifically O 0 4.939730402497844e-08
and O 0 8.48296655142633e-10
more O 0 7.32679195092345e-10
directly O 0 4.850277512957746e-09
, O 0 1.4414125275308276e-11
an O 0 1.7267909324658604e-11
association O 0 1.0343666895229475e-10
was O 0 2.631708850842074e-09
also O 0 2.109205345102172e-11
observed O 0 6.741519148478758e-11
between O 0 4.18757355180599e-11
the O 0 1.0991891424838585e-10
presence O 0 6.582215328343466e-10
of O 0 5.277793202473902e-10
a O 0 5.440431216641173e-09
PTEN O 0 0.01414439920336008
mutation O 0 1.0093173841596581e-05
and O 0 1.1484365813885233e-06
malignant B-Disease 1 0.9999994039535522
breast I-Disease 0 0.07533442974090576
disease I-Disease 0 2.6606447136146016e-05
. O 0 5.379010303840914e-08

Secondly O 0 5.6961616792250425e-06
, O 0 1.660200865671868e-08
there O 0 2.4175865753761627e-09
appeared O 0 2.2692849821481786e-09
to O 0 3.708137616409424e-11
be O 0 7.789438538630122e-11
an O 0 2.158253298301105e-10
interdependent O 0 6.95853970000826e-08
association O 0 2.1728606469650913e-08
between O 0 3.307767570959186e-08
mutations O 0 4.55738131677208e-07
upstream O 0 7.435800171151641e-07
and O 0 1.7354326309337864e-10
within O 0 9.72441571711613e-10
the O 0 1.3669574805419415e-08
PTPase O 0 8.758104286243906e-07
core O 0 6.393290163941856e-08
motif O 0 6.933870366765404e-08
, O 0 2.3288571071589104e-10
the O 0 1.8816910252184016e-09
core O 0 2.5218945154392713e-08
motif O 0 2.7043274286597807e-09
containing O 0 6.089711374057671e-11
the O 0 4.0610681484309907e-10
majority O 0 4.686991905700211e-10
of O 0 2.1460884624957544e-08
missense O 0 3.8181732975317573e-07
mutations O 0 1.9496537717600404e-08
, O 0 1.6124752921786722e-10
and O 0 3.604375131693871e-11
the O 0 6.450768252896921e-10
involvement O 0 1.464746990365029e-09
of O 0 2.290732936671702e-09
all O 0 1.4028600503479538e-10
major O 0 9.213056983981005e-10
organ O 0 1.5212270554343377e-08
systems O 0 3.45424098213698e-08
( O 0 6.535207486280115e-09
central O 0 0.1446467489004135
nervous O 0 6.484066398115829e-05
system O 0 0.00013388415391091257
, O 0 1.2777804592190023e-08
thyroid O 0 3.2663192541804165e-06
, O 0 2.616549821254921e-08
breast O 0 7.3892944783438e-05
, O 0 2.438650703595613e-08
skin O 1 0.9999943971633911
and O 0 0.001594454632140696
gastrointestinal O 1 1.0
tract O 1 0.9878106117248535
) O 0 1.8168440973909128e-08
. O 0 1.725472316138621e-06

However O 0 9.604402748664143e-07
, O 0 4.856757662707878e-09
these O 0 2.0962731550611124e-09
observations O 0 2.1126751903466356e-08
would O 0 6.57325444075596e-11
need O 0 2.7825758364130593e-10
to O 0 5.058228280674371e-10
be O 0 6.453155787511378e-10
confirmed O 0 2.4979092128063485e-09
by O 0 8.488141439721986e-11
studying O 0 3.819636551494199e-10
a O 0 2.5022078159464556e-11
larger O 0 1.2771066149053212e-10
number O 0 8.681844132496508e-11
of O 0 9.01160923660882e-10
CD B-Disease 0 1.6863653229393094e-07
families O 0 5.7100145056665497e-08
. O 0 2.1191007704146614e-07

Molecular O 0 1.798996891011484e-05
defects O 0 0.0005138340056873858
leading O 0 7.772990784360445e-08
to O 0 1.1221007456541088e-10
human O 0 1.5428025523789302e-09
complement B-Disease 0 6.848416091997933e-07
component I-Disease 1 0.999996542930603
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 8.121593675358696e-11
an O 0 3.788435537499524e-11
African O 0 3.533157447166424e-11
- O 0 8.233974613247597e-11
American O 0 1.1609107425369913e-10
family O 0 9.458759331337774e-10
. O 0 1.7182275602323216e-09

Complement B-Disease 0 2.2608665517509507e-07
component I-Disease 0 2.876063263101969e-05
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 2.3890107669899407e-09
C6D B-Disease 0 1.3482433132594451e-05
) O 0 2.4082047120344008e-11
was O 0 8.81355710635745e-10
diagnosed O 0 8.400993234403131e-10
in O 0 1.3280663027637196e-11
a O 0 7.840655902313642e-11
16 O 0 7.488533682042942e-10
- O 0 8.728168188198993e-11
year O 0 2.3555402073327514e-10
- O 0 1.0527297089613086e-10
old O 0 7.880018415562517e-09
African O 0 8.778655580243822e-11
- O 0 1.4662326908165824e-11
American O 0 1.2627033750198247e-12
male O 0 4.378679276800801e-12
with O 0 1.3890982548253605e-12
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 5.789420054469474e-09

The O 0 3.0152399688176956e-08
patients O 0 9.233357967097788e-10
father O 0 2.0852160886875026e-08
and O 0 9.973400993956716e-10
two O 0 2.577575042295166e-09
brothers O 0 4.3905636459840025e-08
also O 0 2.28589702722104e-09
had O 0 1.2509692837170405e-08
C6D B-Disease 1 0.9999738931655884
, O 0 1.2256308468128196e-10
but O 0 1.3851021718469525e-10
gave O 0 8.18339174202265e-10
no O 0 1.4870325804050566e-10
history O 0 1.5947058118470636e-09
of O 0 3.968251949260093e-09
meningitis B-Disease 1 1.0
or O 0 1.529238069508665e-09
other O 0 3.669486936530575e-09
neisserial B-Disease 0 6.9565553530992474e-06
infection I-Disease 0 8.186832474166295e-07
. O 0 4.287089794274834e-08

By O 0 1.5220271709637245e-09
using O 0 5.169141226168961e-10
exon O 0 1.967982221628972e-09
- O 0 4.343108650495253e-10
specific O 0 2.2420921022558993e-11
polymerase O 0 7.44179926015498e-11
chain O 0 3.961587169420966e-10
reaction O 0 2.7356922283061635e-10
( O 0 1.4412998572410629e-11
PCR O 0 1.90149021528363e-10
) O 0 1.024364794377508e-11
/ O 0 2.872858374802778e-11
single O 0 2.1210540268601363e-11
- O 0 4.9350613873233584e-11
strand O 0 3.8308703431688684e-11
conformation O 0 3.819851119440942e-12
polymorphism O 0 2.855735396420367e-12
as O 0 7.028086879828921e-12
a O 0 3.854278007864309e-12
screening O 0 4.993269686615065e-12
step O 0 5.009718334614277e-11
and O 0 1.3631020791271542e-11
nucleotide O 0 1.0256400589936376e-10
sequencing O 0 3.809828286183148e-10
of O 0 3.6146849957674476e-09
target O 0 2.354635419976603e-08
exons O 0 1.6946577474641344e-08
, O 0 9.966061309540919e-10
we O 0 1.4947872106763072e-10
determined O 0 3.954950811291269e-10
that O 0 5.691911872385269e-11
the O 0 4.537179076891107e-09
proband O 0 9.289244644605787e-07
was O 0 5.322661422724195e-09
a O 0 3.9700970289047177e-10
compound O 0 1.2667393356480261e-08
heterozygote O 0 4.5084721023158636e-07
for O 0 4.661015573503846e-09
two O 0 2.051811520686897e-08
C6 O 0 2.0024941477458924e-05
gene O 0 2.1756481771717517e-07
mutations O 0 6.072071755625075e-06
. O 0 9.330307193522458e-07

The O 0 7.253312617194752e-08
first O 0 3.719200236673714e-08
, O 0 9.113540477834192e-10
1195delC O 0 3.696904968819581e-07
located O 0 2.0193844818550133e-08
in O 0 8.512416882489049e-10
exon O 0 3.0702679509886366e-08
7 O 0 2.6628850946508464e-07
, O 0 7.416466885068473e-10
is O 0 8.254810029972859e-11
a O 0 1.4364757994211885e-10
novel O 0 4.176989865101177e-10
mutation O 0 1.3262342613007405e-10
, O 0 2.2530923307617634e-11
while O 0 1.4764316158544233e-10
the O 0 4.050395130406059e-09
second O 0 1.1114558162717003e-08
, O 0 1.2480229072409088e-09
1936delG O 0 5.335756014801518e-08
in O 0 2.642679408637605e-09
exon O 0 8.343747914807409e-09
12 O 0 4.377886497763939e-08
, O 0 1.8746839636207824e-09
has O 0 5.731023433597215e-10
been O 0 6.41797615053008e-10
described O 0 6.290097331884681e-10
before O 0 2.1606380573579997e-10
to O 0 4.973371159344708e-10
cause O 0 1.7687104048036417e-07
C6D B-Disease 0 0.0009465033072046936
in O 0 2.1217350099078658e-10
an O 0 2.0108691101139442e-10
unrelated O 0 1.6742300879002414e-09
African O 0 5.370957012473809e-10
- O 0 1.2469045795882039e-09
American O 0 1.2315741759749699e-09
individual O 0 3.06681324779845e-09
. O 0 3.306014306758698e-08

Both O 0 1.0166777641984481e-08
mutations O 0 3.597937592303424e-08
result O 0 4.9353481301750435e-09
in O 0 3.4971020523855145e-10
premature O 0 3.1196591976367927e-07
termination O 0 2.7972424732070067e-07
codons O 0 3.3955359413084807e-07
and O 0 5.5860361669601843e-08
C6 O 0 0.00013357988791540265
null O 0 1.6704116205801256e-06
alleles O 0 1.4295653727458557e-07
. O 0 3.793554128606047e-07

Allele O 0 4.0909096554742064e-08
- O 0 1.0715445419862135e-08
specific O 0 4.962266708652407e-10
PCR O 0 2.2829689250158935e-09
indicated O 0 4.263632502610193e-10
that O 0 2.3331228442280416e-12
the O 0 7.873821039616757e-11
probands O 0 3.491460276450198e-08
two O 0 2.6034543965103296e-10
brothers O 0 7.697096293668437e-09
also O 0 2.5061447361807154e-10
inherited O 0 1.40207765397804e-08
the O 0 3.098185485939098e-09
1195delC O 0 1.2176676555952781e-08
mutation O 0 7.156981257638861e-11
from O 0 3.019989466834794e-11
their O 0 3.282403515658672e-11
heterozygous O 0 6.684770792464434e-11
mother O 0 1.6306861416737206e-10
and O 0 3.311265844851974e-11
the O 0 3.8977587824007287e-10
1936delG O 0 5.59549118150926e-09
mutation O 0 6.503579619288047e-11
from O 0 1.9870134704280673e-10
their O 0 4.906447470531816e-10
homozygous O 0 8.297249110000848e-09
father O 0 2.0413484946857352e-07
. O 0 1.8079838071116683e-08
. O 0 8.769247017426096e-08

PAX6 O 0 0.004379420541226864
mutations O 0 2.8745880626956932e-05
reviewed O 0 4.39403765994939e-06
. O 0 6.241473897716787e-07

Mutations O 0 1.3770606983598555e-06
in O 0 1.509834248736297e-07
PAX6 O 0 0.0014744397485628724
are O 0 3.3906020213692045e-09
responsible O 0 1.78473269496493e-09
for O 0 7.914795485675086e-10
human O 0 3.6726612506754464e-07
aniridia B-Disease 1 1.0
and O 0 1.3206852145231096e-07
have O 0 2.7084762210805025e-10
also O 0 3.5059160435890746e-11
been O 0 5.1912185487779094e-12
found O 0 1.5641394429666278e-12
in O 0 5.207529286260781e-13
patients O 0 7.524861267947658e-13
with O 0 1.9962347747037867e-12
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.885448908112153e-09
with O 0 5.889989296292697e-08
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 2.9981503502085616e-08
with O 0 1.4126881886511455e-09
autosomal B-Disease 1 0.612737774848938
dominant I-Disease 1 0.9999995231628418
keratitis I-Disease 1 1.0
, O 0 8.540111950949836e-10
and O 0 1.094970572546039e-10
with O 0 5.893444621207777e-10
isolated B-Disease 1 1.0
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.8652557730674744

No O 0 7.674611879338045e-08
locus O 0 2.5560204619523574e-08
other O 0 5.504390276911408e-10
than O 0 3.793875213986553e-10
chromosome O 0 1.0217983792415453e-08
11p13 O 0 2.9310069749044487e-07
has O 0 7.185325112679664e-10
been O 0 5.182725359986762e-10
implicated O 0 4.4340198179781964e-09
in O 0 2.7672020230795624e-09
aniridia B-Disease 1 1.0
, O 0 2.2398032317738625e-09
and O 0 1.8224899367424996e-09
PAX6 O 0 0.0004071585717611015
is O 0 2.024142187195821e-09
clearly O 0 9.738191586450284e-09
the O 0 9.657157740150524e-09
major O 0 2.595891146484064e-07
, O 0 9.056322913814085e-10
if O 0 1.1197964777664993e-09
not O 0 6.612314584764079e-10
only O 0 3.6445853002220474e-09
, O 0 6.617651426843452e-10
gene O 0 4.638489148334202e-09
responsible O 0 5.088870125291578e-08
. O 0 4.372566309029935e-07

Twenty O 0 5.812630661239382e-07
- O 0 1.1888706907825508e-08
eight O 0 4.292905142477821e-09
percent O 0 2.03603733872626e-09
of O 0 3.45909662025079e-10
identified O 0 4.043231971451178e-09
PAX6 O 0 1.6229744232987287e-06
mutations O 0 1.67848739351939e-07
are O 0 5.232690281076202e-09
C O 0 0.03277193009853363
- O 0 0.00012767697626259178
T O 0 7.647529855603352e-06
changes O 0 4.1881285106626365e-09
at O 0 3.37133343464302e-09
CpG O 0 3.3143592315099113e-09
dinucleotides O 0 2.1272885675216457e-08
, O 0 4.984622437032016e-11
20 O 0 5.4008614247536e-10
% O 0 6.674247265969768e-11
are O 0 2.9866092238206576e-12
splicing O 0 5.544029124671113e-10
errors O 0 1.671550542425848e-08
, O 0 2.5937893499694553e-10
and O 0 6.478904218676362e-11
more O 0 2.2308051239594562e-11
than O 0 1.1179947245754107e-10
30 O 0 7.656683287393662e-09
% O 0 4.370414863341665e-10
are O 0 2.469124080542451e-12
deletion O 0 6.139593000664689e-11
or O 0 3.9342304414269336e-10
insertion O 0 2.647856156556827e-09
events O 0 2.187060132996521e-08
. O 0 5.903642659177422e-07

There O 0 5.490123022866555e-09
is O 0 1.6645146372340491e-10
a O 0 5.556414772733831e-10
noticeably O 0 2.1065555699806282e-07
elevated O 0 5.605257413776599e-08
level O 0 1.3796185305281483e-09
of O 0 1.8932101719659755e-10
mutation O 0 1.2652844050276002e-10
in O 0 5.770661379300712e-11
the O 0 1.3781195074002994e-09
paired O 0 1.9830657116415296e-09
domain O 0 1.8180944527657061e-09
compared O 0 1.1794015764010624e-10
with O 0 1.8010758899913992e-12
the O 0 2.0560911306866103e-10
rest O 0 1.7439147903530738e-09
of O 0 1.1843570568714767e-09
the O 0 1.7150385556163883e-09
gene O 0 1.675700467274055e-08
. O 0 3.819888547695882e-07

Increased O 0 9.294321756669888e-09
mutation O 0 1.4100903777958251e-09
in O 0 1.2423176376508138e-10
the O 0 1.0846217257665103e-09
homeodomain O 0 1.0323931576294854e-07
is O 0 5.2059856425756834e-11
accounted O 0 2.694142409165323e-10
for O 0 3.038013200382106e-12
by O 0 5.7682185417018417e-11
the O 0 1.56674939688628e-08
hypermutable O 0 2.134907390427543e-06
CpG O 0 6.956947373737421e-08
dinucleotide O 0 4.461618985374116e-08
in O 0 8.901411163719786e-09
codon O 0 2.9809672241754015e-07
240 O 0 7.57523821448558e-08
. O 0 7.093186837892063e-08

Very O 0 2.0013855461797903e-08
nearly O 0 1.2803836213493014e-08
all O 0 1.696091739278316e-10
mutations O 0 7.052533557150298e-10
appear O 0 2.5413841170385254e-11
to O 0 2.5486106280947496e-12
cause O 0 3.093200418025077e-10
loss O 0 4.813557885618991e-10
of O 0 3.978746498933816e-10
function O 0 4.015616172914349e-10
of O 0 8.192984957133831e-09
the O 0 3.447663710076654e-09
mutant O 0 6.915205297275406e-09
allele O 0 2.285757583209147e-09
, O 0 7.831135739877482e-11
and O 0 7.996590369041545e-12
more O 0 3.7456470217134274e-12
than O 0 1.1399923539878731e-11
80 O 0 4.2553457979543907e-10
% O 0 8.378378546503029e-11
of O 0 1.909318397830262e-10
exonic O 0 2.2700914925621873e-08
substitutions O 0 9.752091356673986e-10
result O 0 2.4485302674293052e-09
in O 0 2.6899948935010798e-09
nonsense O 0 2.4378840635108645e-07
codons O 0 1.7429533727408852e-06
. O 0 1.357871042273473e-06

In O 0 1.065400034860886e-08
a O 0 2.7435422822463806e-09
gene O 0 1.1170957492367961e-09
with O 0 1.4525548819310785e-10
such O 0 3.618277344408227e-10
extraordinarily O 0 3.3717466152438647e-08
high O 0 9.189649929908228e-09
sequence O 0 3.310099416786727e-10
conservation O 0 3.92555277173301e-09
throughout O 0 4.974898826226593e-10
evolution O 0 7.206438112916658e-09
, O 0 3.032879503095387e-11
there O 0 1.7564186216567634e-10
are O 0 2.5860930064069976e-10
presumed O 0 1.4032087847226649e-06
undiscovered O 0 5.216890258452622e-06
missense O 0 7.519556675106287e-07
mutations O 0 7.917036981552883e-08
, O 0 3.686555061221952e-09
these O 0 2.539056076500401e-09
are O 0 1.6478931552654785e-09
hypothesized O 0 8.257325845306696e-08
to O 0 1.6342054376394799e-09
exist O 0 3.8550499681377914e-08
in O 0 5.1998276795472975e-09
as O 0 3.84264389197142e-08
- O 0 2.6799485297601677e-08
yet O 0 2.0322206140122034e-08
unidentified O 0 6.787038842048787e-07
phenotypes O 0 1.0114867876609424e-07
. O 0 5.86457282736319e-09
. O 0 3.562959349778794e-08

Genetic O 0 8.379466862606932e-07
heterogeneity O 0 9.35928937906283e-07
and O 0 1.1342762284982655e-09
penetrance O 0 2.0013671075957973e-07
analysis O 0 9.983792681467207e-10
of O 0 1.3608123516917203e-09
the O 0 6.886065051503465e-09
BRCA1 O 0 1.4154946370581456e-07
and O 0 2.0089352403829253e-08
BRCA2 O 0 9.857570830718032e-07
genes O 0 3.3639554430919816e-07
in O 0 3.986521335264115e-08
breast B-Disease 0 2.67515633822768e-06
cancer I-Disease 0 1.9843507743644295e-06
families O 0 1.7538226870783546e-08
. O 0 7.323389183966356e-08

The O 0 9.3940807346371e-06
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 1.1051414503526757e-06
Consortium O 0 1.3828333145227134e-08
. O 0 2.7521165346655607e-09

The O 0 5.719971718498584e-10
contribution O 0 2.4432864620393957e-09
of O 0 2.031754542386466e-09
BRCA1 O 0 1.2727502607390306e-08
and O 0 1.4046090957009483e-09
BRCA2 O 0 2.4472253699059365e-06
to O 0 2.3596129494762863e-07
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 3.0731022171437417e-09
assessed O 0 1.1587273501811879e-10
by O 0 3.253523752494436e-12
linkage O 0 6.0160845194445756e-09
and O 0 2.093562129212856e-11
mutation O 0 1.5879145220942803e-11
analysis O 0 9.043057969115864e-12
in O 0 2.5037485106016444e-12
237 O 0 1.1763058582747732e-10
families O 0 1.6905365995967259e-10
, O 0 3.7764017607466727e-11
each O 0 1.4608235454627305e-10
with O 0 1.6720783091450642e-10
at O 0 3.6709011386193424e-09
least O 0 5.157736460148499e-10
four O 0 1.5252027418810599e-10
cases O 0 1.8493760967075445e-09
of O 0 4.899896310917029e-08
breast B-Disease 0 3.7114060091880674e-07
cancer I-Disease 0 2.8168129162509103e-08
, O 0 2.1919176543261365e-11
collected O 0 2.4728219472081037e-10
by O 0 3.547540386450443e-11
the O 0 8.969518461299231e-08
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 6.901214533172606e-08
Consortium O 0 3.298580075750124e-09
. O 0 7.203744267769707e-09

Families O 0 8.476566115689366e-09
were O 0 2.0833297587063981e-10
included O 0 5.638981902950091e-12
without O 0 3.0153501223706414e-11
regard O 0 1.5245046891543268e-10
to O 0 8.932385213433758e-12
the O 0 2.29550822794522e-10
occurrence O 0 6.263644536375068e-07
of O 0 2.1056507648609113e-06
ovarian B-Disease 1 0.9999974966049194
or I-Disease 0 8.245145727414638e-05
other I-Disease 0 2.2233232357393717e-06
cancers I-Disease 0 0.10974633693695068
. O 0 8.506289361775998e-08

Overall O 0 3.9188853406812996e-06
, O 0 7.2878121315511635e-09
disease O 0 1.0212088454863988e-05
was O 0 3.6162937533390505e-08
linked O 0 1.297548646306268e-08
to O 0 5.099660138618844e-10
BRCA1 O 0 7.902234422374477e-09
in O 0 2.731097813180039e-11
an O 0 5.193942064635193e-12
estimated O 0 1.087684543127354e-11
52 O 0 2.0799827138429094e-10
% O 0 3.628475991890312e-11
of O 0 1.267857208109291e-10
families O 0 4.1251937976660713e-10
, O 0 9.943195572459373e-11
to O 0 1.933436521994736e-09
BRCA2 O 0 4.340965809035424e-09
in O 0 9.444314774675888e-11
32 O 0 2.0536112810276563e-09
% O 0 1.4848360041508357e-10
of O 0 2.254649800192965e-10
families O 0 2.398670984060658e-10
, O 0 2.1157124663329085e-11
and O 0 2.370443945298728e-11
to O 0 2.287605660455938e-10
neither O 0 1.7889620895772396e-09
gene O 0 1.6487348986071737e-10
in O 0 6.07500438842834e-10
16 O 0 1.1642002917255923e-08
% O 0 2.543509292074475e-10
( O 0 6.035119019115465e-12
95 O 0 2.5919113522121506e-09
% O 0 3.6982653051076397e-10
confidence O 0 9.575459314348223e-10
interval O 0 1.0370146519278478e-08
[ O 0 5.0511850702150696e-08
CI O 0 1.5565867670375155e-06
] O 0 2.6449903600678226e-08
6 O 0 9.978337800475856e-08
% O 0 5.4987059350253276e-09
- O 0 2.3922845926449554e-09
28 O 0 3.1150271695423726e-08
% O 0 1.117345105328127e-09
) O 0 1.5969626662726277e-11
, O 0 1.8181688793417194e-11
suggesting O 0 3.207830112650356e-10
other O 0 3.3933694743026876e-10
predisposition O 0 7.641973752470221e-06
genes O 0 1.5802628468009061e-06
. O 0 5.789449915027944e-07

The O 0 2.1359648272323284e-08
majority O 0 1.136407190571731e-09
( O 0 2.9074781471294386e-10
81 O 0 2.839587764924545e-08
% O 0 1.4400144965343031e-10
) O 0 4.750978798741257e-13
of O 0 7.660327233649511e-11
the O 0 9.855223481736175e-08
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.8164783838491303e-09
were O 0 5.014190018054476e-12
due O 0 2.9558890057845844e-11
to O 0 1.9749339663643894e-10
BRCA1 O 0 1.1907264063637513e-09
, O 0 7.75079826709213e-12
with O 0 5.247972195698836e-13
most O 0 4.556861138427237e-11
others O 0 3.465500456045767e-11
( O 0 1.5268843481242023e-11
14 O 0 4.40237624133033e-09
% O 0 1.1549549094880263e-09
) O 0 1.3197785746210666e-11
due O 0 3.1582312320921346e-09
to O 0 3.205503062986281e-08
BRCA2 O 0 7.5295479291526135e-06
. O 0 9.229604529537028e-07

Conversely O 0 1.6502725941336394e-07
, O 0 2.191283543506728e-10
the O 0 2.388731434876945e-10
majority O 0 2.0678613335545215e-11
of O 0 4.911812623298317e-10
families O 0 1.994295978358096e-10
with O 0 1.8384014796590797e-11
male B-Disease 0 1.9361081626811938e-07
and I-Disease 0 2.1422813745175517e-07
female I-Disease 0 0.1970796287059784
breast I-Disease 1 0.9999849796295166
cancer I-Disease 1 1.0
were O 0 1.4223004995983501e-08
due O 0 3.641918766561503e-08
to O 0 2.1755187873395698e-08
BRCA2 O 0 3.308234965970769e-07
( O 0 7.116773281801159e-10
76 O 0 1.1475931671611761e-07
% O 0 2.29958030395494e-09
) O 0 8.700576370479496e-11
. O 0 5.274113146214177e-09

The O 0 1.4781518231643531e-08
largest O 0 2.2039525759964818e-08
proportion O 0 2.0703221359497093e-09
( O 0 2.2108710695523115e-11
67 O 0 2.3082724620593353e-09
% O 0 3.7372355210507635e-11
) O 0 1.3020326190913561e-13
of O 0 2.045361276181712e-11
families O 0 1.82827468442337e-11
due O 0 1.7815279806931983e-10
to O 0 5.123866608780503e-11
other O 0 2.235193141686409e-10
genes O 0 1.3272927201768425e-09
was O 0 4.703307743270102e-10
found O 0 1.8379972023530033e-12
in O 0 2.7068622950737753e-12
families O 0 3.2081403505968e-11
with O 0 2.277607356188094e-12
four O 0 2.1935488148105975e-11
or O 0 4.577207970285491e-12
five O 0 2.694941492187297e-12
cases O 0 6.405694724653799e-11
of O 0 1.729578791298536e-08
female O 0 6.421909347409382e-05
breast B-Disease 0 0.0290217325091362
cancer I-Disease 0 0.00025662692496553063
only O 0 9.712059778621551e-08
. O 0 2.8348725322757673e-07

These O 0 1.577800112784189e-08
estimates O 0 1.9169546305874974e-07
were O 0 3.8361736010017466e-10
not O 0 3.2407420497149175e-11
substantially O 0 7.993793404992289e-10
affected O 0 6.314809092300422e-11
either O 0 1.882579335477086e-11
by O 0 6.92049889616797e-12
changing O 0 6.283202291790246e-10
the O 0 5.381036727314381e-10
assumed O 0 8.717923605239264e-10
penetrance O 0 4.5778434376586574e-09
model O 0 8.877093504722211e-10
for O 0 4.126287367345327e-10
BRCA1 O 0 2.761676221041398e-09
or O 0 1.7582554856510058e-10
by O 0 4.6625762278873495e-11
including O 0 3.648128674149653e-11
or O 0 3.749348387316331e-09
excluding O 0 2.8953397901432254e-08
BRCA1 O 0 1.8484319852518638e-08
mutation O 0 2.7879056840873773e-09
data O 0 3.16608570471999e-08
. O 0 1.6374144706787774e-07

Among O 0 4.8655288686916265e-09
those O 0 5.35730848572058e-10
families O 0 4.387838425934376e-10
with O 0 1.4805875275802904e-11
disease O 0 2.04574277518077e-08
due O 0 1.051694620279875e-09
to O 0 5.48684375711872e-10
BRCA1 O 0 6.757401393997498e-08
that O 0 2.861223202810237e-10
were O 0 9.918155186028343e-11
tested O 0 1.4071336110199617e-11
by O 0 3.634001086161298e-12
one O 0 8.510837173902885e-11
of O 0 1.8728210648966126e-10
the O 0 9.116282728705016e-11
standard O 0 5.7513223350458276e-11
screening O 0 1.3623430508702405e-11
methods O 0 3.311406704398223e-10
, O 0 5.936402064365964e-11
mutations O 0 4.840441936160289e-10
were O 0 3.1393534993817696e-10
detected O 0 1.447908681839749e-09
in O 0 1.4036334594624833e-10
the O 0 3.502504286601038e-09
coding O 0 2.8100247462248262e-08
sequence O 0 1.81716632852158e-08
or O 0 9.786026211600074e-09
splice O 0 5.962760241118303e-08
sites O 0 5.012457116038149e-09
in O 0 4.8050431689095063e-11
an O 0 3.813170612598782e-11
estimated O 0 2.2751781014740402e-10
63 O 0 2.5310393780841878e-09
% O 0 2.2824540868437992e-10
( O 0 2.3592938366845395e-11
95 O 0 1.1158654444898275e-08
% O 0 2.2479478278825127e-09
CI O 0 8.398229311978866e-08
51 O 0 2.2428569224075545e-08
% O 0 1.3779407614933348e-09
- O 0 4.931582364697817e-10
77 O 0 4.436405465213511e-09
% O 0 3.9358069581219013e-10
) O 0 4.695794100784134e-11
. O 0 3.030320883112836e-09

The O 0 1.7412989938847545e-09
estimated O 0 1.2927925396866158e-09
sensitivity O 0 2.4500672601845963e-09
was O 0 1.2703244012257642e-09
identical O 0 1.4475434739757986e-10
for O 0 1.1189477296114081e-11
direct O 0 6.143426323212964e-10
sequencing O 0 3.1040159331752193e-10
and O 0 2.865428450071761e-10
other O 0 5.261811542034422e-10
techniques O 0 2.4572483425799874e-07
. O 0 1.529682833734114e-07

The O 0 1.0002747785620159e-07
penetrance O 0 5.7081400882452726e-05
of O 0 6.076481895433972e-07
BRCA2 O 0 4.155523356530466e-07
was O 0 4.469069114776403e-09
estimated O 0 1.1308151637301478e-10
by O 0 6.582586038750282e-12
maximizing O 0 2.6154021171009845e-08
the O 0 7.690933223614138e-09
LOD O 0 6.376519741024822e-05
score O 0 3.471195242354952e-08
in O 0 5.847628159472151e-09
BRCA2 O 0 3.230773515383589e-08
- O 0 6.424568876894909e-09
mutation O 0 7.427395365411371e-10
families O 0 5.906205524652819e-10
, O 0 1.89294916547178e-11
over O 0 4.578938964105994e-11
all O 0 9.602633271876826e-11
possible O 0 1.3149187516603433e-08
penetrance O 0 2.607717078717542e-06
functions O 0 2.9418435687489364e-08
. O 0 1.1357386142663017e-07

The O 0 8.798810013921354e-10
estimated O 0 7.804343837847227e-10
cumulative O 0 8.087717162652552e-09
risk O 0 8.734838630175545e-09
of O 0 9.146457813358211e-09
breast B-Disease 0 4.235471351421438e-07
cancer I-Disease 0 1.8350870334415958e-07
reached O 0 2.9126153933134447e-08
28 O 0 1.45290277586696e-08
% O 0 1.1678866207454064e-10
( O 0 5.696948121580725e-12
95 O 0 2.7640265631845296e-09
% O 0 5.634052668845868e-10
CI O 0 2.4766757533711825e-08
9 O 0 2.806033405633457e-09
% O 0 2.8944974195255213e-10
- O 0 1.0678403300490302e-10
44 O 0 1.6234499300438188e-09
% O 0 4.0261283890119515e-11
) O 0 7.700277590040605e-14
by O 0 4.314649494890216e-13
age O 0 1.9763207737000243e-10
50 O 0 9.982493304194762e-11
years O 0 2.7488716164425497e-11
and O 0 3.129027939530182e-11
84 O 0 1.53114088075057e-09
% O 0 5.055697874234433e-11
( O 0 1.8177589425003027e-12
95 O 0 1.351165290763845e-09
% O 0 4.581125201408298e-10
CI O 0 2.052359349136168e-08
43 O 0 5.90260418320554e-09
% O 0 1.9436442733056225e-10
- O 0 7.150404573996738e-11
95 O 0 1.0174823206199335e-09
% O 0 4.142221982084138e-11
) O 0 1.3214901178545957e-13
by O 0 2.754990463191276e-12
age O 0 3.0725746391624398e-09
70 O 0 7.356117048828992e-09
years O 0 1.9958306118894598e-09
. O 0 2.8495383830318133e-08

The O 0 1.1250833154008433e-07
corresponding O 1 0.9998458623886108
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 7.439467140102352e-07
were O 0 1.3503305140716293e-09
0 O 0 2.138590282640962e-08
. O 0 1.3267947629458376e-08

4 O 0 5.379758363233123e-07
% O 0 2.79730150154478e-09
( O 0 3.9635277698790716e-11
95 O 0 4.378318152475913e-09
% O 0 6.734338087177605e-10
CI O 0 7.565690296473804e-09
0 O 0 4.397666120148358e-10
% O 0 1.1330173604884308e-10
- O 0 2.123750307558847e-11
1 O 0 2.442455959705825e-10
% O 0 1.7142093300392958e-11
) O 0 2.470073265663144e-14
by O 0 1.694957379744927e-13
age O 0 2.6609965966817306e-11
50 O 0 2.3796671230758015e-11
years O 0 8.688366866238528e-12
and O 0 6.199627183151035e-12
27 O 0 7.654226141795561e-10
% O 0 3.129648623589887e-11
( O 0 1.707404942256907e-12
95 O 0 1.087320677939374e-09
% O 0 3.6594899333053377e-10
CI O 0 3.023623573739087e-09
0 O 0 4.518953544696558e-10
% O 0 2.363339246524987e-10
- O 0 7.168812071745023e-11
47 O 0 1.6902215183023372e-09
% O 0 4.968846167852092e-11
) O 0 1.7996258509008628e-13
by O 0 1.6677575119528054e-12
age O 0 1.7119533568532574e-09
70 O 0 2.5734681052824726e-09
years O 0 1.6174015460279634e-09
. O 0 1.8579649818661892e-08

The O 0 1.5800466712789785e-08
lifetime O 0 1.246715584102276e-07
risk O 0 7.219193207674834e-07
of O 0 6.832387953181751e-07
breast B-Disease 0 0.004774914123117924
cancer I-Disease 0 0.01149401068687439
appears O 0 9.042618320798113e-10
similar O 0 4.273968765705627e-12
to O 0 3.400767167871521e-11
the O 0 5.795814383979803e-10
risk O 0 1.3205202487043266e-09
in O 0 5.701150662673626e-10
BRCA1 O 0 7.030430460019943e-09
carriers O 0 5.949860604204105e-10
, O 0 5.444474038274194e-11
but O 0 1.5320573976129737e-10
there O 0 3.6906125377988985e-10
was O 0 8.758591074631283e-10
some O 0 4.595168690002538e-11
suggestion O 0 5.445559558836521e-09
of O 0 1.617768696782207e-09
a O 0 4.1028633823714244e-09
lower O 0 4.230360062251748e-08
risk O 0 1.9689283536905577e-09
in O 0 5.957707660542155e-10
BRCA2 O 0 2.058599735121902e-09
carriers O 0 1.5809555053980517e-10
< O 0 1.309284569650515e-09
50 O 0 2.279505473268273e-09
years O 0 1.4355041599856122e-09
of O 0 1.2009819805314237e-08
age O 0 3.340298917464679e-07
. O 0 3.239468355786812e-07

Eye B-Disease 0 0.0001455609453842044
movement I-Disease 0 1.1034921953978483e-05
abnormalities I-Disease 0 6.897674666106468e-06
correlate O 0 1.9763490399782313e-08
with O 0 2.8071371182408766e-12
genotype O 0 5.954984061418145e-09
in O 0 1.5288929844370358e-10
autosomal O 1 0.9993554949760437
dominant O 1 1.0
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 1.2124482964281924e-06

We O 0 3.282239191548797e-08
compared O 0 6.859195167407961e-08
horizontal O 0 1.0312047379557043e-05
eye O 0 0.0002929212059825659
movements O 0 6.001582278258866e-06
( O 0 1.1092256890776753e-08
visually O 0 5.2548763562754175e-08
guided O 0 7.815791747134426e-08
saccades O 0 3.354674333877483e-07
, O 0 7.247635824825238e-10
antisaccades O 0 8.643409188380247e-08
, O 0 1.7654670780853365e-10
and O 0 7.013226804852835e-11
smooth O 0 4.842842793451041e-10
pursuit O 0 1.742079702715671e-09
) O 0 3.168290499747095e-12
in O 0 2.2118072998122962e-11
control O 0 1.208292466081673e-09
subjects O 0 1.1734969440624354e-08
( O 0 1.320444031893686e-10
n O 0 7.478442309860611e-10
= O 0 4.946779874615004e-09
14 O 0 9.815936508061895e-09
) O 0 6.4315475688248025e-12
and O 0 5.981566804369454e-12
patients O 0 4.494073516103647e-12
with O 0 2.36077677589e-13
three O 0 2.1075838557010895e-12
forms O 0 1.290053508462563e-09
of O 0 1.4915370627477387e-07
autosomal O 1 0.9999997615814209
dominant O 1 1.0
cerebellar B-Disease 1 1.0
ataxias I-Disease 0 0.05478358268737793
type I-Disease 0 0.0011537413811311126
I I-Disease 0 0.00037743168650195
spinocerebellar B-Disease 0 0.0003019543073605746
ataxias I-Disease 0 4.972697297489503e-06
1 I-Disease 0 1.7501227489447047e-07
and I-Disease 0 2.592840830928367e-09
2 I-Disease 0 5.1075694784685766e-08
( O 0 2.7096298538253905e-09
SCA1 B-Disease 0 3.123570422758348e-05
, O 0 2.2830910495486023e-09
n O 0 1.4085796973262177e-09
= O 0 6.8787002760473115e-09
11 O 0 7.394379775149673e-09
; O 0 8.490639302749514e-10
SCA2 B-Disease 0 1.1450420061009936e-06
, O 0 2.711919022679865e-10
n O 0 2.5879184906152375e-10
= O 0 2.1123760518548806e-09
10 O 0 2.106887331265739e-09
) O 0 4.0998711370310303e-11
and O 0 7.535285173609907e-10
SCA3 B-Disease 1 1.0
/ O 0 3.346261223668989e-07
Machado B-Disease 0 5.916290746199593e-08
- I-Disease 0 2.8215179526114298e-08
Joseph I-Disease 0 5.4793712678247175e-08
disease I-Disease 0 0.0001316602574661374
( O 0 2.05805816833049e-09
MJD B-Disease 1 1.0
) O 0 2.8141250441038324e-10
( O 0 7.877816454726627e-11
n O 0 5.232128619248044e-10
= O 0 1.1450848269589642e-08
16 O 0 3.152383243332224e-08
) O 0 6.70579369810298e-10
. O 0 8.664698292193407e-09

In O 0 1.6987232243081962e-07
SCA1 B-Disease 0 0.0004603734705597162
, O 0 3.2800908655872263e-09
saccade O 0 9.997445005183181e-08
amplitude O 0 3.1206630612956587e-09
was O 0 4.1022510388621924e-10
significantly O 0 7.014648306657989e-10
increased O 0 6.908978944508704e-10
, O 0 2.4654500663245926e-11
resulting O 0 1.2753935685339002e-09
in O 0 1.1495768781344395e-09
hypermetria B-Disease 0 6.906824182806304e-06
. O 0 2.3379793390176928e-07

The O 0 1.983952415685053e-07
smooth O 0 5.707499184381959e-08
pursuit O 0 1.5821493093426398e-07
gain O 0 4.175397236849676e-07
was O 0 1.15909820408433e-07
decreased O 0 3.219882387384132e-07
. O 0 5.208566022929517e-08

In O 0 2.9150339742045617e-07
SCA2 B-Disease 0 0.0011173291131854057
, O 0 1.0297418029381333e-08
saccade O 0 3.5542109344532946e-07
velocity O 0 1.2961615425410855e-07
was O 0 1.540039562542006e-08
markedly O 0 3.954329486077768e-07
decreased O 0 7.601492484354821e-07
. O 0 5.005800574053865e-08

The O 0 5.645342326943137e-08
percentage O 0 7.985752290551318e-07
of O 0 4.989186308534954e-08
errors O 0 4.4201829041412566e-07
in O 0 3.37676659967201e-08
antisaccades O 0 2.933156065410003e-05
was O 0 2.4915058460805994e-08
greatly O 0 4.909220585602725e-09
increased O 0 5.750601106413455e-10
and O 0 1.8702605436571318e-11
was O 0 1.1729005267024917e-10
significantly O 0 1.1340463984543803e-10
correlated O 0 7.400414170355418e-10
with O 0 2.0420117419900352e-12
age O 0 2.2894313111976317e-09
at O 0 1.4805664472206104e-09
disease O 0 2.479161942403607e-08
onset O 0 7.8066292985568e-08
. O 0 1.3731244585812874e-08

In O 0 2.108616170559685e-09
addition O 0 9.257711264254453e-10
, O 0 1.1708569010171477e-11
a O 0 2.1693332893923944e-11
correlation O 0 9.57259271849864e-10
between O 0 2.1244724035529572e-10
smooth O 0 1.2400763749198518e-09
pursuit O 0 1.8681054481106685e-09
gain O 0 1.6954069259611515e-09
and O 0 5.535190361616316e-12
the O 0 3.4011692767732526e-11
number O 0 5.480212394992634e-10
of O 0 2.4587336611148203e-08
trinucleotide O 0 4.55595272796927e-06
repeats O 0 1.4472611553628667e-07
was O 0 3.204977261361819e-08
found O 0 2.9849851479468725e-09
. O 0 5.812781012082269e-08

In O 0 1.2040471801810781e-06
SCA3 B-Disease 1 1.0
, O 0 3.6120235336056794e-07
gaze B-Disease 0 0.00010595051571726799
- I-Disease 0 6.268018069022219e-07
evoked I-Disease 0 1.8888567865360528e-06
nystagmus I-Disease 0 3.301375272712903e-06
was O 0 2.5470303643970738e-09
often O 0 1.6720454881768987e-11
present O 0 3.201282294806873e-11
as O 0 9.743291590202929e-11
was O 0 1.5179220103078706e-09
saccade O 0 5.5221786254833205e-08
hypometria O 0 1.4046679552848218e-07
and O 0 1.7461249113281951e-09
smooth O 0 1.1508740627164116e-08
pursuit O 0 2.119294251201609e-08
gain O 0 8.930904016324348e-08
was O 0 1.8884732000401527e-08
markedly O 0 6.2362738617594e-07
decreased O 0 4.5798589098922093e-07
. O 0 3.492179700970155e-08

Three O 0 1.4221485322707395e-08
major O 0 3.8063603824411985e-08
criteria O 0 3.060830877643639e-08
, O 0 2.175044810925897e-09
saccade O 0 3.09451422708662e-07
amplitude O 0 1.208518973783157e-08
, O 0 6.741702196499944e-10
saccade O 0 7.746660202201383e-08
velocity O 0 5.949889470002745e-08
, O 0 4.517609064613737e-10
and O 0 3.3514951924829006e-10
presence O 0 3.3717977743208394e-08
of O 0 2.3051184143696446e-06
gaze B-Disease 1 0.5288628935813904
- I-Disease 0 2.314420726179378e-06
evoked I-Disease 0 1.5385885490104556e-06
nystagmus I-Disease 0 2.2862388959765667e-07
, O 0 1.6258466795093796e-11
permitted O 0 9.542745760260374e-11
the O 0 3.3083619177531887e-11
correct O 0 3.48765655244776e-10
assignment O 0 1.5475408454701522e-10
of O 0 1.9888601876516532e-10
90 O 0 4.717649382257605e-09
% O 0 7.49493522800293e-10
of O 0 1.1763333640502083e-09
the O 0 1.0298596642144275e-08
SCA1 B-Disease 0 3.5214272884331876e-06
, O 0 9.796624622637751e-11
90 O 0 2.295487355752357e-09
% O 0 2.4062821180059757e-10
of O 0 5.884278619916472e-10
the O 0 4.351875748653811e-09
SCA2 B-Disease 0 1.259555688193359e-06
, O 0 3.7894472282307134e-11
and O 0 2.32805632410793e-11
93 O 0 1.7766491611226343e-09
% O 0 5.5756916444993365e-11
of O 0 1.0050985738141449e-10
the O 0 5.38399380634047e-10
patients O 0 3.3115835074148947e-10
with O 0 2.5599564690281795e-09
SCA3 B-Disease 1 1.0
to O 0 1.6109153122556563e-08
their O 0 8.632268233554896e-09
genetically O 0 1.5367826122769657e-08
confirmed O 0 6.217790726736894e-09
patient O 0 6.361575710656098e-09
group O 0 2.9408867008307027e-10
and O 0 4.88436457946051e-10
, O 0 2.372797514027525e-10
therefore O 0 5.1820063795560145e-09
, O 0 1.8263794643313958e-10
may O 0 8.69454286345217e-10
help O 0 3.0902903347396204e-08
orient O 0 5.352398511604406e-05
diagnoses O 0 1.2355459148238879e-05
of O 0 4.7371327127621043e-07
SCA1 B-Disease 1 0.5685584545135498
, O 0 1.9963872333050858e-08
SCA2 B-Disease 0 0.03161603957414627
, O 0 3.1371223396803316e-09
and O 0 2.788720898649899e-08
SCA3 B-Disease 1 1.0
at O 0 2.6651761686480313e-08
early O 0 9.44403666380822e-09
clinical O 0 1.254265691308376e-09
stages O 0 9.762456398831887e-10
of O 0 2.534894738559501e-09
the O 0 8.328294498483046e-09
diseases O 0 1.704022452031495e-07
. O 0 3.6972231942655753e-09
. O 0 5.1128917988307876e-08

Genetic O 0 1.5801793651348817e-08
basis O 0 2.7265203428328277e-09
and O 0 4.517259830083553e-12
molecular O 0 7.118973188724453e-10
mechanism O 0 4.384017593395129e-09
for O 0 1.899395973836704e-09
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 0.33923661708831787

Ventricular B-Disease 1 0.9999841451644897
fibrillation I-Disease 0 0.10603327304124832
causes O 0 2.951610156287643e-07
more O 0 1.893440265687829e-11
than O 0 1.8686418731816978e-11
300 O 0 1.0122921945132646e-10
, O 0 1.5748023544925882e-12
000 O 0 5.617688536574406e-10
sudden O 0 5.706644601310984e-10
deaths O 0 5.695759419666047e-10
each O 0 3.154405556204942e-11
year O 0 5.617932855028762e-11
in O 0 8.237540510824815e-11
the O 0 3.1149005597086443e-09
USA O 0 3.983055663070445e-08
alone O 0 1.1413539446891718e-08
. O 0 4.7544897796569785e-08

In O 0 8.963324305000242e-09
approximately O 0 6.370269645117332e-09
5 O 0 7.394379775149673e-09
- O 0 8.789919903051668e-10
12 O 0 4.190062075082324e-09
% O 0 1.0037690123532172e-10
of O 0 1.2910368087093449e-11
these O 0 2.4338502133819384e-12
cases O 0 3.029150541511427e-11
, O 0 2.6582154446369577e-12
there O 0 4.985808640944889e-12
are O 0 1.723983043995514e-12
no O 0 5.013315318436184e-10
demonstrable O 0 1.2958371371496469e-05
cardiac O 0 0.004613334313035011
or O 0 8.07442393124802e-06
non O 1 1.0
- O 0 0.045561257749795914
cardiac O 0 0.30748775601387024
causes O 0 8.123479489086094e-08
to O 0 2.6094187574599026e-11
account O 0 1.4223253651246548e-11
for O 0 8.165780551738777e-12
the O 0 1.753795109138423e-09
episode O 0 6.772737370930315e-10
, O 0 2.938831686685739e-12
which O 0 4.991419604027936e-13
is O 0 1.9399155133832668e-13
therefore O 0 3.6009103684953025e-12
classified O 0 6.404509561575011e-11
as O 0 1.0093390567789129e-09
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 1.0369976735091768e-05
IVF B-Disease 1 1.0
) O 0 6.769563576369819e-09
. O 0 2.7301071625629447e-08

A O 0 1.9876226531323482e-07
distinct O 0 2.356702211159245e-08
group O 0 9.907062947789314e-10
of O 0 5.1447108795343865e-09
IVF B-Disease 1 1.0
patients O 0 3.364352707535545e-08
has O 0 6.1011980190262e-11
been O 0 1.7645001779142966e-11
found O 0 3.6363518533116812e-12
to O 0 1.4960185867884945e-11
present O 0 1.9075856172445782e-10
with O 0 1.6129850927137923e-11
a O 0 9.722542770873588e-10
characteristic O 0 1.214708191810132e-07
electrocardiographic O 0 1.8324460597796133e-06
pattern O 0 7.825948387107928e-07
. O 0 1.048928979230368e-07

Because O 0 8.722285116391504e-09
of O 0 1.6700209215514406e-08
the O 0 1.226716506153025e-09
small O 0 1.3070283744198719e-10
size O 0 1.718180875354136e-10
of O 0 2.3859492159772344e-10
most O 0 4.550139084957827e-11
pedigrees O 0 4.273763565265654e-09
and O 0 2.6490455662386836e-11
the O 0 1.2069467647535248e-10
high O 0 2.921633157626502e-09
incidence O 0 1.759079104601824e-08
of O 0 7.650708955253549e-10
sudden B-Disease 0 3.093368761142301e-08
death I-Disease 0 2.9109168053764733e-07
, O 0 2.2218347162095142e-09
however O 0 2.009525523760658e-08
, O 0 2.510881780271035e-10
molecular O 0 1.5370280603832498e-09
genetic O 0 1.3298471213119e-09
studies O 0 1.846204078503888e-09
of O 0 7.842354321496714e-09
IVF B-Disease 1 1.0
have O 0 1.0648631976195588e-09
not O 0 4.470959436009281e-10
yet O 0 3.5338751924740563e-09
been O 0 4.442264778248273e-09
done O 0 1.8460642792206272e-08
. O 0 1.6568436933539488e-07

Because O 0 1.0058148980363057e-08
IVF B-Disease 1 1.0
causes O 0 9.344519753540226e-07
cardiac O 0 1.06736315501621e-05
rhythm O 0 2.3241041162691545e-06
disturbance O 0 0.0002700104669202119
, O 0 8.074484136866289e-11
we O 0 3.090286013196497e-11
investigated O 0 1.7822007758461211e-10
whether O 0 1.352856160430349e-10
malfunction O 0 1.1395036381145474e-06
of O 0 4.625467120433768e-09
ion O 0 3.658125891092823e-08
channels O 0 3.201718890011307e-09
could O 0 1.7823130471494864e-10
cause O 0 2.5189715202600382e-08
the O 0 1.0652125848054084e-09
disorder O 0 3.5780352014569416e-09
by O 0 1.8039717289419777e-11
studying O 0 6.594200185894294e-11
mutations O 0 7.421160908016589e-11
in O 0 1.1045940204179594e-11
the O 0 4.5463763309605554e-10
cardiac O 0 3.203785325922581e-08
sodium O 0 1.8429089720939373e-07
channel O 0 2.9815552693435166e-08
gene O 0 1.0417473106372199e-07
SCN5A O 0 0.00018412695499137044
. O 0 4.557937529625633e-07

We O 0 2.130797227550829e-08
have O 0 2.5957985760882707e-10
now O 0 1.2703602059183083e-10
identified O 0 3.03598868267585e-10
a O 0 5.16813536410865e-10
missense O 0 1.6637552846532344e-07
mutation O 0 3.015134808492803e-09
, O 0 1.214803813098797e-10
a O 0 5.101265521112452e-10
splice O 0 1.2833204721118818e-07
- O 0 8.08265898655236e-09
donor O 0 1.6296921589997737e-09
mutation O 0 5.72224156947243e-10
, O 0 7.825622094781437e-12
and O 0 2.6798971028418883e-12
a O 0 4.150573287842185e-11
frameshift O 0 5.044952899879718e-09
mutation O 0 2.281765228151489e-11
in O 0 2.537144973280281e-12
the O 0 2.219761353894345e-11
coding O 0 1.3615963911917106e-09
region O 0 6.378062966660991e-09
of O 0 9.182115512373912e-09
SCN5A O 0 1.7674250557320192e-05
in O 0 6.189460610706021e-10
three O 0 6.260655993628461e-09
IVF B-Disease 1 1.0
families O 0 2.1673804084798576e-08
. O 0 4.691584365446033e-08

We O 0 1.5128934549579753e-08
show O 0 5.141091108384899e-09
that O 0 4.3819732564731595e-11
sodium O 0 5.315303197583887e-10
channels O 0 2.3683379909988922e-11
with O 0 4.016107650432754e-13
the O 0 1.0760697194411861e-10
missense O 0 2.5684187221486354e-08
mutation O 0 1.3043692792535921e-09
recover O 0 1.2968434326410261e-08
from O 0 5.2443205333929654e-09
inactivation O 0 2.0367838970969387e-08
more O 0 4.9403446611417934e-11
rapidly O 0 4.19854012667642e-10
than O 0 1.2866954030021915e-11
normal O 0 2.975956148176806e-10
and O 0 5.7828451228980615e-12
that O 0 6.038884670100941e-12
the O 0 4.141307852201237e-10
frameshift O 0 8.039688736971584e-08
mutation O 0 1.4109889923119567e-09
causes O 0 2.670354826150856e-09
the O 0 3.6708449613342964e-09
sodium O 0 1.2290638728984504e-08
channel O 0 1.0553780072086738e-09
to O 0 2.961353107178155e-10
be O 0 4.848316415007048e-09
non O 0 5.684694315277738e-07
- O 0 2.838424393303285e-07
functional O 0 1.0638314051902853e-06
. O 0 5.7185484791943964e-08

Our O 0 1.7251912254323543e-07
results O 0 2.773174045955784e-08
indicate O 0 1.3797929909742379e-08
that O 0 1.1976775127209294e-10
mutations O 0 2.52530107935911e-09
in O 0 5.7229615491039e-10
cardiac O 0 5.2129191630001515e-08
ion O 0 2.3951383809617255e-06
- O 0 2.965419980682782e-06
channel O 0 2.3990850195332314e-08
genes O 0 2.144085464728107e-10
contribute O 0 2.3644969662783843e-11
to O 0 6.820904084603452e-12
the O 0 2.977515803359587e-11
risk O 0 1.1788393872169678e-10
of O 0 1.0851653603483058e-10
developing O 0 2.3301033991174336e-08
IVF B-Disease 1 1.0
. O 0 1.889117839937171e-08
. O 0 6.728091506147393e-08

Molecular O 0 1.6357334686745162e-07
heterogeneity O 0 1.9335857359692454e-07
in O 0 1.7471776248001447e-09
mucopolysaccharidosis B-Disease 0 3.517500090310932e-06
IVA I-Disease 0 0.0015046255430206656
in O 0 1.276483807544082e-09
Australia O 0 1.63651210638438e-11
and O 0 4.589571431234951e-11
Northern O 0 4.1450869403547586e-09
Ireland O 0 7.136670421292735e-11
: O 0 7.573392607485019e-11
nine O 0 9.110586174365665e-10
novel O 0 2.521406139432969e-10
mutations O 0 1.5117036789025207e-10
including O 0 3.593172981375403e-11
T312S O 0 2.3324427900206501e-07
, O 0 4.827236527171763e-11
a O 0 6.988110090588862e-11
common O 0 7.315365674331886e-11
allele O 0 2.796649301028964e-10
that O 0 5.21681742943203e-12
confers O 0 8.183458355404127e-09
a O 0 1.8739760854202814e-09
mild O 0 1.870970436357311e-07
phenotype O 0 5.14798273343331e-07
. O 0 1.260093682731167e-07

Mucopolysaccharidosis B-Disease 0 0.0006728181033395231
IVA I-Disease 1 1.0
( O 0 0.00011920712859136984
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 3.318761931936365e-09
is O 0 6.523370038591381e-11
an O 0 2.1539896533084857e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 3.4910152635347913e-07
by O 0 7.884261819801619e-12
a O 0 9.852471061222445e-10
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 4.702088163277551e-10
N O 0 6.9090355658829594e-09
- O 0 2.107888308344741e-09
acetylgalactosamine O 0 3.288480598939714e-08
- O 0 1.7839634214311673e-09
6 O 0 9.911357068403959e-09
- O 0 2.810875754377662e-09
sulfate O 0 9.154311975123619e-09
sulfatase O 0 1.372847435732183e-07
( O 0 6.380314054865721e-09
GALNS O 0 2.696318188100122e-05
) O 0 5.867023311623143e-09
. O 0 4.9372342658671187e-08

Previous O 0 3.807507908959451e-08
studies O 0 1.7426248222207619e-09
of O 0 1.0893253660215763e-10
patients O 0 5.994495698435909e-12
from O 0 9.572016790304616e-12
a O 0 1.1141857401975042e-11
British O 0 4.103109865760679e-11
- O 0 9.371855375084337e-11
Irish O 0 2.5804254566441642e-11
population O 0 2.6574360767472882e-11
showed O 0 3.326541125892035e-11
that O 0 4.5460922352968947e-13
the O 0 2.7051706361080896e-11
I113F O 0 2.6534934249866637e-09
mutation O 0 1.365246804496678e-10
is O 0 3.641217102140493e-12
the O 0 7.268990097342165e-12
most O 0 2.1384675714247736e-12
common O 0 4.2151291138048386e-12
single O 0 6.836403405180436e-12
mutation O 0 1.396085330673813e-10
among O 0 8.177759025507214e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 2.1667561966864923e-08
and O 0 6.006561914517761e-11
produces O 0 1.428890061827559e-10
a O 0 2.2719418360517274e-11
severe O 0 3.3126905663038997e-09
clinical O 0 6.242840910886116e-09
phenotype O 0 7.201974199233518e-07
. O 0 1.1454807236077613e-07

We O 0 4.897915673041098e-08
studied O 0 5.549070181132265e-08
mutations O 0 7.707967597525567e-09
in O 0 3.37850913911808e-10
the O 0 2.919533059753121e-09
GALNS O 0 1.9102656096947612e-06
gene O 0 2.8887617298245516e-10
from O 0 4.645127060776133e-10
23 O 0 5.673445602205618e-10
additional O 0 1.366492807797215e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 3.702134598881912e-09
( O 0 1.6848317879736285e-11
15 O 0 8.18354772835761e-10
from O 0 3.9969327847444447e-10
Australia O 0 1.0575875245000255e-11
, O 0 3.596654441287428e-12
8 O 0 5.2161733266054e-11
from O 0 1.1267331512243572e-10
Northern O 0 1.202507982078771e-09
Ireland O 0 1.4523111879771733e-10
) O 0 3.37882326284511e-11
, O 0 5.989078590701302e-12
with O 0 4.323703396182099e-13
various O 0 1.8883883345921504e-10
clinical O 0 1.121340176268859e-08
phenotypes O 0 4.213449926737667e-07
( O 0 4.071851300579965e-09
severe O 0 8.425277542301046e-07
, O 0 1.947534356006031e-09
16 O 0 1.0031843800106799e-08
cases O 0 1.0240923664639467e-09
; O 0 8.43424330376763e-10
intermediate O 0 3.697888217857326e-08
, O 0 1.4846832097070717e-10
4 O 0 1.7622652226378932e-09
cases O 0 4.715919876829844e-10
; O 0 4.17025747267985e-09
mild O 0 8.332953171930058e-08
, O 0 2.87966261947048e-10
3 O 0 2.7186581874616422e-09
cases O 0 2.040204449826888e-09
) O 0 8.488404978912456e-10
. O 0 3.410060500641521e-08

We O 0 2.0219745877625428e-08
found O 0 2.477128058231415e-09
two O 0 2.115931596602394e-10
common O 0 1.1553111939344163e-10
mutations O 0 4.4326309289743904e-10
that O 0 1.5325827412704385e-11
together O 0 3.2097607991637966e-12
accounted O 0 1.1160005558563668e-10
for O 0 1.7830320553358092e-12
32 O 0 2.25309459978007e-09
% O 0 2.831391510138559e-10
of O 0 5.484436793601333e-10
the O 0 2.159687317870862e-09
44 O 0 1.8610185392731182e-08
unrelated O 0 2.40035635812319e-09
alleles O 0 7.415137392996485e-10
in O 0 3.680110938208969e-10
these O 0 1.1026144441927954e-09
patients O 0 2.968729262420311e-09
. O 0 4.2185639870240266e-08

One O 0 1.0556160390251534e-08
is O 0 5.229973676357247e-10
the O 0 2.175994939790371e-09
T312S O 0 4.5081409894009994e-07
mutation O 0 8.567917930690783e-09
, O 0 1.278349509581389e-10
a O 0 3.47140344247876e-10
novel O 0 9.761004227115677e-10
mutation O 0 3.8049918771321245e-10
found O 0 6.86997403409606e-11
exclusively O 0 3.7184022527725347e-10
in O 0 1.6890604193076086e-10
milder O 0 7.783796718285885e-07
patients O 0 8.426802367011987e-09
. O 0 5.97475988683982e-08

The O 0 2.494729933744111e-08
other O 0 7.41078198807088e-10
is O 0 2.339176352617045e-10
the O 0 5.938341485212106e-10
previously O 0 6.564600529834763e-10
described O 0 3.218027233575782e-10
I113F O 0 1.995599241411128e-08
that O 0 9.472958875655912e-12
produces O 0 1.5170413536491623e-10
a O 0 1.0519088378124763e-10
severe O 0 2.370818386054907e-08
phenotype O 0 9.700578402771498e-07
. O 0 1.944443965840037e-07

The O 0 6.264946961209716e-08
I113F O 0 7.382460012195224e-07
and O 0 1.0905191194510166e-09
T312S O 0 4.0045218696604934e-08
mutations O 0 6.887769243846265e-10
accounted O 0 4.775461137640491e-10
for O 0 1.685661159267493e-11
8 O 0 6.552003939397366e-10
( O 0 1.8780676666607654e-11
18 O 0 3.269784221160421e-09
% O 0 9.229233349783428e-11
) O 0 3.767577883787704e-13
and O 0 1.6519447268437126e-11
6 O 0 1.2436910390434264e-09
( O 0 2.4848959695455974e-11
14 O 0 5.2270441308621685e-09
% O 0 2.0534850209141808e-10
) O 0 1.6178463733626525e-12
of O 0 1.5662578178865516e-10
44 O 0 2.7361997112507197e-09
unrelated O 0 1.4544464521648592e-09
alleles O 0 1.2611359734293615e-09
, O 0 2.035159818447596e-09
respectively O 0 2.205803006916085e-08
. O 0 1.4121776814590703e-07

The O 0 1.046061939291576e-07
relatively O 0 3.4883558441833884e-07
high O 0 2.866853492378141e-07
residual O 0 9.14552656468004e-05
GALNS O 1 0.9734912514686584
activity O 0 5.544880465890856e-08
seen O 0 2.7438862293394095e-10
when O 0 4.634909209905169e-12
the O 0 1.051874125995722e-11
T312S O 0 2.976472679439013e-10
mutant O 0 1.8785334399140652e-11
cDNA O 0 1.8867178652737238e-10
is O 0 5.813082654126944e-11
overexpressed O 0 1.8181093963676176e-08
in O 0 1.378560460230105e-10
mutant O 0 1.1629658347445115e-09
cells O 0 3.264629122590179e-10
provides O 0 8.295626685583812e-11
an O 0 1.7006511216638431e-12
explanation O 0 1.0005405531865463e-10
for O 0 4.9084924493014714e-12
the O 0 4.768916372910326e-10
mild O 0 1.7586833322980056e-08
phenotype O 0 9.85191128677343e-09
in O 0 5.312867853990433e-11
patients O 0 2.842965099447703e-11
with O 0 3.786050032511534e-12
this O 0 1.383396452947494e-10
mutation O 0 1.5635281513937116e-08
. O 0 1.617103073670023e-08

The O 0 1.6912728995066573e-09
distribution O 0 3.9365724568973803e-10
and O 0 4.5095290349128625e-12
relative O 0 4.184150248498497e-10
frequencies O 0 1.5725289126411468e-10
of O 0 1.5764388405781204e-10
the O 0 2.2338804417376679e-10
I113F O 0 6.1274674223454895e-09
and O 0 2.0756313334757692e-10
T312S O 0 9.833551750659808e-09
mutations O 0 6.89298673695049e-10
in O 0 8.597587919378924e-11
Australia O 0 1.719452011328393e-11
corresponded O 0 8.518296068515951e-10
to O 0 1.0651348553158968e-10
those O 0 3.2004962569054385e-10
observed O 0 1.2060038523387107e-09
in O 0 3.758925115615597e-11
Northern O 0 3.3442044689024897e-09
Ireland O 0 2.5634094846793687e-10
and O 0 3.4548981453497163e-09
are O 0 1.4371499823528922e-10
unique O 0 5.167731242927687e-10
to O 0 2.712032820539889e-10
these O 0 8.7943802240531e-10
two O 0 1.8240026156135514e-09
populations O 0 6.136063657180557e-09
, O 0 1.5809886733109124e-10
suggesting O 0 3.0052709210082185e-09
that O 0 2.421277067732319e-10
both O 0 1.4890171318171497e-09
mutations O 0 1.3666342724150127e-08
were O 0 1.7938585061827439e-09
probably O 0 8.593116773703002e-10
introduced O 0 2.760156860015517e-11
to O 0 7.178088679005157e-11
Australia O 0 6.055574444663314e-12
by O 0 4.692821131691005e-11
Irish O 0 9.493118513503873e-10
migrants O 0 1.3715121482960058e-08
during O 0 8.260106487689711e-10
the O 0 2.011802502366322e-09
19th O 0 1.3644626051245723e-07
century O 0 2.2482626604869438e-07
. O 0 1.1851084025238379e-07

Haplotype O 0 2.5918765800270194e-07
analysis O 0 8.294780862172502e-09
using O 0 3.8166674265482925e-09
6 O 0 1.1965900625909853e-07
RFLPs O 0 2.5345826770717395e-07
provides O 0 3.439773188507189e-10
additional O 0 1.1224218082750426e-10
data O 0 3.3707853175357627e-10
that O 0 3.235146872615502e-11
the O 0 5.579151585166642e-10
I113F O 0 4.294275157690208e-08
mutation O 0 5.371961209199583e-10
originated O 0 6.671794228196859e-10
from O 0 9.659764654834646e-11
a O 0 1.0310613474118213e-10
common O 0 6.876479941020364e-10
ancestor O 0 2.2077441030887712e-07
. O 0 7.595826900796965e-08

The O 0 8.719344890550929e-08
other O 0 1.126579629584512e-08
9 O 0 5.73207863396874e-08
novel O 0 1.6837251592960456e-09
mutations O 0 1.6364949395608619e-09
identified O 0 1.214461531340305e-09
in O 0 3.927540931369933e-11
these O 0 4.87070522803279e-11
23 O 0 1.8756602937486377e-09
patients O 0 2.4450289015653937e-10
were O 0 1.7140565355955317e-10
each O 0 7.851531924618627e-12
limited O 0 7.853272893099117e-11
to O 0 8.664771677935335e-11
a O 0 1.255342718664565e-09
single O 0 3.3662832521486052e-09
family O 0 5.4101146673701805e-08
. O 0 1.946139605024655e-07

These O 0 1.5516212314992117e-08
data O 0 7.354629794065204e-09
provide O 0 9.055338701102755e-10
further O 0 5.475740416649444e-10
evidence O 0 1.0245573278666598e-09
for O 0 5.6614220256268055e-11
extensive O 0 2.293351730742188e-09
allelic O 0 2.155692158112288e-08
heterogeneity O 0 3.989822872085824e-08
in O 0 1.2658087911177063e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 9.484520946401176e-10
British O 0 1.5445573708916527e-09
- O 0 3.7219591852988287e-09
Irish O 0 7.390846962218589e-11
patients O 0 3.2857418175158415e-11
and O 0 2.5720363339143404e-12
provide O 0 1.3336507245775842e-11
evidence O 0 3.3225225348765264e-10
for O 0 3.111240085007516e-11
their O 0 2.659678588479153e-10
transmission O 0 5.7467448577597224e-09
to O 0 8.044186150524268e-11
Australia O 0 4.3942744408498324e-12
by O 0 1.4819352342487768e-11
British O 0 5.043238049395882e-10
- O 0 1.3666388021249531e-09
Irish O 0 2.2345153505298754e-10
migrants O 0 2.3303909912897325e-09
. O 0 4.438383827132242e-10
. O 0 1.55876396235044e-08

Identification O 0 1.702640872736083e-08
of O 0 1.6949526582266117e-07
constitutional O 0 3.200965693395119e-06
WT1 O 0 0.02381242625415325
mutations O 0 1.142546238952491e-06
, O 0 4.993027102884184e-10
in O 0 1.432860340794262e-11
patients O 0 6.629950494857484e-12
with O 0 2.502283102945313e-12
isolated O 0 9.813712154027598e-08
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 3.166950729438511e-11
and O 0 3.306951880301806e-13
analysis O 0 8.702597670273704e-12
of O 0 7.912904359530515e-11
genotype O 0 2.0036390324662534e-08
/ O 0 2.6750560877530916e-08
phenotype O 0 1.297234408781378e-08
correlations O 0 3.5154614774768334e-09
by O 0 7.970886103936259e-12
use O 0 1.7351348136074307e-10
of O 0 1.6493867383005067e-09
a O 0 5.574481987125068e-10
computerized O 0 3.156474548404731e-08
mutation O 0 7.60684226719377e-09
database O 0 7.67825767411523e-08
. O 0 3.357769458034454e-07

Constitutional O 0 7.15686780949909e-08
mutations O 0 2.086179478055783e-07
of O 0 4.1192535604750447e-08
the O 0 1.9933320771770013e-08
WT1 O 0 8.55155974477384e-07
gene O 0 1.3696084266712205e-09
, O 0 2.1254857596186838e-10
encoding O 0 3.70815378403222e-10
a O 0 1.1212675232741276e-08
zinc O 0 5.74582728063433e-08
- O 0 3.894914613056244e-09
finger O 0 3.528601411062482e-09
transcription O 0 1.6612676789762304e-09
factor O 0 8.817895302826173e-10
involved O 0 8.985070326650302e-11
in O 0 7.00325852864836e-10
renal O 1 1.0
and O 0 0.007560020312666893
gonadal O 1 1.0
development O 1 1.0
, O 0 8.854534883084852e-10
are O 0 7.470380217200479e-12
found O 0 7.57635100490095e-12
in O 0 8.095973435921777e-13
most O 0 2.506668267052148e-12
patients O 0 3.2042435111484524e-12
with O 0 1.3554642651347759e-11
Denys B-Disease 1 0.9999997615814209
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.8996464859810658e-05
DDS B-Disease 1 1.0
) O 0 1.0405866168738953e-09
, O 0 7.970571425097717e-11
or O 0 9.735792172449464e-10
diffuse B-Disease 1 0.9999979734420776
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 2.274061117191195e-08
DMS B-Disease 0 2.0660904738178942e-06
) O 0 1.2628148526871996e-11
associated O 0 3.283901484074647e-10
with O 0 3.642594212371897e-11
pseudohermaphroditism B-Disease 1 1.0
and O 0 1.87549673569265e-08
/ O 0 3.6785993984267407e-07
or O 0 2.821232847338706e-08
Wilms B-Disease 0 1.4922306945663877e-05
tumor I-Disease 0 6.926369678694755e-05
( O 0 1.556903939103904e-08
WT B-Disease 1 1.0
) O 0 2.5908832856913477e-09
. O 0 2.4464448244998493e-08

Most O 0 1.5912124951000806e-08
mutations O 0 1.925962891391464e-07
in O 0 4.225447103323177e-09
DDS B-Disease 1 1.0
patients O 0 8.897968939436396e-08
lie O 0 2.014675715145131e-08
in O 0 1.009331396240043e-09
exon O 0 2.3567608309349453e-08
8 O 0 9.484746499310859e-08
or O 0 2.0905235320611837e-09
exon O 0 6.917804107331449e-09
9 O 0 2.291687017930144e-08
, O 0 1.3152007261041376e-10
encoding O 0 5.40685229921678e-09
zinc O 0 1.089114448404871e-06
finger O 0 5.202068109610991e-07
2 O 0 1.9548190266505117e-07
or O 0 6.546150643771398e-08
zinc O 0 4.3132126847922336e-07
finger O 0 5.254295132317566e-08
3 O 0 1.2784752811967337e-08
, O 0 1.2993922604565e-10
respectively O 0 1.100133539821968e-09
, O 0 1.106095163377896e-11
with O 0 3.6700976459302925e-12
a O 0 1.07287123629618e-09
hot O 0 5.174823627385194e-07
spot O 0 2.479907550423377e-07
( O 0 4.482529625260412e-10
R394W O 0 4.3061188392812255e-08
) O 0 1.0922734938745293e-10
in O 0 1.1787388842776636e-09
exon O 0 2.1409942263517223e-08
9 O 0 1.0699698123062262e-06
. O 0 4.4760409423361125e-07

We O 0 5.8226978794095885e-09
analyzed O 0 2.787373887258582e-09
a O 0 3.0554148100492284e-10
series O 0 9.724372695973926e-11
of O 0 2.1361339086478637e-10
24 O 0 2.35317498820109e-09
patients O 0 1.5795810492935658e-10
, O 0 8.711536353400717e-11
10 O 0 1.1476467554061287e-09
with O 0 3.614662735795804e-10
isolated B-Disease 0 0.095720574259758
DMS I-Disease 1 1.0
( O 0 1.5848041812205338e-07
IDMS B-Disease 0 0.4948340058326721
) O 0 5.20992138319798e-10
, O 0 4.7068054315202446e-11
10 O 0 7.558787623596075e-11
with O 0 3.4131135417947434e-11
DDS B-Disease 1 1.0
, O 0 3.3933178489320426e-10
and O 0 7.973140897510334e-11
4 O 0 3.7060345903228153e-09
with O 0 3.798320824532908e-10
urogenital B-Disease 0 3.166872193105519e-05
abnormalities I-Disease 0 0.0036150203086435795
and O 0 1.172527959170111e-06
/ O 0 0.49887868762016296
or O 0 0.024918382987380028
WT B-Disease 1 1.0
. O 0 1.6123867681017146e-06

We O 0 1.4139322956907563e-07
report O 0 1.1027184143586055e-07
WT1 O 0 5.995626997901127e-05
heterozygous O 0 1.0343109124733019e-07
mutations O 0 5.86439696803609e-08
in O 0 1.5333094793845703e-09
16 O 0 8.164017017975311e-09
patients O 0 3.8627157028514603e-10
, O 0 4.454240101758877e-11
4 O 0 3.889465638451384e-09
of O 0 1.5061045743891555e-08
whom O 0 5.968927752064701e-08
presented O 0 1.208773028338328e-07
with O 0 2.9784008148681096e-08
IDMS B-Disease 1 0.9999970197677612
. O 0 3.2988953080348438e-06

One O 0 1.4975597650845884e-08
male O 0 9.08716213388061e-09
and O 0 2.2169696634044556e-10
two O 0 1.542225097628247e-10
female O 0 1.1585164827465633e-08
IDMS B-Disease 0 0.0007085661636665463
patients O 0 3.7850589329480044e-09
with O 0 3.661083658457187e-09
WT1 O 1 1.0
mutations O 1 1.0
underwent O 0 0.02432033233344555
normal O 0 0.0006865629111416638
puberty O 0 3.5209234283684054e-06
. O 0 2.603437465609204e-08

Two O 0 2.465459090217337e-07
mutations O 0 4.5767285428155446e-07
associated O 0 1.5890007034613518e-06
with O 0 8.216035851660308e-09
IDMS B-Disease 1 1.0
are O 0 8.986424798740344e-11
different O 0 4.8031554428229484e-11
from O 0 3.3813390976078495e-10
those O 0 1.2180885640422634e-11
described O 0 5.290671373225919e-11
in O 0 6.527602069983374e-11
DDS B-Disease 1 1.0
patients O 0 6.613832148616439e-09
. O 0 1.3942586640780519e-08

No O 0 7.084309459060023e-07
WT1 O 0 3.081424438278191e-05
mutations O 0 1.8557909697847208e-07
were O 0 2.5143767068414036e-09
detected O 0 2.861508363594112e-09
in O 0 3.117149940945474e-11
the O 0 1.9689949670720353e-10
six O 0 1.7864279500123814e-10
other O 0 7.613210617485322e-10
IDMS B-Disease 1 0.999996542930603
patients O 0 8.83517259353539e-09
, O 0 1.5038639777920082e-10
suggesting O 0 1.0925699234221042e-09
genetic O 0 4.679367648918742e-08
heterogeneity O 0 8.294845770251413e-07
of O 0 4.087818972209334e-09
this O 0 1.0897456270697603e-09
disease O 0 2.1993254506469384e-07
. O 0 7.569389026684803e-08

We O 0 9.652995736075809e-09
analyzed O 0 2.2149178491304156e-08
genotype O 0 6.45141469135524e-08
/ O 0 5.2498172919968056e-08
phenotype O 0 1.7018811249158716e-08
correlations O 0 1.2298987606129685e-08
, O 0 1.2390749017099356e-11
on O 0 1.9995130551286877e-11
the O 0 3.239158507389872e-12
basis O 0 1.0319212151443935e-10
of O 0 1.1606865642221909e-11
the O 0 3.093853992441886e-11
constitution O 0 3.5350533611477886e-10
of O 0 3.420494554262632e-09
a O 0 5.124790369848142e-09
WT1 O 0 1.393122943227354e-06
mutation O 0 1.1565111091016433e-09
database O 0 3.299838624570839e-09
of O 0 3.024028671916312e-08
84 O 0 2.272381607326679e-07
germ O 0 5.518447323993314e-06
- O 0 9.893094556900905e-07
line O 0 1.1232174301767373e-06
mutations O 0 1.4571953643738311e-09
, O 0 6.179121884303251e-12
to O 0 5.239433453069209e-12
compare O 0 3.221675148878944e-10
the O 0 4.725085878121149e-10
distribution O 0 2.0554766777536315e-09
and O 0 2.6248647699844696e-10
type O 0 7.008301849964482e-08
of O 0 2.459029815327085e-07
mutations O 0 1.5238725836752565e-08
, O 0 1.8633823650748838e-10
according O 0 9.80655140425668e-11
to O 0 1.8059004291970382e-10
the O 0 2.1455552889904084e-09
different O 0 1.3753603589350405e-08
symptoms O 0 1.7892176629175083e-06
. O 0 6.63740351569686e-08

This O 0 1.4315997276526105e-09
demonstrated O 0 5.9569607024911875e-09
( O 0 1.2850821795584721e-10
1 O 0 1.4939272041658569e-09
) O 0 4.154801069161662e-12
the O 0 2.4358020808690206e-11
association O 0 4.164124947636516e-11
between O 0 4.603337988573486e-10
mutations O 0 3.532464876165875e-10
in O 0 1.1403018113087526e-10
exons O 0 4.065945358178169e-09
8 O 0 1.0986473064633628e-08
and O 0 6.54341136829828e-10
9 O 0 1.558115947375427e-08
and O 0 5.20414422666704e-09
DMS B-Disease 0 9.586183296050876e-07
; O 0 4.792215957394319e-09
( O 0 2.508708241144575e-10
2 O 0 5.056956631221965e-09
) O 0 1.6970747723776825e-11
among O 0 4.570387818203514e-11
patients O 0 2.615163641195295e-11
with O 0 4.587226432040126e-11
DMS B-Disease 0 2.403533699180116e-06
, O 0 2.360427998893133e-11
a O 0 2.3778704699717323e-11
higher O 0 2.8070379354261377e-10
frequency O 0 2.4628946104776617e-10
of O 0 5.480567666360514e-10
exon O 0 6.198794255674045e-10
8 O 0 4.541325981932687e-09
mutations O 0 1.3260502695899845e-09
among O 0 2.0733836869624156e-10
46 O 0 5.852024642649667e-09
, O 0 1.3226167383528775e-10
XY O 0 9.493180641584331e-08
patients O 0 8.098479352403043e-12
with O 0 3.0119574369324997e-12
female O 0 1.0255774701706244e-10
phenotype O 0 3.01522529166931e-10
than O 0 1.1618760641096681e-11
among O 0 2.1415053758078173e-11
46 O 0 3.318147978603747e-09
, O 0 2.921414499201802e-10
XY O 0 2.7732116905099247e-06
patients O 0 1.1514349890218156e-10
with O 0 3.0113025788203185e-12
sexual O 0 4.515229162782575e-11
ambiguity O 0 4.2449047055193034e-10
or O 0 3.837342596457738e-11
male O 0 1.2420664496914924e-10
phenotype O 0 6.762255755354829e-10
; O 0 5.924615659180787e-11
and O 0 2.6213925474749544e-10
( O 0 1.8824798664329734e-10
3 O 0 2.1666901162120666e-08
) O 0 1.2708084584645007e-10
statistically O 0 3.960312522366394e-09
significant O 0 1.3789970554345388e-10
evidence O 0 2.148770050780513e-09
that O 0 8.022597169921042e-11
mutations O 0 1.3285565980680758e-09
in O 0 8.209969371009151e-10
exons O 0 1.3766699780148883e-08
8 O 0 3.694419703492713e-08
and O 0 2.447512414960329e-09
9 O 0 2.0460353411522192e-08
preferentially O 0 8.39723313106333e-09
affect O 0 7.239670907210893e-08
amino O 0 2.2896422535723104e-08
acids O 0 1.8234843635056563e-09
with O 0 7.325694738324895e-12
different O 0 8.65636382019197e-11
functions O 0 1.0325654775655835e-09
. O 0 4.0201758588764847e-10
. O 0 7.848938388121951e-09

The O 0 2.2769067697936407e-07
185delAG O 0 2.235817191831302e-06
BRCA1 O 0 1.0698029484501603e-07
mutation O 0 1.8648764754658487e-09
originated O 0 5.477265307973767e-10
before O 0 2.8309526597936063e-11
the O 0 1.8895870979029894e-11
dispersion O 0 1.1932888011045861e-09
of O 0 3.045767527076748e-10
Jews O 0 4.2311146253304344e-10
in O 0 6.948436964693272e-11
the O 0 1.015669437443023e-09
diaspora O 0 1.5379840734297545e-09
and O 0 3.9097244886043825e-10
is O 0 2.8702732898788774e-11
not O 0 9.479542845136635e-11
limited O 0 1.1083454154459105e-09
to O 0 1.7883523995010364e-08
Ashkenazim O 0 8.723503924557008e-06
. O 0 4.503465902416792e-07

The O 0 3.866582076739178e-08
185delAG O 0 3.835021971099195e-07
mutation O 0 3.126704228861854e-09
in O 0 8.436110143783537e-10
BRCA1 O 0 9.008056522930019e-09
is O 0 9.321546312612838e-11
detected O 0 2.43822045886688e-10
in O 0 6.833903581915379e-11
Ashkenazi O 0 2.1955306461762802e-09
Jews O 0 9.956256930010454e-10
both O 0 5.777027120568157e-11
in O 0 3.262556058647448e-10
familial B-Disease 1 0.9991613626480103
breast I-Disease 1 1.0
and I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.7181526127129096e-11
in O 0 5.536150964741138e-12
the O 0 1.0064337557791347e-10
general O 0 4.0584355320838483e-10
population O 0 1.971764834740597e-10
. O 0 6.93435664445019e-09

All O 0 1.211350575403003e-08
tested O 0 5.480915721278734e-09
Ashkenazi O 0 1.5354398863465235e-09
mutation O 0 4.099730277484781e-11
carriers O 0 1.2703546548031852e-11
share O 0 7.71142698308136e-12
the O 0 4.217011288776273e-12
same O 0 2.1364342586704943e-11
allelic O 0 3.2471817235091294e-08
pattern O 0 6.722024892269474e-08
at O 0 7.164855375663137e-09
the O 0 7.600171159083402e-09
BRCA1 O 0 1.0598046884524592e-07
locus O 0 4.503040429426619e-08
. O 0 1.169435179804168e-07

Our O 0 9.439249026854668e-08
previous O 0 9.32973787115543e-09
study O 0 3.1185429238966833e-10
showed O 0 7.32631247335469e-11
that O 0 3.7699354814117736e-13
this O 0 1.5635376673928114e-11
Ashkenazi O 0 8.436705223324736e-10
mutation O 0 1.482543809938619e-10
also O 0 9.735521416809334e-12
occurs O 0 1.1246627761030137e-11
in O 0 2.0106036627276502e-11
Iraqi O 0 7.492484144222544e-08
Jews O 0 5.98245497585026e-09
with O 0 3.715144945154458e-12
a O 0 5.593629379130327e-11
similar O 0 1.289649359526024e-10
allelic O 0 9.24064238461142e-08
pattern O 0 2.2078135941683286e-07
. O 0 1.2530473725291813e-07

We O 0 3.157209249593507e-08
extended O 0 7.233721532884374e-08
our O 0 3.1165408032052255e-09
analysis O 0 2.4644217222480336e-10
to O 0 9.084795415947866e-11
other O 0 7.922513201030768e-10
non O 0 3.014768168441151e-08
- O 0 5.469960484560943e-09
Ashkenazi O 0 2.3760593492738735e-09
subsets O 0 1.7814022479356595e-10
354 O 0 5.619960607994301e-10
of O 0 8.316856925372207e-11
Moroccan O 0 1.1555409962227259e-09
origin O 0 1.014964445822386e-09
, O 0 6.028713639416594e-11
200 O 0 4.5913073343228916e-10
Yemenites O 0 3.726407626913897e-08
and O 0 4.993674918019053e-10
150 O 0 7.96442467532188e-09
Iranian O 0 8.431211284687379e-08
Jews O 0 5.6407788662227176e-08
. O 0 5.024731564162721e-08

Heteroduplex O 0 1.0316887710359879e-05
analysis O 0 9.35977073623917e-09
complemented O 0 3.485118194035408e-09
by O 0 1.4555578964348115e-11
direct O 0 1.386969206151889e-09
DNA O 0 1.5305043898905524e-09
sequencing O 0 5.923966206466957e-09
of O 0 3.6852775053830555e-08
abnormally O 0 1.1108161146466955e-07
migrating O 0 1.639882896142808e-08
bands O 0 6.682457254214569e-09
were O 0 2.0095320962809637e-09
employed O 0 3.2811563244194986e-08
. O 0 3.216791100157934e-08

Four O 0 3.477687915420802e-09
of O 0 6.343098934991076e-09
Moroccan O 0 4.4823718070574614e-08
origin O 0 1.6912341527230978e-09
( O 0 1.5888233437233445e-11
1 O 0 2.0181273319153092e-10
. O 0 5.088490826615777e-12
1 O 0 1.3839138168769693e-10
% O 0 1.9657818775553615e-11
) O 0 8.194449486369562e-14
and O 0 8.943308875582201e-13
none O 0 1.104965424714166e-10
of O 0 3.445242702238005e-10
the O 0 2.902105666890975e-09
Yemenites O 0 1.1110768127764459e-07
or O 0 7.789219824694271e-10
Iranians O 0 2.7251321199628364e-09
was O 0 8.270636953078281e-10
a O 0 3.9245159205725244e-11
carrier O 0 6.432925026000902e-11
of O 0 2.721619318801771e-10
the O 0 4.89866014419249e-09
185delAG O 0 8.95949597179424e-07
mutation O 0 1.7441593058720173e-07
. O 0 3.5196472936149803e-07

BRCA1 O 0 7.5907369136984926e-06
allelic O 0 1.4414472389034927e-06
patterns O 0 8.070307444540958e-08
were O 0 4.231921757469337e-10
determined O 0 1.3434015011526412e-10
for O 0 2.972216570085173e-11
four O 0 2.3455470898881003e-10
of O 0 3.690683036960962e-10
these O 0 5.118376902868427e-11
individuals O 0 3.968262871079098e-11
and O 0 4.0793719097154124e-11
for O 0 7.797659046238081e-11
12 O 0 8.229880665844291e-10
additional O 0 6.042742306533455e-09
non O 0 2.785709739328013e-06
- O 0 2.7125278734274616e-07
Ashkenazi O 0 6.149338371841395e-09
185delAG O 0 2.8194453438601386e-09
mutation O 0 4.151222768311591e-11
carriers O 0 8.667119105743026e-11
who O 0 6.051920076188821e-10
had O 0 4.3464532950565626e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.943036047843634e-07

Six O 0 6.024274625815451e-07
non O 0 3.0940529995859833e-06
- O 0 1.4023991923295398e-07
Ashkenazi O 0 3.6400142899850607e-09
individuals O 0 3.752864685679924e-11
shared O 0 1.2428817697252015e-10
the O 0 3.3545759919872964e-11
common O 0 3.2907215147259805e-11
Ashkenazi O 0 3.2012900663680455e-10
haplotype O 0 2.502907436863211e-09
, O 0 9.071152162754004e-11
four O 0 8.31705093684576e-10
had O 0 1.5152522570005544e-09
a O 0 2.387406106141299e-10
closely O 0 8.070635132417792e-11
related O 0 1.0038231357256677e-09
pattern O 0 1.506460911571139e-08
, O 0 1.493076842717933e-11
and O 0 1.0076068451825293e-11
the O 0 1.3910226304147955e-09
rest O 0 1.1334399196982758e-08
( O 0 1.7809707875127145e-10
n O 0 2.1066544064751724e-09
= O 0 1.9787856686548366e-08
6 O 0 3.308600327045497e-08
) O 0 2.394998782628832e-11
displayed O 0 1.4372164569564916e-09
a O 0 2.564773948776633e-10
distinct O 0 8.262820649918012e-09
BRCA1 O 0 4.59174955835806e-08
allelic O 0 5.312541588864406e-07
pattern O 0 8.259702894974907e-07
. O 0 2.6232839900330873e-07

We O 0 1.207316380202883e-08
conclude O 0 1.3314923386076316e-08
that O 0 5.3257228488368114e-11
the O 0 1.7021529741256813e-09
185delAG O 0 5.248365937404742e-07
BRCA1 O 0 2.373134577737801e-08
mutation O 0 1.1781409181566005e-09
occurs O 0 2.691538381061065e-10
in O 0 2.9183998967452496e-11
some O 0 4.630266170480013e-10
non O 0 6.10203926498798e-07
- O 0 2.0618847429432208e-07
Ashkenazi O 0 1.0337640965474293e-08
populations O 0 1.6522490042802929e-09
at O 0 1.8898044240600598e-10
rates O 0 4.079216478491965e-11
comparable O 0 3.7551989295891985e-11
with O 0 1.1544376565808534e-12
that O 0 3.264994871687854e-11
of O 0 3.908890988668645e-09
Ashkenazim O 0 2.8567254162226163e-07
. O 0 1.5424215860093682e-07

The O 0 2.7229720700461257e-08
majority O 0 2.0973009995373104e-09
of O 0 1.1615325945513177e-07
Jewish O 0 3.3085486847994616e-06
185delAG O 0 1.8521663491810614e-07
mutation O 0 3.988723240588854e-10
carriers O 0 1.0050468790545608e-10
have O 0 1.3355675072823647e-11
a O 0 7.01011054760059e-11
common O 0 2.144838057160925e-10
allelic O 0 7.524262457536679e-08
pattern O 0 8.626873437833638e-08
, O 0 1.4591861052792865e-10
supporting O 0 4.410131426713093e-10
the O 0 4.226793137718232e-09
founder O 0 3.818919225295758e-08
effect O 0 3.696294470501016e-08
notion O 0 2.297981183119191e-08
, O 0 4.919648022294609e-11
but O 0 6.379248518317837e-11
dating O 0 1.6076823206034874e-09
the O 0 3.6829478355926426e-10
mutations O 0 4.8860232526593e-10
origin O 0 5.133534153323183e-10
to O 0 3.6193539831863575e-10
an O 0 3.381894209120162e-10
earlier O 0 6.336602353940179e-10
date O 0 9.178333648662829e-09
than O 0 1.157278939345474e-09
currently O 0 3.160461004014792e-09
estimated O 0 5.8547627190819185e-08
. O 0 2.2386477382951853e-07

However O 0 4.830172883885098e-08
, O 0 1.5842638312335566e-10
the O 0 2.0788313778719036e-11
different O 0 3.937847270485406e-11
allelic O 0 9.015244728516336e-08
pattern O 0 6.875423963492722e-08
at O 0 3.943714244059038e-09
the O 0 4.22303791935974e-09
BRCA1 O 0 4.011935672565414e-09
locus O 0 9.99446303495688e-10
even O 0 7.47075845630718e-10
in O 0 4.65998239995713e-10
some O 0 2.2055326454051283e-09
Jewish O 0 4.510776818733575e-08
mutation O 0 8.00306876325152e-10
carriers O 0 3.8991046502623306e-10
, O 0 5.442511719078169e-11
might O 0 8.718255561923627e-10
suggest O 0 6.473278357788104e-09
that O 0 4.3249306913573093e-10
the O 0 7.024104409225629e-09
mutation O 0 9.3230143605183e-09
arose O 0 1.0694475527373015e-08
independently O 0 7.976526106290294e-09
. O 0 7.38369676511752e-09
. O 0 9.235127862439185e-08

Crystal O 0 8.568319458390761e-07
structure O 0 1.745387265827958e-07
of O 0 9.899591191242507e-08
the O 0 7.73753399130328e-08
hemochromatosis B-Disease 1 1.0
protein O 0 0.04056185111403465
HFE O 0 0.0015802017878741026
and O 0 1.908823238361279e-10
characterization O 0 5.205457398460567e-08
of O 0 4.723123669947427e-09
its O 0 2.1930060545294339e-10
interaction O 0 6.730563328893879e-10
with O 0 5.931376917400755e-11
transferrin O 0 2.3305706520204694e-07
receptor O 0 4.63884532564407e-07
. O 0 2.7552220061011212e-08

HFE O 1 0.9999954700469971
is O 0 2.8515347594293416e-07
an O 0 3.7216342008150605e-08
MHC O 0 9.353275345347356e-07
- O 0 1.0023103413914214e-06
related O 0 3.816829803326982e-07
protein O 0 1.834346932128028e-07
that O 0 9.632859614139289e-12
is O 0 7.791020975068952e-13
mutated O 0 7.488872716399086e-11
in O 0 4.77875690407803e-11
the O 0 7.297200621536604e-09
iron B-Disease 1 0.9993934631347656
- I-Disease 1 0.999945878982544
overload I-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 9.575498552294448e-05

HFE O 0 0.00011744072253350168
binds O 0 6.228000870578398e-08
to O 0 5.567588612365171e-09
transferrin O 0 1.8279362734574534e-07
receptor O 0 1.3693902189970686e-07
( O 0 3.6955170035213314e-09
TfR O 0 1.0352859192153119e-07
) O 0 4.837476599850454e-11
and O 0 9.193708294663594e-11
reduces O 0 3.0505131753955084e-09
its O 0 1.552694223194706e-10
affinity O 0 3.8516967393320556e-09
for O 0 1.8494783482481125e-09
iron O 0 7.936419876841683e-08
- O 0 1.4372392165284964e-08
loaded O 0 5.47717711185669e-08
transferrin O 0 4.54918307468688e-07
, O 0 3.810578963481248e-09
implicating O 0 6.1763512348989025e-06
HFE O 1 0.9941226840019226
in O 0 4.4423368308343925e-06
iron O 1 0.9998607635498047
metabolism O 1 0.999991774559021
. O 0 2.3624099867447512e-06

The O 0 1.21945708997373e-06
2 O 0 2.7635910555545706e-06
. O 0 5.164795879863959e-07

6 O 0 4.625297515303828e-05
A O 0 3.821940026682569e-06
crystal O 0 4.0870368138712365e-06
structure O 0 6.463830004577176e-07
of O 0 7.138088449210045e-07
HFE O 1 0.9996637105941772
reveals O 0 2.3196207621367648e-08
the O 0 2.1099548497272025e-10
locations O 0 3.5702432121809125e-09
of O 0 8.69715464091314e-08
hemochromatosis B-Disease 1 1.0
mutations O 0 0.12548740208148956
and O 0 2.3091939027608532e-08
a O 0 2.166351187327109e-08
patch O 0 5.913952918490395e-05
of O 1 0.9833047389984131
histidines O 0 4.9508311349200085e-05
that O 0 4.501670702872218e-10
could O 0 1.1763469087711087e-09
be O 0 1.567690088855045e-09
involved O 0 7.035125371146478e-09
in O 0 1.738704646925271e-08
pH O 0 1.100205281545641e-06
- O 0 1.1833009239126113e-06
dependent O 0 1.2773487014783313e-06
interactions O 0 2.970527077650331e-07
. O 0 1.0187473975520334e-07

We O 0 8.820073560400488e-08
also O 0 4.09339762086347e-09
demonstrate O 0 6.11588468757418e-09
that O 0 4.0566110470763306e-09
soluble O 0 4.195281235297443e-06
TfR O 0 3.618430355345481e-06
and O 0 9.403593459467174e-09
HFE O 0 3.2991438274621032e-06
bind O 0 9.482102214519728e-09
tightly O 0 5.223635302087359e-09
at O 0 3.612334875668921e-09
the O 0 4.678078480147008e-10
basic O 0 3.1797369182129387e-09
pH O 0 5.098310662532413e-09
of O 0 5.01775643257929e-09
the O 0 8.603059598044638e-09
cell O 0 1.0360103885886929e-08
surface O 0 1.6499791755109072e-08
, O 0 8.758903324856959e-11
but O 0 1.3548136224006413e-10
not O 0 3.7603756219972695e-10
at O 0 2.4882718108187873e-08
the O 0 5.255438040308036e-08
acidic O 0 3.038998784177238e-06
pH O 0 1.2061514098604675e-06
of O 0 7.387404252767737e-07
intracellular O 0 1.7888492038764525e-06
vesicles O 0 8.09931952971965e-06
. O 0 5.457097813632572e-07

TfR O 0 0.0005485663423314691
HFE O 0 0.0002787731064017862
stoichiometry O 0 1.4916479358362267e-06
( O 0 6.726343926288791e-09
2 O 0 1.451371112182187e-08
1 O 0 4.440045664466652e-09
) O 0 7.0195130090489055e-12
differs O 0 1.5999331026694819e-10
from O 0 1.0861924554239621e-10
TfR O 0 1.0846036957445904e-08
transferrin O 0 1.0349636703210763e-08
stoichiometry O 0 1.0879767309290855e-08
( O 0 1.1454287518475326e-10
2 O 0 1.6795105306499636e-09
2 O 0 4.135815689920719e-09
) O 0 9.913294490848656e-11
, O 0 4.790364979689876e-11
implying O 0 5.046605910941082e-10
a O 0 2.8480070732306295e-11
different O 0 2.4493218217513935e-11
mode O 0 2.9383653288306277e-09
of O 0 4.236411776936677e-10
binding O 0 1.2248226877176194e-09
for O 0 1.015443285012907e-08
HFE O 0 2.28029766731197e-05
and O 0 7.977591032215514e-09
transferrin O 0 1.8058442208257475e-07
to O 0 9.869402184392584e-09
TfR O 0 1.5191558304650243e-06
, O 0 4.13597128767762e-10
consistent O 0 1.1213059813997006e-08
with O 0 1.1393322396635597e-10
our O 0 1.0487306134621122e-08
demonstration O 0 1.2270166216410416e-08
that O 0 1.0179929121889586e-09
HFE O 0 4.311043085181154e-06
, O 0 1.607887933907648e-09
transferrin O 0 1.0018767682140606e-07
, O 0 7.928560030734388e-10
and O 0 1.0728139487881094e-09
TfR O 0 1.2370558977181645e-07
form O 0 3.647309398946419e-10
a O 0 1.6263632662827376e-09
ternary O 0 5.838147387748904e-08
complex O 0 1.1764179816964315e-06
. O 0 4.5069501197758655e-07

Identification O 0 8.284029462402032e-09
of O 0 1.4514762725070796e-08
three O 0 8.722314537301656e-10
novel O 0 1.4157012229176758e-09
mutations O 0 6.678809727489465e-10
and O 0 8.847621420227103e-12
a O 0 2.8493709128274425e-11
high O 0 2.476399640904958e-10
frequency O 0 2.418369393630826e-10
of O 0 8.830530751069432e-11
the O 0 3.7343445002946396e-10
Arg778Leu O 0 1.685399908524232e-08
mutation O 0 5.211034936891679e-10
in O 0 3.822797634001063e-11
Korean O 0 1.145625927456706e-09
patients O 0 5.1304578640998244e-11
with O 0 9.854457527769256e-11
Wilson B-Disease 0 3.0441270837400225e-08
disease I-Disease 0 6.402344752132194e-07
. O 0 8.88162361434297e-08

Four O 0 2.683796083147172e-07
mutations O 0 9.692666225191715e-08
- O 0 2.2806549537790488e-08
- O 0 2.187927883312568e-08
R778L O 0 6.078231251649413e-08
, O 0 5.674330103011549e-11
A874V O 0 2.039733715264447e-09
, O 0 6.949228952696229e-12
L1083F O 0 5.243417922073945e-10
, O 0 7.413560217106596e-12
and O 0 1.7062533677614233e-11
2304delC O 0 9.218541485722653e-10
- O 0 1.0548824314060568e-10
- O 0 4.824477484177692e-10
in O 0 9.125333266801761e-10
the O 0 3.098884349128639e-08
copper O 0 1.825984163872363e-08
- O 0 2.9328428574615373e-10
transporting O 0 6.462899104775488e-10
enzyme O 0 6.990046319543808e-10
, O 0 4.168839440321648e-10
P O 0 1.5869667890910932e-07
- O 0 1.4342925069854573e-08
type O 0 1.6573439509670607e-08
ATPase O 0 3.007417248568345e-08
( O 0 7.314253092083334e-10
ATP7B O 0 2.428827201583772e-06
) O 0 1.7432480806101047e-11
, O 0 7.954271789845091e-12
were O 0 9.040022203032905e-12
identified O 0 4.01769000013541e-11
in O 0 6.979381482474789e-12
Korean O 0 6.019685860891855e-10
Patients O 0 2.6422433685446833e-11
with O 0 5.702604360946495e-11
Wilson B-Disease 0 5.333395591833323e-08
disease I-Disease 1 1.0
. O 0 2.364736246818211e-06

Arg778Leu O 0 7.524218381149694e-05
, O 0 8.077619462198982e-09
the O 0 3.5427905054064013e-09
most O 0 3.738848675105544e-10
frequently O 0 1.5669658626205063e-10
reported O 0 8.255156280778664e-11
mutation O 0 1.6020552939810528e-10
of O 0 2.9403710022357643e-10
this O 0 5.2553898732821125e-11
enzyme O 0 1.3933514342312492e-09
, O 0 1.076437203262337e-10
was O 0 1.1291648727151937e-09
found O 0 1.675215348384551e-11
in O 0 1.1628004982500162e-11
six O 0 9.917265619829863e-11
of O 0 2.317190606060393e-10
eight O 0 8.201295198517755e-11
unrelated O 0 1.0654889193162376e-09
patients O 0 1.5854850765606443e-10
studied O 0 1.3235057494398461e-09
, O 0 4.518828020105836e-12
an O 0 6.8654387730404665e-12
allele O 0 1.98543764762249e-10
frequency O 0 4.895753247247114e-10
of O 0 7.029840265460052e-09
37 O 0 5.226269763625169e-07
. O 0 3.7861303781028255e-07

5 O 0 2.8330853183433646e-06
% O 0 3.754889021934105e-08
, O 0 1.791156667430016e-10
which O 0 4.3210861971898495e-11
is O 0 1.1044929727754838e-11
considerably O 0 2.403066912126661e-10
higher O 0 3.1434999048229884e-10
than O 0 3.78143827015065e-12
those O 0 7.781074395918353e-12
in O 0 9.58667086686793e-12
other O 0 9.187958033285426e-11
Asian O 0 4.817719001515286e-10
populations O 0 9.285316404650246e-10
. O 0 7.625988729387245e-09

The O 0 1.8618919739310513e-08
novel O 0 5.090071475422064e-09
single O 0 3.15052872679189e-10
nucleotide O 0 3.889391475553339e-09
deletion O 0 7.416697034301478e-09
, O 0 1.7759106407666536e-09
2304delC O 0 1.267525249204482e-07
, O 0 9.85596715352699e-10
was O 0 3.917191016000743e-09
found O 0 1.1575565506127816e-10
in O 0 9.639481574064135e-11
one O 0 1.4746086574035644e-09
patient O 0 1.9608194179454586e-08
. O 0 9.586560878460659e-08

Since O 0 3.49007400757273e-09
a O 0 1.234744639866392e-09
mutation O 0 7.560926329475137e-10
at O 0 6.589828127623321e-10
cDNA O 0 6.054024836998906e-09
nucleotide O 0 2.9055078343276364e-08
2302 O 0 1.657007942412747e-06
( O 0 5.053292895240702e-09
2302insC O 0 1.4700663086841814e-07
) O 0 2.7307395233933107e-10
had O 0 2.151944622497126e-09
been O 0 4.957234067681782e-10
previously O 0 5.245358036809478e-10
described O 0 3.183673880080562e-10
, O 0 2.1961681605231487e-12
this O 0 3.4257648801050422e-12
region O 0 5.437067462921163e-10
of O 0 3.384141189499701e-09
the O 0 7.459601647497038e-08
ATP7B O 0 0.0014457672368735075
gene O 0 1.2034033325392102e-08
may O 0 1.2527170412113264e-08
be O 0 9.462999273068817e-10
susceptible O 0 2.2921240017126365e-08
to O 0 1.296778462389625e-09
gene O 0 2.057451240489172e-07
rearrangements O 0 1.726262598822359e-05
causing O 0 6.512192612717627e-06
Wilson B-Disease 0 9.298267400481564e-07
disease I-Disease 0 2.0692845282610506e-05
. O 0 2.1236810709979181e-07

Disruption O 0 1.088173121388536e-05
of O 0 3.637091481323296e-07
splicing O 0 1.7024208887050918e-07
regulated O 0 1.05620451051891e-07
by O 0 9.38678024198225e-10
a O 0 9.78070779922291e-09
CUG O 0 8.37358402350219e-06
- O 0 1.9359791547657323e-09
binding O 0 3.0455367117099286e-09
protein O 0 2.0547799906012187e-08
in O 0 3.4509511914748714e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.2310226793488255e-06

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.0063494300993625e-05
DM B-Disease 1 1.0
) O 0 2.3121544678872397e-09
is O 0 7.295231779780309e-11
caused O 0 1.7061892176872817e-10
by O 0 1.6196627372622174e-11
a O 0 1.1539970090623797e-09
CTG O 0 3.957448370783823e-06
expansion O 0 1.909546121225958e-08
in O 0 9.736176448393863e-11
the O 0 2.092525180907856e-10
3 O 0 1.2503483803882887e-09
untranslated O 0 8.85604492850689e-07
region O 0 3.950324067858446e-09
of O 0 7.2245356363964675e-09
the O 0 2.1151635110072675e-07
DM B-Disease 1 1.0
gene O 0 3.77713604393648e-07
. O 0 7.42047802759771e-07

One O 0 7.642205757107945e-10
model O 0 6.795618734400932e-09
of O 0 2.118894038005692e-08
DM B-Disease 1 1.0
pathogenesis O 1 0.9932115077972412
suggests O 0 3.2563223228976312e-09
that O 0 1.5161729510770883e-11
RNAs O 0 1.634865576249922e-10
from O 0 1.8660319123231517e-10
the O 0 3.8884104269776287e-10
expanded O 0 2.0190898952776593e-10
allele O 0 6.3839593333892e-11
create O 0 2.48892295662273e-11
a O 0 1.3693307598927618e-10
gain O 0 1.5039459455579163e-08
- O 0 1.8442332105905734e-09
of O 0 1.1750580952707423e-08
- O 0 2.665032416970803e-09
function O 0 1.0399432703867006e-10
mutation O 0 2.269321709713612e-11
by O 0 8.150795142991552e-12
the O 0 3.8051442552422543e-10
inappropriate O 0 3.144143168043456e-09
binding O 0 4.096186057012119e-09
of O 0 1.299074003924261e-08
proteins O 0 4.3387368697800355e-10
to O 0 1.1977010494490514e-09
the O 0 1.0322533938733613e-07
CUG O 0 0.0009080396266654134
repeats O 0 6.658019628957845e-07
. O 0 2.7887665510206716e-07

Data O 0 5.7417626209144146e-08
presented O 0 2.087169903575159e-08
here O 0 3.2542548655811743e-09
indicate O 0 9.91037385489335e-09
that O 0 9.458159255792964e-11
the O 0 3.2044071840431343e-09
conserved O 0 6.470836666494506e-08
heterogeneous O 0 1.0563596930524e-07
nuclear O 0 1.073149974217813e-06
ribonucleoprotein O 0 8.814825378067326e-06
, O 0 2.278915545161908e-08
CUG O 0 7.120443569874624e-06
- O 0 1.153278006427172e-08
binding O 0 1.8167227722187818e-08
protein O 0 1.5327698577038973e-07
( O 0 1.4058366692992763e-09
CUG O 0 4.6090626710793e-06
- O 0 6.79944633930063e-08
BP O 0 8.818593499881899e-08
) O 0 1.8633743853468943e-11
, O 0 2.3422331782430028e-11
may O 0 2.480668448434642e-10
mediate O 0 8.527712758166217e-09
the O 0 7.495510878641198e-09
trans O 0 2.3717352526375635e-09
- O 0 2.0437331826883565e-09
dominant O 0 1.5553723642369732e-08
effect O 0 3.402887216452655e-08
of O 0 1.2901673507315081e-08
the O 0 6.274953889828794e-09
RNA O 0 2.8921549599658647e-08
. O 0 5.837067362790549e-08

CUG O 0 0.3218064308166504
- O 0 6.007897900417447e-05
BP O 0 2.878219856938813e-05
was O 0 9.983569526639258e-09
found O 0 6.649593202456838e-12
to O 0 9.525824139905437e-13
bind O 0 9.54416060072738e-12
to O 0 7.614713547210439e-12
the O 0 1.1783381215213495e-10
human O 0 1.422435391695842e-09
cardiac O 0 1.6625304851913825e-05
troponin O 0 4.367662768345326e-06
T O 0 2.8720889531541616e-05
( O 0 3.31633209782467e-09
cTNT O 0 5.566805327816837e-08
) O 0 2.5827989053039957e-11
pre O 0 9.50623579853982e-10
- O 0 1.5290038679616202e-10
messenger O 0 1.9264599637747182e-10
RNA O 0 1.4220113975227378e-10
and O 0 2.4982927185335235e-11
regulate O 0 8.45227568491147e-11
its O 0 1.1772192942682835e-10
alternative O 0 2.7127065038712317e-09
splicing O 0 3.8023983961466e-08
. O 0 1.2856675368766446e-07

Splicing O 0 6.225531024028896e-08
of O 0 2.1561658058999456e-07
cTNT O 0 2.627929006848717e-06
was O 0 3.512474222588935e-08
disrupted O 0 1.3284690680848144e-07
in O 0 2.9233164777764387e-09
DM B-Disease 1 1.0
striated O 0 2.856989453903225e-07
muscle O 0 8.87273010619083e-09
and O 0 4.2101358510571174e-10
in O 0 1.634189034094291e-10
normal O 0 5.866679231303351e-08
cells O 0 5.1842103943045e-09
expressing O 0 1.2691780959528387e-10
transcripts O 0 1.1942792310648542e-09
that O 0 6.201535118766088e-11
contain O 0 4.7994239693593954e-09
CUG O 0 4.475241803447716e-05
repeats O 0 1.9760142322411411e-07
. O 0 1.3288162392655067e-07

Altered O 0 6.782554464734858e-07
expression O 0 4.748997639580921e-07
of O 0 7.431610811181599e-07
genes O 0 2.5664044756013027e-07
regulated O 0 9.210710771867525e-08
posttranscriptionally O 0 2.720480836160277e-07
by O 0 3.6208749332189427e-09
CUG O 0 0.006256823427975178
- O 0 1.5674569340262678e-06
BP O 0 3.027422792456491e-07
therefore O 0 9.262214883953845e-10
may O 0 1.1847314795865316e-10
contribute O 0 4.986574486665063e-10
to O 0 5.2743742706695684e-09
DM B-Disease 1 1.0
pathogenesis O 0 0.0001428322575520724
. O 0 1.094435031490093e-08
. O 0 2.3647261926385e-08

Identification O 0 3.549594618235119e-09
of O 0 3.6227882915795817e-09
a O 0 5.837573757716541e-10
novel O 0 4.855590152175182e-09
nonsense O 0 1.1409643008164494e-08
mutation O 0 1.876450106408356e-10
and O 0 1.0709196550384714e-11
a O 0 5.628861959872111e-11
missense O 0 1.050508391386984e-08
substitution O 0 2.7427364823751077e-09
in O 0 3.3266442378554473e-10
the O 0 4.144122822680174e-09
vasopressin O 0 4.636766703924877e-08
- O 0 1.4613489085490983e-08
neurophysin O 0 5.806963088161865e-08
II O 0 1.2682478178760448e-08
gene O 0 3.858472222284526e-11
in O 0 7.123179823764758e-11
two O 0 7.705814458747184e-11
Spanish O 0 6.253328077576725e-09
kindreds O 0 2.2945087607695314e-07
with O 0 5.244737977250225e-10
familial B-Disease 0 0.013960692100226879
neurohypophyseal I-Disease 1 0.9999980926513672
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 1.2260759376658825e-06

Familial B-Disease 1 0.9996682405471802
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 3.887287505222048e-07
FNDI B-Disease 1 1.0
) O 0 3.578611712518054e-11
is O 0 1.776480546868131e-12
an O 0 1.5226238672672032e-11
autosomal B-Disease 1 0.9999990463256836
dominant I-Disease 1 0.9999921321868896
disease I-Disease 1 0.9999918937683105
caused O 0 2.1043493614314457e-09
by O 0 1.228846278206186e-11
deficiency O 1 0.9999786615371704
in O 0 1.027579021872782e-09
the O 0 2.1680790496247937e-08
antidiuretic O 0 4.59521025675258e-08
hormone O 0 1.4141743776008298e-08
arginine O 0 2.1436502350979936e-08
vasopressin O 0 4.764966377024393e-08
( O 0 1.3431382672735026e-09
AVP O 0 3.008966231732302e-08
) O 0 2.753918837763991e-12
encoded O 0 8.89544080756588e-12
by O 0 9.566327591192803e-11
the O 0 1.6451084050572717e-08
AVP O 0 1.562238139740657e-06
- O 0 1.0200656674896891e-07
neurophysin O 0 1.9473368411127012e-06
II O 0 4.958182398695499e-05
( O 0 9.973790326966991e-08
AVP O 0 6.411720823962241e-05
- O 0 6.022617981216172e-06
NPII O 0 0.0009846696630120277
) O 0 4.802920283708545e-10
gene O 0 1.060800780550153e-09
on O 0 1.2427359585842623e-08
chromosome O 0 3.857580566091201e-08
20p13 O 0 9.084441785489616e-07
. O 0 1.0191866550712803e-07

In O 0 8.169422471837606e-09
this O 0 1.7389292228386921e-09
study O 0 6.686125542110233e-10
, O 0 4.479715556837682e-11
we O 0 5.276703726742049e-11
analyzed O 0 5.46925837952017e-10
two O 0 9.013959717529829e-11
families O 0 2.2391700993384944e-10
with O 0 7.589530393037336e-11
FNDI B-Disease 1 1.0
using O 0 6.318161549501156e-10
direct O 0 9.436222470071698e-09
automated O 0 4.477449877526851e-08
fluorescent O 0 5.381267698112424e-08
, O 0 4.5487530409005217e-10
solid O 0 3.1824267665570005e-08
phase O 0 1.2187271636321384e-08
, O 0 2.3293011963687604e-10
single O 0 3.0749533475038504e-10
- O 0 3.6681992998666146e-09
stranded O 0 1.5861219893054113e-08
DNA O 0 5.231948763118055e-10
sequencing O 0 1.433542506923402e-09
of O 0 1.3755937722237377e-08
PCR O 0 1.6954602699570387e-07
- O 0 7.450003636222391e-07
amplified O 0 1.593015440448653e-06
AVP O 0 1.3648568710777909e-05
- O 0 7.794055250087695e-07
NPII O 0 1.7226166164618917e-05
DNA O 0 1.706188328398639e-07
. O 0 8.15833942624522e-08

In O 0 2.437175350422649e-09
one O 0 1.3879218885293199e-09
of O 0 2.003385901616639e-09
the O 0 8.28073998260237e-10
families O 0 2.065501103487577e-10
, O 0 4.966276088286259e-12
affected O 0 1.0583057867552537e-11
individuals O 0 2.567502634109875e-12
presented O 0 2.573722346355112e-10
a O 0 6.604169294766038e-11
novel O 0 2.715490332594328e-10
nonsense O 0 1.2582432873387006e-09
mutation O 0 1.6626235110894783e-10
in O 0 2.910783766796321e-11
exon O 0 9.523404287392623e-10
3 O 0 1.066398347404629e-08
of O 0 1.3520011776790852e-08
the O 0 5.97368643440177e-09
gene O 0 9.884545404403866e-10
, O 0 2.1090897084352633e-10
consisting O 0 3.25005196366579e-11
in O 0 4.5541674598137405e-11
a O 0 3.9267114559926597e-10
G O 0 1.6358777443770123e-08
to O 0 2.4707826895564722e-08
T O 0 8.040912575779657e-07
transition O 0 5.704169225850819e-08
at O 0 1.2743923250013722e-08
nucleotide O 0 8.34152125150922e-09
2101 O 0 7.127999879230629e-07
, O 0 8.862709177659411e-11
which O 0 3.3625944910464778e-12
produces O 0 6.9859608549383e-12
a O 0 2.1746432779523595e-12
stop O 0 4.0616857099884385e-11
signal O 0 3.261120706810061e-09
in O 0 5.618310261468196e-10
codon O 0 2.0607798489891138e-07
82 O 0 9.014029842546734e-07
( O 0 1.5098954975201195e-08
Glu O 0 1.3963206129119499e-06
) O 0 3.006474846856122e-09
of O 0 1.8471565965683112e-07
NPII O 0 0.014669938012957573
. O 0 1.5557527603959898e-06

The O 0 3.3391962972473266e-08
premature O 0 6.638655918322911e-07
termination O 0 1.5064527758568147e-07
eliminates O 0 1.4099948941748153e-07
part O 0 1.8732257967002397e-09
of O 0 1.3528008047103413e-08
the O 0 2.60515591321564e-08
C O 0 2.892975032864342e-07
- O 0 2.9780187205119546e-09
terminal O 0 2.6424880061881595e-09
domain O 0 6.74017230917201e-10
of O 0 1.6784249545764851e-09
NPII O 0 1.2299816262384411e-05
, O 0 1.583593117748805e-10
including O 0 1.659444977264446e-11
a O 0 9.613561058330333e-10
cysteine O 0 8.048225974555123e-10
residue O 0 6.707012278894808e-09
in O 0 1.7194527746067223e-10
position O 0 9.408974932512137e-09
85 O 0 7.916626465487298e-09
, O 0 2.3362234022328288e-11
which O 0 3.8953840153510555e-12
could O 0 2.322813642818833e-11
be O 0 4.76872326349298e-11
involved O 0 1.0474780764990754e-10
in O 0 1.3862121173158215e-10
the O 0 5.3903148611311735e-09
correct O 0 3.65346181752102e-07
folding O 0 2.111238700308604e-06
of O 0 8.030018250337889e-08
the O 0 5.985470465930121e-07
prohormone O 0 0.000521414855029434
. O 0 1.8603089984026155e-06

In O 0 1.1692914414496158e-09
the O 0 2.4292161615591112e-09
second O 0 7.010064528856219e-09
family O 0 8.738967327559521e-10
, O 0 1.7492897755322367e-11
a O 0 3.618944727223905e-11
G279A O 0 3.6052452134782698e-09
substitution O 0 1.1884234707437713e-09
at O 0 1.4200904896455313e-09
position O 0 1.7452058687084104e-09
- O 0 1.0135460526417006e-10
1 O 0 1.0827924112888354e-09
of O 0 6.515936679107881e-10
the O 0 4.1302875009030515e-10
signal O 0 1.351353473566519e-09
peptide O 0 3.2799704619002057e-10
was O 0 1.9432968567656417e-09
observed O 0 1.428405033143676e-10
in O 0 4.382014889836583e-11
all O 0 1.1916755082719277e-10
affected O 0 3.444929230767002e-09
individuals O 0 8.795488226631676e-10
. O 0 9.442148751759305e-08

This O 0 6.707690403118249e-09
missense O 0 3.125417606497649e-06
mutation O 0 5.3073662797942234e-08
, O 0 1.0440199815775486e-09
which O 0 1.0817499118687124e-09
replaces O 0 1.4003946944285417e-06
Ala O 0 9.943007626134204e-07
with O 0 8.475628199278162e-09
Thr O 0 4.012394856545143e-05
, O 0 2.088064610106244e-09
is O 0 4.8651898482132694e-11
frequent O 0 5.914073120116825e-10
among O 0 1.4043091134396946e-09
FNDI B-Disease 1 1.0
patients O 0 6.051660079720023e-07
and O 0 9.34654686979286e-10
is O 0 9.642681791932617e-11
thought O 0 1.4047529806049397e-10
to O 0 9.438642228909444e-11
reduce O 0 1.586472064829536e-09
the O 0 1.3859167147245444e-09
efficiency O 0 3.029669315424144e-08
of O 0 4.312083579094406e-09
cleavage O 0 1.170095220714984e-08
by O 0 3.68737596012636e-10
signal O 0 4.435752316567232e-07
peptidases O 0 1.7323178553851903e-06
. O 0 2.2195528970314626e-08
. O 0 2.7938378366343386e-07

Genetic O 0 2.5064920805561997e-07
heterogeneity O 0 2.8417553039616905e-06
of O 0 5.780507308372762e-07
Saethre B-Disease 1 0.9951403141021729
- I-Disease 1 0.999723494052887
Chotzen I-Disease 1 0.9999985694885254
syndrome I-Disease 1 1.0
, O 0 6.539044861142429e-10
due O 0 6.40430819487392e-09
to O 0 1.168689478525664e-09
TWIST O 0 0.4191780090332031
and O 0 7.923971168111166e-08
FGFR O 1 0.9996908903121948
mutations O 0 1.1862332030432299e-05
. O 0 4.761187426538527e-07

Thirty O 0 1.017433351080399e-05
- O 0 1.1300664226610024e-07
two O 0 7.061457529822235e-10
unrelated O 0 2.207493965400431e-09
patients O 0 3.056870381823451e-11
with O 0 4.3419177216293126e-13
features O 0 8.64380858556224e-11
of O 0 9.947245693808782e-09
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 4.2467977051652284e-11
a O 0 2.180625298386918e-11
common O 0 2.928466080742709e-10
autosomal B-Disease 0 8.696389386386727e-07
dominant I-Disease 0 1.1747604133915956e-07
condition I-Disease 0 2.5939403514030346e-08
of O 0 2.5748037035810967e-09
craniosynostosis B-Disease 0 5.274276873024064e-07
and O 0 1.5304167932939094e-09
limb B-Disease 0 0.015390683896839619
anomalies I-Disease 0 3.0794682970736176e-05
, O 0 1.6395160784554719e-09
were O 0 9.287565716498136e-10
screened O 0 9.089531904926673e-10
for O 0 1.5957699051050156e-10
mutations O 0 3.790101565925852e-09
in O 0 1.1130419919069823e-09
TWIST O 0 1.7752430494510918e-06
, O 0 1.0409702433378243e-08
FGFR2 O 0 9.444621537113562e-05
, O 0 7.872747787018852e-09
and O 0 6.853441192333776e-08
FGFR3 O 0 0.10023146867752075
. O 0 1.476491547691694e-06

Nine O 0 7.54649747136682e-08
novel O 0 4.585043900107166e-09
and O 0 3.0914193427378223e-10
three O 0 6.573759314676408e-10
recurrent O 0 1.6575199879298452e-07
TWIST O 0 3.660210268208175e-06
mutations O 0 2.511704053631547e-07
were O 0 2.0460733107796614e-09
found O 0 2.2962087786737584e-10
in O 0 1.9449349075717492e-10
12 O 0 3.160063322127371e-09
families O 0 4.846004930669778e-09
. O 0 4.2809613631789034e-08

Seven O 0 5.128205771143257e-08
families O 0 5.128662827758035e-09
were O 0 2.655127229189702e-10
found O 0 1.959485525226956e-11
to O 0 1.7861816192787927e-11
have O 0 4.2446757914094135e-11
the O 0 3.8443133121290884e-09
FGFR3 O 0 2.3244709154823795e-05
P250R O 0 1.6693942939127737e-07
mutation O 0 1.9156518593632654e-09
, O 0 3.390715139217626e-11
and O 0 2.678380781051537e-11
one O 0 1.2925453762857586e-10
individual O 0 4.537375475344163e-10
was O 0 1.8820939473584986e-08
found O 0 1.4762964462011752e-10
to O 0 8.269754325773704e-10
have O 0 9.976311998727283e-10
an O 0 1.060024601429177e-08
FGFR2 O 0 1.4620070942328312e-05
VV269 O 0 4.6399338771152543e-07
- O 0 3.966528439036665e-08
270 O 0 1.9318267874268713e-08
deletion O 0 1.4149460270118652e-08
. O 0 6.884268799467463e-08

To O 0 5.734153152303634e-09
date O 0 2.1832865115811728e-07
, O 0 2.3087776135355398e-10
our O 0 1.5583462298351947e-10
detection O 0 1.1491319007461698e-09
rate O 0 1.9212932633738689e-10
for O 0 2.069258132897378e-11
TWIST O 0 5.63419746413274e-07
or O 0 2.2336866578598347e-08
FGFR O 0 1.8164259017794393e-05
mutations O 0 1.364503710021836e-08
is O 0 1.462083509817802e-10
68 O 0 5.355247800764573e-09
% O 0 2.8953037189971553e-10
in O 0 7.001946245033253e-11
our O 0 2.3793530701254895e-08
Saethre B-Disease 0 0.0003766312438528985
- I-Disease 0 0.00013188243610784411
Chotzen I-Disease 0 1.591729960637167e-05
syndrome I-Disease 0 9.449492608837318e-06
patients O 0 1.3432329692975031e-09
, O 0 1.965407003812203e-11
including O 0 9.526373613566452e-12
our O 0 2.3226933265618754e-08
five O 0 3.597508957398077e-10
patients O 0 1.9799691053368207e-10
elsewhere O 0 1.1912353325982394e-09
reported O 0 2.2133246346811575e-09
with O 0 2.1571708308520954e-10
TWIST O 0 1.6188601875910535e-05
mutations O 0 1.5706560816397541e-06
. O 0 1.3372525131671864e-07

More O 0 8.318719935118679e-09
than O 0 2.4051409752701147e-09
35 O 0 2.002286692004418e-08
different O 0 9.573889458991403e-10
TWIST O 0 2.498754838597961e-07
mutations O 0 1.0402120054209263e-08
are O 0 5.602876496091369e-11
now O 0 3.566530057397266e-11
known O 0 2.0854875118492266e-11
in O 0 4.302212405771222e-11
the O 0 8.607354828882308e-10
literature O 0 1.1821865264494136e-08
. O 0 1.6228625554504106e-08

The O 0 1.4468300335579443e-08
most O 0 5.899202237813483e-10
common O 0 1.6944168290677908e-10
phenotypic O 0 4.516698126622032e-09
features O 0 8.224847469762153e-09
, O 0 9.489492525105447e-11
present O 0 1.101172070194778e-10
in O 0 2.6864952970551137e-11
more O 0 7.68578863746816e-12
than O 0 1.4803193393309044e-11
a O 0 1.1902807905972423e-10
third O 0 1.1555586487688174e-09
of O 0 1.4463712449952482e-09
our O 0 1.0280697182452059e-08
patients O 0 1.05279041040518e-09
with O 0 1.758450940414491e-09
TWIST O 0 6.400156416930258e-05
mutations O 0 6.446156248784973e-07
, O 0 8.887907299026665e-09
are O 0 7.583143002420911e-09
coronal B-Disease 0 0.00021610059775412083
synostosis I-Disease 0 6.957814912311733e-05
, O 0 7.650847066997812e-08
brachycephaly B-Disease 0 0.0010119229555130005
, O 0 5.902364819121431e-07
low B-Disease 1 0.9999959468841553
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 0 8.781622682363377e-07
facial B-Disease 1 1.0
asymmetry I-Disease 1 1.0
, O 0 1.0437993296363857e-06
ptosis B-Disease 0 0.1824999302625656
, O 0 3.2849570175130793e-08
hypertelorism B-Disease 0 0.0002119356649927795
, O 0 1.0007594397620778e-07
broad B-Disease 0 0.00041979190427809954
great I-Disease 1 0.9999996423721313
toes I-Disease 1 0.9999997615814209
, O 0 2.1455362286815216e-07
and O 0 5.790168415842345e-07
clinodactyly B-Disease 0 0.07485631853342056
. O 0 2.9258671929710545e-06

Significant O 0 1.893318653856113e-06
intra O 0 2.0337331079645082e-05
- O 0 5.968153971025458e-08
and O 0 3.4974556584188576e-10
interfamilial O 0 3.2979023956158926e-08
phenotypic O 0 1.137988991928296e-08
variability O 0 2.5372526124556316e-07
is O 0 1.0749353490657754e-10
present O 0 6.485530862354594e-11
for O 0 1.4394928304906074e-10
either O 0 1.3754469563309613e-08
TWIST O 0 4.47334059572313e-06
mutations O 0 8.728969760340988e-07
or O 0 2.5079268084482464e-07
FGFR O 0 0.0005414621555246413
mutations O 0 3.9471510717703495e-06
. O 0 6.056781671759381e-07

The O 0 1.0393953431275804e-07
overlap O 0 1.0634900604600261e-07
in O 0 5.440469741380127e-10
clinical O 0 1.2030906271220942e-09
features O 0 4.657449426126448e-10
and O 0 9.410276030630271e-11
the O 0 9.598829509016582e-10
presence O 0 1.0689656937401537e-09
, O 0 7.909188928789668e-12
in O 0 7.316059216777582e-12
the O 0 1.0324330279587457e-10
same O 0 1.0283589257920056e-10
genes O 0 1.0168014208389309e-09
, O 0 1.2174156127642277e-10
of O 0 4.865767788686526e-10
mutations O 0 1.0338735423331968e-10
for O 0 2.2322437301380837e-11
more O 0 8.386084188183318e-11
than O 0 5.980808626127043e-10
one O 0 1.0152244378502928e-08
craniosynostotic B-Disease 0 5.92688422784704e-07
condition I-Disease 0 2.783401598094315e-08
- O 0 3.810375570623137e-09
such O 0 7.222024644981673e-10
as O 0 1.4409502036016875e-08
Saethre B-Disease 0 4.598630312102614e-07
- I-Disease 0 5.280930182038901e-08
Chotzen I-Disease 0 5.728837209062476e-07
, I-Disease 0 1.2298980722746933e-09
Crouzon I-Disease 0 1.344368683930952e-06
, I-Disease 0 4.53192861016305e-09
and I-Disease 0 6.245082317946071e-08
Pfeiffer I-Disease 0 4.988749424228445e-05
syndromes I-Disease 0 0.000607097230385989
- O 0 4.124539827898843e-06
support O 0 2.247200427518692e-06
the O 0 8.97841630376206e-07
hypothesis O 0 4.542047449263009e-08
that O 0 7.906745570773754e-12
TWIST O 0 1.3504600104852216e-08
and O 0 1.2166938290203433e-10
FGFRs O 0 1.1368716634763132e-08
are O 0 1.981591757002632e-12
components O 0 2.3239106194949954e-09
of O 0 2.820714772866495e-09
the O 0 2.492282769051002e-10
same O 0 8.262308198725421e-11
molecular O 0 4.5210310495313877e-10
pathway O 0 1.6640797073641522e-10
involved O 0 1.6414973763936858e-12
in O 0 1.6535736538716983e-12
the O 0 1.2978684967024368e-11
modulation O 0 1.484700806742012e-09
of O 0 2.382339880924178e-09
craniofacial O 1 0.863067626953125
and O 0 9.745226634549908e-07
limb O 1 0.9998456239700317
development O 0 9.591798288965947e-07
in O 0 6.905105376375786e-10
humans O 0 3.953323890470983e-09
. O 0 2.064301174442562e-09
. O 0 1.8255002842693102e-08

Mutation O 0 1.6916341660788703e-09
analysis O 0 5.452166496056066e-10
of O 0 1.9073937984614986e-09
UBE3A O 1 0.9984717965126038
in O 0 1.420368107574177e-07
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 4.267644442279561e-07
. O 0 1.8943859814157804e-08

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.959645709983306e-06
AS B-Disease 1 1.0
) O 0 1.413439504327485e-10
is O 0 2.3229288284576377e-11
caused O 0 2.59089194543094e-10
by O 0 4.645036091877053e-11
chromosome O 0 5.2935462235836894e-08
15q11 O 0 4.25114421886974e-07
- O 0 8.852108379642232e-09
q13 O 0 2.5795731772859654e-08
deletions O 0 3.770633583144445e-09
of O 0 1.4900335132406184e-10
maternal O 0 1.465168986136689e-09
origin O 0 1.354630158045822e-10
, O 0 4.411456009517645e-12
by O 0 2.9900363435197974e-11
paternal O 0 0.0014499671524390578
uniparental B-Disease 1 0.9975908994674683
disomy I-Disease 1 0.5408854484558105
( O 0 1.0484504855412524e-06
UPD B-Disease 1 1.0
) O 0 3.392943925817349e-09
15 O 0 6.58077823345593e-08
, O 0 1.6039172767712273e-10
by O 0 5.333918862149289e-10
imprinting O 0 0.00425956305116415
defects O 1 0.9997325539588928
, O 0 1.3419885203092008e-09
and O 0 7.683740449460075e-11
by O 0 1.7034738897248047e-10
mutations O 0 1.2520625425338494e-08
in O 0 8.275686802505788e-10
the O 0 1.7938695862085297e-08
UBE3A O 0 4.771678504766896e-06
gene O 0 2.3126105475057557e-07
. O 0 7.321810358007497e-07

UBE3A O 0 0.0005449996679089963
encodes O 0 6.331980557661154e-07
a O 0 6.87640806518175e-08
ubiquitin O 0 5.861120300210132e-08
- O 0 2.5239012657607418e-08
protein O 0 1.0343538470181102e-08
ligase O 0 9.998204930639076e-09
and O 0 2.3349695510432866e-09
shows O 0 1.112596859087489e-08
brain O 0 1.2752366274071392e-07
- O 0 4.149508736617236e-09
specific O 0 1.7244361494306304e-09
imprinting O 0 1.8830043018169818e-06
. O 0 3.143772886460283e-08

Here O 0 5.497209087934607e-08
we O 0 2.0132033817787942e-09
describe O 0 1.1357728979533022e-08
UBE3A O 0 1.3394658708421048e-05
coding O 0 1.092372485800297e-06
- O 0 2.0639201920857886e-06
region O 0 1.6089416021713987e-07
mutations O 0 3.915624091632708e-08
detected O 0 1.0303272013345577e-08
by O 0 2.566173384899173e-10
SSCP O 0 5.06859396409709e-06
analysis O 0 1.0883933754257669e-09
in O 0 1.8154253100810536e-10
13 O 0 1.266304483493741e-08
AS B-Disease 1 1.0
individuals O 0 9.630293090756581e-11
or O 0 7.407645052914802e-10
families O 0 9.846196080687264e-10
. O 0 2.809471322251511e-09

Two O 0 3.00596070701431e-07
identical O 0 9.597800953997648e-07
de O 0 4.688852641265839e-06
novo O 0 1.6896942724997643e-06
5 O 0 4.7424350668734405e-07
- O 0 1.6796178670119843e-07
bp O 0 9.13483262365844e-08
duplications O 0 4.316841994977949e-08
in O 0 3.2257352344799983e-09
exon O 0 1.2397671333985727e-08
16 O 0 1.500253574704402e-07
were O 0 1.4557682170845965e-08
found O 0 1.1621327011823723e-08
. O 0 4.356321170462252e-08

Among O 0 3.5353938443449806e-08
the O 0 2.145707789225071e-08
other O 0 3.384347913026886e-09
11 O 0 8.608903812046265e-09
unique O 0 3.4939169335501674e-09
mutations O 0 7.444816318979974e-09
, O 0 6.539643271352702e-10
8 O 0 2.250943786918924e-08
were O 0 3.3851872416335027e-09
small O 0 7.243535105061483e-09
deletions O 0 4.2040333880777325e-08
or O 0 9.253779076345836e-09
insertions O 0 1.3977152946154092e-07
predicted O 0 2.1373423919612833e-08
to O 0 9.619394170101714e-10
cause O 0 2.593436647657654e-07
frameshifts O 0 1.1980442650383338e-05
, O 0 9.459463212735386e-10
1 O 0 1.619170930666769e-08
was O 0 3.804834225462628e-09
a O 0 7.309256672138886e-11
mutation O 0 4.059532571210056e-11
to O 0 5.151087889565531e-11
a O 0 6.446193023812441e-10
stop O 0 4.4570152013534425e-09
codon O 0 2.512953933830886e-08
, O 0 1.1719596404446975e-09
1 O 0 1.1163976409989118e-08
was O 0 4.632830563622292e-09
a O 0 7.973069426903123e-10
missense O 0 2.165871926251839e-08
mutation O 0 6.045297595846932e-10
, O 0 3.210815641141451e-11
and O 0 4.249487914331773e-11
1 O 0 4.467705316812953e-09
was O 0 6.254986306686305e-09
predicted O 0 1.4133646475400496e-09
to O 0 4.4869153531523764e-11
cause O 0 1.603807975314453e-09
insertion O 0 5.809851710836256e-09
of O 0 5.314272133460918e-09
an O 0 3.770424861215815e-09
isoleucine O 0 7.271499953276361e-07
in O 0 5.505724209875495e-10
the O 0 1.0539683792387677e-08
hect O 0 1.062317664946022e-06
domain O 0 4.54123281201646e-08
of O 0 4.3344073219486745e-08
the O 0 1.6450321993488615e-07
UBE3A O 0 3.687039225042099e-06
protein O 0 9.92659039411592e-08
, O 0 3.5747249604867193e-10
which O 0 5.0555823416509327e-11
functions O 0 4.109635964866243e-10
in O 0 9.42707800710707e-10
E2 O 0 6.519025674833756e-08
binding O 0 3.568493722738708e-09
and O 0 2.068581528291702e-09
ubiquitin O 0 6.750638448238533e-08
transfer O 0 2.501053131709341e-06
. O 0 5.453871949612221e-07

Eight O 0 6.929916906983635e-08
of O 0 2.4182796209970547e-08
the O 0 1.1031718871734597e-09
cases O 0 4.1101927417130923e-10
were O 0 4.6317324975397867e-10
familial O 0 1.4753513966070386e-09
, O 0 1.5817396004091933e-10
and O 0 9.606278966733939e-11
five O 0 3.02071256896852e-09
were O 0 8.562722086935537e-09
sporadic O 0 3.453316821833141e-06
. O 0 5.081780045657069e-07

In O 0 1.590769471704334e-08
two O 0 1.7188045431382193e-09
familial O 0 1.3723179925761997e-08
cases O 0 3.5744593396280777e-10
and O 0 1.672792113160959e-11
one O 0 4.380084836497211e-11
sporadic O 0 4.4932058074209635e-09
case O 0 1.1765420859788378e-09
, O 0 4.381164597777598e-10
mosaicism O 0 5.737205719924532e-05
for O 0 4.519957741422331e-08
UBE3A O 0 4.1090585000347346e-05
mutations O 0 5.043368034307605e-08
was O 0 6.912063144071112e-10
detected O 0 4.899384370427029e-11
in O 0 2.658144537814877e-12
the O 0 9.457942762303162e-11
mother O 0 2.880827243423312e-10
of O 0 7.557321990425692e-10
three O 0 9.107441467648414e-10
AS B-Disease 1 1.0
sons O 0 1.1014487455440758e-07
, O 0 5.660677135366221e-11
in O 0 3.020473107739896e-11
the O 0 8.356916270102488e-10
maternal O 0 5.402525360409527e-08
grandfather O 0 2.835664929534687e-07
of O 0 7.290790904335154e-08
two O 0 4.534791209209743e-09
AS B-Disease 1 1.0
first O 0 6.174006195180937e-09
cousins O 0 4.721970814358656e-09
, O 0 1.9989496169436904e-10
and O 0 9.257582894717231e-11
in O 0 2.2125300203068576e-10
the O 0 8.191832279180744e-08
mother O 0 2.59085002340953e-08
of O 0 1.6045990491875273e-07
an O 0 8.321755018414478e-08
AS B-Disease 1 1.0
daughter O 0 6.308795855147764e-05
. O 0 6.180610853334656e-06

The O 0 9.398537059723822e-09
frequencies O 0 3.08431791218311e-09
with O 0 1.4078316637466948e-11
which O 0 4.455871782660381e-11
we O 0 6.136537111789409e-11
detected O 0 4.919538110215171e-10
mutations O 0 8.620071878517876e-10
were O 0 4.712431000974959e-10
5 O 0 3.025371508869057e-09
( O 0 1.0189636634461152e-10
14 O 0 6.339833102941839e-09
% O 0 2.0380644394357716e-10
) O 0 7.336821037859376e-13
of O 0 8.09910055687979e-11
35 O 0 8.743101242991713e-10
in O 0 1.5464601821335577e-11
sporadic O 0 1.2833143436807859e-09
cases O 0 7.382337796624228e-11
and O 0 1.1159834861773632e-10
8 O 0 3.4016593986052612e-09
( O 0 2.9077320412573826e-11
80 O 0 3.203172838084356e-09
% O 0 1.3635864659633512e-10
) O 0 1.3714256509936296e-12
of O 0 1.7511268823877657e-10
10 O 0 4.760674077175509e-10
in O 0 1.1440183522726244e-10
familial O 0 4.613237347683707e-09
cases O 0 8.533793671716694e-10
. O 0 2.6803459451940626e-09
. O 0 4.358124527925611e-08

The O 0 3.334847860969603e-06
hemochromatosis B-Disease 1 1.0
845 O 0 3.4564138786663534e-06
G O 0 1.157941369456239e-07
- O 0 4.984332946378345e-09
- O 0 1.4220934430042576e-09
> O 0 2.375632468520905e-10
A O 0 5.256936552733293e-10
and O 0 9.664712606605175e-13
187 O 0 1.1157573996667391e-11
C O 0 2.1317135556753186e-10
- O 0 1.8333100662570878e-11
- O 0 6.01380681364283e-11
> O 0 1.126331389267321e-10
G O 0 2.40548025942644e-09
mutations O 0 3.5117336816270495e-10
: O 0 3.235159015679834e-11
prevalence O 0 1.1409311273524736e-09
in O 0 3.371047191391696e-11
non O 0 7.471303575812271e-09
- O 0 4.1250385329760775e-09
Caucasian O 0 3.3684539602063523e-09
populations O 0 7.079869579484921e-09
. O 0 6.496755133866827e-09

Hemochromatosis B-Disease 0 0.0004555405757855624
, O 0 8.679353236118459e-09
the O 0 2.1601131550141872e-07
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 7.185123607200694e-09
leads O 0 1.18594598461641e-05
, O 0 6.014750364435884e-10
if O 0 2.0662920974245935e-07
untreated O 1 1.0
, O 0 9.343405910078317e-11
to O 0 3.703730877546718e-09
progressive O 1 1.0
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 0 4.2024544200103264e-07
premature B-Disease 0 4.03357989853248e-05
death I-Disease 0 1.5857201560720569e-06
. O 0 4.105238247120724e-07

The O 0 2.0550660337903537e-06
hemochromatosis B-Disease 1 1.0
gene O 1 0.9990507960319519
, O 0 7.581490990560269e-06
HFE O 1 0.9999998807907104
, O 0 2.0027144387313456e-08
recently O 0 2.5043207507735588e-09
has O 0 4.428614766571748e-11
been O 0 2.7219242484943784e-11
identified O 0 7.627173892466033e-11
, O 0 4.295921257613244e-12
and O 0 3.5551659272742286e-12
characterization O 0 5.201186592529439e-09
of O 0 3.0615183721494077e-09
this O 0 1.30983099366766e-10
gene O 0 2.3325834597187622e-09
has O 0 7.796146506144908e-10
shown O 0 4.402456177388103e-11
that O 0 5.132902349685997e-12
it O 0 3.032305092784404e-12
contains O 0 1.2330529392673428e-12
two O 0 4.578237962349352e-12
mutations O 0 4.619889887313988e-11
that O 0 1.9933213066258837e-11
result O 0 4.724400315403443e-10
in O 0 1.327860044142426e-09
amino O 0 1.2569485896563037e-08
acid O 0 2.259687992278714e-09
substitutions O 0 8.660348549405228e-10
- O 0 8.142692631274429e-10
cDNA O 0 2.172929836063986e-09
nucleotides O 0 9.756370156210892e-10
845 O 0 3.4659932701686103e-09
G O 0 2.456477909973387e-09
- O 0 7.088135633992465e-10
- O 0 5.762547661269934e-10
> O 0 3.439694640228197e-10
A O 0 5.391497914786214e-09
( O 0 2.356307683692993e-11
C282Y O 0 3.4766381440398675e-10
) O 0 1.0616329863821772e-12
and O 0 2.169220532366456e-12
187 O 0 2.4260001993403613e-11
C O 0 1.0992378118857005e-09
- O 0 1.1165882107810887e-10
- O 0 4.077662651980063e-10
> O 0 5.584762652333097e-10
G O 0 7.043989569410769e-08
( O 0 7.304135518637622e-09
H63D O 0 2.5571582227712497e-05
) O 0 1.5858941937452187e-09
. O 0 1.2150367822982844e-08

Although O 0 1.4790070679282508e-07
hemochromatosis B-Disease 1 1.0
is O 0 2.955001576765426e-09
common O 0 2.3698756845824676e-10
in O 0 8.773198834077789e-11
Caucasians O 0 5.326601382193985e-09
, O 0 8.179518173889733e-11
affecting O 0 7.509903254820927e-10
> O 0 1.0722124299533675e-09
= O 0 2.9589890537806696e-09
1 O 0 3.72838204754089e-09
/ O 0 1.7837958887767513e-10
300 O 0 4.507751463767029e-11
individuals O 0 1.8622505881110696e-12
of O 0 8.400332512925601e-11
northern O 0 2.780671248814315e-10
European O 0 6.560654103315855e-11
origin O 0 3.014214655649994e-09
, O 0 8.595702621905232e-11
it O 0 5.558850255105163e-11
has O 0 1.4138377968375693e-11
not O 0 2.6247282125524407e-11
been O 0 1.2754658440528033e-10
recognized O 0 2.785406072458585e-10
in O 0 1.5887030579975203e-10
other O 0 2.0201000872077657e-09
populations O 0 1.5699111344247285e-08
. O 0 8.647845106679597e-08

The O 0 4.748146054112112e-08
present O 0 2.7781490441469714e-09
study O 0 7.344949648491195e-11
used O 0 2.033520227207042e-11
PCR O 0 1.0494083380052643e-09
and O 0 1.7863460710643153e-10
restriction O 0 6.6991749925193744e-09
- O 0 1.351134315541458e-09
enzyme O 0 2.66102334611773e-10
digestion O 0 6.658099072076595e-11
to O 0 2.726666982477699e-12
analyze O 0 1.0658334458069074e-11
the O 0 1.573788321884706e-11
frequency O 0 1.3467033044278764e-10
of O 0 2.435682489032587e-10
the O 0 9.436612602442551e-10
845 O 0 2.9009543656144388e-09
G O 0 1.5740840852984661e-09
- O 0 7.584773364932573e-10
- O 0 6.827393095321099e-10
> O 0 1.827452772440452e-10
A O 0 9.781842003064867e-10
and O 0 4.817925572386805e-12
187 O 0 6.670044291195998e-12
C O 0 5.209998404920313e-11
- O 0 3.09305597627485e-12
- O 0 1.623411127749108e-11
> O 0 2.518410480156774e-11
G O 0 6.26913687629127e-10
mutations O 0 9.488713981209429e-11
in O 0 3.56790465227963e-11
HLA O 0 1.9569923459528127e-09
- O 0 7.117071931794783e-10
typed O 0 1.4943254966759412e-10
samples O 0 3.782758394715868e-12
from O 0 1.6816532541485962e-11
non O 0 1.7794055118258711e-10
- O 0 3.4738392717947875e-11
Caucasian O 0 1.790356578268426e-11
populations O 0 1.675573221837645e-11
, O 0 4.553746160533556e-13
comprising O 0 1.8104855722261837e-12
Australian O 0 2.5758130003938895e-11
Aboriginal O 0 6.444054179155501e-10
, O 0 2.8626517822871733e-11
Chinese O 0 1.4010664850516719e-09
, O 0 9.302453252146847e-11
and O 0 7.842439475602703e-10
Pacific O 0 6.154009923875492e-08
Islanders O 0 3.539179544986837e-07
. O 0 1.866304870645763e-07

Results O 0 1.5224874516661657e-07
showed O 0 3.957414662636438e-08
that O 0 1.8944526503084091e-10
the O 0 4.467475278602251e-09
845 O 0 1.2536874649526908e-08
G O 0 8.895437275668883e-09
- O 0 2.8852167321957722e-09
- O 0 1.3096792539357693e-09
> O 0 1.1078735151492936e-10
A O 0 2.1329905897093937e-10
mutation O 0 7.050993035967457e-12
was O 0 3.1173386354915733e-12
present O 0 1.0274554373534278e-13
in O 0 1.9330381479526482e-13
these O 0 2.0080118123821933e-12
populations O 0 8.633197629004385e-11
( O 0 1.9590594771412562e-11
allele O 0 2.386586483993369e-10
frequency O 0 1.645831665397779e-10
0 O 0 6.616437259188146e-11
. O 0 2.6324843346858806e-11
32 O 0 3.3440130664530443e-09
% O 0 4.2064277061548694e-10
) O 0 9.711003702561616e-12
, O 0 4.1999796002167855e-11
and O 0 1.4615091081804366e-10
, O 0 1.9011890672882004e-10
furthermore O 0 1.2504748347907935e-09
, O 0 6.788486439646135e-11
it O 0 1.2929052273236152e-10
was O 0 1.0948463469162562e-08
always O 0 1.69102776226282e-09
seen O 0 3.5702909517709713e-09
in O 0 1.8487719688486948e-10
conjunction O 0 1.6515463441280076e-09
with O 0 3.119280944652303e-10
HLA O 0 7.94316474639345e-06
haplotypes O 0 1.0905367275881872e-07
common O 0 2.7678234704175964e-10
in O 0 1.687572720454611e-10
Caucasians O 0 3.309230001136143e-09
, O 0 4.9474736807386677e-11
suggesting O 0 3.1926311594432377e-10
that O 0 1.0311557857578535e-10
845 O 0 3.3317004710653464e-09
G O 0 1.072221245124183e-08
- O 0 1.4737996600899805e-08
- O 0 4.586664203998225e-08
> O 0 1.1445083991645788e-08
A O 0 6.076667204979458e-07
may O 0 2.0486505825090262e-09
have O 0 9.907982767565215e-11
been O 0 3.290878680672904e-11
introduced O 0 4.423200954811746e-12
into O 0 2.450222316707773e-12
these O 0 1.8101403622544643e-12
populations O 0 1.528729053068556e-11
by O 0 7.645671595835069e-11
Caucasian O 0 7.092577902767516e-08
admixture O 0 6.687769769087026e-07
. O 0 9.065612260883427e-08

187 O 0 7.312878835818992e-08
C O 0 2.1755147017188392e-08
- O 0 1.8310604421589716e-10
- O 0 1.3115283858944338e-10
> O 0 5.927938695471369e-11
G O 0 9.420283442196364e-10
was O 0 1.8811230351190034e-10
present O 0 1.0343739753615466e-11
at O 0 1.2663364280796063e-11
an O 0 5.912350145055589e-13
allele O 0 2.5519196131251753e-11
frequency O 0 1.503680513437189e-10
of O 0 4.599599312538061e-10
2 O 0 2.323402092940796e-08
. O 0 1.1813755662615222e-07

68 O 0 5.072251383353432e-07
% O 0 4.458577673727149e-10
in O 0 7.207719230489795e-12
the O 0 1.87631334080951e-11
two O 0 3.0233769047344206e-12
populations O 0 1.769221401326515e-11
analyzed O 0 1.0890095769600094e-10
( O 0 5.151635628503071e-12
Australian O 0 2.4386623276306807e-10
Aboriginal O 0 2.1552881701580873e-09
and O 0 3.763159506231517e-10
Chinese O 0 8.193922873545034e-09
) O 0 2.8771701687801965e-10
. O 0 2.11577226849613e-08

In O 0 1.9618348612304715e-10
the O 0 4.3309072994546227e-10
Australian O 0 1.2442081809282968e-09
Aboriginal O 0 1.2920110536995821e-09
samples O 0 1.8335906404320923e-10
, O 0 4.487540200548423e-11
187 O 0 1.13910186838595e-10
C O 0 8.967013243044164e-10
- O 0 6.348224723673468e-11
- O 0 2.1136485617301304e-10
> O 0 2.5088711663734387e-10
G O 0 5.335936581474243e-09
was O 0 1.7859551615373448e-09
found O 0 1.034977919339708e-11
to O 0 4.925438962938289e-12
be O 0 1.621201783930104e-11
associated O 0 9.021566826916683e-10
with O 0 1.1552428458294628e-10
HLA O 0 5.7121094869216904e-05
haplotypes O 0 3.4169531204497616e-07
common O 0 1.7271847285726949e-09
in O 0 3.4090555378618603e-10
Caucasians O 0 5.810793624050348e-09
, O 0 2.472235784145571e-11
suggesting O 0 4.942449227662848e-10
that O 0 1.3534362866551852e-11
it O 0 2.1737360175744236e-11
was O 0 1.9097991243999246e-10
introduced O 0 1.9684982810463936e-11
by O 0 2.7815237960138184e-11
recent O 0 3.446368523896126e-09
admixture O 0 5.379152980822255e-07
. O 0 8.715154820038151e-08

In O 0 5.3655124787610475e-09
the O 0 7.507487076452435e-09
Chinese O 0 6.452420819869076e-09
samples O 0 3.8312891748049083e-10
analyzed O 0 1.0359821889238674e-09
, O 0 2.3211309610471353e-11
187 O 0 2.880188448850518e-11
C O 0 1.5415281551245386e-10
- O 0 4.135762045331948e-12
- O 0 1.9548789670364997e-11
> O 0 2.7321710865946258e-11
G O 0 5.708005179627662e-10
was O 0 2.5759419597370936e-10
present O 0 2.002463125871934e-11
in O 0 9.516203797188538e-12
association O 0 7.058693213268796e-11
with O 0 1.0759912058566634e-11
a O 0 5.43576073042118e-10
wide O 0 1.447033493029437e-09
variety O 0 1.7811381258781012e-09
of O 0 3.5694281308451536e-08
HLA O 0 0.00011261466715950519
haplotypes O 0 3.4346376764915476e-07
, O 0 8.922688699009029e-10
showing O 0 6.585417766657997e-10
this O 0 2.6720434892490985e-11
mutation O 0 1.73083040955202e-11
to O 0 1.4454899950611111e-11
be O 0 7.561297421521118e-11
widespread O 0 1.9057682099088424e-09
and O 0 1.660449555629384e-10
likely O 0 2.475163407567038e-09
to O 0 1.1732949056764141e-09
predate O 0 6.782567538721196e-07
the O 0 6.081174674932299e-09
more O 0 6.254350926049312e-10
genetically O 0 4.413095666677691e-09
restricted O 0 1.2260621851112319e-08
845 O 0 2.4038671497805808e-08
G O 0 3.668550974111895e-08
- O 0 2.4938925591300176e-08
- O 0 2.8905612126095548e-08
> O 0 6.2239609022185505e-09
A O 0 1.2760852818871626e-08
mutation O 0 3.648981339310353e-09
. O 0 7.3359682772888846e-09

Genotype O 0 7.622137445650878e-07
- O 0 2.511579566544242e-07
phenotype O 0 7.882592711894176e-08
correlations O 0 8.727631950478099e-08
in O 0 2.124133091641056e-09
attenuated B-Disease 1 0.9999949932098389
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 3.024867964995792e-06

Germ O 0 0.00012424064334481955
- O 0 5.285472980176564e-06
line O 0 7.476565997421858e-07
mutations O 0 2.327904624621624e-08
of O 0 2.9106310694970716e-09
the O 0 8.836448794902196e-10
tumor B-Disease 0 3.4086340860994824e-07
suppressor O 0 2.8855354685219936e-05
APC O 0 4.449704249509523e-08
are O 0 4.0840584386581114e-11
implicated O 0 7.371042665127447e-10
in O 0 1.5839655143068399e-09
attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 0.002689897082746029
AAPC B-Disease 1 1.0
) O 0 2.0729001848351913e-11
, O 0 2.0562017529184712e-13
a O 0 5.870974279648111e-13
variant O 0 1.1837388846913655e-08
of O 0 3.276003894825408e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 5.385471695262822e-07
FAP B-Disease 0 1.6608033774900832e-06
) O 0 1.21860099788762e-09
. O 0 1.610780131500178e-08

AAPC B-Disease 1 1.0
is O 0 1.1882761441484035e-09
recognized O 0 1.7325356427289051e-10
by O 0 1.0391298065071108e-11
the O 0 6.902468874248058e-11
occurrence O 0 2.4084920724476433e-09
of O 0 5.64245206113867e-10
< O 0 2.5262176350793197e-08
100 O 0 1.3323179892665848e-08
colonic B-Disease 0 5.500328938978782e-07
adenomas I-Disease 0 1.4712246354520175e-07
and O 0 5.376219434916063e-12
a O 0 1.3742543561456877e-11
later O 0 1.1419384882138672e-10
onset O 0 1.394473429172649e-06
of O 0 1.4640166057233728e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 5.2964063690374985e-11
age O 0 4.4131603926800267e-10
> O 0 6.155718712541614e-10
40 O 0 4.122356234148583e-09
years O 0 8.539687845754429e-10
) O 0 2.0497049890710883e-10
. O 0 8.816823715562805e-09

The O 0 2.651890618210473e-08
aim O 0 3.0559892394421695e-08
of O 0 2.3959834116737966e-09
this O 0 6.173470762371736e-11
study O 0 4.6046177287761836e-11
was O 0 5.733228822246694e-11
to O 0 1.2796369866507895e-11
assess O 0 1.806767002676679e-08
genotype O 0 2.6834069899450697e-07
- O 0 8.346599429387425e-07
phenotype O 0 1.2811938177037518e-07
correlations O 0 3.8003580016265914e-07
in O 0 1.6967989679983475e-08
AAPC B-Disease 1 1.0
families O 0 1.0192391641794529e-07
. O 0 1.1316733150579239e-07

By O 0 3.015416583096453e-09
protein O 0 1.192934746541141e-07
- O 0 1.8262909406985273e-08
truncation O 0 3.166472239968243e-08
test O 0 9.165225800522592e-10
( O 0 2.128635046005911e-09
PTT O 0 3.624967703785842e-08
) O 0 3.747841013229669e-12
assay O 0 1.6486027820672433e-10
, O 0 2.5986940464101105e-12
the O 0 4.8049676217021275e-12
entire O 0 2.8863808912427125e-11
coding O 0 3.709271223506505e-10
region O 0 1.4649007562539396e-09
of O 0 2.265436060966408e-09
the O 0 8.339133827917067e-09
APC B-Disease 0 7.24218107706065e-09
gene O 0 1.1717249392972917e-09
was O 0 1.4242985457713075e-08
screened O 0 4.838429656928156e-10
in O 0 1.746113149903028e-11
affected O 0 1.2404093030493613e-10
individuals O 0 9.627152547375672e-11
from O 0 2.03016323752081e-08
11 O 0 2.0870550088147866e-07
AAPC B-Disease 1 1.0
kindreds O 0 1.4277303534981911e-06
, O 0 2.512539065691044e-10
and O 0 5.881481413005929e-11
their O 0 2.7729596396852685e-10
phenotypic O 0 2.6466961955406987e-08
differences O 0 1.6438075078895054e-07
were O 0 6.058462531655096e-08
examined O 0 4.7197221419992275e-07
. O 0 1.8707669369177893e-07

Five O 0 2.6164149957708105e-08
novel O 0 2.408741295312211e-08
germ O 0 2.0367003799037775e-06
- O 0 3.9605492929695174e-07
line O 0 8.02670797384053e-07
APC B-Disease 0 8.938534357127992e-09
mutations O 0 1.381880831985427e-09
were O 0 2.4357335592917195e-10
identified O 0 3.7009464937121095e-10
in O 0 2.1933657667894124e-10
seven O 0 1.791117476557247e-08
kindreds O 0 1.3192065125622321e-05
. O 0 5.19319030445331e-07

Mutations O 0 8.280050565190322e-07
were O 0 1.5074810733040067e-08
located O 0 2.2294843748937865e-09
in O 0 3.762976041876698e-12
three O 0 2.544024561325353e-13
different O 0 6.087266107845934e-13
regions O 0 5.7428600069853175e-11
of O 0 4.673859632653432e-10
the O 0 3.5010816468172834e-09
APC B-Disease 0 2.515791797108591e-09
gene O 0 4.696441568974308e-10
( O 0 1.7488303860613286e-10
1 O 0 9.704835157720026e-09
) O 0 1.8882288094212996e-11
at O 0 8.899675441043087e-10
the O 0 4.0628808650744475e-10
5 O 0 7.572154570034684e-10
end O 0 1.0843549391736929e-09
spanning O 0 2.5975830375557507e-09
exons O 0 2.4382866836702988e-09
4 O 0 8.305023335708484e-09
and O 0 5.550165327328216e-10
5 O 0 1.718484199386694e-08
, O 0 5.469446562322844e-10
( O 0 6.339161834345575e-11
2 O 0 1.755940615133511e-09
) O 0 1.1818961608012213e-11
within O 0 9.300802489287108e-11
exon O 0 3.184481844886733e-10
9 O 0 3.3786331510299306e-09
, O 0 5.314093956543253e-11
and O 0 3.84385509533125e-11
( O 0 9.01684369530864e-12
3 O 0 9.35537536328468e-10
) O 0 1.0991004113780622e-11
at O 0 1.0295978514207604e-09
the O 0 3.537144188658914e-10
3 O 0 2.4551429778085776e-09
distal O 0 7.42144052878757e-08
end O 0 3.0634826231334955e-08
of O 0 4.507973017098266e-08
the O 0 3.681378402120572e-08
gene O 0 9.72403384480458e-08
. O 0 7.05010450019472e-07

Variability O 0 5.551240178647276e-07
in O 0 1.7200103841208403e-10
the O 0 1.2145397187968143e-10
number O 0 3.428206329925132e-10
of O 0 6.157097942605105e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 5.053464313675704e-10
most O 0 6.820123459039262e-12
apparent O 0 4.805174036448534e-10
in O 0 8.15095126810439e-12
individuals O 0 3.8283703464314645e-12
with O 0 5.218121074124227e-12
mutations O 0 2.0708977588324018e-10
in O 0 6.782092942803075e-11
region O 0 1.1900543883669457e-09
1 O 0 1.5232652472718655e-08
, O 0 3.492864220078218e-09
and O 0 1.9110952109713253e-07
upper O 1 0.9999685287475586
- O 0 0.48222145438194275
gastrointestinal O 0 0.0006698619108647108
manifestations O 0 4.9642196245258674e-05
were O 0 1.9395716144288144e-09
more O 0 1.3974420509654806e-09
severe O 0 2.983601063988317e-07
in O 0 4.87304241403308e-09
them O 0 2.1021639540208525e-08
. O 0 5.364921094042074e-07

In O 0 1.2726331100054722e-09
individuals O 0 6.559928295013506e-11
with O 0 9.636682944680341e-12
mutations O 0 1.1721670856168487e-10
in O 0 8.886350856551761e-12
either O 0 2.1777491268637483e-11
region O 0 2.87443818747235e-10
2 O 0 2.5266971848125763e-10
or O 0 9.155245311864846e-11
region O 0 7.502888310639833e-10
3 O 0 3.821436223017116e-10
, O 0 6.087826857209544e-12
the O 0 5.005879044617245e-11
average O 0 1.1859891957399782e-09
number O 0 4.0978170856575957e-10
of O 0 2.3432333406958605e-08
adenomas B-Disease 0 7.397301828859781e-07
tended O 0 1.0229883429246911e-07
to O 0 2.9243092392050585e-09
be O 0 1.8587793526592122e-09
lower O 0 9.935148703732466e-09
than O 0 1.0668203820340949e-10
those O 0 3.5089597894000235e-11
in O 0 1.6881256809098133e-11
individuals O 0 5.435765552952443e-12
with O 0 8.827646946762968e-12
mutations O 0 2.0944897205499302e-10
in O 0 2.3626621492578437e-11
region O 0 8.060916378838101e-10
1 O 0 3.1563767155518008e-09
, O 0 1.1506534614014186e-10
although O 0 8.856224642528332e-10
age O 0 5.2521009763495385e-08
at O 0 1.987394604441306e-08
diagnosis O 0 3.966422568169037e-08
was O 0 2.7262185842147346e-09
similar O 0 1.9898815928343083e-09
. O 0 8.084913361017243e-08

In O 0 3.8081612530049824e-08
all O 0 8.072429977801221e-07
AAPC B-Disease 1 1.0
kindreds O 0 3.035759618796874e-05
, O 0 3.193922348820877e-10
a O 0 7.208551533466334e-10
predominance O 0 3.0294204407255165e-05
of O 0 1.557603718538303e-05
right O 1 1.0
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 0.00014293116691987962
rectal B-Disease 1 0.9999293088912964
polyp I-Disease 0 5.671075768987066e-07
sparing O 0 5.327224172901879e-08
was O 0 1.035796959314439e-08
observed O 0 1.2716485642272346e-08
. O 0 1.228374912898289e-08

No O 0 1.0089939678437077e-05
desmoid B-Disease 1 0.9999927282333374
tumors I-Disease 1 1.0
were O 0 2.400934562274415e-08
found O 0 2.8134164442583653e-10
in O 0 7.978343680159483e-11
these O 0 5.303060213179833e-10
kindreds O 0 3.2377063234889647e-06
. O 0 1.0914524040117612e-07

Our O 0 5.132197884449852e-07
data O 0 1.2896143175566976e-07
suggest O 0 2.1442758679768303e-08
that O 0 4.2986630921504343e-10
, O 0 2.182990177512778e-10
in O 0 1.2857938047616813e-09
AAPC B-Disease 1 1.0
families O 0 1.6958630055796675e-09
, O 0 7.211308373361591e-12
the O 0 9.45209535641034e-12
location O 0 3.5604390546950526e-08
of O 0 6.518327211324504e-09
the O 0 2.4500451445419458e-08
APC B-Disease 0 1.8640137966485781e-07
mutation O 0 1.832879092944495e-08
may O 0 6.903976945693557e-09
partially O 0 1.1411776412728614e-08
predict O 0 2.397610776583292e-09
specific O 0 3.515542079668421e-09
phenotypic O 0 1.401458007421752e-07
expression O 0 2.507276803953573e-06
. O 0 2.242295749965706e-06

This O 0 5.380985101943736e-10
should O 0 3.673559026418083e-11
help O 0 3.762956612973767e-11
in O 0 7.966179105256543e-11
the O 0 2.417281097510937e-10
design O 0 2.024822798318837e-08
of O 0 5.637657007895314e-09
tailored O 0 7.619086517252072e-08
clinical O 0 2.0374601561456984e-08
- O 0 1.8863527628809607e-08
management O 0 3.3511307617750674e-10
protocols O 0 7.387778167000647e-10
in O 0 2.431225359922351e-11
this O 0 1.344490230953399e-11
subset O 0 1.9440384857460913e-09
of O 0 1.6001047153935133e-09
FAP B-Disease 0 4.7902446453917946e-08
patients O 0 2.896651252193294e-10
. O 0 1.997868093184252e-09
. O 0 1.1476522132625178e-07

Wilms B-Disease 0 0.0007620473043061793
' I-Disease 0 1.463938701817824e-06
tumor I-Disease 0 5.906537694500003e-07
1 O 0 6.699561083678418e-08
and O 0 1.271041827344277e-09
Dax O 0 4.3740819819504395e-06
- O 0 1.3830172562734333e-09
1 O 0 1.4617941301864334e-09
modulate O 0 2.328076620372599e-09
the O 0 6.854062872818645e-10
orphan O 0 2.2980588543219937e-09
nuclear O 0 2.2877029159928952e-09
receptor O 0 1.2914328273438969e-08
SF O 0 2.8821548312407685e-06
- O 0 1.413667316541023e-08
1 O 0 1.6337949659828155e-08
in O 0 1.8145634994581883e-10
sex O 0 2.0935459962845293e-11
- O 0 1.6481146308811034e-11
specific O 0 1.0715285429785393e-11
gene O 0 1.9682178109547976e-10
expression O 0 2.633853135591835e-09
. O 0 1.1125246501819674e-08

Products O 0 5.195468943952619e-08
of O 0 2.325481318621314e-08
steroidogenic O 0 9.246395507034322e-07
factor O 0 3.911070578510589e-08
1 O 0 3.7195761137809313e-08
( O 0 6.71941613461513e-10
SF O 0 6.822608042966749e-07
- O 0 3.686224436805219e-09
1 O 0 4.2815062606393894e-09
) O 0 2.850528840747657e-11
and O 0 2.5095603373159747e-10
Wilms B-Disease 0 1.8792535172451608e-07
tumor I-Disease 0 2.397576110979571e-07
1 O 0 1.5107862338936684e-07
( O 0 4.556978794312272e-09
WT1 O 0 1.8454888959240634e-06
) O 0 3.2026947760499525e-10
genes O 0 1.351623396539381e-10
are O 0 1.9095131292140577e-12
essential O 0 3.747785762286959e-11
for O 0 1.4324859007319724e-11
mammalian O 0 5.613710030161201e-08
gonadogenesis O 0 9.463892780559036e-08
prior O 0 2.9757361019733253e-09
to O 0 1.0347539491917246e-09
sexual O 0 4.503570849578864e-09
differentiation O 0 2.1551831252963893e-07
. O 0 8.384960636931282e-08

In O 0 4.392119112850423e-09
males O 0 2.580344382607791e-09
, O 0 5.561376914542393e-10
SF O 0 2.2893357254361035e-06
- O 0 3.819574700969497e-08
1 O 0 1.0257901550403403e-07
participates O 0 3.0600338929431814e-10
in O 0 1.2866143914158634e-11
sexual O 0 4.851954341772435e-12
development O 0 3.3384764137195377e-12
by O 0 2.020820576847937e-13
regulating O 0 1.0215225887399981e-10
expression O 0 4.6027673339388286e-10
of O 0 8.288261188482693e-10
the O 0 2.8026527765234732e-09
polypeptide O 0 1.329678269712531e-07
hormone O 0 1.6079743758723453e-08
Mullerian O 0 2.49962710086038e-07
inhibiting O 0 4.221622518230106e-08
substance O 0 4.97230452367603e-08
( O 0 8.633868731067196e-08
MIS O 0 3.246323103667237e-05
) O 0 1.0108903936156821e-08
. O 0 5.4160619100684926e-08

Here O 0 1.8098199916494195e-07
, O 0 3.827675509882056e-09
we O 0 7.782655631061175e-10
show O 0 1.096053581228773e-09
that O 0 5.638363664850488e-10
WT1 O 0 3.948302946810145e-06
- O 0 3.384508318049484e-07
KTS O 0 1.0140544873138424e-05
isoforms O 0 7.776149146820899e-08
associate O 0 2.0062439887169603e-07
and O 0 6.221927972838159e-10
synergize O 0 3.555803473886954e-08
with O 0 4.265568454009383e-10
SF O 0 7.875062692619395e-06
- O 0 6.232159677210802e-08
1 O 0 4.129134012487157e-08
to O 0 2.9107978249953703e-09
promote O 0 8.125262240810116e-08
MIS O 0 8.841783710522577e-06
expression O 0 2.198188475688312e-08
. O 0 7.467246376791081e-08

In O 0 1.0487865687025533e-08
contrast O 0 1.3574124579918134e-07
, O 0 1.3713708391094315e-08
WT1 O 0 0.00010232024942524731
missense O 0 2.9817199447279563e-06
mutations O 0 7.556262460184371e-08
, O 0 1.3505307983052717e-10
associated O 0 2.6266777641836825e-10
with O 0 3.013717400635052e-11
male B-Disease 0 1.1073046124465691e-07
pseudohermaphroditism I-Disease 1 1.0
in O 0 9.117042765183214e-08
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.5957356203653035e-08
fail O 0 1.9934649486685885e-08
to O 0 5.925570700782146e-09
synergize O 0 4.0152454516828584e-07
with O 0 4.030450639902483e-09
SF O 0 0.0006006297189742327
- O 0 6.382430910889525e-06
1 O 0 1.2818644790968392e-05
. O 0 3.603405218655098e-07

Additionally O 0 8.206632173823891e-07
, O 0 1.1915443076659926e-09
the O 0 1.9129535733242164e-09
X O 0 3.4944300750794355e-06
- O 0 1.9467445326881716e-06
linked O 0 7.59839986130828e-06
, O 0 3.3677391431119474e-10
candidate O 0 9.158305780410103e-10
dosage O 0 1.267841565066874e-08
- O 0 7.534466384129246e-10
sensitive O 0 2.428141465671274e-09
sex O 0 7.029913456912951e-11
- O 0 3.380210833459074e-10
reversal O 0 2.1405970329624324e-09
gene O 0 2.151680916773202e-10
, O 0 3.1986349680046544e-10
Dax O 0 4.2704903080448275e-07
- O 0 4.698233468936053e-10
1 O 0 1.3819203559251036e-09
, O 0 4.110167067805648e-11
antagonizes O 0 3.2688551865334148e-09
synergy O 0 2.0368762232436666e-09
between O 0 5.1089794617098505e-09
SF O 0 1.6588008975304547e-06
- O 0 4.943971987358964e-08
1 O 0 1.160790645826637e-07
and O 0 7.507386712291009e-09
WT1 O 0 3.855289833154529e-06
, O 0 3.1595312477428195e-10
most O 0 8.785004668165897e-11
likely O 0 9.257477423529892e-11
through O 0 4.85230605695719e-12
a O 0 2.7452302583941268e-11
direct O 0 9.944205459078148e-10
interaction O 0 3.1369069564135543e-09
with O 0 5.930700930356636e-10
SF O 0 0.00028486456722021103
- O 0 9.629049600334838e-06
1 O 0 1.3237609891803004e-05
. O 0 3.0776502057960897e-07

We O 0 1.9630046921292887e-08
propose O 0 3.5488163518948568e-09
that O 0 9.355054508830563e-10
WT1 O 0 3.918959464499494e-06
and O 0 3.3120983289336436e-08
Dax O 0 0.00023411060101352632
- O 0 1.2628023071670214e-08
1 O 0 6.7964740502191034e-09
functionally O 0 1.3578203006403555e-09
oppose O 0 6.202102720287428e-11
each O 0 2.761103195039749e-12
other O 0 1.0679354969789223e-11
in O 0 4.847590384660094e-11
testis O 0 1.0179623366468604e-08
development O 0 1.3068046644804099e-09
by O 0 1.9828565178681146e-10
modulating O 0 8.862924261165972e-08
SF O 0 1.1170737707288936e-05
- O 0 1.6833028837481834e-07
1 O 0 4.0407712731393985e-07
- O 0 8.804123297068145e-08
mediated O 0 3.5794468544736446e-07
transactivation O 0 8.60317527440202e-07
. O 0 7.1741546037173975e-09
. O 0 1.1733358284971018e-08

A O 0 8.619997515779687e-08
mouse O 0 1.5577525935839276e-09
model O 0 5.559375182428994e-09
for O 0 5.2854720600237215e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 1.0
centre O 1 0.9997684359550476
mutations O 0 2.841989044100046e-07
. O 0 2.1771791480773572e-08

Imprinting O 0 1.2078654663127963e-06
in O 0 3.3351528205827208e-09
the O 0 6.705413113650138e-09
15q11 O 0 1.331269317006445e-07
- O 0 4.089823146813387e-09
q13 O 0 2.0485735774400382e-08
region O 0 1.418625078519753e-10
involves O 0 2.5508976875254774e-11
an O 0 2.99624769439788e-11
imprinting O 0 7.822293923709367e-08
centre O 0 2.5781818635550735e-07
( O 0 5.754595133744544e-10
IC O 0 4.650760820368305e-05
) O 0 3.5818023547129485e-10
, O 0 1.4836866457645925e-10
mapping O 0 4.955267307593658e-10
in O 0 7.94402668646832e-11
part O 0 8.804110218640915e-11
to O 0 2.75690137385709e-10
the O 0 5.295613725309067e-09
promoter O 0 4.9981778715846303e-08
and O 0 1.279374606255601e-09
first O 0 5.193484309273799e-09
exon O 0 1.4665424430404528e-08
of O 0 7.095797514011792e-07
SNRPN O 1 0.7434217929840088
. O 0 2.2788342448620824e-06

Deletion O 0 1.2426981221835831e-08
of O 0 6.445139533184374e-09
this O 0 2.602089099745797e-10
IC O 0 1.1354120488249464e-06
abolishes O 0 4.072863646342739e-07
local O 0 2.7911205791042448e-08
paternally O 0 1.5011551113275345e-07
derived O 0 1.4764822697799218e-10
gene O 0 3.533972767200133e-11
expression O 0 8.25784926550277e-11
and O 0 4.6384823065848124e-12
results O 0 5.894992133326227e-11
in O 0 7.988154027138705e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
PWS B-Disease 1 1.0
) O 0 2.7874868635535677e-08
. O 0 2.9236748133598667e-08

We O 0 8.960691744164251e-09
have O 0 1.0123809429662955e-10
created O 0 9.296515779411152e-10
two O 0 9.757052804593158e-11
deletion O 0 5.721826901172733e-10
mutations O 0 2.549703781440371e-09
in O 0 2.5310090134844643e-10
mice O 0 4.4178768976443905e-10
to O 0 3.126822134547069e-10
understand O 0 1.1674227806679482e-07
PWS B-Disease 1 1.0
and O 0 1.5071210945905023e-09
the O 0 1.3207166471573828e-09
mechanism O 0 5.8666427271703014e-09
of O 0 4.835145062109802e-10
this O 0 1.2227243662010778e-09
IC O 0 3.0204460927052423e-05
. O 0 6.005436716804979e-07

Mice O 0 4.695479674410308e-06
harbouring O 0 1.954459003172815e-05
an O 0 9.430715763869557e-09
intragenic O 0 3.827488228580478e-07
deletion O 0 5.962507820811425e-09
in O 0 2.137822585623894e-09
Snrpn O 0 9.99359144771006e-07
are O 0 2.3405921645291983e-09
phenotypically O 0 8.846820128383115e-05
normal O 0 3.4823008263629163e-06
, O 0 2.6732988045452544e-10
suggesting O 0 3.952615124092063e-09
that O 0 1.4858758667912753e-10
mutations O 0 2.9363498299517232e-08
of O 0 9.176674353739145e-08
SNRPN O 0 0.0003438401035964489
are O 0 4.872027226099362e-10
not O 0 4.2210063222469785e-10
sufficient O 0 2.9173190085884926e-08
to O 0 1.3440409674103648e-08
induce O 0 0.0007147084106691182
PWS B-Disease 1 1.0
. O 0 8.035055543587077e-06

Mice O 0 3.0173225695762085e-08
with O 0 1.8547684221825733e-11
a O 0 8.752407132384121e-11
larger O 0 3.1622202079084616e-10
deletion O 0 3.7753236648008226e-10
involving O 0 1.79417911083668e-10
both O 0 5.877817677024666e-10
Snrpn O 0 1.8038821281152195e-07
and O 0 1.5556200771982276e-10
the O 0 1.965731355468847e-09
putative O 0 3.7684749258914962e-06
PWS O 1 1.0
- O 0 4.287858246243559e-08
IC O 0 2.673465644420503e-07
lack O 0 6.828695942040497e-10
expression O 0 8.561668735085348e-11
of O 0 6.242313888016326e-10
the O 0 5.290028415316783e-10
imprinted O 0 9.321893479352639e-09
genes O 0 7.775982524549363e-09
Zfp127 O 0 1.3344471483378584e-07
( O 0 1.2071078858699735e-10
mouse O 0 2.4440043322471183e-09
homologue O 0 1.0861194255085138e-07
of O 0 1.4274532667002404e-08
ZNF127 O 0 1.4456307326327078e-05
) O 0 2.035458690485825e-09
, O 0 7.229704834799122e-09
Ndn O 0 9.569860139890807e-07
and O 0 3.5561411593221237e-09
Ipw O 0 6.660400799773925e-07
, O 0 3.901874379153014e-09
and O 0 1.1429567292609022e-09
manifest O 0 1.6793705981399398e-08
several O 0 1.2235689128559102e-09
phenotypes O 0 1.821038893012883e-07
common O 0 6.221610782120024e-09
to O 0 1.0563053365331143e-07
PWS B-Disease 1 1.0
infants O 1 0.9974960684776306
. O 0 1.2707292853519903e-06

These O 0 1.5456065316499235e-09
data O 0 2.032742862922987e-09
demonstrate O 0 9.686041968492987e-10
that O 0 2.2826619067162213e-11
both O 0 4.334441833231395e-11
the O 0 1.880688937916375e-10
position O 0 7.711552507672081e-10
of O 0 7.53193729607915e-10
the O 0 9.237938192185879e-10
IC O 0 4.0869409190236183e-07
and O 0 1.39390624043223e-10
its O 0 2.0878446194139144e-10
role O 0 8.398889916882979e-11
in O 0 1.6898846905144538e-11
the O 0 7.98135724178195e-11
coordinate O 0 1.825561091184369e-10
expression O 0 1.5590188029435126e-09
of O 0 8.794452277527398e-09
genes O 0 1.572643570924015e-09
is O 0 9.060050626397143e-11
conserved O 0 1.1944022437759827e-09
between O 0 5.457077012493983e-10
mouse O 0 5.9005555996805015e-09
and O 0 4.5053727415478306e-10
human O 0 6.002602304100435e-10
, O 0 5.039543088392051e-11
and O 0 2.9574002968768554e-11
indicate O 0 5.047318119011379e-10
that O 0 3.490922828586207e-11
the O 0 7.243034505499679e-10
mouse O 0 7.207011654131179e-10
is O 0 3.867726625084167e-11
a O 0 3.4238722967927515e-11
suitable O 0 4.768209826977454e-09
model O 0 2.1900474767022615e-09
system O 0 1.7859100309713938e-10
in O 0 6.30931903944365e-11
which O 0 1.6129850927137923e-11
to O 0 1.455889020451906e-10
investigate O 0 2.1757002865996355e-09
the O 0 2.0044714776901174e-09
molecular O 0 2.4397950326715545e-08
mechanisms O 0 7.305696048121035e-09
of O 0 2.5358328770153094e-09
imprinting O 0 2.512038577151543e-08
in O 0 4.144750861967417e-11
this O 0 3.0406004103422646e-11
region O 0 1.720812159433649e-09
of O 0 2.1189010546152076e-09
the O 0 4.214492310694595e-09
genome O 0 2.4977757639987885e-09
. O 0 3.636572154519513e-09
. O 0 5.821668125349788e-08

Mutations O 0 7.030044457678741e-08
of O 0 8.436821907764624e-09
the O 0 1.153605322379292e-09
ATM O 0 1.2511320335306664e-07
gene O 0 1.8431501880300516e-09
detected O 0 2.339079152591239e-09
in O 0 5.691162818788342e-11
Japanese O 0 3.6032029129273724e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 0.014183648861944675
: O 0 2.3315746035257323e-12
possible O 0 4.169124073749586e-11
preponderance O 0 2.613458036648808e-07
of O 0 1.3102239293516504e-09
the O 0 1.7392177698027922e-09
two O 0 9.935277045514113e-10
founder O 0 6.520978246271625e-08
mutations O 0 1.793797821392218e-08
4612del165 O 0 5.427395777246602e-08
and O 0 1.600043653127159e-09
7883del5 O 0 7.023952548479429e-07
. O 0 1.1546100608939014e-07

The O 0 6.143912401057605e-08
ATM O 0 2.7869005862157792e-05
( O 0 1.7549122048876598e-06
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 3.8218811448942347e-10
mutated O 0 2.2962262646863962e-10
) O 0 1.0689518931475406e-12
gene O 0 6.377201718088532e-12
on O 0 1.6366002997258988e-10
human O 0 4.3052908460516903e-11
chromosome O 0 9.96937377095719e-09
11q22 O 0 1.0578713727227296e-06
. O 0 7.179646388522087e-08

3 O 0 9.813703400141094e-06
has O 0 3.4086282685308333e-09
recently O 0 5.761613408594712e-10
been O 0 3.0442443704759015e-11
identified O 0 1.0872205913337041e-10
as O 0 8.171498200315597e-12
the O 0 2.3753713839641533e-12
gene O 0 3.184551580770467e-12
responsible O 0 3.586557049614636e-12
for O 0 4.672114474815747e-13
the O 0 2.4436661028026663e-11
human O 0 1.438670871323211e-08
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.187315078534425e-09
. O 0 7.559833647974301e-09

In O 0 1.1287815127047907e-09
order O 0 3.437917173165772e-10
to O 0 1.2751009970113358e-10
define O 0 1.4041269258413536e-09
the O 0 1.8678908420000084e-10
types O 0 5.116586265785372e-09
of O 0 4.005765052994548e-09
disease O 0 1.1182223147443437e-07
- O 0 2.2420870493533585e-08
causing O 0 5.2021022156623076e-08
ATM O 0 7.29604835214559e-07
mutations O 0 7.0266228391346885e-09
in O 0 1.2012420225193665e-10
Japanese O 0 1.9450560273526207e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.4278344728779757e-08
as O 0 2.770358664694328e-10
well O 0 1.382266870408877e-11
as O 0 1.3917059345225358e-11
to O 0 1.3737197143703916e-11
look O 0 1.1348037093350527e-10
for O 0 9.458407147777681e-12
possible O 0 1.7624869341759108e-09
mutational O 0 5.317458544595866e-07
hotspots O 0 6.453198864164733e-08
, O 0 7.897649201282775e-10
reverse O 0 1.0007782158538703e-08
- O 0 6.943885910715153e-09
transcribed O 0 1.7867967105900107e-09
RNA O 0 3.5642064299956644e-10
derived O 0 6.875427310815141e-11
from O 0 2.7481796352479826e-11
ten O 0 2.433268031509783e-10
patients O 0 1.7511461031238795e-11
belonging O 0 5.2485581852890206e-11
to O 0 5.890586629586636e-11
eight O 0 1.859030152040475e-10
unrelated O 0 6.6472063409150905e-09
Japanese O 0 1.4288620775460004e-07
A B-Disease 1 1.0
- I-Disease 1 0.9861515164375305
T I-Disease 1 1.0
families O 0 1.0686951767979735e-08
was O 0 1.4428086503315285e-09
analyzed O 0 1.1189546511580772e-10
for O 0 1.3145831645466899e-11
mutations O 0 1.9482988833363635e-10
by O 0 6.357470105911034e-11
the O 0 9.628791097782141e-10
restriction O 0 9.235564313314626e-09
endonuclease O 0 3.159269112984475e-08
fingerprinting O 0 4.859797009260092e-09
method O 0 1.1645828124073887e-07
. O 0 2.6313747980566404e-07

As O 0 2.520986299714423e-07
has O 0 2.893969064388102e-09
been O 0 4.1079589729875465e-10
reported O 0 1.7636461735470732e-10
by O 0 1.3487435127079728e-11
others O 0 5.576183403910306e-10
, O 0 6.778731048706632e-11
mutations O 0 4.032078559923491e-10
that O 0 4.4855976572000245e-11
lead O 0 1.0189175059238664e-09
to O 0 2.7686803960591533e-09
exon O 0 7.405631663459644e-08
skipping O 0 1.210124764838838e-07
or O 0 2.5538518855228176e-08
premature O 0 1.33139380409375e-07
protein O 0 5.851781992305405e-08
truncation O 0 1.0413241824380748e-07
were O 0 2.1725610199752055e-09
also O 0 5.564347316244778e-10
predominant O 0 3.512246493642124e-08
in O 0 7.548793257150521e-10
our O 0 4.712921608529541e-08
mutants O 0 2.8869945367659966e-07
. O 0 1.8995785922015784e-07

Six O 0 3.250007551969247e-08
different O 0 1.5315119172853997e-09
mutations O 0 5.26231591635451e-09
were O 0 6.042873840206298e-11
identified O 0 7.531488627199323e-11
on O 0 7.627144749111636e-11
12 O 0 1.9684881502612939e-10
of O 0 4.873346726164129e-10
the O 0 3.217464294991146e-09
16 O 0 2.383595720800713e-08
alleles O 0 4.304148149003595e-08
examined O 0 9.85222186500323e-07
. O 0 7.388207450276241e-07

Four O 0 2.8282636677090522e-08
were O 0 8.459796752013915e-10
deletions O 0 6.740599634014188e-09
involving O 0 1.6195152163778204e-10
a O 0 2.6952012843750595e-10
loss O 0 7.763564013885116e-09
of O 0 1.5763983896022182e-08
a O 0 1.4473564569073005e-09
single O 0 9.566842873454107e-10
exon O 0 4.62359706077109e-09
exon O 0 3.088281275154259e-08
7 O 0 3.511021589019947e-07
, O 0 3.904368384155532e-09
exon O 0 1.0875244704777742e-08
16 O 0 1.597687884213883e-07
, O 0 5.136474801048507e-09
exon O 0 1.7851419897851883e-08
33 O 0 2.2686896272716695e-07
or O 0 6.875906954917355e-09
exon O 0 2.656578601545334e-08
35 O 0 6.751481578248786e-07
. O 0 2.4388282326981425e-07

The O 0 2.3581101515901537e-07
others O 0 2.1503700153857608e-08
were O 0 3.3552640665845956e-09
minute O 0 6.788935991153267e-08
deletions O 0 1.4982131801843934e-07
, O 0 7.060339535236437e-10
4649delA O 0 4.265508124490225e-08
in O 0 8.876687163095198e-10
exon O 0 9.6611376676492e-09
33 O 0 1.832512737109937e-07
and O 0 1.2999408216529673e-09
7883del5 O 0 1.4743990561782994e-07
in O 0 1.1199652316662423e-09
exon O 0 3.795471315015675e-08
55 O 0 4.7453758611482044e-07
. O 0 1.9107307025478804e-07

The O 0 5.225920745033363e-07
mutations O 0 2.8257304052203835e-07
4612del165 O 0 2.3917982616694644e-07
and O 0 5.917706880076423e-10
7883del5 O 0 8.571207388285984e-08
were O 0 5.603060793113457e-10
found O 0 7.936484108794772e-11
in O 0 5.26110405241198e-12
more O 0 4.1105651868433846e-12
than O 0 1.2768161528065036e-11
two O 0 9.443229184724622e-12
unrelated O 0 8.166609749560294e-11
families O 0 9.321150622187968e-12
; O 0 3.3138168858276584e-12
44 O 0 7.608028096406372e-10
% O 0 1.974334064291927e-11
( O 0 2.571059142496279e-13
7 O 0 9.306729692459825e-11
of O 0 3.1693694890755353e-10
16 O 0 2.924385733571455e-10
) O 0 1.0794893624821444e-12
of O 0 5.543825121190338e-11
the O 0 8.217673763688538e-11
mutant O 0 1.0435714792311757e-10
alleles O 0 5.706282321660261e-11
had O 0 1.224716994485675e-10
one O 0 9.873083600675514e-11
of O 0 1.3597485359895245e-09
the O 0 6.836179178293378e-09
two O 0 9.304467418758122e-09
mutations O 0 2.2803487809142098e-07
. O 0 4.328203431214206e-07

The O 0 1.8706028015458287e-07
4612del165 O 0 2.3732712861601613e-07
mutations O 0 3.727244290985254e-09
in O 0 4.712716675236983e-11
three O 0 1.90888689403923e-12
different O 0 4.975776735083315e-12
families O 0 2.557864857422043e-11
were O 0 2.1302168362602458e-11
all O 0 2.9017524060676037e-12
ascribed O 0 2.3859050291008543e-09
to O 0 1.4859920238752267e-10
the O 0 2.8353217551568832e-09
same O 0 5.214010112553069e-09
T O 0 1.2149626194002394e-08
- O 0 1.4632893785559986e-09
- O 0 1.521794912306973e-09
> O 0 2.684319710954952e-10
A O 0 5.799839497555581e-10
substitution O 0 2.6550764364863255e-10
at O 0 2.844594004791645e-10
the O 0 1.898735751959535e-10
splice O 0 1.365170110290137e-08
donor O 0 2.4615525173743436e-09
site O 0 6.281578635025653e-08
in O 0 3.024408279372892e-09
intron O 0 2.0721956843772205e-06
33 O 0 3.2534981073695235e-06
. O 0 5.668778157996712e-07

Microsatellite O 0 2.11210863199085e-06
genotyping O 0 2.81860366158071e-07
around O 0 8.799753814514588e-09
the O 0 9.520938704099535e-09
ATM O 0 3.545581648722873e-06
locus O 0 4.0216676211457525e-08
also O 0 8.143951069072841e-10
indicated O 0 4.698932354330054e-10
that O 0 2.1859293888870646e-12
a O 0 1.62916832802118e-11
common O 0 4.090490099417643e-11
haplotype O 0 1.174383701396664e-08
was O 0 1.9224306591070217e-09
shared O 0 3.9928619438578394e-11
by O 0 5.684682759243831e-12
the O 0 1.189559145631236e-10
mutant O 0 8.942589446725435e-10
alleles O 0 9.354715890808052e-10
in O 0 1.278096628531955e-09
both O 0 1.025883644700798e-08
mutations O 0 2.5633784161982476e-07
. O 0 2.5653790203250537e-07

This O 0 4.789675767113977e-09
suggests O 0 2.1805913519301612e-08
that O 0 9.918382087859001e-11
these O 0 1.3216945315974726e-09
two O 0 1.7257588691421688e-09
founder O 0 1.135193912205068e-07
mutations O 0 9.047660398664448e-09
may O 0 2.4069338189214307e-10
be O 0 4.650071300238423e-11
predominant O 0 1.2168875684892555e-08
among O 0 9.438407694295492e-11
Japanese O 0 4.32101643355054e-09
ATM O 0 1.0323635990516777e-07
mutant O 0 3.0875568768351513e-08
alleles O 0 6.710329358838862e-08
. O 0 2.5208515808117227e-07

W474C O 0 5.3450835366675165e-06
amino O 0 5.42017488669444e-08
acid O 0 3.9065189971765335e-10
substitution O 0 3.2080565981473796e-10
affects O 0 5.329705773937654e-11
early O 0 8.959550115705817e-12
processing O 0 1.3324157055460972e-10
of O 0 3.980461793506862e-10
the O 0 2.584751579437494e-10
alpha O 0 5.98398899875896e-11
- O 0 4.498481448456104e-12
subunit O 0 1.7795088319561003e-12
of O 0 7.975970578444347e-11
beta O 0 1.370496216512862e-10
- O 0 1.8618155628313815e-10
hexosaminidase O 0 5.276759473815673e-09
A O 0 3.3789360198710483e-09
and O 0 1.6902779523264577e-11
is O 0 4.9244150424065936e-12
associated O 0 1.6677274838894363e-10
with O 0 6.684400949419356e-11
subacute O 0 1.4258567716751713e-05
G B-Disease 0 0.05569633096456528
( I-Disease 0 5.024376150686294e-06
M2 I-Disease 1 1.0
) I-Disease 0 3.614473342850033e-08
gangliosidosis I-Disease 0 8.23384034447372e-05
. O 0 4.241344413458137e-07

Mutations O 0 3.7018399012822556e-08
in O 0 1.2221204048756817e-09
the O 0 9.47978673337957e-09
HEXA O 0 2.315731109092667e-07
gene O 0 7.505091548232201e-10
, O 0 7.895626513709786e-11
encoding O 0 1.3013766453351394e-10
the O 0 1.5019899768375922e-09
alpha O 0 8.803707762794488e-11
- O 0 3.895339779902418e-12
subunit O 0 1.2574400071532765e-12
of O 0 3.474753471066627e-11
beta O 0 1.4185440322389553e-10
- O 0 2.726451286960696e-10
hexosaminidase O 0 1.1231382046617e-08
A O 0 1.6635798516517752e-08
( O 0 1.121946702209442e-10
Hex O 0 1.3407226440165232e-08
A O 0 2.711663249499452e-08
) O 0 3.7174787553828637e-11
, O 0 1.527720484839623e-11
that O 0 9.058110164716915e-12
abolish O 0 5.130325941848923e-09
Hex O 0 2.4145279553522414e-08
A O 0 4.185781055099369e-09
enzyme O 0 5.505170097563905e-09
activity O 0 2.458461878518392e-08
cause O 0 2.12524118978763e-05
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 5.279263137758505e-10
TSD B-Disease 0 2.7491175842442317e-06
) O 0 4.547863387965867e-12
, O 0 1.851674412758908e-12
the O 0 1.3561133119233126e-11
fatal O 0 2.7939848212810148e-09
infantile B-Disease 0 7.760458231587108e-08
form I-Disease 0 1.6370123312459128e-10
of I-Disease 0 6.418679987518772e-08
G I-Disease 0 2.227800723630935e-05
( I-Disease 0 3.001051140927302e-07
M2 I-Disease 1 0.8652202486991882
) I-Disease 0 7.560237769155265e-09
gangliosidosis I-Disease 0 1.0662944305295241e-06
, I-Disease 0 7.821167602450885e-10
Type I-Disease 0 6.796422091781551e-09
1 I-Disease 0 2.4928186803663266e-07
. O 0 2.2941367205930874e-07

Less O 0 2.2681870603946663e-08
severe O 0 3.8070504615461687e-07
, O 0 1.2508349911399819e-09
subacute O 0 1.0660169209586456e-06
( O 0 1.1051382725613124e-10
juvenile O 0 2.1427513274829835e-07
- O 0 5.095717483527551e-07
onset O 1 0.9999973773956299
) O 0 9.206693046825976e-11
and O 0 1.2809422411663718e-09
chronic O 0 0.01536514051258564
( O 0 8.99716065538847e-11
adult O 0 8.556996363040525e-06
- O 0 2.2511376585043763e-07
onset O 0 1.3767096788797062e-05
) O 0 9.932424674397033e-12
variants O 0 1.1898632079621052e-10
are O 0 4.328194486841186e-12
characterized O 0 3.383826205349827e-12
by O 0 2.86144778661665e-13
a O 0 2.4458672934213332e-11
broad O 0 3.606481502327341e-10
spectrum O 0 1.3163006240546338e-09
of O 0 1.117508655057442e-10
clinical O 0 2.2296833823709505e-10
manifestations O 0 1.6443797434817498e-09
and O 0 4.771234102252109e-11
are O 0 3.685994218183275e-12
associated O 0 2.499409290646071e-10
with O 0 2.4582235552683684e-11
residual O 0 0.0005904472782276571
levels O 0 6.706196131744946e-08
of O 0 1.0752485479770257e-07
Hex O 0 6.263931027206127e-07
A O 0 3.045271910195879e-07
enzyme O 0 3.1624045959688374e-07
activity O 0 1.0899832432187395e-06
. O 0 6.58646612805569e-08

We O 0 1.8492711362227965e-08
identified O 0 4.952076082531676e-09
a O 0 1.9392241146221068e-09
1422 O 0 2.124053821717098e-07
G O 0 3.4939255044719175e-08
- O 0 8.609593038499952e-09
- O 0 8.952730112810059e-09
> O 0 2.3642692248415642e-09
C O 0 7.415734692983733e-09
( O 0 8.56973519924864e-12
amino O 0 4.352037480392923e-11
acid O 0 7.626370021607265e-12
W474C O 0 9.926704423735e-12
) O 0 7.154069389267383e-16
substitution O 0 1.0778243532058585e-13
in O 0 1.226344465430143e-13
the O 0 1.902917710558394e-12
first O 0 3.9181262401211114e-12
position O 0 1.3153562961054632e-10
of O 0 1.1824717593977851e-10
exon O 0 2.4793961328484215e-10
13 O 0 7.028312154488958e-09
of O 0 8.891777270036982e-08
HEXA O 0 0.00023654568940401077
of O 0 5.138682581673493e-07
a O 0 1.878342636985053e-08
non O 0 1.3014606565775466e-06
- O 0 9.570575087991529e-08
Jewish O 0 1.960167173820082e-05
proband O 0 3.3414631616324186e-05
who O 0 2.0863956395889005e-10
manifested O 0 4.327150304739291e-10
a O 0 2.9058358150257924e-11
subacute O 0 9.485701113476352e-09
variant O 0 8.89458817709965e-09
of O 0 1.576869635755429e-06
G B-Disease 1 0.9999901056289673
( I-Disease 0 0.1381845325231552
M2 I-Disease 1 1.0
) I-Disease 0 1.4341755161240144e-07
gangliosidosis I-Disease 0 8.017770596779883e-05
. O 0 5.416789576884184e-07

On O 0 3.2416309636573715e-08
the O 0 1.6853228146374022e-08
second O 0 9.676336532038476e-08
maternally O 0 2.634729753481224e-06
inherited O 0 1.1323433000143268e-06
allele O 0 2.5985308127474127e-08
, O 0 3.6135044956253637e-10
we O 0 3.4431783813015926e-11
identified O 0 2.969418599896301e-10
the O 0 1.6898402122045297e-10
common O 0 1.1400876687162054e-08
infantile O 1 0.9999992847442627
disease O 0 0.12614211440086365
- O 0 9.464720278629102e-07
causing O 0 0.00013893030700273812
4 O 0 9.538571612210944e-05
- O 0 3.780512088269461e-06
bp O 0 5.4452303999141805e-08
insertion O 0 7.404964641466449e-09
, O 0 4.541063913787724e-10
+ O 0 5.618709941757061e-09
TATC O 0 5.27834527019877e-06
1278 O 0 7.843402158869139e-07
, O 0 3.451477992300056e-10
in O 0 4.680684173585803e-10
exon O 0 1.7729806955912863e-08
11 O 0 2.021554905695666e-07
. O 0 2.1743598210832715e-07

Pulse O 0 2.110654804710066e-06
- O 0 1.5423303523220966e-07
chase O 0 1.4900975564557939e-08
analysis O 0 9.635364034421556e-11
using O 0 1.3190494529968788e-10
proband O 0 4.24872467874593e-07
fibroblasts O 0 1.923873753639782e-07
revealed O 0 1.1007091238468547e-08
that O 0 9.816413654162304e-11
the O 0 2.3500756896055464e-09
W474C O 0 1.2826885331662652e-08
- O 0 1.5984871759577857e-10
containing O 0 4.518554627686022e-11
alpha O 0 1.1285097162305746e-10
- O 0 1.3600532158819512e-11
subunit O 0 3.988019116329955e-12
precursor O 0 6.279644582107835e-10
was O 0 1.068268695725294e-09
normally O 0 6.741673191923425e-11
synthesized O 0 4.6237708106744435e-10
, O 0 4.352933985485308e-11
but O 0 1.0958919882675389e-10
not O 0 8.707333465363121e-11
phosphorylated O 0 2.9446769467256217e-09
or O 0 4.234020911653147e-10
secreted O 0 1.976257602009923e-09
, O 0 4.966126815331151e-11
and O 0 2.6862917446024426e-10
the O 0 1.646922953568719e-08
mature O 0 8.241104154649292e-08
lysosomal O 0 3.3018460499079083e-07
alpha O 0 8.439300813734008e-09
- O 0 1.1854600634464418e-09
subunit O 0 4.247788232270011e-10
was O 0 2.8922859662827705e-09
not O 0 2.1357753066109098e-10
detected O 0 3.195131981215127e-08
. O 0 3.074839227679149e-08

When O 0 1.3350907934750467e-08
the O 0 1.0869313449290985e-08
W474C O 0 2.2687583367542175e-08
- O 0 2.8159827247797864e-10
containing O 0 3.2347024364609567e-11
alpha O 0 1.1941572730655992e-11
- O 0 2.6190410517407114e-12
subunit O 0 1.217033635328435e-12
was O 0 1.271467930941128e-10
transiently O 0 7.418221037447381e-10
co O 0 8.047915112108228e-11
- O 0 3.008766499834614e-11
expressed O 0 7.54072672359829e-12
with O 0 4.071998272424382e-13
the O 0 1.2981035517334316e-11
beta O 0 1.5305313440239221e-12
- O 0 3.5055847656152717e-13
subunit O 0 8.836701037790232e-14
to O 0 1.3467300191694065e-12
produce O 0 7.369760357534005e-11
Hex O 0 7.715793337581545e-09
A O 0 8.346330560016213e-08
( O 0 1.0973252306811787e-09
alphabeta O 0 2.0449007820388942e-07
) O 0 2.4864034442462213e-11
in O 0 4.0050374128242083e-10
COS O 0 4.216802267364983e-07
- O 0 6.085340231720693e-09
7 O 0 5.807015757142153e-09
cells O 0 6.854533052269574e-10
, O 0 4.7449520007569745e-11
the O 0 4.618130045042079e-10
mature O 0 1.592376785986005e-10
alpha O 0 5.8025254739968446e-11
- O 0 1.4603046202821268e-11
subunit O 0 3.832447380280879e-12
was O 0 2.3696675177653503e-10
present O 0 5.6425565608808625e-11
, O 0 8.535412827914701e-12
but O 0 1.8415598906917907e-11
its O 0 2.291338299653667e-11
level O 0 7.570825633074207e-10
was O 0 3.0189428734672674e-10
much O 0 2.5797117914061474e-11
lower O 0 9.91630180746661e-11
than O 0 3.7944070628570525e-12
that O 0 3.224808961532766e-11
from O 0 1.432747032126258e-09
normal O 0 5.571742178744898e-09
alpha O 0 3.0069610690297566e-10
- O 0 1.3390703823557004e-10
subunit O 0 1.126393631145639e-10
transfections O 0 1.014521799902468e-08
, O 0 1.0799285944662618e-11
although O 0 7.524319708962501e-12
higher O 0 1.4962134309293162e-10
than O 0 3.1911303027126747e-12
in O 0 1.4787445573594127e-11
those O 0 3.955071548045197e-10
cells O 0 3.621351440941112e-09
transfected O 0 6.0733160722747925e-09
with O 0 5.126014196443762e-12
an O 0 1.0749886397709574e-10
alpha O 0 2.9782443178305584e-10
- O 0 8.703448378666323e-11
subunit O 0 7.324468115355032e-11
associated O 0 3.666758452425256e-09
with O 0 3.78119136001942e-09
infantile O 1 0.9998823404312134
TSD B-Disease 0 0.0036635221913456917
. O 0 5.451162792269315e-07

Furthermore O 0 8.44980618808222e-08
, O 0 1.9630101710799153e-10
the O 0 2.096608026080915e-10
precursor O 0 1.7074345493028886e-08
level O 0 7.870375462459833e-09
of O 0 3.3127411924738226e-09
the O 0 1.86793824852316e-09
W474C O 0 6.318285450390704e-09
alpha O 0 3.1304667191811575e-11
- O 0 1.3813603039203315e-11
subunit O 0 6.9820447166912825e-12
was O 0 1.3522784281239097e-10
found O 0 3.866604085522862e-12
to O 0 7.635044506348887e-12
accumulate O 0 7.769511423116882e-11
in O 0 9.101458302296361e-12
comparison O 0 9.325996641607048e-10
to O 0 3.0926575189660355e-10
the O 0 1.734534471609095e-08
normal O 0 4.7427516136622216e-08
alpha O 0 5.197755559294137e-09
- O 0 2.608087745770149e-09
subunit O 0 1.7449895972632135e-09
precursor O 0 9.157807312476507e-08
levels O 0 2.8403896124018502e-08
. O 0 1.823238449105702e-08

We O 0 2.5050004737181553e-08
conclude O 0 4.16749195153443e-08
that O 0 1.746410377423402e-10
the O 0 4.499887129583158e-09
1422 O 0 5.162943921277474e-07
G O 0 1.9230263603731146e-07
- O 0 6.666825669299214e-08
- O 0 4.550735965835884e-08
> O 0 2.923093544993094e-09
C O 0 1.090423418226294e-09
mutation O 0 1.3705575303141204e-12
is O 0 3.6603065142661734e-14
the O 0 9.383610560667957e-14
cause O 0 4.3329707877237666e-11
of O 0 2.8136368235287534e-10
Hex B-Disease 0 3.2416346584795974e-07
A I-Disease 0 2.830762696248712e-06
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 3.5518501473319475e-09
the O 0 1.5662712016251135e-08
proband O 0 2.1311664113454754e-06
. O 0 2.5616085252977427e-08

The O 0 5.243940393029334e-09
resulting O 0 5.522923451906081e-09
W474C O 0 5.7462436586774857e-08
substitution O 0 3.139470550195256e-08
clearly O 0 6.08922956502056e-09
interferes O 0 3.2236440183908144e-09
with O 0 2.480946177663146e-11
alpha O 0 2.0294296798617495e-10
- O 0 1.5220606025545536e-11
subunit O 0 6.0034889386162416e-12
processing O 0 2.156788220242234e-10
, O 0 1.3569172912022975e-12
but O 0 1.4014064431480677e-12
because O 0 7.370849265143919e-13
the O 0 8.031774572682393e-13
base O 0 3.250825390127554e-12
substitution O 0 3.9137366958375e-11
falls O 0 3.254273517327988e-09
at O 0 8.822045871603734e-11
the O 0 1.19211654436846e-10
first O 0 4.4756098827036794e-10
position O 0 1.3477478688628253e-08
of O 0 9.925829935752972e-09
exon O 0 1.2284123052097584e-08
13 O 0 4.99473742365808e-07
, O 0 1.6291894056053025e-08
aberrant O 0 2.982078584068404e-08
splicing O 0 2.2959394385679843e-08
may O 0 1.3044743951695636e-08
also O 0 3.9690292719107845e-10
contribute O 0 2.6310815748331606e-09
to O 0 4.49469750307685e-09
Hex B-Disease 0 8.742092177271843e-06
A I-Disease 0 4.123352027818328e-06
deficiency I-Disease 0 3.3297123991360422e-06
in O 0 1.972570995434353e-09
this O 0 2.6235849048816817e-09
proband O 0 2.724796331676771e-06
. O 0 1.0511456594031188e-08
. O 0 4.7661117719144386e-08

Two O 0 2.4042328128359713e-09
frequent O 0 3.580275986792003e-08
missense O 0 1.679952447375399e-06
mutations O 0 7.378195050478098e-07
in O 0 1.9869169420871913e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.7982275721806218e-06

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.3985620439527224e-09
an O 0 1.582786097742428e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 3.138961446325084e-08
by O 0 2.311039814378857e-12
early O 0 1.1726288384750205e-08
childhood O 1 0.9999992847442627
deafness B-Disease 1 1.0
and O 0 0.0009165136725641787
goiter B-Disease 1 1.0
. O 0 1.3011480177738122e-06

A O 0 6.096339006944618e-07
century O 0 4.6318607616058216e-08
after O 0 4.9792534678738676e-11
its O 0 1.7071770429602506e-12
recognition O 0 1.3330461734462062e-10
as O 0 1.7510533301123843e-10
a O 0 4.1170816755808914e-10
syndrome O 0 1.6926485102430888e-08
by O 0 1.1036047770085489e-10
Vaughan O 0 4.2263600619207864e-08
Pendred O 0 2.4994174054882023e-06
, O 0 1.1394061388836363e-10
the O 0 5.21600651559595e-10
disease O 0 3.3789233633285676e-09
gene O 0 2.6312572121156563e-09
( O 0 6.929570250946426e-09
PDS O 0 7.85047814133577e-05
) O 0 7.11883330062335e-11
was O 0 2.090543516075627e-09
mapped O 0 2.496432838228202e-09
to O 0 1.5878464099117195e-09
chromosome O 0 2.1723266740991676e-07
7q22 O 0 1.0829501661646646e-05
- O 0 2.065414719254477e-06
q31 O 0 9.773849342309404e-06
. O 0 1.698088283319521e-07

1 O 0 1.625835807317344e-06
and O 0 3.673262938264088e-08
, O 0 4.2141867773182184e-09
recently O 0 5.487369669765485e-09
, O 0 7.854216582670048e-11
found O 0 3.105968954253413e-11
to O 0 9.992303512396106e-11
encode O 0 1.0396527194700411e-08
a O 0 2.2411805744582125e-08
putative O 0 4.00600674765883e-06
sulfate O 0 1.2875009360868717e-06
transporter O 0 9.198874977300875e-07
. O 0 1.3443157342862833e-07

We O 0 6.824688814077717e-09
performed O 0 1.0510163572785558e-10
mutation O 0 9.065755091075545e-11
analysis O 0 9.208976636809751e-11
of O 0 2.315242442207932e-10
the O 0 2.7433120219910734e-09
PDS B-Disease 0 2.341907247682684e-06
gene O 0 7.287460634941567e-10
in O 0 4.4586798142454143e-10
patients O 0 1.5653825458095127e-10
from O 0 5.442337691619059e-10
14 O 0 4.3551224848670245e-09
Pendred B-Disease 0 2.7708423999683873e-08
families O 0 7.255460815480674e-11
originating O 0 3.101069123712108e-10
from O 0 8.016447228254009e-11
seven O 0 3.469409134981838e-11
countries O 0 5.133607081098113e-12
and O 0 9.596152344970577e-11
identified O 0 3.0884150792331866e-09
all O 0 3.5295439904103887e-09
mutations O 0 1.9406130036259128e-07
. O 0 1.0058190724748783e-07

The O 0 7.236398857912718e-08
mutations O 0 1.769170232535089e-08
include O 0 2.8254948380990186e-10
three O 0 3.6410399695263607e-10
single O 0 1.7078560787808783e-10
base O 0 4.554789434507711e-09
deletions O 0 4.516682849953213e-08
, O 0 9.723284399854037e-10
one O 0 2.547370536731819e-09
splice O 0 3.8797472257101617e-07
site O 0 5.169491146261862e-08
mutation O 0 1.1183365344891172e-09
and O 0 1.1901679641823648e-09
10 O 0 6.17337292396769e-08
missense O 0 2.450504098305828e-06
mutations O 0 2.526351181586506e-06
. O 0 1.1934108670175192e-06

One O 0 1.6955047144051605e-08
missense O 0 6.578744660146185e-07
mutation O 0 6.5088356926423785e-09
( O 0 9.978672332877636e-10
L236P O 0 3.0094710723460594e-08
) O 0 2.5582452822803248e-11
was O 0 2.7107296962647354e-10
found O 0 2.8418903515181615e-12
in O 0 1.0871365656653365e-12
a O 0 1.298271993382949e-11
homozygous O 0 8.171377463561669e-11
state O 0 1.0595828381365635e-10
in O 0 9.599190886611098e-11
two O 0 1.7192758328121727e-10
consanguineous O 0 1.794324688830784e-08
families O 0 8.593735445483475e-11
and O 0 1.3901194431675812e-11
in O 0 1.705960372966331e-11
a O 0 1.4077840282400444e-10
heterozygous O 0 2.829539658133484e-10
state O 0 2.2839043156697159e-10
in O 0 2.8759519765664265e-10
five O 0 5.884301379488477e-10
additional O 0 7.3597936633973404e-09
non O 0 5.826767051075876e-07
- O 0 7.22039146694442e-07
consanguineous O 0 4.819019977730932e-06
families O 0 3.277159521530848e-08
. O 0 6.722242318346616e-08

Another O 0 2.0006909906555848e-08
missense O 0 8.621828442301194e-07
mutation O 0 1.5733464309164447e-08
( O 0 1.4212366838961543e-09
T416P O 0 4.227682381952036e-08
) O 0 1.5939196143510692e-11
was O 0 1.5460302482672716e-10
found O 0 5.1380345290896745e-12
in O 0 1.8808305607409537e-12
a O 0 9.54375987960443e-12
homozygous O 0 4.5065392390020165e-11
state O 0 3.4071946652947105e-11
in O 0 5.5655549613398136e-11
one O 0 2.5957541671672857e-10
family O 0 4.0476896834285014e-10
and O 0 2.900779963455058e-11
in O 0 2.374679446137673e-11
a O 0 8.424640846049769e-11
heterozygous O 0 1.3019824107729505e-10
state O 0 2.6331334335161216e-10
in O 0 6.173543898313483e-10
four O 0 2.8014663921993588e-09
families O 0 1.8571782334220188e-08
. O 0 1.570870296063731e-07

Pendred B-Disease 0 3.256362833781168e-05
patients O 0 2.498615891965983e-08
in O 0 2.2099626573179876e-09
three O 0 2.408726329505839e-09
non O 0 9.312886106727092e-08
- O 0 2.709047386417751e-08
consanguineous O 0 5.41260135378252e-07
families O 0 5.18498222135122e-09
were O 0 2.1524279580908967e-10
shown O 0 2.4179991342521134e-11
to O 0 2.3769273008178438e-11
be O 0 5.313080878033283e-11
compound O 0 1.0628745661378503e-09
heterozygotes O 0 7.897201115270036e-09
for O 0 4.45628201006798e-10
L236P O 0 5.3866898497290094e-08
and O 0 1.9429855502295368e-09
T416P O 0 7.859628112782957e-07
. O 0 1.281158432675511e-07

In O 0 3.402652160033881e-09
total O 0 4.943233822274351e-09
, O 0 1.182086095674606e-10
one O 0 1.0541844480682627e-10
or O 0 6.474444591564321e-11
both O 0 1.8252302447230306e-10
of O 0 2.376449037555517e-09
these O 0 1.342282257565941e-10
mutations O 0 1.6168832939200684e-09
were O 0 1.5006004772111226e-10
found O 0 3.3421095751995367e-11
in O 0 4.238592116179163e-11
nine O 0 1.0515180948189595e-09
of O 0 3.276608095958977e-09
the O 0 1.1981059699905927e-08
14 O 0 2.7430621329926907e-08
families O 0 1.3246706842551248e-08
analyzed O 0 1.463516809963039e-07
. O 0 1.9167498521710513e-07

The O 0 8.674036489075831e-10
identification O 0 1.9960322283907317e-09
of O 0 2.6320954304992483e-09
two O 0 4.46700454403981e-10
frequent O 0 3.722280439433234e-08
PDS B-Disease 0 0.0006051386008039117
mutations O 0 6.466589486109342e-09
will O 0 2.4887092386904897e-11
facilitate O 0 1.5814147769077636e-09
the O 0 2.892852624114539e-10
molecular O 0 5.876097475265851e-08
diagnosis O 0 1.872662323876284e-06
of O 0 2.1910896919052902e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.445100110686326e-06

Insertional O 0 2.6847155822906643e-05
mutation O 0 1.6961388737968264e-08
by O 0 4.157587885078584e-10
transposable O 0 3.6601295505533926e-07
element O 0 4.206303216847118e-08
, O 0 7.259714496221648e-10
L1 O 0 3.7492216620194085e-07
, O 0 5.649599191248633e-11
in O 0 6.473691027686357e-11
the O 0 1.5607215075874592e-08
DMD B-Disease 1 1.0
gene O 0 9.200649486729162e-08
results O 0 1.4252474045406416e-07
in O 0 9.713538418054668e-09
X B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999990463256836
linked I-Disease 1 0.999672532081604
dilated I-Disease 0 0.3541141450405121
cardiomyopathy I-Disease 1 1.0
. O 0 1.1413928859838052e-06

X B-Disease 1 0.9999427795410156
- I-Disease 1 0.9999734163284302
linked I-Disease 1 0.9992048144340515
dilated I-Disease 1 0.9999934434890747
cardiomyopathy I-Disease 1 1.0
( O 0 1.5201342193904566e-06
XLDCM B-Disease 1 1.0
) O 0 1.0285643864405003e-11
is O 0 4.375871681065041e-13
a O 0 1.5416588361807926e-12
clinical O 0 2.495593454110434e-10
phenotype O 0 4.192055058638289e-08
of O 0 1.1729509807878458e-08
dystrophinopathy B-Disease 0 2.2689566776534775e-06
which O 0 8.161206432877322e-11
is O 0 3.871533735960719e-12
characterized O 0 2.4051097485128237e-12
by O 0 1.578928827961068e-12
preferential O 0 3.629824263384762e-08
myocardial B-Disease 0 2.948490021026373e-07
involvement I-Disease 0 5.586552331848793e-10
without O 0 1.8553070191273946e-10
any O 0 2.548943833780015e-10
overt O 0 1.0595515576028447e-08
clinical O 0 1.2730457799037254e-09
signs O 0 1.0660913041249387e-08
of O 0 2.061028858690861e-08
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 7.64254218665883e-06

To O 0 2.6452817714073262e-09
date O 0 2.2886385409037757e-07
, O 0 2.8168314902821123e-10
several O 0 1.1967686563973956e-10
mutations O 0 1.2699221674239425e-09
in O 0 1.2180752240187331e-10
the O 0 1.381578496051361e-08
Duchenne B-Disease 0 0.00014735152944922447
muscular I-Disease 0 0.0025239945389330387
dystrophy I-Disease 1 0.9658676385879517
gene O 0 0.00025214560446329415
, O 0 2.3504047419464769e-07
DMD O 1 1.0
, O 0 6.515066819368087e-10
have O 0 5.4229790796833655e-11
been O 0 5.4853760422801656e-11
identified O 0 1.0066410899289835e-10
in O 0 1.154495596344951e-11
patients O 0 2.7771292210321263e-11
with O 0 4.956607346784381e-11
XLDCM B-Disease 1 1.0
, O 0 1.3204036475311653e-10
but O 0 4.4996596726409877e-11
a O 0 3.1830958008294274e-11
pathogenic O 0 9.263840805573409e-10
correlation O 0 3.424019290321212e-09
of O 0 4.188046576203419e-10
these O 0 4.21984724940927e-10
cardiospecific O 0 7.790549716446549e-08
mutations O 0 9.207018258905464e-09
in O 0 1.4691343697137427e-09
DMD O 1 1.0
with O 0 2.8434329890636434e-10
the O 0 2.7531784851930752e-08
XLDCM B-Disease 1 0.7150481939315796
phenotype O 0 2.3432338025486388e-07
has O 0 2.1409727324339656e-09
remained O 0 2.5343158682744615e-08
to O 0 6.057278012505662e-10
be O 0 1.227199231124132e-08
elucidated O 0 2.867121838789899e-05
. O 0 4.257485670677852e-07

We O 0 1.7963998288905714e-08
report O 0 1.5753695015163771e-09
here O 0 3.2170072161719077e-11
the O 0 1.0464931005094158e-11
identification O 0 2.776309737662075e-10
of O 0 5.641870304273766e-10
a O 0 6.839592781027193e-10
unique O 0 9.945557266632932e-09
de O 0 2.2825179257779382e-07
novo O 0 1.985398512260872e-07
L1 O 0 2.726941090713808e-07
insertion O 0 1.733805765624652e-09
in O 0 4.943939146961895e-10
the O 0 2.640794916075606e-09
muscle O 0 3.891810429479392e-09
exon O 0 2.6327380275859014e-09
1 O 0 5.3594169102666456e-09
in O 0 1.5208316828108082e-09
DMD O 1 1.0
in O 0 4.179478541033177e-09
three O 0 2.4852302438205243e-09
XLDCM B-Disease 0 2.271656740049366e-05
patients O 0 3.5929142994106655e-10
from O 0 7.56574469740201e-10
two O 0 1.3493103856454525e-10
unrelated O 0 5.196327812484469e-09
Japanese O 0 1.2975535312875763e-08
families O 0 1.5592686031240532e-09
. O 0 2.2256148923816e-08

The O 0 8.200238710287522e-09
insertion O 0 3.998293962581556e-08
was O 0 2.1382678738746108e-08
a O 0 8.539753348912882e-10
5 O 0 9.099788478295068e-09
- O 0 7.152727299342132e-10
truncated O 0 1.2900681634064881e-09
form O 0 4.209900830720592e-11
of O 0 1.7651707873156397e-10
human O 0 2.455516345811759e-10
L1 O 0 1.9205558032808767e-07
inversely O 0 1.007404648589727e-08
integrated O 0 4.964150202013684e-10
in O 0 1.8983509209036242e-11
the O 0 1.344475503151088e-10
5 O 0 1.5138338360642933e-09
- O 0 1.0460531330025447e-09
untranslated O 0 2.7397322810429614e-07
region O 0 1.3409445775991458e-09
in O 0 2.257244391401514e-10
the O 0 2.859778636121746e-09
muscle O 0 1.4790141333875795e-09
exon O 0 2.0434602898689036e-09
1 O 0 9.223453112383595e-09
, O 0 2.0223649144224254e-11
which O 0 2.5315953760401966e-12
affected O 0 4.927809549304385e-11
the O 0 3.059285463846706e-11
transcription O 0 6.892733606100876e-11
or O 0 1.332414994309472e-11
the O 0 1.0457732596558245e-10
stability O 0 1.8376494770322438e-09
of O 0 3.960237027200719e-09
the O 0 1.5661957286638994e-09
muscle O 0 1.5805282638226004e-09
form O 0 2.03181649283124e-09
of O 0 6.160269805377538e-08
dystrophin O 0 9.006289758417552e-08
transcripts O 0 3.5055653935245346e-09
but O 0 6.914222666631886e-11
not O 0 1.3567782314316545e-11
that O 0 2.9190570099979496e-11
of O 0 1.5410026588114079e-09
the O 0 5.4286353190491354e-09
brain O 0 7.266869062050318e-08
or O 0 7.796715273400423e-09
Purkinje O 0 4.77458286241017e-07
cell O 0 1.2764480139537682e-08
form O 0 1.6738054275933223e-09
, O 0 6.652263739859166e-10
probably O 0 6.055756784917321e-09
due O 0 2.3966735263059036e-09
to O 0 2.8390001460820713e-10
its O 0 3.920133662127512e-10
unique O 0 1.2606286015071078e-09
site O 0 2.3349260303007213e-08
of O 0 5.7175530976394384e-09
integration O 0 9.94948905486126e-08
. O 0 3.2632445368108165e-07

We O 0 1.1791915000003428e-08
speculate O 0 5.3608502526003576e-08
that O 0 5.212431181123023e-12
this O 0 1.8489112151021114e-12
insertion O 0 1.1304858160698927e-09
of O 0 4.198620340289949e-10
an O 0 3.8663125478954896e-10
L1 O 0 4.846876890951535e-07
sequence O 0 9.093329422782404e-10
in O 0 1.1903267260748862e-09
DMD O 1 1.0
is O 0 6.176087974374411e-10
responsible O 0 4.322553773250526e-11
for O 0 2.719437305551131e-12
some O 0 9.989839684643176e-12
of O 0 2.639925951453126e-11
the O 0 1.7042206187922737e-11
population O 0 7.401776240534286e-12
of O 0 2.752670140437896e-11
Japanese O 0 7.039833160860098e-10
patients O 0 2.6673181025005377e-11
with O 0 9.983864429630174e-11
XLDCM B-Disease 0 6.6853390308097e-05
. O 0 1.0801320726727681e-08
. O 0 1.3559193234868872e-07

Severe O 0 3.206795327059808e-06
early O 0 4.409359098644927e-05
- O 0 0.0009229109855368733
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 4.4632655904486285e-10
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 5.312417616920584e-09
red O 0 4.82604718854418e-06
hair O 0 1.8440869098412804e-05
pigmentation O 0 0.00015454304229933769
caused O 0 3.0183591093191353e-07
by O 0 1.914133385128025e-08
POMC O 0 0.001658362802118063
mutations O 0 1.700149425687414e-07
in O 0 9.025800662421091e-10
humans O 0 1.3263367293347983e-08
. O 0 1.4572629325471098e-08

Sequential O 0 8.075217010627966e-07
cleavage O 0 4.3487585799084627e-07
of O 0 2.994663717004187e-08
the O 0 4.088458460671518e-09
precursor O 0 2.677184696153745e-08
protein O 0 4.442707535190493e-08
pre O 0 2.7261005897116775e-08
- O 0 4.115623397638046e-09
pro O 0 9.154349811524298e-08
- O 0 1.6599341279288637e-07
opiomelanocortin O 0 2.9771692311442166e-07
( O 0 7.307671134881843e-10
POMC O 0 2.8054253675691143e-07
) O 0 1.868827141648932e-11
generates O 0 1.6341174247092027e-10
the O 0 2.1654154858108399e-10
melanocortin O 0 7.265414581070218e-08
peptides O 0 3.0216650515058063e-08
adrenocorticotrophin O 0 1.4329411897051614e-06
( O 0 5.805332214947612e-09
ACTH O 0 2.3382156655316066e-07
) O 0 2.7031502036756194e-10
, O 0 5.813894365935823e-10
melanocyte O 0 6.28509610578476e-07
- O 0 8.50709909627767e-07
stimulating O 0 6.032114896470375e-08
hormones O 0 1.1041850100923511e-08
( O 0 3.406085413715232e-10
MSH O 0 2.432844041777571e-07
) O 0 1.8779387767065003e-11
alpha O 0 1.0297170754958174e-10
, O 0 2.7178400589106255e-12
beta O 0 3.987030323948648e-12
and O 0 1.230093284176892e-12
gamma O 0 2.6820922219283894e-11
as O 0 2.7746088412938796e-11
well O 0 2.244959079744646e-11
as O 0 1.2487080813805562e-10
the O 0 2.780161934001768e-10
opioid O 0 4.022080002386019e-09
- O 0 1.9339787549199627e-09
receptor O 0 8.575503862573441e-09
ligand O 0 9.937824785311022e-08
beta O 0 1.3156743250419822e-07
- O 0 8.867304046589197e-08
endorphin O 0 3.0866497127135517e-06
. O 0 5.8141559122759645e-08

While O 0 2.6923356877261995e-09
a O 0 1.3001758003561292e-10
few O 0 1.168013602503848e-10
cases O 0 8.06580288670311e-11
of O 0 8.172632348646403e-09
isolated O 0 0.05793372169137001
ACTH B-Disease 1 0.9999333620071411
deficiency I-Disease 1 0.999991774559021
have O 0 3.897686617904128e-09
been O 0 1.1131736643577028e-09
reported O 0 7.274979285654126e-09
( O 0 6.346315140071113e-10
OMIM O 0 8.923055429477245e-05
201400 O 0 2.0485831555561163e-06
) O 0 9.481011531420336e-10
, O 0 4.921659191303718e-10
an O 0 2.260516573926452e-08
inherited O 1 1.0
POMC O 1 1.0
defect O 1 1.0
has O 0 7.395412637833942e-08
not O 0 7.244043143117551e-10
been O 0 6.875273683704108e-10
described O 0 6.790432660608303e-10
so O 0 6.133568097865805e-10
far O 0 1.189287957004126e-08
. O 0 4.194910019350573e-08

Recent O 0 8.793936245865552e-08
studies O 0 5.272362546548948e-09
in O 0 2.672277850390703e-11
animal O 0 3.8597108842353123e-10
models O 0 4.408231002450691e-10
elucidated O 0 1.1056581428192658e-08
a O 0 1.3265934184492068e-10
central O 0 1.9032111442385258e-09
role O 0 5.960412718941654e-10
of O 0 7.0286074738135085e-09
alpha O 0 4.012073340220468e-09
- O 0 5.145731840627832e-09
MSH O 0 4.683680572270532e-07
in O 0 3.666894565768075e-11
the O 0 9.002722872741842e-11
regulation O 0 3.8984579453504864e-10
of O 0 3.7884084758132985e-10
food O 0 7.871376883628045e-10
intake O 0 2.39261527257284e-11
by O 0 4.08458423334368e-13
activation O 0 2.856502145931472e-09
of O 0 1.0570889052985422e-08
the O 0 3.280612048683906e-08
brain O 0 3.408877660149301e-07
melanocortin O 0 1.232491655400736e-07
- O 0 7.812389846151291e-09
4 O 0 1.7883898806303478e-08
- O 0 1.6738660457704668e-09
receptor O 0 6.9062688901055935e-09
( O 0 6.879418701366546e-10
MC4 O 0 7.510440127589391e-07
- O 0 4.391164321049246e-09
R O 0 2.8089783832285775e-09
; O 0 2.1032248165298029e-10
refs O 0 4.254089969180086e-09
3 O 0 1.0766656455274415e-09
- O 0 2.8655798220422746e-11
5 O 0 2.708888148517108e-11
) O 0 3.463155868847767e-14
and O 0 3.322921094100345e-14
the O 0 1.4965258849850005e-12
linkage O 0 3.461586572939268e-09
of O 0 1.0284334495125336e-10
human O 0 5.2833959429676725e-09
obesity B-Disease 1 1.0
to O 0 4.75836758884185e-10
chromosome O 0 2.5974442596776726e-09
2 O 0 2.275092558789993e-09
in O 0 7.208039026762592e-11
close O 0 2.6051147905548078e-09
proximity O 0 4.066526670953863e-09
to O 0 9.092318564718482e-11
the O 0 4.594875147034827e-09
POMC O 0 1.2210479098939686e-06
locus O 0 3.4653850899957206e-09
, O 0 1.0188665189314605e-10
led O 0 1.1188586862553862e-10
to O 0 2.764160775270419e-11
the O 0 2.017057632031083e-10
proposal O 0 6.614434000518088e-10
of O 0 2.34848390734399e-10
an O 0 1.711932817727302e-10
association O 0 5.226615140685453e-09
of O 0 7.640484795956581e-07
POMC O 1 0.9999983310699463
with O 0 1.902830959465973e-08
human O 1 0.770175039768219
obesity B-Disease 1 1.0
. O 0 1.7340620672712248e-07

The O 0 1.1605422400862153e-08
dual O 0 2.778585184159965e-08
role O 0 4.0616765062395643e-08
of O 0 7.266938268912781e-07
alpha O 0 1.3664549669556436e-07
- O 0 1.1501328600616034e-07
MSH O 0 4.8639444685250055e-06
in O 0 5.339599318254784e-10
regulating O 0 8.867993450678568e-09
food O 0 2.987657765629592e-08
intake O 0 4.006827314384509e-09
and O 0 4.4151116790347444e-11
influencing O 0 1.0406451167455089e-07
hair O 0 5.246561613603262e-06
pigmentation O 0 3.408403927096515e-06
predicts O 0 1.8173941240817726e-09
that O 0 2.345880434351244e-12
the O 0 3.405128609634822e-11
phenotype O 0 1.6234933397640816e-09
associated O 0 1.0188004606614953e-10
with O 0 2.224566451186627e-12
a O 0 2.003010535212013e-10
defect O 0 5.350390352987233e-08
in O 0 4.589751245731577e-09
POMC O 0 0.00011540968262124807
function O 0 1.1127490040507837e-09
would O 0 1.4511924995019854e-10
include O 0 1.0603435907086123e-09
obesity B-Disease 1 1.0
, O 0 3.1290653401683244e-10
alteration O 0 1.0208598411054481e-07
in O 0 2.9822817548819103e-09
pigmentation O 1 0.9999988079071045
and O 0 6.755565209459746e-06
ACTH B-Disease 1 0.9992747902870178
deficiency I-Disease 0 0.00184830988291651
. O 0 4.95598612815229e-07

The O 0 2.582275726581429e-08
observation O 0 9.06547086287901e-07
of O 0 9.76284830755958e-10
these O 0 4.5252843139387267e-10
symptoms O 0 1.7670323586571612e-06
in O 0 8.398009371246573e-11
two O 0 2.2285098766339217e-10
probands O 0 8.844128387863748e-06
prompted O 0 9.500114472871246e-09
us O 0 2.665127563084013e-10
to O 0 1.1201526511905868e-10
search O 0 1.6190959684081463e-09
for O 0 8.843913795741898e-11
mutations O 0 1.9119369198961067e-08
within O 0 2.8416560216015796e-09
their O 0 9.868728767514767e-08
POMC O 0 0.00011523669672897086
genes O 0 1.3916145462644636e-06
. O 0 5.729345389227092e-07

Patient O 0 1.6393269675063493e-07
1 O 0 1.374359186456786e-07
was O 0 1.3264582321426133e-08
found O 0 4.937057013210122e-11
to O 0 1.6744456515782602e-11
be O 0 2.948456409579414e-11
a O 0 8.959947367381815e-11
compound O 0 1.1701994928614567e-09
heterozygote O 0 2.0331704320142308e-08
for O 0 9.450008831013434e-11
two O 0 1.6775215938569232e-10
mutations O 0 6.639790384177502e-10
in O 0 3.4680283644838994e-10
exon O 0 6.9161290028318945e-09
3 O 0 5.4135625759954564e-08
( O 0 2.6650068818412365e-09
G7013T O 0 1.5079045567745197e-07
, O 0 9.424956370907012e-10
C7133delta O 0 9.481215812456867e-09
) O 0 1.1901144132686614e-11
which O 0 5.075966990480962e-12
interfere O 0 4.3653722997527566e-11
with O 0 1.9978801599207507e-12
appropriate O 0 1.0656393545360743e-09
synthesis O 0 1.1716633707692381e-07
of O 0 1.995443881241954e-07
ACTH O 0 1.559839438414201e-05
and O 0 1.2732459708786337e-07
alpha O 0 1.9585452264436753e-06
- O 0 2.5537651708873454e-06
MSH O 0 0.00014739646576344967
. O 0 3.2427911378363206e-07

Patient O 0 1.2577111796474583e-08
2 O 0 9.564147696039527e-09
was O 0 2.742013283096867e-10
homozygous O 0 1.6150353623900493e-11
for O 0 2.7809972207026856e-12
a O 0 1.750377967568717e-11
mutation O 0 3.745648929909251e-11
in O 0 4.213274867881367e-11
exon O 0 1.238686375693021e-09
2 O 0 3.8613197972381386e-08
( O 0 2.658148590128917e-09
C3804A O 0 7.398982404538401e-08
) O 0 3.197529394038945e-11
which O 0 5.07182768005876e-11
abolishes O 0 3.9680006125308864e-07
POMC O 0 1.7476639186497778e-05
translation O 0 6.298326411524613e-07
. O 0 5.478879643305845e-07

These O 0 5.816812032044538e-10
findings O 0 8.83262352147085e-10
represent O 0 1.3086896843983453e-10
the O 0 2.671416733657228e-11
first O 0 9.717082173621439e-12
examples O 0 6.865179952297851e-11
of O 0 1.5616450840805207e-11
a O 0 4.733833464110049e-11
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 1.5424141963649163e-09
the O 0 1.6322866391860202e-09
POMC O 0 1.682025470017834e-07
gene O 0 1.3549739108498216e-10
and O 0 1.4027015660111886e-11
define O 0 6.635254151676762e-11
a O 0 3.907038581552058e-11
new O 0 3.4074971733133452e-09
monogenic B-Disease 1 0.9995741248130798
endocrine I-Disease 1 0.9925245642662048
disorder I-Disease 0 0.00011624100443441421
resulting O 0 1.0681994178085574e-09
in O 0 2.465163143061666e-11
early O 0 1.0039251492344192e-06
- O 0 5.3635270887752995e-05
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 1.6451514595061667e-09
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 8.520040637449711e-07
red O 0 0.00025714663206599653
hair O 0 7.1084205046645366e-06
pigmentation O 0 4.071522653248394e-06
. O 0 1.7258749096527026e-08
. O 0 8.764916969994374e-08

A O 0 8.70103775696407e-08
European O 0 9.62686907968191e-09
multicenter O 0 2.0766960915352684e-06
study O 0 1.656771164704196e-09
of O 0 1.5963749433467456e-07
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 2.2414272660142842e-09
classification O 0 3.8371927857383525e-09
of O 0 1.711075170440779e-09
105 O 0 5.299058969399084e-09
mutations O 0 3.060395548093453e-10
and O 0 1.5079132387185723e-11
a O 0 6.914908923238983e-11
general O 0 1.0367803143784826e-10
system O 0 7.430505863381676e-12
for O 0 6.5035763233134425e-12
genotype O 0 1.8992138417495141e-10
- O 0 1.6640734623596387e-10
based O 0 1.451646441941179e-10
prediction O 0 9.148795498958862e-09
of O 0 9.888844187955215e-10
metabolic O 0 5.751353910454782e-06
phenotype O 0 1.223621779899986e-06
. O 0 4.358644218882546e-07

Phenylketonuria B-Disease 0 2.7416392185841687e-05
( O 0 8.663479178494526e-08
PKU B-Disease 0 4.704793809651164e-06
) O 0 3.5459660208125854e-10
and O 0 2.689716505077655e-10
mild B-Disease 0 0.17690390348434448
hyperphenylalaninemia I-Disease 1 1.0
( O 0 2.008086539717624e-06
MHP B-Disease 1 1.0
) O 0 3.622240840606139e-10
are O 0 6.273032787662558e-11
allelic B-Disease 0 2.8535313845168275e-07
disorders I-Disease 0 1.0119286741883116e-07
caused O 0 2.480597394161066e-10
by O 0 2.9826867972010396e-12
mutations O 0 3.7709046996070583e-10
in O 0 1.6024058815955478e-11
the O 0 3.039927684578281e-11
gene O 0 1.7343416702786385e-09
encoding O 0 6.353926806923482e-08
phenylalanine O 0 5.864609647687757e-06
hydroxylase O 0 3.444728690737975e-06
( O 0 2.6533783170634706e-08
PAH O 0 6.54517953080358e-06
) O 0 5.622322607479191e-09
. O 0 1.7651455408440597e-08

Previous O 0 2.2297328428066976e-07
studies O 0 9.25021481634758e-09
have O 0 1.8203723251009052e-11
suggested O 0 4.910704481941863e-11
that O 0 1.2318166235300576e-12
the O 0 2.3253583086857432e-11
highly O 0 6.719903522522941e-10
variable O 0 1.1615352377702948e-06
metabolic O 1 0.9336967468261719
phenotypes O 0 0.031389594078063965
of O 0 0.0003455640107858926
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 0 0.00043989531695842743
with O 0 2.11446931075443e-08
PAH O 1 0.9999991655349731
genotypes O 0 2.277939347550273e-05
. O 0 8.813128715701168e-08

We O 0 4.077588755535544e-08
identified O 0 2.141774224639903e-08
both O 0 4.506750084232181e-09
causative O 0 4.372011801478948e-07
mutations O 0 1.983138453454103e-08
in O 0 6.012364495155964e-10
686 O 0 9.186060623278536e-08
patients O 0 3.3550895395251246e-10
from O 0 2.2420600931383206e-09
seven O 0 3.398721748482103e-09
European O 0 8.555328001591533e-09
centers O 0 2.2540592681252747e-07
. O 0 1.0531910277222778e-07

On O 0 1.676876193457133e-09
the O 0 1.7028461973822573e-11
basis O 0 1.0449995729855388e-10
of O 0 5.0947258564693065e-12
the O 0 4.7229902280787606e-12
phenotypic O 0 7.870491480765907e-10
characteristics O 0 7.700624138351486e-08
of O 0 4.3338946653648236e-08
297 O 0 4.9999606233086524e-08
functionally O 0 1.0390465376985958e-07
hemizygous O 0 2.2173531988300965e-07
patients O 0 1.500523177933033e-10
, O 0 1.1001364749740894e-11
105 O 0 1.7335082258540524e-09
of O 0 1.4337639964168147e-09
the O 0 1.255850423653726e-09
mutations O 0 1.1857742565624108e-09
were O 0 1.0159149910204945e-10
assigned O 0 2.4892600133941123e-11
to O 0 1.4099222657437682e-11
one O 0 1.327879473045357e-10
of O 0 1.2854358688585421e-09
four O 0 4.4062803405964246e-10
arbitrary O 0 3.25143325596855e-08
phenotype O 0 3.8439785043919983e-07
categories O 0 2.1869854549549927e-07
. O 0 2.1368333591453847e-07

We O 0 3.9707067855943023e-08
proposed O 0 2.602424586939378e-08
and O 0 1.062388177430762e-09
tested O 0 2.442344104736094e-10
a O 0 4.7993182344940877e-11
simple O 0 1.487568054847621e-11
model O 0 1.2928578346782515e-11
for O 0 1.9782912287491516e-12
correlation O 0 3.3002775512436244e-10
between O 0 5.751772322315496e-11
genotype O 0 2.477666738442963e-09
and O 0 2.3049673281150262e-10
phenotypic O 0 3.695265604619635e-08
outcome O 0 8.865221730047779e-07
. O 0 7.894386158113775e-07

The O 0 5.135945890799576e-09
observed O 0 5.246171053130411e-09
phenotype O 0 2.379289476550639e-08
matched O 0 1.6117205348109565e-08
the O 0 8.791563033128114e-10
predicted O 0 7.81049802611733e-09
phenotype O 0 8.60531979007817e-10
in O 0 3.283110935892175e-11
79 O 0 5.655729218290162e-09
% O 0 7.19967141460387e-11
of O 0 5.392489926814292e-11
the O 0 4.925694921387169e-11
cases O 0 4.7768435040840274e-11
, O 0 5.188261625876933e-11
and O 0 5.7086224636293537e-11
in O 0 8.181295918507914e-11
only O 0 1.5723070068140999e-10
5 O 0 3.8824074510834805e-10
of O 0 1.2094540646767626e-10
184 O 0 2.668652521187198e-10
patients O 0 8.020362846083984e-11
was O 0 1.6097995159114475e-09
the O 0 1.2008302130439574e-09
observed O 0 5.07533570726082e-09
phenotype O 0 2.544743304966346e-09
more O 0 9.424808850022615e-11
than O 0 2.0453272409071133e-10
one O 0 5.793404644904854e-10
category O 0 1.722831877160047e-09
away O 0 8.574653875825788e-09
from O 0 2.449464409082225e-09
that O 0 1.3201928439343646e-09
expected O 0 9.978052872838816e-08
. O 0 2.1675793959730072e-07

Among O 0 4.402319930818521e-08
the O 0 7.254817635526933e-09
seven O 0 8.191590183947994e-10
contributing O 0 1.9536583462098633e-09
centers O 0 1.1051620729674028e-09
, O 0 7.947053605461551e-12
the O 0 6.704715949101825e-11
proportion O 0 1.0679671591518058e-09
of O 0 3.464456499457924e-11
patients O 0 7.299529036774999e-12
for O 0 4.6083432209131914e-11
whom O 0 1.1650983111621827e-07
the O 0 2.933473410848819e-07
observed O 0 5.252649426523703e-09
phenotype O 0 9.55520884637906e-10
did O 0 7.058801460013697e-11
not O 0 1.3233832432679726e-11
match O 0 1.6547996306570667e-10
the O 0 8.966021813883174e-10
predicted O 0 3.956627914192268e-09
phenotype O 0 1.8479973107332626e-09
was O 0 1.091193246871569e-09
4 O 0 3.1382714205108186e-09
% O 0 7.703290227922821e-10
- O 0 8.65935767535575e-10
23 O 0 1.0846988196533403e-08
% O 0 2.657692288465796e-09
( O 0 4.3678899386279113e-10
P O 0 1.682108887735012e-07
< O 0 3.4736900023091266e-09
. O 0 5.481947673580123e-10
0001 O 0 3.6639760114809405e-09
) O 0 9.702937064925976e-11
, O 0 1.4750685048414702e-11
suggesting O 0 1.2989140318886427e-10
that O 0 1.2151508098356967e-11
differences O 0 8.859801087224284e-11
in O 0 6.354872357505759e-12
methods O 0 4.1205362039109517e-11
used O 0 2.6964940696982964e-12
for O 0 6.4005866579064374e-12
mutation O 0 1.0471630229602624e-09
detection O 0 2.7228252985622703e-09
or O 0 6.574574773487996e-10
phenotype O 0 9.056866190348956e-08
classification O 0 1.535311100475667e-09
may O 0 2.402938681367317e-10
account O 0 2.524248692015174e-11
for O 0 3.366534915422159e-12
a O 0 2.1979839823216274e-11
considerable O 0 9.277066892465768e-10
proportion O 0 3.768771072998334e-09
of O 0 1.4610805898485069e-09
genotype O 0 2.6545737341621134e-07
- O 0 3.11685107590165e-06
phenotype O 0 9.111730037147936e-07
inconsistencies O 0 6.096751690165547e-07
. O 0 3.6413220527720114e-07

Our O 0 9.513935594895884e-08
data O 0 5.767765642872291e-08
indicate O 0 2.0289052216071468e-08
that O 0 1.5499453109857342e-10
the O 0 2.878917104709444e-09
PAH O 0 1.0348816203986644e-06
- O 0 2.670884402533602e-09
mutation O 0 4.102875331146727e-11
genotype O 0 1.2860476572562618e-11
is O 0 1.8596833328918955e-13
the O 0 9.647564865045144e-13
main O 0 2.2081328432399516e-10
determinant O 0 5.096757860201251e-08
of O 0 9.39353661522091e-09
metabolic O 0 0.1342456340789795
phenotype O 0 3.906173162704363e-07
in O 0 3.738991338764208e-10
most O 0 6.720890510791833e-10
patients O 0 3.1636575581472925e-09
with O 0 7.500645438085485e-09
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 2.781947614494129e-06

In O 0 1.1409267974826776e-09
the O 0 1.243572356202094e-09
present O 0 5.970767213980821e-10
study O 0 4.4204202798159287e-11
, O 0 1.5154203846651226e-12
the O 0 1.8820982966571975e-11
classification O 0 2.626483697198978e-09
of O 0 1.2467149979045189e-08
105 O 0 3.7393911611616204e-07
PAH O 0 2.370607035118155e-06
mutations O 0 8.650579808033854e-09
may O 0 4.773946862823841e-11
allow O 0 8.992301694932259e-12
the O 0 3.4093790290956605e-11
prediction O 0 4.638037953696994e-09
of O 0 9.929777139427998e-11
the O 0 2.0172499781700992e-10
biochemical O 0 1.811055660994043e-08
phenotype O 0 2.048464153858731e-08
in O 0 1.0760476953919351e-09
> O 0 1.543288874472637e-08
10 O 0 1.421909878729366e-08
, O 0 7.621709374738828e-10
000 O 0 2.8874202584461273e-08
genotypes O 0 2.4599398784630466e-07
, O 0 1.3414690469559787e-09
which O 0 1.7266831020545936e-10
may O 0 2.2281441969251858e-10
be O 0 3.845042687022904e-11
useful O 0 1.079950240345795e-09
for O 0 5.061004393347446e-11
the O 0 2.0151282864588893e-09
management O 0 4.718342605514181e-09
of O 0 3.908162682364491e-08
hyperphenylalaninemia B-Disease 1 1.0
in O 0 4.181306323403078e-08
newborns O 0 9.970479908361085e-08
. O 0 1.0697254282376889e-07

Somatic O 0 6.388097517628921e-07
instability O 0 1.2761952916662267e-07
of O 0 1.4920711777222095e-08
the O 0 1.926748538494394e-08
CTG O 0 2.416150164208375e-05
repeat O 0 5.162246630163736e-09
in O 0 2.979108071343717e-10
mice O 0 4.3499231994204024e-10
transgenic O 0 8.31741564510935e-10
for O 0 5.797709968363707e-12
the O 0 6.911470284975962e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 4.878494408444567e-08
is O 0 2.3360374745706736e-10
age O 0 3.0073179502210223e-09
dependent O 0 4.424912436462591e-09
but O 0 1.2303807972458003e-10
not O 0 6.283786685434833e-11
correlated O 0 1.8797181589036427e-09
to O 0 2.576962775113767e-11
the O 0 5.006129399909298e-10
relative O 0 1.778240914518392e-07
intertissue O 0 6.017028226779075e-07
transcription O 0 3.7747520309494575e-07
levels O 0 1.1981910574832e-07
and O 0 1.2655849701559418e-08
proliferative O 1 0.9998213648796082
capacities O 0 2.1101452148286626e-05
. O 0 9.068030522030313e-07

A O 0 2.7050593416788615e-05
( O 0 2.0612574758160918e-07
CTG O 0 4.968183202436194e-05
) O 0 6.538196650751615e-10
nexpansion O 0 8.788050109842516e-08
in O 0 1.7116226491697972e-10
the O 0 6.009452935273885e-10
3 O 0 6.234642135893864e-09
- O 0 8.913236371199673e-09
untranslated O 0 7.2993302637769375e-06
region O 0 6.804295349382983e-09
( O 0 3.0576186027531094e-10
UTR O 0 5.1161191549908835e-06
) O 0 7.678115088172177e-11
of O 0 2.161380852072625e-09
the O 0 4.0660090405708615e-08
DM O 1 1.0
protein O 0 1.610797539797204e-06
kinase O 0 3.949972438022087e-07
gene O 0 8.715072397080803e-08
( O 0 4.0832009062796715e-07
DMPK O 1 1.0
) O 0 6.078443304247116e-11
is O 0 2.5110276271472776e-12
responsible O 0 1.836003571398237e-12
for O 0 2.511492316198405e-12
causing O 0 4.664690678168881e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.6597202829871094e-06
DM B-Disease 1 1.0
) O 0 4.34900471191213e-09
. O 0 1.981043951104766e-08

Major O 0 1.8106769857695326e-05
instability O 0 0.00012896432599518448
, O 0 4.956858035143341e-09
with O 0 5.917680928613223e-11
very O 0 2.1101037583903803e-10
large O 0 2.6776059147692877e-10
expansions O 0 2.459750403360772e-09
between O 0 1.5122176844073465e-09
generations O 0 4.954003429702425e-09
and O 0 1.9732433742536415e-10
high O 0 3.0925295657624474e-09
levels O 0 2.0070871353805586e-10
of O 0 1.7505791261029913e-10
somatic O 0 8.676046547861915e-08
mosaicism O 0 4.3362601331864425e-07
, O 0 1.9090926062226288e-10
is O 0 5.218004153761946e-11
observed O 0 7.085458886280094e-10
in O 0 3.0086533264750415e-10
patients O 0 2.0645332110547088e-09
. O 0 6.988653211692508e-08

There O 0 4.176035961478419e-09
is O 0 1.0382487231064275e-10
a O 0 7.270491847455318e-11
good O 0 4.684453380754405e-10
correlation O 0 2.058250458958355e-09
between O 0 4.950657661595415e-10
repeat O 0 1.3270243792717906e-09
size O 0 8.478813207091207e-09
( O 0 5.807278546932082e-10
at O 0 1.9221080282960656e-09
least O 0 1.57667934264083e-10
in O 0 8.860444322689176e-11
leucocytes O 0 5.844777106744914e-08
) O 0 9.17901952363076e-12
, O 0 2.0191801789609665e-12
clinical O 0 3.386591354570534e-11
severity O 0 3.2593547860670924e-09
and O 0 1.2812055583122373e-10
age O 0 6.258269991121779e-08
of O 0 2.0568862169056956e-07
onset O 0 1.3699646842724178e-05
. O 0 1.2522446013463195e-07

The O 0 1.339946180678453e-07
trinucleotide O 0 0.00029861193615943193
repeat O 0 1.4584981045118184e-07
instability O 0 1.5110600770640303e-07
mechanisms O 0 2.5188080954308134e-08
involved O 0 6.196548274495228e-10
in O 0 8.304845144913031e-10
DM B-Disease 1 1.0
and O 0 3.86671833441099e-10
other O 0 3.480292096180726e-11
human O 0 6.077835124074227e-09
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 2.1790702922630523e-11
unknown O 0 1.9141552343171497e-08
. O 0 5.535378377885536e-09

We O 0 9.379947485399498e-09
studied O 0 9.290688218754894e-09
somatic O 0 6.999552226716332e-08
instability O 0 1.9647943272360635e-09
by O 0 1.9360657174671836e-11
measuring O 0 7.214910446862177e-09
the O 0 4.163938527312894e-09
CTG O 0 1.4193622064340161e-06
repeat O 0 1.5299032041227179e-09
length O 0 1.0061137478700743e-09
at O 0 1.0235221559184993e-09
several O 0 6.561730325760351e-11
ages O 0 3.818004801203756e-10
in O 0 3.1337924876612133e-12
various O 0 4.020020080708342e-11
tissues O 0 5.356736165751386e-10
of O 0 8.497379466732013e-10
transgenic O 0 7.041300431609443e-09
mice O 0 2.9603927642618544e-10
carrying O 0 6.120502438200504e-10
a O 0 5.404212632953431e-09
( O 0 1.2963612405769709e-08
CTG O 0 9.861182661552448e-06
) O 0 1.9805368456360384e-09
55expansion O 0 1.745317348422759e-07
surrounded O 0 1.4868433151349336e-09
by O 0 2.4198169509825895e-11
45 O 0 2.2137340849326392e-09
kb O 0 3.694123762443269e-08
of O 0 6.680877184805922e-09
the O 0 3.5575520307418174e-09
human O 0 2.6259138863338194e-08
DM B-Disease 1 1.0
region O 0 1.6208370823278528e-07
, O 0 1.3005577170766003e-10
using O 0 1.8745041630019443e-10
small O 0 6.365216798087658e-09
- O 0 3.241501289608095e-08
pool O 0 8.24829058387877e-08
PCR O 0 1.4940825110443257e-07
. O 0 2.5371701894982834e-07

These O 0 4.363896977110926e-08
mice O 0 9.163763081687648e-09
have O 0 5.620751086787834e-11
been O 0 1.1692724045941905e-11
shown O 0 1.6511218390788396e-12
to O 0 8.306479961327218e-13
reproduce O 0 1.8343708496626476e-10
the O 0 4.8407163694141886e-11
intergenerational O 0 5.177597239836018e-10
and O 0 6.337562852981593e-12
somatic O 0 1.7244270011929075e-08
instability O 0 3.844826679255675e-09
of O 0 1.4647860702154958e-09
the O 0 6.371971394969478e-09
55 O 0 9.156166669299637e-08
CTG O 0 1.8160975514547317e-06
repeat O 0 8.021870279151244e-09
suggesting O 0 1.0677029038674846e-08
that O 0 2.649031827228754e-10
surrounding O 0 2.7414341907672224e-09
sequences O 0 4.665834385519929e-10
and O 0 1.6495409482786272e-09
the O 0 6.53136966732859e-09
chromatin O 0 4.198976455427328e-08
environment O 0 5.365440980398262e-09
are O 0 3.44751553693623e-11
involved O 0 6.330341112414928e-11
in O 0 2.400382670408874e-10
instability O 0 1.0097731006908361e-07
mechanisms O 0 5.641929874400375e-07
. O 0 2.3231855550420732e-07

As O 0 2.323251457880815e-08
observed O 0 3.796403635902834e-09
in O 0 2.266039092480021e-11
some O 0 3.341778243015625e-11
of O 0 2.6733651403709757e-10
the O 0 1.826449130826191e-10
tissues O 0 2.8984767919126853e-09
of O 0 1.1030377500276245e-08
DM B-Disease 1 1.0
patients O 0 6.852494127684849e-10
, O 0 8.322755679079918e-12
there O 0 1.0773609435132947e-11
is O 0 4.5865676708001235e-12
a O 0 1.0055563152977509e-11
tendency O 0 3.694261008213573e-10
for O 0 1.2027176997386757e-11
repeat O 0 4.4562312173646035e-10
length O 0 1.0705327735394121e-09
and O 0 4.683354815071539e-10
somatic O 0 1.6606956876330514e-07
mosaicism O 0 6.024652776659423e-08
to O 0 4.9722118783401825e-11
increase O 0 1.0511025383408423e-10
with O 0 1.9270865285470062e-12
the O 0 1.4958195793113305e-10
age O 0 2.3959743078449947e-09
of O 0 1.2076312172482062e-09
the O 0 2.2316755110551867e-09
mouse O 0 1.9523925587350277e-08
. O 0 8.532451545306685e-08

Furthermore O 0 3.662504184376303e-07
, O 0 1.7801633500624803e-09
we O 0 1.554878448217778e-10
observed O 0 6.088410331450689e-11
no O 0 1.2934917026363735e-11
correlation O 0 2.6051183432684866e-10
between O 0 2.6576085082608003e-11
the O 0 6.587537459967763e-11
somatic O 0 9.832130132281236e-08
mutation O 0 1.0443431008866355e-08
rate O 0 4.508366124866825e-09
and O 0 6.926607065693702e-10
tissue O 0 1.873609392077924e-07
proliferation O 0 9.757834050105885e-05
capacity O 0 6.988466338953003e-07
. O 0 1.1767215823965671e-07

The O 0 8.019227948352636e-08
somatic O 0 1.4198725466485485e-06
mutation O 0 1.3803983733851055e-08
rates O 0 2.344573202250899e-09
in O 0 7.496386324190585e-12
different O 0 3.7157700527590265e-11
tissues O 0 2.7729030183110126e-09
were O 0 6.262479979035618e-10
also O 0 5.340754748173193e-12
not O 0 2.6366237752123434e-12
correlated O 0 9.41774991325417e-10
to O 0 2.0350761006926454e-11
the O 0 1.0546434836555818e-09
relative O 0 1.047893647410092e-06
inter O 0 9.060423167284171e-07
- O 0 2.992345926600137e-08
tissue O 0 2.4217494676292972e-09
difference O 0 1.7269574659195541e-09
in O 0 1.7673529306705404e-11
transcriptional O 0 2.5052284691184923e-09
levels O 0 7.470886131955012e-10
of O 0 2.0366110187186592e-10
the O 0 1.2385351633170671e-09
three O 0 7.580449046251658e-10
genes O 0 7.873543594882904e-09
( O 0 3.0649305315932907e-09
DMAHP O 0 2.0795918317162432e-05
, O 0 2.427863687870513e-09
DMPK O 0 5.6146054703276604e-06
and O 0 1.9761294822728814e-09
59 O 0 1.711369890244896e-08
) O 0 5.827202609332005e-11
surrounding O 0 9.507618692339292e-09
the O 0 1.7977846766825678e-08
repeat O 0 1.6879734943131552e-08
. O 0 2.0854985294249673e-08
. O 0 1.4423449101741426e-07

A O 0 1.1854904613528561e-07
novel O 0 1.3351925787219443e-08
missense O 0 1.709941557237471e-07
mutation O 0 1.0673480987932749e-09
in O 0 3.455718697309429e-11
patients O 0 2.543144340949599e-11
from O 0 8.359606062935399e-11
a O 0 6.791960327490187e-10
retinoblastoma B-Disease 0 9.21091759664705e-06
pedigree O 0 4.741123760254595e-08
showing O 0 1.8127033207804288e-09
only O 0 3.2490246604233164e-10
mild O 0 2.393452991356071e-09
expression O 0 1.3132762655132524e-09
of O 0 1.8709047644449583e-09
the O 0 5.46401679457631e-09
tumor B-Disease 0 3.6370846601130324e-07
phenotype O 0 1.9774357440383028e-07
. O 0 7.14072427854262e-08

We O 0 6.334817115316582e-09
have O 0 3.3558815448753165e-11
used O 0 8.255656575029136e-12
single O 0 4.125773681029621e-11
strand O 0 4.045220269865979e-10
conformation O 0 3.004111681637056e-10
polymorphism O 0 1.2383337411048245e-10
analysis O 0 1.4917105745082537e-11
to O 0 1.7782816885691943e-11
study O 0 4.2412285489179524e-11
the O 0 2.1585579157434864e-10
27 O 0 6.102414573661008e-09
exons O 0 1.787390679908185e-08
of O 0 1.8999838147237824e-08
the O 0 6.573251454256024e-08
RB1 O 0 3.1785552891960833e-06
gene O 0 2.069432819551409e-10
in O 0 8.705258042196462e-11
individuals O 0 7.978674144981657e-12
from O 0 8.789127065034208e-11
a O 0 2.2085361317536467e-11
family O 0 5.451893450580947e-11
showing O 0 9.553054181044018e-11
mild O 0 2.6360580385187404e-10
expression O 0 5.3979848368967964e-11
of O 0 2.718143488067426e-10
the O 0 2.5543667181437968e-09
retinoblastoma B-Disease 0 7.805891982570756e-06
phenotype O 0 4.695523330155993e-07
. O 0 1.5787610152528941e-07

In O 0 3.432271133974041e-09
this O 0 3.041181750873534e-10
family O 0 1.090165624439976e-09
affected O 0 2.563125822696577e-10
individuals O 0 1.1711763503452488e-11
developed O 0 3.5956175814533253e-09
unilateral B-Disease 0 2.0606442774351308e-07
tumors I-Disease 1 1.0
and O 0 6.747568614962063e-10
, O 0 5.664724331971849e-12
as O 0 4.754226092668068e-12
a O 0 7.456343702194612e-12
result O 0 1.584717218561238e-10
of O 0 1.2542513694313584e-09
linkage O 0 1.2018486472697987e-07
analysis O 0 1.5336933500975647e-08
, O 0 1.669867244480372e-09
unaffected O 0 1.7631435866860556e-08
mutation O 0 4.573634249105396e-10
carriers O 0 4.681630638714296e-10
were O 0 5.654000601040821e-10
also O 0 2.0539235590089078e-10
identified O 0 3.4081535371655036e-09
within O 0 2.81800449641878e-09
the O 0 2.2834491630874254e-08
pedigree O 0 6.566179308720166e-06
. O 0 4.3970922547487135e-07

A O 0 8.668914688314544e-07
single O 0 3.84786380536184e-09
band O 0 5.2738915456984614e-09
shift O 0 3.857806518681173e-09
using O 0 4.984558321652344e-10
SSCP O 0 5.471414988278411e-05
was O 0 5.813354242434343e-09
identified O 0 3.6161520999833385e-10
in O 0 3.6086130611456824e-11
exon O 0 3.0819877205878754e-10
21 O 0 2.433538259793977e-09
which O 0 7.692139460113712e-12
resulted O 0 2.1304048802850417e-10
in O 0 3.781259680368798e-11
a O 0 2.201321569472725e-09
missense O 0 3.733415496753878e-07
mutation O 0 2.205811533428914e-08
converting O 0 3.2679526640322365e-08
a O 0 7.628040421536753e-09
cys O 0 3.181741305979813e-07
- O 0 4.922424423625671e-08
- O 0 5.3074877826020384e-08
> O 0 4.150751742315606e-09
arg O 0 1.0810795592064437e-09
at O 0 1.6445357575722852e-10
nucleotide O 0 5.7736562059096386e-11
position O 0 2.8553910347284273e-09
28 O 0 3.8124765566749375e-09
in O 0 1.3254097819270783e-10
the O 0 2.690805578353661e-09
exon O 0 4.37942304643002e-08
. O 0 2.0968566616375028e-07

The O 0 2.1346988887671614e-07
mutation O 0 3.8702756910424796e-07
destroyed O 0 3.4984448120667366e-06
an O 0 2.0700426262010296e-08
NdeI O 0 1.8751106836134568e-06
restriction O 0 3.7687485132664733e-07
enzyme O 0 4.7185071139210777e-07
site O 0 1.1624339322224841e-06
. O 0 1.8215253305697843e-07

Analysis O 0 1.9594874611783553e-09
of O 0 4.3719841080758215e-09
all O 0 2.375432905932229e-10
family O 0 9.945760881535648e-10
members O 0 6.719050663073212e-12
demonstrated O 0 4.0533427309030756e-11
that O 0 5.087731451414168e-13
the O 0 1.0643829567724694e-11
missense O 0 1.1098711283352714e-08
mutation O 0 6.00774852088648e-09
co O 0 1.5186098778485757e-07
- O 0 6.306353498075623e-06
segregated O 0 1.2864155962688528e-07
with O 0 5.2674520994999696e-11
patients O 0 9.014708091115153e-09
with O 0 2.8986812949938212e-09
tumors B-Disease 1 1.0
or O 0 0.010767382569611073
who O 0 5.984693984828482e-07
, O 0 1.6756020182473463e-11
as O 0 1.648498178241642e-11
a O 0 1.1977910850669016e-11
result O 0 5.422886098505053e-11
of O 0 2.1910075143072305e-10
linkage O 0 5.560520488501197e-09
analysis O 0 1.3713702395889982e-09
had O 0 4.922488194836205e-09
been O 0 9.532544753554362e-10
predicted O 0 3.7061473889821173e-09
to O 0 2.714330427089351e-10
carry O 0 7.501117949004765e-09
the O 0 1.8205730256681818e-08
predisposing O 0 3.748443123186007e-05
mutation O 0 9.7255622222292e-07
. O 0 7.27639701381122e-07

These O 0 5.364571453725375e-09
observations O 0 3.391069469671493e-08
point O 0 2.2396366983201688e-09
to O 0 3.4790889787139623e-12
another O 0 2.5516228019384357e-11
region O 0 7.778026001048488e-10
of O 0 6.569810806489329e-10
the O 0 2.3585819519666984e-08
RB1 O 0 1.911627987283282e-05
gene O 0 3.907482337695001e-09
where O 0 1.5270234854369846e-08
mutations O 0 2.913479180133294e-10
only O 0 1.7815304786950037e-11
modify O 0 2.3013034533558852e-10
the O 0 8.954242208814023e-11
function O 0 1.1830740553886443e-10
of O 0 1.9461383615748673e-09
the O 0 1.7053213285933566e-09
gene O 0 1.065139532130388e-09
and O 0 2.0353654317517567e-09
raise O 0 3.785449287363463e-09
important O 0 2.2273125566130147e-09
questions O 0 5.040718398241495e-10
for O 0 4.780051701680499e-11
genetic O 0 1.2430861895396106e-09
counseling O 0 3.529165015780933e-10
in O 0 7.697118636906808e-11
families O 0 1.197028864918792e-10
with O 0 1.4356178572316747e-11
these O 0 2.6084548410132413e-10
distinctive O 0 1.981758224189889e-08
phenotypes O 0 5.25079855151489e-08
. O 0 9.866466754715475e-09
. O 0 7.59801466188037e-08

Maternal B-Disease 0 3.461566666373983e-05
disomy I-Disease 0 8.724196231923997e-05
and O 0 3.2104841807267803e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 5.580173819907941e-05
with O 0 6.128135759259079e-12
gamete O 0 2.9312182903140638e-08
complementation O 0 1.938343929808184e-09
in O 0 4.0631075435594577e-13
a O 0 5.418713980125112e-13
case O 0 1.039712673595039e-11
of O 0 2.337954274622689e-10
familial O 0 1.5337656700253888e-09
translocation O 0 9.775467546546679e-09
( O 0 1.0104557468526565e-10
3 O 0 2.7923332535095824e-09
; O 0 2.5513757773154566e-10
15 O 0 3.1453186721819293e-09
) O 0 2.3828420139815343e-11
( O 0 3.469958348434332e-11
p25 O 0 9.118743982128308e-09
; O 0 1.3971217238673006e-10
q11 O 0 1.61658491037997e-08
. O 0 3.041135399062256e-10
2 O 0 6.5463856557812505e-09
) O 0 7.889745523570468e-10
. O 0 3.422558592092173e-08

Maternal B-Disease 1 0.6312410831451416
uniparental I-Disease 1 0.9999996423721313
disomy I-Disease 1 0.9999995231628418
( I-Disease 0 4.9540707550477237e-05
UPD I-Disease 1 1.0
) I-Disease 0 8.601480083747504e-10
for I-Disease 0 1.69493391544151e-10
chromosome I-Disease 0 1.48615786343953e-08
15 I-Disease 0 1.977623576010501e-08
is O 0 6.763271886978117e-11
responsible O 0 3.3863009618606554e-11
for O 0 9.356133055804516e-12
an O 0 3.4772597995447185e-11
estimated O 0 9.938000422593518e-11
30 O 0 2.3009787131211823e-10
% O 0 6.1187569767862104e-12
of O 0 1.496748580111229e-12
cases O 0 1.1817248568579686e-11
of O 0 3.624303701599274e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
PWS B-Disease 1 1.0
) O 0 3.974783169269358e-08
. O 0 3.1975645242710016e-08

We O 0 2.0668943889745606e-08
report O 0 6.4735869997889495e-09
on O 0 2.5212379406447383e-10
an O 0 7.080966455547122e-12
unusual O 0 4.7662679358850824e-11
case O 0 2.630919648805019e-10
of O 0 5.965829608101103e-09
maternal B-Disease 0 0.042479582130908966
disomy I-Disease 0 0.41918614506721497
15 I-Disease 0 1.2153199691056216e-07
in O 0 6.545075148522983e-09
PWS B-Disease 1 1.0
that O 0 6.744480529619068e-10
is O 0 2.756799996617154e-11
most O 0 2.158153343534419e-11
consistent O 0 1.200770594067535e-09
with O 0 4.004958864545216e-11
adjacent O 0 1.1269578159556204e-08
- O 0 1.1048986170436592e-09
1 O 0 4.863904834451205e-09
segregation O 0 1.0278887740966525e-09
of O 0 3.777052282050164e-10
a O 0 1.4927707958634073e-09
paternal O 0 4.6792339958301454e-07
t O 0 5.491191057416245e-09
( O 0 1.5915145590295054e-10
3 O 0 5.84351456112131e-09
; O 0 2.631722617607579e-10
15 O 0 2.888167927039831e-09
) O 0 1.514591924101083e-11
( O 0 1.2453537333312337e-11
p25 O 0 4.2007131106913675e-09
; O 0 3.7662595264720267e-11
q11 O 0 3.5262801567625957e-09
. O 0 9.987153465340626e-12
2 O 0 6.865939761180329e-11
) O 0 2.8208059260799445e-13
with O 0 4.732312089937574e-13
simultaneous O 0 4.3322620491004216e-10
maternal O 0 1.7977303912175557e-07
meiotic O 0 6.550984608111321e-07
nondisjunction O 0 1.1939686146433814e-06
for O 0 7.821172154365286e-09
chromosome O 0 6.081247079237073e-07
15 O 0 1.4071780469748774e-06
. O 0 3.3530656651237223e-07

The O 0 3.6850174467417673e-08
patient O 0 1.280586303664677e-08
( O 0 1.4421042138224038e-09
J O 0 2.488068560069223e-07
. O 0 4.559315147645293e-10
B O 0 5.500541799818848e-09
. O 0 1.3694189011925761e-11
) O 0 1.578992036947724e-12
, O 0 2.9733828246780725e-12
a O 0 4.75733064053685e-11
17 O 0 4.907355077854447e-10
- O 0 6.757198967033418e-11
year O 0 3.977266571641991e-10
- O 0 9.368696929357156e-10
old O 0 1.1077187167529701e-07
white O 0 5.531217150966938e-10
male O 0 1.915351210968197e-10
with O 0 5.617235843136115e-11
PWS B-Disease 1 1.0
, O 0 2.9199714868255455e-10
was O 0 6.538570240799402e-10
found O 0 3.5396644382929e-12
to O 0 1.2657447139019506e-11
have O 0 7.672288498961066e-11
47 O 0 8.924191163828255e-09
chromosomes O 0 2.7575378092059566e-10
with O 0 1.7141735947356906e-11
a O 0 1.670459659486312e-09
supernumerary O 0 1.7651577763899695e-06
, O 0 3.1240934283971455e-09
paternal O 0 4.741434895549901e-05
der O 0 4.105236712348415e-06
( O 0 3.143242055525519e-10
15 O 0 2.776591845332632e-09
) O 0 1.0921661795434967e-12
consisting O 0 8.129850091742608e-12
of O 0 4.5105227886033106e-10
the O 0 1.3967174083973077e-09
short O 0 3.248813995604394e-10
arm O 0 6.788438144944564e-10
and O 0 3.208503185359035e-10
the O 0 4.5083169197823736e-08
proximal O 0 0.028241345658898354
long O 0 5.473469499861494e-08
arm O 0 3.693827821393825e-08
of O 0 2.7423194381981375e-08
chromosome O 0 3.689434180387252e-08
15 O 0 5.939609764027409e-07
, O 0 3.040139473498016e-09
and O 0 1.2354049339080575e-08
distal O 0 4.477533730096184e-05
chromosome O 0 3.832979200524278e-05
arm O 0 8.838126814225689e-05
3p O 0 0.00020274614507798105
. O 0 1.5060060150062782e-06

The O 0 2.150845602955087e-06
t O 0 4.1644806714202787e-08
( O 0 1.1428238355648546e-09
3 O 0 6.2459375449464005e-09
; O 0 5.5182424602007174e-11
15 O 0 6.910428895778864e-10
) O 0 1.6471930156664039e-12
was O 0 9.11847403139987e-11
present O 0 6.16012883064565e-12
in O 0 2.32398258623312e-12
the O 0 3.274605586689461e-11
balanced O 0 1.2081396993934845e-10
state O 0 2.154546159538473e-11
in O 0 4.593915525763492e-11
the O 0 5.833211136341276e-10
patients O 0 3.569730622210443e-10
father O 0 6.474142555390472e-09
and O 0 2.5168909179029697e-09
a O 0 2.3534814985737285e-08
sister O 0 4.420903962909506e-07
. O 0 3.171326170559041e-07

Fluorescent O 0 1.615797827980714e-06
in O 0 6.894331328055614e-09
situ O 0 6.382945372251925e-08
hybridization O 0 1.2167099272542004e-10
analysis O 0 6.105609767770304e-11
demonstrated O 0 1.1547824502189385e-10
that O 0 4.5413967725282944e-12
the O 0 5.323917418031954e-10
PWS B-Disease 1 1.0
critical O 0 7.870915474939011e-09
region O 0 7.4575359221285e-09
resided O 0 1.6888697018657695e-07
on O 0 2.1353567802862017e-09
the O 0 4.2056894078434937e-10
derivative O 0 4.830260080801452e-10
chromosome O 0 2.8221985859389065e-10
3 O 0 1.2362810775101707e-09
and O 0 2.928414455372064e-11
that O 0 8.072478449583365e-12
there O 0 4.880991097411247e-11
was O 0 2.5807811443456785e-10
no O 0 1.0736704927905016e-11
deletion O 0 5.966733357398724e-11
of O 0 5.385708545802004e-10
the O 0 7.929139123064033e-09
PWS B-Disease 1 1.0
region O 0 1.3387504793627159e-07
on O 0 1.4575074480660533e-08
the O 0 8.487567093595771e-09
normal O 0 1.7135059593442747e-08
pair O 0 2.2322714787748055e-09
of O 0 3.5857008473527685e-09
15s O 0 7.667881618544925e-08
present O 0 1.0285796214759557e-08
in O 0 1.1468553218207944e-08
J O 0 2.9403478038148023e-05
. O 0 6.395235345735273e-07

B O 0 0.00048394009354524314
. O 0 1.7886666228150716e-06

Methylation O 0 3.017667893345788e-08
analysis O 0 6.01337690753212e-09
at O 0 1.7433959831336665e-09
exon O 0 4.272294185092562e-10
alpha O 0 2.980415081399457e-10
of O 0 2.8869823198718336e-10
the O 0 2.573093960123174e-10
small O 0 3.9326850109766553e-10
nuclear O 0 4.027315370080942e-09
ribonucleoprotein O 0 5.795488888793443e-08
- O 0 2.153200950871792e-09
associated O 0 2.253808029095694e-09
polypeptide O 0 5.852172790810073e-08
N O 0 7.245442024128579e-09
( O 0 7.698527926258691e-11
SNRPN O 0 2.5295187811025244e-07
) O 0 2.43675782676811e-12
gene O 0 6.4082085991790105e-12
showed O 0 2.2664972329500266e-11
a O 0 1.0867384466275998e-12
pattern O 0 1.2234818713707796e-10
characteristic O 0 4.718274729254013e-11
of O 0 2.4397263723163753e-11
only O 0 5.232534891486118e-11
the O 0 1.4922953983642628e-09
maternal O 0 1.0391020310862586e-07
chromosome O 0 1.2884483702180205e-08
15 O 0 8.371792858952176e-08
in O 0 2.9086182351534262e-08
J O 0 9.873212547972798e-05
. O 0 9.67232949733443e-07

B O 0 0.0003901636227965355
. O 0 1.7658295519140665e-06

Maternal B-Disease 0 7.989806908881292e-05
disomy I-Disease 0 0.00017590282368473709
was O 0 3.521664382333256e-08
confirmed O 0 1.7004388175312357e-10
by O 0 1.8721155268380807e-12
polymerase O 0 1.5363883776320364e-10
chain O 0 1.2776378566226043e-10
reaction O 0 3.4171394880377903e-11
analysis O 0 1.2182605618749065e-11
of O 0 8.021800584900873e-11
microsatellite O 0 6.585533895986373e-09
repeats O 0 7.647750877026738e-09
at O 0 2.2122317311357165e-09
the O 0 9.97456117701745e-10
gamma O 0 2.054450831678878e-08
- O 0 7.702691817712548e-09
aminobutyric O 0 2.5623464239288296e-08
acid O 0 7.771872034822991e-10
receptor O 0 7.707850357974166e-09
beta3 O 0 4.055893398913213e-08
subunit O 0 1.8139725277421803e-09
( O 0 3.1281122137016837e-09
GABRB3 O 0 6.0799989114457276e-06
) O 0 1.659250514762789e-09
locus O 0 2.486312489224929e-08
. O 0 4.7682028991857806e-08

A O 0 7.665718840144109e-06
niece O 0 8.234878805524204e-06
( O 0 6.667116192460298e-09
B O 0 8.054345812524843e-08
. O 0 1.2678595673332183e-10
B O 0 8.487497926701337e-10
. O 0 4.104759501050159e-12
) O 0 9.22735398831663e-14
with O 0 7.567464992315476e-13
45 O 0 3.258383285409394e-10
chromosomes O 0 7.738246154964656e-11
and O 0 2.243811733637635e-11
the O 0 4.911172857280377e-11
derivative O 0 8.263995043833461e-11
3 O 0 1.4859211083795287e-10
but O 0 1.029469131469396e-11
without O 0 1.7996973356027013e-10
the O 0 1.0808038908294293e-08
der O 0 1.7986427280902717e-07
( O 0 1.282870754071297e-10
15 O 0 3.7211784764679123e-09
) O 0 1.580852289351231e-11
demonstrated O 0 3.4367764190079697e-10
a O 0 5.736381925025569e-10
phenotype O 0 1.8654395361750176e-08
consistent O 0 2.4623463268369505e-09
with O 0 4.414436264449373e-12
that O 0 6.093728820155686e-12
reported O 0 1.7671987484479956e-10
for O 0 2.1138570061030038e-11
haploinsufficiency O 0 1.2077940709787072e-06
of O 0 1.0557594265492298e-07
distal O 0 7.985296178958379e-06
3 O 0 9.960594070435036e-06
p O 0 7.344780897255987e-06
. O 0 4.35819544009064e-07

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 2.9630575681949267e-07
with O 0 1.3246573837832898e-09
unbalanced O 0 0.000911831040866673
segregation O 0 1.7517786545795389e-06
of O 0 1.0118898217115202e-06
non O 0 2.4733990358072333e-05
- O 0 1.1635497685347218e-06
Robertsonian O 0 2.232401811852469e-06
translocations O 0 1.2402855986692884e-07
has O 0 9.759124619534987e-10
been O 0 1.5835990851975623e-10
reported O 0 5.00028962679977e-10
previously O 0 3.114322688624327e-10
but O 0 1.1947752509566811e-10
has O 0 5.509113998325432e-11
not O 0 4.046745577523936e-11
, O 0 1.6016358378445616e-11
to O 0 1.1559680990202992e-10
our O 0 5.042692041712371e-09
knowledge O 0 3.585237351444448e-08
, O 0 2.67600774872534e-10
been O 0 1.699965307411233e-10
observed O 0 2.2573951041771068e-10
in O 0 1.599450086264831e-11
a O 0 1.6722950801906222e-10
case O 0 5.203389275010295e-09
of O 0 4.2031675206999353e-07
PWS B-Disease 1 1.0
. O 0 5.3267026487446856e-06

Furthermore O 0 1.4330163139675278e-05
, O 0 3.947493709688388e-08
our O 0 3.531794945388356e-08
findings O 0 1.1718239711910883e-08
are O 0 3.030178885587986e-11
best O 0 1.91438698227131e-10
interpreted O 0 2.692770728618399e-10
as O 0 4.883970658453585e-11
true O 0 5.28612753569746e-09
gamete O 0 6.152074547571829e-07
complementation O 0 1.4296144001946232e-07
resulting O 0 1.351000999960661e-08
in O 0 7.170241733689409e-09
maternal B-Disease 1 0.999610960483551
UPD I-Disease 1 1.0
15 I-Disease 0 0.0002168944920413196
and O 0 9.418884474143852e-06
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9999969005584717
- I-Disease 1 1.0
Jampel I-Disease 1 0.9999994039535522
syndrome I-Disease 1 0.9999653100967407
type I-Disease 0 5.9184689149560654e-08
2 I-Disease 0 2.856078928914485e-08
and O 0 2.370648677363363e-10
Stuve B-Disease 0 0.12882854044437408
- I-Disease 1 0.5943052768707275
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 9.930004041258655e-11
a O 0 3.415171617726642e-11
case O 0 1.9721287103369178e-11
for O 0 1.1120732806846334e-11
" O 0 1.719629993957028e-10
lumping O 0 4.02850597325255e-09
" O 0 6.158281884438566e-09
. O 0 7.310200800247912e-08

Recent O 0 9.044830662219283e-09
studies O 0 4.979673895455505e-10
demonstrated O 0 1.7453313794213443e-10
the O 0 5.0321663502828073e-11
existence O 0 5.162046901041606e-10
of O 0 1.262049909023233e-10
a O 0 1.9725396316339072e-10
genetically O 0 4.768800465626555e-09
distinct O 0 8.879401214301197e-09
, O 0 5.877658082464876e-11
usually O 0 4.2306097861044556e-12
lethal O 0 3.304565301953666e-11
form O 0 1.1196052765449771e-11
of O 0 1.4365963973972384e-10
the O 0 3.852181684749212e-09
Schwartz B-Disease 0 0.3718162477016449
- I-Disease 1 0.9999992847442627
Jampel I-Disease 1 0.9999685287475586
syndrome I-Disease 1 0.9999994039535522
( O 0 5.198789665428194e-08
SJS B-Disease 0 0.0002957345568574965
) O 0 3.561388073336502e-09
of O 0 5.629850784316659e-05
myotonia B-Disease 1 1.0
and O 0 0.12144870311021805
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 1.9378035176487174e-06
which O 0 3.4274055593641606e-08
we O 0 1.1187658799372002e-08
called O 0 3.6312925999482104e-08
SJS B-Disease 0 2.0245568521204405e-05
type I-Disease 0 1.839899232436437e-05
2 I-Disease 0 1.1352646652085241e-05
. O 0 2.5786343371692055e-07

This O 0 3.1521891763475196e-09
disorder O 0 0.00022029211686458439
is O 0 2.1057937338309074e-10
reminiscent O 0 1.7573922761471295e-08
of O 0 6.25325347058947e-10
another O 0 1.027441395851092e-10
rare O 0 2.7648952571901475e-10
condition O 0 8.161510578474918e-09
, O 0 2.7968773130826463e-11
the O 0 7.166984228312856e-10
Stuve B-Disease 1 0.9318264126777649
- I-Disease 1 0.9999880790710449
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.0002317884936928749
SWS B-Disease 1 0.9999845027923584
) O 0 2.4152520261555566e-11
, O 0 7.826920535303206e-12
which O 0 1.1115494809310622e-11
comprises O 0 1.3348475103036606e-10
campomelia B-Disease 0 1.909861339299823e-06
at O 0 2.2815294542510856e-08
birth O 0 1.032690519764401e-07
with O 0 4.467083591919163e-09
skeletal B-Disease 1 0.9999947547912598
dysplasia I-Disease 1 0.9999979734420776
, O 0 5.337700414997926e-08
contractures B-Disease 1 0.78951096534729
, O 0 5.251557411156682e-09
and O 0 1.347775446802757e-09
early B-Disease 0 2.635599230416119e-06
death I-Disease 0 1.8302158650840283e-06
. O 0 5.748522653448163e-07

To O 0 8.082192692882018e-10
test O 0 1.703395237362404e-11
for O 0 1.666721621829126e-11
possible O 0 2.9611511020988246e-09
nosologic O 0 2.8080266929464415e-06
identity O 0 1.3960734790430251e-08
between O 0 2.307467994455692e-08
these O 0 5.90372994935251e-09
disorders O 0 2.5531406322443218e-08
, O 0 5.2733230976320655e-11
we O 0 1.5917381995800284e-11
reviewed O 0 1.4749371168853997e-10
the O 0 1.0001246358859461e-10
literature O 0 2.676411037239035e-10
and O 0 7.10087500951917e-12
obtained O 0 4.932711461513861e-10
a O 0 7.037869592663171e-11
follow O 0 1.5042714296420456e-10
- O 0 1.3119111352821733e-10
up O 0 3.496882228226639e-10
of O 0 3.6692962557260955e-10
the O 0 1.055310977493562e-10
only O 0 3.51956415400867e-11
two O 0 1.6198728122751582e-11
surviving O 0 4.2718890647108765e-09
patients O 0 1.0259706972881588e-10
, O 0 5.1392525651783316e-11
one O 0 5.933823987724907e-10
with O 0 1.436755936445877e-09
SJS B-Disease 0 1.8548172420196352e-06
type I-Disease 0 2.7759904241975164e-07
2 I-Disease 0 6.585235468037354e-08
at O 0 6.952566966589302e-09
age O 0 1.2905456703293794e-09
10 O 0 1.1539721955777793e-10
years O 0 2.772524744509841e-11
and O 0 1.2902736171160889e-11
another O 0 1.6719635398398935e-10
with O 0 4.470141201640132e-10
SWS B-Disease 0 8.202374374377541e-06
at O 0 9.148203083952922e-09
age O 0 5.2141718498432965e-08
7 O 0 7.104898713805596e-08
years O 0 2.5532090219826387e-08
. O 0 1.6147026826729416e-07

Patients O 0 2.343054461562133e-08
reported O 0 3.527390157742616e-09
as O 0 2.860175429830747e-10
having O 0 8.863084710597491e-10
either O 0 1.0155191887406545e-07
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 1 0.9354362487792969
SWS B-Disease 1 0.9999967813491821
presented O 0 6.112951117520637e-11
a O 0 1.9857611648771423e-12
combination O 0 9.055036234717484e-12
of O 0 3.4116281848184382e-12
a O 0 4.934493785802019e-12
severe O 0 7.681414393445607e-10
, O 0 4.623627522515328e-11
prenatal O 0 7.658964022994041e-07
- O 0 8.403042102145264e-07
onset O 1 0.999990701675415
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 4.980567069878816e-10
with O 0 2.2406226873883384e-10
congenital B-Disease 1 1.0
joint I-Disease 0 1.9716583210538374e-07
contractures I-Disease 1 1.0
, O 0 2.0777353171297364e-09
respiratory O 1 1.0
and O 0 7.230906930999481e-07
feeding O 1 0.9999996423721313
difficulties O 1 0.9420133233070374
, O 0 4.869019409881048e-09
tendency O 0 5.126768201080267e-07
to O 0 6.268554564314854e-09
hyperthermia B-Disease 1 0.9999536275863647
, O 0 6.036676020171328e-11
and O 0 7.499676227262775e-12
frequent O 0 1.1245646774904472e-10
death O 0 1.0902279079516575e-09
in O 0 1.9114108074091973e-09
infancy O 0 1.3796345683658728e-06
) O 0 1.362075556510245e-11
with O 0 5.009448585113763e-12
a O 0 7.096156995345382e-10
distinct O 0 4.630535954674997e-08
campomelic B-Disease 0 0.00021732528693974018
- I-Disease 0 8.992108632810414e-05
metaphyseal I-Disease 0 0.00013553346798289567
skeletal I-Disease 1 0.5540558099746704
dysplasia I-Disease 1 0.9999709129333496
. O 0 1.531059569970239e-05

The O 0 4.430384947795574e-09
similarity O 0 1.799222673071199e-07
of O 0 8.103223336775045e-08
the O 0 2.956321942804152e-08
clinical O 0 4.005132936413247e-08
and O 0 2.1850157239100554e-09
radiographic O 0 0.0010277389083057642
findings O 0 3.462130564457766e-07
is O 0 1.5870167402454172e-09
so O 0 1.4779425461242113e-09
extensive O 0 1.6320257145707728e-08
that O 0 7.579003535873596e-10
these O 0 1.8760728082156675e-08
disorders O 0 2.607224587336532e-07
appear O 0 3.1293176938618217e-09
to O 0 2.0532735234279897e-10
be O 0 9.048962967828089e-11
a O 0 3.3949232314256506e-10
single O 0 4.3971379315443926e-10
entity O 0 1.473018897968359e-07
. O 0 2.241715435502556e-07

The O 0 1.7120497375344712e-07
follow O 0 1.705416430297646e-08
- O 0 3.2125340165833904e-09
up O 0 4.2346828821315796e-10
observation O 0 6.947055197770169e-08
of O 0 6.667936341964165e-11
an O 0 8.067367954223137e-12
identical O 0 2.369241781929876e-11
and O 0 1.0018667753047827e-12
unique O 0 9.471012862860562e-11
pattern O 0 1.0129383554158267e-06
of O 0 6.58377814488631e-07
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 7.875150309644141e-09
the O 0 1.5308087242260626e-08
two O 0 1.4339682219421945e-10
patients O 0 5.8599937402537e-11
( O 0 1.1020392931548884e-11
one O 0 2.9653207667124093e-10
with O 0 7.074683061603082e-10
SJS B-Disease 0 2.542324466503487e-07
type I-Disease 0 4.9671669444251165e-08
2 I-Disease 0 4.994565827587394e-08
, O 0 1.3080483918237462e-10
one O 0 2.606639626367979e-10
with O 0 3.5820210686487997e-10
SWS B-Disease 0 1.7697660723570152e-06
) O 0 3.330095921239007e-11
surviving O 0 2.710934552396793e-07
beyond O 0 9.123546647060721e-07
infancy O 0 2.4531836970709264e-06
adds O 0 1.8722541295090878e-09
to O 0 1.669566984663362e-10
the O 0 2.649248875830068e-10
evidence O 0 1.4655519020578822e-09
in O 0 4.906585207575809e-11
favor O 0 1.7576462507662427e-09
of O 0 1.1317888848338953e-09
identity O 0 2.4387622588051272e-08
. O 0 1.192178444853198e-07

The O 0 6.168982480403429e-08
hypothesis O 0 1.4265039283145597e-07
that O 0 3.698711559252388e-09
SWS B-Disease 0 9.297157703258563e-06
and O 0 1.1335199445738908e-08
SJS B-Disease 0 1.4462665376413497e-06
type I-Disease 0 3.0170122045092285e-07
2 I-Disease 0 3.331556399643887e-07
are O 0 1.2606929389313848e-10
the O 0 5.971131367132898e-10
same O 0 5.521172408151642e-10
disorder O 0 1.132897420319523e-08
should O 0 7.538545482299597e-11
be O 0 9.302257575338757e-11
testable O 0 1.4572017370539925e-08
by O 0 7.384675509980454e-11
molecular O 0 1.1844609737465817e-09
methods O 0 4.423899913064133e-09
. O 0 3.2403744132381007e-09
. O 0 5.016103798993754e-08

A O 0 2.210014393710935e-08
mouse O 0 1.1559686541318115e-09
model O 0 6.600142654633601e-10
of O 0 2.38940117691655e-10
severe O 0 1.547733336337842e-05
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9340267181396484
defects O 1 1.0
in O 0 3.0429202979576075e-07
hemostasis O 0 0.0009813891956582665
and O 0 3.47062574235224e-08
thrombosis B-Disease 0 2.5580015972082037e-06
. O 0 5.673050651466838e-08

von B-Disease 1 0.9958398342132568
Willebrand I-Disease 1 0.9999897480010986
factor I-Disease 0 0.1761508285999298
( I-Disease 0 0.000597529811784625
vWf I-Disease 1 0.9999914169311523
) I-Disease 0 1.5143911014092737e-06
deficiency I-Disease 1 1.0
causes O 1 0.9999651908874512
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 2.5371946321683936e-06
humans O 0 7.928065883788804e-07
. O 0 3.3004554644833206e-09

We O 0 4.175494172642402e-09
generated O 0 9.676992540619267e-10
a O 0 1.5105448836205682e-10
mouse O 0 4.676240505929741e-10
model O 0 5.440490280506083e-10
for O 0 1.5254988244839396e-11
this O 0 4.3545781563958386e-11
disease O 0 4.699792777174139e-10
by O 0 9.31381100716111e-12
using O 0 1.1728244764253049e-10
gene O 0 1.3175924351571666e-08
targeting O 0 4.1021894503501244e-07
. O 0 6.885673542456061e-08

vWf B-Disease 0 0.0002992800436913967
- I-Disease 0 4.5593278628075495e-05
deficient I-Disease 0 7.0894993768888526e-06
mice O 0 1.5139448805712163e-07
appeared O 0 4.2643037545531115e-08
normal O 0 2.0117957078014115e-08
at O 0 4.969825107004056e-10
birth O 0 8.328396999823795e-11
; O 0 1.0417433408960175e-11
they O 0 1.5512932952099767e-11
were O 0 1.0118191701158352e-10
viable O 0 7.281381897428219e-08
and O 0 2.3430846152194817e-09
fertile O 0 4.736482424050337e-06
. O 0 2.592308874227456e-07

Neither O 0 8.097504905890673e-05
vWf O 0 0.006388835143297911
nor O 0 0.0003230700676795095
vWf O 0 0.005077675450593233
propolypeptide O 0 0.003189424052834511
( O 0 5.171473844711727e-07
von B-Disease 0 0.001898702816106379
Willebrand I-Disease 0 1.3965702237328514e-05
antigen O 0 3.586960772850034e-08
II O 0 0.00012059856089763343
) O 0 2.412722022171465e-09
were O 0 2.6652915430247504e-09
detectable O 0 3.0737837164451776e-08
in O 0 1.1622378753850526e-10
plasma O 0 6.7355876431918205e-09
, O 0 2.320626156515626e-11
platelets O 0 8.487789915356814e-10
, O 0 1.3235497767216664e-11
or O 0 3.340586487987629e-11
endothelial O 0 2.1932990146300568e-10
cells O 0 2.01979100111771e-10
of O 0 8.990881650294824e-11
the O 0 1.502780261342096e-10
homozygous O 0 1.6381782597107986e-09
mutant O 0 1.8878073149153352e-07
mice O 0 2.057349348660864e-07
. O 0 1.4907207912528975e-07

The O 0 5.954302384481025e-09
mutant O 0 7.725117967538608e-08
mice O 0 7.413588321014686e-08
exhibited O 0 1.6051224349666882e-07
defects O 0 1.906344238022939e-07
in O 0 1.5989454205111997e-09
hemostasis O 0 1.56828363628847e-07
with O 0 1.1626918178242462e-11
a O 0 5.75178571438073e-10
highly O 0 6.735793256495981e-09
prolonged O 0 7.542323032794229e-07
bleeding O 0 5.538342406907759e-07
time O 0 7.188399209212548e-09
and O 0 1.8068970764062442e-09
spontaneous O 0 1.9472480516924406e-07
bleeding O 0 2.149599254153145e-08
events O 0 7.990496458942786e-11
in O 0 2.9682391960994536e-11
approximately O 0 1.9106372040056385e-10
10 O 0 5.450669360307359e-10
% O 0 4.176758661156299e-10
of O 0 1.342774447188333e-09
neonates O 0 3.1404769629261864e-07
. O 0 2.1806415873015794e-07

As O 0 3.2866600552239333e-09
in O 0 1.4337822595855698e-10
the O 0 1.633350815710699e-10
human O 0 2.874624704940487e-10
disease O 0 3.600340292564397e-08
, O 0 1.821855687145213e-11
the O 0 8.507656384937334e-11
factor O 0 1.7845522837234284e-09
VIII O 0 4.130276920477627e-07
level O 0 8.725351108296309e-08
in O 0 9.919579602168938e-10
these O 0 2.3762904977076005e-09
mice O 0 6.248987993728861e-09
was O 0 5.010927672799426e-09
reduced O 0 7.222865083811314e-10
strongly O 0 6.327516982596038e-11
as O 0 3.094450043428232e-11
a O 0 2.767262634317813e-11
result O 0 2.650987762642387e-10
of O 0 7.235606003241912e-10
the O 0 1.246880820815477e-09
lack O 0 1.5251316654030234e-08
of O 0 2.254418651759238e-09
protection O 0 2.4352761585078042e-08
provided O 0 1.6002367431156017e-08
by O 0 6.394324181258071e-09
vWf O 0 4.199864633847028e-05
. O 0 7.985127581378038e-07

Defective O 0 2.5838486180873588e-05
thrombosis B-Disease 0 1.1528730965437717e-06
in O 0 9.92179338688004e-10
mutant O 0 1.4469154763219194e-08
mice O 0 6.67427979550439e-09
was O 0 1.074995314986893e-09
also O 0 1.5410363957135687e-11
evident O 0 7.356393827429031e-10
in O 0 5.609887988172746e-12
an O 0 8.656970106046824e-12
in O 0 3.7941897887416864e-12
vivo O 0 5.338845476821064e-10
model O 0 1.6066614705323445e-09
of O 0 1.0672814632073369e-08
vascular B-Disease 0 0.007594378665089607
injury I-Disease 1 0.9999992847442627
. O 0 2.4010294509935193e-05

In O 0 2.3311157448802078e-09
this O 0 2.289207573502594e-10
model O 0 4.463259539733144e-09
, O 0 1.1567576063686857e-10
the O 0 2.0007511203345985e-09
exteriorized O 0 2.3758395855111303e-06
mesentery O 0 5.459807198349154e-06
was O 0 5.134920044724822e-08
superfused O 0 3.0170812692631443e-07
with O 0 5.124690116709019e-10
ferric O 0 1.0708236430900797e-07
chloride O 0 5.170507222373999e-08
and O 0 2.228638384949022e-09
the O 0 2.430348011728256e-08
accumulation O 0 0.00021923353779129684
of O 0 9.38686298468383e-06
fluorescently O 0 5.534564479603432e-06
labeled O 0 1.125617785646682e-07
platelets O 0 1.5622171645190974e-07
was O 0 7.136201407575982e-09
observed O 0 5.889241316836547e-10
by O 0 3.077746391078051e-10
intravital O 0 2.344110498597729e-06
microscopy O 0 4.62214444496567e-07
. O 0 7.884773367550224e-08

We O 0 1.1098843089030197e-07
conclude O 0 1.4376921342318383e-07
that O 0 5.594282814769258e-10
these O 0 1.4211716248269113e-09
mice O 0 6.4783547415459e-09
very O 0 4.033401668213088e-10
closely O 0 1.0684785278769482e-09
mimic O 0 1.2774250990332803e-07
severe O 0 9.971695362764876e-07
human O 0 6.320357351796702e-05
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.00034178313217125833
will O 0 1.2935817972348218e-09
be O 0 1.9821229380045935e-10
very O 0 1.8675692936565014e-11
useful O 0 2.380013408576076e-10
for O 0 1.1121241948186533e-11
investigating O 0 1.8224229070273879e-10
the O 0 3.7691788579152785e-10
role O 0 2.7836213889465e-10
of O 0 4.339392845054135e-09
vWf O 0 1.6403497227202024e-07
in O 0 2.800082610221466e-09
normal O 0 5.725669325329363e-07
physiology O 0 3.492732503218576e-08
and O 0 2.4156587841162036e-10
in O 0 2.3288393435905164e-10
disease O 0 8.533961093348807e-09
models O 0 1.1190071091959908e-08
. O 0 1.914125080659801e-09
. O 0 6.42226822833436e-08

Oral O 0 2.7144375280840904e-07
contraceptives O 0 2.5464154873588996e-07
and O 0 1.1365345470304433e-10
the O 0 3.2717603626331027e-10
risk O 0 1.7944759633792273e-07
of O 0 1.096302003134042e-05
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.3692516631635954e-07

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 0.9999997615814209
Clinical O 0 6.858476098159372e-08
Study O 0 1.671144056469842e-10
Group O 0 7.674278573732707e-11
. O 0 7.015611425131851e-10

BACKGROUND O 0 0.011636189185082912
Women O 0 3.979651719276944e-09
with O 0 5.2839146252869895e-11
mutations O 0 1.1291604318230952e-09
in O 0 5.3978817943223234e-11
either O 0 6.031592447719447e-10
the O 0 2.8924627137882908e-09
BRCA1 O 0 2.131105958369517e-08
or O 0 1.2823845318976623e-09
the O 0 3.717375962608571e-09
BRCA2 O 0 3.5650513652285554e-09
gene O 0 3.0863761546484625e-10
have O 0 6.566838739452407e-11
a O 0 1.6250042977894452e-10
high O 0 1.549606221118438e-09
lifetime O 0 8.74347261259345e-09
risk O 0 8.691481525602285e-07
of O 1 0.5149863362312317
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.3134354876219732e-07

Oral O 0 3.0650485314254183e-06
contraceptives O 0 1.8347391232964583e-05
protect O 0 2.586910341051407e-06
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.946450112200182e-09
general O 0 4.789072693967e-09
, O 0 9.498324002321645e-12
but O 0 1.2797175645562486e-11
it O 0 7.606540397553374e-12
is O 0 5.258936949109616e-12
not O 0 8.069245792385882e-12
known O 0 2.9161034698077515e-10
whether O 0 1.0623638635465227e-09
they O 0 6.975742206094537e-10
also O 0 1.3170106671900328e-10
protect O 0 9.988168625518767e-11
against O 0 4.731010028180549e-10
hereditary B-Disease 1 1.0
forms I-Disease 1 1.0
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.5462855884607052e-08

METHODS O 0 1.6112878142848786e-07
We O 0 5.6820875782293e-10
enrolled O 0 3.3575622282455697e-09
207 O 0 5.36338140566528e-10
women O 0 1.2089419743066543e-10
with O 0 8.563159070718029e-10
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 8.633029187354868e-12
161 O 0 7.368157473042203e-11
of O 0 1.7896267801020826e-10
their O 0 5.646941803050254e-10
sisters O 0 7.382527922317195e-09
as O 0 3.457647279603293e-09
controls O 0 1.8311391514203024e-08
in O 0 2.452493763627217e-09
a O 0 5.1078687945960155e-09
case O 0 1.3551742839013059e-08
- O 0 1.8875295992870633e-08
control O 0 5.650104029086833e-08
study O 0 9.123702682245494e-09
. O 0 1.2831681495129033e-08

All O 0 3.116166436001322e-09
the O 0 1.6686001469423672e-09
patients O 0 1.6995826968013716e-10
carried O 0 4.3404647931399865e-11
a O 0 4.108887275561246e-12
pathogenic O 0 2.0292359459439524e-10
mutation O 0 9.908549675197165e-11
in O 0 8.209870977493594e-11
either O 0 3.759072164655208e-09
BRCA1 O 0 1.132083138344342e-08
( O 0 2.4087895567070916e-10
179 O 0 3.74271769132406e-09
women O 0 1.9145660057340308e-10
) O 0 7.36413915958245e-11
or O 0 3.391818159670379e-09
BRCA2 O 0 2.355632844341926e-08
( O 0 5.591648255531823e-10
28 O 0 3.4277854865649715e-07
women O 0 4.6869605085930743e-08
) O 0 1.1379911235565032e-08
. O 0 2.4737539661146e-07

The O 0 2.2608787730860058e-08
control O 0 1.3838596935045189e-08
women O 0 1.671460414520709e-09
were O 0 1.67719615973283e-09
enrolled O 0 8.688773589504706e-10
regardless O 0 1.9491881442235126e-09
of O 0 3.566722472925221e-10
whether O 0 6.879585789931753e-11
or O 0 6.406443153750274e-10
not O 0 2.7224758558652695e-10
they O 0 3.020232952621882e-10
had O 0 1.903414315052032e-09
either O 0 7.313364136507516e-09
mutation O 0 7.310731575671525e-08
. O 0 1.292492868287809e-07

Lifetime O 0 1.9324170352774672e-07
histories O 0 8.341045258930535e-07
of O 0 3.5413302157394355e-07
oral O 0 1.709604724453584e-08
- O 0 2.408593102742884e-09
contraceptive O 0 2.6604449199219005e-10
use O 0 8.775877247124697e-11
were O 0 3.2542763622744886e-11
obtained O 0 4.0625633412894047e-10
by O 0 1.0395526106599107e-10
interview O 0 5.348507747804376e-10
or O 0 2.0864822022903518e-11
by O 0 4.00823515003812e-12
written O 0 1.1754771418390209e-12
questionnaire O 0 7.737323151971176e-13
and O 0 1.1706018099300053e-12
were O 0 1.1497709034857806e-11
compared O 0 4.269554848557178e-11
between O 0 2.383155651985991e-11
patients O 0 8.848094132374307e-12
and O 0 1.798423215904066e-11
control O 0 2.7843292116358498e-09
women O 0 6.502838267863353e-10
, O 0 4.552569779492366e-11
after O 0 4.597176112008938e-11
adjustment O 0 1.2483538647245496e-09
for O 0 2.4153257519032856e-11
year O 0 3.5163316702835345e-10
of O 0 2.6678803610735713e-09
birth O 0 1.786197856290528e-08
and O 0 2.1023925711460834e-08
parity O 0 3.2963414469122654e-06
. O 0 7.138218052205048e-07

RESULTS O 0 7.265372232723166e-07
The O 0 7.970503368426307e-09
adjusted O 0 3.1054022997523134e-07
odds O 0 1.9004519913323747e-07
ratio O 0 2.499578499737254e-08
for O 0 4.586410540241559e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 1.3757774475209317e-08
with O 0 2.8452745801793577e-12
any O 0 5.6498361544754516e-11
past O 0 1.961292378505064e-10
use O 0 4.500612382773994e-11
of O 0 3.2525962478935355e-10
oral O 0 8.914013416294608e-10
contraceptives O 0 1.2857258369081137e-08
was O 0 1.1337124128374398e-08
0 O 0 7.030580206901504e-08
. O 0 1.725294822563228e-07

5 O 0 3.991566472905106e-07
( O 0 1.1675219679929683e-09
95 O 0 3.891990729698591e-08
percent O 0 5.521227475213664e-09
confidence O 0 1.8092869424890523e-09
interval O 0 2.1027124486039384e-09
, O 0 5.743407485714336e-11
0 O 0 5.832298533015035e-10
. O 0 1.0118327009589478e-10
3 O 0 7.782225419639133e-10
to O 0 3.8637620880521695e-10
0 O 0 3.4380629454489053e-09
. O 0 8.547053620411305e-10
8 O 0 2.0460431571223126e-08
) O 0 1.5660701624398143e-09
. O 0 3.3518052333647574e-08

The O 0 1.287620410295176e-08
risk O 0 2.346193994640089e-08
decreased O 0 2.3264163928615744e-09
with O 0 4.724177321037415e-13
increasing O 0 1.0229479069367997e-10
duration O 0 5.160098459633389e-10
of O 0 9.870541189949122e-11
use O 0 2.0791854349333505e-10
( O 0 1.5744795744954132e-10
P O 0 3.923308966591321e-08
for O 0 1.210536393347894e-10
trend O 0 4.0864097883286377e-08
, O 0 3.3244351715921994e-11
< O 0 1.4489355548708005e-10
0 O 0 6.345431402543511e-10
. O 0 2.903809415144565e-10
001 O 0 5.719778428669997e-09
) O 0 6.819642073274679e-12
; O 0 3.028132215462942e-12
use O 0 6.368960480535035e-12
for O 0 6.018120723982889e-11
six O 0 2.368845120059859e-10
or O 0 1.2305732821626947e-10
more O 0 6.982980166325703e-11
years O 0 2.2023746715227333e-10
was O 0 2.675226984383272e-10
associated O 0 4.021608046578251e-11
with O 0 2.3014504798440916e-12
a O 0 9.759919955554253e-11
60 O 0 5.177706041692431e-10
percent O 0 1.6723908369264961e-10
reduction O 0 2.3402338400480005e-10
in O 0 1.8356763331617287e-10
risk O 0 5.455396845377436e-08
. O 0 1.7182522071834683e-07

Oral O 0 1.008495814858179e-06
- O 0 4.1292675945214796e-08
contraceptive O 0 1.3071387305885196e-09
use O 0 8.844235066529649e-11
protected O 0 1.6427964510512538e-05
against O 1 0.9999998807907104
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 3.059737521942524e-13
for O 0 1.0633341605771791e-14
carriers O 0 1.4001793431292486e-13
of O 0 3.400129570257926e-12
the O 0 2.544271182625124e-10
BRCA1 O 0 5.307374095764317e-09
mutation O 0 2.4048838476176115e-09
( O 0 6.433566457353379e-10
odds O 0 9.681008350526099e-08
ratio O 0 1.8293238923661193e-08
, O 0 8.760996372814134e-10
0 O 0 2.555468059384225e-09
. O 0 4.754004412355073e-10
5 O 0 8.405256490817692e-10
; O 0 3.272307771973182e-11
95 O 0 3.1123885690931274e-09
percent O 0 8.704896248268312e-10
confidence O 0 4.248825458130767e-10
interval O 0 3.407794324505886e-10
, O 0 2.3086576053654717e-11
0 O 0 2.2626799045522006e-10
. O 0 4.754745555612949e-11
3 O 0 2.5377042134344663e-10
to O 0 2.06129391333576e-10
0 O 0 2.1566699537345357e-09
. O 0 4.3269604566020803e-10
9 O 0 3.3123621623332156e-09
) O 0 3.0179264035729014e-12
and O 0 6.228781596409605e-13
for O 0 3.4888487498302423e-13
carriers O 0 2.3719002456568106e-11
of O 0 1.5204480730002246e-10
the O 0 1.2138276161977046e-08
BRCA2 O 0 5.394364279709407e-07
mutation O 0 1.5412679132964513e-08
( O 0 5.2916862003371534e-09
odds O 0 6.988972813815053e-07
ratio O 0 6.73974085430018e-08
, O 0 1.3624223971220317e-09
0 O 0 4.230922723280628e-09
. O 0 3.101069123712108e-10
4 O 0 6.96114832443584e-10
; O 0 4.722326002459809e-11
95 O 0 2.9059494810468323e-09
percent O 0 6.590255563487801e-10
confidence O 0 5.208729003669532e-10
interval O 0 1.2959378015153789e-09
, O 0 7.547867886259496e-11
0 O 0 3.5276712107013e-10
. O 0 9.385234950309851e-11
2 O 0 4.6313436419254117e-10
to O 0 3.2717853426511567e-10
1 O 0 7.289146619626763e-09
. O 0 6.984795519748843e-10
1 O 0 1.885191025507993e-08
) O 0 2.3954533912018405e-09
. O 0 5.3309751280039563e-08

CONCLUSIONS O 0 0.00031727217719890177
Oral O 0 1.6686858543835115e-06
- O 0 7.937434531868348e-08
contraceptive O 0 1.5709765710525403e-09
use O 0 2.569100661375945e-11
may O 0 2.241809862746358e-11
reduce O 0 2.3507099045083635e-11
the O 0 2.32324784410487e-11
risk O 0 1.7397761453707972e-08
of O 0 6.222954311851936e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 5.356327603678324e-10
women O 0 6.643710321468932e-12
with O 0 2.650093957213412e-13
pathogenic O 0 4.688312238432246e-11
mutations O 0 8.962391939704162e-11
in O 0 2.550168236303829e-11
the O 0 3.0756117652686044e-09
BRCA1 O 0 2.3108886182399146e-07
or O 0 1.202129453758971e-07
BRCA2 O 0 2.3449490527127637e-06
gene O 0 1.3635609320772346e-05

A O 0 4.893377436587798e-08
Japanese O 0 1.0965224284120723e-08
family O 0 4.6008011289622175e-10
with O 0 5.8171197026002375e-11
adrenoleukodystrophy B-Disease 1 1.0
with O 0 4.52954557542129e-12
a O 0 2.915517827162262e-11
codon O 0 2.560268885787309e-09
291 O 0 1.2923486725213706e-09
deletion O 0 1.6734055807710035e-10
: O 0 6.077713332608425e-11
a O 0 4.967418143486668e-10
clinical O 0 7.830082360271717e-09
, O 0 3.951798888124358e-10
biochemical O 0 2.670387289072096e-07
, O 0 2.55836996032599e-09
pathological O 0 5.445911938295467e-06
, O 0 3.698267247997933e-09
and O 0 1.4184770025238436e-09
genetic O 0 2.17564377180679e-07
report O 0 3.8678653169199606e-08
. O 0 7.511987831776423e-08

We O 0 4.3765484569746604e-09
report O 0 4.001135534004163e-10
a O 0 3.488440092347389e-11
Japanese O 0 6.951940134669599e-10
family O 0 2.783122621252687e-10
with O 0 1.8376029864430876e-10
adrenoleukodystrophy B-Disease 1 1.0
( O 0 9.140357093428975e-08
ALD B-Disease 1 1.0
) O 0 4.22272590158701e-12
with O 0 1.5983018402700166e-13
a O 0 6.2995398827925264e-12
three O 0 5.288651027529623e-12
base O 0 1.6675278935451843e-09
pair O 0 1.4790310087775538e-09
deletion O 0 2.223899508990712e-09
( O 0 2.1323858234723048e-09
delGAG O 0 3.2009549499889545e-07
291 O 0 8.715866250952331e-09
) O 0 1.0365978908577489e-11
in O 0 1.5124708430125366e-10
the O 0 3.5120788055564844e-08
ALD B-Disease 1 1.0
gene O 0 1.0083457482323865e-06
. O 0 9.629018222767627e-07

A O 0 3.2274604677695606e-07
variety O 0 1.2237983071372582e-08
of O 0 1.0769311664660108e-08
phenotypes O 0 1.0634879998860924e-07
were O 0 1.4895114031077128e-09
observed O 0 9.525802369125813e-10
within O 0 8.252479949399927e-11
this O 0 1.6344291198233662e-10
family O 0 7.894716880230135e-09
. O 0 3.067230380793262e-08

While O 0 3.139313253797127e-09
the O 0 9.368611664228865e-09
proband O 0 2.231333155577886e-06
( O 0 2.2141510847006884e-10
patient O 0 2.63660759891593e-09
1 O 0 1.1243062481014476e-08
) O 0 2.462437719008559e-11
was O 0 3.160182115991006e-10
classified O 0 7.351004527311744e-11
as O 0 3.679519536281539e-11
having O 0 1.2700663437614779e-11
a O 0 1.1899169150009214e-11
rare O 0 1.1029293450759425e-10
intermediate O 0 1.1413968659113038e-09
type O 0 7.810017077503062e-10
of O 0 1.7180507017044988e-09
adult O 0 5.817794246354424e-08
cerebral O 0 6.354184733936563e-06
and O 0 1.7963690979172497e-08
cerebello O 0 0.0002781009243335575
- O 0 5.4129814088810235e-06
brain O 0 1.3285555269249016e-06
stem O 0 5.148480308747594e-09
forms O 0 4.787864549271603e-10
, O 0 7.28803736110839e-12
his O 0 3.083951427562681e-10
younger O 0 2.2095127505394885e-08
brother O 0 3.636005274643139e-08
( O 0 4.324813077105638e-11
patient O 0 4.0544276269649515e-10
2 O 0 8.477014090679802e-10
) O 0 1.0306282736960437e-11
and O 0 7.801114199068593e-10
nephew O 0 2.225975094916066e-06
( O 0 8.638934012594746e-10
patient O 0 3.1849108950154914e-07
3 O 0 6.103971372795058e-07
) O 0 5.354203191920703e-10
had O 0 1.1137901267943562e-08
a O 0 6.920338080362853e-09
childhood O 0 1.6490092093590647e-05
ALD B-Disease 1 1.0
type O 0 2.5240624381694943e-05
. O 0 2.572184598648164e-07

Another O 0 8.672986240298997e-08
nephew O 0 5.330204203346511e-06
( O 0 2.1415036410843413e-09
patient O 0 4.999271219219281e-09
4 O 0 3.748719112905974e-09
) O 0 1.9180802779406037e-12
of O 0 1.4112790103215644e-10
patient O 0 9.605606310358894e-10
1 O 0 1.0674503947427638e-08
was O 0 4.902249273186499e-09
classified O 0 3.287774497096052e-10
as O 0 6.323104262406787e-10
having O 0 4.6057793690046367e-10
an O 0 9.098951037067593e-10
adolescent O 0 7.892683839827441e-09
form O 0 3.132554216023209e-09
. O 0 5.918683143590897e-08

The O 0 5.334308106341723e-09
tau O 0 5.129347613319624e-09
level O 0 1.294665374906856e-09
in O 0 2.0156836269547007e-11
the O 0 2.5165212136357695e-09
cerebrospinal O 0 2.475231895004981e-06
fluid O 0 5.1060987971141e-07
( O 0 2.0810878353927365e-08
CSF O 1 0.8101159334182739
) O 0 2.1322260623790612e-10
in O 0 2.9505226040171806e-10
patient O 0 1.666272808620306e-08
1 O 0 8.521895722424233e-08
was O 0 5.279791892576213e-08
as O 0 1.191880705242454e-09
high O 0 4.4853543101908144e-09
as O 0 3.254685757014819e-11
that O 0 1.169597513457632e-12
of O 0 3.4117729474925085e-11
patients O 0 1.5645350293080895e-10
with O 0 1.5230087191397956e-09
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.986021101474762
( O 0 4.616300675053253e-09
AD B-Disease 0 0.0006530996761284769
) O 0 3.156894301525881e-09
. O 0 6.550222053647303e-08

His O 0 1.122999435665406e-07
brain O 0 2.1817504602950066e-07
magnetic O 0 5.012545756244435e-08
resonance O 0 1.068110311308601e-08
image O 0 1.6104145572626294e-08
( O 0 2.975836799201659e-10
MRI O 0 2.035326360783074e-07
) O 0 4.7232093236537764e-11
showed O 0 1.0954495088810745e-09
abnormalities B-Disease 0 1.9895249891987987e-09
in I-Disease 0 9.314792687176165e-11
the I-Disease 0 3.5595748570926844e-09
bilateral I-Disease 0 9.138759651250439e-07
cerebellar I-Disease 1 0.9999998807907104
hemispheres I-Disease 0 0.010782684199512005
and O 0 9.381096077731854e-08
brain O 0 1.6242880519712344e-05
stem O 0 1.873752495384906e-07
, O 0 5.744832040632808e-11
but O 0 1.1658608106701607e-11
not O 0 8.430021437855206e-12
in O 0 7.160613074708166e-11
the O 0 3.762343325774964e-09
cerebral O 0 4.052553777000867e-07
white O 0 1.4633116940387936e-09
matter O 0 3.849067731209743e-09
, O 0 3.6538810171959923e-11
where O 0 4.5278201327159096e-11
marked O 0 1.2973913610103693e-10
reductions O 0 1.2332901366818305e-09
of O 0 8.637056625460104e-10
the O 0 9.489900421044695e-09
cerebral O 0 1.866450816123688e-07
blood O 0 3.0238889170419725e-09
flow O 0 1.4786876612049582e-08
and O 0 4.026898536846346e-10
oxygen O 0 1.473177690947125e-09
metabolism O 0 2.2788546161223167e-08
were O 0 4.433501898937209e-10
clearly O 0 1.133026450439445e-09
demonstrated O 0 1.959949841312536e-10
by O 0 1.0132830685627425e-10
positron O 0 9.558717550817164e-08
emission O 0 5.433579275404554e-08
tomography O 0 1.5935488306695333e-07
( O 0 1.1552815593063315e-08
PET O 0 3.501969786157133e-06
) O 0 8.439075216415404e-09
. O 0 7.734126228342575e-08

In O 0 2.1571799901920485e-09
patients O 0 5.334072072926688e-10
2 O 0 3.578028318074189e-09
and O 0 1.8816290192624763e-10
3 O 0 8.46612824290105e-09
, O 0 3.107011523062475e-11
the O 0 6.33444824371665e-11
autopsy O 0 3.826076788726596e-09
findings O 0 5.340780595552985e-10
showed O 0 7.431703030746917e-10
massive O 0 6.257897755546082e-09
demyelination B-Disease 1 1.0
of I-Disease 0 6.002155714668334e-07
the I-Disease 0 3.235442136428901e-07
cerebral I-Disease 0 7.137767170206644e-06
white I-Disease 0 8.474730639473904e-11
matter I-Disease 0 6.51628195846854e-11
with O 0 4.4686509267227725e-13
sparing O 0 1.0768032021601925e-09
of O 0 2.2233821450612368e-09
the O 0 7.875916807620342e-09
U O 0 7.312501679734851e-07
- O 0 3.692081236295053e-07
fibers O 0 2.83555050373252e-06
, O 0 3.881955590312458e-10
compatible O 0 2.641872942632517e-09
with O 0 7.335034489519554e-12
the O 0 4.3278022832105023e-10
findings O 0 2.6980726541836475e-09
of O 0 5.778796108302231e-09
childhood O 0 2.484213655407075e-05
ALD B-Disease 1 1.0
. O 0 3.0575656637665816e-06

Oleic O 0 6.0727739764843136e-05
and O 0 4.1504458181407244e-07
erucic O 0 5.481917833094485e-05
acids O 0 2.3400632471748395e-06
( O 0 1.2639300273065146e-08
Lorenzos O 0 4.798191071131441e-07
Oil O 0 7.094512710636991e-08
) O 0 9.249847415793155e-12
were O 0 1.6584513276574064e-11
administered O 0 2.2430833232500724e-12
to O 0 7.146038101535357e-12
patients O 0 1.4514880616878223e-11
1 O 0 5.683691295388371e-10
and O 0 4.2221823259858127e-10
4 O 0 1.2851423036863707e-08
, O 0 8.620758273902851e-11
but O 0 5.772488737010306e-11
sufficient O 0 1.1660532539536916e-09
effectiveness O 0 7.341903529578531e-09
was O 0 2.283317535045626e-09
not O 0 3.1654665000324655e-10
obtained O 0 6.06721641815966e-08
. O 0 2.0368467801290535e-07

The O 0 3.613267551827448e-07
findings O 0 4.159725364161204e-08
in O 0 2.705208002051762e-10
this O 0 6.993483570028047e-11
family O 0 2.1382046133666677e-10
suggest O 0 2.3033763785207384e-10
that O 0 1.456965299274915e-12
delGAG291 O 0 1.6791614765310214e-09
is O 0 2.5443753007281522e-12
part O 0 6.113099609850181e-12
of O 0 2.993562689401763e-11
the O 0 4.7949172410355345e-11
cause O 0 1.6164731775347718e-09
of O 0 4.87117457481645e-09
Japanese O 0 2.6653341933524644e-07
ALD B-Disease 1 1.0
with O 0 1.368531815648666e-10
phenotypic O 0 4.194734160023472e-08
variations O 0 2.3438148843979434e-07
. O 0 1.4779692492083996e-07

Moreover O 0 2.0110175569243438e-07
, O 0 2.5059440633690144e-10
although O 0 8.143651031300436e-11
the O 0 8.149338842633469e-11
scale O 0 1.6902924615536108e-09
of O 0 5.476075148891368e-10
the O 0 8.728006095637397e-10
study O 0 8.763783448939577e-11
is O 0 7.499446376402208e-12
limited O 0 2.086702061143697e-10
, O 0 1.252481590663379e-10
there O 0 1.279042871615843e-09
is O 0 2.555642364399091e-10
a O 0 6.919502748559125e-10
possibility O 0 2.450690139710332e-08
that O 0 3.152910821313526e-09
PET O 0 1.2155371678090887e-06
can O 0 4.149896426497435e-09
detect O 0 1.1796957721799117e-07
an O 0 5.202476671684053e-09
insidious B-Disease 0 1.5698709830758162e-05
lesion I-Disease 0 0.04947230964899063
which O 0 8.114815486237603e-10
is O 0 3.222658806478762e-10
undetectable O 0 6.988130518692515e-09
by O 0 7.270976876139201e-11
computed O 0 1.141178032071366e-07
tomogram O 0 2.947549546661321e-06
( O 0 7.60411467126687e-09
CT O 0 9.056950602825964e-07
) O 0 3.4699271234117646e-10
or O 0 8.00447319537767e-10
MRI O 0 1.4846172291527182e-07
analysis O 0 1.0400844629998574e-09
, O 0 1.951734607263944e-11
and O 0 5.315997208404921e-12
that O 0 2.093752688586692e-12
the O 0 4.896730937398175e-11
higher O 0 1.2766274704034686e-09
level O 0 3.2205571542931466e-10
of O 0 2.803399734574441e-10
tau O 0 1.343166466938328e-09
reflects O 0 6.005212993542841e-10
the O 0 2.85701167584973e-11
process O 0 3.2628363899611657e-10
of O 0 3.1145381829134067e-09
neuronal B-Disease 0 0.0001448989933123812
degeneration I-Disease 1 0.9906516075134277
in O 0 7.980455052347679e-08
ALD B-Disease 1 1.0
. O 0 1.7777962284526438e-06

Lorenzos O 0 4.112049282412045e-05
Oil O 0 1.015059751807712e-06
should O 0 1.1229807361790023e-10
be O 0 1.99719928095643e-11
given O 0 9.332184330856919e-11
in O 0 6.398404028828963e-11
the O 0 5.390744517441703e-10
early O 0 1.1092172513826881e-08
stage O 0 1.7088280790389376e-09
. O 0 3.061179532082292e-09
. O 0 4.567632316820891e-08

Nonsense O 0 2.2988015757618996e-07
mutation O 0 3.463600961595148e-09
in O 0 2.727543468861171e-10
exon O 0 8.098785642118855e-09
4 O 0 3.1774714415178096e-08
of O 0 1.0711557196785293e-09
human O 0 3.8712494321302415e-10
complement O 0 2.3681700156430452e-08
C9 O 0 1.165863977803383e-05
gene O 0 7.610466146168449e-10
is O 0 6.170457200749269e-11
the O 0 3.7427994731276115e-11
major O 0 1.1836474855808632e-10
cause O 0 2.6960973453782344e-09
of O 0 7.038131855097163e-09
Japanese O 0 2.2233201946164627e-07
complement B-Disease 0 8.116276148939505e-06
C9 I-Disease 1 0.9999990463256836
deficiency I-Disease 1 0.6247814893722534
. O 0 1.7554613123138552e-06

Deficiency B-Disease 0 1.7604135109650088e-06
of I-Disease 0 6.318842338259856e-08
the I-Disease 0 5.402151614930517e-09
ninth I-Disease 0 3.989518404523551e-08
component I-Disease 0 1.4015109073284293e-08
of I-Disease 0 2.146439248562615e-09
human I-Disease 0 1.1394674093168078e-09
complement I-Disease 0 1.6905858046811773e-07
( O 0 1.3193445225212486e-09
C9 O 1 0.9999786615371704
) O 0 5.1401546213858396e-11
is O 0 4.808598397937347e-12
the O 0 7.81054648041346e-12
most O 0 1.757439853367071e-11
common O 0 9.317071558712087e-10
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.971442564752124e-09
Japan O 0 1.7242914873705217e-09
but O 0 1.8081408592607318e-10
is O 0 2.2991965969998418e-11
rare O 0 1.314308106792339e-10
in O 0 4.286543689446809e-11
other O 0 2.3164968554478804e-10
countries O 0 5.087215648735821e-10
. O 0 4.0392102107489336e-08

We O 0 6.815478847954637e-09
studied O 0 4.2639602959582135e-09
the O 0 2.6237172157106414e-11
molecular O 0 6.310044153856609e-10
basis O 0 1.573543739752381e-09
of O 0 3.3563840595718375e-09
C9 B-Disease 1 0.9999902248382568
deficiency I-Disease 0 0.0003108291421085596
in O 0 7.040564753424405e-08
four O 0 1.1991581061465695e-07
Japanese O 0 1.0785513950395398e-05
C9 B-Disease 1 0.9903069734573364
- I-Disease 0 4.149616870563477e-06
deficient I-Disease 0 6.920697614987148e-08
patients O 0 3.7800087504535895e-09
who O 0 4.340582893114231e-10
had O 0 5.058498064869354e-10
suffered O 0 4.546898857427095e-09
from O 0 3.489341704465687e-09
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 3.883085142319942e-08

Direct O 0 1.49359191681242e-08
sequencing O 0 9.034261339024852e-09
of O 0 2.566014600802191e-08
amplified O 0 7.112979716339396e-08
C9 O 0 4.416257525008405e-06
cDNA O 0 1.3610725879686925e-08
and O 0 5.531554658766424e-10
DNA O 0 2.297471546341967e-09
revealed O 0 1.4121466218597334e-09
a O 0 3.0109725823734834e-10
nonsense O 0 4.650572371645012e-09
substitution O 0 5.3466133742574584e-09
( O 0 3.934868542110337e-10
CGA O 0 1.3439492363431782e-07
- O 0 4.3224179790968265e-09
- O 0 4.846430368132815e-09
> O 0 1.9724692990052972e-09
TGA O 0 2.2628071860708587e-08
) O 0 1.909714400505358e-11
at O 0 1.5461364133440014e-10
codon O 0 3.8355663090072767e-10
95 O 0 3.6306238571093274e-10
in O 0 4.0597959022337093e-11
exon O 0 6.633233406994066e-10
4 O 0 1.3018894406968684e-08
in O 0 2.2344481820368856e-09
the O 0 6.732456370173168e-08
four O 0 6.509806382837269e-08
C9 B-Disease 0 0.0013742467854171991
- I-Disease 0 2.9857665140298195e-06
deficient I-Disease 0 2.8569294840963266e-07
individuals O 0 3.607116161319368e-09
. O 0 8.928314798595238e-08

An O 0 2.2900440654893828e-08
allele O 0 2.0455670934893533e-08
- O 0 3.6951224302583796e-09
specific O 0 2.0267759692771392e-10
polymerase O 0 1.903414315052032e-09
chain O 0 3.807302473290974e-09
reaction O 0 1.3154373146306853e-09
system O 0 1.280834049932622e-10
designed O 0 1.757678863567591e-10
to O 0 2.9022464986816487e-11
detect O 0 1.6979237460468255e-10
exclusively O 0 3.361595724005184e-11
only O 0 1.911014315542081e-12
one O 0 3.822095851618856e-12
of O 0 1.431737541024436e-11
the O 0 6.869319002511531e-11
normal O 0 7.064731022410342e-10
and O 0 1.5528503830020135e-11
mutant O 0 2.0749503504280398e-10
alleles O 0 2.821627931304249e-10
indicated O 0 6.661456386503062e-10
that O 0 1.167948463637325e-11
all O 0 4.10165477970903e-11
the O 0 2.182819480722742e-10
four O 0 4.165531114486143e-11
patients O 0 2.1048530973732937e-11
were O 0 3.4617878008624814e-11
homozygous O 0 3.9493557729697315e-11
for O 0 9.929474603653787e-11
the O 0 1.2824481476769733e-09
mutation O 0 2.8849236888284224e-10
in O 0 2.1295029628554119e-10
exon O 0 1.2866623322338455e-09
4 O 0 1.2327828535774188e-08
and O 0 2.1242051173597787e-10
that O 0 4.201005168735783e-11
the O 0 5.83067483184152e-10
parents O 0 5.329475194493227e-10
of O 0 1.1528463739196582e-09
patient O 0 1.7591754719603614e-09
2 O 0 2.670692111905737e-08
were O 0 1.7369643501297105e-08
heterozygous O 0 2.753220407214485e-08
. O 0 2.485180061739811e-07

The O 0 6.496915894160793e-09
common O 0 2.6259427965413806e-09
mutation O 0 4.411849996444062e-09
at O 0 1.7395562768030004e-09
codon O 0 7.94848986629404e-09
95 O 0 1.4044759133469142e-08
in O 0 5.946207415341576e-10
exon O 0 3.80370224206672e-09
4 O 0 1.7132608221004375e-08
might O 0 1.1354581719302814e-09
be O 0 3.0104099768557546e-10
responsible O 0 7.955974767881457e-11
for O 0 1.1592578980090806e-10
most O 0 1.0896256341652588e-08
Japanese O 0 1.1077298722739215e-06
C9 B-Disease 0 0.007060842122882605
deficiency I-Disease 0 9.378156391903758e-06
. O 0 5.065048824803853e-08
. O 0 2.1332498079118523e-07

BRCA1 O 0 2.0824704449751152e-07
required O 0 9.63504298567841e-09
for O 0 5.526727520077657e-09
transcription O 0 4.784665634360863e-06
- O 0 9.320417120761704e-06
coupled O 0 5.2734044402313884e-06
repair O 0 3.1446959383174544e-06
of O 0 7.533827073302746e-08
oxidative O 0 1.2016610071441391e-06
DNA O 0 1.3641050600199378e-06
damage O 0 0.015040862374007702
. O 0 2.715830760280369e-07

The O 0 2.52730302463533e-07
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9999616146087646
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 9.529244948680571e-08
gene O 0 7.36086125385782e-09
BRCA1 O 0 6.008724540151889e-08
encodes O 0 6.5406693394720605e-09
a O 0 5.168413697020924e-09
zinc O 0 6.584695455558176e-08
finger O 0 1.606867705561399e-08
protein O 0 3.342828591712532e-08
of O 0 3.5762885985946014e-09
unknown O 0 4.573010770059227e-08
function O 0 4.8360702109562226e-09
. O 0 1.6215382814266377e-08

Association O 0 2.657473885392392e-07
of O 0 2.103833196542837e-07
the O 0 1.008295029691908e-07
BRCA1 O 0 4.4790215980583525e-08
protein O 0 3.247466651146169e-08
with O 0 8.588262739861463e-11
the O 0 2.759706907440318e-09
DNA O 0 1.7093244153443266e-08
repair O 0 1.760197534395047e-07
protein O 0 3.21737161357305e-07
Rad51 O 0 6.829001364394571e-08
and O 0 3.0735504419343584e-11
changes O 0 2.2499488383509458e-11
in O 0 1.1662522510225148e-11
the O 0 4.329277908388107e-11
phosphorylation O 0 9.304670922638536e-11
and O 0 8.252255649654483e-12
cellular O 0 1.7771803473287662e-10
localization O 0 1.5779326290044082e-08
of O 0 6.703316568490436e-09
the O 0 1.2002812077582803e-08
protein O 0 3.278216098578923e-08
after O 0 2.3182749053773932e-09
exposure O 0 6.571581501191304e-09
to O 0 1.1919717435304733e-09
DNA O 0 3.9775361670990605e-08
- O 0 4.161756805842742e-08
damaging O 0 2.422809188828978e-07
agents O 0 4.023161803701214e-09
are O 0 4.073043291530354e-11
consistent O 0 6.377828820625098e-10
with O 0 3.783535713463432e-13
a O 0 1.813306622910904e-11
role O 0 2.6762769084198723e-11
for O 0 2.7590685292011585e-10
BRCA1 O 0 8.612845547872894e-09
in O 0 2.1996173771299254e-09
DNA O 0 1.9549234764326684e-07
repair O 0 1.2803519894077908e-05
. O 0 8.982510166788416e-07

Here O 0 1.6704245808796259e-07
, O 0 6.598619983755327e-10
it O 0 1.984300918023152e-11
is O 0 4.09702393538991e-12
shown O 0 9.01257974500469e-12
that O 0 9.482394904003488e-12
mouse O 0 9.503262621279873e-10
embryonic O 0 1.905900148813089e-08
stem O 0 5.808369607507302e-08
cells O 0 3.2453243647978525e-08
deficient B-Disease 0 1.494865742301954e-08
in I-Disease 0 5.262032476416323e-10
BRCA1 I-Disease 0 7.03106106669793e-09
are O 0 8.615300833847428e-11
defective O 0 7.688762515556391e-09
in O 0 4.457055835516144e-10
the O 0 1.6616700238003546e-09
ability O 0 6.696718735099694e-10
to O 0 1.3080464489334531e-09
carry O 0 5.724842377929917e-09
out O 0 5.906332312122231e-09
transcription O 0 4.1028505393114756e-07
- O 0 8.089955940704385e-07
coupled O 0 1.5855569017730886e-06
repair O 0 1.5562291082460433e-06
of O 0 1.0906365588425615e-07
oxidative O 0 4.4435725499170076e-07
DNA O 0 3.1504512776336924e-07
damage O 0 6.406855391105637e-05
, O 0 2.787219566258159e-09
and O 0 1.2854800557349222e-09
are O 0 3.4976760376892457e-10
hypersensitive O 0 1.0258111160510452e-06
to O 0 5.4503217938872695e-08
ionizing O 0 0.00013699989358428866
radiation O 0 0.00010692221985664219
and O 0 7.411874669571716e-09
hydrogen O 0 5.170960903910782e-08
peroxide O 0 4.7218424015227356e-07
. O 0 3.6582864737511045e-08

These O 0 4.6134861264590654e-08
results O 0 6.426777332535494e-08
suggest O 0 1.418435005007268e-07
that O 0 1.456951626011005e-08
BRCA1 O 0 1.1593833448841906e-07
participates O 0 6.106513072978714e-09
, O 0 1.5893728000371254e-10
directly O 0 7.448363592565954e-10
or O 0 5.065382002733543e-10
indirectly O 0 8.162397868716198e-09
, O 0 3.4713884544679274e-11
in O 0 5.1149029456354356e-11
transcription O 0 3.070935505888883e-08
- O 0 1.7564464371844224e-07
coupled O 0 5.721449838347326e-07
repair O 0 5.735441277465725e-07
of O 0 3.892436239993913e-08
oxidative O 0 2.6556219268059067e-07
DNA O 0 6.470250468737504e-07
damage O 0 1.733594217512291e-05
. O 0 1.6185534690293935e-08
. O 0 2.954450728509528e-08

Truncation O 0 2.785417336781393e-06
mutations O 0 4.4167020263330414e-08
in O 0 3.0584232368902065e-10
the O 0 4.255605590142153e-10
transactivation O 0 1.0376260206612642e-06
region O 0 2.4680652188635577e-08
of O 0 5.439998318479411e-08
PAX6 O 0 0.00016761565348133445
result O 0 1.8006198843067978e-07
in O 0 1.6479976494565562e-08
dominant O 0 0.0004076743498444557
- O 0 1.0024336916103493e-06
negative O 0 6.02981486963472e-08
mutants O 0 3.1210337425591206e-08
. O 0 1.488918499603642e-08

PAX6 O 0 0.0014911288162693381
is O 0 1.3840947055143715e-08
a O 0 3.323690433987281e-09
transcription O 0 5.21900780370288e-08
factor O 0 2.4506388029976733e-08
with O 0 1.8857428119023467e-10
two O 0 1.8376379584683633e-10
DNA O 0 2.247120489684562e-09
- O 0 1.4928961400428875e-09
binding O 0 3.308308738070309e-09
domains O 0 3.216950617002112e-08
( O 0 2.8613542091271427e-10
paired O 0 6.984369194107387e-10
box O 0 4.679113208005958e-10
and O 0 5.974865047164712e-11
homeobox O 0 6.519085271605718e-09
) O 0 1.716935101037098e-11
and O 0 1.154914636147808e-10
a O 0 1.7726415890706448e-09
proline O 0 2.2808244182215276e-08
- O 0 8.354963654255698e-08
serine O 0 3.3342828942295455e-08
- O 0 1.8895040909683303e-07
threonine O 0 4.429643496450808e-08
( O 0 7.887052122512728e-10
PST O 0 2.176537236664444e-06
) O 0 6.158478726980832e-10
- O 0 5.277111192469874e-09
rich O 0 1.062254995076728e-08
transactivation O 0 1.1847766927530756e-06
domain O 0 1.3042198077073408e-07
. O 0 4.3359449364288594e-08

PAX6 O 0 0.09674299508333206
regulates O 0 6.006919193168869e-06
eye O 0 2.4547458451706916e-05
development O 0 4.00239912323741e-08
in O 0 2.017888772742893e-10
animals O 0 2.7638932809104233e-10
ranging O 0 2.456566727815357e-09
from O 0 8.303704390755229e-10
jellyfish O 0 7.765244697255369e-11
to O 0 9.496916447693238e-11
Drosophila O 0 4.4826922729335195e-10
to O 0 2.1609017353263482e-10
humans O 0 1.5259695729241685e-08
. O 0 6.454504131170324e-08

Heterozygous O 0 1.385298986633643e-08
mutations O 0 6.30396090883778e-09
in O 0 1.4848076934637078e-10
the O 0 1.767454932410928e-10
human O 0 3.802641257433237e-10
PAX6 O 0 1.292488377657719e-06
gene O 0 1.7993962986295742e-09
result O 0 6.518526163290517e-09
in O 0 6.142533010011775e-11
various O 0 3.152560434926954e-10
phenotypes O 0 4.091456062838006e-08
, O 0 2.9335128076679595e-11
including O 0 2.4279073543298502e-11
aniridia B-Disease 1 1.0
, O 0 4.030511924213442e-09
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 8.773374915449494e-09
autosomal B-Disease 0 2.609040620882297e-06
dominant I-Disease 0 1.5113054359972011e-05
keratitis I-Disease 1 1.0
, O 0 8.751181113098028e-09
and O 0 1.5872961611762548e-08
familial B-Disease 1 0.9999970197677612
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.012282069772481918

It O 0 1.165881946540992e-09
is O 0 1.016622550031876e-10
believed O 0 1.4329785968936193e-10
that O 0 3.163373426054439e-13
the O 0 1.2588060802065648e-11
mutated O 0 3.1480555939822352e-09
allele O 0 4.424112987067019e-08
of O 0 2.2777683739150234e-08
PAX6 O 0 5.538593904930167e-05
produces O 0 2.5053827457099942e-08
an O 0 6.91501744753964e-10
inactive O 0 8.810334684028476e-09
protein O 0 6.191684054357438e-09
and O 0 1.6196818886093922e-10
aniridia B-Disease 1 1.0
is O 0 5.111345791064537e-10
caused O 0 4.6173571632834864e-09
due O 0 2.0686958812632383e-09
to O 0 1.6489400955777e-09
genetic O 0 1.3139856491761748e-06
haploinsufficiency O 0 1.0102687156177126e-05
. O 0 1.6155591708866268e-07

However O 0 2.5700268224682077e-07
, O 0 3.2435527597129976e-09
several O 0 4.153729360467651e-09
truncation O 0 1.8222725373107096e-07
mutations O 0 2.9755675257092662e-08
have O 0 2.6922211682212094e-10
been O 0 1.0499143221487373e-10
found O 0 1.1074081755768628e-11
to O 0 1.708787104870435e-11
occur O 0 2.5214783039295696e-10
in O 0 6.75558775586893e-11
the O 0 1.254064740940919e-09
C O 0 2.833382417577468e-08
- O 0 7.258039169677488e-10
terminal O 0 2.3043793540011848e-09
half O 0 6.561255011527933e-11
of O 0 1.542054539616089e-10
PAX6 O 0 2.805189147636611e-08
in O 0 1.711683746130621e-11
patients O 0 2.506631187337849e-11
with O 0 4.5057828995664906e-11
Aniridia B-Disease 1 1.0
resulting O 0 4.058408364926436e-08
in O 0 3.8358663467796816e-10
mutant O 0 4.216478277641045e-09
proteins O 0 1.802102689296703e-09
that O 0 1.7930024132084554e-10
retain O 0 7.099829613110842e-09
the O 0 2.2447441239137333e-08
DNA O 0 1.4028320727277332e-08
- O 0 4.3982053554714184e-09
binding O 0 3.051642272211552e-09
domains O 0 5.150287307742474e-09
but O 0 5.890027909849493e-10
have O 0 8.173295373836709e-11
lost O 0 1.8288763836693533e-09
most O 0 3.3261240983684104e-10
of O 0 1.8171134597011473e-09
the O 0 9.128942046743305e-09
transactivation O 0 2.363600060562021e-06
domain O 0 1.8011676274909405e-06
. O 0 9.119858077610843e-07

It O 0 6.807579389089824e-09
is O 0 2.1915592951504692e-10
not O 0 3.665474868075336e-11
clear O 0 6.939275820627699e-10
whether O 0 2.6444617329257625e-11
such O 0 2.836292485597358e-11
mutants O 0 2.0719506110822294e-08
really O 0 7.620013064979503e-09
behave O 0 2.074203475643799e-09
as O 0 2.2169202029687085e-09
loss O 0 7.183931227672247e-09
- O 0 8.178543176029507e-09
of O 0 1.4555968164131627e-07
- O 0 2.1511413095254284e-08
function O 0 1.0208296430391783e-09
mutants O 0 5.245500478423537e-09
as O 0 2.955146405358988e-10
predicted O 0 4.259619323931929e-09
by O 0 1.026249196733886e-09
haploinsufficiency O 0 8.739058102946728e-06
. O 0 3.9504320170635765e-07

Contrary O 0 3.186733579241263e-07
to O 0 1.0781041615004483e-09
this O 0 4.557672295124604e-10
theory O 0 2.862748793575065e-08
, O 0 1.888456752086043e-10
our O 0 7.281930614055909e-10
data O 0 9.542610257540218e-09
showed O 0 3.6640317446767767e-09
that O 0 5.386568621701393e-11
these O 0 3.3246588815316613e-10
mutants O 0 9.407611578637898e-09
are O 0 4.5544654159179743e-10
dominant O 0 7.277508018432854e-08
- O 0 1.9294038366979294e-08
negative O 0 6.8577272749337226e-09
in O 0 3.6136288406041217e-10
transient O 0 4.249169904824157e-08
transfection O 0 9.063170658407671e-09
assays O 0 7.567880766501389e-10
when O 0 7.668108370495474e-10
they O 0 4.4814951749572174e-10
are O 0 3.712258278554259e-10
coexpressed O 0 8.011512591110659e-07
with O 0 1.696474516421631e-09
wild O 0 2.416251447812101e-07
- O 0 2.9178877980484685e-07
type O 0 7.119759288798377e-07
PAX6 O 0 8.97147401701659e-05
. O 0 5.943315954937134e-07

We O 0 4.843473622173633e-09
found O 0 8.268712936576605e-10
that O 0 3.095760453541985e-11
the O 0 9.806705447701347e-10
dominant O 0 4.032698086575692e-08
- O 0 8.04516098185104e-09
negative O 0 1.061286392101124e-09
effects O 0 1.2304846030986027e-09
result O 0 5.783512557755444e-10
from O 0 1.0156191443400076e-09
the O 0 7.598398577002285e-10
enhanced O 0 2.2656078402238933e-10
DNA O 0 3.406065984812301e-10
binding O 0 5.234943589726981e-10
ability O 0 2.7471238617238214e-09
of O 0 2.7207034847265277e-08
these O 0 4.877934056679578e-09
mutants O 0 4.311173142923508e-07
. O 0 7.545978775169715e-08

Kinetic O 0 3.439134559357626e-07
studies O 0 5.473185016313664e-09
of O 0 2.9902089138111876e-10
binding O 0 1.3238061757903097e-09
and O 0 4.5197376397076994e-10
dissociation O 0 1.6086493914713174e-08
revealed O 0 7.808677038312339e-10
that O 0 5.531169272599001e-12
various O 0 1.5863986513320327e-10
truncation O 0 3.851640073548879e-08
mutants O 0 1.0574236597449271e-08
have O 0 3.786313762521587e-10
3 O 0 2.585818004163798e-09
- O 0 6.144902919835715e-10
5 O 0 4.740948966741598e-09
- O 0 1.137766991732292e-09
fold O 0 4.064239611523135e-09
higher O 0 2.3007429295063275e-09
affinity O 0 8.680867136234838e-11
to O 0 8.645375387805743e-11
various O 0 2.206398258541853e-10
DNA O 0 2.0337889705679402e-10
- O 0 2.388407006892468e-11
binding O 0 4.7842653450036465e-11
sites O 0 3.9197445289573807e-10
when O 0 1.495562181041965e-11
compared O 0 5.366038863252598e-11
with O 0 1.3353479563424364e-12
the O 0 5.102520628241791e-10
wild O 0 4.536953923661713e-09
- O 0 1.3183867331179044e-08
type O 0 9.425090752301912e-08
PAX6 O 0 2.9454500690917484e-05
. O 0 5.663341653416865e-07

These O 0 9.355789920562074e-09
results O 0 2.589134462382958e-09
provide O 0 6.902946547704403e-10
a O 0 1.286902112651589e-10
new O 0 2.5727306396383653e-10
insight O 0 1.679571370871713e-09
into O 0 3.1033221131737676e-11
the O 0 4.52438433939939e-11
role O 0 6.041629002639937e-11
of O 0 2.5619284471645187e-10
mutant O 0 1.4078874954748244e-08
PAX6 O 0 6.796969501010608e-06
in O 0 7.47050599159138e-09
causing O 0 9.73106352830655e-07
aniridia B-Disease 1 1.0
. O 0 6.21142817180953e-08
. O 0 1.0884919987574904e-07

Reversal O 0 2.2140609701182257e-07
of O 0 4.134679709721922e-09
severe O 0 2.2179167444846826e-06
hypertrophic B-Disease 1 0.9999996423721313
cardiomyopathy I-Disease 1 1.0
and O 0 1.2298729146209553e-08
excellent O 0 1.170256354043886e-07
neuropsychologic O 0 2.6905667255050503e-05
outcome O 0 2.931822336904588e-06
in O 0 1.4488514388233398e-08
very B-Disease 0 7.469738960708128e-08
- I-Disease 0 2.0349790474938345e-07
long I-Disease 0 1.6544042580335372e-07
- I-Disease 0 5.6993076924527486e-08
chain I-Disease 0 4.506494732936517e-08
acyl I-Disease 0 1.6129635582728952e-07
- I-Disease 0 3.694785988272997e-08
coenzyme I-Disease 0 1.1534540433899565e-08
A I-Disease 0 2.351552694790371e-07
dehydrogenase I-Disease 0 1.3868900623492664e-06
deficiency I-Disease 0 5.309168773237616e-05
. O 0 4.973879086378474e-08

Very B-Disease 0 5.696019798051566e-07
- I-Disease 0 5.432531793303497e-07
long I-Disease 0 1.776355240679095e-08
- I-Disease 0 3.1146212275956486e-09
chain I-Disease 0 5.996091401172521e-10
acyl I-Disease 0 1.887269451827933e-09
- I-Disease 0 1.0240645831327555e-10
coenzyme I-Disease 0 1.591984183368922e-11
A I-Disease 0 3.728302111483117e-10
dehydrogenase I-Disease 0 4.212513393664352e-10
( I-Disease 0 9.57534537771032e-11
VLCAD I-Disease 0 6.659073505943525e-07
) I-Disease 0 4.505969816021027e-12
deficiency I-Disease 0 1.0908139669307815e-10
is O 0 7.150670030056649e-13
a O 0 1.3036093905738344e-11
disorder O 0 3.992419124188018e-07
of O 0 2.75331558441394e-06
fatty O 0 1.1125426908620284e-06
acid O 0 1.7420074271967678e-08
beta O 0 4.64294797053455e-10
oxidation O 0 4.460789237992202e-10
that O 0 4.044099430333681e-11
reportedly O 0 6.42846331722069e-10
has O 0 4.970530931291961e-12
high O 0 2.757874206782418e-10
rates O 0 6.331407065296446e-10
of O 0 1.6748552544854078e-10
morbidity O 0 3.7410569575513364e-07
and O 0 3.252132563247301e-09
mortality O 0 4.983950816495053e-07
. O 0 1.246344680794209e-07

We O 0 6.316137057815752e-10
describe O 0 6.419274001245867e-10
the O 0 2.4240034979250424e-10
outcome O 0 1.769624780045831e-09
of O 0 1.024952234196519e-09
a O 0 3.3278879651987836e-10
5 O 0 1.9723300770380092e-09
- O 0 2.0217064133909446e-10
year O 0 5.109269118896975e-10
- O 0 1.526280324348761e-09
old O 0 3.226536549050252e-08
girl O 0 7.041229821425077e-10
with O 0 3.502514250852684e-11
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 5.567341587742192e-10
was O 0 9.826435498627717e-11
first O 0 1.3486149696984029e-11
seen O 0 1.8952477087719188e-10
at O 0 9.242057119607239e-11
5 O 0 3.353765321012503e-10
months O 0 1.1214567469108871e-10
of O 0 6.629792825840752e-10
age O 0 3.5767524497742897e-09
with O 0 1.059633353284184e-10
severe O 0 5.800735607408569e-07
hypertrophic B-Disease 1 0.999998927116394
cardiomyopathy I-Disease 1 1.0
, O 0 8.710068186701392e-07
hepatomegaly B-Disease 1 1.0
, O 0 2.300578074709847e-07
encephalopathy B-Disease 0 8.377876656595618e-05
, O 0 1.4044490903586393e-08
and O 0 6.093112858707173e-08
hypotonia B-Disease 1 0.9956924319267273
. O 0 5.534548563446151e-06

Biochemical O 0 8.442364560323767e-06
studies O 0 2.2198031501829973e-07
indicated O 0 4.274089860700769e-06
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 1.7669688645582937e-07
by O 0 1.592419252016697e-10
a O 0 9.697988190282558e-09
stable O 0 1.0065135938930325e-05
yet O 0 6.808150931902901e-09
inactive O 0 2.440931012870351e-08
enzyme O 0 6.553933928898914e-08
. O 0 1.9154116515096575e-08

Molecular O 0 1.6598557195379726e-08
genetic O 0 4.2125636312562165e-09
analysis O 0 2.866205939255906e-09
of O 0 1.0535985417448046e-08
her O 0 1.1161549018368078e-08
VLCAD O 1 0.9986880421638489
gene O 0 4.4980872360156354e-08
revealed O 0 3.521637381709297e-08
a O 0 1.6651505729825544e-09
T1372C O 0 8.419528541026011e-08
( O 0 3.270425041890235e-10
F458L O 0 4.535623432389002e-08
) O 0 2.580431701648678e-10
missense O 0 8.493109504570384e-08
mutation O 0 9.22083209786706e-09
and O 0 1.3205404547633748e-09
a O 0 2.9497773113007497e-08
1668 O 0 0.00019426575454417616
ACAG O 1 0.9990002512931824
1669 O 0 0.00057292974088341
splice O 0 4.7619527322240174e-05
site O 0 3.0397231967072003e-06
mutation O 0 8.67169319462846e-07
. O 0 3.43615795372898e-07

After O 0 1.8253704103798896e-09
initial O 0 1.541843541730259e-09
treatment O 0 5.988581852633956e-10
with O 0 6.265750418510407e-11
intravenous O 0 1.335006682978701e-08
glucose O 0 2.2101996677292846e-08
and O 0 2.5685042981393735e-10
carnitine O 0 2.495253426104682e-08
, O 0 7.47323383731846e-11
the O 0 6.362980697893761e-10
patient O 0 3.818720450965429e-09
has O 0 1.3258802389337632e-10
thrived O 0 8.578579624440863e-09
on O 0 2.4720494540275695e-09
a O 0 1.3323103509321754e-08
low O 0 2.690340750177711e-07
- O 0 3.498766787402019e-08
fat O 0 6.886435954811532e-08
diet O 0 5.099691779975046e-09
supplemented O 0 1.0324985311171986e-09
with O 0 3.2626852608519386e-11
medium O 0 4.4123741105295267e-08
- O 0 1.866507304271181e-08
chain O 0 3.8794134127329016e-08
triglyceride O 0 1.9319637090120523e-07
oil O 0 1.496775041687215e-07
and O 0 8.456666478195984e-10
carnitine O 0 1.0729495514283371e-08
and O 0 1.1993417370348425e-10
avoidance O 0 1.4703347872568884e-08
of O 0 1.4532160363955882e-08
fasting O 0 1.303067307389938e-07
. O 0 7.637302701368753e-08

Her O 0 1.8625070197231253e-07
ventricular O 0 0.2153894156217575
hypertrophy O 1 0.9999791383743286
resolved O 0 1.7278058805914043e-07
significantly O 0 1.16331246857726e-08
over O 0 1.2449505315537124e-10
1 O 0 6.769482752133626e-10
year O 0 1.2322548537113676e-10
, O 0 1.673066372942511e-11
and O 0 7.223701498082491e-11
cognitively O 0 2.083470818092792e-08
, O 0 9.659027050412661e-11
she O 0 1.2762835233104397e-10
is O 0 1.473409415309046e-11
in O 0 5.37837586966905e-11
the O 0 1.2497618495643792e-09
superior O 0 9.08181050363055e-08
range O 0 8.308781218602235e-08
for O 0 3.418400895682794e-09
age O 0 1.4694483070343267e-06
. O 0 3.1897803864922025e-07

Clinical O 0 3.311176399733995e-08
recognition O 0 6.781345405215689e-07
of O 1 0.9999979734420776
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 4.79772177541804e-09
important O 0 2.3011819116902643e-09
because O 0 4.878831366683656e-11
it O 0 3.4556374688826663e-12
is O 0 1.6229769264630711e-12
one O 0 4.943546873942273e-12
of O 0 1.2108528069099123e-10
the O 0 6.745934366669815e-10
few O 0 4.96634022795206e-09
directly O 0 6.289524456803974e-09
treatable O 0 1.7728709735820303e-06
causes O 0 6.676749819689576e-09
of O 0 2.3605744026156117e-09
cardiomyopathy B-Disease 1 1.0
in O 0 1.2003636307156285e-08
children O 0 9.717243898421657e-09
. O 0 3.5038274504017863e-09
. O 0 4.6253632035586634e-08

Cloning O 0 1.633773116793691e-08
of O 0 8.67511662505649e-09
a O 0 3.59604068744801e-10
novel O 0 1.5191008451154175e-09
member O 0 8.997749212369399e-10
of O 0 1.6563674876124423e-08
the O 0 1.58997380594883e-07
low O 0 9.065375934369513e-07
- O 0 3.024294059628119e-08
density O 0 2.0989148197259055e-08
lipoprotein O 0 1.1400076971312956e-07
receptor O 0 2.1362606275943108e-05
family O 0 5.002479497306922e-07
. O 0 7.409602176267072e-08

A O 0 1.2005564542505454e-07
gene O 0 1.8509499488672532e-09
encoding O 0 3.5134910536527286e-09
a O 0 5.143778736282911e-09
novel O 0 4.8632835536466246e-09
transmembrane O 0 3.3790714670800526e-09
protein O 0 4.200160219625104e-09
was O 0 4.131035791221649e-10
identified O 0 1.1321592101320999e-11
by O 0 6.451201877387402e-13
DNA O 0 1.773113253444869e-11
sequence O 0 2.3533421305427238e-12
analysis O 0 6.003157172751461e-12
within O 0 6.5581737089537295e-12
the O 0 9.325316213670831e-11
insulin B-Disease 0 9.519936611468438e-06
- I-Disease 0 4.8694678298488725e-06
dependent I-Disease 0 2.242852860945277e-05
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 3.425025374426127e-09
IDDM B-Disease 0 3.499364174786024e-05
) O 0 1.9285630037391144e-10
locus O 0 1.7216731151847853e-08
IDDM4 O 0 5.3763251344207674e-06
on O 0 1.5357219496081598e-08
chromosome O 0 1.0297971186901123e-07
11q13 O 0 4.5429583224176895e-06
. O 0 2.2792508502789133e-07

Based O 0 2.0889700635962072e-08
on O 0 3.122341940553497e-09
its O 0 1.9084810121139384e-10
chromosomal O 0 2.1295463170645235e-07
position O 0 7.201692824310157e-07
, O 0 1.6183232531830072e-10
this O 0 1.3316223124171245e-11
gene O 0 8.090516451231267e-11
is O 0 6.780230543679266e-11
a O 0 6.114315304062146e-11
candidate O 0 2.66355215661207e-10
for O 0 2.441062282865225e-11
conferring O 0 2.9526027844894998e-08
susceptibility O 0 3.5335174288775306e-06
to O 0 6.831359655734559e-08
diabetes B-Disease 1 0.999834418296814
. O 0 5.021838092034159e-07

The O 0 1.9458538247363322e-07
gene O 0 1.22451325523798e-07
, O 0 3.775579671128071e-08
termed O 0 2.3042801444717043e-07
low O 0 1.8287383340975794e-07
- O 0 7.92897214552113e-09
density O 0 1.5795998953294088e-09
lipoprotein O 0 2.020042355610485e-09
receptor O 0 1.4227237166153373e-08
related O 0 4.849574075649343e-09
protein O 0 1.2305839014459252e-08
5 O 0 2.434666468431601e-09
( O 0 2.4241409227188093e-11
LRP5 O 0 6.843826838576206e-08
) O 0 2.40645871285583e-12
, O 0 4.241353633322592e-13
encodes O 0 2.409048871845898e-12
a O 0 1.7093479409702184e-11
protein O 0 2.5105095780020292e-09
of O 0 7.355148934351519e-09
1615 O 0 1.0589817520667566e-06
amino O 0 1.5097722894097387e-07
acids O 0 6.409712227650743e-08
that O 0 8.123638567392177e-11
contains O 0 9.674164941353425e-11
conserved O 0 2.8371067717358756e-09
modules O 0 1.8038624760574606e-10
which O 0 2.170194059181174e-11
are O 0 6.819161121190964e-12
characteristic O 0 5.656807910980888e-09
of O 0 6.2679204049231885e-09
the O 0 8.038522736342202e-08
low O 0 3.6661976992036216e-06
- O 0 4.7544537551402755e-07
density O 0 1.777257665480647e-07
lipoprotein O 0 3.28314769149074e-07
( O 0 1.2932919446484448e-07
LDL O 0 2.6504424113227287e-06
) O 0 2.8526148110330496e-09
receptor O 0 7.1111207944341e-07
family O 0 3.251359004252663e-08
. O 0 1.5116935259129605e-08

These O 0 9.826534030921152e-10
modules O 0 5.34738531232648e-10
include O 0 2.675092959647518e-11
a O 0 4.2439171621388994e-10
putative O 0 3.5013837162978234e-08
signal O 0 2.7113566947178924e-09
peptide O 0 2.913840557727809e-10
for O 0 2.2991088199919574e-11
protein O 0 2.1501804781109968e-09
export O 0 5.49961809426236e-09
, O 0 1.6021614590577826e-11
four O 0 4.1734917605174005e-11
epidermal O 0 1.5268836861537238e-08
growth O 0 7.666357326741036e-09
factor O 0 2.6274307174389833e-09
( O 0 2.0411541346021522e-09
EGF O 0 1.141427674156148e-06
) O 0 6.117887862977511e-10
repeats O 0 6.990473200296776e-10
with O 0 5.723130736684512e-12
associated O 0 4.944959552943828e-09
spacer O 0 5.2371760261848976e-08
domains O 0 4.592748226173171e-08
, O 0 1.568704055543435e-09
three O 0 1.1985008541159914e-09
LDL O 0 7.55467723934089e-08
- O 0 1.5939592401537084e-07
receptor O 0 4.566370535030728e-06
( O 0 4.458624403014255e-08
LDLR O 1 0.9998956918716431
) O 0 1.0010330064869066e-10
repeats O 0 2.5330712527527055e-10
, O 0 5.053092493045863e-12
a O 0 2.3465840381931002e-11
single O 0 8.593899897268997e-11
transmembrane O 0 1.3037175783381372e-09
spanning O 0 6.473426239494984e-09
domain O 0 3.135981430091306e-08
, O 0 1.383539727228822e-09
and O 0 8.859671329908281e-10
a O 0 2.8897893855628354e-08
cytoplasmic O 0 2.476211648172466e-06
domain O 0 1.0213345831289189e-06
. O 0 3.198059346232185e-07

The O 0 1.8093470544044976e-07
encoded O 0 3.453977726053381e-08
protein O 0 7.813821980562352e-07
has O 0 2.1407754735580653e-10
a O 0 4.7064643848848675e-11
unique O 0 2.5155888483396893e-10
organization O 0 1.929597814864792e-09
of O 0 9.24041021477251e-09
EGF O 0 0.00024881225544959307
and O 0 7.058446840346733e-07
LDLR O 1 0.9999991655349731
repeats O 0 7.431086146425514e-08
; O 0 1.055718179543419e-09
therefore O 0 5.5019580003090596e-09
, O 0 5.159074834004684e-10
LRP5 O 0 0.00014913112681824714
likely O 0 1.6324243290455343e-08
represents O 0 1.2967363849369917e-09
a O 0 1.3133055754011025e-10
new O 0 5.366635469350456e-10
category O 0 4.023629873728396e-09
of O 0 6.261049900757598e-09
the O 0 4.38568399374617e-08
LDLR O 0 0.0007103585521690547
family O 0 3.066745080104738e-07
. O 0 2.8379966465763573e-07

Both O 0 2.593841585962764e-08
human O 0 2.683344746401417e-08
and O 0 1.716805919649289e-09
mouse O 0 3.9740861268455774e-08
LRP5 O 0 1.6675781807862222e-05
cDNAs O 0 3.035436080267573e-08
have O 0 3.908171702926566e-11
been O 0 1.1294916391069165e-10
isolated O 0 1.5142265219481033e-09
and O 0 7.894452452861245e-11
the O 0 9.753672314261053e-10
encoded O 0 6.05630767758214e-10
mature O 0 4.213576154654675e-09
proteins O 0 3.456287200886976e-10
are O 0 1.302622593124525e-11
95 O 0 2.0169701464567424e-09
% O 0 9.980969523093464e-11
identical O 0 1.6709369998757495e-10
, O 0 9.530554297143556e-12
indicating O 0 4.569501443896229e-10
a O 0 1.1821831014113826e-10
high O 0 3.288541439161463e-09
degree O 0 1.1947309808135742e-08
of O 0 2.2434460955622626e-09
evolutionary O 0 5.966810334712136e-08
conservation O 0 4.2663295118927635e-08
. O 0 5.218975029919193e-09
. O 0 9.541575707316952e-08

The O 0 4.333870435857534e-07
APC B-Disease 0 2.174324720272125e-07
variants O 0 4.517699636608086e-08
I1307K O 0 4.878690447185363e-07
and O 0 1.477429512064532e-09
E1317Q O 0 1.0526949978384437e-07
are O 0 6.494840082416076e-11
associated O 0 2.249960751044e-08
with O 0 9.094218853533675e-07
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 9.704084064088292e-11
but O 0 2.4223475655893445e-11
not O 0 4.067329112400486e-11
always O 0 4.5135416237851445e-11
with O 0 1.3640610993168045e-12
a O 0 2.901329176907552e-10
family O 0 9.530999323104083e-10
history O 0 1.6306193728610197e-08
. O 0 7.099358612094875e-08

Classical O 1 0.9994009733200073
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 4.566739733036229e-07
FAP B-Disease 0 2.1382411432568915e-06
) O 0 4.6598020581045674e-11
is O 0 1.881502592615547e-11
a O 0 1.0100650316147153e-09
high O 1 0.9999984502792358
- O 1 1.0
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
that O 0 5.133785757616138e-11
predisposes O 0 9.654432808758884e-09
to O 0 2.6797297020264566e-11
hundreds O 0 7.014350211775877e-11
or O 0 9.00474486642544e-12
thousands O 0 8.463923312218569e-11
of O 0 5.804845049084406e-09
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 1.8241416910314e-07
carcinoma I-Disease 1 1.0
and O 0 1.0772834013739185e-10
that O 0 2.507797962347791e-11
results O 0 7.245410937883889e-10
from O 0 2.2225172813250538e-09
truncating O 0 2.3476351529438944e-08
mutations O 0 2.5074848863937405e-09
in O 0 4.3944131666862063e-10
the O 0 1.1031092483904104e-08
APC B-Disease 0 1.3216880745403614e-07
gene O 0 1.605321386932701e-07
. O 0 1.2152312365287798e-06

A O 0 1.7034725630082903e-08
variant O 0 2.7463288532203478e-08
of O 0 3.6963629934660958e-09
FAP B-Disease 0 1.4737257743036025e-06
is O 0 7.607969809697579e-10
attenuated B-Disease 1 0.9993287324905396
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999998807907104
coli I-Disease 1 1.0
, O 0 1.7839625610083232e-10
which O 0 4.9892616080238206e-12
results O 0 5.7288781357689444e-11
from O 0 1.5317448698315417e-10
germ O 0 1.7313175249000778e-07
- O 0 3.829384365161559e-09
line O 0 1.067654054054401e-08
mutations O 0 5.381454309949518e-11
in O 0 1.57551818813495e-11
the O 0 1.1814527134390573e-10
5 O 0 2.648905539359703e-10
and O 0 1.8830248124657167e-11
3 O 0 5.697585181430043e-10
regions O 0 3.022211148007159e-09
of O 0 1.066067198962628e-07
the O 0 2.826347724749212e-07
APC B-Disease 0 9.548458024255524e-08
gene O 0 5.7613114279320143e-08
. O 0 6.552059517161979e-07

Attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999995231628418
coli I-Disease 1 1.0
patients O 0 1.3578210555920123e-08
have O 0 8.012361607523388e-12
" O 0 1.5020573326807174e-11
multiple O 0 1.0243189629832727e-09
" O 0 6.786023050153744e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 7.608739194253644e-10
typically O 0 4.597106029180509e-11
fewer O 0 1.0184895982146003e-10
than O 0 1.3931879087880628e-11
100 O 0 2.4486784822030927e-10
) O 0 1.8391009743747022e-13
without O 0 2.3148778900694555e-12
the O 0 4.094010200295095e-11
florid O 0 3.0378803472785876e-08
phenotype O 0 3.7117803941555394e-08
of O 0 1.0135991601600836e-08
classical O 0 3.2517223758077307e-07
FAP B-Disease 0 8.106953828246333e-06
. O 0 3.232607923564501e-07

Another O 0 1.802670723805022e-08
group O 0 4.826870569907271e-10
of O 0 6.341994707170784e-10
patients O 0 6.898651788711518e-11
with O 0 1.0620750806600299e-11
multiple O 0 1.757289140869034e-07
adenomas B-Disease 1 1.0
has O 0 3.1974227709952174e-09
no O 0 9.298998793205726e-10
mutations O 0 3.1941433942250796e-09
in O 0 2.4645721574678703e-10
the O 0 1.1139722477793157e-09
APC B-Disease 0 4.1013278884172166e-10
gene O 0 1.4370457601664555e-10
, O 0 2.8571261675991444e-11
and O 0 5.451994758431944e-12
their O 0 3.204685128377349e-11
phenotype O 0 2.8444109290148845e-09
probably O 0 9.475854823026708e-11
results O 0 2.6429490540547107e-11
from O 0 2.752010286322104e-10
variation O 0 1.2129436122165771e-08
at O 0 3.863690256622476e-09
a O 0 2.4053290470504862e-09
locus O 0 2.8533113649586994e-09
, O 0 5.757427867791876e-10
or O 0 5.635868993714155e-10
loci O 0 2.9124473943653584e-09
, O 0 1.2286173467490613e-10
elsewhere O 0 1.024983431463511e-09
in O 0 2.9594784956010756e-10
the O 0 4.482369586611412e-09
genome O 0 1.2901255175279402e-08
. O 0 6.810660124756396e-08

Recently O 0 6.413197866095288e-07
, O 0 1.5101223604929714e-09
however O 0 1.3066326909338954e-09
, O 0 1.0731832089660998e-11
a O 0 2.379086164183697e-11
missense O 0 1.5538304865003738e-08
variant O 0 1.4803158698839525e-08
of O 0 8.317629607290655e-08
APC B-Disease 0 2.0072543804872112e-07
( O 0 4.7186574647639645e-09
I1307K O 0 1.9292976105589332e-07
) O 0 9.601901218569964e-11
was O 0 6.036380284513143e-10
described O 0 2.8302830565318793e-11
that O 0 1.3301823835118465e-12
confers O 0 2.0843362591449477e-09
an O 0 3.470368784008748e-11
increased O 0 1.6965585603045952e-09
risk O 0 6.13555073414318e-08
of O 0 0.1258346438407898
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 9.54315182433163e-10
including O 0 2.489972464325696e-11
multiple O 0 2.7186581874616422e-09
adenomas B-Disease 0 5.128734414938663e-07
, O 0 3.319443886429241e-10
in O 0 3.4577591900841753e-09
Ashkenazim O 0 2.8995123102504294e-06
. O 0 4.3856007891918125e-07

We O 0 3.0381585247596377e-08
have O 0 8.934303297181145e-10
studied O 0 5.334308106341723e-09
a O 0 8.372148113666711e-11
set O 0 2.452445746481402e-10
of O 0 9.763215236269218e-11
164 O 0 3.665141523612192e-10
patients O 0 1.3909575748149994e-11
with O 0 6.865857708759915e-12
multiple O 0 9.068998565453512e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 6.078254699559693e-08
/ I-Disease 0 0.00014476847718469799
or I-Disease 0 1.3792858908345806e-06
carcinoma I-Disease 1 1.0
and O 0 1.6489674903308327e-10
analyzed O 0 9.545025880797198e-10
codons O 0 7.106549126945083e-09
1263 O 0 1.786157781680231e-07
- O 0 6.482668624130383e-09
1377 O 0 1.4158996464175289e-07
( O 0 4.4562989409691056e-10
exon O 0 3.61518148750406e-09
15G O 0 1.330850523117988e-07
) O 0 4.456160787591479e-11
of O 0 6.974970601092423e-10
the O 0 5.760528054565839e-09
APC B-Disease 0 1.1751275508231629e-08
gene O 0 2.215837957564304e-09
for O 0 1.0607810629892356e-08
germ O 0 3.636686960817315e-05
- O 0 1.0856311973839183e-06
line O 0 2.3126413850604877e-07
variants O 0 8.261339168313953e-09
. O 0 2.4119733765815e-08

Three O 0 7.7303177192789e-09
patients O 0 2.2241784802812248e-10
with O 0 4.371802832942029e-12
the O 0 5.637331157437586e-10
I1307K O 0 5.206179487515783e-09
allele O 0 3.881429899710298e-10
were O 0 6.441519539990281e-11
detected O 0 1.0696545732491458e-10
, O 0 1.0079714840571796e-12
each O 0 3.5971759425323935e-12
of O 0 2.1860995236266945e-09
Ashkenazi O 0 3.097867917745134e-08
descent O 0 1.2020458939332457e-07
. O 0 9.69477369494598e-08

Four O 0 1.761916479381398e-08
patients O 0 2.853534519786649e-09
had O 0 2.06891281884225e-09
a O 0 7.216695574463472e-10
germ O 0 1.365174966849736e-06
- O 0 4.800104136393202e-08
line O 0 3.899778278082522e-08
E1317Q O 0 1.0871511690879743e-08
missense O 0 3.3288929390806743e-09
variant O 0 1.3276294508202113e-09
of O 0 1.472686084191821e-09
APC O 0 7.335097529370671e-10
that O 0 2.931957801544094e-11
was O 0 4.88132811948816e-10
not O 0 1.481005595938001e-11
present O 0 1.6166387672988947e-10
in O 0 2.392716857979593e-10
controls O 0 2.2355524098571777e-09
; O 0 2.707494783926734e-10
one O 0 1.172020036577237e-09
of O 0 1.1177990755228961e-09
these O 0 1.9204067502887057e-10
individuals O 0 4.784651008726826e-10
had O 0 5.74343550496792e-09
an O 0 1.7587988010436817e-10
unusually O 0 2.0110110798832181e-10
large O 0 4.439465461913983e-11
number O 0 6.729471979660673e-10
of O 0 8.374635029895217e-08
metaplastic B-Disease 0 0.00029780055047012866
polyps I-Disease 0 1.4826861161054694e-06
of I-Disease 0 3.500156253721798e-07
the I-Disease 0 3.915945683274913e-07
colorectum I-Disease 0 1.2737486940750387e-05
. O 0 4.0026324654718337e-07

There O 0 2.201944049318172e-08
is O 0 2.53882248557602e-10
increasing O 0 1.838637297968404e-10
evidence O 0 1.4587442365154857e-09
that O 0 6.112450129380775e-11
there O 0 3.1568445080232266e-10
exist O 0 3.028910899871562e-09
germ O 0 2.0179048476620665e-07
- O 0 1.3840569801359948e-09
line O 0 1.1068602701058694e-09
variants O 0 2.3556345762898445e-10
of O 0 5.468434594035898e-10
the O 0 1.2700942519927594e-09
APC B-Disease 0 1.7319746747901377e-09
gene O 0 1.2377834868182447e-10
that O 0 1.1455510845470585e-10
predispose O 0 9.551025925702561e-08
to O 0 2.610963667493138e-10
the O 0 4.5762957312511787e-10
development O 0 1.0440319719862146e-09
of O 0 4.2490763685343325e-10
multiple O 0 1.5762336715852143e-06
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 3.0727044304512674e-06
carcinoma I-Disease 1 1.0
, O 0 2.4564940359628196e-11
but O 0 4.904636159014375e-12
without O 0 1.3709346158297109e-11
the O 0 1.982311953474536e-10
florid O 0 9.699342484736917e-08
phenotype O 0 1.587117459678211e-08
of O 0 3.867066666884966e-09
classical O 0 3.6261983638041784e-08
FAP B-Disease 0 7.357719482570246e-07
, O 0 2.3982316132986625e-10
and O 0 5.0824410652294816e-11
possibly O 0 2.6909532935270875e-10
with O 0 4.206439450232802e-12
importance O 0 1.5110305895404963e-08
for O 0 5.46743876839173e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 4.506214845712009e-10
in O 0 5.239173678228681e-12
the O 0 3.124757744221718e-11
general O 0 1.3607104332180597e-10
population O 0 2.7357534640448655e-11
. O 0 2.2186956438741134e-10
. O 0 1.2671210747328132e-08

Genomic O 0 1.3310632596130745e-08
structure O 0 2.526693521076595e-09
of O 0 3.5123165487149777e-10
the O 0 1.0334205713391498e-09
human O 0 3.1796892017155187e-06
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 0.0012574908323585987
CLD B-Disease 1 1.0
) O 0 1.3593343339834973e-08
gene O 0 3.4185441109002568e-06
. O 0 1.3422639995042118e-06

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9997894167900085
CLD B-Disease 1 1.0
) O 0 4.492854532855972e-09
is O 0 7.1572817117449e-11
caused O 0 2.8113836259002767e-10
by O 0 6.1174849907974505e-12
mutations O 0 1.1036432878697156e-09
in O 0 7.430533618957291e-12
a O 0 1.4061329357828445e-11
gene O 0 2.4559739658647217e-11
which O 0 9.11735617559195e-12
encodes O 0 3.3713318248196344e-10
an O 0 8.151970209979709e-10
intestinal O 0 1.3193280778978078e-07
anion O 0 2.5189314101226046e-07
transporter O 0 1.2495751207097783e-06
. O 0 1.5124672358979296e-07

We O 0 3.3056595238889486e-09
report O 0 1.5893796279087269e-09
here O 0 9.896273384102372e-11
the O 0 3.1627492291796955e-11
complete O 0 6.678461950127002e-11
genomic O 0 5.39574607216764e-09
organization O 0 1.132931415348537e-09
of O 0 1.1653417120172094e-09
the O 0 2.395078579908727e-09
human O 0 1.010624384178982e-08
CLD B-Disease 1 0.9999921321868896
gene O 0 8.440652621288791e-09
which O 0 7.305497318199627e-10
spans O 0 3.048210128753226e-09
approximately O 0 3.7355413207151855e-10
39kb O 0 1.0769439029445493e-07
, O 0 2.2639232155619027e-10
and O 0 7.287682679546492e-10
comprises O 0 3.1409901346535207e-09
21 O 0 7.233418131136204e-08
exons O 0 5.128215434524463e-07
. O 0 9.650768788560526e-07

All O 0 3.2772973668215855e-08
exon O 0 7.199447509265156e-07
/ O 0 1.822333047130087e-06
intron O 0 4.603834611316415e-07
boundaries O 0 3.062898201733333e-08
conform O 0 5.096230104584265e-09
to O 0 1.817903827472378e-09
the O 0 2.0667918931849272e-08
GT O 0 9.438742267775524e-07
/ O 0 1.6077834743555286e-06
AG O 0 3.238027056795545e-05
rule O 0 5.052153824181005e-07
. O 0 4.7550838644383475e-07

An O 0 1.4289118499544173e-10
analysis O 0 1.965730356268125e-10
of O 0 1.9976918730346682e-10
the O 0 2.1474250155861796e-10
putative O 0 6.096239246744517e-08
promoter O 0 1.9872170753387763e-07
region O 0 1.705546637253974e-08
sequence O 0 5.647555201271359e-10
shows O 0 9.06703934155928e-10
a O 0 2.3395967385653194e-09
putative O 0 2.0336804027465405e-06
TATA O 0 1.2697820466200938e-06
box O 0 5.668810842962557e-08
and O 0 3.3586384784456413e-09
predicts O 0 3.2669369431914674e-08
multiple O 0 1.8658301570440017e-09
transcription O 0 2.6672262265492463e-07
factor O 0 4.6776452933272594e-08
binding O 0 2.4076396698546887e-07
sites O 0 2.463772034388967e-06
. O 0 5.519939918485761e-07

The O 0 1.8155454029056273e-07
genomic O 0 2.059198322967859e-07
structure O 0 3.093386524710695e-08
was O 0 5.286621806988023e-09
determined O 0 1.7750902137070312e-10
using O 0 2.3116670036515963e-11
DNA O 0 9.177804072280082e-10
from O 0 6.299870625170456e-10
several O 0 1.9348264657104153e-10
sources O 0 2.387316344609758e-09
including O 0 4.981872987058766e-12
multiple O 0 7.126730316997509e-10
large O 0 4.323225777369544e-09
- O 0 6.513579897671207e-09
insert O 0 2.0445099835342262e-08
libaries O 0 1.1706403313382907e-07
and O 0 8.082311209189896e-11
genomic O 0 4.157484634337294e-10
DNA O 0 1.8321791861453107e-09
from O 0 5.706418892970078e-09
Finnish O 0 1.3796529856335837e-06
CLD B-Disease 0 0.0003288017469458282
patients O 0 1.4034744033608604e-08
and O 0 5.243820488942674e-09
controls O 0 1.4676151067760657e-06
. O 0 3.9323484202213876e-07

Exon O 0 9.853211935251238e-08
- O 0 3.345405374943766e-08
specific O 0 1.6293192350858021e-09
primers O 0 1.596657561719894e-08
developed O 0 7.578309646483206e-10
in O 0 2.390576278599177e-11
this O 0 1.724108703027305e-11
study O 0 9.250765084511947e-12
will O 0 3.0912275777311704e-12
facilitate O 0 2.0045583248862187e-10
mutation O 0 1.0517101078910684e-10
screening O 0 2.3243117500126864e-11
studies O 0 1.1621580781051577e-10
of O 0 7.265001794598547e-11
patients O 0 5.48999214144974e-11
with O 0 3.3033555058015196e-11
the O 0 7.819978442569209e-09
disease O 0 1.1487647810781709e-07
. O 0 3.013342464441848e-08

Genomic O 0 6.6518865970977e-09
sequencing O 0 4.583495805121629e-09
of O 0 7.223777576115253e-09
a O 0 9.185391114385766e-09
BAC O 0 2.298462504768395e-06
clone O 0 1.349622351654034e-07
H O 1 1.0
_ O 0 9.711274007173643e-10
RG364P16 O 0 3.333996900778402e-08
revealed O 0 3.278919635807398e-10
the O 0 3.276767399085223e-11
presence O 0 1.2112176539513797e-10
of O 0 3.4210148602831225e-10
another O 0 1.458877796345348e-09
, O 0 1.2611546529317508e-10
highly O 0 1.8620534281144074e-10
homologous O 0 3.238196516486269e-11
gene O 0 5.4263343818306e-10
3 O 0 5.5893824679742465e-08
of O 0 3.5522109698149507e-08
the O 0 7.037007065946455e-08
CLD B-Disease 0 0.00010886057862080634
gene O 0 5.270190950312781e-09
, O 0 6.184740497516827e-10
with O 0 1.3681762320305602e-11
a O 0 9.061571631940879e-11
similar O 0 4.75979949898786e-11
genomic O 0 3.631906997370038e-09
structure O 0 4.861966829139419e-09
, O 0 4.2163373487058564e-11
recently O 0 2.7063989938014288e-11
identified O 0 9.057580380167352e-11
as O 0 3.513393395659925e-11
the O 0 1.1754227591254107e-09
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 4.748689264033601e-08
( O 0 2.7034829486183298e-08
PDS B-Disease 0 3.3482032449683174e-05
) O 0 2.137796883960874e-10
. O 0 1.3780143692798674e-09
. O 0 3.6075444853622685e-08

The O 0 1.1355804474533215e-07
APCI1307K O 0 0.2531717121601105
allele O 0 5.469049710882246e-07
and O 0 6.250061357349068e-09
cancer B-Disease 0 3.908110457473413e-08
risk O 0 1.2752038314189917e-09
in O 0 3.5941326304023136e-11
a O 0 1.568311452926352e-10
community O 0 3.2712860198458316e-10
- O 0 1.5128399921682245e-10
based O 0 9.473397760695335e-11
study O 0 2.04586833585374e-11
of O 0 1.3234799367545236e-10
Ashkenazi O 0 7.525418066478551e-10
Jews O 0 8.246965776947945e-09
. O 0 2.413478128460156e-08

Mutations O 0 3.1196412919598515e-07
in O 0 5.135025293867557e-09
APC O 0 4.543191067796215e-08
are O 0 3.526350739191386e-11
classically O 0 1.762017376449876e-08
associated O 0 1.1566882562874525e-08
with O 0 9.067669282103452e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 8.02307340563857e-07
FAP B-Disease 0 2.0548957309074467e-06
) O 0 2.060522412417054e-11
, O 0 9.03157323234316e-13
a O 0 1.2581123642885217e-11
highly O 0 3.35248046212655e-07
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 1.2151906503277132e-06
by O 0 2.78779804796514e-10
multiple O 0 9.385888510848872e-09
intestinal O 0 0.0038662105798721313
polyps B-Disease 0 1.4447044804910547e-07
and O 0 2.946752911126005e-11
, O 0 1.268956619469852e-12
without O 0 6.7628940642050495e-12
surgical O 0 1.2852741093638542e-09
intervention O 0 2.111303493146366e-10
, O 0 1.8979843738331503e-12
the O 0 1.5092885274903267e-11
development O 0 6.017071285668862e-09
of O 0 1.4381721769041178e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.8211128988431255e-09
CRC B-Disease 0 1.0577745115369908e-06
) O 0 1.2913433655725726e-09
. O 0 5.209330922184563e-08

APC B-Disease 0 9.345266335003544e-06
is O 0 1.4028427308687696e-08
a O 0 3.914974300300855e-08
tumour O 1 1.0
- O 0 1.5295982791485585e-07
suppressor O 0 1.623909895442921e-07
gene O 0 9.384738541839965e-10
, O 0 7.125788847872627e-11
and O 0 1.3038231952422485e-11
somatic O 0 1.2872718002654437e-08
loss O 0 3.0316851251654953e-09
occurs O 0 2.09506612058874e-09
in O 0 4.889969318355725e-09
tumours B-Disease 1 1.0
. O 0 1.5021275885374052e-06

The O 0 4.721081950265216e-06
germline O 0 2.7906506147701293e-05
T O 0 3.892696440743748e-07
- O 0 4.035481282471665e-09
to O 0 7.280110958518549e-10
- O 0 2.746912974860294e-10
A O 0 9.441023518519387e-10
transversion O 0 1.416749273452922e-09
responsible O 0 2.547667805885556e-12
for O 0 1.11360736170657e-12
the O 0 9.461750133388236e-11
APC O 0 1.9377857096714024e-09
I1307K O 0 3.678905624582285e-09
allele O 0 2.4983606849993123e-10
converts O 0 9.082218865863467e-10
the O 0 6.797274409997556e-10
wild O 0 1.95400851055183e-09
- O 0 2.99496955014078e-10
type O 0 8.75917116616165e-11
sequence O 0 1.1957321417732647e-11
to O 0 6.5004418514647e-11
a O 0 2.3002162397034454e-09
homopolymer O 0 5.034933565184474e-06
tract O 0 4.093676125194179e-06
( O 0 3.4178682994934206e-08
A8 O 0 4.285081104171695e-06
) O 0 6.044199862831334e-11
that O 0 2.043968987119893e-11
is O 0 9.966834996211205e-11
genetically O 0 5.788925960814595e-08
unstable O 0 9.194950689561665e-05
and O 0 2.06726902263199e-08
prone O 0 3.1516293574895826e-07
to O 0 1.8348799812883954e-08
somatic O 0 0.00014730935799889266
mutation O 0 6.879056968500663e-07
. O 0 1.4479377341558575e-07

The O 0 8.171685550451002e-08
I1307K O 0 1.27064447497105e-06
allele O 0 4.149977783640679e-08
was O 0 2.24724168162993e-08
found O 0 5.498283495164458e-10
in O 0 1.0338385703079211e-09
6 O 0 2.1513798742489598e-07
. O 0 2.2320071479953185e-07

1 O 0 3.770635714772652e-07
% O 0 1.401419957858252e-08
of O 0 1.5772675610037368e-08
unselected O 0 5.678258457919583e-05
Ashkenazi O 0 1.9653088045856748e-08
Jews O 0 2.7219426712576933e-09
and O 0 7.815005587108459e-11
higher O 0 2.5219748511773332e-09
proportions O 0 4.873832448737403e-09
of O 0 1.7921733430625864e-08
Ashkenazim O 0 3.095181000389857e-07
with O 0 3.920327951156821e-10
family O 0 2.3038257968011067e-09
or O 0 2.547513588968542e-11
personal O 0 5.670199865193126e-10
histories O 0 2.1206760791869783e-09
of O 0 9.351886376407492e-08
CRC B-Disease 0 0.00018492642266210169
( O 0 1.9889720093146934e-08
ref O 0 1.1674422921714722e-06
. O 0 9.823975233302917e-08
2 O 0 4.343507100657007e-07
) O 0 6.727909340753513e-09
. O 0 9.460481464884651e-08

To O 0 1.947051631034924e-09
evaluate O 0 7.626599796139999e-09
the O 0 1.2301561991279186e-09
role O 0 8.40435832039077e-10
of O 0 4.224528282747997e-09
I1307K O 0 1.564778955298607e-07
in O 0 1.4721187602262376e-09
cancer B-Disease 0 4.760842031714674e-08
, O 0 5.84363446520797e-10
we O 0 3.939939929864522e-09
genotyped O 0 1.689508962954278e-06
5 O 0 1.5631172800567583e-07
, O 0 2.075411487112433e-08
081 O 0 2.797885144900647e-06
Ashkenazi O 0 5.4326363851942006e-08
volunteers O 0 4.093155592244102e-09
in O 0 1.0817886170189084e-10
a O 0 3.690978911397025e-10
community O 0 2.472992699509291e-09
survey O 0 2.25055316604994e-08
. O 0 2.065137039153342e-08

Risk O 0 3.898729801221634e-07
of O 0 1.3785518149234122e-07
developing O 1 0.8899000287055969
colorectal B-Disease 1 1.0
, I-Disease 0 4.366880148154451e-06
breast I-Disease 0 0.00014294178981799632
and I-Disease 0 1.5555732257865884e-09
other I-Disease 0 5.500341959674415e-09
cancers I-Disease 0 0.007961399853229523
were O 0 1.55280080460507e-10
compared O 0 3.5495320571676814e-10
between O 0 8.920527649891596e-10
genotyped O 0 4.023470623337744e-08
I1307K O 0 4.24617008221162e-09
carriers O 0 8.441996407482222e-11
and O 0 6.375538291747418e-11
non O 0 1.4897501010580072e-09
- O 0 9.708286952125889e-11
carriers O 0 3.8977866073652834e-11
and O 0 2.664043638467284e-11
their O 0 3.6835853811645336e-11
first O 0 9.207997697657788e-10
- O 0 1.5311847345600427e-09
degree O 0 1.507823377266959e-08
relatives O 0 3.165832396234691e-08
. O 0 9.672498890722636e-08

Sperm O 0 1.5791428609190916e-08
DNA O 0 2.660689890632284e-09
analysis O 0 1.5774162531734248e-10
in O 0 2.4427808734128753e-11
a O 0 3.218483257683147e-09
Friedreich B-Disease 1 0.6450823545455933
ataxia I-Disease 1 1.0
premutation O 1 0.9992006421089172
carrier O 0 1.8441497218191216e-08
suggests O 0 3.6249518942099712e-09
both O 0 3.725806885235272e-10
meiotic O 0 6.844610567213749e-08
and O 0 9.7082919481295e-10
mitotic O 0 1.7278248165553123e-08
expansion O 0 3.081773058966064e-08
in O 0 6.772014060629772e-10
the O 0 2.2528979570779484e-08
FRDA B-Disease 0 4.093383176950738e-05
gene O 0 1.7514166472665238e-07
. O 0 7.706000246798794e-07

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 6.307237526925746e-06
usually O 0 9.810396051079806e-09
caused O 0 2.158472511837317e-09
by O 0 2.8003081624372594e-12
an O 0 7.634943025025542e-12
expansion O 0 2.0473225337269696e-09
of O 0 2.597621562294705e-10
a O 0 8.404635210013112e-09
GAA O 1 1.0
trinucleotide O 1 0.9999837875366211
repeat O 0 2.4429196443520595e-08
in O 0 1.4194649899934575e-09
intron O 0 2.994600833972072e-08
1 O 0 7.637313892416842e-09
of O 0 3.925560321249577e-09
the O 0 2.1909011493903563e-08
FRDA B-Disease 0 8.708891073183622e-06
gene O 0 7.756950992643397e-08
. O 0 8.056541105361248e-07

Occasionally O 0 7.476708674403199e-07
, O 0 1.1451061210365765e-09
a O 0 9.154306757075403e-10
fully O 0 1.4519214719399542e-09
expanded O 0 8.220216729526442e-10
allele O 0 1.6009228387403596e-09
has O 0 5.359707469509978e-11
been O 0 3.266433651338829e-11
found O 0 4.9004849657363625e-12
to O 0 2.460381377800136e-11
arise O 0 8.843294430072035e-10
from O 0 1.725886378256547e-10
a O 0 2.2097759733163969e-10
premutation O 0 1.66725584449523e-07
of O 0 3.889005562029979e-09
100 O 0 7.338683438717908e-09
or O 0 1.303272489927565e-09
less O 0 2.6208052616993882e-08
triplet O 0 1.7818852029449772e-06
repeats O 0 3.3050815773094655e-07
. O 0 1.8709131666128087e-07

We O 0 3.266849901706337e-08
have O 0 6.438108379747121e-10
examined O 0 8.519339900203704e-09
the O 0 6.392638085550573e-10
sperm O 0 2.056802284045034e-09
DNA O 0 4.75202144301079e-09
of O 0 5.887346610222721e-09
a O 0 1.4312837137708811e-08
premutation O 0 9.5923514891183e-06
carrier O 0 8.326058065222242e-08
. O 0 1.6208834097142244e-07

This O 0 2.826412659473476e-09
mans O 0 9.240392273568432e-07
leucocyte O 0 9.723198957090062e-08
DNA O 0 3.749291099808261e-09
showed O 0 7.598544016218511e-10
one O 0 3.845049972861503e-11
normal O 0 8.094035858219328e-11
allele O 0 9.99426149478344e-12
and O 0 1.0109018656889734e-12
one O 0 7.408400282127303e-12
allele O 0 3.261765857409671e-10
of O 0 4.5643969159847586e-10
approximately O 0 8.889377012266664e-10
100 O 0 9.1964880155615e-09
repeats O 0 4.679117893147122e-08
. O 0 8.102743720428407e-08

His O 0 1.1778724484656777e-07
sperm O 0 7.906036358917845e-08
showed O 0 1.4330640007997886e-09
an O 0 8.932351386325976e-12
expanded O 0 2.21903311697913e-11
allele O 0 1.6286129389531112e-10
in O 0 7.686907360637818e-11
a O 0 3.190161468324959e-09
tight O 0 4.859799318523983e-08
range O 0 2.308987632204662e-07
centering O 0 2.118550668228636e-08
on O 0 5.814061454501029e-10
a O 0 6.628322890556149e-11
size O 0 1.0843114184311275e-09
of O 0 1.9181600752204986e-09
approximately O 0 4.902623640390402e-09
320 O 0 5.401278713179636e-08
trinucleotide O 0 1.9444458303041756e-05
repeats O 0 5.548905619434663e-07
. O 0 3.189725532593002e-07

His O 0 1.049477305059554e-07
affected O 0 9.670779945736285e-07
son O 0 2.96108682960039e-05
has O 0 7.374192922959821e-10
repeat O 0 6.77410683103119e-10
sizes O 0 1.4642114187779498e-08
of O 0 8.402262885454093e-09
1040 O 0 2.8489623105087958e-08
and O 0 1.7549529607308045e-09
540 O 0 1.45278420404793e-07
. O 0 5.7706262879264614e-08

These O 0 1.6732787377904401e-09
data O 0 4.822492627454267e-09
suggest O 0 1.1962535406695451e-09
that O 0 8.13028463997334e-12
expansion O 0 5.425195848118847e-10
occurs O 0 1.5205168721332818e-11
in O 0 2.091162529596624e-12
two O 0 3.3031773930686237e-12
stages O 0 7.214434605273823e-11
, O 0 6.202099164104302e-12
the O 0 1.9601742451413884e-10
first O 0 4.322605051676476e-10
during O 0 4.01377042713591e-10
meiosis O 0 5.776920053435219e-10
followed O 0 1.2776572855255353e-10
by O 0 1.0193149276027658e-11
a O 0 4.651883045436733e-10
second O 0 3.379890367583016e-09
mitotic O 0 1.26780577147656e-07
expansion O 0 1.2419668564689346e-06
. O 0 4.848799903811596e-07

We O 0 1.0219523893795213e-08
also O 0 5.246998946439874e-10
show O 0 2.8733856960450055e-10
that O 0 7.910637422892108e-12
in O 0 2.7847779637824033e-11
all O 0 6.94244939314359e-11
informative O 0 4.696139033200097e-09
carrier O 0 4.8420090853484865e-11
father O 0 2.9223562458824404e-10
to O 0 1.1584976034040295e-10
affected O 0 3.3170659552439474e-09
child O 0 2.4139557019964286e-09
transmissions O 0 2.235319698229432e-07
, O 0 4.2738732691782744e-11
with O 0 2.1863630697560588e-12
the O 0 6.467742313942537e-11
notable O 0 3.3917971209440623e-10
exception O 0 1.7870626090044084e-09
of O 0 1.9387358385358766e-09
the O 0 4.0944359014361e-09
premutation O 0 9.142537038542287e-08
carrier O 0 1.6503434174808262e-09
, O 0 2.5006202664101806e-10
the O 0 1.2082556066772554e-09
expansion O 0 5.991009288663918e-08
size O 0 3.8741116981100276e-08
decreases O 0 2.0174026360564312e-07
. O 0 7.629902931682864e-09
. O 0 1.7805606944421015e-07

The O 0 1.7674736341177777e-08
R496H O 0 1.508021000518056e-06
mutation O 0 7.086465814154508e-08
of O 0 1.4023664896001264e-08
arylsulfatase O 0 5.264706032903632e-06
A O 0 1.5243733741954202e-07
does O 0 1.435589092046996e-09
not O 0 1.7791214057538696e-09
cause O 0 7.881952114985324e-06
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 4.158742683557648e-07

Deficiency B-Disease 0 3.6161000025458634e-05
of I-Disease 0 9.882099902824848e-07
arylsulfatase I-Disease 1 0.9999927282333374
A I-Disease 1 0.9998005032539368
( O 0 8.489981837556115e-07
ARSA O 0 0.0063814506866037846
) O 0 5.090097787707748e-10
enzyme O 0 2.0500978692439276e-08
activity O 0 2.105494623094728e-08
causes O 0 9.134083001072213e-08
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 5.6748255872207665e-08
MLD B-Disease 1 1.0
) O 0 1.7078211067556026e-09
. O 0 1.0255158500172001e-08

A O 0 1.1195817961606735e-07
number O 0 2.7938584779008124e-08
of O 0 3.7191190926932904e-07
ARSA O 0 3.063802432734519e-05
gene O 0 2.398568881289975e-07
mutations O 0 3.622970439209894e-07
responsible O 0 9.917029863970583e-09
for O 0 3.499252443361911e-09
MLD B-Disease 1 1.0
have O 0 1.2357395995366005e-08
been O 0 2.7153883586095162e-09
identified O 0 2.3348992073124464e-08
. O 0 1.5373924355799318e-08

Recently O 0 5.6419192873136126e-08
, O 0 1.4763640310277992e-10
the O 0 2.3535690063525294e-10
R496H O 0 4.0249673816106224e-08
mutation O 0 1.1533258792439938e-09
of O 0 7.019683945230781e-09
ARSA O 0 2.5920326152117923e-05
was O 0 1.4703516626468627e-08
proposed O 0 2.9875180107552524e-10
to O 0 4.789789745385242e-11
be O 0 2.5464059680291307e-11
a O 0 9.358637476086784e-11
cause O 0 4.346021853507409e-08
of O 0 5.920106218582077e-07
MLD B-Disease 1 1.0
( O 0 1.2033854090987006e-07
Draghia O 0 8.418880497629289e-06
et O 0 5.720194735658879e-07
al O 0 2.2504077890062035e-07
. O 0 1.5496209870846656e-09
, O 0 2.7816049463780246e-10
1997 O 0 9.57637302789749e-10
) O 0 6.9021033333172e-10
. O 0 3.323419406342509e-08

We O 0 3.3559249601466945e-08
have O 0 9.214322638229078e-10
investigated O 0 4.6863322111789785e-09
the O 0 1.2400644955334883e-09
R496H O 0 3.321207842077456e-08
mutation O 0 3.47009282419819e-10
and O 0 8.932215210533112e-12
found O 0 1.1916430515956922e-11
this O 0 8.002236026594112e-12
mutation O 0 2.238298990597798e-10
at O 0 3.3235239560447383e-10
a O 0 6.779441591442392e-11
relatively O 0 2.987677605315042e-10
high O 0 6.084532877537185e-11
frequency O 0 1.2154915962625523e-11
in O 0 4.555448900045445e-13
an O 0 2.7188459816862576e-12
African O 0 1.2268013211205742e-12
American O 0 1.1407689029518941e-11
population O 0 8.35620635186718e-12
( O 0 2.0777283973177907e-12
f O 0 4.659111429994311e-10
= O 0 7.461388173979344e-10
0 O 0 1.5208547754497204e-09
. O 0 7.364536758203144e-10
09 O 0 1.6060312191257253e-08
, O 0 6.069907909633798e-10
n O 0 2.707475577068408e-09
= O 0 5.630309729554028e-08
61 O 0 1.7774712546270166e-07
subjects O 0 1.141835639373312e-07
) O 0 6.005238972761617e-09
. O 0 7.156827308563152e-08

The O 0 7.306950010388391e-06
ARSA O 0 3.879635551129468e-05
enzyme O 0 4.087883453962604e-08
activity O 0 5.207751385682968e-08
in O 0 2.485683880948386e-10
subjects O 0 1.5749038739798493e-09
with O 0 5.638099796062557e-12
and O 0 9.218039526137645e-12
without O 0 2.291722887848291e-11
the O 0 2.0847090720366168e-10
R496H O 0 2.0453359006467053e-09
mutation O 0 1.6184838191879436e-10
was O 0 4.3248069014900636e-10
determined O 0 4.891319016486761e-10
and O 0 6.528526053095618e-10
found O 0 1.1397457422290813e-09
to O 0 2.6839679367895997e-09
be O 0 1.8155589032176067e-08
normal O 0 8.394832207159197e-07
. O 0 1.8814736790773168e-07

It O 0 7.161740978034459e-09
is O 0 5.758701848712633e-10
therefore O 0 1.674332228418507e-09
concluded O 0 2.7005631064724867e-10
that O 0 2.635799131039951e-12
the O 0 2.2655992359954524e-10
R496H O 0 1.0943541184360583e-07
mutation O 0 1.2603527999033304e-08
of O 0 5.1981547954937923e-08
ARSA O 0 4.7933749556250405e-06
does O 0 2.724124037456477e-09
not O 0 6.589124246225708e-10
negatively O 0 5.9899907256522056e-09
influence O 0 3.76270925528388e-09
the O 0 6.702750576792482e-10
activity O 0 2.271919541385614e-08
of O 0 9.982427329191523e-09
ARSA O 0 1.2914673789055087e-05
and O 0 1.2173466679143985e-09
is O 0 8.794711486848072e-11
not O 0 4.0220757280273745e-11
a O 0 1.0902092562048438e-09
cause O 0 6.851872740298859e-07
of O 0 8.105840606731363e-06
MLD B-Disease 1 1.0

Down O 0 1.0401346344224294e-06
- O 0 1.8743630647577447e-08
regulation O 0 1.515995862177988e-08
of O 0 8.774413196022124e-09
transmembrane O 0 3.563748123269761e-07
carbonic O 0 5.90158742852509e-06
anhydrases O 0 1.8796849872160237e-06
in O 0 1.0325896582230598e-08
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999998807907104
lines O 0 1.4961980099315042e-08
by O 0 9.057424255054514e-11
wild O 0 3.688638727794569e-08
- O 0 1.3717056823736584e-08
type O 0 2.1422079043986741e-07
von B-Disease 0 0.00040154208545573056
Hippel I-Disease 0 0.0004744771576952189
- I-Disease 0 0.0001768228248693049
Lindau I-Disease 0 0.00022422474285122007
transgenes O 0 0.00011012274626409635
. O 0 1.6697650835340028e-06

To O 0 1.3876314319816174e-08
discover O 0 2.217445604912882e-08
genes O 0 1.2655463343946849e-08
involved O 0 1.8473876872704409e-09
in O 0 2.0466117689466046e-09
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( O 0 5.719442924601026e-06
VHL B-Disease 1 1.0
) O 0 1.201896271396663e-08
- O 0 1.299441265700807e-07
mediated O 0 2.961169457194046e-06
carcinogenesis O 0 6.112300070526544e-06
, O 0 3.11050976642413e-11
we O 0 6.915432202575511e-12
used O 0 1.5705324540871146e-10
renal B-Disease 1 0.9999997615814209
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 1.7396753264620202e-06
stably O 0 3.6932681268808665e-07
transfected O 0 4.547699106183245e-08
with O 0 1.7281195918705805e-10
wild O 0 2.0115578536206158e-08
- O 0 1.5546131493238136e-08
type O 0 1.161638962798861e-07
VHL O 0 6.827100150985643e-05
- O 0 5.790140562567103e-07
expressing O 0 2.5222457011864208e-08
transgenes O 0 3.1298884550778894e-06
. O 0 6.089871362746635e-08

Large O 0 4.245443676609284e-07
- O 0 6.909644412189664e-08
scale O 0 4.3829160745190165e-08
RNA O 0 2.6876678660414655e-08
differential O 0 2.8786878658593196e-08
display O 0 5.316796780618915e-09
technology O 0 1.692932549701709e-08
applied O 0 7.205462448922617e-09
to O 0 2.5504803824460964e-10
these O 0 3.9511810490111543e-10
cell O 0 8.718160415810416e-09
lines O 0 1.12853171252425e-09
identified O 0 1.9102654180702672e-10
several O 0 7.577843214034985e-11
differentially O 0 1.727979714871708e-08
expressed O 0 3.614138710528181e-10
genes O 0 5.008249925886332e-10
, O 0 6.083117343180788e-11
including O 0 1.3338135283758046e-11
an O 0 1.4684002902498605e-09
alpha O 0 1.9036258791516047e-08
carbonic O 0 1.6887923948161188e-07
anhydrase O 0 1.7429121612622112e-07
gene O 0 1.5825078136799675e-08
, O 0 3.038546481093363e-08
termed O 0 1.5095865819603205e-06
CA12 O 0 0.003780961036682129
. O 0 8.338166139765235e-07

The O 0 2.6178557277489745e-07
deduced O 0 4.920059382129693e-07
protein O 0 2.1330741617475724e-08
sequence O 0 8.093670178510592e-10
was O 0 1.250260117657831e-09
classified O 0 2.336942028779987e-10
as O 0 8.163775905289938e-11
a O 0 1.2947562466614215e-10
one O 0 6.728945178835488e-10
- O 0 3.931666991974225e-09
pass O 0 4.082748361611266e-08
transmembrane O 0 6.955898612659439e-08
CA O 0 7.692212733445558e-08
possessing O 0 2.1861174204218514e-08
an O 0 4.3932441684546575e-08
apparently O 0 5.136193337307304e-08
intact O 0 5.853877826922371e-09
catalytic O 0 1.929491011409823e-09
domain O 0 1.195421628352733e-08
in O 0 1.3845904422993272e-09
the O 0 1.6633696020562638e-07
extracellular O 0 2.0051618776051328e-05
CA O 0 3.816223761532456e-05
module O 0 4.1051481503018294e-07
. O 0 1.5679039222504798e-07

Reintroduced O 0 3.2327420740330126e-06
wild O 0 1.615674477761786e-06
- O 0 4.5509793267228815e-07
type O 0 2.0791365784589289e-07
VHL B-Disease 0 9.441957081435248e-05
strongly O 0 1.1178379999421395e-08
inhibited O 0 2.557686729076636e-09
the O 0 8.96434107500177e-11
overexpression O 0 2.1763986168821248e-08
of O 0 2.688793354632679e-10
the O 0 5.058363172771863e-10
CA12 O 0 4.034683342979406e-07
gene O 0 7.567645121664412e-11
in O 0 1.7827142539950103e-10
the O 0 2.176439029000221e-09
parental O 0 2.137030787707772e-05
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999990463256836
lines O 0 1.1496758816065267e-06
. O 0 4.4897646489516774e-08

Similar O 0 3.4840479390396695e-09
results O 0 6.474932590094795e-09
were O 0 4.942128928320244e-10
obtained O 0 2.024447276482988e-09
with O 0 8.214883634449777e-11
CA9 O 0 2.2711819838150404e-06
, O 0 5.8019391374619644e-11
encoding O 0 2.58854077062054e-10
another O 0 8.625289815711312e-09
transmembrane O 0 3.492766893486987e-07
CA O 0 1.0007220225816127e-06
with O 0 2.020531963964345e-09
an O 0 4.398425801355188e-08
intact O 0 2.248592920750525e-07
catalytic O 0 1.9398285644456337e-07
domain O 0 1.036543039845128e-06
. O 0 5.412704240370658e-07

Although O 0 1.0450246001880714e-08
both O 0 2.33827623929983e-09
domains O 0 1.085837695313785e-07
of O 0 8.970989284762254e-08
the O 0 1.1198039118198722e-07
VHL B-Disease 0 3.1465104257222265e-05
protein O 0 7.500004528537829e-08
contribute O 0 6.026509846712713e-10
to O 0 1.032366067632573e-10
regulation O 0 7.533794033065533e-09
of O 0 2.1163276642255369e-07
CA12 O 1 0.9978781938552856
expression O 0 3.1794422739039874e-07
, O 0 1.5810076581246335e-09
the O 0 4.405955156272512e-09
elongin O 0 3.23375139998916e-08
binding O 0 3.303969986490074e-09
domain O 0 2.6437648514843204e-08
alone O 0 2.818208777455311e-09
could O 0 1.183937059501261e-09
effectively O 0 1.821855022399177e-08
regulate O 0 5.932398039476539e-07
CA9 O 0 0.0015457975678145885
expression O 0 2.0645404674723977e-06
. O 0 6.639447178713453e-07

We O 0 3.101504546521028e-07
mapped O 0 7.712772458035033e-06
CA12 O 0 0.002020645886659622
and O 0 3.168768500927399e-07
CA9 O 0 0.0007577156065963209
loci O 0 5.153120241629949e-08
to O 0 3.3594969028882815e-09
chromosome O 0 1.1197158755749115e-08
bands O 0 2.5648841273095968e-08
15q22 O 0 1.6822468751342967e-07
and O 0 2.4439483770066772e-09
17q21 O 0 2.1122659745742567e-06
. O 0 1.0177782172604566e-07

2 O 0 8.806850360087992e-07
respectively O 0 6.945995068008415e-08
, O 0 9.618879026618288e-10
regions O 0 6.844542266293274e-09
prone O 0 1.3890401717731038e-08
to O 0 1.971566687686277e-09
amplification O 0 6.648159711630797e-08
in O 0 2.783182351251412e-09
some O 0 1.1567633073639172e-08
human O 0 9.532096783004818e-07
cancers B-Disease 0 0.040043752640485764
. O 0 7.596550943844704e-08

Additional O 0 4.4816875544029244e-08
experiments O 0 3.173752460838841e-08
are O 0 2.9370790521898726e-11
needed O 0 3.02099345539375e-10
to O 0 8.957572877887898e-11
define O 0 2.3059181231133152e-09
the O 0 3.1023603686008983e-09
role O 0 8.259968709012355e-09
of O 0 4.355665055300051e-07
CA O 0 3.73041552848008e-06
IX O 0 0.01210165023803711
and O 0 1.9492672436172143e-05
CA O 0 6.956898869248107e-05
XII O 0 8.77814909472363e-06
enzymes O 0 8.775011273165489e-10
in O 0 8.12215086853918e-11
the O 0 2.3081699052074356e-10
regulation O 0 2.1857076148990018e-09
of O 0 1.0848705045418683e-08
pH O 0 1.404162475182602e-08
in O 0 6.003083030670098e-10
the O 0 1.2014860217846035e-08
extracellular O 0 2.5140357706732175e-07
microenvironment O 0 7.573575544483901e-07
and O 0 2.1370548386467902e-10
its O 0 2.3486093625457727e-10
potential O 0 1.2703977425587709e-08
impact O 0 1.8911698873580463e-07
on O 0 6.415289277583724e-08
cancer B-Disease 0 1.5023209698483697e-07
cell O 0 8.041787395995925e-07
growth O 0 1.3703177614843298e-07
. O 0 3.2172696506904686e-08

A O 0 2.0746753648381855e-08
gene O 0 3.440987217384617e-10
encoding O 0 3.5868088499313444e-09
a O 0 1.0592970056677586e-08
transmembrane O 0 4.1585511922903606e-08
protein O 0 5.6520192970310745e-09
is O 0 2.1383899425492237e-12
mutated O 0 6.827532289532812e-11
in O 0 1.983391532608958e-12
patients O 0 3.1884789947200787e-11
with O 0 8.589245287238256e-11
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 2.6827205346080518e-08
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 2.057654846510104e-08
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 1.48904555352658e-09
. O 0 9.17829900970446e-09

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.461150481598452e-05
WFS B-Disease 1 0.8647998571395874
; O 0 4.2259244992237655e-08
OMIM O 0 0.11077704280614853
222300 O 0 3.632359550920228e-07
) O 0 2.8676465715915533e-11
is O 0 9.076442722411038e-12
an O 0 8.720883459822915e-10
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 2.101220974992657e-09
by O 0 5.13818397551713e-11
young O 0 2.9877324436711206e-07
- O 0 0.002732951892539859
onset O 1 1.0
non O 1 1.0
- O 0 0.004848696291446686
immune O 1 0.9834983944892883
insulin B-Disease 1 0.9999998807907104
- I-Disease 0 1.5973870176821947e-05
dependent I-Disease 0 1.5827001789148198e-06
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 1.1692736778812218e-09
progressive O 0 1.1603029861362302e-06
optic B-Disease 0 1.4150847164273728e-05
atrophy I-Disease 0 9.176654316433996e-07
. O 0 2.0121603938605404e-08

Linkage O 0 7.142909907997819e-07
to O 0 7.172020310974858e-09
markers O 0 3.083096657974238e-07
on O 0 5.9216642256387786e-08
chromosome O 0 2.527461901991046e-07
4p O 0 2.295715057698544e-05
was O 0 4.003895526238921e-08
confirmed O 0 1.1968880331281184e-09
in O 0 1.0658217364234446e-10
five O 0 5.778528766597901e-10
families O 0 3.3136386967669296e-09
. O 0 3.9184183009410845e-08

On O 0 8.053113731421035e-09
the O 0 5.577183159743981e-10
basis O 0 7.25382154342924e-09
of O 0 3.2418829842839614e-09
meiotic O 0 1.2896223779534921e-05
recombinants O 1 0.7778623700141907
and O 0 1.1282228484787993e-07
disease O 0 2.395624960627174e-06
- O 0 5.0309260757330776e-08
associated O 0 3.5521438235264213e-07
haplotypes O 0 4.354821783181251e-07
, O 0 1.4302316275749405e-10
the O 0 3.1091489383072712e-09
WFS B-Disease 0 8.913092983675597e-07
gene O 0 4.298485123399587e-09
was O 0 9.6564578555558e-09
localized O 0 8.42649683363561e-09
to O 0 2.847557745155882e-10
a O 0 1.1907429708912787e-08
BAC O 0 6.41277165414067e-06
/ O 0 1.0780659920328617e-07
P1 O 0 3.24311599797511e-07
contig O 0 3.2911353287090606e-07
of O 0 1.8032821902380647e-09
less O 0 7.959849446237399e-10
than O 0 1.372829766532746e-10
250 O 0 4.004427900383689e-09
kb O 0 7.343586503338884e-07
. O 0 1.5938772435220017e-07

Mutations O 0 3.572145601538068e-08
in O 0 3.831983341751055e-10
a O 0 2.5821203508691326e-10
novel O 0 2.7874378361048002e-09
gene O 0 4.8608908009839524e-09
( O 0 2.696329914897433e-08
WFS1 O 0 0.00021511547674890608
) O 0 1.276502653579925e-10
encoding O 0 1.0436933539637039e-09
a O 0 8.858797251320993e-09
putative O 0 4.483714022285312e-08
transmembrane O 0 2.5040725049052526e-09
protein O 0 3.7103349281863984e-09
were O 0 1.0946093337294016e-10
found O 0 1.044237959990646e-11
in O 0 8.147935451341404e-12
all O 0 1.096884649082197e-11
affected O 0 8.524029398992994e-11
individuals O 0 1.0616862423928897e-11
in O 0 1.3514739327646907e-10
six O 0 9.728701177991184e-10
WFS B-Disease 0 1.7864554138213862e-06
families O 0 2.584378266945464e-09
, O 0 1.1287765860901189e-10
and O 0 4.127474056980773e-11
these O 0 8.13079950590101e-11
mutations O 0 3.3897484819078727e-09
were O 0 1.2902841295403533e-10
associated O 0 5.755736998125371e-10
with O 0 1.3655326001893453e-11
the O 0 1.3609264826186518e-09
disease O 0 6.14476789451146e-08
phenotype O 0 7.364023701939004e-08
. O 0 2.501600881998911e-08

WFS1 O 0 0.002021992579102516
appears O 0 2.077898919594645e-08
to O 0 5.647746159631595e-11
function O 0 2.5830598077147826e-11
in O 0 1.7523220721682442e-11
survival O 0 1.8841382143364171e-07
of O 0 8.820557617639224e-09
islet O 0 1.725835474530868e-08
beta O 0 2.1133040206677833e-08
- O 0 1.6139477310161965e-08
cells O 0 4.415233956223119e-09
and O 0 1.015324713193877e-09
neurons O 0 5.297768623790944e-08
. O 0 1.764922652469636e-09
. O 0 1.0523974580678441e-08

Stable O 0 7.265732051564555e-07
interaction O 0 7.904736420982772e-09
between O 0 8.14368683599298e-10
the O 0 9.56008952557319e-11
products O 0 4.897536820536175e-10
of O 0 5.496417210260063e-10
the O 0 1.1825783685637248e-09
BRCA1 O 0 1.659738657622256e-08
and O 0 1.512722613838946e-09
BRCA2 O 0 1.2682671801655943e-08
tumor B-Disease 0 1.3252746455805209e-08
suppressor O 0 1.1572071656473781e-07
genes O 0 2.043394120576636e-09
in O 0 1.2366773161076594e-09
mitotic O 0 1.257927664255476e-07
and O 0 4.0217596364300334e-08
meiotic O 0 6.151180514279986e-06
cells O 0 2.709724640226341e-06
. O 0 3.074194694363541e-07

BRCA1 O 0 0.00010459393524797633
and O 0 4.550076653231372e-07
BRCA2 O 0 4.3116665437992197e-07
account O 0 3.665777403849546e-10
for O 0 4.011592707325873e-12
most O 0 1.2952223495121817e-11
cases O 0 4.8197109497882806e-11
of O 0 3.543775273229244e-10
familial O 0 9.632433517481331e-09
, O 0 3.296651840400955e-11
early O 0 1.3818729494019522e-09
onset O 0 7.089311111485586e-07
breast B-Disease 0 1.919958663165744e-07
and I-Disease 0 6.934914864586972e-08
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 5.236708636169318e-11
encode O 0 5.722336840485731e-11
products O 0 9.440465076338e-10
that O 0 1.616724462638608e-11
each O 0 3.9065917167846465e-11
interact O 0 4.876080095250757e-10
with O 0 9.180849969148142e-10
hRAD51 O 0 1.4893950037730974e-06
. O 0 1.9882139667970478e-07

Results O 0 6.324280121816628e-08
presented O 0 4.988177693121543e-08
here O 0 3.683848781577126e-09
show O 0 1.3346140859127331e-09
that O 0 7.625602926886188e-11
BRCA1 O 0 5.568087324547832e-09
and O 0 2.4096591388911293e-09
BRCA2 O 0 3.423942729341434e-08
coexist O 0 3.1993505622551766e-09
in O 0 7.418472086628825e-11
a O 0 4.014582000166911e-10
biochemical O 0 9.126177502594146e-08
complex O 0 1.3021576705796178e-08
and O 0 1.6934743607421865e-09
colocalize O 0 1.1958615004914463e-06
in O 0 1.2656011794121014e-09
subnuclear O 0 2.195221668443992e-06
foci O 0 1.4354070287936338e-07
in O 0 3.9820716168925685e-10
somatic O 0 1.6247827971938023e-08
cells O 0 5.456983753759914e-10
and O 0 1.763386311970372e-11
on O 0 1.5954076948432316e-10
the O 0 3.3769421287077606e-11
axial O 0 2.1363673052832155e-09
elements O 0 5.847759498855964e-10
of O 0 2.8151572184498264e-09
developing O 0 2.7588873408035397e-08
synaptonemal O 0 6.280027378124942e-07
complexes O 0 2.1341979561384505e-07
. O 0 2.298328070082789e-07

Like O 0 3.374803441147378e-07
BRCA1 O 0 2.07043581212929e-06
and O 0 1.6866130181369954e-07
RAD51 O 0 0.00015957423602230847
, O 0 6.014148112853945e-08
BRCA2 O 0 4.5971395934429893e-07
relocates O 0 2.2262992160904105e-07
to O 0 9.622077357107628e-09
PCNA O 0 1.776392991814646e-06
+ O 0 3.2170839325829093e-09
replication O 0 1.6926079982049202e-10
sites O 0 1.6638861122242332e-10
following O 0 1.631954987812989e-11
exposure O 0 2.9215105890045834e-09
of O 0 1.0234679770348976e-08
S O 0 1.2775225854966266e-07
phase O 0 1.0898044244811445e-08
cells O 0 1.1335760774500159e-08
to O 0 8.182990285376945e-09
hydroxyurea O 0 1.339536311206757e-06
or O 0 7.007326274788284e-08
UV O 0 5.94924931647256e-05
irradiation O 0 9.066629331755394e-07
. O 0 2.319063341360561e-08

Thus O 0 3.5432390177447814e-07
, O 0 3.421670768943841e-08
BRCA1 O 0 1.20246781420974e-07
and O 0 9.736316641806297e-09
BRCA2 O 0 2.7212379904995032e-08
participate O 0 5.261751589991093e-10
, O 0 8.326728889729296e-11
together O 0 1.0258899632575869e-11
, O 0 4.107852946688695e-12
in O 0 3.508014842154572e-12
a O 0 3.927555849991826e-11
pathway O 0 1.6611630959673107e-09
( O 0 6.526953977292749e-11
s O 0 6.497569149388482e-10
) O 0 7.4156106602552e-12
associated O 0 1.1034995833769656e-10
with O 0 3.759389067409247e-12
the O 0 1.950232059177992e-10
activation O 0 1.5905017303197155e-09
of O 0 1.1051810577811239e-09
double O 0 2.4139451548776947e-10
- O 0 5.812422987361288e-09
strand O 0 4.36120739522039e-09
break O 0 5.047263051949358e-09
repair O 0 2.572091375441232e-07
and O 0 1.950506174352995e-07
/ O 0 2.105080739056575e-06
or O 0 5.298041116930108e-08
homologous O 0 3.2200244692859314e-09
recombination O 0 3.0655149529934533e-09
. O 0 1.4888787980282814e-08

Dysfunction O 0 1.3905975720263086e-05
of O 0 9.80945173978398e-07
this O 0 1.6913825895414902e-09
pathway O 0 2.2006138067354186e-07
may O 0 4.1590075827713235e-10
be O 0 3.4887728123100814e-11
a O 0 2.0130065669921038e-10
general O 0 1.7581357480978e-09
phenomenon O 0 5.407171599358662e-09
in O 0 1.7576643265848624e-11
the O 0 8.182482469365482e-11
majority O 0 3.5885686783254656e-12
of O 0 2.2876787270087462e-11
cases O 0 4.018839774855287e-11
of O 0 3.3272931077021894e-09
hereditary B-Disease 1 0.9999655485153198
breast I-Disease 1 0.9999995231628418
and I-Disease 1 0.9922771453857422
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.221025391906494e-09
. O 0 2.2495949547618466e-09

A O 0 3.842680769139406e-07
novel O 0 6.696392773619664e-08
Arg362Ser O 0 5.412590553532937e-07
mutation O 0 1.3881231719636844e-09
in O 0 1.1097684576855116e-10
the O 0 1.054882847739691e-09
sterol O 0 1.667049218667671e-07
27 O 0 2.1101264735534642e-07
- O 0 1.9644206261659747e-08
hydroxylase O 0 4.384320817507614e-08
gene O 0 7.341259156135038e-09
( O 0 1.313234410105224e-08
CYP27 O 0 0.00026176098617725074
) O 0 4.612185980357175e-11
: O 0 4.835232474825757e-12
its O 0 1.9557367877953702e-11
effects O 0 1.2062638665710779e-09
on O 0 1.7470743740588546e-09
pre O 0 3.3702340918040363e-09
- O 0 8.429675846244322e-10
mRNA O 0 8.737567336325469e-10
splicing O 0 1.6604028152400474e-09
and O 0 8.736033563216949e-10
enzyme O 0 4.870923664412885e-09
activity O 0 5.654383983255684e-08
. O 0 2.2824782064390092e-08

A O 0 4.2389947907395253e-07
novel O 0 3.10013774651452e-08
C O 0 2.724707393042536e-08
to O 0 4.708592543645196e-11
A O 0 2.713084423788814e-09
mutation O 0 1.3098784557019627e-10
in O 0 3.102919310382646e-11
the O 0 9.665667155545066e-10
sterol O 0 7.491641440537933e-08
27 O 0 9.808024259427839e-08
- O 0 2.0222175933781728e-08
hydroxylase O 0 4.575122147798538e-08
gene O 0 6.963781551405646e-09
( O 0 6.0642175725433844e-09
CYP27 O 0 2.4222479623858817e-05
) O 0 6.406891683852223e-11
was O 0 5.781042311525653e-10
identified O 0 1.958461864903782e-11
by O 0 5.943967106708525e-12
sequencing O 0 9.192134275970432e-10
amplified O 0 1.2781534053374344e-08
CYP27 O 0 1.1972514357694308e-06
gene O 0 7.184475792065825e-10
products O 0 1.0442355424800098e-08
from O 0 5.013085502270087e-10
a O 0 1.3829269673859557e-10
patient O 0 7.145281588627483e-10
with O 0 1.8771732779310213e-10
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 5.0410026375402595e-08
CTX B-Disease 0 5.755793608841486e-05
) O 0 1.8895541131769278e-08
. O 0 1.4393411618129903e-07

The O 0 1.6879221576004966e-08
mutation O 0 2.2089523099566577e-08
changed O 0 7.367799703672517e-09
the O 0 1.4544990767362265e-09
adrenodoxin O 0 4.7789104229423174e-08
cofactor O 0 8.911094084851356e-09
binding O 0 1.585299180817401e-08
residue O 0 3.2996709364851995e-07
362Arg O 0 8.528270001306737e-08
to O 0 4.40569447590633e-09
362Ser O 0 2.920125098171411e-06
( O 0 6.888800641036141e-08
CGT O 0 0.00017869455041363835
362Arg O 0 1.2590693359015859e-06
to O 0 3.5745173931900354e-08
AGT O 0 1.1942491255467758e-05
362Ser O 0 9.175327164712144e-08
) O 0 1.0268398631385622e-10
, O 0 2.4916305130240346e-11
and O 0 1.1388275739099285e-11
was O 0 2.0458849891991093e-10
responsible O 0 3.142185470150771e-11
for O 0 9.314366639090466e-11
deficiency O 0 0.3540511131286621
in O 0 5.3129369348425826e-08
the O 0 1.5392872228403576e-05
sterol O 0 4.274240836821264e-06
27 O 0 1.402835437147587e-06
- O 0 2.585992717740737e-07
hydroxylase O 0 6.175299063215789e-07
activity O 0 1.415313732877621e-07
, O 0 5.045445831963757e-12
as O 0 3.108995916614732e-12
confirmed O 0 3.798042175900962e-12
by O 0 5.378801787650489e-13
expression O 0 6.283643050331023e-11
of O 0 1.9344870150206361e-10
mutant O 0 2.859171788216486e-10
cDNA O 0 2.229675777343232e-09
into O 0 1.1165211866170921e-08
COS O 0 7.259883659571642e-06
- O 0 1.018378270600806e-07
1 O 0 8.417714525421616e-08
cells O 0 3.680844429254648e-08
. O 0 4.563722555417371e-08

Quantitative O 0 2.1993628251948394e-08
analysis O 0 4.128249742052503e-09
showed O 0 8.836348319718468e-10
that O 0 3.315302459644398e-12
the O 0 9.545221557605288e-11
expression O 0 2.3144619554216206e-09
of O 0 1.6313535411427438e-08
CYP27 O 0 1.4928248219803208e-06
gene O 0 4.882222404134495e-10
mRNA O 0 1.5977930090116388e-09
in O 0 6.349835240948565e-11
the O 0 3.412633786670227e-10
patient O 0 1.797043402973486e-09
represented O 0 1.094215917873953e-08
52 O 0 7.075984171933669e-07
. O 0 2.6143578679693746e-07

5 O 0 1.8692546177589975e-07
% O 0 2.4735069548142974e-09
of O 0 1.1163012736403743e-09
the O 0 4.818410559437325e-09
normal O 0 4.66322347847381e-07
level O 0 5.485043175212923e-07
. O 0 6.252686546304176e-08

As O 0 6.678376185398349e-10
the O 0 2.5565491390544537e-10
mutation O 0 5.74937319974822e-10
occurred O 0 2.3685482464230745e-09
at O 0 4.839663739208966e-11
the O 0 1.3625587637344783e-11
penultimate O 0 4.0807593415514987e-10
nucleotide O 0 6.749473202560807e-10
of O 0 3.0826241559367418e-09
exon O 0 4.105008333255e-09
6 O 0 5.701438965388661e-08
( O 0 4.81361284165871e-10
- O 0 2.3803958804080594e-09
2 O 0 3.4280840388589695e-09
position O 0 6.989730128026395e-09
of O 0 5.691016546904848e-09
exon O 0 8.702145670724803e-09
6 O 0 3.2470771316184255e-07
- O 0 1.7085102399505558e-07
intron O 0 2.435446333493019e-07
6 O 0 1.9529520045580284e-07
splice O 0 1.246720273684332e-07
site O 0 5.067280994808243e-08
) O 0 3.3507776414642976e-11
of O 0 2.4134769738282102e-09
the O 0 5.089527466139998e-09
gene O 0 2.1576656017430196e-09
, O 0 4.093092975665513e-09
we O 0 2.632977724736918e-10
hypothesized O 0 1.1159627666401661e-09
that O 0 3.3852590869409838e-12
the O 0 1.2588138864622067e-10
mutation O 0 3.672432913326418e-10
may O 0 3.963680772489653e-10
partially O 0 1.0635362812649873e-08
affect O 0 4.40006786561753e-09
the O 0 4.687870092112689e-09
normal O 0 2.825841338705004e-09
splicing O 0 1.6054453322311701e-09
efficiency O 0 3.1039406600541497e-09
in O 0 3.8329556195648706e-10
exon O 0 8.10940470330479e-09
6 O 0 5.0561492770384575e-08
and O 0 4.3702064189687917e-10
cause O 0 1.5722596558020996e-09
alternative O 0 1.3084906491656056e-09
splicing O 0 1.6904214694690722e-09
elsewhere O 0 3.91293397683512e-09
, O 0 9.027375201531296e-12
which O 0 4.281948927375989e-12
resulted O 0 3.910604617907154e-10
in O 0 9.567970721269248e-11
decreased O 0 7.790457168255216e-09
transcript O 0 2.9219007213754367e-09
in O 0 1.2300663265740752e-10
the O 0 2.029237000655826e-09
patient O 0 1.2346888844660953e-08
. O 0 4.287907628963694e-08

Transfection O 0 1.188765418191906e-05
of O 0 7.081202397785091e-07
constructed O 0 6.914746109032421e-07
minigenes O 0 7.480176918761572e-06
, O 0 2.695612622005683e-10
with O 0 3.1344740171468377e-12
or O 0 2.1428660929023735e-11
without O 0 1.2628732781738705e-10
the O 0 5.296721949932248e-10
mutation O 0 8.929715994421272e-11
, O 0 9.660496361196813e-12
into O 0 1.11321185602975e-09
COS O 0 2.0251627574907616e-06
- O 0 2.110049557302318e-08
1 O 0 1.1123804988244501e-08
cells O 0 1.6652014211970823e-09
confirmed O 0 1.6526137402994578e-10
that O 0 1.016284062113626e-12
the O 0 1.8369151685848628e-11
mutant O 0 9.529164124444378e-10
minigene O 0 7.258709899815585e-08
was O 0 1.3769659856777139e-09
responsible O 0 3.200580078743798e-11
for O 0 1.831387819173358e-11
a O 0 3.2729460808234023e-10
mRNA O 0 1.3320760050561375e-09
species O 0 3.704829151796041e-11
alternatively O 0 5.684388071358626e-09
spliced O 0 2.9818943403370213e-07
at O 0 3.73169939393847e-08
an O 0 3.6949250326046013e-09
activated O 0 5.9353808978812594e-08
cryptic O 0 1.8574677085325675e-07
5 O 0 1.4182911733939818e-08
splice O 0 9.944821499630052e-08
site O 0 8.133913809160731e-08
88 O 0 2.6012632048377782e-08
bp O 0 3.3906666363492377e-09
upstream O 0 4.3795709281369e-09
from O 0 3.85745879682986e-10
the O 0 1.1231847674153528e-09
3 O 0 5.540374381496349e-09
end O 0 7.568735860274955e-09
of O 0 2.0948512258200935e-08
exon O 0 2.9053857986127696e-08
6 O 0 4.858284228248522e-07
. O 0 2.4784748120509903e-07

Our O 0 5.2501377467706334e-08
data O 0 1.1954923273549412e-08
suggest O 0 2.020924982915062e-09
that O 0 2.043294526632433e-11
the O 0 1.3973668055999866e-10
C O 0 6.168929811423141e-10
to O 0 3.610249469168658e-12
A O 0 4.6516523966033674e-10
mutation O 0 7.332324331033035e-11
at O 0 5.413161585643422e-11
the O 0 3.4925607544922244e-11
penultimate O 0 4.945749920715059e-10
nucleotide O 0 1.50838855295099e-10
of O 0 1.039539232472464e-09
exon O 0 1.197381194195657e-09
6 O 0 2.6673680153521673e-08
of O 0 1.1651800413403635e-08
the O 0 2.408575916490463e-08
CYP27 O 0 2.5124998046521796e-06
gene O 0 1.9844757781495304e-10
not O 0 5.135705402614654e-11
only O 0 1.134470434260848e-10
causes O 0 3.894045530472567e-09
the O 0 1.1824159429352221e-09
deficiency B-Disease 0 8.72784795546977e-08
in I-Disease 0 1.7355593628920474e-09
the I-Disease 0 8.375929638759771e-08
sterol I-Disease 0 8.05830836725363e-07
27 I-Disease 0 2.404998156180227e-07
- I-Disease 0 5.7941843323305875e-08
hydroxylase I-Disease 0 1.5289215582470206e-07
activity I-Disease 0 8.641628568284432e-08
, O 0 5.4740878496772893e-11
but O 0 1.0621080404060734e-10
also O 0 4.234860795371276e-10
partially O 0 4.091469829603511e-09
leads O 0 4.240535145250135e-10
to O 0 1.833510288040685e-10
alternative O 0 1.1706622338181205e-08
pre O 0 4.6900523464898924e-09
- O 0 5.231370336922225e-10
mRNA O 0 3.8774494726112607e-10
splicing O 0 1.2328809084749537e-09
of O 0 2.2723862791451666e-09
the O 0 1.653705616888601e-09
gene O 0 1.361103763031224e-08
. O 0 4.0692452785151545e-07

To O 0 1.0101405933937713e-08
our O 0 2.9105551746511082e-08
knowledge O 0 1.7459125700725053e-08
, O 0 1.4837821943336493e-11
this O 0 3.347287941615762e-12
is O 0 2.1828879849528082e-12
the O 0 8.486777253180477e-12
first O 0 4.1566260849945635e-11
report O 0 6.546354430758683e-11
regarding O 0 6.102527927431822e-10
effects O 0 2.357866790703156e-08
on O 0 1.9349132074353292e-08
pre O 0 4.939963105243805e-09
- O 0 1.675535821199503e-10
mRNA O 0 9.45303765820249e-11
splicing O 0 9.881447743387284e-11
of O 0 8.854682959080762e-11
a O 0 5.3727779170120726e-11
mutation O 0 1.7547109598670119e-10
at O 0 9.206750362089622e-10
the O 0 9.58986334786971e-10
- O 0 1.0564372709964687e-09
2 O 0 3.50406792470892e-09
position O 0 2.226553341699855e-08
of O 0 9.144852874953813e-09
a O 0 1.2694264306389869e-08
5 O 0 8.673234219713777e-08
splice O 0 1.0517914006413775e-06
site O 0 1.255407710232248e-06
. O 0 3.1559332569486287e-07

ATM O 0 0.0002163500466849655
germline O 0 2.5611707314965315e-05
mutations O 0 1.2965422513389058e-07
in O 0 1.5026175859134128e-09
classical O 0 0.17512398958206177
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 0.012043822556734085
in O 0 8.774705267944327e-11
the O 0 1.097902602165135e-10
Dutch O 0 6.778035910315339e-10
population O 0 3.922435293235438e-11
. O 0 5.968671668021841e-10

Germline O 0 1.104610419133678e-05
mutations O 0 1.4998671815646958e-07
in O 0 1.3643832730281247e-09
the O 0 1.1439840186255879e-09
ATM O 0 5.401989611186764e-08
gene O 0 1.1781201014748888e-10
are O 0 9.398176681330028e-13
responsible O 0 3.8073672903662925e-13
for O 0 1.5499141683625317e-12
the O 0 4.029135141081497e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999997615814209
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 4.4965497991711345e-09
. O 0 6.347492309544123e-09

In O 0 4.7619135301602e-08
our O 0 6.60210019987062e-08
study O 0 1.0679915840583476e-09
, O 0 2.7787451159499987e-11
we O 0 1.0528978730550698e-11
have O 0 2.941394090100191e-12
determined O 0 1.7991413914231202e-10
the O 0 4.18988427286493e-10
ATM O 0 4.990176094565868e-08
mutation O 0 8.303672749399027e-10
spectrum O 0 1.6345671483009028e-09
in O 0 1.1944790989648624e-10
19 O 0 7.771772558839984e-09
classical O 0 1.1353469744790345e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.6512320399897362e-08
, O 0 9.643816994975296e-12
including O 0 8.860265494382846e-13
some O 0 1.1543590736073917e-11
immigrant O 0 2.4426947131672705e-09
populations O 0 2.6797619678831097e-10
, O 0 1.1743862826651963e-11
as O 0 9.198303230206761e-11
well O 0 4.251011695433071e-11
as O 0 9.4790182647575e-11
12 O 0 4.922964258469165e-10
of O 0 6.587239642641407e-10
Dutch O 0 7.170898541630777e-09
ethnic O 0 3.5662619524146066e-09
origin O 0 6.772149419020934e-08
. O 0 2.2307537506094377e-07

Both O 0 2.4737851767042685e-09
the O 0 2.6761317606371904e-09
protein O 0 4.422533006476215e-09
truncation O 0 4.15778789175647e-09
test O 0 3.8373665356417064e-10
( O 0 9.542537426909803e-09
PTT O 0 7.30098975054716e-07
) O 0 1.0235763625576766e-10
and O 0 5.924129242718124e-11
the O 0 1.2139098060082176e-10
restriction O 0 1.2810889016279248e-09
endonuclease O 0 1.3067754878193227e-08
fingerprinting O 0 6.9569043859019075e-09
( O 0 1.0419118012805484e-08
REF O 0 2.2920066555798257e-07
) O 0 8.641830306910236e-11
method O 0 9.0579466149876e-10
were O 0 8.88437240442741e-11
used O 0 4.0607871232278825e-11
and O 0 6.287575321506367e-11
compared O 0 3.284346405951766e-10
for O 0 3.3395734094776586e-11
their O 0 6.749859560173377e-10
detection O 0 5.797641922100638e-09
efficiency O 0 3.3822051825893595e-09
, O 0 1.6231077246131598e-11
identifying O 0 1.911731661863314e-09
76 O 0 8.647049298815546e-09
% O 0 6.304640143284246e-11
and O 0 3.4447004710475015e-12
60 O 0 2.393689413349165e-10
% O 0 6.539889463308413e-11
of O 0 2.6702209887652373e-10
the O 0 1.1286350742878426e-09
mutations O 0 7.337228158377229e-09
, O 0 2.4170423440494915e-09
respectively O 0 3.8850856753924745e-08
. O 0 3.766502914004377e-07

Most O 0 6.023159926371591e-08
patients O 0 1.1103455044292332e-08
were O 0 1.0272538375488693e-09
found O 0 1.8095967779796496e-10
to O 0 1.0347613044192627e-10
be O 0 8.298353115776536e-10
compound O 0 2.3486346378831513e-07
heterozygote O 0 3.2626601750962436e-05
. O 0 2.634181726079987e-07

Seventeen O 0 2.15245017898269e-06
mutations O 0 2.1779067083116388e-07
were O 0 6.8239596195951435e-09
distinct O 0 9.692551650175574e-09
, O 0 1.63117144791336e-10
of O 0 1.5163768019021973e-09
which O 0 7.411329883133533e-11
10 O 0 6.58940069175884e-10
were O 0 2.6564847543930625e-10
not O 0 6.627403625891759e-10
reported O 0 3.9649396654795055e-08
previously O 0 3.476004906133312e-08
. O 0 7.689029501989353e-08

Mutations O 0 1.5147551266636583e-06
are O 0 3.625947542218455e-09
small O 0 5.575335304541795e-09
deletions O 0 3.9844468346927897e-07
or O 0 5.852295430486265e-07
point O 0 7.687279321544338e-06
mutations O 0 1.5178206069776934e-07
frequently O 0 6.166933186335655e-09
affecting O 0 1.9511642079805824e-08
splice O 0 1.7060466461771284e-06
sites O 0 1.4838941524430993e-06
. O 0 4.01232085778247e-07

Moreover O 0 2.571694039943395e-06
, O 0 7.856336914358053e-09
a O 0 2.8326907042242055e-08
16 O 0 8.198223326871812e-07
. O 0 4.121234837839438e-07

7 O 0 1.589937483004178e-06
- O 0 3.913772061991949e-08
kb O 0 7.910259824939203e-08
genomic O 0 1.982759290086733e-09
deletion O 0 2.7649005307495145e-10
of O 0 6.809731667445362e-10
the O 0 1.8107326749117192e-10
3 O 0 7.681282832017189e-10
end O 0 1.9403894047087533e-09
of O 0 3.742446352816842e-09
the O 0 1.1717652403930856e-09
gene O 0 2.2382562470113498e-10
, O 0 9.89230988790446e-11
most O 0 6.988843531674505e-11
likely O 0 2.222058231859947e-10
a O 0 2.647701849434192e-11
result O 0 3.26768140324063e-10
of O 0 5.490832233334686e-10
recombination O 0 5.120876639397309e-11
between O 0 1.9054120503625427e-09
two O 0 3.033651996275921e-09
LINE O 0 4.449629614100559e-06
elements O 0 3.3389655484938885e-09
, O 0 1.9394227890323634e-10
was O 0 4.676135478831611e-09
identified O 0 2.5922142654621894e-08
. O 0 1.445713309067287e-07

The O 0 2.344753937677524e-07
most O 0 1.6163351546083504e-08
frequently O 0 9.362783881528003e-10
found O 0 2.32864266064281e-11
mutation O 0 2.5535946621135786e-11
, O 0 2.8791654390486476e-12
identified O 0 5.6439988099787897e-11
in O 0 3.101339671185421e-11
three O 0 6.693318815864657e-11
unrelated O 0 4.122521435334647e-09
Turkish O 0 1.6038829642184282e-07
A B-Disease 1 1.0
- I-Disease 1 0.9999749660491943
T I-Disease 1 1.0
individuals O 0 2.8422848519227273e-09
, O 0 1.4870127351684914e-10
was O 0 3.953729288408425e-10
previously O 0 1.008778408029265e-10
described O 0 1.6129174384982292e-11
to O 0 8.04947688365365e-12
be O 0 3.111572111080818e-11
a O 0 3.6407341030830764e-10
Turkish O 0 2.155984759610874e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 8.721842459635809e-05
mutation O 0 1.3436698509394773e-07
. O 0 3.5290675270971406e-08

The O 0 3.7499578553479296e-08
presence O 0 7.076119601379105e-08
of O 0 5.129497253619775e-07
a O 0 2.6444656242574638e-08
founder O 0 3.7824707987965667e-07
mutation O 0 1.1260762322606865e-09
among O 0 5.547685921758472e-11
relatively O 0 7.909765203928387e-11
small O 0 1.582746954331693e-11
ethnic O 0 1.6834825200540138e-11
population O 0 3.121336739422831e-12
groups O 0 1.43672562995939e-13
in O 0 2.167396687471901e-12
Western O 0 2.8604699164880287e-10
Europe O 0 4.855085777855095e-11
could O 0 1.33622821141266e-10
indicate O 0 1.9590165045713093e-09
a O 0 5.357513321868623e-10
high O 0 2.6621669313442453e-09
carrier O 0 2.6789476886834862e-11
frequency O 0 3.1479457929251e-10
in O 0 3.009455185054577e-11
such O 0 5.016299597926377e-10
communities O 0 3.4880525134894924e-08
. O 0 3.9379665395244956e-07

In O 0 1.5677791009860442e-10
patients O 0 3.607403264993536e-10
of O 0 2.062026327465105e-09
Dutch O 0 1.612409228357592e-08
ethnic O 0 1.8326545836444552e-09
origin O 0 2.2198408444751294e-08
, O 0 1.5892000215789182e-10
however O 0 1.7901329307790093e-09
, O 0 2.00489472246268e-10
no O 0 2.6256621321607554e-09
significant O 0 1.171502503893862e-07
founder O 0 1.0056711516881478e-06
effect O 0 2.656782100984856e-07
could O 0 6.50702336457698e-09
be O 0 4.669451048044948e-09
identified O 0 1.2583139152866352e-07
. O 0 1.1391447429787149e-07

The O 0 1.587698861271747e-08
observed O 0 2.5577404638710277e-09
genetic O 0 2.787224895328677e-09
heterogeneity O 0 3.0953106744391334e-08
including O 0 1.9033797107881334e-11
the O 0 5.44597200669017e-10
relative O 0 3.29803526710748e-07
high O 0 2.424015690394299e-07
percentage O 0 2.0018673296817724e-07
of O 0 1.9401461770485184e-08
splice O 0 2.1082075818412704e-07
- O 0 4.198151870582478e-08
site O 0 5.7035165923480236e-08
mutations O 0 6.8681207388010534e-09
had O 0 1.4214318611038834e-09
no O 0 4.4970277501832356e-10
reflection O 0 2.0371015985176655e-09
on O 0 9.263539935133736e-10
the O 0 3.176027441043061e-09
phenotype O 0 2.907740110913437e-07
. O 0 1.3839157020356652e-07

All O 0 2.9611511020988246e-09
patients O 0 5.539315117708554e-10
manifested O 0 6.484795811445565e-09
classical O 0 3.0752261181987706e-08
A B-Disease 1 1.0
- I-Disease 1 0.9998902082443237
T I-Disease 1 1.0
and O 0 2.767972739903257e-09
increased O 0 1.0336378863939899e-08
cellular O 0 7.2265615713718034e-09
radioresistant O 0 2.5569418582449543e-08
DNA O 0 3.419072580612692e-09
synthesis O 0 3.9168188692428885e-08
. O 0 3.57577185639002e-08

Determination O 0 4.432329170356297e-09
of O 0 6.497448801212613e-09
the O 0 4.732878533530993e-10
genomic O 0 4.905972073032672e-09
structure O 0 6.555653797590821e-10
of O 0 3.877833887333537e-10
the O 0 4.863429658996665e-10
COL4A4 O 0 1.0624950164128677e-06
gene O 0 1.9268349416012853e-10
and O 0 3.616046698184938e-11
of O 0 1.440003671859813e-10
novel O 0 9.623614127818314e-10
mutations O 0 5.094595394439239e-07
causing O 0 7.293647854567098e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 4.719799107988365e-06

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 4.250608476308315e-10
a O 0 3.9830516662675564e-10
progressive O 0 0.054086003452539444
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 3.0605448841924954e-08
by O 0 7.628749298937976e-10
glomerular B-Disease 1 0.99997878074646
basement I-Disease 0 4.3746465962613e-05
membrane I-Disease 0 7.511801669579654e-08
abnormalities I-Disease 0 1.3480465099746652e-07
and O 0 4.0643512860816244e-11
associated O 0 6.931364926465733e-10
with O 0 2.1622035759061298e-11
mutations O 0 1.9392016881170093e-09
in O 0 4.088953481362623e-11
either O 0 2.0425044988670038e-10
the O 0 6.0154419223579225e-09
COL4A3 O 0 6.6028896981151775e-06
or O 0 2.865248038830259e-10
the O 0 1.7260387563666768e-09
COL4A4 O 0 2.9927801392659603e-07
gene O 0 3.2899830082477877e-10
, O 0 1.2212950095680242e-10
which O 0 2.398029171069016e-11
encode O 0 2.4463175929412273e-09
the O 0 4.311131718282013e-08
alpha3 O 0 4.285763679945376e-06
and O 0 1.516860592687408e-08
alpha4 O 0 2.3982056518434547e-06
type O 0 2.064609958551955e-07
IV O 0 6.952959665795788e-05
collagen O 0 4.231581442581955e-06
chains O 0 2.8455683604988735e-06
, O 0 2.827805190008803e-08
respectively O 0 8.711033672170743e-08
. O 0 2.084616426145658e-07

To O 0 6.876653912968322e-09
date O 0 8.823623431908345e-08
, O 0 1.702957358462598e-10
mutation O 0 1.6658476681419288e-11
screening O 0 3.839485587103786e-12
in O 0 2.925639591699891e-11
the O 0 9.533909217651626e-10
two O 0 3.344260424142931e-10
genes O 0 5.131598257435144e-09
has O 0 2.927589282109011e-10
been O 0 1.285300338382811e-10
hampered O 0 3.0337674594704822e-09
by O 0 1.456279888345513e-11
the O 0 1.7082220082897948e-09
lack O 0 8.115968341826374e-08
of O 0 1.631882717845201e-08
genomic O 0 5.346840126208008e-08
structure O 0 2.9090399422670998e-08
information O 0 4.425826460874305e-08
. O 0 1.9833962028315e-07

We O 0 4.766427696978326e-09
report O 0 1.4674118586910367e-09
here O 0 1.02578286143018e-10
the O 0 4.0980104726306976e-11
complete O 0 4.6848618734385283e-11
characterization O 0 3.208957766176468e-09
of O 0 5.487220122724068e-10
the O 0 4.962834587729503e-10
48 O 0 5.556799020922654e-09
exons O 0 1.873219446224539e-08
of O 0 5.27715471321244e-08
the O 0 1.7272192565087607e-07
COL4A4 O 0 0.00031813871464692056
gene O 0 4.894905814012418e-09
, O 0 5.010332704280529e-10
a O 0 1.7442267075118423e-10
comprehensive O 0 3.189745967357993e-10
gene O 0 7.848930533294052e-11
screen O 0 3.170592455248311e-09
, O 0 1.006842664796892e-10
and O 0 8.007717752778198e-12
the O 0 1.4043720179823804e-11
subsequent O 0 1.3252675866437524e-11
detection O 0 2.2011106826091975e-10
of O 0 1.2400212801022548e-10
10 O 0 1.1034911873153419e-10
novel O 0 4.3166872853994676e-11
mutations O 0 1.2795790815811614e-10
in O 0 1.2855375618181508e-11
eight O 0 3.619340382954306e-10
patients O 0 2.0481973894703742e-09
diagnosed O 0 7.055540152123285e-08
with O 0 7.071529140034727e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 5.008192829336622e-07

Furthermore O 0 1.4570231599009276e-07
, O 0 1.219028766819008e-09
we O 0 4.775279061064452e-10
identified O 0 1.0187154453333847e-09
a O 0 3.0811175832923254e-10
glycine O 0 3.6689254412358707e-10
to O 0 1.3251166830485772e-10
alanine O 0 2.4726531933083606e-09
substitution O 0 2.6529163310584636e-09
in O 0 2.1324253474119814e-10
the O 0 2.810318200374695e-09
collagenous O 0 4.1380317838957126e-07
domain O 0 2.329666903833072e-09
that O 0 2.976811852573036e-11
is O 0 4.717051055314059e-11
apparently O 0 2.5429431893542187e-09
silent O 0 4.4178768976443905e-10
in O 0 3.208856444447683e-11
the O 0 4.050732804738999e-10
heterozygous O 0 2.3108834290574976e-10
carriers O 0 3.4701985729412854e-10
, O 0 1.622275924706429e-10
in O 0 9.940773759709032e-10
11 O 0 1.7159155163426476e-07
. O 0 5.68508994547301e-07

5 O 0 1.590190805700331e-07
% O 0 2.039247437579661e-09
of O 0 5.185711304811491e-10
all O 0 1.8418199257408396e-11
control O 0 1.1558379947596009e-10
individuals O 0 4.894853966597168e-11
, O 0 1.545121669499494e-11
and O 0 4.4021179930464616e-12
in O 0 1.0841594115518216e-11
one O 0 2.274231150622974e-11
control O 0 3.5851908247730435e-11
individual O 0 2.4735657966346025e-11
homozygous O 0 1.4404925863242823e-10
for O 0 1.1440575570231815e-10
this O 0 1.3889381311749105e-10
glycine O 0 2.910481411433352e-09
substitution O 0 5.681496872966818e-08
. O 0 8.626873437833638e-08

There O 0 2.0703861736137696e-08
has O 0 3.805775972143266e-10
been O 0 4.204869091806174e-11
no O 0 1.5168699629697358e-11
previous O 0 1.500237017948436e-10
finding O 0 1.1309473357812294e-09
of O 0 4.208883241929584e-10
a O 0 1.865402138312433e-10
glycine O 0 3.10591719010489e-10
substitution O 0 1.457595710796511e-09
that O 0 4.795356473019652e-11
is O 0 1.2430658932749417e-11
not O 0 9.759170034595588e-12
associated O 0 3.684198501829883e-10
with O 0 2.308097289682731e-12
any O 0 9.964350455859972e-10
obvious O 0 6.123217133335856e-08
phenotype O 0 9.026441816217812e-09
in O 0 1.5979934042675836e-10
homozygous O 0 2.5683684068411594e-09
individuals O 0 9.997575212139509e-09
. O 0 2.164724435260723e-07

Founder O 0 2.165685873478651e-05
BRCA1 O 0 1.489075430072262e-06
and O 0 9.809292045304119e-09
BRCA2 O 0 8.79151684785029e-09
mutations O 0 1.853867337420212e-10
in O 0 3.2127144694582555e-11
French O 0 9.47575617971097e-09
Canadian O 0 1.6491600263179862e-06
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.2052183957252964e-09
. O 0 6.723304135647368e-09

We O 0 1.8523634182088244e-08
have O 0 3.562106443144586e-10
identified O 0 1.8252626077241985e-09
four O 0 6.987536937952399e-11
mutations O 0 6.53734566480324e-11
in O 0 9.889400062745857e-12
each O 0 4.882070789302695e-11
of O 0 1.6451240369974585e-08
the O 0 3.744866035049199e-06
breast B-Disease 0 0.0017958668759092689
cancer I-Disease 0 0.0007144557312130928
- O 0 1.8046287095785374e-06
susceptibility O 0 5.85340203542728e-05
genes O 0 7.363432814599946e-07
, O 0 3.405093318420427e-09
BRCA1 O 0 1.081589573459496e-08
and O 0 7.925309297718286e-10
BRCA2 O 0 1.7143060304647406e-09
, O 0 2.853219830539766e-12
in O 0 4.7711678358153264e-12
French O 0 5.427351457143459e-09
Canadian O 0 4.736802949878438e-08
breast B-Disease 0 1.6044708900153637e-05
cancer I-Disease 0 0.007275316398590803
and O 0 0.0007491239812225103
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.963298105842284e-10
from O 0 2.899050166593753e-10
Quebec O 0 1.3263367293347983e-08
. O 0 6.763033244538974e-09

To O 0 3.704311879459965e-08
identify O 0 8.854726729623508e-07
founder O 0 2.996744296979159e-05
effects O 0 0.00020730948017444462
, O 0 1.8014325586790392e-09
we O 0 1.5131430830539472e-10
examined O 0 5.578055795041337e-10
independently O 0 3.214309929333581e-10
ascertained O 0 1.0114597870369835e-07
French O 0 4.67169636308995e-09
Canadian O 0 1.9817385510378926e-09
cancer B-Disease 0 9.29444132768964e-10
families O 0 1.2887781987436231e-11
for O 0 9.572049099529356e-13
the O 0 1.2615943012495023e-11
distribution O 0 2.0731227845516287e-10
of O 0 1.70672947996664e-10
these O 0 3.8140382518925264e-10
eight O 0 3.862422826017564e-09
mutations O 0 1.319768472285432e-07
. O 0 2.1024733598551393e-07

Mutations O 0 5.034492573940952e-07
were O 0 1.163949470139869e-08
found O 0 9.303074283151247e-11
in O 0 3.1990667059833555e-11
41 O 0 6.998535084790092e-09
of O 0 1.3214423999485803e-09
97 O 0 4.558850363878264e-08
families O 0 3.7302885225187765e-09
. O 0 5.148423909417943e-08

Six O 0 5.7349328841382885e-08
of O 0 2.2813551936451404e-08
eight O 0 6.330806989751636e-09
mutations O 0 1.4441418727528799e-08
were O 0 3.4345761790177676e-09
observed O 0 4.714411527828588e-09
at O 0 1.5507120032509647e-09
least O 0 1.8552336333854669e-09
twice O 0 1.900346369154704e-08
. O 0 3.8399473822892105e-08

The O 0 6.42709039766487e-07
BRCA1 O 0 5.593493028754892e-07
C4446T O 0 6.99512042956485e-07
mutation O 0 7.2473773649051054e-09
was O 0 2.954714029002048e-09
the O 0 1.4696015238069293e-10
most O 0 3.0049011889854427e-11
common O 0 7.004644086983092e-11
mutation O 0 3.0567554043514633e-10
found O 0 9.320746258145718e-11
, O 0 3.0244626247899475e-11
followed O 0 9.034683418063238e-11
by O 0 3.9843111449000546e-11
the O 0 1.5172050282785676e-08
BRCA2 O 0 5.994204457238084e-07
8765delAG O 0 1.6601352115230839e-07
mutation O 0 1.8306851146121517e-08
. O 0 9.583781945821102e-08

Together O 0 4.9421903014490454e-08
, O 0 2.0515129595111148e-09
these O 0 4.281364984759506e-10
mutations O 0 5.65277380459861e-09
were O 0 5.220366361413653e-10
found O 0 2.7413737946346828e-11
in O 0 1.2838467268461162e-11
28 O 0 1.992130016503779e-09
of O 0 9.369143239013056e-10
41 O 0 7.086895514873959e-09
families O 0 2.394355824719696e-10
identified O 0 8.101670445626041e-10
to O 0 7.192811901646223e-10
have O 0 8.699253539745655e-10
a O 0 4.761938399155952e-09
mutation O 0 4.41707257436974e-08
. O 0 3.161379069638315e-08

The O 0 7.283295744286988e-09
odds O 0 6.776232197580612e-08
of O 0 8.20109188892637e-11
detection O 0 2.4463070458224934e-10
of O 0 5.0889015223987144e-11
any O 0 1.4433913786415786e-10
of O 0 1.1517501619096038e-08
the O 0 5.807547331926344e-09
four O 0 1.2146978978222478e-09
BRCA1 O 0 1.113675374142531e-08
mutations O 0 1.0572502873174017e-08
was O 0 2.1714146924978195e-08
18 O 0 1.0518239434986754e-07
. O 0 2.603641462428641e-07

7x O 0 0.0003238588687963784
greater O 0 5.719202249565569e-07
if O 0 4.603834469207868e-08
one O 0 2.3084090194913642e-09
or O 0 2.6801181066127278e-11
more O 0 2.0354594745808363e-12
cases O 0 1.0843708569963084e-10
of O 0 1.746139055569529e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 5.639331779327961e-10
also O 0 7.982236399639575e-12
present O 0 1.5323489005458768e-11
in O 0 2.5458329888650155e-11
the O 0 1.9652066640674093e-09
family O 0 1.790980874716297e-08
. O 0 3.39244081715151e-08

The O 0 2.7433184612846162e-08
odds O 0 9.367007436367203e-08
of O 0 8.122678224475877e-11
detection O 0 2.4646662488692073e-10
of O 0 6.118491824302907e-11
any O 0 1.6697199178850042e-10
of O 0 1.3033751855573428e-08
the O 0 1.0508690806432242e-08
four O 0 6.975745758808216e-09
BRCA2 O 0 8.387727490344332e-08
mutations O 0 1.7922793915658985e-08
was O 0 4.954337029516864e-08
5 O 0 1.0465748090382476e-07
. O 0 1.7634067717153812e-07

3x O 0 3.0006499400769826e-06
greater O 0 2.4194145353817476e-08
if O 0 6.137807595507638e-09
there O 0 5.580569784058298e-09
were O 0 1.685167672071941e-09
at O 0 2.675972221588552e-10
least O 0 2.768212915837953e-11
five O 0 1.4772476644719923e-11
cases O 0 1.1656078879873633e-10
of O 0 3.991952102211371e-09
breast B-Disease 0 2.0115660959163506e-07
cancer I-Disease 0 2.5739734610397136e-07
in O 0 1.1401348753992124e-09
the O 0 7.519427214219832e-08
family O 0 1.621099841031537e-07
. O 0 1.0479531908913486e-07

Interestingly O 0 7.002489041951776e-07
, O 0 5.139216274763214e-10
the O 0 4.204357972881212e-10
presence O 0 5.692829763148666e-09
of O 0 1.8990853334344138e-08
a O 0 3.724389685544338e-08
breast B-Disease 0 8.870163270557896e-08
cancer I-Disease 0 3.6580405371466895e-09
case O 0 2.6422042331830653e-10
< O 0 6.611167169268128e-10
36 O 0 1.8974624094170167e-09
years O 0 1.483460299045447e-10
of O 0 6.008306630000959e-10
age O 0 2.171372193160437e-09
was O 0 2.5621432753197837e-10
strongly O 0 9.657438043708666e-12
predictive O 0 2.825203959666567e-10
of O 0 9.630880815070242e-11
the O 0 8.472193085973245e-11
presence O 0 3.0963406838502294e-10
of O 0 1.9623513924926783e-10
any O 0 1.170795571603378e-09
of O 0 3.57192746491819e-08
the O 0 3.42773240902261e-08
eight O 0 1.994651555037308e-08
mutations O 0 1.4432391992613702e-07
screened O 0 1.9376801674297894e-07
. O 0 1.5787217932938802e-07

Carriers O 0 4.525985808356836e-09
of O 0 1.1214685180505057e-08
the O 0 4.938267572640598e-09
same O 0 1.4347432131245341e-09
mutation O 0 3.9509098770373896e-10
, O 0 8.331951448226071e-12
from O 0 1.2084110621868316e-11
different O 0 2.4148190391759528e-11
families O 0 4.739039161094638e-10
, O 0 1.5263283692501517e-11
shared O 0 3.6673001441167585e-11
similar O 0 5.6348883892276547e-11
haplotypes O 0 7.778416133419341e-09
, O 0 2.934307311019957e-11
indicating O 0 6.930651053060899e-10
that O 0 1.0290195778805966e-11
the O 0 2.453830749704622e-10
mutant O 0 1.4600469722125808e-09
alleles O 0 9.80330261413087e-10
were O 0 1.876293787006489e-09
likely O 0 9.954548296775556e-10
to O 0 1.9876122969719745e-10
be O 0 3.499430745179666e-10
identical O 0 9.805153355912921e-10
by O 0 7.54093176791315e-11
descent O 0 1.0342013911923686e-09
for O 0 2.7162659274604373e-11
a O 0 2.238512430974282e-10
mutation O 0 4.6238238238238694e-10
in O 0 2.0812684908833035e-10
the O 0 8.91769058597447e-09
founder O 0 5.717250246561889e-07
population O 0 8.629486458744395e-09
. O 0 7.525482459413979e-08

The O 0 2.9503594012325607e-10
identification O 0 1.4343246590442504e-09
of O 0 2.0935162492463633e-09
common O 0 2.3883012900682843e-08
BRCA1 O 0 2.267072659378755e-06
and O 0 3.7353743209678214e-07
BRCA2 O 0 5.494881065715163e-07
mutations O 0 9.549018464838355e-09
will O 0 1.289049283981214e-10
facilitate O 0 9.165960768164894e-10
carrier O 0 1.5163927405414945e-11
detection O 0 3.0369617931569337e-10
in O 0 3.6880071913047985e-11
French O 0 3.372331747186763e-08
Canadian O 0 4.644179512069968e-07
breast B-Disease 0 0.000621952407527715
cancer I-Disease 1 0.7323691844940186
and O 0 5.5182284995680675e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.61038859814289e-09
. O 0 3.924983449365982e-09

Are O 0 5.967866645306685e-09
Dp71 O 0 2.1813893908984028e-06
and O 0 2.4711490631545985e-09
Dp140 O 0 7.407489306388015e-07
brain O 0 2.2708283609063074e-07
dystrophin O 0 3.111930482191383e-07
isoforms O 0 6.952672659821246e-09
related O 0 1.1667651289570813e-09
to O 0 9.898878244873899e-11
cognitive B-Disease 0 4.364463563888421e-07
impairment I-Disease 0 4.027957857033471e-06
in O 0 7.880619712352654e-09
Duchenne B-Disease 1 0.9894383549690247
muscular I-Disease 1 0.9999990463256836
dystrophy I-Disease 1 1.0
? O 0 6.309241143753752e-05

Molecular O 0 3.25273333601217e-07
study O 0 2.2521149389831407e-09
and O 0 2.797064142801009e-11
neuropsychological O 0 1.6218963949654608e-09
analysis O 0 1.480848887958075e-09
were O 0 3.733361397806334e-10
performed O 0 3.590638203432306e-11
concurrently O 0 4.462422931172938e-10
on O 0 9.334783640513322e-11
49 O 0 5.595510166322981e-10
patients O 0 2.619510728121832e-12
with O 0 2.2547087460966786e-11
Duchenne B-Disease 0 3.6851684853900224e-05
muscular I-Disease 1 0.9996700286865234
dystrophy I-Disease 1 1.0
( O 0 1.737783748012589e-07
DMD B-Disease 1 1.0
) O 0 2.1116929385667227e-11
in O 0 5.3234959843107e-12
order O 0 1.1475887948253494e-11
to O 0 2.3006178559437096e-11
find O 0 3.0836339037776384e-10
a O 0 1.9213438132159588e-11
molecular O 0 6.265144514294718e-10
explanation O 0 7.788580891343599e-10
for O 0 4.9220509612535324e-11
the O 0 5.8807025915541544e-09
cognitive B-Disease 0 2.2803908450441668e-06
impairment I-Disease 0 1.00655972801178e-06
observed O 0 4.6996158076240135e-09
in O 0 1.2492608336689415e-10
most O 0 6.122619300441556e-09
DMD B-Disease 1 1.0
patients O 0 2.843571600408268e-08
. O 0 6.743688629740063e-08

Complete O 0 1.0899701141653395e-09
analysis O 0 2.0396364597274896e-09
of O 0 1.515307102017971e-09
the O 0 6.671221908227665e-10
dystrophin O 0 3.289421712793228e-08
gene O 0 7.61131246918012e-09
was O 0 4.731619895892436e-08
performed O 0 3.632670553255224e-12
to O 0 8.294451930845881e-12
define O 0 6.6269861820345e-10
the O 0 5.858230567312717e-10
localization O 0 8.024505859793862e-08
of O 0 9.678769785637087e-09
deletions O 0 2.9253873989887325e-08
and O 0 2.0070805017979865e-09
duplications O 0 4.6590535873747285e-08
in O 0 5.581972106760702e-10
relation O 0 1.908452951226991e-09
to O 0 2.2689118639451777e-10
the O 0 1.1215577355727646e-09
different O 0 3.448619168011646e-08
DMD B-Disease 1 1.0
promoters O 0 1.0436288903292734e-05
. O 0 8.842778242978966e-07

Qualitative O 0 3.605673271067644e-08
analysis O 0 5.596985985789615e-09
of O 0 1.0164064256912297e-08
the O 0 2.53915430903362e-08
Dp71 O 0 1.3911183032178087e-06
transcript O 0 3.032230466715191e-08
and O 0 3.2927747334321467e-11
testing O 0 5.1157394292955516e-12
for O 0 9.747859637532219e-12
the O 0 1.0993987664686955e-10
specific O 0 1.7663899509745562e-10
first O 0 4.2886882933856896e-10
exon O 0 6.811394781536251e-10
of O 0 1.9927389516283256e-08
Dp140 O 0 2.9347495456022443e-07
were O 0 1.035447372288445e-08
also O 0 1.9191517264260938e-09
carried O 0 6.603117608250386e-09
out O 0 3.5036402667998345e-09
. O 0 3.94846537687954e-08

Neuropsychological O 0 5.14996614242591e-08
analysis O 0 1.8305943427776583e-08
assessed O 0 4.063257108555263e-08
verbal O 0 4.048929369560028e-08
and O 0 3.1969105140916554e-09
visuospatial O 0 5.433585556602338e-06
intelligence O 0 6.120986739688306e-08
, O 0 2.553441458275074e-09
verbal O 0 3.405374116027815e-08
memory O 0 1.1580938917177264e-05
, O 0 5.9530984586331215e-09
and O 0 1.3423033795589845e-09
reading O 0 1.4496011147002719e-07
skills O 0 1.656274889683118e-06
. O 0 4.982838959222136e-07

Comparison O 0 1.2017127346553025e-06
of O 0 1.0291982732724136e-07
molecular O 0 1.6838968974752788e-07
and O 0 4.563989630668175e-09
psychometric O 0 4.2942465938722307e-07
findings O 0 5.6644118728854664e-08
demonstrated O 0 6.792975071334695e-09
that O 0 1.7896198412081787e-10
deletions O 0 1.7079946346143515e-08
and O 0 5.133592995143488e-10
duplications O 0 1.0791930016296192e-08
that O 0 6.035409672033865e-11
were O 0 9.744294954261434e-11
localized O 0 3.289294170372159e-09
in O 0 4.201021128191762e-11
the O 0 3.878854459848924e-10
distal O 0 3.065773768184954e-08
part O 0 8.748256008495048e-10
of O 0 2.525408504538973e-08
the O 0 3.232314327306085e-08
gene O 0 1.109430947110468e-08
seemed O 0 6.443421085577938e-08
to O 0 2.0081057650056522e-10
be O 0 2.0288221103115234e-10
preferentially O 0 2.4669344345085165e-09
associated O 0 4.714429291396982e-09
with O 0 1.2714630737153954e-10
cognitive B-Disease 0 7.180739885370713e-06
impairment I-Disease 0 3.128706885036081e-05
. O 0 3.066639635562751e-07

Two O 0 7.946476898723631e-08
altered O 0 3.3925451248251193e-07
Dp71 O 0 4.5442757254932076e-06
transcripts O 0 7.550326586169831e-08
and O 0 1.3636078932677265e-09
two O 0 9.288770308479855e-10
deleted O 0 4.497879402265426e-09
Dp140 O 0 1.2912258817721067e-08
DNA O 0 1.9170177945060374e-10
sequences O 0 5.85054574231414e-11
were O 0 8.067894963215139e-11
found O 0 1.0540754033505628e-11
in O 0 5.810064235278745e-12
four O 0 1.5662776631231168e-11
patients O 0 2.9907607640433653e-11
with O 0 4.5261971254317857e-11
severe O 0 2.883973138523288e-05
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 0.9975628852844238
. O 0 5.298981022860971e-07

These O 0 3.5335670389713414e-08
findings O 0 4.6363155092876696e-08
suggest O 0 4.9353481301750435e-09
that O 0 6.017750967673985e-12
some O 0 1.1163321135543303e-11
sequences O 0 2.1262712077141366e-11
located O 0 3.526870462344789e-10
in O 0 6.319384251995963e-12
the O 0 1.7312737354835406e-10
distal O 0 2.083272221398147e-08
part O 0 2.842381052747811e-10
of O 0 2.865998105505696e-09
the O 0 4.720457802420697e-09
gene O 0 9.715775961538498e-10
and O 0 1.0551067575192974e-08
, O 0 1.350092954099935e-10
in O 0 4.4607956217745937e-11
particular O 0 6.394174079105142e-10
, O 0 2.365182702468438e-11
some O 0 1.8521921496539306e-10
DMD B-Disease 1 1.0
isoforms O 0 5.269205960445333e-09
expressed O 0 8.238110194014325e-10
in O 0 2.910207907991236e-10
the O 0 4.983781387579711e-09
brain O 0 4.762186023299364e-08
may O 0 2.584751579437494e-10
be O 0 8.286466131324222e-12
related O 0 9.020632851797217e-11
to O 0 7.712092076062049e-11
the O 0 1.7480810132752822e-09
cognitive B-Disease 0 3.228368541385862e-07
impairment I-Disease 0 8.712596155646679e-08
associated O 0 2.0349977702949218e-08
with O 0 2.9312896554500867e-09
DMD B-Disease 1 1.0
. O 0 2.0512322507215686e-08
. O 0 6.427990939528172e-08

I1307K O 0 5.987873464619042e-06
APC O 0 4.4228056594874943e-07
and O 0 4.186387680960024e-09
hMLH1 O 0 1.7753180259205692e-07
mutations O 0 5.696196847537749e-09
in O 0 3.03494090969636e-10
a O 0 1.1796407184405666e-09
non O 0 8.4737408201363e-08
- O 0 1.259799908837067e-08
Jewish O 0 1.8816744784544426e-07
family O 0 5.63924518193204e-10
with O 0 1.3453623631809464e-11
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.8916161315682984e-07

We O 0 1.4033263440182964e-09
describe O 0 4.203347947484559e-10
a O 0 1.5208309611658422e-10
French O 0 4.820267296423708e-09
Canadian O 0 3.970752260329391e-08
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 3.738945153486384e-08
HNPCC B-Disease 0 0.0046258652582764626
) O 0 4.119993929352361e-11
kindred O 0 3.0776906356777545e-08
which O 0 1.0468878368363743e-12
carries O 0 5.735766375747353e-11
a O 0 4.733406375190263e-12
novel O 0 2.8295613074824644e-10
truncating O 0 1.310284591937716e-08
mutation O 0 2.3265493975799245e-09
in O 0 2.4963755507201313e-09
hMLH1 O 0 2.8329934593784856e-06
. O 0 4.3103875668748515e-07

Interestingly O 0 3.8705081806256203e-07
, O 0 1.6542481828807354e-09
the O 0 2.703698154249423e-09
I1307K O 0 2.1298995989127434e-07
APC O 0 1.1046378034507143e-08
polymorphism O 0 5.209437325959243e-09
, O 0 2.3328403098155093e-10
associated O 0 6.444189626364505e-10
with O 0 8.468247804371831e-12
an O 0 3.4023891343215595e-11
increased O 0 3.883310895069769e-10
risk O 0 9.327425054550531e-09
of O 0 3.3057165182981407e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.89031998387712e-10
is O 0 4.924508717474296e-12
also O 0 1.8333477097565165e-12
present O 0 4.8509642483485216e-12
in O 0 7.448043917723801e-12
this O 0 1.9827317565557223e-10
family O 0 1.510033698082225e-08
. O 0 5.2738943878694045e-08

The O 0 5.4320146603004105e-08
I1307K O 0 5.2948490036897056e-08
polymorphism O 0 6.967567856008827e-09
has O 0 4.281177357068344e-10
previously O 0 2.081260580544253e-10
only O 0 6.450322914686168e-11
been O 0 6.112030326299589e-11
identified O 0 1.6809678649032378e-10
in O 0 1.7225243800766954e-11
individuals O 0 7.681337510501152e-11
of O 0 5.258924851148095e-09
self O 0 4.628840599707473e-08
- O 0 1.0482489898322456e-07
reported O 0 7.666770329706196e-08
Ashkenazi O 0 4.9811585967063365e-09
Jewish O 0 1.3166628676231085e-08
origins O 0 7.299389892523322e-08
. O 0 2.0918088594612527e-08

In O 0 4.132961084479803e-09
addition O 0 7.61809459959295e-09
, O 0 1.2691951656318423e-10
in O 0 5.6025128980508043e-11
this O 0 1.9911412796336236e-10
family O 0 3.2118234738476303e-09
, O 0 3.292536035481852e-11
there O 0 2.1625375101752553e-11
appears O 0 1.576814651071956e-10
to O 0 1.2449594306851441e-11
be O 0 5.501249455974744e-11
no O 0 2.684816535758472e-10
relationship O 0 1.3676497434556012e-10
between O 0 3.1392999311208314e-10
the O 0 2.3650664759955475e-10
I1307K O 0 2.31154584362514e-09
polymorphism O 0 2.116924552320043e-10
and O 0 3.21216317433759e-11
the O 0 2.444870139672872e-10
presence O 0 2.1872714750514888e-09
or O 0 9.423056113178063e-09
absence O 0 1.963740714927553e-06
of O 0 8.038661292175675e-08
cancer B-Disease 0 4.5629217737541694e-08
. O 0 4.180171764289753e-09
. O 0 5.1370751208423826e-08

Identification O 0 1.2546246264122374e-09
of O 0 1.7190471268690999e-09
a O 0 5.134980288201696e-11
novel O 0 6.953448233870674e-11
mutation O 0 8.947395602199038e-11
of O 0 5.204617847809345e-10
the O 0 6.210276293217021e-09
CPO O 0 4.0563816128269536e-07
gene O 0 7.651598799007786e-10
in O 0 9.025697411679801e-10
a O 0 3.191938713342779e-09
Japanese O 0 1.4141183157789783e-07
hereditary B-Disease 0 0.23856553435325623
coproporphyria I-Disease 0 0.002546154661104083
family O 0 3.661889138584229e-07
. O 0 7.260869949732296e-08

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 9.388733815285377e-06
HCP B-Disease 1 1.0
) O 0 1.2166548879477546e-09
is O 0 3.7749112863361134e-11
an O 0 2.279599981003244e-10
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 3.4212302435499e-10
by O 0 7.276866284024186e-13
a O 0 1.155738768576775e-10
deficiency B-Disease 1 0.999789297580719
of I-Disease 0 0.10251392424106598
coproporphyrinogen I-Disease 0 4.2924108129227534e-05
oxidase I-Disease 0 1.4654380819933976e-08
( O 0 6.036909860895889e-10
CPO O 0 3.3775137353586615e-08
) O 0 5.163932649543401e-12
caused O 0 2.3238905591527192e-11
by O 0 2.2606586741469314e-12
a O 0 3.122243782960332e-11
mutation O 0 1.244179065329476e-10
in O 0 5.1148831697878094e-11
the O 0 4.160738864555924e-09
CPO O 0 7.163901045714738e-07
gene O 0 4.29142588131981e-08
. O 0 9.989208820115891e-07

Only O 0 4.666978270506661e-08
11 O 0 7.491740916520939e-08
mutations O 0 3.469474307848941e-08
of O 0 5.711757466997369e-08
the O 0 6.032170762892974e-09
gene O 0 5.09976993967598e-09
have O 0 1.582226238916462e-09
been O 0 6.340011848848803e-10
reported O 0 7.127791135097539e-10
in O 0 3.1598565430890346e-10
HCP B-Disease 0 0.004313045181334019
patients O 0 2.5147327775698614e-08
. O 0 2.334114128643705e-07

We O 0 1.8211844476923034e-08
report O 0 1.9427854880404993e-09
another O 0 1.7750834135910054e-10
mutation O 0 3.224121802869462e-10
in O 0 6.019705567350542e-11
a O 0 8.087743808005143e-10
Japanese O 0 7.27009989986982e-08
family O 0 4.5872855736206475e-08
. O 0 1.2857532283305773e-07

Polymerase O 0 6.175751821047015e-08
chain O 0 3.5482631943750675e-08
reaction O 0 4.331123903966727e-09
- O 0 1.109184966097132e-09
single O 0 2.0350722843009983e-11
strand O 0 2.7564528784496112e-11
conformational O 0 2.7457107767969724e-12
polymorphism O 0 7.0693338335980904e-12
and O 0 5.254725474190813e-12
direct O 0 1.9330557987640162e-10
sequence O 0 1.4086543043134725e-10
analyses O 0 2.848828950519078e-10
demonstrated O 0 8.055198730261282e-10
a O 0 1.2313626784887788e-09
C O 0 1.363176949098488e-08
to O 0 2.2652708875359195e-10
T O 0 1.046811526350666e-09
substitution O 0 5.326647109504812e-11
in O 0 4.3581488244626154e-12
exon O 0 1.7484994355165817e-11
1 O 0 1.7071070945728906e-10
of O 0 3.918929902813062e-10
the O 0 3.1608831108087543e-09
CPO O 0 5.665600255611025e-08
gene O 0 2.2563748092174762e-10
at O 0 3.5432634604148916e-09
nucleotide O 0 1.994114429137994e-09
position O 0 1.042555908270515e-08
85 O 0 8.316388466766966e-09
, O 0 1.5531406022395444e-11
which O 0 1.3855082879599134e-11
lies O 0 6.136212649110462e-10
in O 0 4.5783626889672746e-11
the O 0 2.1337811517696537e-09
putative O 0 2.729654795530223e-07
presequence O 0 1.4108557877534622e-07
for O 0 7.088892250983747e-10
targeting O 0 2.6618840465175708e-08
to O 0 2.4672978327089368e-08
mitochondria O 0 2.7119299375044648e-06
. O 0 5.553728783525003e-07

This O 0 2.026485923511956e-10
mutation O 0 3.3816230371463973e-10
changes O 0 6.077110342728176e-11
the O 0 1.9437332299254706e-10
codon O 0 6.172025113215795e-10
for O 0 3.393393552264534e-11
glutamine O 0 6.014636011464347e-10
to O 0 5.423827359463118e-11
a O 0 4.995313052091888e-10
termination O 0 6.470528290947186e-08
codon O 0 1.0042472098348298e-07
at O 0 9.808323397919594e-08
amino O 0 5.0456677058718924e-08
acid O 0 1.8423143899326533e-08
position O 0 4.0488131958227314e-08
29 O 0 3.302466495824774e-07
. O 0 1.7602948787498462e-07

MaeI O 0 1.7664680854068138e-05
restriction O 0 2.3663260151352006e-07
analysis O 0 2.5563469563394392e-08
showed O 0 6.381969175350832e-09
two O 0 4.840217809887193e-11
other O 0 3.03494521181058e-11
carriers O 0 6.511088196381465e-11
in O 0 9.149066226843416e-11
the O 0 4.520033236588006e-09
family O 0 7.394467615995381e-08
. O 0 1.9306007459363173e-07

The O 0 3.1492065772908973e-06
C O 0 0.42540526390075684
- O 0 1.3704794582736213e-05
T O 0 4.582030044275598e-07
mutation O 0 1.1156010559787433e-09
is O 0 4.009146833960919e-11
located O 0 2.751915639809255e-10
within O 0 2.5201981126987683e-11
a O 0 7.149886238622116e-11
recently O 0 5.7279278542488044e-11
proposed O 0 1.3583189260868433e-11
putative O 0 7.001161317354843e-10
alternative O 0 1.918455394545049e-10
translation O 0 2.0012728974005967e-10
initiation O 0 6.861436419036693e-11
codon O 0 1.0495950775180063e-08
( O 0 2.938230769800043e-09
TIC O 0 2.0871180339554485e-08
- O 0 4.898118355356473e-09
1 O 0 4.460621205737425e-09
) O 0 1.432278254331898e-11
, O 0 6.3508495337649684e-12
supporting O 0 1.388068826546629e-11
that O 0 1.649816221138689e-11
TIC O 0 4.191162972233542e-10
- O 0 7.213912106562859e-11
1 O 0 4.722220392494592e-10
is O 0 3.0414355062236e-11
the O 0 5.800492308694061e-10
real O 0 1.0229825164742579e-07
TIC O 0 4.380723783725671e-09
rather O 0 4.288344679359568e-10
than O 0 2.9631044839995013e-10
TIC O 0 3.856173158567344e-09
- O 0 1.248165792944178e-09
2 O 0 2.1784158921178687e-09
. O 0 4.715703938451554e-10
. O 0 5.084395127141761e-09

Human B-Disease 0 1.3612977411980864e-09
complement I-Disease 0 4.987397872469046e-08
factor I-Disease 0 8.68053064095875e-07
H I-Disease 1 1.0
deficiency I-Disease 0 0.029015768319368362
associated O 0 1.6588168136877357e-06
with O 0 6.329287884909718e-07
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999738931655884

This O 0 2.2305095548347253e-09
study O 0 3.56311202764914e-10
reports O 0 7.66281135766711e-11
on O 0 8.737458673246934e-12
six O 0 1.8401966148801074e-12
cases O 0 7.946311143813833e-12
of O 0 1.0278334433566627e-10
deficiency B-Disease 0 8.489077174544946e-08
in I-Disease 0 1.1033143842986703e-10
the I-Disease 0 3.9750372438085435e-10
human I-Disease 0 1.2572062835225495e-10
complement I-Disease 0 2.0065933636903566e-10
regulatory I-Disease 0 2.0641503784002424e-10
protein I-Disease 0 5.732141428183013e-09
Factor I-Disease 0 1.414038774960602e-09
H I-Disease 1 0.9999334812164307
( O 0 9.088093055886759e-10
FH O 0 6.045821976385923e-08
) O 0 2.3918612316459198e-12
in O 0 7.966231840850213e-13
the O 0 1.556395962630519e-12
context O 0 2.8816060648750863e-11
of O 0 6.2474769281506415e-12
an O 0 1.0554881968438679e-10
acute B-Disease 0 0.14753226935863495
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.166485162684694e-06

Five O 0 3.2039505271086455e-08
of O 0 3.172346607627219e-09
the O 0 9.115622146005364e-11
cases O 0 3.672900178441907e-11
were O 0 1.0920104230593974e-11
observed O 0 8.508203690194005e-12
in O 0 2.592870308650713e-13
children O 0 1.6173435203950537e-12
presenting O 0 2.7537533364707656e-10
with O 0 6.355460602236462e-10
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999997615814209
HUS B-Disease 1 1.0
) O 0 6.230068265722366e-07
. O 0 1.804945327421592e-06

Two O 0 9.674704370965514e-10
of O 0 1.4662761005368452e-09
the O 0 1.9616927526833194e-10
children O 0 5.602384875458277e-11
exhibited O 0 1.7750538816585504e-09
a O 0 3.2720973153210764e-10
homozygous O 0 3.3554126588342115e-08
deficiency O 0 2.30798877964844e-06
characterized O 0 1.8361770437458347e-10
by O 0 8.115024277555172e-12
the O 0 3.7065857050322393e-09
absence O 0 3.15789918658993e-07
of O 0 9.0112521888841e-09
the O 0 1.1488996420894182e-09
150 O 0 3.182150098979264e-10
- O 0 2.0424811841834867e-10
kD O 0 1.6340333253150874e-10
form O 0 6.944855714813292e-12
of O 0 1.2111484037902187e-10
Factor O 0 1.472714172834344e-09
H O 1 1.0
and O 0 2.1080612810919774e-09
the O 0 1.3377238872180897e-08
presence O 0 1.6092807086920402e-09
, O 0 3.374238041753408e-11
upon O 0 8.280628960299907e-10
immunoblotting O 0 8.040561993993833e-08
, O 0 7.714519995039026e-11
of O 0 2.5793946978325266e-09
the O 0 1.046592412734526e-08
42 O 0 3.78015485580363e-08
- O 0 8.628531666943218e-09
kD O 0 9.646186960310388e-09
Factor O 0 2.4711630519647088e-09
H O 0 0.00038798435707576573
- O 0 1.295614726615213e-08
like O 0 6.036126598552016e-10
protein O 0 1.3308119051202993e-08
1 O 0 9.831863323483958e-09
( O 0 3.053573782718644e-10
FHL O 0 2.7091334686701884e-07
- O 0 1.6093544275008753e-09
1 O 0 1.5186054636018298e-09
) O 0 5.990038326464386e-12
and O 0 1.2628799048175487e-11
other O 0 7.064619722552123e-11
FH O 0 1.7935446905426033e-08
- O 0 8.066837753339939e-10
related O 0 1.3811877197511535e-09
protein O 0 5.266706537554455e-08
( O 0 9.098117814687612e-10
FHR O 0 1.2018354937026743e-05
) O 0 5.53849077711277e-10
bands O 0 2.6123162299995784e-08
. O 0 2.8744413071990493e-08

Southern O 0 4.149662231611728e-07
blot O 0 1.9372846793430654e-07
and O 0 2.9602049977928147e-11
PCR O 0 3.947460136544123e-10
analysis O 0 1.8613425037394826e-11
of O 0 2.6604538017060975e-11
DNA O 0 1.0008955469986702e-10
of O 0 1.2930977122405096e-10
one O 0 2.4516588412182294e-11
patient O 0 1.2573932173243207e-10
with O 0 2.7770020658013372e-11
homozygous O 0 1.888501799385267e-08
deficiency O 0 1.497936068517447e-06
ruled O 0 7.176946592579725e-09
out O 0 2.102310270313268e-10
the O 0 1.0984178150375001e-10
presence O 0 1.55706267324085e-10
of O 0 5.4451387843101884e-11
a O 0 1.8830211695464172e-11
large O 0 1.5721922028144597e-11
deletion O 0 8.221498482008371e-11
of O 0 7.486177233673175e-10
the O 0 2.622043915323502e-09
FH O 0 6.717525735666641e-08
gene O 0 2.4711716006819984e-10
as O 0 1.0078230472387872e-09
the O 0 1.8143808677706375e-09
underlying O 0 4.9337604224319875e-08
defect O 0 1.60789479508594e-08
for O 0 1.4077041754489983e-09
the O 0 5.492471473189653e-07
deficiency O 0 0.0799737498164177
. O 0 2.336384341106168e-06

The O 0 1.116142200885406e-08
other O 0 5.451771811770811e-10
four O 0 1.6848904216271166e-10
children O 0 6.55775156399585e-11
presented O 0 2.506474749974785e-10
with O 0 2.8887269312716235e-11
heterozygous O 0 3.8328478169091795e-09
deficiency O 0 1.775058962039111e-07
and O 0 1.2020716366745177e-10
exhibited O 0 4.3586645404047886e-08
a O 0 4.3406742089580064e-10
normal O 0 8.873733037262355e-08
immunoblotting O 0 1.3377959362514957e-07
pattern O 0 8.983211507995748e-09
of O 0 5.64925717316811e-10
proteins O 0 2.139391719335748e-10
of O 0 1.1426711798989686e-09
the O 0 7.052806338947448e-09
FH O 0 4.538558641797863e-06
family O 0 1.053138873885473e-07
. O 0 1.7361470838750392e-07

Factor B-Disease 0 3.055801789741963e-05
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999409914016724
is O 0 3.774200396655658e-10
the O 0 4.2385456255900067e-10
only O 0 2.9518074651235793e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 8.208520796415542e-08
with O 0 1.3697546430435636e-09
HUS B-Disease 1 1.0
. O 0 1.128420308305067e-06

These O 0 2.2439950342345583e-08
observations O 0 2.03914026997154e-07
suggest O 0 1.5716300483248347e-09
a O 0 2.604686188956151e-10
role O 0 2.2245857933533841e-10
for O 0 2.625295258962268e-10
FH O 0 1.1995931572528207e-06
and O 0 3.593533248746894e-09
/ O 0 3.0712637766328044e-08
or O 0 2.045979607956383e-09
FH O 0 4.786244645060833e-08
receptors O 0 7.860019857197642e-10
in O 0 8.217324390380476e-12
the O 0 5.214173884326989e-11
pathogenesis O 0 3.228322498216585e-07
of O 0 4.683767595992094e-09
idiopathic O 0 6.678597128484398e-05
HUS B-Disease 1 1.0
. O 0 1.845300801051053e-07
. O 0 6.557685310326633e-07

Further O 0 4.183737356555639e-09
evidence O 0 1.4096439571176234e-09
for O 0 1.633910888532153e-11
a O 0 3.1606748468471224e-11
major O 0 1.291594053931533e-10
ancient O 0 2.5449082841078052e-09
mutation O 0 2.1803417737942254e-08
underlying O 0 1.128738968958487e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 8.152234443059569e-10
linkage O 0 2.935465026610018e-08
disequilibrium O 0 2.138427213083105e-08
studies O 0 5.620611961965061e-11
in O 0 1.678627289253276e-12
the O 0 4.739985834389948e-11
Japanese O 0 1.0523046878319064e-09
population O 0 1.7146843667159573e-10
. O 0 7.518506706105654e-09

The O 0 2.8545484198616577e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 7.219606459329952e-07
DM B-Disease 1 1.0
) O 0 9.114752702599205e-11
mutation O 0 1.187419190751271e-10
is O 0 4.913737819411956e-12
an O 0 5.1813785900689524e-11
unstable O 0 3.629727629572699e-08
( O 0 5.175832651360679e-09
CTG O 0 9.475003753323108e-05
) O 0 6.17996431806489e-10
n O 0 1.5088640337168613e-09
repeat O 0 1.1942519195784485e-09
, O 0 6.197443946920345e-11
present O 0 1.2191700426988916e-10
at O 0 7.339417962271e-11
a O 0 1.111691034366702e-12
copy O 0 3.024918163174739e-11
number O 0 1.828937348791193e-11
of O 0 1.832961282755008e-10
5 O 0 9.495834119022106e-10
- O 0 1.1860480375602833e-09
37 O 0 1.1377480291230313e-08
repeats O 0 7.29961924239575e-10
on O 0 1.3517659214201672e-09
normal O 0 2.926730857666371e-09
chromosomes O 0 2.243282504199584e-10
but O 0 1.571920094090018e-10
amplified O 0 4.658737839946525e-10
to O 0 1.4300133299727236e-10
50 O 0 2.0767132458132664e-09
- O 0 3.9938391482863267e-10
3000 O 0 2.3810758920106423e-10
copies O 0 2.2053012749267964e-09
on O 0 4.6583874535599534e-08
DM B-Disease 1 1.0
chromosomes O 0 5.646693352900911e-07
. O 0 2.64329145238662e-07

Previous O 0 1.637685365096786e-08
findings O 0 2.04701011696784e-09
in O 0 4.202351661097836e-11
Caucasian O 0 9.171801096385934e-10
populations O 0 1.0004317513301331e-10
of O 0 3.9392317185971137e-10
a O 0 8.78337136356322e-09
DM B-Disease 1 1.0
founder O 0 1.974461156351026e-05
chromosome O 0 8.250285787880784e-09
raise O 0 1.5407910503029143e-09
a O 0 7.372347177181382e-11
question O 0 2.838307089358949e-10
about O 0 1.938238285148497e-11
the O 0 7.513610567055906e-11
molecular O 0 4.158935973386235e-10
events O 0 5.916551970575057e-11
involved O 0 8.636392295757744e-11
in O 0 1.0996797916718037e-10
the O 0 1.3100064366611264e-09
expansion O 0 1.4601292264160293e-07
mutation O 0 1.0687811169418637e-07
. O 0 9.829504676872602e-08

To O 0 2.5838557959900754e-09
investigate O 0 1.93779325918797e-09
whether O 0 5.245018308563942e-10
a O 0 1.111794434294211e-09
founder O 0 8.53288639746097e-09
chromosome O 0 3.9775552296283934e-10
for O 0 2.2874736826938857e-11
the O 0 2.197068305065386e-09
DM B-Disease 1 1.0
mutation O 0 1.3606661630749528e-10
exists O 0 3.068460069366452e-11
in O 0 2.4248795246067933e-12
the O 0 1.801763946374102e-11
Japanese O 0 1.1977010494490514e-09
population O 0 9.308434578692015e-11
, O 0 4.717573207080328e-11
we O 0 9.02438901384528e-10
genotyped O 0 1.5496075889132044e-07
families O 0 2.601627802079065e-10
using O 0 1.5859499477577366e-11
polymorphic O 0 6.806355479227477e-10
markers O 0 3.1479128637101894e-08
near O 0 3.2955699680314865e-07
the O 0 1.2678191296799923e-07
( O 0 2.5623855037792964e-08
CTG O 0 8.484894351568073e-06
) O 0 8.974490595115014e-10
n O 0 3.6853038398731996e-09
repeat O 0 5.6940567816354815e-09
region O 0 3.6434474992574906e-08
and O 0 8.098491655061935e-09
constructed O 0 4.848984644922893e-07
haplotypes O 0 2.569320940892794e-06
. O 0 4.896827476841281e-07

Six O 0 1.3432875256569332e-08
different O 0 1.7038940258728985e-09
haplotypes O 0 8.709687904229213e-08
were O 0 6.14287565259275e-10
found O 0 1.1535298410914052e-10
and O 0 3.3727209913791967e-10
DM B-Disease 1 1.0
alleles O 0 4.2493137897281485e-09
were O 0 1.7479775404893871e-09
always O 0 6.745959901799381e-10
haplotype O 0 3.581573793098869e-08
A O 0 5.515982479664672e-07
. O 0 2.943932599919208e-07

To O 0 4.680362764020174e-10
find O 0 2.158825479492421e-10
an O 0 2.877682900997991e-12
origin O 0 6.512131806024613e-11
of O 0 1.357079171260267e-10
the O 0 3.230821388200411e-09
( O 0 3.5550287158514493e-09
CTG O 0 8.333799087267835e-06
) O 0 3.4270425386395686e-10
n O 0 1.2888237144181858e-09
repeat O 0 1.0403206074371951e-09
mutation O 0 1.9203261203415423e-10
and O 0 5.749773053509433e-12
to O 0 7.314916034006913e-12
investigate O 0 1.9398397818615187e-11
the O 0 5.1697694736230204e-11
mechanism O 0 4.4094250473136753e-10
of O 0 9.634629205557133e-11
the O 0 4.762687119685971e-11
expansion O 0 2.070088128691694e-10
mutation O 0 5.852875042261507e-12
in O 0 6.002046516045967e-12
the O 0 7.237686144856426e-11
Japanese O 0 1.0823795193459773e-09
population O 0 4.8767101468172314e-11
we O 0 1.6539918046287738e-10
have O 0 1.5592975521894203e-10
studied O 0 4.080621174296084e-09
90 O 0 1.8052057626505302e-09
Japanese O 0 2.4554719146863135e-08
DM B-Disease 1 1.0
families O 0 1.7170154187340358e-09
comprising O 0 2.4133006704119e-10
190 O 0 4.761863126034882e-10
affected O 0 3.388428149175837e-10
and O 0 1.1300864410923595e-10
130 O 0 4.715238866026539e-09
unaffected O 0 1.4877240062105557e-07
members O 0 1.76496972592588e-09
. O 0 4.3615671074803686e-08

The O 0 6.088373538659653e-07
results O 0 1.1493938245621393e-07
suggest O 0 3.2665131044495865e-08
that O 0 2.780484349707013e-11
a O 0 2.41746067608517e-10
few O 0 1.2851490982512814e-09
common O 0 5.383859469354491e-10
ancestral O 0 5.0981288524099e-08
mutations O 0 2.06038319738866e-09
in O 0 1.466731180954639e-10
both O 0 4.0587680438797236e-10
Caucasian O 0 9.907685782906128e-10
and O 0 5.496854707520704e-11
Japanese O 0 1.1295784307918666e-09
populations O 0 1.0222808710658171e-10
have O 0 6.617102265432662e-12
originated O 0 4.3319049736201265e-11
by O 0 7.278628654655561e-13
expansion O 0 8.840528309406182e-10
of O 0 1.8151137537447681e-10
an O 0 3.623844002653698e-10
ancestral O 0 2.352718553311206e-08
n O 0 1.953822215128298e-09
= O 0 4.9615307418093835e-09
5 O 0 6.042891964597175e-09
repeat O 0 1.176793440471613e-09
to O 0 3.0280329355036883e-09
n O 0 6.539946362238425e-09
= O 0 4.4433942747446054e-08
19 O 0 1.2201255117361143e-07
- O 0 9.302178582970555e-09
37 O 0 1.2774977520280117e-08
copies O 0 9.410932477749157e-09
. O 0 3.285784444528872e-08

These O 0 8.636875103995578e-10
data O 0 2.439085322603063e-10
support O 0 2.7188176709991296e-10
multistep O 0 9.772376330374755e-08
models O 0 7.63596261776911e-08
of O 0 1.6502569621934526e-07
triplet O 0 1.2858665741077857e-06
repeat O 0 3.309591534161882e-08
expansion O 0 6.763989972569107e-07
that O 0 6.032812027711998e-10
have O 0 1.5858782342892397e-10
been O 0 1.1048769538168912e-10
proposed O 0 6.39237829336281e-11
for O 0 1.1157472862288742e-10
both O 0 2.5032905526245486e-08
DM B-Disease 1 1.0
and O 0 1.7764305937362224e-07
Friedreichs B-Disease 0 1.6852118278620765e-05
ataxia I-Disease 1 0.842626690864563
. O 0 3.1645828357795835e-07
. O 0 5.795946549369546e-07

The O 0 3.1208118311809585e-09
molecular O 0 2.2111949604664005e-08
basis O 0 4.014800580875999e-08
of O 0 8.971537113211525e-08
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.8202100937614318e-10
the O 0 2.3611451682725715e-10
western O 0 1.6774200917168969e-09
Cape O 0 3.467315545790939e-09
, O 0 4.018732568944472e-11
South O 0 1.189489395869714e-09
Africa O 0 3.703094941798213e-09
. O 0 3.019291128225632e-08

Deficiency B-Disease 0 1.3079769587420742e-06
of I-Disease 0 6.174644795464701e-08
the I-Disease 0 5.838177941086542e-09
sixth I-Disease 0 6.052952983282012e-08
component I-Disease 0 5.032135419469341e-08
of I-Disease 0 8.301380916009293e-09
human I-Disease 0 4.80314188422426e-09
complement I-Disease 0 8.022437896215706e-07
( O 0 9.019712976510164e-09
C6 O 0 0.4527871608734131
) O 0 1.0574669612184451e-10
has O 0 5.805569913697184e-11
been O 0 1.976157605609874e-11
reported O 0 1.1687752328459755e-11
in O 0 3.7853260023007484e-13
a O 0 2.1108746261350175e-12
number O 0 5.1853109479804704e-12
of O 0 3.600349185450824e-11
families O 0 7.07018341442045e-12
from O 0 2.5751154680841992e-11
the O 0 1.7751579373115334e-10
western O 0 4.359111294149898e-09
Cape O 0 2.6438591316235716e-09
, O 0 1.0668244065925592e-10
South O 0 1.1546266165396446e-09
Africa O 0 2.4276458621130814e-09
. O 0 4.356661520432681e-08

Meningococcal B-Disease 0 2.7495123504195362e-05
disease I-Disease 0 4.0827765701578755e-07
is O 0 1.9555650501712485e-11
endemic O 0 3.725193764569923e-11
in O 0 4.552063587182076e-12
the O 0 1.535205018665664e-10
Cape O 0 4.1792372340587747e-10
and O 0 1.7749428229268949e-12
almost O 0 6.004783476010189e-12
all O 0 2.2849346113101854e-12
pedigrees O 0 6.8975669620385816e-09
of O 0 1.5621800519838303e-09
total O 0 1.963720563935567e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 3.356953186539613e-07
C6Q0 O 1 0.9979566335678101
) O 0 4.628588345934048e-10
have O 0 3.781937957247905e-11
been O 0 3.129714543081974e-11
ascertained O 0 2.5095914679695852e-08
because O 0 2.726248393702946e-10
of O 0 5.21895460181554e-09
recurrent O 0 6.66869755150401e-06
disease O 0 2.5968172394641442e-06
. O 0 1.643077212065691e-07

We O 0 2.3825170725189082e-09
have O 0 5.36787142513262e-11
sequenced O 0 2.600734627655754e-10
the O 0 1.1223576235064314e-10
expressed O 0 1.7268610152942898e-10
exons O 0 4.757254146170453e-09
of O 0 2.6446171474958646e-08
the O 0 3.758471933679175e-08
C6 O 0 3.478884309515706e-07
gene O 0 2.466086224117703e-10
from O 0 1.177067332491788e-09
selected O 0 7.123233947137209e-11
cases O 0 1.9256067226858242e-11
and O 0 9.18098149588209e-12
have O 0 6.826110423435727e-12
found O 0 8.878359158970284e-11
three O 0 6.21022330782317e-11
molecular O 0 5.434874950083213e-08
defects O 0 1.3237029179435922e-06
leading O 0 1.7306547306361608e-08
to O 0 1.6587062834361177e-09
total O 0 6.851728784340594e-08
deficiency O 0 5.932485146331601e-05
879delG O 0 4.912594704364892e-06
, O 0 1.390931675393503e-10
which O 0 2.4022958969305286e-11
is O 0 7.385431675943632e-12
the O 0 3.7395742752410754e-11
common O 0 7.279150199268614e-11
defect O 0 2.0002322020928887e-09
in O 0 1.1481761374998456e-10
the O 0 1.1313815662106208e-08
Cape O 0 5.7856034629821806e-08
and O 0 1.5174184131439006e-09
hitherto O 0 7.496099669879186e-07
unreported O 0 3.960707886108139e-07
, O 0 2.3072016519520844e-10
and O 0 7.712685490268711e-10
1195delC O 0 7.53167128664245e-08
and O 0 1.958848416805381e-09
1936delG O 0 1.411393952821527e-07
, O 0 3.389061531411386e-10
which O 0 1.9075130364143433e-10
have O 0 2.882635796730426e-10
been O 0 8.272657003871586e-10
previously O 0 4.791207985910262e-10
reported O 0 7.307949800861024e-10
in O 0 1.914905595201688e-10
African O 0 2.8474236302145073e-09
- O 0 1.2762508383445947e-08
Americans O 0 2.421767675286901e-09
. O 0 4.6594355040951996e-08

We O 0 3.039711771180009e-08
also O 0 1.6729213569988133e-09
show O 0 4.09871581119603e-10
that O 0 7.089385502256906e-12
the O 0 1.3668491338769684e-10
879delG O 0 7.33843421585334e-08
and O 0 1.775301017303832e-09
1195delC O 0 2.037735839621746e-06
defects O 0 1.8351887774770148e-05
are O 0 5.656967116962619e-10
associated O 0 3.476111132272308e-08
with O 0 3.2525977466946188e-09
characteristic O 1 0.999990701675415
C6 O 1 1.0
/ O 0 7.916815957287326e-05
C7 O 0 4.5343349484028295e-05
region O 0 5.511550682513189e-08
DNA O 0 7.861451933877106e-08
marker O 0 4.612817576798989e-07
haplotypes O 0 1.7100850868700945e-07
, O 0 1.063130139478119e-09
although O 0 1.0057875643454395e-09
small O 0 2.5878903464615632e-09
variations O 0 2.0256146981978418e-08
were O 0 1.3518671515555525e-08
observed O 0 1.3498669204636826e-07
. O 0 1.5730981317574333e-07

The O 0 9.146705792772991e-08
1936delG O 0 1.7909384268932627e-06
defect O 0 6.064498165869736e-07
was O 0 6.910421745942585e-08
observed O 0 2.1075545753035385e-09
only O 0 1.466652910231403e-10
once O 0 3.7052833024020515e-10
in O 0 5.079591955392537e-11
the O 0 3.9283016839419815e-09
Cape O 0 5.5045848768031647e-08
, O 0 1.640056424001557e-10
but O 0 2.5240670664672393e-10
its O 0 2.4007443255591454e-10
associated O 0 4.023384292395349e-09
haplotype O 0 4.5606768139805354e-08
could O 0 6.0914131516653924e-09
be O 0 1.2582294317553533e-08
deduced O 0 5.8921855270455126e-06
. O 0 2.5741920239852334e-07

The O 0 1.0546701290081728e-08
data O 0 2.884666505664768e-09
from O 0 8.236444859477388e-10
the O 0 8.429257847275551e-10
haplotypes O 0 2.5367773659468185e-08
indicate O 0 1.1857540505033626e-09
that O 0 4.0785608397542195e-12
these O 0 2.7260235735404592e-11
three O 0 3.9058319079021686e-11
molecular O 0 5.253010026962102e-09
defects O 0 2.4805855147747025e-08
account O 0 1.548881439772387e-10
for O 0 2.4353016825351403e-10
the O 0 1.8786801092574024e-07
defects O 0 0.005234023090451956
in O 0 1.8597048345725398e-09
all O 0 2.284850975087238e-09
the O 0 1.431177309996201e-08
38 O 0 3.445614282782117e-08
unrelated O 0 1.3202741122597672e-08
C6Q0 O 0 1.3887364502807031e-06
individuals O 0 2.9180730054534365e-10
we O 0 1.3985540503469451e-09
have O 0 3.8766356791342105e-10
studied O 0 2.3530852821807002e-09
from O 0 5.252085988338706e-10
the O 0 2.30362351416602e-09
Cape O 0 6.040059474798909e-08
. O 0 2.425014145046589e-08

We O 0 3.205350296298093e-08
have O 0 8.984201715911411e-10
also O 0 1.5451989687775836e-10
observed O 0 3.3514310771032285e-10
the O 0 2.809073529341788e-10
879delG O 0 4.4997609194297183e-08
defect O 0 3.035447804222713e-08
in O 0 1.251154735371074e-09
two O 0 1.9216544799860458e-08
Dutch O 1 0.9999934434890747
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 3.499275635476806e-06
, O 0 6.189505158404884e-11
but O 0 1.6706174638114746e-11
the O 0 1.2183354325401297e-10
879delG O 0 1.231034651993923e-08
defect O 0 3.615560961733877e-09
in O 0 4.840201572875458e-10
the O 0 1.428709452966359e-07
Cape O 0 5.972731287329225e-08
probably O 0 3.571121842682601e-09
did O 0 3.6070044173719396e-10
not O 0 1.8843909765919875e-10
come O 0 8.306714205374988e-10
from O 0 6.382042005981248e-09
The O 0 3.068042042642105e-09
Netherlands O 0 6.563038557061418e-09
. O 0 1.3483804295333357e-08
. O 0 2.045007931883447e-07

Complement B-Disease 0 0.006174171809107065
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 2.1473933742299778e-09
seven O 0 2.560854861499706e-09
further O 0 8.948974894451567e-09
molecular O 0 1.6503306596860057e-06
defects O 0 0.26491066813468933
and O 0 4.8882906611424914e-09
their O 0 3.744367038649443e-09
associated O 0 9.018879154609749e-07
marker O 0 8.388786227442324e-06
haplotypes O 0 1.0238790082439664e-06
. O 0 1.5644148732008034e-07

Seven O 0 2.7386709788856933e-08
further O 0 5.0213180280422876e-09
molecular O 0 2.647589880666601e-08
bases O 0 5.044330109171824e-08
of O 0 0.0020976171363145113
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 2.5616769150360597e-08
described O 0 5.397951952090807e-08
. O 0 4.337368153528587e-08

All O 0 2.6612634318468054e-09
these O 0 9.033309100736631e-10
new O 0 3.3405771482364344e-09
molecular O 0 2.7600137286754034e-08
defects O 0 5.375779466021413e-08
involve O 0 3.0681107654473294e-10
single O 0 1.6824755477706788e-10
- O 0 2.9953366453838726e-09
nucleotide O 0 7.657676270866887e-09
events O 0 4.508761808352801e-09
, O 0 1.984464537141406e-10
deletions O 0 1.4534978776126195e-09
and O 0 1.6895888854673302e-10
substitutions O 0 1.162234086748981e-09
, O 0 2.6992177590279276e-11
some O 0 2.089326628373911e-10
of O 0 2.651354513716342e-08
which O 0 1.237531521702806e-09
alter O 0 9.752321972200662e-08
splice O 0 2.0769407171883358e-07
sites O 0 5.3208776051860696e-08
, O 0 4.558011190702871e-10
and O 0 3.335793585801383e-10
others O 0 1.6635919308782832e-09
codons O 0 3.5842123224938405e-07
. O 0 2.450295824019122e-07

They O 0 7.025148907047196e-09
are O 0 8.779493798627414e-11
distributed O 0 5.300006544750602e-10
along O 0 2.0826276259100496e-09
the O 0 5.619406273638106e-09
C7 O 0 3.6900325994793093e-07
gene O 0 1.070982080797478e-09
, O 0 3.0303423659283624e-10
but O 0 6.074097474995099e-11
predominantly O 0 7.984524152959693e-11
towards O 0 7.525504108762959e-10
the O 0 4.000151043737077e-10
3 O 0 9.243018794791169e-09
end O 0 4.7279574033609606e-08
. O 0 1.7014406239468371e-07

All O 0 1.3116272512547766e-08
were O 0 2.413854449656583e-09
found O 0 1.6880910558292328e-10
in O 0 2.4620245078765812e-11
compound O 0 1.1591877457917121e-09
heterozygous O 0 4.823207944149033e-10
individuals O 0 7.343272656612498e-10
. O 0 5.643491007845114e-08

The O 0 6.176168426463846e-06
C6 O 1 0.9233943223953247
/ O 0 5.4870171879883856e-05
C7 O 0 3.098988236160949e-05
marker O 0 2.883601553094195e-07
haplotypes O 0 6.716449263421964e-08
associated O 0 6.946231145832371e-09
with O 0 3.839548401440851e-10
most O 0 4.1790622162807267e-07
C7 B-Disease 1 1.0
defects I-Disease 1 1.0
are O 0 6.032690436086341e-08
tabulated O 0 3.7305431987988413e-07
. O 0 5.2111296611201396e-08
. O 0 1.2826940576360357e-07

A O 0 5.754733138019219e-06
genome O 0 7.5089651829785e-08
- O 0 1.5548087262118315e-08
wide O 0 2.1989128295984983e-09
search O 0 1.9561181840987985e-10
for O 0 1.3959010163044905e-11
chromosomal O 0 4.3213816525167204e-07
loci O 0 2.7370373345547705e-07
linked O 0 7.852113412809558e-07
to O 0 1.3560292888570302e-09
mental O 0 1.972731297428254e-06
health O 0 1.9446920518362276e-08
wellness O 0 8.312601806892417e-08
in O 0 7.615429120644279e-11
relatives O 0 1.0156156804441707e-08
at O 0 3.5293283850990065e-09
high O 0 3.3219853534660615e-09
risk O 0 5.576704653620368e-10
for O 0 1.206030830758209e-10
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 8.330250125254679e-07
the O 0 2.775254586140363e-07
Old O 0 3.2968959118306884e-08
Order O 0 5.40685229921678e-09
Amish O 0 3.429790069731098e-07
. O 0 1.0477273093556505e-07

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 0.0007429689867421985
BPAD B-Disease 1 1.0
; O 0 1.9102528767689364e-06
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 2.6900653926631435e-10
is O 0 9.51738427651394e-12
characterized O 0 3.657058596923113e-12
by O 0 2.889914327806886e-13
episodes O 0 4.2325976057355774e-11
of O 0 2.2538801380811435e-10
mania B-Disease 0 3.575442830694442e-09
and O 0 5.652102674780224e-10
/ O 0 3.362729472655701e-08
or O 0 6.71467947910287e-09
hypomania B-Disease 0 1.3998671875015134e-06
interspersed O 0 6.5311205332818645e-09
with O 0 4.851324637150656e-12
periods O 0 9.238823928114925e-09
of O 0 2.1994663867985764e-09
depression B-Disease 0 1.1547995626415286e-07
. O 0 3.712389329280086e-08

Compelling O 0 1.3390045694450237e-07
evidence O 0 1.7910080529759398e-08
supports O 0 5.016012050162999e-10
a O 0 2.1193071603198277e-11
significant O 0 1.3155569689171642e-10
genetic O 0 5.450713658206041e-09
component O 0 1.3475140114849182e-08
in O 0 7.300855059400035e-11
the O 0 5.489041998707478e-10
susceptibility O 0 8.786073379951631e-08
to O 0 6.5689369499466466e-09
develop O 0 5.236250217421912e-06
BPAD B-Disease 1 1.0
. O 0 1.5704763427493162e-06

To O 0 3.409434512491316e-09
date O 0 1.1302776670163439e-07
, O 0 5.841717110044442e-10
however O 0 3.728202468966657e-10
, O 0 1.0907453412700718e-10
linkage O 0 2.7878220620891625e-08
studies O 0 4.948910725666167e-10
have O 0 4.187195729032922e-12
attempted O 0 3.797277770001273e-10
only O 0 4.363474165325343e-11
to O 0 9.223988933770855e-11
identify O 0 3.1710154502206933e-09
chromosomal O 0 1.1857612207677448e-06
loci O 0 2.091067585752171e-07
that O 0 7.408267332920104e-10
cause O 0 7.704396232099953e-09
or O 0 8.671897921974647e-11
increase O 0 6.684273273771524e-11
the O 0 6.817552078430822e-11
risk O 0 2.7623716647440233e-09
of O 0 4.812642728779792e-09
developing O 0 2.3744216832710663e-06
BPAD B-Disease 1 1.0
. O 0 1.1091939313701005e-06

To O 0 3.679930360434014e-09
determine O 0 9.839779657738745e-09
whether O 0 2.7613549224980716e-09
there O 0 1.4896932576391464e-09
could O 0 6.01576011227678e-10
be O 0 2.459392689502238e-10
protective O 0 4.506406359183757e-09
alleles O 0 2.5212392174012166e-09
that O 0 9.951391793938669e-11
prevent O 0 3.3658464904107177e-09
or O 0 1.3435892398661053e-09
reduce O 0 2.073728744278469e-09
the O 0 3.017975591657063e-10
risk O 0 3.957254524067366e-09
of O 0 2.9873372664468434e-09
developing O 0 3.235335952922469e-06
BPAD B-Disease 1 1.0
, O 0 8.264325335183287e-11
similar O 0 4.95522459870168e-12
to O 0 5.772092526168393e-11
what O 0 7.233394438976859e-11
is O 0 5.002631121853174e-12
observed O 0 2.1050217124951587e-11
in O 0 2.2821733652172993e-12
other O 0 1.2279478545096367e-09
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 2.6101867889316566e-10
we O 0 4.867825934007364e-11
used O 0 1.4634395084645035e-10
mental O 0 4.047709367682728e-08
health O 0 1.2459923759422509e-08
wellness O 0 1.620787628553444e-07
( O 0 1.2759088230396287e-10
absence O 0 8.42199820993983e-09
of O 0 4.3818418338226195e-10
any O 0 2.574150670398012e-09
psychiatric B-Disease 0 9.012619557324797e-07
disorder I-Disease 0 3.452087327104891e-08
) O 0 1.9630232769157763e-12
as O 0 8.504602404257877e-12
the O 0 5.5145596422612186e-11
phenotype O 0 3.550353344650148e-09
in O 0 7.995557688156296e-11
our O 0 3.739421217119343e-09
genome O 0 3.653759073074525e-09
- O 0 6.5317187214475325e-09
wide O 0 4.932772768029281e-08
linkage O 0 1.4921232605047408e-07
scan O 0 3.26349933743586e-08
of O 0 1.6105957456602482e-08
several O 0 7.602316998145398e-09
large O 0 2.3444275143447157e-07
multigeneration O 0 1.52470929606352e-05
Old O 0 1.285716564325412e-07
Order O 0 8.636797055316947e-09
Amish O 0 3.6258668956179463e-07
pedigrees O 0 4.808424591828953e-07
exhibiting O 0 8.587488764533191e-08
an O 0 5.270570646587203e-10
extremely O 0 1.5690003740687075e-09
high O 0 1.4743618770296507e-08
incidence O 0 1.0829894563357811e-05
of O 0 1.2081524801033083e-05
BPAD B-Disease 1 1.0
. O 0 8.359100320376456e-05

We O 0 6.629989002249204e-08
have O 0 5.961913740470948e-10
found O 0 1.1799146382163173e-10
strong O 0 4.575752277080625e-11
evidence O 0 1.282949024794533e-10
for O 0 4.440987508291805e-12
a O 0 1.7216909842243666e-10
locus O 0 1.5282437537678106e-09
on O 0 2.0740176243094766e-09
chromosome O 0 7.178126537610297e-08
4p O 0 2.211976061516907e-05
at O 0 6.685889530899658e-08
D4S2949 O 0 1.4622166588651453e-07
( O 0 1.1703106539417973e-10
maximum O 0 1.4194141861878506e-08
GENEHUNTER O 0 6.067487447580788e-06
- O 0 1.9273146634191107e-08
PLUS O 0 2.3225648959623868e-08
nonparametric O 0 5.6163234063433265e-08
linkage O 0 1.0246164805494118e-08
score O 0 4.66165550605524e-09
= O 0 4.613519344331962e-09
4 O 0 1.1154696721860091e-08
. O 0 8.715895227773274e-10
05 O 0 4.532908093324295e-08
, O 0 9.039014536860179e-10
P O 0 9.178284443578377e-08
= O 0 2.938892240678115e-09
5 O 0 4.798893282753625e-09
. O 0 5.120925558599332e-11
22 O 0 2.810107702089226e-10
x O 0 1.135003424579395e-09
10 O 0 8.001989293404677e-09
( O 0 2.8512209260256327e-10
- O 0 1.380592529187652e-09
4 O 0 1.9891379654524144e-09
) O 0 1.697162028968524e-11
; O 0 1.319882536598982e-10
SIBPAL O 0 2.6885146553468076e-07
Pempirical O 0 7.3635284536521795e-09
value O 0 5.448528295204369e-10
< O 0 5.125058710753194e-11
3 O 0 9.23719364886999e-11
x O 0 3.4602976040076783e-10
10 O 0 1.8717685179581167e-09
( O 0 7.822745229368877e-11
- O 0 3.497809264452201e-10
5 O 0 9.351824870051928e-10
) O 0 1.4443875782921278e-11
) O 0 3.5025658588760944e-12
and O 0 7.209066243268891e-12
suggestive O 0 1.4951379023742106e-10
evidence O 0 6.149543374522892e-11
for O 0 9.64234508210593e-12
a O 0 2.2731914961493516e-10
locus O 0 1.12199485258202e-08
on O 0 1.7128165552549035e-08
chromosome O 0 1.8875280147767626e-06
4q O 0 1.9286389942863025e-05
at O 0 3.527593861463174e-08
D4S397 O 0 1.002046801090728e-07
( O 0 2.841004376197276e-10
maximum O 0 1.8455219574775583e-08
GENEHUNTER O 0 3.0942419471102767e-06
- O 0 1.7951874653476807e-08
PLUS O 0 2.1349221057676004e-08
nonparametric O 0 2.253405106955597e-08
linkage O 0 3.51822548871894e-09
score O 0 4.50580461830441e-09
= O 0 1.6446997097574467e-09
3 O 0 4.005360487724374e-09
. O 0 4.757387817022618e-10
29 O 0 3.2607616162749764e-08
, O 0 1.512102332235088e-09
P O 0 1.3439954216210026e-07
= O 0 1.2630376744482419e-09
2 O 0 1.653778114452109e-09
. O 0 5.1695724090361495e-11
57 O 0 4.723824109653663e-10
x O 0 8.379597016272555e-10
10 O 0 3.451223307138207e-09
( O 0 2.1533230754045007e-10
- O 0 7.567837467803429e-10
3 O 0 1.5377787931925013e-09
) O 0 1.8033526061334015e-11
; O 0 1.0357841667696377e-10
SIBPAL O 0 2.768967704014358e-07
Pempirical O 0 7.668463197774145e-09
value O 0 5.067633535027483e-10
< O 0 7.746161351240843e-11
1 O 0 2.222727973899552e-10
x O 0 1.1608404237861691e-09
10 O 0 6.088532789050305e-09
( O 0 3.6298761219022424e-10
- O 0 1.9778112481105836e-09
3 O 0 3.1927425148126076e-09
) O 0 2.9482086910670446e-11
) O 0 4.959157650502588e-12
that O 0 6.916276579227443e-12
are O 0 2.041537598695964e-11
linked O 0 4.08566780407682e-09
to O 0 7.859720652092506e-10
mental O 0 0.004123579245060682
health O 0 1.095434527087491e-05
wellness O 0 0.00019951460126321763
. O 0 5.894169134990079e-07

These O 0 1.5972879907621973e-08
findings O 0 7.716852934436247e-09
are O 0 6.837110738677765e-11
consistent O 0 1.8298498272173447e-09
with O 0 3.0328719136801796e-12
the O 0 3.315070093434791e-11
hypothesis O 0 2.2699593593689116e-10
that O 0 2.2533865507053108e-13
certain O 0 4.4682806066287384e-11
alleles O 0 7.306918403671148e-10
could O 0 1.2335253929407486e-09
prevent O 0 4.0589482885877715e-09
or O 0 1.5858730995077508e-09
modify O 0 7.579932237433695e-09
the O 0 4.4033232615703355e-10
clinical O 0 1.2217521438984136e-09
manifestations O 0 9.409517787162258e-08
of O 0 5.427054006190701e-08
BPAD B-Disease 1 1.0
and O 0 8.83320916411634e-11
perhaps O 0 7.967592557944769e-11
other O 0 3.9903493703752346e-11
related O 0 2.9842237125876636e-08
affective B-Disease 0 0.24750350415706635
disorders I-Disease 0 1.0669013136066496e-05
. O 0 2.0602553263415757e-07

Segregation O 0 1.1227290315218852e-06
distortion O 0 1.9742633412533905e-06
in O 0 4.48078161241483e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 2.012684035435086e-06

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.0010661280248314142
DM B-Disease 1 1.0
) O 0 6.9790591084029074e-09
is O 0 1.4330059361356007e-10
an O 0 1.6656516443891434e-10
autosomal B-Disease 1 0.7300814986228943
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
which O 0 3.5857125602056783e-10
, O 0 3.977521003534212e-12
in O 0 1.0811568654234271e-11
the O 0 7.642818045106026e-10
typical O 0 2.5250518120856213e-08
pedigree O 0 1.8643047994260087e-08
, O 0 4.3569044205771235e-11
shows O 0 1.4207535148358374e-10
a O 0 1.6311528516776974e-10
three O 0 3.188201092019227e-10
generation O 0 2.394175702136181e-08
anticipation O 0 7.307998828309792e-08
cascade O 0 9.025048370858713e-07
. O 0 3.490629012503632e-07

This O 0 6.091174786782005e-11
results O 0 4.4811021560065e-10
in O 0 7.524410261527947e-11
infertility B-Disease 0 8.58655675983755e-06
and O 0 4.537706654872409e-09
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 6.055618229083848e-09
CDM B-Disease 0 7.979146232628409e-08
) O 0 3.818435910345197e-13
with O 0 8.680638944203595e-14
the O 0 3.4890319799973923e-11
disappearance O 0 1.1918904974095312e-08
of O 0 6.692217624504337e-08
DM B-Disease 1 1.0
in O 0 1.0324990640242504e-08
that O 0 8.758557212829032e-10
pedigree O 0 1.2161714266767376e-06
. O 0 1.8451565608756937e-07

The O 0 4.822732435627586e-09
concept O 0 1.01180281930624e-08
of O 0 3.451875008053662e-09
segregation O 0 3.6481690557366164e-08
distortion O 0 2.660265465692646e-07
, O 0 8.532260314941809e-11
where O 0 3.319644906185637e-11
there O 0 3.2425457718171513e-12
is O 0 6.393457269680825e-13
preferential O 0 2.8371271998395287e-10
transmission O 0 2.854474989710809e-10
of O 0 3.709729745615675e-11
the O 0 5.485982848552062e-11
larger O 0 9.263840805573409e-10
allele O 0 5.005425851578593e-09
at O 0 3.7025300603232836e-09
the O 0 1.0704250819060235e-08
DM B-Disease 1 1.0
locus O 0 6.635463734028235e-09
, O 0 2.1673327021964894e-10
has O 0 6.623949999617906e-11
been O 0 1.7818983788497889e-10
put O 0 2.8828457399043828e-09
forward O 0 3.3274467625687976e-08
to O 0 2.6392743546210795e-09
explain O 0 5.784588807955515e-08
partially O 0 4.393361408006058e-08
the O 0 4.008308129854754e-10
maintenance O 0 9.71631752832991e-09
of O 0 1.4609642384755261e-08
DM B-Disease 1 1.0
in O 0 1.5290337884721339e-09
the O 0 4.181918367152093e-09
population O 0 6.947645236898836e-10
. O 0 8.16253820090651e-09

In O 0 1.529736892713629e-09
a O 0 1.5393076813197126e-09
survey O 0 2.909543272977544e-09
of O 0 2.549212396729672e-09
DM B-Disease 1 1.0
in O 0 5.466351815641701e-09
Northern O 0 8.009062213432117e-08
Ireland O 0 2.458535597327227e-09
, O 0 2.5269584202902706e-09
59 O 0 7.71960912970826e-08
pedigrees O 0 5.007815389035386e-07
were O 0 4.671956688184764e-08
ascertained O 0 4.538320808933349e-06
. O 0 3.5221387406636495e-07

Sibships O 0 5.627513928629924e-06
where O 0 2.450660785413561e-09
the O 0 2.1192192445340652e-10
status O 0 5.019323845445456e-10
of O 0 5.979222672536366e-10
all O 0 4.909112352735612e-11
the O 0 7.669805346388614e-10
members O 0 4.7011349674219716e-11
had O 0 3.3270566857090955e-10
been O 0 5.530043090118397e-11
identified O 0 3.7900277360947143e-10
were O 0 6.514019879055866e-11
examined O 0 6.113732436974217e-11
to O 0 2.8750933925292266e-12
determine O 0 1.5011415721577492e-10
the O 0 1.676207089795767e-10
transmission O 0 4.767345629375086e-09
of O 0 1.040806885121981e-09
the O 0 9.289359503839023e-09
DM B-Disease 1 1.0
expansion O 0 5.665956948064377e-08
from O 0 7.60115304032638e-10
affected O 0 1.1844181191378311e-09
parents O 0 1.364184737395746e-10
to O 0 4.0181136196082434e-10
their O 0 7.341959928908182e-09
offspring O 0 4.853421842199168e-07
. O 0 9.346269536081309e-08

Where O 0 8.02552779788357e-09
the O 0 3.9744856294987585e-09
transmitting O 0 5.472811892559548e-08
parent O 0 1.2030406892904466e-08
was O 0 9.492470809391307e-09
male O 0 2.9922415656358226e-09
, O 0 1.1591766435614659e-09
58 O 0 6.162137822229852e-08
. O 0 5.993238261225997e-08

3 O 0 9.469598438727189e-08
% O 0 1.5447606527274615e-09
of O 0 7.822301695270539e-10
the O 0 4.151494148452173e-10
offspring O 0 1.5787685603285695e-09
were O 0 3.011598748159372e-10
affected O 0 5.878422748573087e-10
, O 0 9.82824845813246e-12
and O 0 4.604194196039524e-12
in O 0 8.952614691248861e-12
the O 0 5.334811412072149e-11
case O 0 5.860753549136177e-11
of O 0 2.2021015566586755e-10
a O 0 1.2458490905586928e-09
female O 0 1.3599904313821298e-08
transmitting O 0 2.3683874417201878e-07
parent O 0 2.757461459168553e-08
, O 0 2.5108637391468847e-09
68 O 0 1.3432470780117e-07
. O 0 1.5411541198773193e-07

7 O 0 4.578480002237484e-06
% O 0 4.634759775967723e-08
were O 0 2.717367220128608e-09
affected O 0 2.5707910467076545e-08
. O 0 6.19374134203099e-08

Studies O 0 3.4690902595002626e-08
on O 0 8.904026849165803e-09
meiotic O 0 1.539464733468776e-07
drive O 0 4.339610271131278e-08
in O 0 4.8451367362645215e-09
DM B-Disease 1 1.0
have O 0 1.936222016052369e-10
shown O 0 2.3450000621871858e-11
increased O 0 3.711329160660526e-11
transmission O 0 9.686479396364689e-11
of O 0 8.514243129975618e-12
the O 0 1.4869806774786554e-11
larger O 0 1.318066072952817e-10
allele O 0 4.999450298193153e-10
at O 0 1.2929157744423492e-09
the O 0 3.062020415001143e-09
DM B-Disease 1 1.0
locus O 0 2.514630725869438e-09
in O 0 9.176718829273511e-10
non O 0 1.217516455653822e-06
- O 0 1.3396166650636587e-05
DM O 1 1.0
heterozygotes O 0 5.775547720077157e-07
for O 0 1.5043275070070194e-08
CTGn O 0 1.7407974155503325e-05
. O 0 2.695585124001809e-07

This O 0 1.3952428545849216e-08
study O 0 1.6950577608199069e-09
provides O 0 2.782782893007152e-10
further O 0 1.5605532144302714e-10
evidence O 0 1.820353423553911e-09
that O 0 2.838946022709621e-10
the O 0 1.1558131518540904e-07
DM B-Disease 1 1.0
expansion O 0 4.261411504558055e-06
tends O 0 6.169064903360777e-08
to O 0 8.275055640716289e-10
be O 0 2.0004611300805664e-09
transmitted O 0 9.279584212151804e-09
preferentially O 0 3.347397026232102e-08
. O 0 2.3832683382352116e-08

Diagnosis O 0 4.335540870670229e-05
of O 0 8.424069164902903e-06
hemochromatosis B-Disease 1 1.0
. O 1 0.6007903814315796

If O 0 1.131586486735614e-06
untreated O 1 0.9999998807907104
, O 0 2.6076566683741476e-08
hemochromatosis B-Disease 1 1.0
can O 0 7.941386570564646e-08
cause O 1 0.9852132201194763
serious O 0 4.080552389496006e-05
illness O 1 0.9999979734420776
and O 0 5.143341655355904e-11
early B-Disease 0 3.609637033719082e-08
death I-Disease 0 2.4359357198022735e-08
, O 0 1.9848610602335448e-11
but O 0 6.954602171926894e-11
the O 0 3.3947028521552625e-10
disease O 0 1.169914476406575e-08
is O 0 3.4236502521878265e-11
still O 0 1.220852446914833e-10
substantially O 0 1.313281927650678e-08
under O 0 1.2673658034145774e-07
- O 0 1.1148771591251716e-05
diagnosed O 0 1.1334116152283968e-06
. O 0 1.340252850923207e-07

The O 0 1.282806465496833e-07
cornerstone O 0 4.2568904063955415e-06
of O 0 6.098016314126653e-09
screening O 0 1.440415564601949e-10
and O 0 8.927888810184026e-12
case O 0 2.446011795886882e-11
detection O 0 4.375778350773629e-10
is O 0 3.3611453464227337e-12
the O 0 2.2311413133691005e-11
measurement O 0 4.995220681536239e-09
of O 0 3.739292875337696e-09
serum O 0 4.984294754706298e-09
transferrin O 0 2.981168734095263e-08
saturation O 0 7.136922164363568e-09
and O 0 2.9191529749006406e-10
the O 0 1.3247869468102635e-08
serum O 0 2.741907110248576e-07
ferritin O 0 2.571237928350456e-06
level O 0 3.859707931042067e-07
. O 0 1.672348588499517e-07

Once O 0 1.1538373456687623e-07
the O 0 8.264018802606188e-09
diagnosis O 0 1.317645654808075e-07
is O 0 4.370640238615664e-10
suspected O 0 2.1214134449110134e-08
, O 0 3.6889377663662515e-10
physicians O 0 4.6059728253666776e-10
must O 0 5.898155852612774e-10
use O 0 1.7510149774579986e-08
serum O 0 7.224879936984507e-06
ferritin O 0 8.904401511244942e-06
levels O 0 1.1686392298315695e-07
and O 0 8.872899748268992e-09
hepatic O 0 0.00015339732635766268
iron O 0 1.0335006663808599e-05
stores O 0 7.803553216945147e-07
on O 0 2.8346905267540023e-08
liver O 0 2.8258966722205514e-08
biopsy O 0 1.7894501436188648e-09
specimens O 0 2.052208541991618e-10
to O 0 3.006024595908485e-11
assess O 0 1.0167354735912681e-09
patients O 0 3.922046368232124e-11
for O 0 3.3574178159856416e-11
the O 0 1.8118908595710081e-09
presence O 0 9.633245667828305e-08
of O 0 1.293154014092579e-06
iron B-Disease 0 9.47208609431982e-05
overload I-Disease 0 0.00014589636703021824
. O 0 1.7317645415459992e-06

Liver O 0 3.256993295508437e-05
biopsy O 0 2.9552415071520954e-05
is O 0 3.843829254890352e-09
also O 0 7.849469685350385e-11
used O 0 8.094803473357448e-12
to O 0 2.8875589419552483e-11
establish O 0 2.134159737821051e-09
the O 0 1.61896629435887e-09
presence O 0 6.127876428507761e-09
or O 0 4.8779242867169614e-09
absence O 0 7.185603863035794e-06
of O 0 1.0753880275160554e-07
cirrhosis B-Disease 0 7.607956376887159e-06
, O 0 4.9355321912747385e-11
which O 0 5.096416778177515e-12
can O 0 1.3959070011004826e-10
affect O 0 1.876424136071364e-07
prognosis O 0 1.857461938925553e-05
and O 0 1.1907110852860114e-08
management O 0 6.337042890436351e-08
. O 0 1.4464455944107613e-07

A O 0 5.196588972466998e-07
DNA O 0 1.6359651411335108e-08
- O 0 2.287789957478026e-09
based O 0 1.114464770468615e-10
test O 0 1.9401756676945547e-12
for O 0 1.328623669416551e-11
the O 0 1.772506252883943e-09
HFE O 0 4.838688028030447e-07
gene O 0 1.7232031357394817e-09
is O 0 2.408628574368521e-10
commercially O 0 3.9676137375543874e-10
available O 0 1.892177664553074e-10
, O 0 1.3007456223235181e-11
but O 0 1.9866941425306095e-11
its O 0 2.339076848878463e-11
place O 0 4.663823771622333e-10
in O 0 7.827009873562218e-12
the O 0 5.857915541529479e-11
diagnosis O 0 3.251482993960053e-08
of O 0 1.4649182311643472e-08
hemochromatosis B-Disease 1 1.0
is O 0 2.1401325156489293e-08
still O 0 7.3106862785721205e-09
being O 0 2.4882658156144544e-09
evaluated O 0 1.9509483806245953e-08
. O 0 7.76744784047878e-08

Currently O 0 1.6448142048375303e-07
, O 0 4.850275181489394e-10
the O 0 7.782566813219205e-10
most O 0 7.082982811379424e-11
useful O 0 6.247209416443411e-10
role O 0 2.6806550035285426e-11
for O 0 3.746254608610888e-12
this O 0 5.464133485955092e-12
test O 0 4.134910296105243e-12
is O 0 3.4545172711980543e-12
in O 0 1.778423003480356e-12
the O 0 9.45339292957037e-12
detection O 0 1.4809533599446922e-09
of O 0 1.8674144453001418e-09
hemochromatosis B-Disease 1 1.0
in O 0 4.482505921998836e-09
the O 0 9.819569157798469e-09
family O 0 1.3697546430435636e-09
members O 0 1.5184244486765586e-11
of O 0 1.8266720080983845e-10
patients O 0 6.258879265558237e-12
with O 0 1.2195013878932293e-12
a O 0 6.537768937331379e-11
proven O 0 4.01120869852889e-09
case O 0 4.843748180327623e-10
of O 0 4.003252396245216e-09
the O 0 1.6859079465803006e-08
disease O 0 2.183892462426229e-07
. O 0 8.066368195613904e-08

It O 0 3.328586295481273e-10
is O 0 2.1242119174758045e-11
crucial O 0 4.195513936267048e-10
to O 0 3.1196975558422935e-10
diagnose O 0 0.3450624942779541
hemochromatosis B-Disease 1 1.0
before O 1 0.9999997615814209
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 9.348476659454263e-09
because O 0 3.1472598832626986e-11
phlebotomy O 0 1.786558989635978e-08
therapy O 0 1.2555814721260106e-10
can O 0 8.384032183783585e-12
avert O 0 1.1035596436670403e-08
serious O 0 7.276162250491325e-08
chronic O 0 0.0012034577084705234
disease O 0 0.0005374919855967164
and O 0 9.164016073759385e-11
can O 0 7.845936400574516e-11
even O 0 9.233076525561046e-10
lead O 0 8.211754609632749e-10
to O 0 3.550243155014954e-10
normal O 0 1.7135223018271972e-08
life O 0 5.884929210608902e-10
expectancy O 0 7.186604200626334e-09
. O 0 6.585078593523974e-10
. O 0 2.765710327423676e-08

Prevalence O 0 6.28054237949982e-07
of O 0 3.4328342390921307e-09
the O 0 1.4915925161673727e-09
I1307K O 0 8.360893843928352e-08
APC B-Disease 0 9.833284186910873e-10
gene O 0 3.234492881865059e-11
variant O 0 5.386571189092138e-10
in O 0 5.6227671824116143e-11
Israeli O 0 1.493824730580684e-09
Jews O 0 3.517472146885581e-10
of O 0 3.6961267380064555e-11
differing O 0 4.742900516774284e-10
ethnic O 0 8.552137470418941e-11
origin O 0 1.1808384270395322e-09
and O 0 1.50318146818762e-10
risk O 0 1.2480901645517406e-08
for O 0 6.446838796136944e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.4122734266238695e-07

BACKGROUND O 0 8.723439532332122e-05
& O 0 1.140407107413921e-06
AIMS O 0 1.6502110611327225e-06
Israeli O 0 2.298753258855868e-07
Jews O 0 2.593435866060645e-08
of O 0 1.4587367758167602e-08
European O 0 1.0027386920796744e-08
birth O 0 6.27119902674167e-07
, O 0 7.539759927510659e-09
i O 0 1.4089780897563742e-08
. O 0 4.497552996696186e-09
e O 0 2.8652002992402004e-09
. O 0 1.2463197140988314e-09
, O 0 7.026056403347525e-10
Ashkenazim O 0 9.766226582996751e-08
, O 0 9.980380411001022e-11
have O 0 1.8020768904891682e-11
the O 0 6.003529895437509e-10
highest O 0 2.7821099024549767e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 1.495365324899467e-07
of O 0 5.300994712631457e-11
any O 0 3.6114583545909795e-10
Israeli O 0 1.9709928267275245e-07
ethnic O 0 1.9356477309884212e-08
group O 0 3.884379928820181e-09
. O 0 1.4611537757502902e-08

The O 0 2.8074435931557673e-07
I1307K O 0 6.960198106753523e-07
APC B-Disease 0 1.2856277820105788e-08
gene O 0 9.8005537019219e-10
variant O 0 1.4827149286134045e-08
was O 0 4.538823095145972e-09
found O 0 1.0577978076797834e-10
in O 0 2.8559235532021887e-10
6 O 0 9.558407043641637e-08
. O 0 1.2504747815000883e-07

1 O 0 9.458442917775756e-08
% O 0 7.049493766508874e-10
of O 0 1.1631981489124144e-10
American O 0 9.882730050980726e-11
Jews O 0 4.949637921747296e-10
, O 0 1.0158930988102277e-11
28 O 0 3.3430502810460894e-09
% O 0 1.179528252848172e-09
of O 0 2.674983345940518e-09
their O 0 7.465276212315075e-06
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 2.868329218586041e-08
, O 0 9.008145791800093e-12
but O 0 1.0933443386762498e-11
not O 0 1.5467285438552913e-11
in O 0 2.5433977146605e-10
non O 0 9.627181718485645e-09
- O 0 5.0582107391505815e-09
Jews O 0 1.936966320670308e-08
. O 0 2.927006015340794e-08

We O 0 4.3081951339729585e-09
assessed O 0 1.9815352914065443e-08
the O 0 8.783417326796439e-10
I1307K O 0 5.2693895469246854e-08
prevalence O 0 2.400768472909931e-09
in O 0 8.760670140717242e-12
Israeli O 0 1.3559569023158247e-09
Jews O 0 3.490258637661725e-10
of O 0 2.293450152013321e-11
differing O 0 2.711458835236158e-10
ethnic O 0 5.0843412813250666e-11
origin O 0 6.790277229384856e-10
and O 0 9.664924416341591e-11
risk O 0 4.174721901506473e-09
for O 0 2.8526054407507218e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.979900048354466e-07

METHODS O 0 1.7450743428071291e-07
DNA O 0 5.712604167484869e-09
samples O 0 2.1375928804800992e-10
from O 0 1.1943288025229037e-10
500 O 0 4.5213822269518644e-11
unrelated O 0 2.852363067962216e-10
Jews O 0 1.9596732570015263e-10
of O 0 1.8373647048264274e-10
European O 0 1.4656685587421947e-10
or O 0 1.971061647232375e-10
non O 0 9.132960498980935e-10
- O 0 2.526189847584792e-11
European O 0 1.4445859439216058e-11
origin O 0 3.7399611185762183e-10
, O 0 6.449580886719319e-12
with O 0 7.833039230263628e-13
or O 0 7.571539749340328e-12
without O 0 2.3513600788671596e-11
a O 0 3.570396409080523e-11
personal O 0 3.2369504299190055e-10
and O 0 5.35607225238266e-10
/ O 0 3.256347191893383e-09
or O 0 9.902036968156835e-10
family O 0 1.408039906891645e-09
history O 0 1.882444866652122e-09
of O 0 8.66968663526535e-10
neoplasia B-Disease 0 1.0275796213932153e-08
, O 0 2.231742568525874e-10
were O 0 1.389921233663216e-10
examined O 0 4.433172162698895e-10
for O 0 7.674644947330833e-11
the O 0 1.4818151150564063e-09
I1307K O 0 8.406527030047073e-09
variant O 0 3.222166977678853e-10
by O 0 2.8449992361956333e-11
the O 0 7.573772164981563e-10
allele O 0 1.2692684681070432e-09
- O 0 1.6131529445573278e-09
specific O 0 2.1410051509462846e-09
oligonucleotide O 0 2.857463528016524e-07
( O 0 2.780652685885343e-08
ASO O 0 2.439103354845429e-06
) O 0 2.348783945116395e-10
method O 0 1.8992954764485148e-08
. O 0 3.8766618359886706e-08

RESULTS O 0 4.727289990569261e-07
In O 0 6.68418764782075e-10
persons O 0 4.39444036715031e-09
at O 0 3.148944216491145e-09
average O 0 2.9278699464896363e-09
risk O 0 6.414280773192615e-10
for O 0 1.5735376335257456e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 5.100972977345464e-10
I1307K O 0 1.8449236804940483e-08
was O 0 1.6415467873898137e-09
found O 0 6.70825894832916e-11
in O 0 1.7730295009954489e-10
5 O 0 2.346614635939659e-08
. O 0 7.551954439577457e-08

0 O 0 5.594000640485319e-08
% O 0 1.6933968671750677e-09
of O 0 4.386591367921966e-10
120 O 0 2.2515909137155177e-09
European O 0 6.76659117626599e-10
and O 0 2.135862153807011e-09
1 O 0 1.229453516771173e-07
. O 0 9.568896075506927e-08

6 O 0 2.1590844880847726e-06
% O 0 6.650364259286334e-09
of O 0 2.4023303346609737e-09
188 O 0 3.9020155995217465e-09
non O 0 1.0911897163623507e-08
- O 0 1.3062863013502124e-09
European O 0 1.317305264869617e-09
Jews O 0 7.112787692165057e-09
( O 0 6.325516777039297e-10
P O 0 8.620113334245616e-08
= O 0 2.026197210014402e-09
0 O 0 2.6131119490457877e-09
. O 0 3.747158694444863e-10
08 O 0 5.75365399768657e-09
) O 0 4.687099042222087e-10
. O 0 7.009783420386384e-09

It O 0 6.2978555703807615e-09
occurred O 0 1.4638044376624748e-07
in O 0 1.524153803167394e-09
15 O 0 6.261350904424035e-08
. O 0 5.8892027254842105e-08

4 O 0 1.804890388257263e-07
% O 0 8.912279803041656e-10
of O 0 4.266699771271476e-10
52 O 0 6.556332365903472e-09
Ashkenazi O 0 7.1387193933958315e-09
Israelis O 0 7.914120914165323e-09
with O 0 2.3441160124093585e-10
familial O 0 7.282062028934888e-07
cancer B-Disease 0 0.009588554501533508
( O 0 6.3457248344889194e-09
P O 0 7.486235972464783e-06
= O 0 1.1297147217703696e-08
0 O 0 4.836438805000398e-09
. O 0 2.3776630664329446e-10
02 O 0 1.1718120918047248e-09
) O 0 2.614399582240301e-12
and O 0 8.088568877184787e-12
was O 0 2.0191900929056317e-10
not O 0 1.230276904656824e-11
detected O 0 4.898396133157235e-10
in O 0 1.279740063919732e-10
51 O 0 2.21655778176455e-08
non O 0 6.661004903207868e-08
- O 0 9.330948458341481e-09
European O 0 9.715947157928895e-09
Jews O 0 5.197787800170772e-08
at O 0 1.0896215485445282e-08
increased O 0 1.5566634203878493e-08
cancer B-Disease 0 5.976708195021274e-08
risk O 0 2.5339195630635913e-08
. O 0 2.7756611231666284e-08

Colorectal B-Disease 0 0.0003151041455566883
neoplasia I-Disease 0 9.060605225386098e-05
occurred O 0 8.614698344899807e-06
personally O 0 2.410652122364354e-09
or O 0 3.5327057251732796e-11
in O 0 7.871324252117784e-12
the O 0 7.325052023277046e-12
families O 0 1.3831715287015989e-11
of O 0 3.883960861261748e-11
13 O 0 1.254282455676048e-09
of O 0 5.9313403966143596e-08
20 O 0 2.4008846821743646e-07
Ashkenazi O 0 1.73408114534368e-08
I1307K O 0 1.2855394970756606e-08
carriers O 0 1.747456623846233e-10
, O 0 1.7396606724617847e-11
8 O 0 8.234198878298571e-10
of O 0 9.854768556749605e-09
whom O 0 1.4133713932551473e-07
also O 0 3.089335720574127e-08
had O 0 5.671089819969666e-09
a O 0 1.0882044154669757e-09
personal O 0 2.4064268799861566e-08
or O 0 5.284786830372923e-09
family O 0 6.233132676669584e-09
history O 0 2.5165368455759562e-08
of O 0 2.998093151518333e-08
noncolonic O 0 6.893511908856453e-06
neoplasia B-Disease 0 3.235006079194136e-05
. O 0 1.4808630339757656e-06

CONCLUSIONS O 0 3.9121961890487e-05
The O 0 9.224159924769992e-08
I1307K O 0 3.6209503377904184e-06
APC O 0 8.786357597045935e-08
variant O 0 1.390206438856012e-08
may O 0 7.974848559300085e-10
represent O 0 4.699667321972356e-10
a O 0 9.122009814177545e-10
susceptibility O 0 6.068524527336194e-08
gene O 0 2.4184641844726684e-08
for O 0 1.313420199267057e-07
colorectal B-Disease 1 1.0
, I-Disease 0 8.331121570392952e-09
or I-Disease 0 2.5598294595141624e-09
other I-Disease 0 9.098400255425076e-09
, I-Disease 0 1.0184356691311791e-09
cancers I-Disease 0 1.419173312200428e-08
in O 0 1.0208724976479289e-09
Ashkenazi O 0 2.716123548296423e-09
Jews O 0 7.3525963095733005e-09
, O 0 4.5869044673629844e-10
and O 0 7.940621493673916e-10
partially O 0 3.5747628857052405e-08
explains O 0 2.5241597700897955e-09
the O 0 8.29219401476955e-11
higher O 0 8.211476831831988e-09
incidence O 0 6.315155474112544e-07
of O 0 4.6396419151051305e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 4.759021510203354e-10
European O 0 9.859576488580046e-10
Israelis O 0 2.4488116423526662e-08
. O 0 1.880472133564126e-08

Systematic O 0 5.223675714205456e-09
analysis O 0 2.5083843890882918e-09
of O 0 6.7522063496028295e-09
coproporphyrinogen O 0 8.341323791682953e-07
oxidase O 0 7.57412550456138e-08
gene O 0 3.360999016877031e-07
defects O 1 0.7903103828430176
in O 0 2.832517864703732e-08
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
and O 0 1.6009542136430355e-08
mutation O 0 1.7888163839074878e-08
update O 0 5.834351668454474e-08
. O 0 2.531793974469565e-08

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 5.644889711220458e-07
HC B-Disease 1 0.9999997615814209
) O 0 5.1979583831629483e-11
is O 0 3.646255606476467e-12
an O 0 1.7817037775702538e-11
acute O 1 0.9999938011169434
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9999997615814209
autosomal O 1 1.0
dominant O 1 1.0
inheritance O 0 1.1141809181935969e-06
caused O 0 2.8043851685310983e-09
by O 0 1.1816392482544291e-11
deficient B-Disease 0 5.416079584819045e-09
activity I-Disease 0 4.590293922746014e-09
of I-Disease 0 4.821552046507804e-10
coproporphyrinogen I-Disease 0 3.6634187239315e-08
III I-Disease 0 2.0167216518984787e-07
oxidase I-Disease 0 1.1405726141333616e-08
( O 0 5.1894937236340866e-09
CPO O 0 1.2642960882658372e-06
) O 0 1.325668463891816e-09
. O 0 2.5104148093646472e-08

Clinical O 0 5.388118395899255e-08
manifestations O 0 6.161134251669864e-07
of O 0 3.632440570555673e-09
the O 0 5.726237262138056e-10
disease O 0 9.039208492822581e-09
are O 0 7.153820721569892e-13
characterized O 0 1.3019414105835958e-12
by O 0 1.3578538521439448e-13
acute O 0 7.1947097168845175e-09
attacks O 0 1.686922684873693e-10
of O 0 5.5356345285417774e-08
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 7.586932859737772e-09
precipitated O 0 1.7039201161139772e-09
by O 0 1.0643219812422888e-11
drugs O 0 1.31594923846734e-09
, O 0 1.1694960277974786e-10
fasting O 0 1.0316525411724342e-08
, O 0 1.3413768984449348e-09
cyclical O 0 1.1158206689287908e-05
hormonal O 0 7.97311997757788e-07
changes O 0 4.618522098098765e-08
, O 0 3.6793057489603598e-09
or O 0 4.0591441319293153e-08
infectious B-Disease 0 2.9720306429226184e-06
diseases I-Disease 0 8.880367659003241e-07
. O 0 6.92307366989553e-08

Skin O 1 0.9998694658279419
photosensitivity O 1 0.9999992847442627
may O 0 2.4167870833480265e-06
also O 0 6.7074088505592044e-09
be O 0 1.0850086384905921e-09
present O 0 8.790729033592015e-09
. O 0 4.0676770396430584e-08

The O 0 5.357446752896067e-08
seven O 0 3.9445588129183307e-08
exons O 0 1.3843327906215563e-07
, O 0 1.4537585579788015e-09
the O 0 2.889881889345247e-09
exon O 0 1.4427268268946136e-08
/ O 0 1.6090053733819332e-08
intron O 0 1.0057189747669781e-08
boundaries O 0 1.5018926102783325e-09
and O 0 3.7342712255750143e-11
part O 0 6.822885312285365e-11
of O 0 4.865433611556114e-10
3 O 0 2.016420141970343e-09
noncoding O 0 9.354358398994123e-10
sequence O 0 9.745266815741616e-10
of O 0 3.291743411182324e-08
the O 0 9.022434710459493e-08
CPO O 0 1.557718434241906e-07
gene O 0 2.294222367638099e-09
were O 0 1.0239991077298782e-08
systematically O 0 3.4333382803453105e-09
analyzed O 0 3.689022143316123e-10
by O 0 1.549991905658299e-11
an O 0 1.2837299279144787e-10
exon O 0 6.583066036736085e-11
- O 0 6.744271807690438e-11
by O 0 4.5867011577716e-11
- O 0 3.4659271008763426e-09
exon O 0 1.3275611721041969e-09
denaturing O 0 1.743281217159165e-07
gradient O 0 1.606319166569392e-08
gel O 0 1.0654651383390501e-08
electrophoresis O 0 2.5583748453072985e-09
( O 0 1.4992079799824864e-09
DGGE O 0 7.844652827770915e-06
) O 0 4.661633579150504e-11
strategy O 0 1.6761718402147352e-10
followed O 0 4.9829086169739245e-12
by O 0 1.3992049164267273e-13
direct O 0 1.291824980320655e-11
sequencing O 0 3.84210111642469e-12
in O 0 6.2697642216891225e-12
seven O 0 1.6584490725168877e-10
unrelated O 0 8.332742496008905e-09
heterozygous O 0 2.3493374357030916e-08
HC B-Disease 0 2.4526318611606257e-06
patients O 0 2.717408742469729e-09
from O 0 9.284647717322514e-09
France O 0 6.282019349157508e-09
, O 0 9.760855457230377e-10
Holland O 0 1.296991847254958e-08
, O 0 7.214768782404235e-10
and O 0 7.541756108508935e-10
Czech O 0 3.2265614180460034e-08
Republic O 0 4.4361416939864284e-07
. O 0 4.637926394934766e-06

Seven O 0 2.580696047971287e-07
novel O 0 1.871291033239686e-08
mutations O 0 1.1107394115583702e-08
and O 0 2.411690291914681e-10
two O 0 1.670401594822124e-10
new O 0 2.913763896827959e-09
polymorphisms O 0 8.036055021420907e-08
were O 0 1.028889773380115e-08
detected O 0 1.1124699739184507e-07
. O 0 3.746526289205576e-08

Among O 0 6.970827115537759e-08
these O 0 9.759389740793267e-09
mutations O 0 2.234257578948018e-08
two O 0 1.487501344321629e-09
are O 0 2.097512025178716e-10
missense O 0 1.5830306665520766e-07
( O 0 1.6070784703003937e-09
G197W O 0 2.7276041691948194e-07
, O 0 8.413677532459474e-10
W427R O 0 4.8285148324112015e-08
) O 0 7.494931758555978e-11
, O 0 1.0454342252996796e-10
two O 0 2.8965296827720977e-10
are O 0 4.60212673525362e-10
nonsense O 0 2.8083800174272255e-08
( O 0 1.0636330705082742e-09
Q306X O 0 1.7247008088361326e-07
, O 0 1.5286139021242207e-09
Q385X O 0 7.606831076145681e-08
) O 0 2.2007327904471907e-10
, O 0 1.9912932414101192e-10
two O 0 3.006851989617587e-10
are O 0 1.441449043459997e-10
small O 0 1.0890480517389278e-08
deletions O 0 2.1066360034183162e-07
( O 0 5.982329298603872e-09
662de14bp O 0 3.462081110683357e-07
; O 0 4.8466799462687504e-09
1168del3bp O 0 3.473189167380042e-07
removing O 0 2.322223657813538e-08
a O 0 2.6652764439916155e-09
glycine O 0 2.124465270370024e-09
at O 0 3.9561904863205655e-09
position O 0 2.414650923654449e-09
390 O 0 7.172454297155184e-10
) O 0 2.455598224759825e-12
, O 0 3.218024154441612e-12
and O 0 2.138544983459889e-12
one O 0 3.1518253285067743e-11
is O 0 1.3514422220195499e-11
a O 0 2.07712819166872e-10
splicing O 0 1.5565358779667804e-08
mutation O 0 1.7627703741140976e-08
( O 0 3.845912033284549e-09
IVS1 O 0 1.020569243337377e-06
- O 0 1.3862241132756026e-08
15c O 0 3.084037203393564e-08
- O 0 4.0771183651422405e-10
- O 0 2.648865016219304e-10
> O 0 4.267828798698581e-11
g O 0 1.0456994992136259e-10
) O 0 3.3395463044233464e-12
which O 0 2.056689237320275e-12
creates O 0 1.8571409687861973e-10
a O 0 7.963596448945509e-11
new O 0 1.1089522633511706e-09
acceptor O 0 1.0012803919323687e-08
splice O 0 3.788697995332768e-06
site O 0 1.2520192740339553e-06
. O 0 1.1715629000264016e-07

The O 0 3.6040763706779444e-09
pathological O 0 4.727749569610751e-07
significance O 0 2.3084945155460446e-07
of O 0 4.9285592496062236e-08
the O 0 2.5479838683395428e-08
point O 0 2.8464566526054114e-07
mutations O 0 9.018370938917997e-09
G197W O 0 5.60119666204173e-08
, O 0 8.954258862159392e-11
W427R O 0 1.3633590256745265e-08
, O 0 6.785819822718864e-11
and O 0 6.119752621325247e-11
the O 0 1.7591118561810504e-09
in O 0 8.072085777577342e-10
- O 0 2.2011452660564146e-09
frame O 0 1.769743995794215e-08
deletion O 0 1.5974639389071399e-09
390delGly O 0 7.431891546616498e-09
were O 0 1.3086548511509477e-10
assessed O 0 8.021988628925669e-10
by O 0 7.53029236189029e-12
their O 0 1.4733680941958482e-10
respective O 0 6.820290554543362e-09
expression O 0 1.8891026520861942e-09
in O 0 9.471644996095208e-11
a O 0 1.8203072382760865e-10
prokaryotic O 0 1.7961514220399266e-10
system O 0 1.8503276688619508e-10
using O 0 3.3701100243810345e-10
site O 0 3.6802902059207554e-08
- O 0 3.2884661660403935e-09
directed O 0 8.6112633690405e-10
mutagenesis O 0 2.3254376912973385e-07
. O 0 2.5999836950063582e-08

These O 0 2.6391735463704435e-09
mutations O 0 1.273984029381836e-08
resulted O 0 5.0315573929538004e-09
in O 0 8.893188269132324e-11
the O 0 6.929924412091282e-10
absence O 0 4.710088319370698e-09
or O 0 5.104046352233382e-11
a O 0 4.287492236243473e-11
dramatic O 0 2.067524373927654e-09
decrease O 0 5.268787006684761e-08
of O 0 5.446164763611705e-08
CPO O 0 2.2503383661387488e-05
activity O 0 1.8605679770189454e-06
. O 0 1.955055779490067e-07

The O 0 2.2202220506528647e-08
two O 0 1.2538997617994596e-09
polymorphisms O 0 1.0633049996044974e-08
were O 0 2.7093338683670254e-10
localized O 0 1.533128179964649e-09
in O 0 2.3608512714212715e-11
noncoding O 0 2.3728257136923503e-09
part O 0 1.4012260796114617e-10
of O 0 3.934622849754987e-09
the O 0 1.6042486228329267e-09
gene O 0 3.48524903381886e-10
1 O 0 4.103567707858247e-09
) O 0 5.803596318798565e-12
a O 0 2.2267847288315323e-10
C O 0 5.020073245987078e-09
/ O 0 1.1050813736313003e-10
G O 0 3.137515802720259e-10
polymorphism O 0 3.19591367259342e-11
in O 0 3.675885637544063e-11
the O 0 5.041757011881032e-10
promotor O 0 4.7090216526157747e-07
region O 0 1.9585991495318922e-08
, O 0 8.98286445227825e-10
142 O 0 1.9227030634283437e-08
bp O 0 8.37119884522508e-09
upstream O 0 5.8094556720789114e-08
from O 0 3.132793358062713e-09
the O 0 4.059939051614947e-09
transcriptional O 0 1.580800379485936e-08
initiation O 0 5.263540714395276e-09
site O 0 2.3993276698774935e-08
( O 0 4.834220870830741e-11
- O 0 6.704515276290124e-10
142C O 0 4.732104930127434e-09
/ O 0 1.4033336992458345e-10
G O 0 7.133434953843221e-10
) O 0 9.438223640134691e-12
, O 0 5.426318682583142e-12
and O 0 4.945112461879342e-12
2 O 0 1.3637918572229069e-10
) O 0 1.927840265897318e-12
a O 0 3.1209709816515385e-10
6 O 0 5.079587417355924e-09
bp O 0 3.172229978698482e-10
deletion O 0 6.204299660833579e-12
polymorphism O 0 2.4102541143489198e-11
in O 0 1.442851220445629e-11
the O 0 9.607304535252936e-11
3 O 0 2.9830996006730004e-10
noncoding O 0 1.9107619930736064e-09
part O 0 2.424382639087952e-10
of O 0 5.8083005072262495e-09
the O 0 2.7561419813082466e-08
CPO O 0 3.9027327147778124e-07
gene O 0 4.330298342125616e-09
, O 0 2.604791715654642e-09
574 O 0 9.65428839094784e-08
bp O 0 1.0020503538044068e-08
downstream O 0 2.6932410079893998e-08
of O 0 4.467839709310084e-10
the O 0 1.1739569039104225e-10
last O 0 2.65685320965936e-11
base O 0 1.921641457069967e-10
of O 0 3.475310317302416e-11
the O 0 2.7732241503208854e-10
normal O 0 5.566325178563147e-09
termination O 0 2.645984409355151e-08
codon O 0 3.876683862813479e-08
( O 0 1.2543955207888757e-08
+ O 0 3.83359264333194e-07
574 O 0 9.332523518423841e-07
delATTCTT O 0 1.6558958577661542e-06
) O 0 6.551257314413306e-09
. O 0 4.776258322181093e-08

Five O 0 3.765004976230557e-06
intragenic O 0 0.00011301971244392917
dimorphisms O 0 3.1142400985118e-05
are O 0 8.240907400924868e-10
now O 0 6.818050013457366e-10
well O 0 1.3022953548880167e-10
characterized O 0 4.2792241972122724e-11
and O 0 1.0007189304647723e-12
the O 0 1.2371244653697211e-11
high O 0 1.378905045701373e-10
degree O 0 5.407777559085503e-10
of O 0 1.555958278887104e-10
allelic O 0 4.666192765512278e-09
heterogeneity O 0 2.5138072956565338e-08
in O 0 5.529413593663435e-10
HC B-Disease 0 0.004504337441176176
is O 0 1.2388965409115826e-09
demonstrated O 0 1.082173017863397e-09
with O 0 3.689400174256008e-11
seven O 0 5.154392468398328e-10
new O 0 6.248267181430123e-11
different O 0 1.1133764049597872e-11
mutations O 0 3.4781087732138616e-11
making O 0 6.109439776996739e-12
a O 0 7.974444889147225e-12
total O 0 1.3742837423613707e-10
of O 0 3.073436172229549e-09
nineteen O 0 7.29842099644884e-07
CPO O 0 1.0693693184293807e-05
gene B-Disease 0 1.74877573044796e-06
defects I-Disease 1 0.9587476849555969
reported O 0 4.557424517770414e-07
so O 0 4.125935149090765e-09
far O 0 1.7185529443963787e-08
. O 0 2.420313283124642e-09
. O 0 2.595227144297496e-08

Coincidence O 0 7.186551442828204e-07
of O 0 1.3578624447063703e-08
two O 0 2.5124050062608205e-10
novel O 0 9.566732961374669e-10
arylsulfatase O 0 1.9836649300941644e-07
A O 0 1.0371927317009977e-08
alleles O 0 3.521851033028156e-09
and O 0 2.061810278064513e-09
mutation O 0 1.3885501637389552e-08
459 O 0 1.5634208594406118e-08
+ O 0 1.8202987561721784e-08
1G O 0 5.801632028124004e-07
> O 0 2.7345408160073248e-09
A O 0 2.721791902970949e-09
within O 0 8.307501908610959e-11
a O 0 8.15544923260525e-11
family O 0 1.3416347199868284e-10
with O 0 4.4413115546371174e-11
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 8.643244106543158e-12
molecular O 0 7.540414126427919e-11
basis O 0 1.9961531039225378e-10
of O 0 1.0196674754547885e-10
phenotypic O 0 5.981977579949671e-08
heterogeneity O 0 2.9612703656312078e-05
. O 0 2.8313404527580133e-06

In O 0 1.8418356839688954e-09
a O 0 2.391992603989479e-09
family O 0 1.036282615274331e-09
with O 0 1.3168618105685592e-11
three O 0 1.1885181727677718e-10
siblings O 0 4.7244390621870025e-09
, O 0 1.1546982120469451e-11
one O 0 7.190308244642285e-12
developed O 0 6.902126786778595e-11
classical O 0 4.133638764614034e-09
late O 0 6.847587883385131e-06
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 4.241928142079132e-09
MLD B-Disease 1 1.0
) O 0 4.234713274486879e-11
, O 0 2.832670209507171e-11
fatal O 0 5.864718044534811e-09
at O 0 6.186985590517224e-09
age O 0 1.894505174959704e-08
5 O 0 1.204772193119652e-08
years O 0 1.2694910678234805e-09
, O 0 7.928676465374096e-11
with O 0 1.2295731273426203e-11
deficient O 0 4.3566117824411776e-08
arylsulfatase O 0 1.4450946537181153e-06
A O 0 1.5403414863612852e-06
( O 0 1.1112649467293068e-08
ARSA O 0 1.1302716984573635e-06
) O 0 5.11686387705268e-11
activity O 0 1.1262653032417802e-09
and O 0 6.217212075027012e-12
increased O 0 9.494820485400624e-10
galactosylsulfatide O 0 1.0328008670512645e-07
( O 0 4.12938394589446e-09
GS O 1 1.0
) O 0 8.605045564991087e-09
excretion O 0 5.636380251416995e-08
. O 0 2.656208764051371e-08

The O 0 4.279712584320805e-08
two O 0 1.0453750087791036e-09
other O 0 1.085919576482297e-09
siblings O 0 2.624967621045471e-08
, O 0 3.373055723621121e-10
apparently O 0 3.7409925823794765e-08
healthy O 0 2.503147378263293e-08
at O 0 7.770259990991235e-09
12 O 0 2.3621238298687786e-09
( O 0 6.0121553568937e-11
1 O 0 2.0177367332507856e-08
/ O 0 1.5649355145086474e-09
2 O 0 3.5345764093364096e-09
) O 0 1.0019800093796771e-11
and O 0 1.9358738570507406e-11
15 O 0 1.5991398483183872e-10
years O 0 1.3563648815217988e-10
, O 0 3.4122024650251603e-11
respectively O 0 2.0476809137193186e-10
, O 0 3.468654877214483e-11
and O 0 1.6907751587691422e-10
their O 0 3.5237657236564246e-09
father O 0 1.4075566241444903e-06
, O 0 7.994803929989303e-09
apparently O 0 5.632404054267681e-08
healthy O 0 3.3457101533684863e-09
as O 0 3.295396178160104e-10
well O 0 2.238491059181058e-10
, O 0 1.2568657226097457e-10
presented O 0 1.6223612675503318e-08
ARSA O 0 1.0159460543945897e-05
and O 0 2.6276927300727948e-08
GS O 1 1.0
values O 0 2.662603693082133e-09
within O 0 2.0569737579911873e-10
the O 0 1.9579883547837795e-10
range O 0 1.5752922521983237e-08
of O 0 1.1044734904430697e-08
MLD B-Disease 1 1.0
patients O 0 2.368224194526647e-08
. O 0 1.2896906298465183e-07

Mutation O 0 1.4603980247329673e-09
screening O 0 2.821423650267718e-10
and O 0 1.1679818570642375e-11
sequence O 0 2.2411857092397014e-11
analysis O 0 5.953001980252282e-11
disclosed O 0 1.3432611689623286e-09
the O 0 8.866225809089912e-11
involvement O 0 4.807264031292391e-10
of O 0 2.7750232667322905e-10
three O 0 1.7593817028260794e-11
different O 0 2.691574463309365e-10
ARSA O 0 5.668150606652489e-07
mutations O 0 1.4314877061494258e-09
being O 0 4.198586270320881e-11
the O 0 1.1437645969225585e-11
molecular O 0 3.267656700778332e-10
basis O 0 6.901195725994569e-10
of O 0 4.989628710205807e-10
intrafamilial O 0 5.611985898212879e-07
phenotypic O 0 4.864269840254565e-07
heterogeneity O 0 6.761068652849644e-05
. O 0 2.891498752433108e-06

The O 0 1.615672573507254e-08
late O 0 7.965231247908378e-07
infantile O 0 2.274509461130947e-05
patient O 0 4.11596889904331e-09
inherited O 0 2.5558934524383403e-08
from O 0 1.534947946524312e-09
his O 0 1.0584003007352294e-08
mother O 0 5.02847763428349e-09
the O 0 8.843092369481553e-10
frequent O 0 4.4311093683191416e-10
0 O 0 4.061364577978566e-09
- O 0 5.1322537331088824e-09
type O 0 7.056105033598215e-08
mutation O 0 7.321406059190849e-08
459 O 0 1.2796926185387747e-08
+ O 0 4.475330328546079e-09
1G O 0 7.64413741194403e-08
> O 0 8.720734134826102e-10
A O 0 8.852817146021152e-09
, O 0 1.2724934821128908e-11
and O 0 5.345228600017737e-12
from O 0 1.4009321480656922e-10
his O 0 1.1162076818393984e-09
father O 0 1.1429676094465435e-09
a O 0 8.080708324698094e-11
novel O 0 1.1407238348359883e-10
, O 0 9.770899367378405e-13
single O 0 9.062102630796876e-12
basepair O 0 9.572491421749874e-08
microdeletion O 0 3.670700436941843e-07
of O 0 6.37277537407499e-08
guanine O 0 2.5180590057516383e-08
at O 0 1.433499363656665e-08
nucleotide O 0 5.268804059710419e-09
7 O 0 5.499691813071195e-09
in O 0 2.826928691135322e-10
exon O 0 2.6227140459411658e-09
1 O 0 5.97064726548524e-08
( O 0 6.034725608117242e-09
7delG O 0 4.7128315827649203e-07
) O 0 5.112488654646086e-09
. O 0 1.0232498226514508e-07

The O 0 8.441506160750123e-09
two O 0 1.8998089768018644e-09
clinically O 0 0.0007231220370158553
unaffected O 0 4.620125935161923e-07
siblings O 0 2.502889451250212e-08
carried O 0 2.4826622979645663e-09
the O 0 1.1673304545212204e-09
maternal O 0 1.7176886046854634e-07
mutation O 0 1.9384817306900004e-08
459 O 0 4.31480060569811e-08
+ O 0 1.6896517962550206e-08
1G O 0 5.286755708766577e-07
> O 0 6.242865335792658e-09
A O 0 5.189427199070451e-08
and O 0 2.8978561217307686e-10
, O 0 3.2906840446988994e-11
on O 0 1.5173105827326339e-10
their O 0 1.3046622115986395e-10
paternal O 0 1.8390252876088198e-07
allele O 0 3.525426395256659e-09
, O 0 5.815522369223558e-11
a O 0 5.639307423810358e-11
novel O 0 4.3936002058764245e-10
cytosine O 0 1.5059709035369906e-10
to O 0 7.07422037615757e-11
thymidine O 0 1.041342088115016e-07
transition O 0 4.1242536497065885e-08
at O 0 2.6855618173726725e-08
nucleotide O 0 7.051612271880003e-08
2435 O 0 2.258354925288586e-06
in O 0 8.461183975683184e-10
exon O 0 6.77900890977412e-09
8 O 0 1.001744553974504e-08
, O 0 2.005788764247729e-11
resulting O 0 1.9120104804981608e-11
in O 0 2.7952119785457086e-12
substitution O 0 6.025176468860138e-10
of O 0 1.909312041803446e-09
alanine O 0 1.6809567071618403e-08
464 O 0 2.9671909373973904e-08
by O 0 1.0401307370955237e-08
valine O 0 7.1465674409409985e-06
( O 0 1.4238150214396228e-08
A464V O 0 8.295185693896201e-07
) O 0 2.8400304330489234e-09
. O 0 3.8204344576797666e-08

The O 0 8.636141757278892e-08
fathers O 0 1.3762873152245447e-07
genotype O 0 1.4691574179437339e-08
thus O 0 8.844699195265093e-09
was O 0 2.151059241839448e-08
7delG O 0 1.8393498066870961e-06
/ O 0 5.809554863844824e-07
A464V O 0 1.1299579455226194e-05
. O 0 2.638108753671986e-07

Mutation O 0 1.3797803433135414e-07
A464V O 0 6.646618544436933e-07
was O 0 3.945022974960466e-09
not O 0 1.535151519793665e-11
found O 0 4.813904483369491e-11
in O 0 7.555040620887965e-11
18 O 0 6.846409217331484e-09
unrelated O 0 4.2003708244919835e-07
MLD B-Disease 1 1.0
patients O 0 8.928072503522344e-09
and O 0 1.037401942127758e-09
50 O 0 5.489759047350162e-08
controls O 0 7.030835149635095e-07
. O 0 2.7274276703792566e-07

A464V O 0 2.11837741517229e-05
, O 0 3.1763427443820547e-09
although O 0 1.6309981143436403e-09
clearly O 0 1.1434915236918641e-08
modifying O 0 3.6372856015987054e-07
ARSA O 0 0.000571373151615262
and O 0 4.2832485291910416e-07
GS O 1 1.0
levels O 0 6.823805733802146e-07
, O 0 3.0989286137206307e-10
apparently O 0 4.320167779070516e-09
bears O 0 2.216726713299977e-08
little O 0 4.1449901844181625e-10
significance O 0 8.119181993393454e-10
for O 0 1.7787361861199003e-11
clinical O 0 1.1117859965992238e-09
manifestation O 0 6.895411956975295e-07
of O 0 2.4625171590741957e-07
MLD B-Disease 1 1.0
, O 0 9.473171580509643e-09
mimicking O 0 1.358721704036725e-07
the O 0 3.733635978164784e-08
frequent O 0 4.913513862447871e-07
ARSA O 0 0.0003848073538392782
pseudodeficiency O 0 2.8893191483803093e-05
allele O 0 4.648664344131248e-06
. O 0 8.293081918964162e-07

Our O 0 1.0260445293397424e-07
results O 0 3.4593228281920574e-09
demonstrate O 0 8.999567757683735e-10
that O 0 1.4802261846802445e-11
in O 0 8.460110216546024e-12
certain O 0 5.308120054614562e-10
genetic O 0 4.6584847979147526e-08
conditions O 0 1.7492550341557944e-07
MLD B-Disease 1 1.0
- O 0 1.604499516361102e-06
like O 0 5.485311049824304e-08
ARSA O 0 5.908710591029376e-05
and O 0 3.557404681941989e-08
GS O 1 1.0
values O 0 8.162861497851281e-10
need O 0 2.6643383679858523e-11
not O 0 3.2595113674122045e-12
be O 0 7.280506926499175e-12
paralleled O 0 1.2514578262567966e-09
by O 0 1.488033307683878e-11
clinical O 0 1.5482767290464494e-09
disease O 0 1.0374855641259728e-08
, O 0 1.2090151796373405e-11
a O 0 6.329496649026822e-11
finding O 0 7.299340576416569e-10
with O 0 1.508520044990469e-11
serious O 0 2.6387556584239746e-09
diagnostic O 0 5.945725689571191e-08
and O 0 3.2933245019961532e-09
prognostic O 0 0.018590394407510757
implications O 0 3.6461838135437574e-06
. O 0 1.3401496516962652e-06

Moreover O 0 4.1053360178011644e-07
, O 0 2.3872614995923414e-09
further O 0 1.0891004365021217e-07
ARSA O 0 0.0005723484791815281
alleles O 0 1.0752525980706196e-07
functionally O 0 1.264892830477038e-07
similar O 0 2.0081211693501189e-10
to O 0 2.521882425110533e-10
A464V O 0 4.7694765470396305e-08
might O 0 5.254530699438931e-10
exist O 0 1.1867676841248453e-09
which O 0 3.6345731979636753e-10
, O 0 1.4555863458998175e-10
together O 0 3.611835136529962e-11
with O 0 3.932293379804719e-11
0 O 0 2.5527999270025248e-08
- O 0 1.2218460021529154e-08
type O 0 1.0511376657973415e-08
mutations O 0 9.21256937402859e-09
, O 0 1.750138367562215e-10
may O 0 6.020650089588742e-10
cause O 0 1.2357199352663883e-07
pathological O 0 0.0010091493604704738
ARSA O 1 0.9995514750480652
and O 0 5.594645699602552e-05
GS O 1 1.0
levels O 0 7.82485949457623e-06
, O 0 1.4442726181673748e-10
but O 0 1.8833408790830397e-11
not O 0 3.207117080586408e-12
clinical O 0 1.5532007624496913e-10
outbreak O 0 1.272361327409044e-09
of O 0 3.7036229638687246e-10
the O 0 3.6161402761081263e-09
disease O 0 4.76271289073793e-08
. O 0 4.5773544954386125e-09
. O 0 4.236093076315228e-08

Human O 0 6.0887027757416945e-06
MLH1 O 1 1.0
deficiency O 1 0.9999983310699463
predisposes O 0 0.00036277659819461405
to O 0 1.5042155965261372e-08
hematological B-Disease 1 0.999998927116394
malignancy I-Disease 1 0.6113600134849548
and O 0 5.838197147944868e-10
neurofibromatosis B-Disease 0 0.00022856223222333938
type I-Disease 0 2.870984189939918e-06
1 I-Disease 0 9.656157999415882e-06
. O 0 1.5566982369819016e-07

Heterozygous O 0 1.0506168734991661e-07
germ O 0 3.541566911735572e-06
- O 0 5.079483145209451e-08
line O 0 1.712832720102142e-08
mutations O 0 3.309506280135821e-10
in O 0 9.39388150600351e-12
the O 0 3.860827976764902e-11
DNA O 0 3.4474401111594943e-09
mismatch O 0 8.271889555544476e-07
repair O 0 2.0020745523652295e-06
genes O 0 7.751632438157685e-07
lead O 0 4.200995533665264e-07
to O 0 6.712672018238663e-08
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.8648124700557673e-08

The O 0 5.675050207543109e-09
disease O 0 1.5884561221923832e-08
susceptibility O 0 2.9020903014043142e-08
of O 0 2.9920930177951277e-09
individuals O 0 5.253728563303639e-10
who O 0 1.3899391149152507e-07
constitutionally O 0 4.8646406014540844e-08
lack O 0 5.36339719303669e-08
both O 0 1.2091316836659871e-09
wild O 0 1.0973153941051805e-08
- O 0 2.594641612674309e-09
type O 0 2.249878061633126e-09
alleles O 0 2.806695431623041e-10
is O 0 2.4590407488034316e-10
unknown O 0 6.762249427083589e-08
. O 0 4.2384527887406875e-08

We O 0 8.985113986170745e-09
have O 0 2.944804677884605e-10
identified O 0 2.2122694787185537e-09
three O 0 3.847639915011136e-11
offspring O 0 9.094335839954226e-10
in O 0 2.556801645403617e-11
a O 0 1.5564874944473672e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.6553718396039585e-09
who O 0 1.771010768591985e-11
developed O 0 2.6652241524871556e-10
hematological B-Disease 0 1.1355884907970903e-06
malignancy I-Disease 0 1.8666498817765387e-06
at O 0 9.470113582210615e-10
a O 0 5.7670087455496954e-11
very O 0 4.6547033588639763e-11
early O 0 2.830545353660341e-09
age O 0 4.991449031876982e-09
, O 0 3.391478417547056e-11
and O 0 8.455339900459435e-11
at O 0 1.2311091035499544e-09
least O 0 4.985433177395748e-10
two O 0 9.445683818443129e-11
of O 0 1.4466160214166024e-10
them O 0 5.5028970963322266e-11
displayed O 0 3.04120817418152e-08
signs O 0 6.151709897039837e-08
of O 0 1.5625502669536218e-08
neurofibromatosis B-Disease 0 5.369699283619411e-05
type I-Disease 0 5.037902155891061e-06
1 I-Disease 0 5.782442894997075e-05
( O 0 3.6621898402700026e-07
NF1 B-Disease 0 0.0005076058441773057
) O 0 6.01878440420478e-08
. O 0 2.7793782919616206e-07

DNA O 0 1.0661603155881494e-08
sequence O 0 1.1281917622341098e-09
analysis O 0 1.3449403812870742e-09
and O 0 4.7251733775732774e-11
allele O 0 2.4576715662583126e-10
- O 0 4.30323866817961e-11
specific O 0 1.0458764930498798e-11
amplification O 0 9.535395389947965e-11
in O 0 1.0909424405514123e-11
two O 0 5.544004838542449e-11
siblings O 0 1.1066918936819548e-08
revealed O 0 2.5497086664216795e-09
a O 0 1.2567250573525257e-09
homozygous O 0 5.721821594306675e-08
MLH1 O 0 8.71789306984283e-05
mutation O 0 4.852741497529678e-08
( O 0 4.877049875062767e-09
C676T O 0 4.491940330808575e-07
- O 0 6.882982006573002e-08
- O 0 8.869114509479914e-08
> O 0 3.487227573373275e-08
Arg226Stop O 0 2.507238150428748e-07
) O 0 1.382647996095443e-09
. O 0 9.172453019345994e-09

Thus O 0 2.6994534607638343e-08
, O 0 1.781181313553759e-10
a O 0 3.450240371183355e-10
homozygous O 0 8.603191048450753e-09
germ O 0 1.3039171790296678e-05
- O 0 2.3552492223188892e-07
line O 0 7.610343288888544e-08
MLH1 O 0 5.059621344116749e-06
mutation O 0 6.312933509278196e-10
and O 0 2.5105882650588995e-11
consequent O 0 2.2082072348439397e-07
mismatch O 0 5.712093479814939e-05
repair O 0 0.022377243265509605
deficiency O 1 0.9999998807907104
results O 0 3.104037205048371e-08
in O 0 2.737717552658836e-10
a O 0 1.3278498300905994e-09
mutator O 0 1.0621566843838082e-06
phenotype O 0 2.8083035896742103e-09
characterized O 0 4.924903367065081e-12
by O 0 1.2750998173993722e-12
leukemia B-Disease 0 6.338445359688194e-07
and O 0 1.882617395310149e-09
/ O 0 4.574553167913109e-05
or O 0 3.605247513860377e-07
lymphoma B-Disease 1 1.0
associated O 0 4.672643072467508e-08
with O 0 5.5940561211054174e-11
neurofibromatosis B-Disease 0 0.023159170523285866
type I-Disease 0 5.0819821808545385e-06
1 I-Disease 0 2.3681238872086396e-06
. O 0 7.808353075233754e-09
. O 0 5.003690972671393e-08

Missense O 0 2.752170985331759e-06
mutations O 0 9.79452678961934e-08
in O 0 1.2450699360400108e-09
the O 0 5.440905503917293e-10
most O 0 7.398576196138151e-11
ancient O 0 1.8792951639312605e-09
residues O 0 1.6966694715847552e-08
of O 0 8.536512052792489e-10
the O 0 1.0087659596536014e-08
PAX6 O 0 1.4992499018262606e-05
paired O 0 2.698526913036403e-08
domain O 0 1.0327176447333386e-08
underlie O 0 2.7496046328678858e-08
a O 0 2.1005706896115584e-10
spectrum O 0 1.9683362495470647e-08
of O 0 8.658035954844934e-10
human O 0 3.171259663758974e-07
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 1.2558108210214414e-05

Mutations O 0 4.2152020540697777e-08
of O 0 1.1945207045727102e-09
the O 0 1.4358074451603642e-10
human O 0 2.6980198630788266e-10
PAX6 O 0 8.311440069519449e-06
gene O 0 2.083181556145064e-07
underlie O 1 0.9999984502792358
aniridia B-Disease 1 1.0
( O 0 7.987489880179055e-06
congenital B-Disease 1 1.0
absence I-Disease 0 0.0839817151427269
of I-Disease 0 6.014228688400181e-07
the I-Disease 0 2.4491761507761112e-08
iris I-Disease 0 2.9262113798722567e-07
) O 0 1.2325933329560002e-10
, O 0 1.0189554061623696e-11
a O 0 3.333756534718013e-11
rare O 0 3.466364972837255e-08
dominant O 1 1.0
malformation B-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 1 0.9999985694885254
eye I-Disease 1 1.0
. O 0 6.407989303625072e-07

The O 0 2.0886114171503323e-08
spectrum O 0 1.2962718756170943e-06
of O 0 1.4228571387775446e-07
PAX6 O 0 0.0001717722334433347
mutations O 0 6.641930099249294e-07
in O 0 2.078533256621995e-08
aniridia B-Disease 1 1.0
patients O 0 1.9972594245132314e-08
is O 0 2.097307882920063e-10
highly O 0 1.6571820582456098e-09
biased O 0 2.4153385069780597e-08
, O 0 1.3000064566504044e-11
with O 0 1.7271029441670582e-12
92 O 0 3.754006439038449e-09
% O 0 4.370587572410933e-11
of O 0 3.55297805065824e-11
all O 0 4.74548594864288e-11
reported O 0 1.0174628917170025e-09
mutations O 0 6.673550601021816e-10
leading O 0 2.8885413505541635e-10
to O 0 6.630346272018528e-11
premature O 0 4.3438259211825425e-08
truncation O 0 2.4466743298035e-07
of O 0 1.5648683415747655e-07
the O 0 2.2358632634222886e-07
protein O 0 9.799522331377375e-07
( O 0 4.540849474210518e-09
nonsense O 0 2.0863300420614905e-08
, O 0 2.831926082524916e-10
splicing O 0 6.649320538620884e-10
, O 0 9.437255837907443e-11
insertions O 0 5.852199835842953e-10
and O 0 5.498721269980855e-11
deletions O 0 1.1107982311742148e-09
) O 0 1.6828502133470202e-11
and O 0 7.13424735954149e-11
just O 0 9.03589425504947e-10
2 O 0 2.086476325047215e-09
% O 0 8.498882153595844e-11
leading O 0 5.195349359055079e-12
to O 0 3.920950207309676e-13
substitution O 0 1.8105220100927966e-10
of O 0 1.5059945512874151e-09
one O 0 9.049467841748537e-10
amino O 0 1.7616905712003472e-09
acid O 0 1.0775793451989202e-10
by O 0 2.2511765021548946e-11
another O 0 3.196855669074239e-09
( O 0 3.774014878388243e-09
missense O 0 3.2746453371146345e-07
) O 0 4.3192280863024735e-09
. O 0 3.025447981030993e-08

The O 0 2.8025992637736863e-09
extraordinary O 0 8.945199025944817e-10
conservation O 0 3.817700822139614e-09
of O 0 3.931065195583727e-10
the O 0 1.02802211188191e-09
PAX6 O 0 4.05998093810922e-07
protein O 0 1.2600643195526118e-08
at O 0 1.965281493099269e-09
the O 0 1.6354214649183518e-09
amino O 0 1.6221228804624843e-08
acid O 0 4.048178237070488e-09
level O 0 9.34327193391482e-09
amongst O 0 1.632810331386736e-08
vertebrates O 0 2.7659115175993065e-07
predicts O 0 1.8356990594270428e-08
that O 0 9.162831604569988e-10
pathological O 0 1.02075421182235e-06
missense O 0 3.325046407098853e-07
mutations O 0 4.581864132546798e-08
should O 0 7.715024730181597e-10
in O 0 1.099005109139739e-09
fact O 0 4.4213015470973005e-09
be O 0 1.02627462084115e-09
common O 0 2.7497029098100256e-09
even O 0 3.0002822448693678e-09
though O 0 2.079341143712554e-09
they O 0 4.969464839632565e-10
are O 0 2.2684269740391727e-10
hardly O 0 5.543801862017972e-08
ever O 0 8.052530198199292e-09
seen O 0 2.599933957014855e-08
in O 0 1.2481496725058605e-08
aniridia B-Disease 1 1.0
patients O 0 1.1581545322769671e-07
. O 0 1.5574926237604814e-07

This O 0 2.653498309967972e-09
indicates O 0 2.6969626532036273e-08
that O 0 5.4383088310405725e-11
there O 0 4.142332657441905e-11
is O 0 1.0342083092695908e-11
a O 0 7.8994526198084e-11
heavy O 0 5.6079205279502276e-08
ascertainment O 0 6.292674243013607e-06
bias O 0 1.1914681863345322e-07
in O 0 7.857677702949317e-11
the O 0 1.4372321388567144e-10
selection O 0 6.751430525753221e-10
of O 0 3.3939906440849654e-10
patients O 0 3.402064741031552e-11
for O 0 4.4379180885734115e-10
PAX6 O 0 5.406936338658852e-07
mutation O 0 6.018652798367441e-10
analysis O 0 2.1707996511466376e-10
and O 0 1.2530017821921202e-11
that O 0 1.8202717111392985e-11
the O 0 2.5939290715371044e-09
missing O 0 7.301992468455865e-07
PAX6 O 0 4.234037987771444e-05
missense O 0 3.345493496453855e-06
mutations O 0 7.664576173738169e-08
frequently O 0 6.456951862077176e-09
may O 0 2.0779455933706004e-09
underlie O 0 3.520903192111291e-06
phenotypes O 0 2.6633474590198603e-06
distinct O 0 5.1909125886595575e-08
from O 0 4.466634351274479e-08
textbook O 0 5.499376584339188e-06
aniridia B-Disease 1 1.0
. O 0 7.344860932789743e-07

Here O 0 9.527082056592917e-08
we O 0 1.373901881152051e-09
present O 0 5.48585954440739e-10
four O 0 2.4937188425333545e-10
novel O 0 6.298011889782629e-09
PAX6 O 0 1.2253208296897355e-05
missense O 0 1.0810924777615583e-06
mutations O 0 1.3261880837944773e-07
, O 0 6.90057677665834e-10
two O 0 1.0624200824649321e-10
in O 0 7.421897124659793e-11
association O 0 2.5615962129243997e-10
with O 0 2.962933370875831e-11
atypical O 0 9.131067599810194e-07
phenotypes O 0 3.1112568876778823e-07
ectopia B-Disease 0 9.63394199970935e-07
pupillae I-Disease 0 3.8574708582927997e-07
( O 0 1.4830103811647177e-10
displaced B-Disease 0 6.518516215692216e-08
pupils I-Disease 0 6.475501024283403e-09
) O 0 2.3717974806380937e-10
and O 0 2.887476284740842e-07
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.99991774559021
( O 0 2.4663413533687617e-09
searching B-Disease 0 9.004074996710187e-08
gaze I-Disease 0 7.840067155484576e-07
) O 0 5.161512883766761e-11
, O 0 6.442747724211273e-11
and O 0 3.4219935218793296e-10
two O 0 3.099976497722423e-09
in O 0 1.6992538931503987e-08
association O 0 5.3636224350839257e-08
with O 0 2.995603487487841e-10
more O 0 2.285183242634048e-08
recognizable O 1 1.0
aniridia B-Disease 1 1.0
phenotypes O 0 4.112355236429721e-05
. O 0 3.698805528529192e-07

Strikingly O 0 1.8164189896197058e-05
, O 0 6.7478937992859755e-09
all O 0 1.4790536573272561e-09
four O 0 8.539101092885915e-10
mutations O 0 3.0693354524657934e-09
are O 0 5.873108249732084e-11
located O 0 1.1919489839584685e-09
within O 0 2.8582175515268204e-10
the O 0 5.966537486301604e-08
PAX6 O 0 8.402950697927736e-06
paired O 0 3.339100729249367e-08
domain O 0 1.0345905465669603e-08
and O 0 6.6568621726048605e-09
affect O 0 2.074027207754625e-07
amino O 0 1.308206094563502e-07
acids O 0 4.187683444456525e-08
which O 0 1.3153864109050062e-10
are O 0 1.7472757615766277e-11
highly O 0 6.86989964915341e-10
conserved O 0 4.611143467059264e-09
in O 0 5.422423066114845e-10
all O 0 2.3161532691773346e-09
known O 0 2.729831294345786e-08
paired O 0 9.187234439878011e-08
domain O 0 1.0444689735322754e-07
proteins O 0 3.0998421607364435e-08
. O 0 1.0717023002371207e-07

Our O 0 7.898575660192364e-08
results O 0 6.8082028903404535e-09
support O 0 9.982822346543685e-10
the O 0 6.027084387127957e-10
hypothesis O 0 9.533963618579833e-10
that O 0 1.060993415520628e-12
the O 0 4.821641697017043e-11
under O 0 1.3741396909239256e-10
- O 0 1.756576134548382e-10
representation O 0 2.3535970949950524e-09
of O 0 4.800705610819023e-09
missense O 0 4.950322818331188e-07
mutations O 0 1.022931712668651e-07
is O 0 7.652883327047277e-10
caused O 0 3.6490299670788318e-09
by O 0 1.189446208194056e-09
ascertainment O 1 0.9988375306129456
bias O 0 4.304313915781677e-05
and O 0 1.7118488848666402e-09
suggest O 0 1.9848858112681e-09
that O 0 1.1388797023503816e-11
a O 0 4.5603566062313305e-11
substantial O 0 1.5586213208962363e-08
burden O 0 1.0512949302210473e-06
of O 0 6.963451596675441e-06
PAX6 B-Disease 1 1.0
- I-Disease 0 0.441078245639801
related I-Disease 0 0.4055185616016388
disease I-Disease 1 0.9999997615814209
remains O 0 5.203045105872661e-08
to O 0 2.1368347369321583e-10
be O 0 4.988400803540571e-10
uncovered O 0 2.9408001367414727e-08
. O 0 1.5389993723857742e-09
. O 0 2.1243206305143758e-08

The O 0 4.796120389727321e-09
chromosomal O 0 3.180976193561946e-08
order O 0 3.3370044505431906e-09
of O 0 1.4327723008022986e-08
genes O 0 8.902637915753076e-08
controlling O 0 6.812518222432118e-06
the O 0 6.409192678802356e-07
major O 0 2.0232251074503438e-07
histocompatibility O 0 2.3768732262396952e-06
complex O 0 2.957579454232473e-06
, O 0 6.003220698325151e-10
properdin O 0 4.765021088815047e-08
factor O 0 1.0689351626069765e-09
B O 0 4.5508903312452276e-09
, O 0 4.168771664675441e-12
and O 0 6.8333533276287994e-12
deficiency B-Disease 0 1.2512035141298838e-07
of I-Disease 0 6.123758794274181e-06
the I-Disease 0 6.602156759072386e-07
second I-Disease 0 3.010631033362188e-08
component I-Disease 0 4.1546832107997034e-07
of I-Disease 0 9.47836298337279e-08
complement I-Disease 0 2.3049570074817893e-07
. O 0 3.956585317155259e-07

The O 0 6.20201401346776e-09
relationship O 0 2.3319786102149465e-09
of O 0 6.674050201382897e-09
the O 0 5.176639672477279e-10
genes O 0 1.2905400359475294e-10
coding O 0 4.5249215485654304e-10
for O 0 1.1573491470739938e-10
HLA O 0 2.8014410347054763e-08
to O 0 1.8476650764931435e-10
those O 0 9.409181073172235e-11
coding O 0 2.139964205838396e-09
for O 0 5.108470313430757e-10
properdin O 0 2.4869865455912077e-07
Factor O 0 3.805313397720056e-09
B O 0 2.7311592987189215e-08
allotypes O 0 1.1056876303427998e-08
and O 0 4.29108961905178e-12
for O 0 1.4289547843604478e-11
deficiency B-Disease 0 3.954381355697478e-08
of I-Disease 0 1.1397941257484945e-08
the I-Disease 0 7.342361718620793e-10
second I-Disease 0 3.2967983898402053e-10
component I-Disease 0 4.051847302122269e-09
of I-Disease 0 8.988764399475713e-09
complement I-Disease 0 2.2422108614250646e-08
( O 0 2.691750378147617e-09
C2 O 0 2.9507843279930057e-08
) O 0 2.6548220219413388e-11
was O 0 5.997407015456702e-10
studied O 0 2.1691884399821504e-11
in O 0 1.552180367743461e-12
families O 0 2.2477698521927714e-11
of O 0 6.134735081042564e-11
patients O 0 3.8333283769453885e-10
with O 0 5.955495208098682e-09
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 4.26681617682334e-06

Patients O 0 1.585027220585289e-08
were O 0 6.438451993773242e-10
selected O 0 3.7361255755818945e-10
because O 0 9.210592705199971e-11
they O 0 2.368934388929933e-11
were O 0 8.865633921439908e-11
heterozygous O 0 1.7040296951265077e-10
or O 0 1.7436345423060828e-10
homozygous O 0 6.6248415642178315e-09
for O 0 8.562007991486098e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.224412017108989e-06

12 O 0 9.562889999870094e-07
families O 0 1.239828595345216e-08
with O 0 8.484261626584555e-10
15 O 0 5.908690070555167e-08
matings O 0 5.128047632751986e-06
informative O 0 3.4192844395875e-06
for O 0 2.7067468977293174e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 4.1203850997817426e-08
found O 0 6.147204079098856e-09
. O 0 3.0319988297833333e-08

Of O 0 8.550845450372435e-06
57 O 0 6.150147783046123e-06
informative O 0 7.031122777334531e-07
meioses O 0 1.8783158566293423e-06
, O 0 3.256637459703171e-10
two O 0 5.304757327850851e-11
crossovers O 0 7.362447540515404e-09
were O 0 1.3287003441941891e-10
noted O 0 4.420894761381078e-10
between O 0 3.569977646833422e-09
the O 0 1.2942213061251095e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 2.466106208132146e-09
and O 0 8.359993253215237e-10
the O 0 4.712613410617905e-09
HLA O 0 1.315945326041401e-07
- O 0 1.6368024091661937e-07
B O 0 5.536405112138709e-08
gene O 0 4.5455243735670336e-11
, O 0 5.043290438044856e-12
with O 0 4.182306831044223e-14
a O 0 6.832984698890154e-13
recombinant O 0 1.9084935454910523e-12
fraction O 0 7.697763954039871e-11
of O 0 6.077554015604392e-10
0 O 0 1.2752384925818205e-08
. O 0 4.815519005774149e-08

035 O 0 0.0010986746056005359
. O 0 6.204581950441934e-06

A O 0 5.541855898627546e-07
lod O 0 1.3755172858509468e-06
score O 0 9.87957271547657e-09
of O 0 4.463055258696613e-09
13 O 0 3.787210989258938e-09
was O 0 2.590338499253164e-10
calculated O 0 1.231087315423096e-10
for O 0 1.461921035617042e-11
linkage O 0 1.6594323142271605e-06
between O 0 4.090187758265529e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 5.186010287872023e-09
HLA O 0 2.2494282347906847e-06
- O 0 1.3468094266499975e-06
B O 0 3.6104083278587495e-07
at O 0 3.3729123660730664e-11
a O 0 9.335944967407347e-14
maximum O 0 7.67165140008047e-13
likelihood O 0 3.0351170795389626e-12
value O 0 1.059879441156486e-11
of O 0 1.6440300509845684e-11
the O 0 3.935504699903447e-11
recombinant O 0 4.438076989243811e-11
fraction O 0 3.1451026227813372e-09
of O 0 4.059660163591161e-09
0 O 0 5.6183697694223156e-08
. O 0 1.6953890735749155e-07

04 O 0 0.0008796137408353388
. O 0 1.1189087672391906e-05

18 O 0 1.486069322709227e-06
families O 0 7.161522042054003e-09
with O 0 1.0269006478491605e-10
21 O 0 1.9068854939519042e-08
informative O 0 9.878103668370386e-09
matings O 0 3.922321312188615e-08
for O 0 9.709810733227187e-10
both O 0 1.857189069198739e-08
properdin O 0 8.047026312851813e-06
Factor O 0 1.4742317944183014e-07
B O 0 7.316519941014121e-07
allotype O 0 2.703661436953553e-07
and O 0 2.777216900895496e-09
HLA O 0 4.956652901455527e-07
- O 0 1.7464558368374128e-06
B O 0 4.028572675451869e-06
were O 0 8.687083274949714e-10
found O 0 4.3135703342578324e-10
. O 0 5.1163131509213144e-09

Of O 0 1.6082978618214838e-05
72 O 0 6.085776931286091e-06
informative O 0 1.7414182593711303e-06
meioses O 0 1.0570451195235364e-05
, O 0 1.767472612712595e-09
three O 0 1.7883378111704928e-09
recombinants O 0 3.2114078294398496e-06
were O 0 5.857362594952065e-09
found O 0 6.7740035802899e-10
, O 0 3.1377355574901955e-11
giving O 0 3.7762147575559624e-11
a O 0 3.305013207555163e-11
recombinant O 0 7.869346840827518e-11
fraction O 0 2.9328162121089463e-09
of O 0 6.10048278559816e-09
0 O 0 1.5036481215702224e-07
. O 0 1.6973336869341438e-07

042 O 0 0.0020693924743682146
. O 0 9.090741514228284e-06

A O 0 4.866747644882707e-07
lod O 0 1.6169987020475673e-06
score O 0 7.0286074738135085e-09
of O 0 9.888659668888522e-09
16 O 0 2.1071457467769505e-08
between O 0 2.160434142695067e-08
HLA O 0 2.921701479863259e-06
- O 0 1.8709931737248553e-06
B O 0 2.2297881230315397e-07
and O 0 4.463033762003299e-11
Factor O 0 2.4146820654102896e-10
B O 0 5.0819615182717826e-09
allotypes O 0 6.5646661440155185e-09
was O 0 2.498679874118892e-10
calculated O 0 2.187316439083986e-10
at O 0 1.0655367213563416e-11
a O 0 3.2389778250978274e-13
maximum O 0 7.808639151951624e-12
likelihood O 0 1.0558344476496728e-10
value O 0 2.2536779387127837e-10
of O 0 2.1377355441387635e-10
the O 0 1.0951919926505127e-10
recombinant O 0 8.438004461819304e-11
fraction O 0 2.2649782049910527e-09
of O 0 1.1365204777291638e-08
0 O 0 1.1761616747207881e-07
. O 0 2.4517825636394264e-07

04 O 0 0.0006224339012987912
. O 0 7.416115749947494e-06

A O 0 1.5927831498174783e-07
crossover O 0 2.598079973381573e-08
was O 0 4.2915053732883734e-09
shown O 0 3.7581080608584116e-11
to O 0 2.7635808572124e-11
have O 0 5.616968348776119e-11
occurred O 0 1.4767033817975062e-08
between O 0 1.4672432713247474e-10
genes O 0 2.9088759179174417e-10
for O 0 8.956718700048327e-11
Factor O 0 1.0129918015522321e-09
B O 0 8.669211126743903e-09
and O 0 4.322069369067094e-10
HLA O 0 6.860176426926046e-08
- O 0 1.510904468204899e-07
D O 0 1.795639370527624e-08
, O 0 1.4073545107073926e-10
in O 0 7.421699366183532e-11
which O 0 7.252914935307331e-11
HLA O 0 2.2468130467245828e-08
- O 0 8.634363268811285e-08
D O 0 1.2066257326637242e-08
segregared O 0 4.404453335382641e-08
with O 0 3.7217284809543116e-11
HLA O 0 1.770540691836686e-08
- O 0 1.133569682565394e-08
A O 0 4.997290830033307e-07
and O 0 7.410386748674114e-10
B O 0 7.995508610747493e-08
. O 0 3.0585534105398438e-09

These O 0 5.7046776191782556e-09
studies O 0 2.3106732083277848e-09
suggest O 0 1.7547745201351717e-10
that O 0 3.0160390244310387e-12
the O 0 1.9541481280360706e-11
genes O 0 2.15008809367756e-11
for O 0 3.6872969955137336e-11
Factor O 0 2.1285874396426152e-08
B O 0 0.00012539394083432853
and O 0 9.238145139534026e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 2.975792945392186e-09
located O 0 1.835678098416338e-08
outside O 0 3.8730312290624624e-09
those O 0 8.212878294111547e-11
for O 0 1.8971609005991041e-10
HLA O 0 2.694305010209064e-07
, O 0 8.710672461109681e-11
that O 0 8.56062009474412e-12
the O 0 1.2451334407970194e-10
order O 0 9.80025394170525e-10
of O 0 1.9094695602461798e-08
genese O 0 1.6503306596860057e-06
is O 0 7.279490343847783e-09
HLA O 0 1.5486207871617808e-07
- O 0 2.938519116923999e-07
A O 0 6.418303382815793e-05
, O 0 1.8975021554012983e-09
- O 0 2.5697894923126796e-09
B O 0 1.3018471634040907e-08
, O 0 7.845338267919999e-11
- O 0 4.5749778965209487e-10
D O 0 1.7047448175322444e-10
, O 0 2.5089080119000684e-11
Factor O 0 7.613936148231915e-10
B O 0 4.7309293904618244e-07
allotype O 0 7.090810868248809e-06
, O 0 1.2629557488708087e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 3.8467739410519286e-11
that O 0 3.725161455345183e-13
the O 0 5.1524019425985834e-12
genes O 0 6.978812666647016e-11
coding O 0 5.692156523906533e-09
for O 0 1.8747776664440607e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 2.1089137103302846e-09
Factor O 0 6.234677663030652e-09
B O 0 4.464862257691493e-08
allotypes O 0 2.3595765341610786e-08
are O 0 1.3074141595736943e-11
approximately O 0 6.40619501890427e-11
3 O 0 1.1729676951954815e-10
- O 0 3.2686898326916847e-11
- O 0 9.060638350710803e-11
5 O 0 2.4477725402149986e-10
centimorgans O 0 4.006108778042972e-09
from O 0 2.988954361793361e-10
the O 0 3.048103991432072e-10
HLA O 0 3.157448524859774e-09
- O 0 1.2109503400026256e-09
A O 0 1.5035901412829844e-08
and O 0 1.7322150658305446e-10
HLA O 0 3.399728143449465e-08
- O 0 4.307005951886822e-08
B O 0 3.224014477609671e-08
loci O 0 2.6685967324802107e-10
, O 0 2.583063537370256e-12
and O 0 4.649673522724371e-14
that O 0 6.1114579109206035e-15
the O 0 2.013564147232763e-13
apparent O 0 1.5306028666728366e-10
lack O 0 2.977653679181458e-10
of O 0 5.09306985474467e-10
recombinants O 0 3.417673326566728e-07
between O 0 6.841210375974072e-10
the O 0 2.604717330711992e-09
Factor O 0 4.334181902265755e-09
B O 0 3.925389790992995e-08
gene O 0 3.781784840839464e-08
and O 0 0.11691142618656158
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 1.2195108034518398e-08
suggests O 0 6.211011260859323e-09
that O 0 4.6435633116459485e-12
these O 0 2.7432464286269997e-11
two O 0 1.4671845682823204e-10
genes O 0 5.751415788068925e-09
lie O 0 4.910306827810018e-09
in O 0 4.6447548585071274e-10
close O 0 5.052534390870278e-08
proximity O 0 1.9066241918608284e-07
to O 0 7.747258390367051e-10
one O 0 3.547834914741088e-09
another O 0 1.3466326720390498e-08
. O 0 1.817926147396065e-07

Distribution O 0 2.2751283523803068e-08
of O 0 5.7692069788117806e-08
emerin O 0 2.38958750742313e-06
and O 0 1.30992905411631e-09
lamins O 0 3.523019358908641e-06
in O 0 1.149316086745955e-09
the O 0 1.35835520609362e-07
heart O 0 4.5738570264575173e-08
and O 0 9.141116197319832e-10
implications O 0 7.769282106551145e-09
for O 0 1.6883269227108144e-09
Emery B-Disease 0 0.00015369043103419244
- I-Disease 1 0.9982737302780151
Dreifuss I-Disease 1 0.9990100860595703
muscular I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
. O 0 2.6341167540522292e-06

Emerin O 0 4.400454054120928e-05
is O 0 6.561724053000262e-09
a O 0 3.534785131265039e-09
nuclear O 0 6.693200305107894e-08
membrane O 0 1.0248471404850079e-08
protein O 0 2.5051866359149244e-08
which O 0 7.055436096470302e-11
is O 0 7.081942671183228e-11
missing O 0 7.398936574531945e-09
or O 0 2.6264788122176697e-09
defective O 0 1.6595525664797606e-07
in O 0 3.4558869099754475e-09
Emery B-Disease 0 0.0032512117177248
- I-Disease 1 0.9997562766075134
Dreifuss I-Disease 1 0.9999879598617554
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.4052135384190478e-06
EDMD B-Disease 1 1.0
) O 0 1.142994410230358e-08
. O 0 4.411751319821633e-08

It O 0 4.746602000338385e-10
is O 0 4.5480567228972646e-11
one O 0 4.758419699935068e-11
member O 0 7.336912327682299e-11
of O 0 1.0135986494574922e-09
a O 0 1.7254724316018155e-09
family O 0 5.222243544267258e-07
of O 0 1.753179276420269e-05
lamina O 1 0.9999817609786987
- O 0 1.1785227798100095e-05
associated O 0 0.4359637498855591
proteins O 0 1.9484271973624345e-08
which O 0 6.06488193000132e-11
includes O 0 3.916955301774827e-11
LAP1 O 0 0.0012388143222779036
, O 0 3.0803435357995568e-09
LAP2 O 1 0.8304372429847717
and O 0 1.1764174701056618e-07
lamin O 0 3.635469693108462e-05
B O 0 5.933947704761522e-06
receptor O 0 2.904186430896516e-06
( O 0 4.172730143636727e-07
LBR O 0 0.0004151657340116799
) O 0 2.291687017930144e-08
. O 0 2.1147641859897703e-07

A O 0 2.842524963853066e-06
panel O 0 1.3840318047186884e-07
of O 0 8.4518205767381e-08
16 O 0 2.3225338097176973e-08
monoclonal O 0 1.7201434943103777e-08
antibodies O 0 1.1757956386304613e-08
( O 0 1.8816048719116907e-09
mAbs O 0 2.295860568324315e-08
) O 0 1.3953799227195418e-10
has O 0 1.4976067608252208e-10
been O 0 2.7342733632806926e-10
mapped O 0 1.237043023571971e-09
to O 0 8.661285577638012e-11
six O 0 2.1218281298640562e-10
specific O 0 5.093681587631238e-10
sites O 0 1.896721535388224e-08
throughout O 0 5.70025093793447e-09
the O 0 7.233073517909361e-08
emerin O 0 6.429438030863821e-07
molecule O 0 4.178513979269383e-09
using O 0 1.373993585573885e-09
phage O 0 2.1516244341768243e-09
- O 0 9.77941616575606e-10
displayed O 0 4.3488137535518945e-09
peptide O 0 3.3678226873945505e-10
libraries O 0 1.1046835668437893e-09
and O 0 2.0773065212420505e-10
has O 0 8.272605517278819e-11
been O 0 2.186059840092458e-11
used O 0 3.2271102456959966e-11
to O 0 3.772689105563387e-10
localize O 0 3.6974972772441106e-07
emerin O 0 5.855483209415979e-07
in O 0 6.322115053691846e-10
human O 0 5.0019801633993666e-09
and O 0 1.5331114155969772e-08
rabbit O 0 3.4020607131424185e-07
heart O 0 2.8920152317368775e-07
. O 0 4.0808339463183074e-07

Several O 0 1.325846596955671e-07
mAbs O 0 6.678611157440173e-07
against O 0 8.598663114867122e-09
different O 0 1.3202639870257826e-08
emerin O 0 2.098844333886518e-06
epitopes O 0 1.745873419167765e-07
did O 0 2.1905739444605388e-09
not O 0 4.119767860188972e-10
recognize O 0 6.492914650380044e-09
intercalated O 0 1.4242732504499145e-07
discs O 0 9.694418601213783e-09
in O 0 9.491633035096925e-10
the O 0 1.1035452729402095e-07
heart O 0 4.257509900185141e-08
, O 0 4.384650698074921e-10
though O 0 8.140860208172285e-10
they O 0 2.124010550774713e-10
recognized O 0 1.5056450308748026e-08
cardiomyocyte O 0 9.974035037885187e-07
nuclei O 0 2.401732217549579e-07
strongly O 0 8.490157910046037e-09
, O 0 3.1646515963323907e-10
both O 0 2.2637169916350786e-09
at O 0 1.0855809762233548e-07
the O 0 8.242786009304837e-08
rim O 0 3.8386812661883596e-07
and O 0 1.3036032253666008e-09
in O 0 3.5719054380933812e-09
intranuclear O 0 2.4128764835040784e-06
spots O 0 1.6435361658295733e-06
or O 0 4.4785775088485025e-08
channels O 0 2.0889387997158337e-07
. O 0 1.5060621194606938e-07

A O 0 2.498773937986698e-06
polyclonal O 0 7.339823696383974e-06
rabbit O 0 1.0133618388863397e-07
antiserum O 0 5.207274398344452e-07
against O 0 6.700606292042721e-09
emerin O 0 2.242383516204427e-06
did O 0 2.178598856872327e-09
recognize O 0 4.744820980562281e-09
both O 0 1.2301685003990315e-08
nuclear O 0 1.1215331596758915e-07
membrane O 0 1.580119146638026e-08
and O 0 3.558405514691998e-10
intercalated O 0 6.309951228189448e-09
discs O 0 2.351752792506545e-09
but O 0 1.055847076436578e-09
, O 0 6.028805232816126e-11
after O 0 5.399755989565769e-11
affinity O 0 1.7780044103687942e-10
purification O 0 3.702582684894651e-11
against O 0 4.085773039341767e-11
a O 0 7.531132939497809e-10
pure O 0 2.8432623366825283e-08
- O 0 1.1748094053132263e-08
emerin O 0 2.0066362083071e-07
band O 0 7.196599427494732e-10
on O 0 6.887007075739859e-10
a O 0 2.7863200635636076e-10
western O 0 1.473164434884211e-08
blot O 0 2.4303952272930474e-07
, O 0 2.5356816646393554e-10
it O 0 1.3323242509244437e-10
stained O 0 8.78944206306187e-08
only O 0 1.8555876835080198e-09
the O 0 1.1720072023990724e-08
nuclear O 0 2.9932709821878234e-07
membrane O 0 3.7955334164507804e-07
. O 0 7.782114153087605e-08

These O 0 2.4774319484777152e-08
results O 0 7.635711618547703e-09
would O 0 1.599173293787004e-10
not O 0 6.229702864679609e-11
be O 0 9.642129455977866e-11
expected O 0 6.397663510071538e-10
if O 0 1.6616891196363781e-09
immunostaining O 0 8.224613452512131e-07
at O 0 1.985003983406841e-08
intercalated O 0 4.4734207449437235e-08
discs O 0 1.3222372530208304e-08
were O 0 1.0592964283517858e-09
due O 0 1.2242085123403967e-09
to O 0 1.0245373299744287e-10
a O 0 2.3709290086770807e-10
product O 0 4.35066382920013e-09
of O 0 7.2015189367391486e-09
the O 0 2.940923593541811e-08
emerin O 0 7.920403390926367e-07
gene O 0 7.026208059812689e-09
and O 0 2.15647357748594e-08
, O 0 1.3401314502559103e-09
therefore O 0 5.391158186540679e-09
, O 0 7.479707825330806e-11
cast O 0 4.3653580750202536e-10
some O 0 5.991000751048858e-11
doubt O 0 1.467915788921914e-09
upon O 0 5.810358305602392e-10
the O 0 8.609813556548218e-11
hypothesis O 0 2.5560142891123405e-09
that O 0 5.615286360893812e-11
cardiac B-Disease 0 5.682060191247729e-07
defects I-Disease 0 6.081704850657843e-05
in O 0 1.0578860099030862e-07
EDMD B-Disease 1 1.0
are O 0 1.108448999254108e-09
caused O 0 3.792393954427098e-09
by O 0 5.12371013672297e-11
absence O 0 5.05775062720204e-07
of O 0 4.999336056243919e-07
emerin O 0 2.6016088668256998e-05
from O 0 2.4070337190096325e-07
intercalated O 0 3.7203610645519802e-06
discs O 0 1.4170601616569911e-06
. O 0 6.156440690574527e-07

Although O 0 4.350965099320092e-08
emerin O 0 4.894669928035e-06
was O 0 9.136170930901244e-09
abundant O 0 1.2292443507533335e-08
in O 0 2.243470687002258e-10
the O 0 1.3362142503581254e-08
membranes O 0 8.19411383190527e-08
of O 0 6.907114169507622e-08
cardiomyocyte O 0 2.8876854685222497e-07
nuclei O 0 2.0648815279855626e-07
, O 0 1.6410357794871544e-10
it O 0 5.246996587215946e-11
was O 0 2.096505191673259e-09
absent O 0 4.677777276640427e-09
from O 0 7.231507614946509e-10
many O 0 5.874231101543614e-10
non O 0 2.2851658343370218e-08
- O 0 7.990017536485539e-09
myocyte O 0 3.4356393285861486e-08
cells O 0 9.075569185057475e-10
in O 0 2.2550883382876918e-10
the O 0 3.982179919148621e-09
heart O 0 2.6499289873527232e-08
. O 0 7.584461769738482e-08

This O 0 1.4133692827211775e-10
distribution O 0 8.724348354860467e-09
of O 0 1.8605998519660716e-08
emerin O 0 7.573895800305763e-06
was O 0 3.636932977002516e-09
similar O 0 1.4693682034994104e-11
to O 0 1.5311306042486983e-11
that O 0 1.6427291818499334e-11
of O 0 1.9949133456265145e-09
lamin O 0 7.220804718599538e-07
A O 0 4.813177270079905e-07
, O 0 2.1442693454165607e-10
a O 0 4.088495375587087e-10
candidate O 0 1.1028478130725716e-09
gene O 0 3.090310785047734e-10
for O 0 1.1194013493920352e-09
an O 0 3.714895058237744e-09
autosomal O 0 3.3997153536802216e-08
form O 0 1.2701966589645508e-08
of O 0 4.971910129825119e-06
EDMD B-Disease 1 1.0
. O 0 6.116410986578558e-06

In O 0 2.295860568324315e-08
contrast O 0 2.1841633213171008e-07
, O 0 1.6329412488857997e-08
lamin O 0 7.030097913229838e-05
B1 O 0 0.00015610108675900847
was O 0 9.103504226004588e-07
absent O 0 1.1961481504840776e-05
from O 0 1.6835803080539335e-06
cardiomyocyte O 0 1.7577029211679474e-05
nuclei O 0 6.310089702310506e-06
, O 0 2.2248074493802505e-09
showing O 0 1.018309969680331e-08
that O 0 2.0401342837317316e-09
lamin O 0 9.001478247228079e-06
B1 O 0 1.7263479321627528e-06
is O 0 7.106840810289228e-11
not O 0 1.5873724210080375e-11
essential O 0 2.271475091353281e-10
for O 0 9.766512598652355e-11
localization O 0 2.303080464116647e-07
of O 0 3.6311121220933273e-08
emerin O 0 9.246845706911699e-07
to O 0 1.5949439102769247e-08
the O 0 1.4005507864567335e-07
nuclear O 0 1.557416544528678e-05
lamina O 0 0.016440123319625854
. O 0 1.4148024547466775e-06

Lamin O 0 0.0015837738756090403
B1 O 0 0.00020598147239070386
is O 0 1.1925476606222674e-08
also O 0 1.8296230086534138e-09
almost O 0 4.157652888636676e-09
completely O 0 5.401340175126279e-08
absent O 0 5.270606493468222e-07
from O 0 3.104380397189743e-08
skeletal O 0 2.4035452952375636e-06
muscle O 0 6.749222052349069e-07
nuclei O 0 5.053476706962101e-05
. O 0 6.96118078735708e-08

In O 0 1.5631023586593074e-07
EDMD B-Disease 1 1.0
, O 0 2.7703167537751483e-10
the O 0 4.609055151427732e-11
additional O 0 1.5805845521299489e-10
absence O 0 3.79841154085625e-08
of O 0 5.779901357527706e-08
lamin O 0 8.006707503227517e-05
B1 O 0 3.6322504456620663e-05
from O 0 1.1596392823776114e-06
heart O 0 0.0044453926384449005
and O 0 8.830839215079322e-05
skeletal O 1 0.9999994039535522
muscle O 1 0.9922783374786377
nuclei O 1 0.9999998807907104
which O 0 1.5154984822629558e-08
already O 0 1.2128734683258813e-09
lack O 0 9.311554549640277e-08
emerin O 0 1.8497016753826756e-06
may O 0 1.6450950601765157e-09
offer O 0 8.101793680381775e-10
an O 0 4.6114032731248145e-11
alternative O 0 2.263069509567117e-09
explanation O 0 1.245094338742092e-08
of O 0 1.0681266537915235e-08
why O 0 4.289721466932406e-09
these O 0 4.221894389644376e-09
tissues O 0 9.690592328581715e-09
are O 0 4.4289799605579105e-10
particularly O 0 3.2997000687373657e-09
affected O 0 5.6068691911548285e-09
. O 0 3.0473554790688695e-09
. O 0 5.368831779151151e-08

Genetic O 0 2.671767340700626e-08
mapping O 0 1.93078797394719e-08
of O 0 7.808531599096113e-09
the O 0 7.2680448326423175e-09
copper B-Disease 0 7.027576884865994e-07
toxicosis I-Disease 0 5.183426310395589e-06
locus O 0 6.9192953588981254e-09
in O 0 2.500101903279983e-09
Bedlington O 0 1.3990762454341166e-05
terriers O 0 1.1077277122240048e-06
to O 0 2.5202919751166064e-09
dog O 0 1.4856534669149823e-08
chromosome O 0 3.874745413412484e-09
10 O 0 8.19132850438109e-09
, O 0 1.4078638428671741e-11
in O 0 1.3293840854522454e-11
a O 0 2.36331232361664e-10
region O 0 4.416429888465245e-09
syntenic O 0 1.37120792942369e-07
to O 0 5.567490357627491e-10
human O 0 4.766509409392938e-09
chromosome O 0 1.2348070299594838e-07
region O 0 1.5053298341172194e-07
2p13 O 0 1.8159694263886195e-06
- O 0 2.2672361410513986e-07
p16 O 0 5.736397952205152e-07
. O 0 5.032471506183356e-08

Abnormal O 1 1.0
hepatic B-Disease 1 1.0
copper I-Disease 0 0.0004890546551905572
accumulation I-Disease 0 6.222767842700705e-05
is O 0 5.3093935498127465e-11
recognized O 0 8.425909969744794e-11
as O 0 3.9834142928629745e-11
an O 0 2.143149130384714e-10
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 1.3833655332362582e-09
man O 0 5.050036389064871e-09
, O 0 6.515486761227152e-11
mouse O 0 1.942155769540932e-09
, O 0 6.129194374260294e-10
rat O 0 7.699856752196865e-09
and O 0 1.2550410710687743e-09
dog O 0 3.2365036872761266e-07
. O 0 5.399475071499182e-07

The O 0 2.662461584534981e-09
major O 0 2.0538122313951135e-08
cause O 0 0.0001255973766092211
of O 1 0.9997840523719788
hepatic B-Disease 1 1.0
copper I-Disease 1 0.999808132648468
accumulation I-Disease 1 0.9999998807907104
in O 0 1.1727276927331332e-07
man O 0 1.3471383226715261e-06
is O 0 1.7356115156186291e-10
a O 0 9.313341209349346e-10
dysfunctional O 0 6.628888371551511e-08
ATP7B O 0 2.8802680390072055e-05
gene O 0 1.0232844793733875e-08
, O 0 6.971392907395568e-10
causing O 0 4.2234990615952483e-08
Wilson B-Disease 0 1.1095455931808829e-07
disease I-Disease 0 0.0923677310347557
( O 0 1.50426711087448e-08
WD B-Disease 0 1.839306059991941e-05
) O 0 1.1941295063877533e-08
. O 0 1.410484458119754e-07

Mutations O 0 1.1458503195171943e-06
in O 0 3.5604930559429704e-08
the O 0 1.386163717143063e-07
ATP7B O 0 0.0003129157703369856
genes O 0 2.604510207504518e-08
have O 0 4.0949965640635355e-10
also O 0 5.6984729435161086e-11
been O 0 2.127382645045195e-11
demonstrated O 0 1.0770451197572584e-10
in O 0 1.3815876220846235e-10
mouse O 0 2.0496914387990728e-08
and O 0 2.359702477860992e-08
rat O 0 4.922762855130713e-07
. O 0 8.738525281160037e-08

The O 0 8.686749310982123e-07
ATP7B O 0 0.00029960920801386237
gene O 0 2.6236209649255215e-08
has O 0 2.071353089050376e-09
been O 0 2.5907190281948544e-10
excluded O 0 7.956889591653749e-10
in O 0 6.823428974622736e-12
the O 0 1.895427564901908e-11
much O 0 1.8771510387760593e-11
rarer O 0 4.956586607818281e-08
human O 0 4.882950932483254e-09
copper B-Disease 0 3.2938797289716604e-07
overload I-Disease 0 7.2364505285804626e-06
disease O 0 1.2736119288092596e-06
non B-Disease 0 4.1156868064717855e-06
- I-Disease 0 1.1392381082941938e-07
Indian I-Disease 0 6.594958468220113e-10
childhood I-Disease 0 1.3129935041433782e-06
cirrhosis I-Disease 0 0.007967308163642883
, O 0 7.739161395070582e-11
indicating O 0 3.3850451330863507e-09
genetic O 0 3.515865643066718e-08
heterogeneity O 0 9.713835424918216e-07
. O 0 1.366793753732054e-07

By O 0 1.7410291264230437e-10
investigating O 0 5.31681365600889e-10
the O 0 1.7749142433576282e-10
common O 0 3.8417184988759345e-09
autosomal O 1 0.9979583024978638
recessive O 1 0.999980092048645
copper B-Disease 1 0.862199068069458
toxicosis I-Disease 0 0.15750470757484436
( O 0 1.6366081823093737e-08
CT B-Disease 0 4.1742887333384715e-06
) O 0 5.1009710344551706e-11
in O 0 2.455985859128873e-09
Bedlington O 0 0.0008074535871855915
terriers O 0 0.007753702346235514
, O 0 3.5129816833290306e-09
we O 0 4.4123524278738557e-10
have O 0 1.179565299602725e-11
identified O 0 5.014211615361752e-11
a O 0 1.0253657298231467e-11
new O 0 1.6069664696138908e-11
locus O 0 3.1643423992200326e-11
involved O 0 2.1497761903965795e-11
in O 0 3.7689779075478214e-10
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 6.887933068355778e-08

We O 0 3.6343550391393364e-08
examined O 0 3.3481885708397385e-08
whether O 0 8.742634949321371e-10
the O 0 6.3519975945780516e-09
WD B-Disease 0 2.10417533708096e-06
gene O 0 2.524065507714113e-07
ATP7B O 1 1.0
was O 0 1.3810100085720478e-07
also O 0 1.7620391257189283e-10
causative O 0 2.1919199788555943e-09
for O 0 2.1195223354197879e-10
CT B-Disease 0 1.850347786103157e-07
by O 0 4.1697124919526374e-11
investigating O 0 9.926828248296715e-10
the O 0 4.519145058168306e-09
chromosomal O 0 1.2242399805018067e-07
co O 0 3.892495570312349e-08
- O 0 8.749478475067463e-09
localization O 0 1.1969781610332575e-07
of O 0 2.0949073586962186e-08
ATP7B O 0 7.574834398837993e-06
and O 0 1.0538512285052093e-09
C04107 O 0 3.669229542424546e-08
, O 0 2.464631970733322e-11
using O 0 4.295732606435232e-12
fluorescence O 0 1.2846637087449153e-09
in O 0 4.11151002133181e-10
situ O 0 3.983541674301705e-08
hybridization O 0 5.31627941668944e-09
( O 0 1.3988101787987262e-09
FISH O 0 2.8820286388508976e-06
) O 0 4.594235214483433e-09
. O 0 5.245713552426423e-08

C04107 O 0 0.00013111004955135286
is O 0 6.608737113111829e-09
an O 0 1.3582994728977837e-09
anonymous O 0 1.4492163025181526e-08
microsatellite O 0 3.2557221629758715e-07
marker O 0 3.8636929389213037e-07
closely O 0 3.20733164471676e-08
linked O 0 3.736492999451002e-07
to O 0 4.8486523240853785e-08
CT B-Disease 0 0.001040570787154138
. O 0 1.7262773610582371e-07

However O 0 9.79480319074355e-07
, O 0 1.0057213017944377e-07
BAC O 0 1.1813539458671585e-05
clones O 0 5.9278459474398915e-08
containing O 0 1.0824006579923662e-08
ATP7B O 0 2.009775380429346e-05
and O 0 3.9511810490111543e-10
C04107 O 0 7.418893233079871e-08
mapped O 0 2.4610220528131777e-09
to O 0 2.6926424978590546e-10
the O 0 3.920314739502828e-09
canine O 0 1.1693840207271933e-07
chromosome O 0 5.6342628340644296e-08
regions O 0 3.318826813369924e-08
CFA22q11 O 0 4.0098191789184057e-07
and O 0 8.119805272599478e-09
CFA10q26 O 0 9.23202549074631e-07
, O 0 7.993823936125466e-10
respectively O 0 2.4204009907435875e-09
, O 0 8.02428054558213e-11
demonstrating O 0 8.825921660182701e-10
that O 0 7.427140014115707e-10
WD B-Disease 0 4.4661490505859547e-07
cannot O 0 1.2007758343202113e-08
be O 0 6.079921899271312e-09
homologous O 0 4.990649227210042e-09
to O 0 8.856468980411591e-08
CT B-Disease 0 8.406928100157529e-05
. O 0 3.338496412652603e-07

The O 0 3.4747306472127093e-06
copper O 0 8.436714779236354e-06
transport O 0 3.5064638836956874e-07
genes O 0 2.4249081320704136e-07
CTR1 O 0 0.10366211086511612
and O 0 1.483439149296828e-08
CTR2 O 1 0.9999992847442627
were O 0 9.504717901620552e-09
also O 0 5.314289563962404e-10
excluded O 0 5.853877826922371e-09
as O 0 8.219276370624584e-10
candidate O 0 3.3783367214823556e-09
genes O 0 1.0081903090153332e-09
for O 0 8.192168610143824e-10
CT B-Disease 0 7.412966169795254e-07
since O 0 1.7213044323227678e-09
they O 0 1.684292844084112e-10
both O 0 1.830899737376157e-10
mapped O 0 4.316296653428253e-09
to O 0 5.234104816231877e-10
canine O 0 1.9426609298989206e-07
chromosome O 0 4.870183261118655e-07
region O 0 1.254475364476093e-06
CFA11q22 O 0 3.726245995494537e-05
. O 0 6.713580660289153e-07

2 O 0 8.318743311974686e-06
- O 0 1.0835128705366515e-06
22 O 0 1.7966436871574842e-06
. O 0 9.175694515306532e-08

5 O 0 3.753944838535972e-05
. O 0 1.204553655043128e-06

A O 0 1.1792677696575993e-06
transcribed O 0 2.2625096463002592e-08
sequence O 0 1.5744593406807894e-09
identified O 0 1.7485645154025065e-09
from O 0 1.2107471691891192e-09
the O 0 1.0349374690576951e-09
C04107 O 0 5.794358326483007e-09
- O 0 1.3866194303879809e-10
containing O 0 1.4075261789425753e-10
BAC O 0 7.624770148595417e-08
was O 0 3.2492539214779015e-10
found O 0 2.908129900086598e-12
to O 0 5.330435745576345e-12
be O 0 1.65875507773805e-11
homologous O 0 3.007762441886719e-11
to O 0 5.05032994591037e-11
a O 0 2.0174731329980489e-10
gene O 0 3.5707199419476865e-09
expressed O 0 6.2651834831228825e-09
from O 0 4.455298352468162e-09
human O 0 1.3431536993735449e-09
chromosome O 0 1.0325265975552611e-08
2p13 O 0 4.9671669444251165e-08
- O 0 1.2368142066065957e-09
p16 O 0 1.5952290599585695e-09
, O 0 2.5925997459985695e-12
a O 0 1.0361195408592483e-11
region O 0 2.9442767668363956e-10
devoid O 0 5.552775661499254e-08
of O 0 1.4552226090813747e-10
any O 0 4.225461092133287e-10
positional O 0 3.53045521706008e-07
candidate O 0 1.4965111176934442e-06
genes O 0 7.506873771490064e-07
. O 0 8.59820488585683e-07

Molecular O 0 6.760531690019889e-09
analysis O 0 1.2749606925765988e-09
of O 0 6.030974386561638e-09
the O 0 5.409740211348435e-09
APC B-Disease 0 4.191541336240334e-09
gene O 0 8.21776743875624e-11
in O 0 8.855375460692372e-11
205 O 0 1.2852194308798914e-10
families O 0 2.2007735911433457e-11
: O 0 3.800404435594373e-12
extended O 0 2.0515678045285313e-09
genotype O 0 1.3400938136953755e-08
- O 0 6.65577246650173e-08
phenotype O 0 1.9762811831469662e-08
correlations O 0 1.1460286941655795e-08
in O 0 2.637270124505875e-10
FAP B-Disease 0 1.2001576621401e-08
and O 0 3.352354635208221e-12
evidence O 0 6.922853262869566e-11
for O 0 5.271329379941125e-12
the O 0 1.7192758328121727e-10
role O 0 5.080640907983991e-10
of O 0 1.934179039153605e-08
APC B-Disease 0 9.311038695614116e-08
amino O 0 3.880316157278685e-08
acid O 0 3.432388817614651e-09
changes O 0 1.7761341286615107e-09
in O 0 7.036081228761759e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9999896287918091
. O 0 5.2846484521751336e-08

BACKGROUND O 0 4.8051660996861756e-05
/ O 0 3.0477906420856016e-07
AIMS O 0 1.5122652996524266e-07
The O 0 1.513792563523353e-10
development O 0 3.969871986697626e-09
of O 0 1.1221617413070817e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.065353313721041e-12
a O 0 5.039614558999261e-13
variable O 0 1.9568858686258572e-11
range O 0 7.259596136038882e-12
of O 0 3.059026773208351e-12
extracolonic O 0 2.5844684614639846e-08
manifestations O 0 2.923288491274434e-07
in O 0 1.314259279183716e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 8.350848901272911e-09
FAP B-Disease 0 7.537391155665318e-08
) O 0 2.011523109538005e-12
is O 0 2.6800797366978435e-13
the O 0 1.040154399244153e-12
result O 0 1.9665994527295894e-11
of O 0 9.657848132338387e-11
the O 0 4.3673148431011555e-10
dominant O 0 1.2189757399028167e-06
inheritance O 0 2.596795093268156e-05
of O 0 1.9856722701661056e-06
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 9.991874883041874e-09
APC B-Disease 0 1.2556354178627771e-08
) O 0 1.0568943636934947e-10
gene O 0 3.004537285633546e-09
mutations O 0 2.6618897663865937e-07
. O 0 1.3132373055668722e-07

In O 0 7.60544960343168e-09
this O 0 2.541176991055494e-10
study O 0 7.730192180810391e-11
, O 0 1.2868075745589569e-12
direct O 0 2.4288336966660218e-11
mutation O 0 1.221713702426186e-11
analysis O 0 2.7545819791807702e-11
of O 0 1.3833834078269547e-10
the O 0 1.0683623985485724e-09
APC B-Disease 0 2.3888602207478016e-09
gene O 0 1.0906876513061547e-09
was O 0 2.0735676287131355e-08
performed O 0 7.147755044095705e-12
to O 0 2.8891236625305794e-11
determine O 0 1.0760395907638554e-09
genotype O 0 1.7319822021022446e-08
- O 0 2.8086798664617163e-08
phenotype O 0 7.571811622142377e-09
correlations O 0 3.6236800227129606e-09
for O 0 1.1172656549929272e-10
nine O 0 8.180446542382924e-09
extracolonic O 0 4.254936811776133e-07
manifestations O 0 3.693686778660776e-08
and O 0 3.31124086483392e-11
to O 0 3.8606368102378497e-11
investigate O 0 5.670351410635988e-10
the O 0 1.0731597832602802e-09
incidence O 0 4.198676606392837e-07
of O 0 6.01231064933927e-09
APC B-Disease 0 1.1086528672876739e-07
mutations O 0 6.312819067488817e-08
in O 0 9.800147360294886e-09
non O 1 0.9999998807907104
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.889244837296246e-08

METHODS O 0 2.3805619093764108e-06
The O 0 4.250840035524561e-08
APC B-Disease 0 2.5981046647416406e-08
gene O 0 3.505344681187239e-09
was O 0 1.1144488887282478e-08
analysed O 0 1.308410824130135e-09
in O 0 7.157362896803576e-11
190 O 0 2.507628549253127e-09
unrelated O 0 8.591809930180716e-09
FAP B-Disease 0 8.034093212927473e-08
and O 0 2.0141818768415476e-10
15 O 0 1.6772768063333388e-08
non O 0 0.006681214552372694
- O 1 0.9852199554443359
FAP O 1 0.9999996423721313
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 7.014511194114448e-11
using O 0 6.169111662485127e-12
denaturing O 0 3.355188837872447e-08
gradient O 0 8.868703993414329e-09
gel O 0 2.0142829626479397e-09
electrophoresis O 0 2.3185922626289823e-10
, O 0 2.248824737538513e-11
the O 0 2.1065489630434087e-10
protein O 0 4.728423430577777e-09
truncation O 0 3.1506262043734523e-09
test O 0 1.296431573205581e-10
, O 0 2.1322260623790612e-10
and O 0 1.3943315946285395e-10
direct O 0 8.69176108864167e-09
sequencing O 0 3.028975825714042e-08
. O 0 1.4258674241318658e-07

RESULTS O 0 7.713639206485823e-05
Chain O 0 4.5455573172148434e-07
terminating O 0 2.3234514401337947e-07
signals O 0 4.884574522634466e-08
were O 0 2.1034814168263694e-10
only O 0 4.3570539537407527e-11
identified O 0 1.6961305970841778e-10
in O 0 9.448489733665522e-12
patients O 0 1.670693965116765e-11
belonging O 0 8.953097291319878e-11
to O 0 1.51338261367151e-10
the O 0 2.5418533056154047e-08
FAP B-Disease 0 7.44192220736295e-07
group O 0 1.2206666788472376e-09
( O 0 3.0464825107046067e-10
105 O 0 7.029199622365923e-08
patients O 0 1.4702219441886655e-09
) O 0 1.3509023899516137e-09
. O 0 1.0932608773828179e-07

Amino O 0 5.117663022247143e-07
acid O 0 9.39122557497285e-09
changes O 0 3.686630445365324e-10
were O 0 5.4924738368544723e-11
identified O 0 4.9657104816969166e-11
in O 0 6.880802351505455e-12
four O 0 2.455186011093846e-12
patients O 0 3.770052412616076e-12
, O 0 1.1800575707571204e-12
three O 0 1.0036670279600646e-11
of O 0 3.8176299455017215e-08
whom O 0 0.000254981656325981
belonged O 1 0.9275919198989868
to O 0 1.244006568867917e-07
the O 0 3.0409928513108753e-06
non O 0 1.4324588846648112e-05
- O 0 2.570556318914896e-07
FAP O 0 1.19348178486689e-05
group O 0 1.031170615561905e-08
of O 0 1.0407776471765828e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.00041305753984488547
. O 0 4.9677353786137246e-08

Genotype O 0 1.426178982910642e-06
- O 0 3.6794415336771635e-07
phenotype O 0 1.908228064451123e-08
correlations O 0 5.358261390142616e-09
identified O 0 1.5507881090393028e-10
significant O 0 2.0980561732386604e-10
differences O 0 3.1681002266026326e-10
in O 0 2.9666546996764964e-11
the O 0 9.489528607353748e-11
nature O 0 6.128130225491191e-10
of O 0 2.743959504059035e-10
certain O 0 4.105149109534523e-09
extracolonic O 0 1.7918388266480179e-06
manifestations O 0 3.7584289458436615e-08
in O 0 2.0273444034657473e-10
FAP B-Disease 0 1.7138230390401077e-08
patients O 0 1.5256908583727302e-11
belonging O 0 6.727569196174343e-11
to O 0 9.568736775156239e-11
three O 0 8.867837020254399e-10
mutation O 0 8.800630979521884e-08
subgroups O 0 1.3206373239427194e-07
. O 0 1.4213436827503756e-07

CONCLUSIONS O 0 1.2860448805440683e-05
Extended O 0 2.1356150625706505e-07
genotype O 0 9.11598263542146e-08
- O 0 5.0968743892099155e-08
phenotype O 0 2.57964192229565e-08
correlations O 0 1.306511254739462e-08
made O 0 2.5925925295489094e-10
in O 0 2.0218944574157405e-11
this O 0 1.7199375604293188e-11
study O 0 2.7307383784758166e-11
may O 0 5.54545402653428e-11
have O 0 4.2657453958039326e-11
the O 0 4.078362647597089e-10
potential O 0 2.0778980758251464e-09
to O 0 1.2083471723212114e-10
determine O 0 2.0875710049494955e-09
the O 0 8.107884363894868e-10
most O 0 1.569526314471048e-10
appropriate O 0 7.979260585599945e-10
surveillance O 0 1.230771040638956e-09
and O 0 2.4396809572557743e-10
prophylactic O 0 2.0654560728416982e-08
treatment O 0 6.347924963456819e-10
regimens O 0 2.1700088947973484e-10
for O 0 1.4303291190342904e-11
those O 0 2.1308398101549386e-10
patients O 0 1.4929352198933543e-10
with O 0 1.038390727570171e-11
mutations O 0 2.2433777058239457e-09
associated O 0 5.829807192547776e-10
with O 0 5.9750672291858375e-12
life O 0 6.031511956550162e-10
threatening O 0 7.730287521212631e-09
conditions O 0 3.891434019465123e-08
. O 0 9.617016871743544e-08

This O 0 7.955437197892934e-09
study O 0 9.277384971362324e-10
also O 0 9.188882293953426e-12
provided O 0 3.0067125872390577e-11
evidence O 0 3.119327018907825e-11
for O 0 2.0171017633963118e-12
the O 0 9.450153160006636e-11
pathological O 0 1.4766997935566906e-07
nature O 0 1.7090570736399968e-08
of O 0 1.75892473919248e-08
amino O 0 6.841762267839613e-09
acid O 0 3.560822470216607e-10
changes O 0 4.2442226816374884e-11
in O 0 3.770509460210292e-10
APC O 0 2.1269640271270873e-08
associated O 0 1.3025102774122388e-08
with O 0 4.288704669175303e-10
both O 0 3.0427382835540584e-09
FAP B-Disease 0 4.0562758840678725e-06
and O 0 9.900493758152606e-09
non O 1 0.9999719858169556
- O 1 0.9999963045120239
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 2.9199522799672195e-08
. O 0 3.167622830702044e-10
. O 0 3.503840551033477e-09

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 3.5988577451462334e-08
cancer B-Disease 0 2.839143417077139e-05
risk O 0 2.2448082503956357e-08
of O 0 3.023924932676891e-08
the O 0 2.989630232264062e-08
APC O 0 3.372885828412109e-07
I1307K O 0 1.9073588930496044e-07
polymorphism O 0 2.0679907564158384e-08
. O 0 4.697709243828285e-08

Germ O 0 1.8097724023391493e-05
- O 0 7.383571869468142e-07
line O 0 5.5814243893337334e-08
and O 0 4.333846823079135e-11
somatic O 0 1.5810234899049647e-08
truncating O 0 5.566898053643854e-09
mutations O 0 1.691263240566343e-09
of O 0 1.058072740534044e-09
the O 0 1.7799188789524578e-09
APC B-Disease 0 3.2322573506604613e-09
gene O 0 8.553120434129369e-10
are O 0 2.205556709489187e-10
thought O 0 3.1709415648784045e-10
to O 0 1.7757945114382778e-10
initiate O 0 5.011503745322443e-08
colorectal B-Disease 1 1.0
tumor I-Disease 0 9.324738130089827e-06
formation O 0 3.739223330967434e-08
in O 0 5.475639053287296e-09
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 2.576346247451511e-09
sporadic O 0 0.001168623799458146
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 1.128431126318219e-08
respectively O 0 7.219180275797044e-08
. O 0 1.2790538050921896e-07

Recently O 0 4.343660293670837e-07
, O 0 2.033898605091622e-09
an O 0 3.1337137329501275e-09
isoleucine O 0 7.293308357247952e-08
- O 0 4.498067696090402e-09
- O 0 1.2463678977781001e-08
> O 0 2.837594159643686e-09
lysine O 0 4.1986223386913935e-09
polymorphism O 0 2.875809312907762e-10
at O 0 4.425011190800632e-10
codon O 0 1.7930649187647418e-09
1307 O 0 2.1761328738989505e-08
( O 0 6.848152600547053e-11
I1307K O 0 1.078322675596155e-08
) O 0 1.218083967025052e-11
of O 0 5.201144515076805e-10
the O 0 2.882554417382721e-09
APC B-Disease 0 3.961589278844713e-09
gene O 0 1.5279726373051972e-09
has O 0 1.0061981248199459e-09
been O 0 1.608040367528929e-10
identified O 0 1.8592286044061268e-10
in O 0 5.333844824151335e-11
6 O 0 2.935340415177734e-09
% O 0 1.991505849119335e-10
- O 0 5.482949164137274e-11
7 O 0 4.2490927443239457e-10
% O 0 4.295579170143782e-11
of O 0 8.117504585181123e-11
the O 0 5.899123411978735e-10
Ashkenazi O 0 3.9948139241019476e-10
Jewish O 0 2.509121355132038e-09
population O 0 2.4910851159631875e-10
. O 0 5.470002228946669e-09

To O 0 1.8940597978911455e-09
assess O 0 2.1802460281605818e-08
the O 0 1.5112604501155147e-09
risk O 0 1.8592720696375409e-09
of O 0 1.618138123493651e-10
this O 0 1.687520435889045e-11
common O 0 5.035231676053797e-10
APC B-Disease 0 4.300258282796676e-08
allelic O 0 6.831749743696491e-08
variant O 0 6.860922496798594e-08
in O 0 4.0927517375166644e-08
colorectal O 1 1.0
carcinogenesis O 1 0.9999920129776001
, O 0 8.285215180592331e-09
we O 0 2.6984223744364044e-09
have O 0 1.707159275055048e-10
analyzed O 0 7.578483396386559e-10
a O 0 8.71509323041586e-11
large O 0 4.226613781188604e-10
cohort O 0 7.235526400251047e-09
of O 0 5.642669442806891e-09
unselected O 0 0.00012769938621204346
Ashkenazi O 0 3.064166662625212e-07
Jewish O 0 5.651024821418105e-07
subjects O 0 3.1406986522597435e-07
with O 0 4.276437870487371e-09
adenomatous B-Disease 0 1.8229831084681791e-06
polyps I-Disease 0 5.406565151133691e-07
and O 0 1.4605400222578169e-09
. O 0 4.242592055447858e-09
or O 0 0.0007350889500230551
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 4.52103736392484e-11
for O 0 4.399576536417982e-11
the O 0 5.46697753733838e-09
APC O 0 7.738346141650254e-08
I1307K O 0 1.0938636307855631e-07
polymorphism O 0 2.0765478225825973e-08
. O 0 8.906527426688626e-08

The O 0 2.523656519315409e-07
APC O 0 3.305567020106537e-07
I1307K O 0 1.3935226661487832e-07
allele O 0 3.6088090293873165e-09
was O 0 1.5900739613883275e-09
identified O 0 1.7419325704093325e-10
in O 0 7.132614637805901e-11
48 O 0 3.744302645714015e-09
( O 0 5.567975941422887e-11
10 O 0 3.4801808657114464e-10
. O 0 7.514886629644835e-11
1 O 0 2.7743420893955317e-09
% O 0 2.858659420290621e-10
) O 0 3.931721268002342e-12
of O 0 3.5767641626271995e-10
476 O 0 1.4723553931617062e-08
patients O 0 4.547644927299643e-09
. O 0 5.395008173536553e-08

Compared O 0 1.172827279738442e-09
with O 0 3.494731413977714e-12
the O 0 2.2590306361647272e-11
frequency O 0 3.647168678178048e-11
in O 0 2.1928782574509587e-12
two O 0 3.631685067690543e-13
separate O 0 7.21113977992377e-13
population O 0 3.692974745450606e-12
control O 0 2.218279900045861e-11
groups O 0 2.4408900248240606e-11
, O 0 3.8697631904449636e-11
the O 0 3.250514302166607e-09
APC O 0 4.189960378653268e-08
I1307K O 0 3.808204951383232e-08
allele O 0 1.1950083145251256e-09
is O 0 4.7021754545628625e-11
associated O 0 1.6029386151750202e-10
with O 0 2.7002410724064063e-12
an O 0 1.468555659023263e-11
estimated O 0 7.046506433905364e-11
relative O 0 7.713026661804179e-09
risk O 0 4.336885961464532e-09
of O 0 2.8423189135651228e-08
1 O 0 8.184068747141282e-07
. O 0 5.812048584630247e-07

5 O 0 8.992694347398356e-06
- O 0 3.9940834994922625e-07
1 O 0 8.232665322793764e-07
. O 0 9.36016704145004e-08

7 O 0 1.3889073215977987e-06
for O 0 3.3209165195557944e-08
colorectal B-Disease 1 1.0
neoplasia I-Disease 0 3.18300117214676e-05
( O 0 1.7671871077595824e-08
both O 0 4.1165677089338715e-08
P O 0 5.449600848805858e-06
= O 0 3.098092449249634e-08
. O 0 3.5888549909657286e-09
01 O 0 6.305766930836398e-08
) O 0 9.096591258028752e-10
. O 0 1.3692172728951846e-08

Furthermore O 0 7.040147806947061e-07
, O 0 3.755109556635716e-09
compared O 0 5.826341631376408e-09
with O 0 3.1922414711615943e-10
noncarriers O 0 5.5974223869270645e-06
, O 0 3.932132397466148e-09
APC O 0 4.111498341785591e-08
I1307K O 0 6.778158478937257e-08
carriers O 0 2.4835183909388547e-10
had O 0 6.971295762880914e-11
increased O 0 7.346266650554156e-11
numbers O 0 2.8740873569965686e-10
of O 0 4.83234474657479e-09
adenomas B-Disease 0 0.0018458983395248652
and O 0 2.4481112632201985e-05
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999018907546997
per O 0 1.6084866771848283e-08
patient O 0 8.117822858366708e-09
( O 0 6.085777992659303e-10
P O 0 5.993827016936848e-07
= O 0 1.1853001247175143e-08
. O 0 1.9387507155244066e-09
03 O 0 8.072166934880443e-09
) O 0 2.4061891368276633e-11
, O 0 3.720762933867583e-11
as O 0 1.5286219512411492e-10
well O 0 8.332639439556644e-11
as O 0 2.3012025618385223e-10
a O 0 1.4150316474115243e-09
younger O 0 3.2890611123548297e-07
age O 0 7.889924745541066e-06
at O 0 3.2114948567141255e-07
diagnosis O 0 1.0039443623099942e-06
. O 0 9.840065473554205e-08

We O 0 1.539722482846173e-08
conclude O 0 2.9128877088169247e-08
that O 0 1.4167431117151352e-10
the O 0 2.1650283787977287e-09
APC O 0 4.3115921499747856e-08
I1307K O 0 4.602534886544163e-08
variant O 0 2.3983622199352794e-08
leads O 0 8.368420623128259e-09
to O 0 1.0725970112090977e-09
increased O 0 2.9204153406681144e-07
adenoma B-Disease 1 1.0
formation O 0 1.7958967646336532e-07
and O 0 2.5155888483396893e-10
directly O 0 5.376614709007299e-10
contributes O 0 9.839470210826207e-11
to O 0 1.2730640326641396e-11
3 O 0 8.305700571753505e-10
% O 0 9.32336013947932e-11
- O 0 1.6796081886427672e-11
4 O 0 1.3956939770576327e-10
% O 0 1.017238723810543e-11
of O 0 1.2794685450012722e-11
all O 0 1.53182369566629e-10
Ashkenazi O 0 8.905644222068076e-08
Jewish O 0 0.0006835029926151037
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.2367280532998848e-07

The O 0 1.2079105715656624e-08
estimated O 0 6.497919979864264e-09
relative O 0 6.296536980698875e-08
risk O 0 2.1471475708523258e-09
for O 0 8.152012398454644e-11
carriers O 0 7.586379302537694e-10
may O 0 5.610814035605927e-10
justify O 0 2.480305072438682e-09
specific O 0 6.043868183702727e-10
clinical O 0 2.982644409232904e-10
screening O 0 1.3897589676292732e-11
for O 0 1.9495840705707757e-11
the O 0 4.5502976386835314e-10
360 O 0 4.989295643298419e-10
, O 0 1.4630702899198766e-11
000 O 0 5.888006193721651e-10
Americans O 0 3.69664125698943e-11
expected O 0 2.2053926740372987e-10
to O 0 2.9222335662382193e-10
harbor O 0 4.288962784926298e-08
this O 0 3.2890589557466043e-11
allele O 0 1.851486630677357e-09
, O 0 8.031078579939788e-11
and O 0 4.9024877907255515e-11
genetic O 0 1.485275097357075e-10
testing O 0 4.850513393717115e-11
in O 0 5.1134589618140325e-11
the O 0 8.059594103215773e-10
setting O 0 9.756727870069426e-09
of O 0 3.229732570275701e-08
long O 0 8.498372672249843e-09
- O 0 1.7846858213488304e-08
term O 0 3.682192684095753e-08
- O 0 6.201351876455874e-09
outcome O 0 5.346929121685662e-09
studies O 0 3.410486337784846e-10
may O 0 5.4650325931326904e-11
impact O 0 6.378902295267608e-09
significantly O 0 5.142035419680724e-08
on O 0 2.571051425093174e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 2.1405071048974378e-09
in O 0 6.518077635790653e-13
this O 0 1.6809661301797618e-12
population O 0 2.7592041498825104e-11
. O 0 2.796469278365521e-09

Localization O 0 3.145107712043682e-07
of O 0 2.731107073827843e-08
human O 0 1.3546754829008023e-08
BRCA1 O 0 1.2832714446631144e-07
and O 0 7.305580584926474e-10
its O 0 3.563159489683443e-10
loss O 0 3.5756337890546774e-09
in O 0 1.6369382516145947e-09
high O 0 1.2792268535122275e-05
- O 0 6.566471597579948e-07
grade O 0 1.6034347254390013e-06
, O 0 2.001691079556167e-08
non B-Disease 1 1.0
- I-Disease 1 1.0
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 6.224798653420294e-06

Although O 0 1.1083221007623933e-09
the O 0 4.191147151555441e-10
link O 0 1.3654409158903036e-08
between O 0 6.438136246345039e-09
the O 0 2.0179214743620832e-08
BRCA1 O 0 8.131538606903632e-07
tumour B-Disease 1 1.0
- O 0 1.8586064243208966e-08
suppressor O 0 3.16907033948155e-08
gene O 0 1.3657840414182942e-09
and O 0 4.2399546096305585e-09
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 1.9446668234057718e-11
established O 0 1.1587179132854786e-11
, O 0 4.558699880259642e-13
the O 0 2.8971857898851816e-11
role O 0 5.6978210344338365e-11
, O 0 8.124657197017271e-12
if O 0 2.2808296917808946e-11
any O 0 4.908665696135017e-10
, O 0 2.623853634364792e-10
of O 0 4.555805510619848e-09
BRCA1 O 0 1.6810024305868865e-07
in O 0 4.615158388787677e-08
non B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999992847442627
familial I-Disease 1 0.9996966123580933
cancers I-Disease 1 0.999993085861206
is O 0 2.1185817544733254e-09
unclear O 0 6.692511078654206e-08
. O 0 7.190116235733512e-08

BRCA1 O 0 2.3359787064691773e-06
mutations O 0 8.446068022749387e-08
are O 0 1.1287120543768125e-10
rare O 0 2.0990460480874162e-09
in O 0 1.1969153446145242e-09
sporadic B-Disease 0 7.47021886127186e-06
cancers I-Disease 0 7.053453737171367e-05
, O 0 6.489193210557076e-11
but O 0 4.4049000558210594e-11
loss O 0 6.617036696354717e-09
of O 0 1.3182791747112788e-07
BRCA1 O 0 4.2047471282558035e-08
resulting O 0 4.316889512523403e-09
from O 0 1.233901869568399e-09
reduced O 0 1.7177033129200936e-09
expression O 0 5.414506620837756e-10
or O 0 1.9377033311229752e-10
incorrect O 0 3.837631989966894e-09
subcellular O 0 1.938341682716782e-07
localization O 0 4.55309780988955e-08
is O 0 4.332047498500913e-10
postulated O 0 3.0835074937840545e-08
to O 0 7.925672340647338e-10
be O 0 6.232380167503493e-10
important O 0 3.850081142786621e-09
in O 0 3.386569247254556e-09
non B-Disease 0 0.00023210010840557516
- I-Disease 0 0.0014230282977223396
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 5.581806590271299e-07

Epigenetic O 0 6.706447311444208e-05
loss O 0 0.00012487059575505555
, O 0 2.358532391610879e-08
however O 0 9.810695367207245e-09
, O 0 1.3187928527003123e-10
has O 0 5.939728743575845e-12
not O 0 1.7042879694312285e-12
received O 0 6.46591738484581e-11
general O 0 2.429511591905964e-10
acceptance O 0 1.3925622877053456e-09
due O 0 5.154766058446114e-10
to O 0 3.719017455106055e-11
controversy O 0 5.326629692881113e-10
regarding O 0 1.1844880631883825e-09
the O 0 1.2888115019649149e-09
subcellular O 0 3.1062336347531527e-06
localization O 0 1.1488846212159842e-06
of O 0 4.711617975772242e-07
BRCA1 O 0 3.9439342458535975e-08
proteins O 0 4.0069649820395625e-09
, O 0 8.912462434729207e-11
reports O 0 1.0061445010478565e-09
of O 0 1.0089078461561485e-09
which O 0 4.628868469080949e-11
have O 0 3.658748651269583e-11
ranged O 0 1.2978183860923309e-08
from O 0 2.49504639171505e-10
exclusively O 0 2.874602778035751e-10
nuclear O 0 3.980334728481694e-09
, O 0 1.743667016329553e-11
to O 0 1.183629305678835e-10
conditionally O 0 3.81122555737079e-09
nuclear O 0 4.3377630376539855e-09
, O 0 2.2184533723934585e-11
to O 0 1.7373139038490137e-10
the O 0 2.5181405405305668e-08
ER O 0 2.8327585823717527e-06
/ O 0 2.0987465987332143e-08
golgi O 0 1.288136814991958e-07
, O 0 7.618759512162399e-10
to O 0 2.1016697271392104e-09
cytoplasmic O 0 1.0351383252782398e-06
invaginations O 0 1.3132728327036602e-06
into O 0 1.4793224423215179e-08
the O 0 3.3377062891304377e-08
nucleus O 0 2.5166771138174227e-06
. O 0 1.2787855041551666e-07

In O 0 1.4871098796831461e-09
an O 0 3.0176358634115275e-10
attempt O 0 6.167070742968406e-10
to O 0 1.5916906681567866e-10
resolve O 0 8.585531729998763e-10
this O 0 1.5768898686818744e-10
issue O 0 3.1090421348523023e-09
, O 0 5.367720712357027e-10
we O 0 1.6028905980292052e-09
have O 0 9.950599233476964e-10
comprehensively O 0 1.0312693632386072e-07
characterized O 0 2.630044271256793e-08
19 O 0 1.32368356275947e-07
anti O 0 4.259873520595647e-08
- O 0 4.903000103695376e-07
BRCA1 O 0 7.351743391836862e-08
antibodies O 0 2.3496600221051267e-08
. O 0 2.6649626505559354e-08

These O 0 2.5617747922979106e-08
reagents O 0 3.06865558741265e-07
detect O 0 1.1933190435797769e-08
a O 0 3.0044569054865633e-09
220 O 0 6.737643332144216e-09
- O 0 1.069622501681522e-09
kD O 0 1.1900452845381437e-09
protein O 0 1.1089347495829571e-10
localized O 0 8.808376944502427e-11
in O 0 9.815467666082767e-13
discrete O 0 9.446549098512946e-11
nuclear O 0 9.942100476223459e-10
foci O 0 5.3041077308080276e-08
in O 0 3.3311398084379107e-10
all O 0 3.5025557454382295e-10
epithelial O 0 1.8738983698085576e-08
cell O 0 8.632008530184976e-08
lines O 0 2.0717401127967605e-09
, O 0 2.3873398917462207e-12
including O 0 4.4135745405626814e-13
those O 0 4.3456006154629634e-11
derived O 0 1.7043369382463425e-08
from O 0 9.101648856812972e-08
breast B-Disease 0 2.1437253963085823e-06
malignancies I-Disease 0 1.695240257504338e-06
. O 0 1.5903788153082132e-07

Immunohistochemical O 0 1.5051164155011065e-05
staining O 0 1.0004787327488884e-06
of O 0 1.4893530853044012e-08
human O 0 4.197693748153597e-09
breast O 0 2.8637485272042795e-08
specimens O 0 5.788194812339498e-09
also O 0 3.3795083398402426e-10
revealed O 0 5.49040546360402e-09
BRCA1 O 0 1.4682531457310688e-07
nuclear O 0 1.1464806703997965e-07
foci O 0 3.648987558335648e-06
in O 0 9.300882730656213e-09
benign O 1 0.9999991655349731
breast O 0 0.0019592533353716135
, O 0 1.851635822447406e-08
invasive B-Disease 0 0.000810374622233212
lobular I-Disease 1 0.9999998807907104
cancers I-Disease 1 1.0
and O 0 0.0004381518519949168
low B-Disease 1 1.0
- I-Disease 1 1.0
grade I-Disease 1 1.0
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 2.0350156773929484e-05

Conversely O 0 6.261888643166458e-07
, O 0 1.237423585820352e-08
BRCA1 O 0 2.5338035669619785e-08
expression O 0 5.323351537356302e-09
was O 0 6.140137287502512e-09
reduced O 0 2.125389420015722e-09
or O 0 1.2753539890830723e-10
undetectable O 0 1.0613613321552862e-09
in O 0 2.3304452985428714e-12
the O 0 2.5527474231679115e-11
majority O 0 1.942301701418625e-11
of O 0 5.520564005934148e-09
high O 0 5.648191745422082e-06
- O 0 4.279065706214169e-06
grade O 0 1.3262275615488761e-06
, O 0 5.493121335575779e-08
ductal B-Disease 1 0.9987286925315857
carcinomas I-Disease 1 1.0
, O 0 3.284703620209939e-10
suggesting O 0 6.555328502244606e-10
that O 0 2.072339001790713e-11
absence O 0 3.4893698597215916e-08
of O 0 5.6747605725604444e-08
BRCA1 O 0 7.099234089480433e-09
may O 0 1.3269325915832297e-10
contribute O 0 5.2494689151139085e-11
to O 0 2.497077891683297e-11
the O 0 4.3907602553794334e-10
pathogenesis O 0 1.0210759882056664e-07
of O 0 4.7522884932815757e-11
a O 0 1.0278564457899542e-11
significant O 0 1.5502477079820665e-09
percentage O 0 2.523819944144634e-07
of O 0 1.3257758268991893e-07
sporadic B-Disease 1 0.9998373985290527
breast I-Disease 1 0.6494524478912354
cancers I-Disease 1 0.9999783039093018
. O 0 8.631415937543352e-08
. O 0 3.5444793411443243e-07

